<SEC-DOCUMENT>0000882095-20-000027.txt : 20201104
<SEC-HEADER>0000882095-20-000027.hdr.sgml : 20201104
<ACCEPTANCE-DATETIME>20201103191214
ACCESSION NUMBER:		0000882095-20-000027
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		80
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201104
DATE AS OF CHANGE:		20201103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILEAD SCIENCES INC
		CENTRAL INDEX KEY:			0000882095
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943047598
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19731
		FILM NUMBER:		201284815

	BUSINESS ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6505743000

	MAIL ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>gild-20200930.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:dd71f5ae-c8d4-497f-83ec-41f4a56b820c,g:fe07381a-9620-491b-af7b-d6c30510011c,d:9a5d0989150642c5998d2a345ad46d37--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:gild="http://www.gilead.com/20200930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>gild-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV80LTEtMS0xLTA_ec9db607-71a4-4138-aa66-985c69d835c2">0000882095</ix:nonNumeric><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV81LTEtMS0xLTA_e70d779a-2282-4416-b9bb-239a0f41570c">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV85LTEtMS0xLTA_769e61cf-1c17-42c3-b1c5-999e66b2ee21">2020</ix:nonNumeric><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV8xMC0xLTEtMS0w_247b3962-0099-46a3-803f-dfaabd59cb85">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV8xMy0xLTEtMS0w_a6b5fa77-9972-46ad-994c-60a2715567db">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gild-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="icc039174bd574d08b570f9adbabafac8_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i8428dd318d974b2db41a333de386ece2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic38a8d4d52c34caa8db328baf10699aa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83a2687827294d87a300d031d1858df3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia542ffe4c807464b9cb360eb9f6c08b4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4ab6f6260e54f569438ef8ea0ff6cd6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96064d1c8c184d5ab1297ec54cb44590_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf6dd01e1e2047839e25939a3ae0a70b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaad7749126c4b9a9ca4c44b1cff7a4f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6e106923dd4893989458d5e54fa96b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb48a35fba64fd59df61666f92213c4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e65980547d349c5a71d09c2359de137_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i535a6da229a34ac799fa2c08e368ed62_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e051c6d4e941d495baf35b525c1fcd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6832292dc744de38ecb457d6fa63dc1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b2c16973a1646478086092143c77e53_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40d55dade8445298ddf59323f025103_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93b18523ecf4d8cad1a70d4ca601e65_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28490f5280b24530b512cc82d79acf78_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id288e44f34634d5c93fb6b663e378514_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c997087db1f4d44953e502e4e51d968_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic20a282f852c4c7dbb87cc18035c48ad_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e1b216261147f0aa8922793f836cec_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92194d01f9f6426db2f230db32348009_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e35c67616af43299f00f59e19a5a18d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie738a97278064bb387639c4cf08d5982_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i697547cbd3024af6ab47310c99aecd30_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6761db60bfad4d1a83000fe1aa00c987_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i060edfd2f245412088dbd1d22a228e8c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1359c5ce919042c9b30bbb420ab9f586_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7a75396cae46eaa5a500fd466bed84_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i286718c980e742f3ad7ff5fa3cb8d52e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i204f0504916b49cda213142878d3d673_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib63cbbf9eb664b268663f0c27aa85f33_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i510270b913b147c08dd65ad6c95c2caa_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86be1800e75d42dcba0a3eb9a98551a3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic72dfa28da994e0a853f4aad7f2a6e63_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae5dc2210454fa58a3557195e59fdba_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ed0ecdfb5ae4e86a678c62132da6ab3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79bf3801a1984d3280d2a88a5644d5f3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc1677cc7c59497aa73455736d88394f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156fd24197fc427e8672e730ff2e10b0_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7ee747ba17a4a47a3ef814fd196e4fc_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0d3e46703834e0098456a41f5ef8be5_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecaaaabb21fa447299f1e341b4985cce_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea68edf9adb482a984d6a2f46ed8c18_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95de9d6ff3964391ab5aa52b050944f9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1572613d4ff74b2786f78674a86e1d1d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic66670c48dad4abbaf4a7e4afd0bfce3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d14e1d51864d97b88c87da0f398d28_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic339b862d834437592eff9f1aeb8752a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib374a36c14ac45c0817de5c423a7dc5c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8b0210f3494723826b5d6eaf202e5f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbf61511cccd4d31be2efc81754d695f_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i042635c737c840d7a0b0cc891e439e49_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c95cf4710d74cd08f24a559657ba257_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i110b9cc08563489b822c59613b540894_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>gild:segment</xbrli:measure></xbrli:unit><xbrli:context id="i405be8dac8594d43b53d27d487d15bf5_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic65b5d2d76914339a0bfc5c853141a8b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7a5f8acf2f948e68c92502a66bd5414_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c2c92fef300487ab03f8620479ac358_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1411829f6bb4060867b0218c7ad64ff_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bde0012620b4b358093fc1ee9a71f5b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaf48f8bb6d943c7b3230cf9b8f49d16_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecd2a02077434613a5f82bf83e672d63_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i772bad7600f04babbcf984bea94a0f49_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67a923c7fdeb42a1881b0f06f38a17b4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a2dea3e60a54f91bbd1ff13643e9957_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94bc6499871f430b883a5c26a9224567_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a11bdc34a1243b683eb633df7c23e11_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea294903d17f4240a785bf9497f358ee_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9e4bc40c0fc45b9ad367dc82a8b46e4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ac6788431d54ecea456ad29ab15114b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96beb5e6c9d64cd88a2b544fa0558012_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9d662f4b0514c71b93ab738ec761143_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37bf74c0f355430b8a23cd0b26f52891_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i316ef52a4bd846c592de38f7af36ea13_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d1ea3f49aa84699a8330b8beaf83836_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2c5c00fd5c74399b684e5b33b4ab1a6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bcba0865c9745c28ae1be5e32d30858_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2b5cdefab314e10af27865b284a261b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i020fa5bbe23148259e98dce5d3e6db76_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia983ed5089b04e17ba4a1f33f9b9848e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c69000ef95548fabbdc3b282e51e2e7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d4d5d7839e94505b43297794bc17592_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic966bee37fa6405b83576f4f740b30df_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45de8b04cd5245018515cdea5655f777_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2910166058884915a9bb2ea6a203d1a6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i855d34f7c7914eabb6d8012d1730432f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied0a00ea00d246fcb752c2b14624ed71_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c8efb370883401b83e55838b7fbc9d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76aeab63735947a3abc22f62baacab4e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2166e16f87b04a429939389261643a67_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac735e4f674431abdbc98a0e04572c0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c3f8e5e8d70429facde72a5fc634bb8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a121061085a43ea9ef1c9a36676b466_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie478e9e1575e48d9a95499553e51f752_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e5ccce04a2f4a5db1b5196399fa7842_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d3683aaebc3492eb3e2b434a9a15ec2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92538fca9ff2482dbc32c61c001b3ea3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4e3405a679d4587b527f12c3cd7f625_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b5fd963d3fe41aaaa285ed9bc365e62_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3144e9c3e72a42adade54c619991a43f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia145801994314a5d8116188b3b69b3ef_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied1a75b107a64c93a3d3f333c07064aa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10a2b8e40abd48c9b7742b2cf6099560_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b41aff3e0f4e9cb626769cea608d12_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd67b9aae7cb40cfbf1e3c78614f30ae_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2743ffe9c1a24dd78139e89db866b972_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ea9576cd9946a4891493d9dd47e7b3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a4fed8fd1443d5bedb3020421da791_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie08938975b3748498c8cc0261e8b436c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie14202ab77ae4a9686d66114ad05a515_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bc975ef1eb341ceadf0507525e9651c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc2b300cda84f6baa63c7b71950cdd1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a5b342cbe6442e48842c846ee6caf71_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0319161df99e404986d1aa33de8ba71e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c0926b30f1a498c81b6140b57053153_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2823fce1a4cf405a8b27b56aac04a3aa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e1c05c57e8343419f9bfde5e1395322_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc4539dbd004ec38a3c5475cd403514_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b237de69f3e4923ac93d5745b8e90d2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71725c2f0354f888e38d6f4ed36cfea_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i644c9ff59ab54478a13d8d84ac3ba4fb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9982b46a2fb427caa4de7e6521eb30c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdf79e96886d4938b1b1a211272ce1a7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cbd8e9ef0a944d486a151c6936fb75a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12ca1f1a0e024c22a8de469e578ba9fc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6086aba1234445049abb9c8cdd8e9f1c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaab34afd10054eefb1e8edd6dd4b0519_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie47edc1cfc9f4eb0a97fb226a0a5a37d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60af3f7f93b047d8ace0daf527ff4265_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92ecb2b4824649fc9f38af061f3b4ef7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ff3a03a206465aaa2896ba1ba6e120_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee22b1cffb1043bfbc54e365d26d4af5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d1453646ea740d890d612ac6873f4aa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dda27b4a5904907ad5d4a661c2c5d3a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bb31aa2cd1546fcbb6fc72d3d42b118_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dd3136d6efa4348a1c8cd540f898277_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35fb08a6be124efc91105a96329d32e9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b87c9b49b5b4c0ebe6fef12c1b938ed_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3221247bffcd4c4f96e064e12dc3ba2a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27dc9139c37245a49548419d47d24b75_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if979cf6c414f426db10c23f8e83a02ec_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1770394dbe848a9a641f08327a05206_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71a54848fe844a30bbbac60e370dcda0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ddf43c851594f2a8bf0c1f63f0ebf86_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4459d3bbac2644ae99e4b532e143767b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58865b745844ff890bb5f1166984a27_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09eff6286d14ec48d858094f19da7cd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4adf09430df24472bbed2f462ed4b1b9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8287111b10174ec98d26d3aa97917df0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f5c18c207ee433db038e9927f2ec41c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fdc0c20d21e46e39f5a774886ca08fa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2274275fb74059946345b7e79e2776_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i023e3c59b73b4c7f8d3da3030435d0c1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib73a8929861940e2a2c89e5e42452c04_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec2a016a7766464484ecbb334372727c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5582c730584d4002b1814d828c048d1f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dc774a64fa54549b0e01a1765162583_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d4379fd8b24c718b703229ff1bdb41_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1df27de735a2435fb01a652087a96fcd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dc70b538fbd4236be65e5c74b37b74c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae2a10921654f3e990c42a09a686fff_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5627a8aa26e48b8a494fc4c472f2e5e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0448ba338934e15a3d8c6bb32a0c7ec_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdce8cc1010a433d867e9991049ce48c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12865b7767774a1c981d8f35ee6a2976_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96870ee369b3451bb3e3ad1e5c6f0632_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8638be037d2a44e8a36d55221e058f60_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f1e832a84c4cb48a7cb31c748947ca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ead7edc72f24ce5915cebe08299ca44_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f7dc5506b3a434a8de2b4b60fdbdcf5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd8bed6771947af86f38ea8c65de78f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b267b50c2af4842a3de6c83f9b6ab45_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e0d8f0313da4158a72192a2602a6ee4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icacd2391f4764a14ab37c6a4543fc4fa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d18645d77f44dfe871bdfeab7f7edbf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieebbbb7c948845dca583fe54913d5e89_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaec3ebe00aaa45b2bed5ac91c8cccaaa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e56d52f566e45598878238694ba623c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b2c25650b44b69acccebcc55606d1f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9e3da549e244cfb2c9f5158ec401fd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i084c745c22464ce3a8fb3c8cebf5ed60_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d68e9a626743bda07e2eefb20fce19_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cc2d2384f34425b810bae675903dc8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e964e7db79a4ccd99b0c7be936bf507_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d58a4e6c2d84e70bc347ef87d4a87f7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046a86b5fdab4ff1b14916d76f73e510_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3e70ff742c140d496526d7b1527c3ce_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffb9eb566b2941829c54cd50ea568c38_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b5a4371abc747f3a1a8c3bd6ed8c486_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3084899d86f64538b7a6f2a33bbec0c8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600ed37165bd4db9ae547ea571cb7978_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i101ecfcaae0e4864b20047dbd8a3e1fd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i684803a0664e4bfcb6efc1517674d221_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icff41edc76614451b4b1bd6a03d7ae63_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i005d53c4c52c4720aeb394e3fbb50e7d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90b6f6af4c6542d191026032ce0f1df6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98bb9c7cfee24ac286f7fff99b0c0715_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57f1ffa20dec429da02ec0b008e998ef_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb3caa46f38f41edbc114ca92e65b04d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84113ab047d242869074a29c0fe984ff_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibebac49aadb9416897c8ab8c4cce79d7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i420f5df1a84346a6ac938d443c5e8a4c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic76dfe31026e42c694ebb48c2f5b658a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b8628d1ff0448278a92b391d45f5eae_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47125f71c9b44d7194c89e9640d482f3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39cdba108be14c79af8376028b06b4cf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eabf5693f71408c90d3d4cc46f5eb22_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398d207fdaaa461195fbeae21a779dd8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d38dfb8dc048e08df6eb090d1f549c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ad8ec3782bd4ea2a07fef27fa912cf0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i135bbf9df1b6455c9fa3dafbd8eb2d1c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c82e95c68504866bf36dd9d81d52cf9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe3be05bfa934699977eb8087f45d14f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i417780d1b25c4ca8b079ea42b721fc54_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ba2a1561ad4430842ec1db3b8257ed_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id254ad4a4ea547639bf93c052e3be138_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i720551245e854687876b7379d1f78d8e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife74578569994b51ae64ef03ce69c1ca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i766eabb290f046f2b9e62b6e3784b275_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a0e17ea897448e5912132a36ff6b28c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c060397c8742309b60bf12b6512021_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e84a4da6fad46a791ebe608e6ee198e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae5847663714779b1bf9154604a6df1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0803d3be2d04db0a4c0867464be9229_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c5b8dca94e743a398f30129643066bd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c39bb504ba14d2986890843ad30a9ef_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fd9a81e73348fa825cda04d1f6cb1e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d9ccdd2e0584f9095a5e2c1d8e8c353_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcae3cba7d164d41a999db4406d7e5b6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d19a5c115024a04beaf946d538fddb3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cc2465f59b5458abb466db3d7f8da8a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4558c2340efd4a3b900cf6ee1d86b0d2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc17d0d001d43998d445fb4be3e013c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0767d0f4ae47b39b6fd2f49267f647_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id85ae5108e3144a5a16efecd6144cfbb_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib43accb591714a6287366d5532b6fd0f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a8489222bf149abb359b6eea6f8bc61_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2645cba50844271a731aae129127e28_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e766da00a6e45ac94d46524fc6f1728_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i871689c0193846e98c4fedd49ddf8879_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia934aa3ae79b4bd5a663f8ac317ecba2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5abcb64ac3454f9b8c7088b53bbf545a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bd381436407454e84dd9a12523cff3d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad03c82878af430ca095a94ae4b7784a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb823a15d78b42bdbb60a26249e4c280_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i075da22059a446ea9056836364417160_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife78a8506d7c4d589c917a4f5d611434_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9bb7b9b91b746c9a6316ed3fbdf29ee_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b50ecf683a64f88a5112a6814698895_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10f2796e131745b49722c54e29dd1a14_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i540c328c3fd14b1bab1625ac3b70947b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4147a1bf6ed04df392a5e94f4d66f8ee_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b3c544ea4624677af1db8cc46d8ba43_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5390c9235c84fc5a5e7cfe2a469da26_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83641512c7304560a36b1a26f5a833c6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d94b806ce2c4380a472c5ded0a0d478_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8447af5ba87c40c0b94c057ccb036d8d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6fc0306b3664070b9024e4164bc3d18_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8053154621043638573e26bca07c8e2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab0b80da40d144dfb51e5296d491561d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c7bdbf4839341078ab571b1ade61e83_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id44c5b80cc3c4605ab9a62fddf9b0edd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9255844714024bfaa7176a097341eaf1_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id46c95e16d09481db3bbf57af272cc8f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcf44eb315184b4daea10d586af9bb99_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ba3f34d91ba4467a1b960bb57ff4f77_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icee191d2a7da42e5b2888a7142bc28e5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97761b52dc964ca1b75b02bb63e6f7e5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia53b54d337a5449196f847ce9e41479f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i750af09cffdf45b2aaa3f24e2a2098d3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e68305b0ec249bea1c290a603e685b2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a4a6615211c46d2927e8dca0a2062b9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bee71fa9ee64eeba4daeabec5940ac3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56bf813b0d4440c08a3e4699f552745b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i231be2fba64f4bf896c38f1aa81104f8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c573558c37477bacbe4f59e9970f84_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c61cbc63afb40c48e57d8fdca17c0a1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifee265db13f644ecbcffa4b46083b9c2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9e932ecab3d42f0bd2a802ca26cd95a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ed61a0e5644751a963832357838e7a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0740e92dc52c4649a9234a51ea22bc60_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ecb7cae048e406eb9a99e8d678c765b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0dfbec2369f4a4d84782aa2a96b2dd6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29f0cb97877c451f8d0410a288a7c508_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i742e3ac34dc14d3ca51197c0177e3a0e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7412e3583c694088b81933255ffe9b92_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i384483b6f05f451d8e772b8b5eebf9d2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9705c0a59c384067b58147f9968d335f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bde46834ced4ac9aca77149c77ff785_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i467448f2935c4949adb25f0dc29fd71d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c9b9f109374b3a9fd9b41bac8d04f6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4205c2046c4142803828d004750696_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a68dbfe80e344da8c9c590f8e88b515_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d9f10d767e14ff0996e4f9207bf98b8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8126adf8f45426599f7339d161fd9c6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3631587c26c450cae9fea5710c15b8f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34b59098d814cb0a08a98e99e0c60a9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i290b413904764919839f932725c8daaf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851f06a9af1042fcb2a409bbe3756a72_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i783ec34abc8144819c7e7d092ae11132_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic755c8fddb3d4084bf2b80625b08ea26_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805a20329e504fa2a33c2687c7ea5ea9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01577dfbd4f147ec828c3cc0fb9ebf13_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d0a27e691146369f40b9b33565966a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95eadaf94faf41fba9c79f5cb150e93d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc833249283042d5b7c62e05feb45290_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16e84af25770413aa8f9456d8ddc2e52_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied066108123545128f8dcb45a48c3bed_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c7cd5d5e7a442f48cb8b9feb0094fe1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbc1fa1c55740df98bd6134594b7219_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d87e9eb0a54aa08eedd0dd9ea5c4e3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb35282d4ad48f783dd0c11877ba0ec_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81dc6799abca4db8ab88cae7fa763d01_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727f0920e4f64f1880a2ebe8c13e3bcb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5fe7357a4c84db8bc7fca6f59f5bd47_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2bc28b56f8d48139043a74668f46dd4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe112c628c62494ab437ea9eeaebc991_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i852a43ddcd8046829ad1899671088c66_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a35be3874ab4149bb860d0946e69a81_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b92f07f2e0a47c3a983d243a98baf35_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc785f3b9046480faf38fea90b8c3023_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aebf9bb5c2346d6a0b7ca54d4d4eabc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9292897cc8904a42948da3e2971f4571_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e9ec444a5cd49f1bfcd9dd0820a2023_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9bc6d09aec41d184db3a49214b840f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i902da8b28069408a8c42b356a90a4950_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida2f089d53c447b199f1aa839ca1668e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia189ef02a42c4b41a97661844b973b00_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75e30ef252704139a8c49152c92d6fe5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb2e5ffe6574e3bb9835ef3ad021eba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10f7621603774791b39109ff98d0b462_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6876a3bead0430cab7025f3a176623c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1216dcb7f79948829a9e8c0013253508_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38621f45cc7c42abb0b3b65928e20ac1_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42a4279f407d406cb284cc2edc96ad1a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82688362eef04085b653508050f8f422_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1d0a82cc5d540e987b6673d38b892bd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia14da41d357c4519ad6e0f90343d204c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic97ad43f65774b7094b3a379df786172_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea3bf3186cb94890a8c57a6616584439_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45b3f782eb04b7e861b03896b46c351_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03eef6be4f4649c3a18607489e2d41fc_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82b54e6960b4405f8590d818220a3f95_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd48fdbbda9146a484254f1e767cc90c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i883550dc5b2e40a5bbb96599635c444b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bf480b492bf4fe09ebf0fc197965303_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9bb91712e39437b936294b2735c13d6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5b7f7113df4f099c265bb2954a56eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3484e902294670acc409da1ba4e0d4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2641a1a842544e209516e50ec96c27b0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6404156b2847f181b5d1bd7b274323_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i770bcef54ce64fe388b602f9e6584063_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dac5ce142294efdb06ad2c8c9ec3cea_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bc1d1479cd648439d07c37d2ab148bb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64b4d4435c8a4f83a0f27f31211068c5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85e0424cfa2f4e97b30415fd7e13e4f2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a3c4e259bef48d08c592ec5a9e88090_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79fdd8a2b3e147d395c164637e7427f9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0fee0ad1ea8468fa383b85fe7b7143b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d935f01a0e4ce7af8e635a7a172ab9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4eec3ec224342aba0682ca3a09c4082_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28996bf75474bb6b566e27bdb76a76d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i168a1ac690494b26a0ffda594222e1bf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4480c0b7198d4340abbdea40d9168391_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i255cdd4a6e2745f6b4c4695c024a26b5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i813e081e9063466a97d1059c75816be2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6244d0354fb04ecd8098b5e3bac74231_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b1edb8c2b0045c7973d66c486950a77_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if758b0a643444e158af4faf00dabffcb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e47efb0a051404592f124c05e259845_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43df52b49eec4fd985700ab74700f187_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12ecda589633462d9718e5074b78e1f6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if14a0f64631c43c587d9d721103ee2c3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i174b7d15e02f410b8f1d31ccdc7a13ff_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i844571eb2df140729ef8179477274f42_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28663efe02324a84b779525d9431c777_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15345e0a267842739752f2512f08855f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12734f9dde1a41feb3c30e72d478860c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic60ae20d01ab4ca884b6a676ad457b13_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f201861e937474292f64e97131f815c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41acb1f4c6d84c1c8cbda1fd11bba630_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea2acca92b854994b32a72c07a2aed73_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib95cfac35a9a4dfaa8213afe8cf1742a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide92661b1b6740029933d532260622e8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5d9b5844fdb44dca1c2ccd68053d3ab_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4924f62835d947d593de516d3eb5bd4b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b19822d0cfa438e89b18807a9cf9e85_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6bbfe6897734d888e60bf1689e0476a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7c3fa3e98e64124ab3a4e81c8b27cfb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffcf254dcfa549e8af3b55df2a518bb5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaef6b26552d46d1a943326e4f631348_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia091375d714a4af68c9a4c3286c57151_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i469fb002cdb84ed4a5287f8c3a0c82f0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie801464f2af24b6db9580bcc799e8ed0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e28ff274164fa5873e4f98ae0032eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a8067a5b7a4233a4795cf8b3a1e2de_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640acf012c444e8896d04840405bc26d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6189e39123304106b05d084b2f10f2eb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369c0f4c20b2434ab53ae12dfd9718fe_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0609460d710a44d795a4a5b9718c88ca_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2525996f7074ffe8fed7cbd90a965d4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46b971cbacba4ffcbe41b30a57c4ada5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cf5589198704a3a9eaf1b0b016c3346_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8a49d3ca5034dc399ac09438153fe99_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i074bdcf660fb4535964c4423fbe341ef_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c1ec0d72918417a956f0174b7d3c346_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1824caa947414b7096f32b2b67d14786_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a83c69b2be54c018955d99da45844b7_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe54791ae9241c4aa29ddeb88cf9d1e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i251385f2e42b4b1aa5d365acc3ea9c9c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b331bf063c54bfabd806c7596fc3c27_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ef2dad4ad2412486b5ea11f53023fa_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic98a59cc78974919ba762eeec3eb216d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i997559821d1a4a16a73dd88830cf5174_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ec3d326d4242959cc35197614e8409_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2af4b394c8b54e37830a1db47238b3ce_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2247de6dfc784a9b868f0819caf83870_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d6b25963e724b4e9173371c02a0efb8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d2cfbbe26ee4febb9b48574fd162233_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8060638d08784ee0a62d3f6ca7218aa3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63441ce40ba84fa7ba414d3c9f749407_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e8741122cb4adb92eba65068bc4aa2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92e99fb19404d699c9090195126fcbe_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i985de888cc224fff89bc3914c4f615ce_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6064ee7dedd34944b949c382cdd8cdbb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc19fdfb19b8400abf3317f7988947dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c2677c28fa40e08640a377bf09b729_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad7b65bb41c9454391dd5c4c5f30cdd3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87253831ae434b6c84a09a210ade93fd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70a1a73cd2a4d09bbcea125f90ccdb6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aaac2bc6875471f9ceeb394f6c3798e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1822fe145b174f858d3559312d4b8f07_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e63b6b02edb4668bfc3e4cf5963b880_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b020739eb14d59b3f71d4b1dbff8fa_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c3814004476430eb98633e8d57f0ec4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i581d05693e9a4a06b56980cfd2f297a6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida77997dde894ccf8cb1e4b0f492b8a3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia74680bc621445ff90e26deda6b247a0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c7d640e5a74988b2acbeca36e215a4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9ba585026444bda0371b5c9792d66c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f7edbbe0058498ba07f1c694f172ae5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae67afc268c481189809b0cb77b19b0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d15d27b4f1147e9a39d0edfa87476a6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib51bea2a549043ccb4d2d8b9b4e6f2fd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d4f1c22279841b1bc41d5c7af3e12f3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf756e786804feaac25586f0993f6ad_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0344ff608be498d82fb0639f25f1fbb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e4c86e2a164127b1e60622b100f769_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3351e615eb324ecfbe90c19cb5ed63af_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cabee79f5b442639e665379940075f6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2d001f2fdfb4dd69dbbf58a803cf0b1_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd52bba8c8b746ceb4390db580f35332_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a8e91519874ec798163966b238f366_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i493449153f79453f9dfe0eacaa0db3b2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id668da46343f4db6a7137fe89d885862_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6441f2721574eb2b066460bd0098a33_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea4251592be4a09bb586ecf7b0877b6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70cc122877ef421aa55fd71bb8bc36aa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92e9a07c98224bbaaaf8f40807d0e83c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i016620e60b0e45a2b86d94e4bedcd1d4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0f034dcaa0404585e485dfbb6d10e3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65f5244a5e8f4ed5b372521b97d023cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4ed4d70910c4494a6240e2ac85171eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cda5ed87da74c01ab8c6f23f4b7f768_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c6e23a89e1448f9ed6fbf3ca90c206_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd5b88ed58b34df29d8e5cad8f3c7ef6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibffb351639be43d6ba1030c106ff8eb8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74c7b09230e8405fb21eb18f3e0dfae7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb611e0fbed54ad5968a92550e95897b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75300f98c39f4d63a888fcd33da6f547_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifae90ac2d91e4170b23f8a6a66efc12f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b24cc4056cf47e784957e18bd3d8fef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08217eba7b4040989c8927514a8e4667_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic06f0fae2eba4968aaef1e5ccbb6b62c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899ff3da4637496c978fdba31ede1851_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f7cfa70f7d44abeb0a42230869dd083_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93f2ac2c6184cdc88f83b027e6b6987_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0205ea3174f84373ad0b7317fb14ee43_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2175ecdb247344f380a11e6cc2fff2c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8d2177f2e648dbbf9fb7e466067dd7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic455f28a60e74c3fb60fa85587a50d84_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3eca0222a334fe6a0daa4b5b8dab50f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c28da23233147d9b46404d8348cc986_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacec8636d81c4ccca6752cd4f9295732_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a82defc66745f690df80e8668e890c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2762aff7213c485a9bd438bb60c288d0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ed3d6b01754487a4a76050317ca559_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ddeab33a06c4acf87407a2dd4a0fa57_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb532ca82c864b69bcefe78f95dbff76_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba47020efd0947a3a230d76409764d71_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e91ec83eb244499df3127b2b341240_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45b5ab6cbfea4b5ba7e0e248c8955c25_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffbc3256a0924126aa99e6bbeadc7d47_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i346980582de5432fab397590fe91e43e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cc2a2681941419293fadf9296a83636_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98a2dbe200754e44ba989b4ac9964ff1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6341635988148b8ae35b14f5506e068_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia390b9822bae42bb96393b307440c66b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c74ca81b25645129c007d405131d946_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8446aa5e56ad47e4866b4ffd7bc9103d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i256bfd9c10a3491e8671599c334071c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ebfc4a0cc6a403fb9a858f1755f42fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb62bb7ec71e4bdab398215247c43327_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80339bdd09004325869ace1cd2d34105_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef34b5a375d4d90a234962b99965328_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06f736d48d424b4bb10af44ec2c200c5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80ed5764050847e49062635ab01cae21_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77e8c6f47d2041209000d04abb655b79_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6533f6ca1a8499c9911c6c29ec5e81d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92ae46288d7648bc98a7b52b5e2a2e94_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic990aad2d80c4f41a16acb8758ad9e39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7457789a3f89476fa8de57c200293d14_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7fb86f9d78a402a80e9cf34ac4e8cd6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49cf4dabb9324f5d8ca59ddfb2c21457_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f94575eafb6420daedc818f3fbaaf52_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96baf7453ec488d8b4ee4a49d5a698d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e53a276f8f04098947f2d530352c0c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2514dcd1744c42d99689f65cf992ea80_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ebf1e84f3954ab8a1cc2392c6e28569_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8598034c1a26461fb3d885c48a66e8ac_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3836c33667544e528fc4feb3ed36fc42_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5a034e702f740f381d179248d096442_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf34775baa8f4d23afc2547f765fed5d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie22107d806154b21b150e48b8ced2120_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i332100bf65a74c73b78f88558ca64905_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc3a038de51d492da6acb057be109969_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca554c2c1754c65b519605f1694f915_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16bea56fb72747d698df8fbf549baa95_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f9c716a8e98448eb4565f3e04a28ebf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2836e0ba225f4e40aaa8bf556a63e011_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4fd4965df6c4aba98b90509f6af2d11_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3680162306264834bb21711e1ff3044a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ecb4569c8314f7c8e009e95c3628aa7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343a612674094b2083c8d08bac298824_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if86851181e3a487098e2236460b2dada_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb6d3cfa89a44fc4b021c0457c085a5f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3fcb255d1824b2288a9ce395b9da146_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15165eda3c9345ff8f6ae2cebaafe873_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1832e7b713ea47d0a15518b89e0f27bb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9bf9c41df7549ccae89be301ed3f03b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia379b9e5e4e84e8b9e9aa4b43ba92bdf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife8fdfe82c0246158810b46b13c00e97_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1ef925d0d174ed992b1c8c45928db38_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bcbde7b6799451db4c9c818cfeead67_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93eadd341c934b73a3e6940d3f6413a4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic41b4012b457481dbffd93eb9153e360_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb5e4a50b9284e4d9af880ee03a84122_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia76f2122a7b7462cb1fc9f410f396ff4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9219113fc2d041d29935ac7469176613_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a61c55dc4b4663867980b24fdcb0a1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d1fdb77ea804ee193031561a281a198_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79bd59bb3d5a446c898736046871d68f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i202d8dd34b4048a6a70528355ccc07d7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aad028e1dd94922b809346982b70e6f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63529910aec24b4797650b819a035d38_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id95a598ab9ac4ba38343c2442e163984_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cf8f6a568ff4422830e566cac20c2b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973aae8a8cc74f1285d8fcfa96228c98_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f86e6b410fe461e99132bb73eb20f07_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f57c5401fe14752b2128178cf57b7b8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib076e25c99fb466c9bc9ec757f4c69ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fd39ebfac5e489099472ca928286c5d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152b037ec98d48b8b0f21c10881726a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab61524bb61c418da02f67470629315a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90378da552dd4d3397c49bfd840fcf32_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ed486534dc045088bf927345ba227e0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280f5420541248679b56a8d625ccd64a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i915f187c67784380afcab80212da1735_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44901ae9d576485b846e66590a5145bb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if908b69b55404379949b8cb6f1d24c00_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d2d59bc54514c03bb9fe2216e669758_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e30f2b68c584a1cae64f4692423ac60_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if077c28b2a3549009e4351063889daee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb967509b8d4595b980817e4efe72c4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0649099fa908450db840cbbb3e57fe0b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ac5e322d254b9da70701bbc22881e2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9901b9b6eb08420fbd35a1817088ca98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesNoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>gild:position</xbrli:measure></xbrli:unit><xbrli:context id="i885c8e3d7c564884960c80c8d85d08fd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a333aeeecec4ed9b2e05cc1f18eca61_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dd9abcdf6fa4e63ac008c910c2064e7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcad679966294ff2a2a4a7fce703e297_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if94c93bbf7284ee089c617ef366c010b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3441f3a2b4f440a8bc916049c259e00f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727aeb50823e469a9b8a9e02739b65d8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36e630b95ff54a039e3b28faf946f40d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69bdaf8a67d84555bf6582631022fc61_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i778d229a5af747b7afc0e73451dbaca6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41cf8059cc904b458c6aeb8f0e345448_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia63da40b12964679bd495e281370437e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3bada8f952b40819bd558e693f22b13_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48fffe834ce34e46a02a3296f02cfe58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i093f149708bc438285250a031a978d87_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fca64d1acd048958ee9a481adb0d0ab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25b6a29b0c8f4d5fae00186fc6544d94_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81637a074d1401ba756b4140e12c426_I20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gild:AssetAcquisitionAxis">gild:FortySevenIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71639a47b1bd4ad797ffe29d99a1a286_D20200407-20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gild:AssetAcquisitionAxis">gild:FortySevenIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-07</xbrli:startDate><xbrli:endDate>2020-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d546d74ae148b5a021eb383025f81b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="gild:AssetAcquisitionAxis">gild:FortySevenIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd56ba38aa8046bba054f36afeef99eb_D20200924-20200924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gild:ImmunomedicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-24</xbrli:startDate><xbrli:endDate>2020-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0f837e863ae43748f6f3d4be7b759a9_I20200924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gild:ImmunomedicsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8a8484ba93b4e959a292d7acd17712e_D20201023-20201023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-23</xbrli:startDate><xbrli:endDate>2020-10-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10ded791c9da4652a9c01c141f86a369_I20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-13</xbrli:startDate><xbrli:endDate>2020-07-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i578e5f2171814bedb8947beb0fec392b_I20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i052a9ab163094c12a8e0e749e1a27ad0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iae7c61328cd345d19182e7d8c3116c73_I20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3562638e6f29454e9b2073af015cfd17_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3d27c4b18e74db390be0856717db477_I20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:CommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-13</xbrli:startDate><xbrli:endDate>2020-07-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>gild:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i17375473d31a4fa98457488c706cd582_I20200619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i211cbe851f934c1b9e00538e84f893fc_D20200713-20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:PionyrMergerAndOptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-13</xbrli:startDate><xbrli:endDate>2020-07-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied8aaf6ee07c4c68b0c9d4a257521bf3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:PionyrMergerAndOptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i665e017e6d564f3f848b9735e5795f2f_I20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:PionyrMergerAndOptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2823e599701c40b09d1834198af15d61_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:ResearchAndDevelopmentServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5669c974fb37460591c74bfced921611_I20200713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:ResearchAndDevelopmentServiceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7c901a1a55647e6ba26816eb4351009_I20200717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib29eaffb63144ef9be056132abb82695_D20200825-20200825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:TizonaMergerAndOptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-25</xbrli:startDate><xbrli:endDate>2020-08-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabe5bc9211f04bfa9c594ba7cff3169b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:TizonaMergerAndOptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23962171ea454e2fa69a3ea748b90d4c_I20200825"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:TizonaMergerAndOptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8210403301349c7b8277961e43603dc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:DevelopmentAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TangoTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-17</xbrli:startDate><xbrli:endDate>2020-08-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6a49596afb64be2a40ce0133770c139_I20200817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">gild:TangoTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1c0da9b7b548618507b7b986013f51_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TangoTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="program"><xbrli:measure>gild:program</xbrli:measure></xbrli:unit><xbrli:context id="i291a141ad60a40e18d8e16c054569bd6_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:LicenseRegistrationRightsAndStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:JounceTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb7dec07426445a0b61fd7ee1c436ae5_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:LicenseRegistrationRightsAndStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">gild:JounceTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2051ed6e5a04c058e858df3aa244c5b_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:LicenseRegistrationRightsAndStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:JounceTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f8f334438e149d4bb54e84038e20f1c_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22eab18f188d4327810ed03862e4e414_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic68ebf48645046309e24289804996aac_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0c15f0a4bf24e5faedca42d6ccbed3f_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:GadetaBVCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b9f2307b7d494fb84ae4a2f95e61ff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:GadetaBVCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1624c0037f5a41c4bfefb2aab54ddab5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib97742c494394b88bc0725331e447507_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad7fd7f958c54653849a9d5ba294d69c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26766cda4c294fe982cb31efc05bed10_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecca81affd53498284282e31cecf32f7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:IntangibleAssetSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a84de8a34fb438289702707097480b8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:IntangibleAssetSofosbuvirMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0778e433874a438dd80bee8239dfb2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:AxicabtageneciloleucelDLBCLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f2eac9102cf4e899ccdac8659d5f711_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:AxicabtageneciloleucelDLBCLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1024af71b9a45278ffccef5760b5fe2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8e66ce2fe3440d99f60869474e8fd99_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0440dbc560c34febb8b14b9e45c4454d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i957437a2c5fb481fbc92c780ca815df7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3160daa24dd5457a91283b0e02bb2b28_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A235SeniorUnsecuredNotesDueFebruary2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b3518888b6449e28a4dd8a1ebb01448_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A235SeniorUnsecuredNotesDueFebruary2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c5233e0d1e34dc1b9b616c2b9958ae9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A255SeniorUnsecuredNotesDueSeptember2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i323f9eee9390464fb82fbcab9d0a9a54_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A255SeniorUnsecuredNotesDueSeptember2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bd2f1324bbe4577aaaa0b02e886a09d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueApril2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f678f93d81402b94b3fe583ae53808_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueApril2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i076a134b65754ba59bc1587c4dba35f0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78b6a868c97f4d47b86b691b5a97102c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5c939d7a664dbcaa1fe8a25b93b1e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cfd9d16d0134db083a80208f18fb127_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A440SeniorUnsecuredNotesDueDecember2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b49b10ace4044ddb35f895db112ee9b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A440SeniorUnsecuredNotesDueDecember2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f3d085128dc47ddbc2b7e8c7b158013_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A195SeniorUnsecuredNotesDueMarch2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i943f74870a1242a68086cfeba9802e0e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A195SeniorUnsecuredNotesDueMarch2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7115ef027e1437da78e8c0e4770de11_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A325SeniorUnsecuredNotesDueSeptember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4445c6b7b641c6ac7e8571db780c2e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A325SeniorUnsecuredNotesDueSeptember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice6ce99e645641b1b447d7873df500b8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A250SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i034bc53776884c94ae8a3268988a8403_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A250SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa3287ce6d5c46038d6d90283ff80eeb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i024047c0ec56431f91c17a86fae8c5fc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb855db743fc4e4d8bfeb913a9465b4b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A075SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1740f93795744755a3ee51a0609192ff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A075SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f786cdbfbe4e19a3f79eb22d33def6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A370SeniorUnsecuredNotesDueApril2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830b9fd58a46421ca2f14073652a8b07_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A370SeniorUnsecuredNotesDueApril2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69184deceb83472e87a54770bd526907_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A350SeniorUnsecuredNotesDueFebruary2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib08649fd40b64b78a3ac992ce45ffe51_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A350SeniorUnsecuredNotesDueFebruary2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db367e747ab469885d1e740050763a3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A365SeniorUnsecuredNotesDueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9037d73ce3734b9781f89c898abc8331_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A365SeniorUnsecuredNotesDueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i819d350aa46949b1927defb662d03b4a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A295SeniorUnsecuredNotesDueMarch2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9543cb5e44cf49dc9f987a6ce144eb4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A295SeniorUnsecuredNotesDueMarch2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e503faf08b4182b4ae149c600e7779_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A120SeniorUnsecuredNotesDueOctober2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a72c53bb76412d862e75ceca21ea29_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A120SeniorUnsecuredNotesDueOctober2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f72724ee7414879a83048bd3532f197_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A165SeniorUnsecuredNotesDueOctober2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if172b80ce0344955a3bae899f1aef873_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A165SeniorUnsecuredNotesDueOctober2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27ddc1e9a89a48ae9793e4c7f3c3ee5e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A460SeniorUnsecuredNotesDueSeptember2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc4618a73204298852a45480a01610f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A460SeniorUnsecuredNotesDueSeptember2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie746e67ba8d64af0b6434070b1135780_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A400SeniorUnsecuredNotesDueSeptember2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i917d5ae043a6482ea2fe51d188f57fdd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A400SeniorUnsecuredNotesDueSeptember2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f741e6d070e4fe882119870d1184cef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A260SeniorUnsecuredNotesDueOctober2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie29e93986f134ebcadfa3bf09afe5797_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A260SeniorUnsecuredNotesDueOctober2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfec6ce2d495407e91872cb50eb1d277_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A565SeniorUnsecuredNotesDueDecember2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie65e28716f114e31bb0b12b21ca5d7b3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A565SeniorUnsecuredNotesDueDecember2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i916f791cc0b141c9acf5ce3bcf4af863_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A480SeniorUnsecuredNotesDueApril2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i516c59fe4fdb420fa10752e3f879ee6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A480SeniorUnsecuredNotesDueApril2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8ad038d121413794732443f43b0dd4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueFebruary2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id493a8861f6f49eebbc2bfe998aabff2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueFebruary2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i924d914a188c41fabc11cc7f15cdc373_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A475SeniorUnsecuredNotesDueMarch2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f55700d855e42528ccc24cdf5849a69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A475SeniorUnsecuredNotesDueMarch2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04dd812e93aa44c9a770b8e0110ad89d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A415SeniorUnsecuredNotesDueMarch2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffee9b8a237845ffb486442200c4c758_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A415SeniorUnsecuredNotesDueMarch2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A280SeniorUnsecuredNotesDueOctober2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic09bf1bed99a4abc8990ec17f2674ada_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A280SeniorUnsecuredNotesDueOctober2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i732e6064e491434f97f7abba277ffc08_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff2cdfdf7c743e5a3c192c472818845_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6942d430090747b99d43a27db7846096_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A075SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d133b8c794a496097f8802c3cee3c74_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A120SeniorUnsecuredNotesDueOctober2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia93111f675b84d0185cffe796ba9ad0f_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A165SeniorUnsecuredNotesDueOctober2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0af1b61d1bd24f02bcf41645b802cfef_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A260SeniorUnsecuredNotesDueOctober2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib35e51d4a6e5413d804346c20c4d645d_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A280SeniorUnsecuredNotesDueOctober2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2873f7c29354cc8a00cc6b3eadad4b9_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i332b81acd0e34cb68ce82c944141e308_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f98f733a534405a4a7aceadcbae8db_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifebe1e104a53429d9f4985f21acfcf6f_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c112e7007ab4912b6828d7439e90eed_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedNovember2014Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if350b42852dd44f48da9f53e1b8ff9e9_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedSeptember2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id43f9dfea2c7418cb87a1a84ccc9a37e_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66ad83bd55674a5489ec01dc33324735_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05c93da51a924b19ae6284b9a552e965_I20201023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bfe479f1cd340f3a96f534ba41654ad_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:CreditFacilityDueMay2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i345776f175ba45628e7886736d46d225_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:CreditFacilityDueJune2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda8f675af864a82a9abe9b9a27454d7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c8da64f2584082a30059c2ef0db569_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadae1c7466ea41e990dd30ccf69b5887_D20161201-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:IndenixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib20b3c03bc154daba1331e8af30fdb76_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:IndenixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375f4aa83089473d80f0894376a87131_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9e6e8a3097447b8a5306434ceee570_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81637e03a86945a093db345c6214f5d9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7181038d12c4972b2d35c23670305e2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61fb468d46454c35be375b3bf645c786_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>gild:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i83dbde55d11d4cca843046da3156ede0_I20160128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e803091b7ae47a28cf31980b4e75241_I20200129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2020StockRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f8986f71eb946ce91a3ac37191c811a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c72d335e955423da6fa2cc5ce0ca6a9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f6d71b9595c455b91d1695466faaa46_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c5133b40b7348ee9a886cf367a8c92a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i126913deb985494cbae4e16c0eefaaa0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31e50be0c1b8444dac6878e054031f95_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92120c1df08941c0baa875930620ab7b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c2d992fc41144e698540022573aae90_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa15a6a2044f4dffbdd84d9bd4107466_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87bf3701a61048ce98060b964e89b9d6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ea6d768f5a439a8c7671f8e1b2734e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i931ba07aa5b84693bb30002c9e25ba8f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9ff79601b7441a89cc4803200d5db3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21170d6027749b8ac405fbc5d0c14f3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i032461dad5024966ae092159c3844bbf_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5caf79123df745c29fab67273cf54adf_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i646702f3b9c14ffda1e398222e462a80_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27914e2a7fbd4b0dbcc730cd7b58c33c_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia16228b8cf344fd0b17a751f84856174_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9a5d0989150642c5998d2a345ad46d37_1"></div><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV84OQ_97285032-48b3-4745-a951-b611c009a14d">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6MGJlZTdlODNmMWNmNGU4NDhkMTUwM2UzNTBiOGJjNjgvdGFibGVyYW5nZTowYmVlN2U4M2YxY2Y0ZTg0OGQxNTAzZTM1MGI4YmM2OF8wLTAtMS0xLTA_0f453487-1599-4987-bd51-8e909531cab2">&#9746;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8xMTA_034e27d6-752a-4e19-869d-4e5b4ab397a5">September 30, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6N2UxY2YxNmEzNWJkNGRjMzk0NzEyNDBiYjc1M2M1OWUvdGFibGVyYW5nZTo3ZTFjZjE2YTM1YmQ0ZGMzOTQ3MTI0MGJiNzUzYzU5ZV8wLTAtMS0xLTA_40bc0dd6-f9aa-4ed3-bbcc-a5590368dd19">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     For the transition period from ________ to ________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No. <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8xOTg_35b2b8f4-6e18-4fe6-bf9d-0cc51bd984d2">0-19731</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMDY_1aa4a7db-d17e-4069-9ca6-4f1b4e7dc69c">GILEAD SCIENCES, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6MTUwN2JmODA0MjYwNGVmZGFjZThiZTk4MzM3OGJiMzUvdGFibGVyYW5nZToxNTA3YmY4MDQyNjA0ZWZkYWNlOGJlOTgzMzc4YmIzNV8wLTAtMS0xLTA_3f62fc65-9ef8-4843-b2ea-788bf95021c0">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6MTUwN2JmODA0MjYwNGVmZGFjZThiZTk4MzM3OGJiMzUvdGFibGVyYW5nZToxNTA3YmY4MDQyNjA0ZWZkYWNlOGJlOTgzMzc4YmIzNV8wLTEtMS0xLTA_29284353-c690-444a-826c-f68fbefde984">94-3047598</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yNzI_9b1589dd-9b71-4e45-b471-49dd308ee457">333 Lakeside Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yNzY_3f357da2-3d51-476c-a085-36e1a11d3e1e">Foster City</ix:nonNumeric>, <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yODA_db5f1d98-ec21-473f-ae65-d5366dd02249">California</ix:nonNumeric> <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yODM_6845189f-1ebb-4916-a3d1-5c1919a92c8a">94404</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8zMzk_1a29947b-2352-4d05-ab15-6428fd117460">650</ix:nonNumeric>-<ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8zNDI_c9ebdc4d-fe1e-43ed-9547-d7902f856b99">574-3000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6YmM3MDQ1ODQ2Zjk5NGEzNjlkOGIzYTVmZTAwYWUzMWYvdGFibGVyYW5nZTpiYzcwNDU4NDZmOTk0YTM2OWQ4YjNhNWZlMDBhZTMxZl8xLTAtMS0xLTA_cbfa6402-425a-4e6a-9ce8-e896beae3c0b">Common Stock, par value, $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6YmM3MDQ1ODQ2Zjk5NGEzNjlkOGIzYTVmZTAwYWUzMWYvdGFibGVyYW5nZTpiYzcwNDU4NDZmOTk0YTM2OWQ4YjNhNWZlMDBhZTMxZl8xLTItMS0xLTA_36eadad2-aacb-4b19-a5d0-cf7d498b4ab3">GILD</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6YmM3MDQ1ODQ2Zjk5NGEzNjlkOGIzYTVmZTAwYWUzMWYvdGFibGVyYW5nZTpiYzcwNDU4NDZmOTk0YTM2OWQ4YjNhNWZlMDBhZTMxZl8xLTQtMS0xLTA_e5cc5408-9c40-4ecb-ae0f-85cbad01858a">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV84MTI_0395088d-0b1f-4461-89be-0a7751821348">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant&#160;has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8xMTMx_24f03407-1a95-45a0-96c1-7c43596ced0a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTEx_6a0bb4bf-be0a-45b6-8b58-c6e1b85e160c">Large accelerated filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated&#160;filer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller&#160;reporting&#160;company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTEy_fc0a141c-4a84-46d2-afef-164ac00beaab">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTA5_3b7457ef-ab31-45aa-abe9-4758485636e3">&#9744;</ix:nonNumeric></span></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTEw_427affc5-df53-4fb7-8429-8f3a7000f790">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of shares outstanding of the issuer&#8217;s common stock, par value $0.001 per share, as of October 30, 2020: <ix:nonFraction unitRef="shares" contextRef="icc039174bd574d08b570f9adbabafac8_I20201030" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTA0_f2d627ff-51ca-4612-be55-de0171eb3db5">1,253,528,149</ix:nonFraction></span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GILEAD SCIENCES, INC.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;I.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_10">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_10">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_13">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_13">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_16">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_16">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_16"> 30, 2020 and December 31, 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_16">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_19">Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_19">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_22">Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_22">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_22"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_22"> 30, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_22">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_25">Condensed Consolidated Statements of Stockholders&#8217; Equity for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_25"> 30, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_25">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_28">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_28"> 30, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_28">7</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_31">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_31">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_73">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_94">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_94">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_97">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_97">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;II.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_100">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_100">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_103">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_103">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_106">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_106">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_109">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_109">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_112">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_112">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_115">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_115">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_118">Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_118">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_121">Exhibits</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_121">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_127">SIGNATURES</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9a5d0989150642c5998d2a345ad46d37_127">53</a></span></div></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We own or have rights to various trademarks, copyrights and trade names used in our business, including the following: GILEAD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, GILEAD SCIENCES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, AMBISOME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, ATRIPLA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, BIKTARVY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, CAYSTON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, COMPLERA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, DESCOVY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, DESCOVY FOR PREP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, EMTRIVA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, EPCLUSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, EVIPLERA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, GENVOYA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, HARVONI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, HEPSERA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, JYSELECA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, LETAIRIS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, ODEFSEY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, RANEXA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, SOVALDI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, STRIBILD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, TECARTUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, TRODELVY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, TRUVADA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, TRUVADA FOR PREP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, TYBOST</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, VEKLURY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, VEMLIDY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, VIREAD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, VOSEVI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, YESCARTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and ZYDELIG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This report also includes other trademarks, service marks and trade names of other companies.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I.&#160;&#160;&#160;&#160;FINANCIAL INFORMATION</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_13"></div><div style="margin-top:16.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_16"></div><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GILEAD SCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMy0xLTEtMS0w_cf3038fe-66fc-4ab2-84e1-be918cab3e14">12,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMy0zLTEtMS0w_97278762-b9a4-45f5-a0d5-f7eb6b5984b0">11,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNC0xLTEtMS0w_c410f611-ba73-487f-8cf8-727fe154da86">11,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNC0zLTEtMS0w_eb102ee9-f9fa-404a-b152-280441291e66">12,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="gild:AllowanceforAccountsReceivableandChargebacks" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0wLTEtMS0wL3RleHRyZWdpb246NTQxYWE4YjNjN2FhNDFmMTk0NDU4MTk4MjYwMGE1Y2NfNDc_eea7ea22-2a85-4898-b545-e026e4eb06fe">714</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="gild:AllowanceforAccountsReceivableandChargebacks" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0wLTEtMS0wL3RleHRyZWdpb246NTQxYWE4YjNjN2FhNDFmMTk0NDU4MTk4MjYwMGE1Y2NfNTQ_2fdfc3f7-8572-454e-ac96-265aa7fbc965">758</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0xLTEtMS0w_70a6d1bb-4065-436a-ada7-88ad32f827ef">3,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0zLTEtMS0w_856b9892-7a48-4544-b7f3-c69a634043db">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNi0xLTEtMS0w_b3c0c200-aa69-4ad7-b5e0-d2f5ca8f66ef">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNi0zLTEtMS0w_40b354c7-c91e-410b-af7b-50ea9d59be66">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNy0xLTEtMS0w_46e49806-1989-42ac-a049-0368827b70f0">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNy0zLTEtMS0w_4a8de30b-3432-4822-8573-28c5a1cfec82">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOC0xLTEtMS0w_836e8251-28ad-424e-b72e-4bb723e463b6">30,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOC0zLTEtMS0w_473df3a4-421b-4934-af0e-24f4441f4eba">30,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOS0xLTEtMS0w_0194ed65-11e8-4d99-bf90-dfb77a2e992a">4,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOS0zLTEtMS0w_2d9d947e-f1b4-4320-ac7b-cf4fdc37dbcb">4,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTAtMS0xLTEtMA_7c94a7c8-fdd4-49c8-bbe1-2d0c54897dad">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTAtMy0xLTEtMA_d5238a0a-dda6-48c2-ae3d-c314454649d2">1,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTEtMS0xLTEtMA_8dd4112f-2000-4fb5-b2a0-121ab7c3f714">12,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTEtMy0xLTEtMA_876ef9df-5d49-4664-b8d7-3850216496c4">13,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTItMS0xLTEtMA_12c00dc5-3c92-4ce8-85fc-d39ffcf3553e">4,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTItMy0xLTEtMA_1671b4fc-f5c2-4752-92e1-d3ad6a489bbf">4,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTMtMS0xLTEtMA_003dd1c6-1199-419f-adc5-8c03ce2a8776">6,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTMtMy0xLTEtMA_0fe195dd-ee68-4ea4-b37a-798ed0ccc9ba">7,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTQtMS0xLTEtMA_ac1d493b-b0e0-4452-b105-2a87110ebb6b">60,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTQtMy0xLTEtMA_53b3b915-73e8-4aae-8d93-b6d31859fb93">61,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTctMS0xLTEtMA_1e4652e7-1285-45fd-847c-94bd689e47d1">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTctMy0xLTEtMA_725aac1c-eff7-4287-91ec-0d4283dd4e5c">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued government and other rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:Accruedgovernmentandotherrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTgtMS0xLTEtMA_ed6d3c4d-0d0c-4d88-b526-ae2d6d6956a5">3,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="gild:Accruedgovernmentandotherrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTgtMy0xLTEtMA_b60aadb4-d9f9-404c-8543-47b571ca3981">3,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTktMS0xLTEtMA_3aebf34d-bb28-4153-b30d-1a7d288c4fb4">4,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTktMy0xLTEtMA_09767e70-3188-40db-a078-e6343aac3c2f">3,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjAtMS0xLTEtMA_b7f212a6-9be6-4fe9-bf9c-231dcac8214a">1,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjAtMy0xLTEtMA_5b6355bc-6306-44ca-9e1d-7f62d556a4d3">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjEtMS0xLTEtMA_b98f70b9-ba21-4aaa-a5ce-6f5b378b0074">9,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjEtMy0xLTEtMA_9ff7ab75-dd34-45ca-bd8b-5e3ca215b598">9,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjItMS0xLTEtMA_63d58040-7f52-4b4c-bf24-2df82482afb3">27,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjItMy0xLTEtMA_78518c58-e5e6-4924-af91-ea536a548190">22,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjMtMS0xLTEtMA_bcb9af8c-a473-42e4-a457-4276aaa643b4">5,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjMtMy0xLTEtMA_e2d318ad-a0a7-44f9-9035-00cfee634dc9">6,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjQtMS0xLTEtMA_6a7e83ee-5467-43c8-a698-9a73df684167">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjQtMy0xLTEtMA_d9ab2c33-506e-4477-9129-806531aa93b5">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjUtMS0xLTEtMA_7018c63c-7020-4917-b66e-668754132872"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjUtMy0xLTEtMA_aa6e420c-f049-4b4f-a0f7-4e95dacb0336"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzMx_97967f8a-4ed6-4ccb-bc5d-a1f1850f92d2"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzMx_e26d60b0-f4ad-4d6e-b001-623d10e6e6b9">0.001</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzQ1_081fccc4-99be-4a6e-b3ae-a651b67af7d3"><ix:nonFraction unitRef="shares" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzQ1_9c41e649-b054-4637-b5f5-a1be817982d8">5</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzY3_2961b04a-3672-4f26-a957-657b9230ab1f"><ix:nonFraction unitRef="shares" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzY3_b621f9a1-bdb7-4af9-b6e2-9f472833a441">no</ix:nonFraction></ix:nonFraction>ne outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMS0xLTEtMA_4cd89ffd-f3d7-457b-b4bd-e1b2513c8473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMy0xLTEtMA_98fe60a3-9b57-4b87-90af-2f7883d16138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzI5_3731d142-fd57-4ab6-b0bf-aea3528e8242"><ix:nonFraction unitRef="usdPerShare" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzI5_d210dfbd-d937-4381-91bb-cdd061db1d0c">0.001</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzQz_9e5ff5f3-614b-47a7-a26d-bdb6abe74744"><ix:nonFraction unitRef="shares" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzQz_a4ffc6c8-6826-4b0e-b4bb-403ed4fec781">5,600</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzY1_a14c586c-4f5e-4651-94ac-00780bbbe62d"><ix:nonFraction unitRef="shares" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzY1_d06a2547-6052-476b-af5a-4ee4f8ce44e4">1,253</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzcy_21c0fea7-2265-4ac8-92c3-a39464f69b6b"><ix:nonFraction unitRef="shares" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzcy_f271e29d-5d91-46ed-9870-7e80de76e8ce">1,266</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMS0xLTEtMA_9ff96449-2bf3-4082-8746-fe7139266986">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMy0xLTEtMA_8b3e8918-0738-445e-b222-9e57306807fe">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjktMS0xLTEtMA_295dbf4e-fb0d-4ec0-8937-19d336883c42">3,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjktMy0xLTEtMA_dc70f31d-0a9d-46b4-92e6-3c0dbf9305ff">3,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzAtMS0xLTEtMA_85d4c6e2-1dd4-4b7a-a424-6cdd9eb187a2">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzAtMy0xLTEtMA_6ca144d5-de64-4d6c-83a9-b2fd9c40358a">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzEtMS0xLTEtMA_d0eed13c-bce3-4b5e-87a9-0269c3e3373c">13,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzEtMy0xLTEtMA_bb9cc643-fcef-4f0c-9533-d8fb780b8213">19,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Gilead stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzItMS0xLTEtMA_87e6477b-e714-482b-b2b5-eb6eb8c9a4f4">17,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzItMy0xLTEtMA_b776b656-fba3-4e43-8bb1-852a23b4179f">22,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzMtMS0xLTEtMA_f0e27a11-6b24-46fd-9da1-c9bf40ea34a1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzMtMy0xLTEtMA_ad811f0c-b342-46dc-8f8a-c22b20e648e1">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzQtMS0xLTEtMA_1d8f011c-4188-40dd-bb14-b9d969fd9590">17,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzQtMy0xLTEtMA_ceba2c44-8f83-4a7e-8cb5-6464ea017dd7">22,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzUtMS0xLTEtMA_b8e55e09-494f-409d-9f50-7953595ecdc8">60,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzUtMy0xLTEtMA_69c7446a-79a5-43c8-8fe2-fa5f88d974f8">61,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> GILEAD SCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic38a8d4d52c34caa8db328baf10699aa_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC0yLTEtMS0w_6e6df5d8-ffea-4b6a-84f2-88cb87c88d81">6,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a2687827294d87a300d031d1858df3_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC00LTEtMS0w_0a960f55-5504-48cb-a57f-b2c902d4faf4">5,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia542ffe4c807464b9cb360eb9f6c08b4_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC02LTEtMS0w_d7e64a90-71fe-4a71-ba53-051b25dd0f51">17,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ab6f6260e54f569438ef8ea0ff6cd6_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC04LTEtMS0w_13a1e097-704f-410a-893d-35767edcce13">16,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96064d1c8c184d5ab1297ec54cb44590_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS0yLTEtMS0w_b80b001f-c7d6-4e38-b59a-3e7209cee112">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf6dd01e1e2047839e25939a3ae0a70b_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS00LTEtMS0w_616ed25d-6f9d-4b0a-8098-60d82089ccb3">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaad7749126c4b9a9ca4c44b1cff7a4f_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS02LTEtMS0w_04cab02d-cdf0-47fa-a56b-9a92e04846b5">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6e106923dd4893989458d5e54fa96b_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS04LTEtMS0w_8a8770e8-d6bf-477c-9d20-2f337a4fd083">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi0yLTEtMS0w_3b66e14b-53fe-472f-8a26-12346a57d6a1">6,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi00LTEtMS0w_aa48d1d2-43d3-43b0-8fd2-9fe2f8951552">5,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi02LTEtMS0w_c95d40e2-dc5a-4922-a044-bd8bb6db32e0">17,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi04LTEtMS0w_ad0823b9-66d1-4aaf-a064-10f821da6979">16,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC0yLTEtMS0w_30f8b9c8-1699-42e1-99f9-76239c946633">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC00LTEtMS0w_c90f5c9d-cc83-460c-9bb4-47297c5b0c85">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC02LTEtMS0w_7b18fb1e-c24a-4ccd-a749-603141a5805e">3,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC04LTEtMS0w_ff8bc89f-dae3-4dd8-84cd-2ffdf894a475">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS0yLTEtMS0w_5dada9e2-0c96-4d68-b7f9-a135514fa11c">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS00LTEtMS0w_07a26715-5b96-4335-b7d5-a907bcd30bba">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS02LTEtMS0w_88f35076-f942-43dc-9e12-f17cf6fdabbc">3,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS04LTEtMS0w_4c6fbc69-d166-4334-bac2-e51f4f93326f">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtMi0xLTEtMA_b8d65786-0326-4879-a165-a6dc9acb1ed0">1,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtNC0xLTEtMA_88efd6cc-8cb6-425a-8470-6181572cdcd6">3,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtNi0xLTEtMA_b32fc3e8-d755-456b-af41-8236595ea73c">5,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtOC0xLTEtMA_c804a500-6661-4356-9099-3ab1016f0c81">4,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtMi0xLTEtMA_8be50941-4367-4b55-8402-d8328968e34d">1,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtNC0xLTEtMA_d03e75c3-34dd-4b8b-b865-bbb35b37b114">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtNi0xLTEtMA_714bb384-9b01-4846-b42b-81f5f0ef872f">3,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtOC0xLTEtMA_061256ad-bc50-4663-b478-751cb4ecea12">3,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItMi0xLTEtMA_11652ef3-3a04-4d19-808e-8e18e4691683">4,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItNC0xLTEtMA_5225d5c7-fcac-4627-826b-fa130ece56c3">7,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItNi0xLTEtMA_ee163517-01f4-4696-bc05-8cd99ce30a46">15,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItOC0xLTEtMA_786b66f6-8a57-46ae-8789-45d9cfc3e55b">13,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtMi0xLTEtMA_66c8be95-f251-4660-ae34-7f7150ad5159">2,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtNC0xLTEtMA_e7ee308b-14ae-4713-809f-e2447f602f46">1,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtNi0xLTEtMA_ced91fc8-db3d-4ede-b2e3-4c37aa0017ac">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtOC0xLTEtMA_2757bac8-ac18-4921-b3a7-61a1d8db6a47">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtMi0xLTEtMA_512a2c84-d52c-4d47-a2fe-509756fe9b18">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtNC0xLTEtMA_13ab5e0f-b93f-48ee-852a-8105d589b6e4">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtNi0xLTEtMA_b968850a-5a19-40dd-a7ed-b752baaac052">717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtOC0xLTEtMA_dd7caa5f-d105-446f-a65f-b745210ca24a">752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtMi0xLTEtMA_cfb5e650-d33a-4697-a4ea-e91648b2cec3">940</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtNC0xLTEtMA_36895465-a48e-43a6-8f69-d815f7e39943">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtNi0xLTEtMA_f7f9d441-e2a0-43ba-90d5-bc81b09bed0f">848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtOC0xLTEtMA_6f5fb7cd-c72a-4ff4-a32c-60ed86dd7dc6">817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtMi0xLTEtMA_9742a7e4-140b-416e-a118-16631ee731bc"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtMi0xLTEtMA_b3f64fc1-fbb2-49b0-95d9-7549807af89c">825</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNC0xLTEtMA_1ba1953b-aaff-4d24-8527-3f9e84027b35"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNC0xLTEtMA_a031a6ca-aa2b-452c-befc-bcd0160841a2">1,501</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNi0xLTEtMA_0b03bae9-1848-49be-a617-4053a01ee632"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNi0xLTEtMA_4ac698fd-868e-4df6-9489-a7c61046caf3">145</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtOC0xLTEtMA_18763f2a-5869-4244-90b5-87294d8830f5"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtOC0xLTEtMA_fdb3fd5d-e46c-4cfd-8ac4-41ca0dd9a05a">3,259</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctMi0xLTEtMA_cfb44b27-6daf-4df4-8d37-7106b8d9fe62">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctNC0xLTEtMA_a1d14eed-d1c4-44fd-9143-f8a1c8033bc4">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctNi0xLTEtMA_59cde5c8-9ce9-4adb-9d44-3fd1ddd2c0d6">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctOC0xLTEtMA_251a80f4-aba4-4073-839b-4facf066efe6">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtMi0xLTEtMA_41f485d2-cf8d-406e-84dd-e00e14d068b5">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtNC0xLTEtMA_04e47547-dbd8-4cc9-a103-e3c5b752dd50">1,168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtNi0xLTEtMA_8829470c-f607-40ba-bc55-dcbd287f0173">1,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtOC0xLTEtMA_c50877f0-a325-40b3-97be-bd11b0a2e6af">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktMi0xLTEtMA_5d877606-6827-4036-8c81-75c1df28c1b9">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktNC0xLTEtMA_91bc9d3c-7037-41a1-8715-4a85cd8f458a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktNi0xLTEtMA_b2fc6651-065f-4544-8b4b-84b94e106421">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktOC0xLTEtMA_93a06059-a9c5-4f00-a9f7-5dd032494fb7">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtMi0xLTEtMA_35172059-0623-4939-a2ab-2632005c8bb4">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtNC0xLTEtMA_b825f899-78bc-4a82-b89c-3f4464b98d9d">1,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtNi0xLTEtMA_4dd5b14c-c310-4e84-a116-e6392ecf99d0">1,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtOC0xLTEtMA_62df4d19-ea2c-4228-ba74-5245f457d6f3">2,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtMi0xLTEtMA_fe324573-1663-48c1-a7c1-717efedb6f15">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtNC0xLTEtMA_9cb4a5ed-8e68-45f7-bb7d-7395eacd649e">0.92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtNi0xLTEtMA_43b6c3d9-202b-4afc-9154-a8add711692b">1.14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtOC0xLTEtMA_6bad210f-e526-4d86-9189-525d142e876a">2.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItMi0xLTEtMA_817ef201-2673-4330-8458-bbc9c0459c51">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItNC0xLTEtMA_afe4a809-7062-40b2-8276-3de0b4606282">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItNi0xLTEtMA_db995722-d092-45d1-9c01-cbf97969c5d3">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItOC0xLTEtMA_c2716530-624d-4015-a2a8-d87a9bde5a94">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtMi0xLTEtMA_d586c26d-20dc-4f6b-8b01-4e24eec59f66">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtNC0xLTEtMA_38044d96-ccbc-4ec2-8a92-f681f5981a36">0.92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtNi0xLTEtMA_69f8cefb-0962-47c3-a1af-11617c333981">1.14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtOC0xLTEtMA_886b01a4-0200-4bec-bf1b-f9799b41c169">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtMi0xLTEtMA_82e80403-44c9-4d71-b8f0-99bb9ccab110">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtNC0xLTEtMA_1ae144cc-b97a-438c-bf7d-4b4f9eea85b4">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtNi0xLTEtMA_fed1a5e0-06a6-4506-b4ac-55b253d80fa9">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtOC0xLTEtMA_ac290765-8f6c-4639-a0bd-12dd0f3f60fe">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> GILEAD SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy0yLTEtMS0w_41f485d2-cf8d-406e-84dd-e00e14d068b5">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy00LTEtMS0w_04e47547-dbd8-4cc9-a103-e3c5b752dd50">1,168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy02LTEtMS0w_d6b6bee0-2a63-4e8b-b47a-0378eaf1efcf">1,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy04LTEtMS0w_d4977638-245d-4a89-bcd4-6fe98f1045f7">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign currency translation gain (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS0yLTEtMS0w_8a75c10b-6ef8-4dad-a3a4-aeeeac78def2">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS00LTEtMS0w_30f83682-efc0-4c4d-816f-73a25e6c1d81">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS02LTEtMS0w_b666e213-fe07-425a-93ec-925db0f67b1e">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS04LTEtMS0w_204b1757-a43d-4ed4-bc15-97d45de39038">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy0yLTEtMS0w_64a7bdd8-cb88-4c6e-9228-464fc7414f4b">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy00LTEtMS0w_5a1890bc-146b-4aae-9752-37126d1a10fb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy02LTEtMS0w_4ea6359c-f74f-4271-a218-2b4d98137e82">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy04LTEtMS0w_d16650fa-cd46-400d-b85a-b1806b93d1ab">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC0yLTEtMS0w_7988b93d-b5d3-40e7-9de0-20d0170cd6cc">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC00LTEtMS0w_952cdc56-2d41-4589-ae7e-2a91fb133ef4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC02LTEtMS0w_9cfa77bf-0880-4d42-bb9f-77d826c94684">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC04LTEtMS0w_4838c9a8-ccc9-44cc-9bfb-eb3c3b0bd0a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS0yLTEtMS0w_8f0d56ad-d072-4f85-ac3f-7c4957f6eb1f">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS00LTEtMS0w_06485557-96ba-4b6e-b1cf-edc8926bd159">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS02LTEtMS0w_e98c2863-1092-454b-ac75-55b1be10c463">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS04LTEtMS0w_c6692efa-3ecb-4167-8e71-d32b701657ce">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss), net of tax </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtMi0xLTEtMA_65b67633-a6cd-49f5-861b-72c7a8d6492c">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtNC0xLTEtMA_481f9afd-2bf9-4bc9-9f25-10c3b13f8c9a">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtNi0xLTEtMA_eb481646-c01e-40e7-84f8-324c7ffa18d6">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtOC0xLTEtMA_6f1dfb1d-24d4-4370-bcd6-e1d1ee790e31">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItMi0xLTEtMA_9657c61e-4452-48ca-add7-d1aae634632c">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItNC0xLTEtMA_df3523f9-0171-43ce-84c5-246cb4095095">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItNi0xLTEtMA_986b026a-2ba0-4e99-bef1-2524ee6564f2">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItOC0xLTEtMA_e193e788-7806-4049-a2cc-d24085c4af22">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtMi0xLTEtMA_b7f5fa07-7fc4-427b-b805-35d4f7d065e5">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtNC0xLTEtMA_760b036e-c630-4118-b2e0-f55ec4191ee6">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtNi0xLTEtMA_ee3ca100-d3a1-477a-b367-6d2765efcb21">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtOC0xLTEtMA_a2bfcf95-177b-41bd-834d-e71975f4a752">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtMi0xLTEtMA_604ee536-0e0f-49d2-b4ce-4f05e69a07eb">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtNC0xLTEtMA_0b73b89d-c6ea-47e8-937b-8947beaaaf8f">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtNi0xLTEtMA_0f44ebbd-2bd0-4b4a-930f-f146428bca68">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtOC0xLTEtMA_29e3161b-7613-480c-a08f-58af25ba71ee">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtMi0xLTEtMA_08ce28ec-d81c-452c-b119-da30a9d1402f">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtNC0xLTEtMA_1c7bbbcb-9446-4ca9-b5d2-cf8191e8a5ef">1,153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtNi0xLTEtMA_09b58e28-9111-4e90-8d3c-909a6deb0b81">1,517</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtOC0xLTEtMA_ae3ca9bd-ada0-4259-9bb0-fbed18ef9f10">2,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Comprehensive (loss) attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtMi0xLTEtMA_e80267f2-db0c-4393-8275-76a55ff72d34">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtNC0xLTEtMA_cef9cd9c-37bc-49a4-b51c-dbd662f7d6b9">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtNi0xLTEtMA_00d4679f-e3d7-4c90-a348-c6662adbdc73">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtOC0xLTEtMA_cb4ab964-1814-4406-ba6a-4fc6d2a1ff71">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctMi0xLTEtMA_ee049e22-0d4b-455e-8455-a2e656d76d93">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctNC0xLTEtMA_21588b65-4d89-4609-a754-846cac0632be">1,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctNi0xLTEtMA_393461e8-0955-428d-996e-9c9b4120666e">1,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctOC0xLTEtMA_058bd25a-9bd7-438f-a8e5-f0aa3d70079f">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GILEAD SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gilead Stockholders&#8217; Equity&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; <br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideb48a35fba64fd59df61666f92213c4_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0yLTEtMS0w_f2a7b13c-e60d-4de5-870e-b024d271d06b">1,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb48a35fba64fd59df61666f92213c4_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC00LTEtMS0w_f97d2a68-a1bf-4f13-986a-144ec624794d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e65980547d349c5a71d09c2359de137_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC02LTEtMS0w_e7e4ec34-5273-4573-9ada-cc080a6e0b65">3,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i535a6da229a34ac799fa2c08e368ed62_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC04LTEtMS0w_456509a9-62a0-44a6-a73e-2d1450271427">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e051c6d4e941d495baf35b525c1fcd_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0xMC0xLTEtMA_f580ad0f-82d9-433e-b1fd-861377054b86">14,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6832292dc744de38ecb457d6fa63dc1_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0xMi0xLTEtMA_d7c873b1-199b-42cb-8ddd-b40d06b5040b">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2c16973a1646478086092143c77e53_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0xNC0xLTEtMA_eb719dc7-02ca-4fc8-9e4f-3068753a3806">18,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in noncontrolling interest (Note 6)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if40d55dade8445298ddf59323f025103_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNS0xMi0xLTEtMA_7bbf9225-ce03-4786-82fd-d2b4d68e942a">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNS0xNC0xLTEtMA_825c8bda-6dc7-409a-86ff-98c00baa9876">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNi0xMC0xLTEtMA_f226e882-02fe-4483-b533-0f86e1bb7d37">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if40d55dade8445298ddf59323f025103_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNi0xMi0xLTEtMA_4261bdec-3e3b-412b-bbfe-c11aeaa5a24b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNi0xNC0xLTEtMA_b1aac66c-2d16-4fbb-868f-4472fdc0a475">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy02LTEtMS0w_f30c2a87-8d2f-49d0-9e18-14d4ea3b1e04">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic93b18523ecf4d8cad1a70d4ca601e65_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy04LTEtMS0w_d9694870-831d-43f1-8c39-fae9dda2300c">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy0xMC0xLTEtMA_d2b0e617-c770-44c2-9fab-66ee26ca5e50">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy0xNC0xLTEtMA_49ef633c-5c66-4ddf-9744-75680648a718">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28490f5280b24530b512cc82d79acf78_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0yLTEtMS02NDA2_5cd1c2b6-786d-4494-8de1-ec30ca4c4379">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC02LTEtMS02NDA2_5d8e5f1a-df4d-407b-9481-69dfeff496d8">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0xNC0xLTEtNjQwNg_d564e36d-d2b9-4687-9b94-e32730c4306c">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28490f5280b24530b512cc82d79acf78_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0yLTEtMS0w_8a7c2db2-ef3e-4d97-90bf-e4cec1510920">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC02LTEtMS0w_608eaf4a-e334-4ce4-abb3-463403b95919">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0xNC0xLTEtMA_49a266a4-f43a-4dd5-9c7e-6e52ef8bc4c1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOS02LTEtMS0w_048c9883-dd88-45aa-8084-cd87ede69b1f">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOS0xNC0xLTEtMA_76a740b0-66f0-453a-b584-0e2f9c8d83b7">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i28490f5280b24530b512cc82d79acf78_D20200701-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtMi0xLTEtMA_e0d27a4c-f632-47dc-bf44-739f7d2b0c84">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtNi0xLTEtMA_974e14b5-e4f9-427f-b0b6-2ca3578823a7">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtMTAtMS0xLTA_bfbdc870-42bc-4d5d-b086-02245bf2dd0f">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtMTQtMS0xLTA_d76b7615-63f2-4cbc-a0e6-019125492539">238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmFiZWY0MTgxZmYwYjQ1OGNhZTliNjdmNTVmYWM0YjZlXzI0_47ff7b2b-8488-44ce-b65c-7f840b190630">0.68</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTEtMTAtMS0xLTA_dafe3397-a3a3-4867-b953-925c074dee73">866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTEtMTQtMS0xLTA_8f801ee9-150a-4c3e-930f-6ba487720be2">866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id288e44f34634d5c93fb6b663e378514_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMi0xLTEtMA_1d97ba06-1b2e-478c-9571-055f1ee7c9c7">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id288e44f34634d5c93fb6b663e378514_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItNC0xLTEtMA_7738ff23-1072-4aae-beec-ba789bee772b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c997087db1f4d44953e502e4e51d968_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItNi0xLTEtMA_fe298efa-261a-4581-a13d-903a770af91d">3,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20a282f852c4c7dbb87cc18035c48ad_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItOC0xLTEtMA_ce59b526-7334-4101-aadc-3456c9916a04">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e1b216261147f0aa8922793f836cec_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMTAtMS0xLTA_bb88ec79-4bc3-4f15-80ae-b9673d251089">13,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92194d01f9f6426db2f230db32348009_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMTItMS0xLTA_fb6052a5-3af2-49a6-890d-30440bed9329">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMTQtMS0xLTA_9904aff0-4e5a-4201-a35f-6fc26331daf3">17,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gilead Stockholders&#8217; Equity&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; <br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e35c67616af43299f00f59e19a5a18d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0yLTEtMS0w_7340b4f8-ecb6-4581-bb69-28ff18159940">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e35c67616af43299f00f59e19a5a18d_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC00LTEtMS0w_cdfec8b6-a7c5-447c-9c39-83b040a3be36">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie738a97278064bb387639c4cf08d5982_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC02LTEtMS0w_8487741b-a6aa-4e46-90a1-0c0efa5698ba">3,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i697547cbd3024af6ab47310c99aecd30_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC04LTEtMS0w_a01fabaa-131a-424d-bcc1-5f2c8aca5ddf">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6761db60bfad4d1a83000fe1aa00c987_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0xMC0xLTEtMA_ada0a1ad-1d6c-4e4e-8d5f-4a9f1b73f04a">19,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i060edfd2f245412088dbd1d22a228e8c_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0xMi0xLTEtMA_fc6c6fc6-a2ec-4d4d-a67d-7e7dd2a6ada4">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0xNC0xLTEtMA_01ddbf44-b5eb-4970-9b60-92a0a334f9cb">22,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect from the adoption of new accounting standard (Note 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1359c5ce919042c9b30bbb420ab9f586_I20200101" decimals="-6" sign="-" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNS0xMC0xLTEtMA_c96a6244-5b57-4b26-8ba5-ee0a00b96779">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d7a75396cae46eaa5a500fd466bed84_I20200101" decimals="-6" sign="-" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNS0xNC0xLTEtMA_4990616f-bd0c-4002-b845-d8d4a0e61486">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in noncontrolling interest (Note 6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i286718c980e742f3ad7ff5fa3cb8d52e_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNi0xMi0xLTEtMA_fb20bbfc-8f62-441d-a1aa-a5c60e92b6a2">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNi0xNC0xLTEtMA_e12b445c-2eac-413e-b45b-25579214f114">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNy0xMC0xLTEtMA_f359619a-a16f-4310-90e6-fb483b7b83b5">1,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i286718c980e742f3ad7ff5fa3cb8d52e_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNy0xMi0xLTEtMA_22488609-e078-485b-a472-446560329f7c">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNy0xNC0xLTEtMA_eedcb353-ef52-4a6f-a087-a5a0f718cc86">1,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC02LTEtMS0w_23f43c92-f6f1-4f75-a7df-a2490fd82703">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC04LTEtMS0w_3e0a955c-0ef1-4949-ad42-23e6de364927">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC0xMC0xLTEtMA_1d846e2f-dd05-4fbd-8918-6262d7ae8b55">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC0xNC0xLTEtMA_13acd8b3-7d67-472d-9486-a8a94aa0de50">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOS0yLTEtMS0w_96fc6d42-6d25-4505-a7b7-450accb9fc17">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOS02LTEtMS0w_f74e3ad5-274e-44c9-8fd0-dd81f4fb6366">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOS0xNC0xLTEtMA_0cfc090a-b83e-4332-8ea1-b08ce1ac4ce6">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under equity incentive plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTAtMi0xLTEtMA_07dd0866-4029-40a3-9172-7fe6acc14890">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTAtNi0xLTEtMA_b3149711-8d1e-4b2d-b5ec-237d1ae0afe5">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTAtMTQtMS0xLTA_6cfd2e80-55a2-4aea-a931-7b0ec5bee189">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTEtNi0xLTEtMA_18010eba-99e0-47f4-9183-bd747a7e9582">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTEtMTQtMS0xLTA_341a6a1c-91b3-4cec-a79a-9c4ee4cf3e90">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItMi0xLTEtMA_7de95830-331f-4369-b1d9-37afe3cfe442">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItNi0xLTEtMA_3c4418e8-67a7-4823-a7e4-97eeb9529c28">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItMTAtMS0xLTA_9a91b743-39cb-40fc-ac18-76abf9d3e4c2">1,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItMTQtMS0xLTA_a43b0c55-b48e-4760-acd6-5d035ef3eb69">1,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjM5Y2RlNWJjNDBkMjRhMDg4MjYzMTk0ZmI1ZDJhMjIzXzI0_a9288b6a-a1cf-41e1-b26f-b830f7a04a7e">2.04</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTMtMTAtMS0xLTA_561ce167-f2f0-4024-aefa-655d6d762a04">2,599</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTMtMTQtMS0xLTA_ca897cf3-513f-45ef-894c-35256c004de7">2,599</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id288e44f34634d5c93fb6b663e378514_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMi0xLTEtMA_0751f2f7-eee3-4b99-b523-331831f0f026">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id288e44f34634d5c93fb6b663e378514_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtNC0xLTEtMA_5e3d22e4-2c87-4b2b-85cf-b3ca28d716ed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c997087db1f4d44953e502e4e51d968_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtNi0xLTEtMA_41865193-18fd-4011-aefd-261489ee2084">3,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20a282f852c4c7dbb87cc18035c48ad_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtOC0xLTEtMA_27f02500-a170-424e-9cd7-8442a4fcb41b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e1b216261147f0aa8922793f836cec_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMTAtMS0xLTA_2cb5e0cb-51e7-49c7-b8d2-8e8130f8e0f0">13,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92194d01f9f6426db2f230db32348009_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMTItMS0xLTA_ddeddf9e-c560-47f5-beb8-80d0bc3a98cf">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMTQtMS0xLTA_113603a4-7192-4b31-befb-2b67011b5098">17,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gilead Stockholders&#8217; Equity&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; <br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib63cbbf9eb664b268663f0c27aa85f33_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0yLTEtMS0w_0caebacd-3ae6-423a-a66e-6ce261de5c53">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63cbbf9eb664b268663f0c27aa85f33_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC00LTEtMS0w_6bd41fc3-5c79-4fca-8987-8c8fb5548855">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i510270b913b147c08dd65ad6c95c2caa_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC02LTEtMS0w_d80da830-7253-46e9-8f5e-9532e985fa93">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86be1800e75d42dcba0a3eb9a98551a3_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC04LTEtMS0w_cf31b5fd-42b5-4f26-876a-5c85b701e547">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic72dfa28da994e0a853f4aad7f2a6e63_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0xMC0xLTEtMA_54a3beec-c1eb-415d-aff4-970fada69559">19,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ae5dc2210454fa58a3557195e59fdba_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0xMi0xLTEtMA_71d07368-0d6c-4c8e-bc2e-91853815fbcb">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed0ecdfb5ae4e86a678c62132da6ab3_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0xNC0xLTEtMA_0130ebf6-2d9c-4516-9926-573d6411bc5d">22,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNS0xMC0xLTEtMA_e460ae51-6367-483d-8e23-9bb49acf6dde">1,165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79bf3801a1984d3280d2a88a5644d5f3_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNS0xMi0xLTEtMA_6530d65d-0b0b-4ae0-ba79-752c307ce874">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNS0xNC0xLTEtMA_c5921b4b-ad3e-4d1d-8b15-bc08420bbb86">1,168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc1677cc7c59497aa73455736d88394f_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNi04LTEtMS0w_70abe768-c856-4292-a2ac-f70d6332daf3">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNi0xNC0xLTEtMA_56c1e62e-7ef2-4865-8fff-0673f075ebda">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0yLTEtMS0xMjg2_9aabec1b-766a-4f9b-b694-b0bd56b82cdb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy02LTEtMS0xMjg2_f6b0334c-df50-4af9-b081-4ef962c36c7c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0xNC0xLTEtMTI4Ng_de8a5392-e2b1-46b2-a8e9-1c23de77c69c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under equity incentive plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0yLTEtMS0w_74e371b8-69ff-476b-b231-5599eea7ba79">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy02LTEtMS0w_5b746e1b-0b1f-47f0-869f-68e1f164b77b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0xNC0xLTEtMA_9dae47a2-3879-416f-b191-ccc2fa6af51b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOC02LTEtMS0w_da504005-1338-43f6-b7a8-2da01ab0429f">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOC0xNC0xLTEtMA_90d8f1aa-534c-42ee-9e46-b9bb6279237d">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS0yLTEtMS0w_7dcb9384-63fc-43ba-8276-f59316f82131">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS02LTEtMS0w_45b18235-f610-4a26-821d-7b736ce34814">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS0xMC0xLTEtMA_37a4d529-7fd0-4083-ac26-a841a0aaeefa">241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS0xNC0xLTEtMA_10589a38-893c-45ff-848c-0f29c5b94a5b">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NWY4NDNmNmE0YzQxYzc5ZDljNjliYTNmY2Q0NzY0XzI0_f7cf66ae-379f-404c-878b-bbbdf27b3195">0.63</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTAtMTAtMS0xLTA_f05075ee-cf1b-48c8-907f-1a0f586d794d">807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTAtMTQtMS0xLTA_86f323a9-0f22-4e41-935c-92214673aede">807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMi0xLTEtMA_bd6f8bce-d352-43af-99b5-16797ec8598d">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtNC0xLTEtMA_9e07ea85-7044-4dca-86a9-d4780f591eb3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ee747ba17a4a47a3ef814fd196e4fc_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtNi0xLTEtMA_8fb24c20-3dbe-4423-9af3-6e03a7058bc0">2,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d3e46703834e0098456a41f5ef8be5_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtOC0xLTEtMA_bd7bfbe0-3661-49c1-a5a5-7149e784918f">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecaaaabb21fa447299f1e341b4985cce_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMTAtMS0xLTA_a84e3b4b-a33b-4a04-a982-aee010db2c6b">17,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea68edf9adb482a984d6a2f46ed8c18_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMTItMS0xLTA_0a4aa86e-74cf-49d5-9661-be127b774fde">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95de9d6ff3964391ab5aa52b050944f9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMTQtMS0xLTA_11916152-1793-442c-ae81-967c372280d7">20,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gilead Stockholders&#8217; Equity&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; <br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comprehensive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1572613d4ff74b2786f78674a86e1d1d_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0yLTEtMS0w_fa435f0d-d443-47f4-8d8c-2a540cd4847a">1,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1572613d4ff74b2786f78674a86e1d1d_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC00LTEtMS0w_ecbb2164-d532-4ada-ab38-1ef13efce8a5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66670c48dad4abbaf4a7e4afd0bfce3_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC02LTEtMS0w_8494755d-79f0-4b7c-856e-48a8e0e3a246">2,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d14e1d51864d97b88c87da0f398d28_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC04LTEtMS0w_d48943c0-e35b-4d69-8e29-c46054651dc2">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic339b862d834437592eff9f1aeb8752a_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0xMC0xLTEtMA_d7153ac9-4b0f-4e88-b5ea-93ac6ec2d5ed">19,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib374a36c14ac45c0817de5c423a7dc5c_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0xMi0xLTEtMA_a2b63018-77e9-4abf-9ea3-f52ef3aca35c">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8b0210f3494723826b5d6eaf202e5f_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0xNC0xLTEtMA_24c94557-026b-4df9-99fb-cf3eaf4d6856">21,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect from the adoption of accounting standard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbf61511cccd4d31be2efc81754d695f_I20190101" decimals="-6" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNS0xMC0xLTEtMA_98c0f9c1-9755-4552-9db2-03015786d458">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i042635c737c840d7a0b0cc891e439e49_I20190101" decimals="-6" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNS0xNC0xLTEtMA_7984dd6e-6756-489c-9e5a-7df1022883e3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNi0xMC0xLTEtMA_b251bade-4abd-48b8-854f-4474f832830b">2,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c95cf4710d74cd08f24a559657ba257_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNi0xMi0xLTEtMA_ff87fc44-491b-4e80-b23e-cf54ef731601">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNi0xNC0xLTEtMA_7b3f3127-3cbd-4b39-9293-6eb586550f7d">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNy04LTEtMS0w_7ce1f6a0-c47c-4a00-8f45-d05ee58e2fb1">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNy0xNC0xLTEtMA_3df9b99b-8bd7-4eb4-845d-1d1c7a61b303">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOC0yLTEtMS0w_4f782ec5-8a07-4681-b6ff-83287973e29d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOC02LTEtMS0w_48ac2639-89a1-47f5-b4b7-7ea5182e7661">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOC0xNC0xLTEtMA_df701541-fed1-4672-a44d-864fcc6e8fa1">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOS0yLTEtMS0w_bac94b18-0df9-49b6-94e7-3c600242a201">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOS02LTEtMS0w_712b5c1c-7d9a-4088-8ca1-f56c3536a10f">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOS0xNC0xLTEtMA_a423dbd6-3a4b-4996-a233-688e4b330a10">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTAtNi0xLTEtMA_e43efb2a-0478-4cb0-a33c-96b2c2eca9a2">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTAtMTQtMS0xLTA_70ef217f-f0fc-4979-89a1-d74b8cc97709">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtMi0xLTEtMA_fbfe9d96-231a-43ad-87d8-bb368ebc36ce">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtNi0xLTEtMA_e154c8e8-87b7-4dfd-b636-a237d5a73ece">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtMTAtMS0xLTA_e0ec3e34-4193-40bb-b2b4-5f6b7b168b84">1,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtMTQtMS0xLTA_66f53d17-c02b-42b6-b381-5a93434e30f6">1,748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmMxNmU3YzA2MTBjNzRhNzQ5YTBlYjA2Zjk4MzI3MjVlXzI0_77f33284-e1a3-40a9-81ba-fade490d08d9">1.89</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTItMTAtMS0xLTA_780645ba-d077-4b37-89f1-3d3c5d9305ea">2,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTItMTQtMS0xLTA_2d3cc34a-a489-4992-9106-632c4e899b17">2,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMi0xLTEtMA_6a0203aa-2994-46a1-9aab-6138e65d1cbf">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtNC0xLTEtMA_d73646d2-6425-4d9f-b32e-de1a406708af">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ee747ba17a4a47a3ef814fd196e4fc_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtNi0xLTEtMA_4f70b9d6-ed06-4368-9f28-93453b18dd98">2,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d3e46703834e0098456a41f5ef8be5_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtOC0xLTEtMA_53da46f4-8e2c-49b9-b5fc-f6ba20d0b2f0">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecaaaabb21fa447299f1e341b4985cce_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMTAtMS0xLTA_fb0f5d82-9835-4a82-a85f-569b75daae46">17,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea68edf9adb482a984d6a2f46ed8c18_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMTItMS0xLTA_6c851c31-1b36-4b4b-b094-4f5a295ec451">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95de9d6ff3964391ab5aa52b050944f9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMTQtMS0xLTA_c02889e0-87c4-47f2-afd5-89398db73923">20,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GILEAD SCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNC0yLTEtMS0w_8829470c-f607-40ba-bc55-dcbd287f0173">1,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNC00LTEtMS0w_c50877f0-a325-40b3-97be-bd11b0a2e6af">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNi0yLTEtMS0w_64ac9a5e-ff20-4154-83b2-939d2173a7c9">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNi00LTEtMS0w_411d29a8-8140-4abe-b458-19246e16cc8c">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNy0yLTEtMS0w_a9a69600-a6c1-48b1-b912-87054d2b11ab">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNy00LTEtMS0w_67caf5f7-df25-4715-9cfb-1b90854dc69d">868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOC0yLTEtMS0w_ea2e5e88-7a6d-41a5-ae50-b70f0f855ec0">482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOC00LTEtMS0w_85a3fe17-f144-4ec4-af7a-ba8873830326">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Acquired in-process research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOS0yLTEtMS0w_3e29f232-421c-4cfe-ba3d-209d2a0c882e">5,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOS00LTEtMS0w_dda6d751-889f-4731-ae7f-0ede34c4fa64">4,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTAtMi0xLTEtMA_f10fb602-e14c-46f6-a1a5-ffb268369feb">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTAtNC0xLTEtMA_a9e4a1aa-af89-47c3-b087-adb607d46203">796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net unrealized (gain) loss from equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTEtMi0xLTEtMA_63f76db4-613c-4db5-9bee-2b288b6e834f">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTEtNC0xLTEtMA_1890ffba-ce16-44b8-a47c-0b4b8fe4340b">312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTItMi0xLTEtMA_562202a0-24f7-4114-bb47-8d74f073854c">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTItNC0xLTEtMA_6b842449-1f40-4335-b76c-080e9a71fe36">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTQtMi0xLTEtMA_1fb6cfde-02a1-4731-9f4d-de1d3d114c60">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTQtNC0xLTEtMA_190300a7-ce96-4246-a38b-9ccfdec65cf6">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTUtMi0xLTEtMA_1d127dae-ca03-412e-855c-3be35ece496e">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTUtNC0xLTEtMA_e691247b-b0be-4141-9535-2126c425a453">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTYtMi0xLTEtMA_8d7996a8-02f0-4c71-b724-fde6cc0c3c45">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTYtNC0xLTEtMA_71ce0017-12bf-4b7c-bad5-14a51fe095df">225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTctMi0xLTEtMA_a5ef6b64-ef5f-4f7c-bfe6-f1190358b3c2">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTctNC0xLTEtMA_da09216c-67bf-423e-82aa-93f792c08ce1">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTgtMi0xLTEtMA_00834d82-0b39-487d-b03c-f6a1506b3ce7">428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTgtNC0xLTEtMA_ed9fd5f5-b198-494f-9e36-bb0ca2892f50">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTktMi0xLTEtMA_72368956-ca2b-4f5b-ac5c-5fda3880c59c">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTktNC0xLTEtMA_7195537d-c876-4a8a-99d8-adfe22887cd1">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjAtMi0xLTEtMA_c5a0e310-3928-4d6b-83d8-98c0b75693b6">6,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjAtNC0xLTEtMA_c761a37d-af9f-4f58-8b93-22a546380919">6,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of marketable debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjItMi0xLTEtMA_bb3ca915-e442-4e8e-af44-522e537609c1">19,809</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjItNC0xLTEtMA_5571b06d-dda9-4ffa-89e8-76404831fa91">24,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from sales of marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjMtMi0xLTEtMA_a9854e0e-6407-4e92-b6ea-5078a029a999">12,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjMtNC0xLTEtMA_8ac6e812-549f-4bc5-9b50-788f74be1d7f">4,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjQtMi0xLTEtMA_07861082-84a0-4079-a4b9-e0dbe996ed3b">8,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjQtNC0xLTEtMA_e04a59bc-53d5-4e16-89f1-4d58cd7d7fad">17,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Acquisitions, including in-process research and development, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjUtMi0xLTEtMA_30db6f9b-901a-4425-aba0-d3dee27ea616">5,804</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjUtNC0xLTEtMA_2db7e955-6b67-4aa6-97ee-35c33aa340ab">4,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjYtMi0xLTEtMA_0c2c3d33-450e-4f22-a8e2-9b68f551ec1a">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjYtNC0xLTEtMA_81c05a0e-dc32-43be-bc03-382b37f362a5">1,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjctMi0xLTEtMA_036a7820-4d6c-418c-b0fb-78877a751764">469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjctNC0xLTEtMA_d9094595-47ed-4963-a115-baa9a61d6daf">622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjgtMi0xLTEtMA_e058e28d-844c-47d0-8e9b-844821f91df4">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjgtNC0xLTEtMA_ab5caa94-f489-4af2-8841-3716a168adc0">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjktMi0xLTEtMA_e8d3ee15-86ff-4398-b340-076d96dfc016">5,638</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjktNC0xLTEtMA_55d76d1f-f933-45cc-8b6c-25341987d2a5">8,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Financing Activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from debt financing, net of issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtMi0xLTEtNjQ0Ng_2839f120-66fb-4850-b091-44e2ddd3c487">7,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtNC0xLTEtNjQ0Ng_e3e8e80a-f10c-4830-a1a4-c371ecd64e15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from issuances of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtMi0xLTEtMA_18894bdd-30c8-4f4f-87d3-1ad5efad92ca">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtNC0xLTEtMA_1ef943ec-c572-4ee6-bf79-edcf93c72df6">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzItMi0xLTEtMA_2a6814d3-bcba-4a08-9b26-926327312182">1,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzItNC0xLTEtMA_b12b14e1-e94b-4c62-a608-313dc763e0dc">1,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repayments of debt and other obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzMtMi0xLTEtMA_d61266ad-eb0f-4e50-8c3b-ae7f85529066">2,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzMtNC0xLTEtMA_bfeef7e8-61f1-4ed7-b1b8-8b755b003a94">2,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments of dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzQtMi0xLTEtMA_b44b86c9-88d8-4462-ae6e-cf4c2bf51ff0">2,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzQtNC0xLTEtMA_0d43264d-97fa-4cff-87c7-2181cd6237e4">2,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzUtMi0xLTEtMA_8d62e467-da72-4230-943c-6a7c08e2b28a">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzUtNC0xLTEtMA_83d34476-3e33-4ffc-b4d0-d1032682f587">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzYtMi0xLTEtMA_f438d7f1-4d02-4e4a-894c-a7b0047746ba">639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzYtNC0xLTEtMA_998b368b-b06f-4467-8202-9bea091f83e5">6,738</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzctMi0xLTEtMA_ada2adfd-c223-4282-8059-3421048c0b64">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzctNC0xLTEtMA_fd5242d0-dfb8-4e57-8fce-4f9ce719a39e">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzgtMi0xLTEtMA_788c5693-90cd-46ac-a2d1-07981fa1340c">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzgtNC0xLTEtMA_4236dea7-e950-4830-9ee7-c5f9590e82b8">8,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzktMi0xLTEtMA_66d7288c-4dac-4f51-b5d3-c20e5da879ba">11,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8b0210f3494723826b5d6eaf202e5f_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzktNC0xLTEtMA_676989ad-6ee1-416e-8ab4-3a076c9db2f2">17,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNDAtMi0xLTEtMA_03716fca-6263-4768-925f-41ee621f8c52">12,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95de9d6ff3964391ab5aa52b050944f9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNDAtNC0xLTEtMA_9b88893e-3f31-43f2-a19c-74b2e88791b4">9,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GILEAD SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_34"></div><div style="margin-top:16.5pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzYwNQ_8c15160f-3317-479a-bc5f-04d4d6790cee" continuedAt="i69292049e351421dbf60e7c700b99c69" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </ix:nonNumeric></span></div><ix:continuation id="i69292049e351421dbf60e7c700b99c69" continuedAt="i8f06bc0fc02e48cbaaa544ba5f840c99"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU5Mw_7b485bf8-4aee-4220-8de2-a346eb1981f4" continuedAt="ieaa64de112f6470a91a7f985a9ee171f" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. The financial statements include all adjustments consisting of normal recurring adjustments that the management of Gilead Sciences, Inc. (&#8220;Gilead&#8221;, &#8220;we&#8221;, &#8220;our&#8221; or &#8220;us&#8221;) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of Gilead, our wholly-owned subsidiaries and certain variable interest entities for which we are the primary beneficiary. All intercompany transactions have been eliminated. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess whether we are the primary beneficiary of a variable interest entity (&#8220;VIE&#8221;) at the inception of the arrangement and at each reporting date. This assessment is based on our power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. </span></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieaa64de112f6470a91a7f985a9ee171f">The accompanying Condensed Consolidated Financial Statements and related Notes to Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December&#160;31, 2019, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission.</ix:continuation> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU3NQ_072f5def-73b2-4974-ac05-8762b2468dd2" continuedAt="ib36006966765480cb07649aa317afff7" escape="true">Segment Information </ix:nonNumeric></span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib36006966765480cb07649aa317afff7">We have <ix:nonFraction unitRef="segment" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfMTgwNQ_dd6b9846-2c6b-42ca-95cc-44694273e3ef">one</ix:nonFraction> operating segment, which focuses on the discovery, development and commercialization of innovative medicines in areas of unmet medical need. Our Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision-maker, manages and allocates resources to the operations of our company on an entity-wide basis. Managing and allocating resources on an entity-wide basis enables our CEO to assess the overall level of resources available and how to best deploy these resources across functions and research and development (&#8220;R&amp;D&#8221;) projects based on unmet medical need and, as necessary, reallocate resources among our internal R&amp;D portfolio and external opportunities to best support the long-term growth of our business.</ix:continuation> See Note 2. Revenues for additional information.</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU3Mw_b94f2fa0-9bb0-4271-8fa7-ef37963b8283" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies, Estimates and Judgments</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. On an ongoing basis, we evaluate our significant accounting policies and estimates. We base our estimates on historical experience and on various market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent coronavirus disease (&#8220;COVID-19&#8221;) could have on our significant accounting estimates. Actual results could differ materially from these estimates under different assumptions or conditions.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU4MA_2465c7ff-cf25-4284-9099-c2cad35c93d3" continuedAt="i4bca7475dd4d408f9d5bd8caa6d3511c" escape="true">Reclassification</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i4bca7475dd4d408f9d5bd8caa6d3511c">Certain amounts for the three and nine months ended September 30, 2019 were reclassified to conform to the current period presentation. Beginning in the second quarter of 2020, acquired in-process research and development (&#8220;IPR&amp;D&#8221;) expenses are reported separately from Research and development expenses on our Condensed Consolidated Statements of Operations. Acquired IPR&amp;D expenses reflect IPR&amp;D impairments as well as the initial costs of externally developed IPR&amp;D projects, acquired directly in a transaction other than a business combination, that do not have an alternative future use, including upfront payments related to various collaborations and the initial costs of rights to IPR&amp;D projects. Our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019, has been conformed to separately present acquired IPR&amp;D expenses.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i8f06bc0fc02e48cbaaa544ba5f840c99"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU2MA_b3eaa43f-b460-435d-8681-1996585f098e" continuedAt="i608857c927284f69bd10fd68ac986236" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to credit risk from our portfolio of cash equivalents and marketable securities. Under our investment policy, we limit amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. We are not exposed to any significant concentrations of credit risk from our investment portfolio. The goals of our investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and a competitive after-tax rate of return. </span></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i608857c927284f69bd10fd68ac986236">We are also subject to credit risk from our accounts receivable related to our product sales. Trade accounts receivable are recorded net of allowances for wholesaler chargebacks related to government and other programs, cash discounts for prompt payment and credit losses. Estimates of our allowance for credit losses consider a number of factors including existing contractual payment terms, individual customer circumstances, historical payment patterns of our customers, a review of the local economic environment and its potential impact on expected future customer payment patterns and government funding and reimbursement practices.</ix:continuation> The majority of our trade accounts receivable arises from product sales in the United States, Europe and Japan. Our allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="i405be8dac8594d43b53d27d487d15bf5_I20200101" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjA1Mw_1dd9ca40-7230-467b-81b9-e4db0c3f8f22"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjA1Mw_e6f8e6a3-b9c4-4fd1-9915-d11bc7af7d56">47</ix:nonFraction></ix:nonFraction> million as of September&#160;30, 2020 and January 1, 2020. There were <ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjExMQ_43c2ab1a-3065-44b7-94b1-06f7af2d6e70"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjExMQ_8705b6fc-0e31-407c-9a78-f378aadf2f18">no</ix:nonFraction></ix:nonFraction> material write-offs charged against the allowance for the three and nine months ended September 30, 2020. </span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzYwMw_72b15f93-bcbe-4c3e-9cc9-fbeff385534a" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016,&#160;the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2016-13 &#8220;Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments&#8221; and has since modified the standard with several ASUs (collectively, &#8220;Topic 326&#8221;).&#160;Topic 326 requires measurement and recognition of expected credit losses for financial assets. On January 1, 2020, we adopted this standard using a modified retrospective approach.&#160;The adoption did not have a material impact on our Condensed Consolidated Financial Statements. In connection with the adoption of Topic 326, we made an accounting policy election to not measure an allowance for credit losses for accrued interest receivable. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018,&#160;the FASB issued Accounting Standards Update No. 2018-18 &#8220;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#8221; (&#8220;ASU 2018-18&#8221;).&#160;ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606, &#8220;Revenue from Contracts with Customers&#8221; when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as customer revenue if the counterparty is not a customer for that transaction. On January 1, 2020, we adopted this standard and applied it retrospectively to January 1, 2018 when we initially adopted Topic 606. The adoption did not have an impact on our Condensed Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_37"></div><div style="margin-top:13.5pt;padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:13.5pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNzE0NjgyNTU4MzM0NA_1ded7b40-3b60-48e6-a150-dc93c64838e9" continuedAt="i9536fe38dfab47baa4e7b0dc1ce743b4" escape="true">REVENUES</ix:nonNumeric></span></div><ix:continuation id="i9536fe38dfab47baa4e7b0dc1ce743b4" continuedAt="i6985f15c737046ddb523544d88f7162b"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTI1NQ_67f5c559-178c-453a-88be-5126b8793efc" continuedAt="i66cabc77d07c48b5a3dde9bfc8eabf98" escape="true"><div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates our product sales by product and geographic region and disaggregates our royalty, contract and other revenues by geographic region (in millions):</span></div><div style="margin-bottom:8pt;margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Atripla</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic65b5d2d76914339a0bfc5c853141a8b_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0yLTEtMS0w_cc3131a3-a1e6-4bcd-b922-7fa2c5762881">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7a5f8acf2f948e68c92502a66bd5414_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy00LTEtMS0w_5a63b103-931a-497f-a37f-b7ce908d2b82">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c2c92fef300487ab03f8620479ac358_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy02LTEtMS0w_d210bbe2-ca14-4f91-99b1-414d23bbdd9d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1411829f6bb4060867b0218c7ad64ff_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy04LTEtMS0w_0eef24be-4101-49fa-9517-8ec2fb5dc634">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bde0012620b4b358093fc1ee9a71f5b_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xMC0xLTEtMA_13e8da8d-6aaf-43b6-9639-a9ed3c6a0719">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaf48f8bb6d943c7b3230cf9b8f49d16_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xMi0xLTEtMA_79509e4b-0380-4a5d-917c-b7747b8551a9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecd2a02077434613a5f82bf83e672d63_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xNC0xLTEtMA_20c4ad11-cae6-4e75-866a-de0552e757af">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i772bad7600f04babbcf984bea94a0f49_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xNi0xLTEtMA_a080a99d-e393-4e3c-b756-84a58eba4ce3">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biktarvy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67a923c7fdeb42a1881b0f06f38a17b4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0yLTEtMS0w_c3b93319-ca5a-4eae-9d4d-8f97d05820b5">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2dea3e60a54f91bbd1ff13643e9957_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC00LTEtMS0w_e4c937a8-917a-432e-b9e5-f0b7d83be8fe">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94bc6499871f430b883a5c26a9224567_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC02LTEtMS0w_c6695f41-3bda-4d06-92d7-ddf4dbb45e61">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a11bdc34a1243b683eb633df7c23e11_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC04LTEtMS0w_60460f6f-113f-4d34-b19f-523fce16444c">1,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea294903d17f4240a785bf9497f358ee_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xMC0xLTEtMA_b9b6d707-0b30-4095-b30e-7b78b7cf520d">1,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9e4bc40c0fc45b9ad367dc82a8b46e4_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xMi0xLTEtMA_2051627a-2702-42b7-ba00-fab4590ea6d0">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac6788431d54ecea456ad29ab15114b_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xNC0xLTEtMA_5ae752e8-e0a1-4a3e-8564-c4aea9dd970c">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96beb5e6c9d64cd88a2b544fa0558012_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xNi0xLTEtMA_86abd518-c5c2-4270-afc3-2a2b7276513c">1,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complera/Eviplera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d662f4b0514c71b93ab738ec761143_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0yLTEtMS0w_ddfb706a-b165-444b-8166-efd7b5f2d763">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37bf74c0f355430b8a23cd0b26f52891_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS00LTEtMS0w_8883796e-2fdf-4220-8992-fed3a10a2301">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316ef52a4bd846c592de38f7af36ea13_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS02LTEtMS0w_3e0c02b1-ca08-4681-9edb-458038f4e9dd">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d1ea3f49aa84699a8330b8beaf83836_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS04LTEtMS0w_2264a89a-fb52-4092-b65f-fabcf111deac">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2c5c00fd5c74399b684e5b33b4ab1a6_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xMC0xLTEtMA_be06d017-3377-4e48-8e98-44510a79243e">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bcba0865c9745c28ae1be5e32d30858_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xMi0xLTEtMA_849fb611-5bba-4a50-a595-59a3855d396c">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b5cdefab314e10af27865b284a261b_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xNC0xLTEtMA_dbb80261-e268-4d57-8e14-e07cf618ed79">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i020fa5bbe23148259e98dce5d3e6db76_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xNi0xLTEtMA_bf12b193-d837-4c02-98c5-833953673a7b">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Descovy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia983ed5089b04e17ba4a1f33f9b9848e_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0yLTEtMS0w_e3d5c129-4a10-4c10-939d-fd0fbd3db2d2">424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c69000ef95548fabbdc3b282e51e2e7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi00LTEtMS0w_018a72a8-072a-4bee-9a20-ee6a8c1ca67a">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4d5d7839e94505b43297794bc17592_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi02LTEtMS0w_384fd4d4-d35f-4275-b253-50dc883b6ece">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic966bee37fa6405b83576f4f740b30df_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi04LTEtMS0w_662c732c-b687-4751-9d20-5adb101d7cd4">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45de8b04cd5245018515cdea5655f777_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xMC0xLTEtMA_9b7bcc81-f508-4e90-a726-540da98633e9">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2910166058884915a9bb2ea6a203d1a6_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xMi0xLTEtMA_87616e3a-c4b6-40bc-a663-d62b44d842d0">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i855d34f7c7914eabb6d8012d1730432f_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xNC0xLTEtMA_89ecd151-c3bd-4cbb-a15d-6ab3b44f7944">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0a00ea00d246fcb752c2b14624ed71_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xNi0xLTEtMA_567b0fab-02c5-454f-9c14-0c62a8865e16">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genvoya</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c8efb370883401b83e55838b7fbc9d5_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0yLTEtMS0w_8417ea68-59ae-4898-8984-55b2e45449df">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76aeab63735947a3abc22f62baacab4e_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy00LTEtMS0w_c81f6992-7537-4822-a2e2-a43b2d90e017">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2166e16f87b04a429939389261643a67_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy02LTEtMS0w_3792eaaf-4c19-4a3a-bed7-ecdc253df62b">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac735e4f674431abdbc98a0e04572c0_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy04LTEtMS0w_81582e46-d3f4-4320-b325-a845036cbc70">846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3f8e5e8d70429facde72a5fc634bb8_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xMC0xLTEtMA_90b9645a-7392-4ccd-920e-f2bcfe39886f">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a121061085a43ea9ef1c9a36676b466_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xMi0xLTEtMA_9544f1f7-4637-46d1-8f43-23ee0b778fb9">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie478e9e1575e48d9a95499553e51f752_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xNC0xLTEtMA_9787dc94-cb33-44fe-8f36-21d7cf0f9984">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5ccce04a2f4a5db1b5196399fa7842_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xNi0xLTEtMA_2b70a406-4f04-457c-87f4-3b180a9aa63f">978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Odefsey</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3683aaebc3492eb3e2b434a9a15ec2_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0yLTEtMS0w_d0f1668f-67a2-4429-904f-4c210a14e87d">309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92538fca9ff2482dbc32c61c001b3ea3_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC00LTEtMS0w_58109f47-ae6e-4778-b561-3ae6ae8db67b">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e3405a679d4587b527f12c3cd7f625_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC02LTEtMS0w_01799bcf-2ccc-496c-afee-59c8fcb23750">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b5fd963d3fe41aaaa285ed9bc365e62_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC04LTEtMS0w_55f2d959-9d77-461c-be4f-a2c058870d7f">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3144e9c3e72a42adade54c619991a43f_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xMC0xLTEtMA_5e688fcf-ce7c-4848-ae57-9f3d99db5f9d">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia145801994314a5d8116188b3b69b3ef_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xMi0xLTEtMA_c66e3f85-e107-4a7c-b82a-b3b69c05d546">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied1a75b107a64c93a3d3f333c07064aa_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xNC0xLTEtMA_1d3b725a-93a8-42c6-9b39-2b6e604fc37a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a2b8e40abd48c9b7742b2cf6099560_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xNi0xLTEtMA_7bb37a23-cfc4-4e2e-9cb7-059ab0412684">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stribild</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b41aff3e0f4e9cb626769cea608d12_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0yLTEtMS0w_583397bf-0856-48d1-9a17-2a962a7da7c0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd67b9aae7cb40cfbf1e3c78614f30ae_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS00LTEtMS0w_97ffcf9f-b7ca-48b4-9db4-20d5b66a5013">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2743ffe9c1a24dd78139e89db866b972_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS02LTEtMS0w_35ccbe3d-d004-4584-a1b0-a05fd9d65d16">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ea9576cd9946a4891493d9dd47e7b3_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS04LTEtMS0w_72de9676-2eaf-44df-938d-3e7cf0245809">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a4fed8fd1443d5bedb3020421da791_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xMC0xLTEtMA_0ddc3d3a-ee1d-481b-95dc-3b20bb5a3e35">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie08938975b3748498c8cc0261e8b436c_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xMi0xLTEtMA_17c29ec8-ec64-4c4b-bbb6-4833b11c35e8">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14202ab77ae4a9686d66114ad05a515_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xNC0xLTEtMA_6bf113e2-761c-46c2-9024-8eaa44f6c796">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc975ef1eb341ceadf0507525e9651c_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xNi0xLTEtMA_b4a5f876-403c-47c2-b8bd-c67a13763b0c">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Truvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc2b300cda84f6baa63c7b71950cdd1_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMi0xLTEtMA_92dbdda2-9eaf-4cf4-af01-ef5858d002e4">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a5b342cbe6442e48842c846ee6caf71_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtNC0xLTEtMA_a638e2b3-ab97-40ee-b068-8d3fdf8a5403">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0319161df99e404986d1aa33de8ba71e_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtNi0xLTEtMA_6d52d45a-2f77-4e56-a515-6b96d3eddb62">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0926b30f1a498c81b6140b57053153_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtOC0xLTEtMA_804e4fad-a90e-434f-9e7b-f9678c0c7862">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2823fce1a4cf405a8b27b56aac04a3aa_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTAtMS0xLTA_c982e014-2eb2-4429-9439-209bdff1dbe2">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e1c05c57e8343419f9bfde5e1395322_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTItMS0xLTA_c3ee4ccd-50e1-484d-bda9-4ae7edb81a38">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc4539dbd004ec38a3c5475cd403514_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTQtMS0xLTA_51afc96e-2cae-4f03-8c65-956a6c1d86ae">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b237de69f3e4923ac93d5745b8e90d2_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTYtMS0xLTA_e63fcf36-3be1-4586-be18-4bee7f197a18">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other HIV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71725c2f0354f888e38d6f4ed36cfea_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMi0xLTEtMA_51ff5a5a-316f-42e2-a341-943aecd742d1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644c9ff59ab54478a13d8d84ac3ba4fb_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtNC0xLTEtMA_564116dd-04a2-4091-b7f9-e3f1f871cee7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9982b46a2fb427caa4de7e6521eb30c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtNi0xLTEtMA_5d1a5298-913c-4157-87d5-2f7ca0309605">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf79e96886d4938b1b1a211272ce1a7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtOC0xLTEtMA_08536139-7b7d-4e28-88a7-da04bbf39656">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbd8e9ef0a944d486a151c6936fb75a_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTAtMS0xLTA_ef17b94b-d5b6-4b99-aa8f-b098402eb1e7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ca1f1a0e024c22a8de469e578ba9fc_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTItMS0xLTA_7221c574-5604-4fa4-b9b6-e862a39a9625">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6086aba1234445049abb9c8cdd8e9f1c_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTQtMS0xLTA_c1b6d941-706e-411c-ab51-915bb1fea203">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab34afd10054eefb1e8edd6dd4b0519_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTYtMS0xLTA_e0a23ccb-acf7-446c-9526-5465a109971e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue share &#8211; Symtuza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie47edc1cfc9f4eb0a97fb226a0a5a37d_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMi0xLTEtMA_de105068-c594-45fe-bebb-59daabcd0277">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60af3f7f93b047d8ace0daf527ff4265_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItNC0xLTEtMA_35a867a4-42b8-4ad7-be40-bb7dadb1b4e2">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ecb2b4824649fc9f38af061f3b4ef7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItNi0xLTEtMA_294107e9-677c-4176-b0a3-1b3534603eb4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ff3a03a206465aaa2896ba1ba6e120_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItOC0xLTEtMA_d15ee309-1f00-4d4f-a96c-92c898dbbec2">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee22b1cffb1043bfbc54e365d26d4af5_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTAtMS0xLTA_554280e8-d370-4fa6-b3f1-4fc31f97b084">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d1453646ea740d890d612ac6873f4aa_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTItMS0xLTA_e43d9429-bf5d-4a46-abad-c1ffe4d1131a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dda27b4a5904907ad5d4a661c2c5d3a_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTQtMS0xLTA_d4ba46d5-2a91-4d31-8ca7-99678508df84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb31aa2cd1546fcbb6fc72d3d42b118_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTYtMS0xLTA_8df59af7-5def-486c-a077-320d7313f2b4">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmBisome</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd3136d6efa4348a1c8cd540f898277_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMi0xLTEtMA_2328976e-67db-4be4-8cda-e719b4d08af1">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fb08a6be124efc91105a96329d32e9_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtNC0xLTEtMA_07f94680-600a-4b0d-84c0-31be6d99c1c9">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b87c9b49b5b4c0ebe6fef12c1b938ed_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtNi0xLTEtMA_724b1c82-49f6-433a-948a-2995365f72d4">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3221247bffcd4c4f96e064e12dc3ba2a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtOC0xLTEtMA_4dc1acde-8a30-4906-90f1-0e6365ba106e">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dc9139c37245a49548419d47d24b75_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTAtMS0xLTA_b5bb2919-a9c1-4b19-8d47-fa5bfe318b37">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if979cf6c414f426db10c23f8e83a02ec_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTItMS0xLTA_06ca236a-7f95-4641-a5e7-75803ebe332a">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1770394dbe848a9a641f08327a05206_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTQtMS0xLTA_add12094-54ff-46ef-9586-e370dc403ffe">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a54848fe844a30bbbac60e370dcda0_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTYtMS0xLTA_e88f863f-9d2a-457b-a1ef-eaadfd9f0ab7">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ledipasvir/Sofosbuvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddf43c851594f2a8bf0c1f63f0ebf86_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMi0xLTEtMA_ad84a47c-9827-4bd0-9028-c15bc5b73339">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4459d3bbac2644ae99e4b532e143767b_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtNC0xLTEtMA_6bce94ca-8655-4825-a952-790fe25929dd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58865b745844ff890bb5f1166984a27_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtNi0xLTEtMA_cb6aefc0-4651-4ae4-b6b1-426a5e777e4b">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09eff6286d14ec48d858094f19da7cd_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtOC0xLTEtMA_f0e18908-9581-409c-a2dc-da9e3b9f2e56">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adf09430df24472bbed2f462ed4b1b9_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTAtMS0xLTA_0c5961f8-bf54-47b3-aecf-4c59c4860052">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8287111b10174ec98d26d3aa97917df0_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTItMS0xLTA_b46e518d-0f2f-4d80-8a00-81b9144c9dfe">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f5c18c207ee433db038e9927f2ec41c_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTQtMS0xLTA_4e7481c8-5c2b-4a5f-b07b-6b555e6158f3">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fdc0c20d21e46e39f5a774886ca08fa_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTYtMS0xLTA_67e1785e-f3cb-4827-affa-f89d20a572a9">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letairis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2274275fb74059946345b7e79e2776_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMi0xLTEtMA_5c9f18bb-b30d-4df7-a410-0fae2d0d5118">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023e3c59b73b4c7f8d3da3030435d0c1_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtNC0xLTEtMA_fe378ebc-8d97-4c92-be99-fe3366d68852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73a8929861940e2a2c89e5e42452c04_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtNi0xLTEtMA_a5d8a558-4c94-4ea5-96f8-354e6fea5797">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2a016a7766464484ecbb334372727c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtOC0xLTEtMA_a5de0eb5-dfb6-4a49-9ff1-857fe9c75348">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5582c730584d4002b1814d828c048d1f_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTAtMS0xLTA_ceff7f05-ace9-471d-88a9-c832ebfc5c94">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc774a64fa54549b0e01a1765162583_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTItMS0xLTA_380b43ca-b2af-4f5b-9c40-0badcd542b8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d4379fd8b24c718b703229ff1bdb41_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTQtMS0xLTA_3e2fef15-0b7b-4128-b8af-2dca996d63b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df27de735a2435fb01a652087a96fcd_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTYtMS0xLTA_ef76829a-0b93-4780-bd78-d03c74f3cb0b">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ranexa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc70b538fbd4236be65e5c74b37b74c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMi0xLTEtMA_5d53db5e-999a-4513-bc3d-15acd1ff274d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae2a10921654f3e990c42a09a686fff_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtNC0xLTEtMA_ecfa2aaf-0376-4e62-b2dc-8773e402865c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5627a8aa26e48b8a494fc4c472f2e5e_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtNi0xLTEtMA_060033c2-02f5-4ac9-89e8-d54f5479b6cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0448ba338934e15a3d8c6bb32a0c7ec_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtOC0xLTEtMA_14473936-f048-4f3e-a139-337222002971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdce8cc1010a433d867e9991049ce48c_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTAtMS0xLTA_c6068fb8-446f-4a68-8e16-4b9159288257">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12865b7767774a1c981d8f35ee6a2976_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTItMS0xLTA_ac0a6a76-fd72-4c12-9baf-d39736b32380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96870ee369b3451bb3e3ad1e5c6f0632_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTQtMS0xLTA_96800f0c-1380-42fe-b8d1-7366d70af5cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8638be037d2a44e8a36d55221e058f60_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTYtMS0xLTA_0576f350-f008-4af8-893a-787f8681a78b">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sofosbuvir/Velpatasvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f1e832a84c4cb48a7cb31c748947ca_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMi0xLTEtMA_48cac303-dae1-4c56-87f5-e8ad9935bfa8">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ead7edc72f24ce5915cebe08299ca44_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctNC0xLTEtMA_ddbb60a3-c165-4fa4-a154-3f1f42978c71">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7dc5506b3a434a8de2b4b60fdbdcf5_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctNi0xLTEtMA_5e7ec18d-5912-4643-a085-2877c720969b">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd8bed6771947af86f38ea8c65de78f_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctOC0xLTEtMA_0da560f4-e125-4207-9f66-df8fd089e3fd">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b267b50c2af4842a3de6c83f9b6ab45_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTAtMS0xLTA_ce4f1710-9688-4647-bfc6-ce501f0a6e3f">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0d8f0313da4158a72192a2602a6ee4_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTItMS0xLTA_d4e3deb3-8239-4b2a-b981-1d0ee88ece0d">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icacd2391f4764a14ab37c6a4543fc4fa_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTQtMS0xLTA_e73bdaa5-445d-43e5-ae4f-4641c7a8a027">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d18645d77f44dfe871bdfeab7f7edbf_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTYtMS0xLTA_7b221869-76f3-4327-b740-8d3053bc62d9">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebbbb7c948845dca583fe54913d5e89_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMi0xLTEtMTQ4Mg_369b6f58-1a3b-4fb7-823e-e83a3f37e32e">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec3ebe00aaa45b2bed5ac91c8cccaaa_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNC0xLTEtMTQ4Ng_0c06bf02-abd1-4941-99db-8a28b0f3c78d">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e56d52f566e45598878238694ba623c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNi0xLTEtMTQ5MA_2e9165e5-f6c7-4f50-a3a4-463dbf69df61">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26b2c25650b44b69acccebcc55606d1f_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtOC0xLTEtMTQ5NA_3b16afcc-532d-428b-a32b-0ad53cf80b73">873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9e3da549e244cfb2c9f5158ec401fd_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTAtMS0xLTE0OTc_bbe5931f-7e3b-46de-bce5-ed80976f045a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c745c22464ce3a8fb3c8cebf5ed60_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTItMS0xLTE1MDE_4e3730f5-b966-4602-ad41-974afa0ddff8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d68e9a626743bda07e2eefb20fce19_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTQtMS0xLTE1MDU_45d87dac-20a2-4e3f-a7f2-0586812dfb7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cc2d2384f34425b810bae675903dc8_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTYtMS0xLTE1MDk_52b0baa1-ed90-40fa-95d8-66dc05df26d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vemlidy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e964e7db79a4ccd99b0c7be936bf507_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMi0xLTEtMA_40ee710f-eaef-4be8-be4a-3280cf937de2">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d58a4e6c2d84e70bc347ef87d4a87f7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNC0xLTEtMA_d91f2619-1f20-49b8-981a-c5ef2791e5f8">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046a86b5fdab4ff1b14916d76f73e510_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNi0xLTEtMA_e571faf7-8750-4962-8d0d-b65ed316c18a">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e70ff742c140d496526d7b1527c3ce_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtOC0xLTEtMA_98dc63fc-98be-42cf-acfa-9db1b3386192">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb9eb566b2941829c54cd50ea568c38_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTAtMS0xLTA_14696b93-8e8f-4726-a5ca-01821813828d">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b5a4371abc747f3a1a8c3bd6ed8c486_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTItMS0xLTA_dd04d0fe-401a-4f83-8cdb-d54870d1e9a2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3084899d86f64538b7a6f2a33bbec0c8_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTQtMS0xLTA_1ce0ac49-3be4-4f24-a783-307a9b58c9d2">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600ed37165bd4db9ae547ea571cb7978_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTYtMS0xLTA_a31b47ca-737e-42d2-bf94-563964789b9e">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viread</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101ecfcaae0e4864b20047dbd8a3e1fd_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMi0xLTEtMA_a0679ed2-151d-4861-b1fc-07d156d9ca9b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684803a0664e4bfcb6efc1517674d221_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktNC0xLTEtMA_7df62dfe-fb68-4e8e-8131-269a5fde4c5f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff41edc76614451b4b1bd6a03d7ae63_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktNi0xLTEtMA_a00c29a1-415c-47ce-8f9c-ab9dfa0bca83">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i005d53c4c52c4720aeb394e3fbb50e7d_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktOC0xLTEtMA_7a4fef71-7a37-41bf-a214-12b79e753524">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b6f6af4c6542d191026032ce0f1df6_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTAtMS0xLTA_5f0ff6a0-b489-4b93-bbe6-cc6d74087302">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bb9c7cfee24ac286f7fff99b0c0715_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTItMS0xLTA_137476b8-19c4-4657-89bd-3880511b25e9">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f1ffa20dec429da02ec0b008e998ef_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTQtMS0xLTA_285e6dd9-10a9-4ab7-a536-e443445950cc">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3caa46f38f41edbc114ca92e65b04d_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTYtMS0xLTA_0c189f2b-9c58-4d00-be06-2bb602f4bde9">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vosevi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84113ab047d242869074a29c0fe984ff_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMi0xLTEtMA_afa11c39-f899-4288-82be-1dddad8ed4e7">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibebac49aadb9416897c8ab8c4cce79d7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtNC0xLTEtMA_c0a77f88-65e2-4615-abb8-c3250a03a1d6">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i420f5df1a84346a6ac938d443c5e8a4c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtNi0xLTEtMA_51465670-6e67-47a6-982c-d552e16f3f29">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76dfe31026e42c694ebb48c2f5b658a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtOC0xLTEtMA_a3642f38-0e33-4651-adb8-b8788b030f9a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8628d1ff0448278a92b391d45f5eae_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTAtMS0xLTA_803aac99-3bc7-46a1-b9b2-66950170cc5f">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47125f71c9b44d7194c89e9640d482f3_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTItMS0xLTA_f5738e3a-8a26-488e-96b7-af667ba2c4c4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39cdba108be14c79af8376028b06b4cf_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTQtMS0xLTA_4f6ff0a2-0a2e-4366-b81a-b5def235daef">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eabf5693f71408c90d3d4cc46f5eb22_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTYtMS0xLTA_e054ebdd-aa3f-469a-8dfa-3afc352f1c6f">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yescarta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398d207fdaaa461195fbeae21a779dd8_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMi0xLTEtMA_1e530295-1c84-487f-b2af-03a04f225297">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d38dfb8dc048e08df6eb090d1f549c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtNC0xLTEtMA_1249f0f6-8354-43c1-a462-2e0c748cf343">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ad8ec3782bd4ea2a07fef27fa912cf0_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtNi0xLTEtMA_0de7a3b6-9169-46dc-9cce-701f4eb39d7a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135bbf9df1b6455c9fa3dafbd8eb2d1c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtOC0xLTEtMA_45cb872b-ff33-458f-aa3c-be00717dde23">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c82e95c68504866bf36dd9d81d52cf9_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTAtMS0xLTA_76f052ee-90af-4e1e-a769-266d489054b0">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe3be05bfa934699977eb8087f45d14f_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTItMS0xLTA_3c1137ee-8ff4-49ab-a666-75f00098f877">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417780d1b25c4ca8b079ea42b721fc54_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTQtMS0xLTA_2399f056-c808-4ddb-a372-940d54d9c5a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ba2a1561ad4430842ec1db3b8257ed_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTYtMS0xLTA_d6f32925-26ca-487d-a45c-98ca722b5692">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydelig</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id254ad4a4ea547639bf93c052e3be138_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMi0xLTEtMA_5c266d9c-9ae7-4d19-a115-dc6a4dded28a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720551245e854687876b7379d1f78d8e_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItNC0xLTEtMA_d829c1a9-522e-41a0-bb9c-f60780312f61">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife74578569994b51ae64ef03ce69c1ca_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItNi0xLTEtMA_9caf44b0-8552-4eac-bad1-25ab9c44fba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766eabb290f046f2b9e62b6e3784b275_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItOC0xLTEtMA_a847d800-6a31-4cd5-b115-dada05657ab4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0e17ea897448e5912132a36ff6b28c_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTAtMS0xLTA_dfc46a61-6511-4cd9-9a87-59780e49d135">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c060397c8742309b60bf12b6512021_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTItMS0xLTA_f637116b-88c8-4d71-b6aa-ebf428c69e35">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e84a4da6fad46a791ebe608e6ee198e_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTQtMS0xLTA_9ecc6bc9-58a5-4083-bc6a-f123c0d8301b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae5847663714779b1bf9154604a6df1_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTYtMS0xLTA_c3f7e04d-76f8-4433-865e-f5f0623d472b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0803d3be2d04db0a4c0867464be9229_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMi0xLTEtMA_e26d4b9b-74cf-4494-a536-3e83141c0d47">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5b8dca94e743a398f30129643066bd_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtNC0xLTEtMA_c6728077-1aff-4f52-b2d4-4af64b004ef5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c39bb504ba14d2986890843ad30a9ef_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtNi0xLTEtMA_152c489b-db30-42a3-b567-c936f5dd5347">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fd9a81e73348fa825cda04d1f6cb1e_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtOC0xLTEtMA_40af96bc-fc83-4fe6-a091-7bc42a50cb44">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d9ccdd2e0584f9095a5e2c1d8e8c353_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTAtMS0xLTA_fe067d30-2b08-4cfd-b280-758b5929f061">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcae3cba7d164d41a999db4406d7e5b6_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTItMS0xLTA_afdd0085-a655-4cd5-8ecc-7495420304af">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d19a5c115024a04beaf946d538fddb3_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTQtMS0xLTA_edf6a713-208d-4cf1-9106-89a8668dafeb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cc2465f59b5458abb466db3d7f8da8a_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTYtMS0xLTA_0ad729b5-dba0-4f9e-9506-a25a2fac284f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4558c2340efd4a3b900cf6ee1d86b0d2_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMi0xLTEtMA_bedf6ac9-fd3e-447b-9edc-a8dc80d54e5a">5,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc17d0d001d43998d445fb4be3e013c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtNC0xLTEtMA_35a43b59-587d-4dcc-86f0-1af8153e66dd">877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a0767d0f4ae47b39b6fd2f49267f647_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtNi0xLTEtMA_5c05318f-fd8f-49ae-bd24-9220fea75b70">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic38a8d4d52c34caa8db328baf10699aa_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtOC0xLTEtMA_963509e0-1b42-4998-8d34-552fb3f62057">6,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id85ae5108e3144a5a16efecd6144cfbb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTAtMS0xLTA_7572b904-899a-4066-8cd7-d097840cc950">4,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43accb591714a6287366d5532b6fd0f_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTItMS0xLTA_ad8a77b4-7c91-4102-ba9a-dd3b8a52c182">804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a8489222bf149abb359b6eea6f8bc61_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTQtMS0xLTA_12bc6103-43f7-4095-b7c6-c9f5c49048df">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a2687827294d87a300d031d1858df3_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTYtMS0xLTA_bcb862e2-0a90-4833-8cb2-97d87ef3850d">5,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2645cba50844271a731aae129127e28_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMi0xLTEtMA_360e7c8c-b29c-4d09-8858-e89432b9767e">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e766da00a6e45ac94d46524fc6f1728_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtNC0xLTEtMA_6d3ae96e-9db8-4aac-aacc-ced3912db54b">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871689c0193846e98c4fedd49ddf8879_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtNi0xLTEtMA_f6ce2b67-28d8-47d3-863f-586d8a3b1536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96064d1c8c184d5ab1297ec54cb44590_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtOC0xLTEtMA_e3636578-7e75-41d5-8d21-396e759d8062">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia934aa3ae79b4bd5a663f8ac317ecba2_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTAtMS0xLTA_3fd54a6f-1d23-4080-a3e3-7a2f837e7afb">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abcb64ac3454f9b8c7088b53bbf545a_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTItMS0xLTA_e8dfe3e3-b167-498d-aa3a-ea1b51017798">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd381436407454e84dd9a12523cff3d_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTQtMS0xLTA_048a83d6-069b-4cba-9bc3-ebea3e355e26">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf6dd01e1e2047839e25939a3ae0a70b_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTYtMS0xLTA_be1b9fac-bc42-456c-baf4-ac78513a02e4">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad03c82878af430ca095a94ae4b7784a_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMi0xLTEtMA_71a20102-de60-4ed9-b669-07fbdb38968f">5,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb823a15d78b42bdbb60a26249e4c280_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtNC0xLTEtMA_1078f513-2a80-4eb8-a135-a4a875201f84">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i075da22059a446ea9056836364417160_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtNi0xLTEtMA_638d756e-1655-4443-ab4d-8438ba80fe58">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtOC0xLTEtMA_af104fbd-ce08-4619-adba-1c882a99546a">6,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife78a8506d7c4d589c917a4f5d611434_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTAtMS0xLTA_acdbae21-23dc-4885-8ee4-437d3cfd4901">4,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9bb7b9b91b746c9a6316ed3fbdf29ee_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTItMS0xLTA_1648b45b-6b2c-4c55-805b-3cec681bc270">871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b50ecf683a64f88a5112a6814698895_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTQtMS0xLTA_fbfa3494-5087-4489-9496-8cd510751f3a">514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTYtMS0xLTA_c3c9485d-01d9-4c83-aea4-b645a18c6922">5,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i6985f15c737046ddb523544d88f7162b" continuedAt="i5b75b49baa8848c4b2642ffe845ed2dc"><ix:continuation id="i66cabc77d07c48b5a3dde9bfc8eabf98"><div style="margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Atripla</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f2796e131745b49722c54e29dd1a14_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0yLTEtMS0w_d78f22ce-41c4-4029-94cb-c2287586f047">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540c328c3fd14b1bab1625ac3b70947b_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy00LTEtMS0w_3c06ab2c-c961-4d1d-8c59-2234b443553d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4147a1bf6ed04df392a5e94f4d66f8ee_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy02LTEtMS0w_d5cf18c3-383b-411f-80ad-66f65d59fb96">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b3c544ea4624677af1db8cc46d8ba43_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy04LTEtMS0w_34c0182b-56e1-4c24-b5a2-9c149bfb9822">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5390c9235c84fc5a5e7cfe2a469da26_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xMC0xLTEtMA_0cca9334-7b90-4040-94f4-a762dcf41926">387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83641512c7304560a36b1a26f5a833c6_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xMi0xLTEtMA_1b2e7992-3fef-40e9-a397-d77e247d5e03">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d94b806ce2c4380a472c5ded0a0d478_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xNC0xLTEtMA_69e7a19a-aa7d-4412-b001-23658b779292">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8447af5ba87c40c0b94c057ccb036d8d_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xNi0xLTEtMA_0f3bce20-7dca-4864-854c-0063440eb811">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biktarvy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fc0306b3664070b9024e4164bc3d18_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0yLTEtMS0w_0c4e9c8f-8c19-49b1-b1b0-88e084085b4a">4,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8053154621043638573e26bca07c8e2_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC00LTEtMS0w_0b605782-b3b4-4836-b9d0-f02a1975c6c9">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0b80da40d144dfb51e5296d491561d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC02LTEtMS0w_5e838b3c-bf3b-42cc-aeb9-4d4ff1d996c1">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c7bdbf4839341078ab571b1ade61e83_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC04LTEtMS0w_af29e8f3-c261-4e4b-a120-a2718c254a47">5,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id44c5b80cc3c4605ab9a62fddf9b0edd_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xMC0xLTEtMA_36ace52a-4308-4c98-8645-dd8bef05090f">2,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9255844714024bfaa7176a097341eaf1_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xMi0xLTEtMA_3c38e1d7-3b51-4db0-a8ee-47a6fba9e848">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id46c95e16d09481db3bbf57af272cc8f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xNC0xLTEtMA_59ecac00-49cf-48c8-af7d-4ee4d095a4ee">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf44eb315184b4daea10d586af9bb99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xNi0xLTEtMA_a866de4b-6cda-4b4d-9482-f1e41462bc64">3,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complera/Eviplera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ba3f34d91ba4467a1b960bb57ff4f77_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0yLTEtMS0w_a2bedceb-82ff-43b7-a631-03c7a0da135c">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icee191d2a7da42e5b2888a7142bc28e5_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS00LTEtMS0w_b0355ab9-0416-4f82-9475-9a305946e08e">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97761b52dc964ca1b75b02bb63e6f7e5_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS02LTEtMS0w_74a8bc5e-9859-4bd8-b19e-5bff9998c5d8">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53b54d337a5449196f847ce9e41479f_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS04LTEtMS0w_1ca3dc9d-003f-46a6-99a1-6e71a8275884">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750af09cffdf45b2aaa3f24e2a2098d3_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xMC0xLTEtMA_a4075f60-101b-40b4-ac7c-df00e56d028f">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e68305b0ec249bea1c290a603e685b2_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xMi0xLTEtMA_9aa177d7-1223-4fe8-a7f2-3c83fcf31719">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4a6615211c46d2927e8dca0a2062b9_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xNC0xLTEtMA_96494025-95fe-47e3-a57b-eeb0b031c2f1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bee71fa9ee64eeba4daeabec5940ac3_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xNi0xLTEtMA_80b6dd1b-c2dd-4939-b5ce-a541b27ebf7f">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Descovy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56bf813b0d4440c08a3e4699f552745b_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0yLTEtMS0w_978c44b3-d717-482e-9895-7d2256ee3090">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231be2fba64f4bf896c38f1aa81104f8_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi00LTEtMS0w_418dadc8-f9d3-4306-ac13-ef67750cbe5e">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c573558c37477bacbe4f59e9970f84_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi02LTEtMS0w_27a7ea02-7fa6-4b76-be5a-874a9b8db749">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c61cbc63afb40c48e57d8fdca17c0a1_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi04LTEtMS0w_b16e8231-7336-4777-a174-603da772578b">1,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee265db13f644ecbcffa4b46083b9c2_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xMC0xLTEtMA_f12f8888-9112-444e-bba0-e71822aace3a">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9e932ecab3d42f0bd2a802ca26cd95a_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xMi0xLTEtMA_15ee0e6b-3683-46b8-b065-7a1aa0b4d04d">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ed61a0e5644751a963832357838e7a_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xNC0xLTEtMA_82aba944-e5a7-4698-be18-3a39d0be9713">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0740e92dc52c4649a9234a51ea22bc60_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xNi0xLTEtMA_7c080644-fa7e-4a80-99d1-c52648d1a6e7">1,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genvoya</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ecb7cae048e406eb9a99e8d678c765b_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0yLTEtMS0w_69cda323-f7b1-4bba-8ab1-163abe074ff6">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0dfbec2369f4a4d84782aa2a96b2dd6_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy00LTEtMS0w_f2ce63bc-125d-489b-89a9-c34804d5a260">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29f0cb97877c451f8d0410a288a7c508_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy02LTEtMS0w_0a622eb7-463e-4a39-aff4-76c2bfd2e3ea">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i742e3ac34dc14d3ca51197c0177e3a0e_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy04LTEtMS0w_89f97b93-ae00-460d-b15b-7686118f776d">2,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7412e3583c694088b81933255ffe9b92_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xMC0xLTEtMA_97f5202a-ee09-449f-a61f-47f8e624cf74">2,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i384483b6f05f451d8e772b8b5eebf9d2_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xMi0xLTEtMA_4db329b0-a01f-40b5-bbbf-4486bc7927c7">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9705c0a59c384067b58147f9968d335f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xNC0xLTEtMA_afbe0fbd-4c1c-4b33-9b41-343c3e6e0263">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bde46834ced4ac9aca77149c77ff785_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xNi0xLTEtMA_261bffe2-498d-43e4-b82e-3f71d0341781">2,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Odefsey</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467448f2935c4949adb25f0dc29fd71d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0yLTEtMS0w_df434a73-e30a-4daf-8936-a8ac28e5100a">851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c9b9f109374b3a9fd9b41bac8d04f6_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC00LTEtMS0w_37ddfc9a-10db-485b-a4fb-477e537daec6">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4205c2046c4142803828d004750696_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC02LTEtMS0w_e09735d5-be9d-444c-9343-0ae1675de0ec">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a68dbfe80e344da8c9c590f8e88b515_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC04LTEtMS0w_e30b1582-50a5-470c-b3b2-e2088e2bffe1">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d9f10d767e14ff0996e4f9207bf98b8_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xMC0xLTEtMA_d33f1014-c172-4d96-a49b-b4949b96c4e3">865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8126adf8f45426599f7339d161fd9c6_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xMi0xLTEtMA_76c8bea1-3d9b-4ee7-afe6-632a7c07fa41">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3631587c26c450cae9fea5710c15b8f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xNC0xLTEtMA_b9f499c4-d949-4635-90ab-3732a888f69f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34b59098d814cb0a08a98e99e0c60a9_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xNi0xLTEtMA_7934b712-0a01-4241-b3ed-b8a852e8178a">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stribild</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290b413904764919839f932725c8daaf_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0yLTEtMS0w_d2f4b288-4e88-473b-a5be-45230b60db2f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851f06a9af1042fcb2a409bbe3756a72_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS00LTEtMS0w_4a6b0c7e-8fb1-4954-886e-8cb986dd9164">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783ec34abc8144819c7e7d092ae11132_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS02LTEtMS0w_a8bf47db-8d7e-4b7f-9dda-091be2e136df">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755c8fddb3d4084bf2b80625b08ea26_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS04LTEtMS0w_c20e5046-90c0-49e3-9e6f-5cdca597353f">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805a20329e504fa2a33c2687c7ea5ea9_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xMC0xLTEtMA_bee521bc-263d-42b1-8a73-115b388cd924">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01577dfbd4f147ec828c3cc0fb9ebf13_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xMi0xLTEtMA_80683970-0e1b-432a-88bb-d6165255f070">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d0a27e691146369f40b9b33565966a_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xNC0xLTEtMA_a3a18057-2fbd-447b-a601-7b6905349e8f">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95eadaf94faf41fba9c79f5cb150e93d_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xNi0xLTEtMA_af745a19-7e28-4cc6-8b85-b99b05d785be">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Truvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc833249283042d5b7c62e05feb45290_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMi0xLTEtMA_66fb378a-99fe-4f9b-b74c-9ed7be021744">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e84af25770413aa8f9456d8ddc2e52_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtNC0xLTEtMA_e0527f74-ae3c-4f6b-96a4-11fdb7ba07f8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied066108123545128f8dcb45a48c3bed_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtNi0xLTEtMA_e9293858-b48e-42f3-add3-3bce2eec2e4c">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7cd5d5e7a442f48cb8b9feb0094fe1_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtOC0xLTEtMA_8703befd-0e8e-4638-9cbb-b35f95875ce9">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc1fa1c55740df98bd6134594b7219_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTAtMS0xLTA_7e438bca-cc69-4a11-babc-5cdb2fc5382d">1,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d87e9eb0a54aa08eedd0dd9ea5c4e3_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTItMS0xLTA_a1275fa1-3674-4f9c-9627-c7d4f29d6717">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb35282d4ad48f783dd0c11877ba0ec_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTQtMS0xLTA_a7be886c-85ee-41cb-bcb8-8996dc87d6ad">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81dc6799abca4db8ab88cae7fa763d01_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTYtMS0xLTA_04652120-52c5-4794-a30f-625f36c83f27">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other HIV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727f0920e4f64f1880a2ebe8c13e3bcb_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMi0xLTEtMA_bd968cd6-5d04-4bc3-bdc4-af64ab7c5ddc">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fe7357a4c84db8bc7fca6f59f5bd47_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtNC0xLTEtMA_9d302a97-6f2f-4d3e-ad59-3cb460822d41">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bc28b56f8d48139043a74668f46dd4_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtNi0xLTEtMA_fa4bad18-390c-4a44-9b68-9ab4e6294a68">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe112c628c62494ab437ea9eeaebc991_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtOC0xLTEtMA_ea1cd606-5a6a-400d-961b-4d046837fd78">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852a43ddcd8046829ad1899671088c66_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTAtMS0xLTA_3456d1e2-ff94-4957-ae80-762f6e87eb35">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a35be3874ab4149bb860d0946e69a81_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTItMS0xLTA_874fb0ae-8467-46e2-a125-e46339015837">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b92f07f2e0a47c3a983d243a98baf35_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTQtMS0xLTA_c50614f6-2e99-44b0-b49e-7f7551819544">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc785f3b9046480faf38fea90b8c3023_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTYtMS0xLTA_c9a42a91-122c-4421-9698-987bad20673f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue share &#8211; Symtuza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aebf9bb5c2346d6a0b7ca54d4d4eabc_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMi0xLTEtMA_8a64018c-dedf-4fc7-9aae-b40fb8595c24">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9292897cc8904a42948da3e2971f4571_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItNC0xLTEtMA_8fb5d969-5de9-4bee-8b07-0c3770299ef1">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e9ec444a5cd49f1bfcd9dd0820a2023_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItNi0xLTEtMA_8663ea6b-954a-42b9-b243-480f4f081fc4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9bc6d09aec41d184db3a49214b840f_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItOC0xLTEtMA_a7c17fea-922a-4d64-ab52-ce0b283cb4b7">362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902da8b28069408a8c42b356a90a4950_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTAtMS0xLTA_dad715b4-9132-4795-aa14-2b7ac8f01411">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2f089d53c447b199f1aa839ca1668e_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTItMS0xLTA_0ece6f38-d479-4a90-b46d-927cb58edfda">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia189ef02a42c4b41a97661844b973b00_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTQtMS0xLTA_b9514d34-1009-4c14-ae6a-e8aef003bcec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e30ef252704139a8c49152c92d6fe5_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTYtMS0xLTA_b23a2966-9730-4d13-ab83-9381ec7c4cc0">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmBisome</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb2e5ffe6574e3bb9835ef3ad021eba_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMi0xLTEtMA_aae15535-5e29-45de-bb7c-c39d12e57aaa">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f7621603774791b39109ff98d0b462_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtNC0xLTEtMA_0219a5ad-21c2-4de0-9be4-ee5424df265b">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6876a3bead0430cab7025f3a176623c_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtNi0xLTEtMA_23bf896d-9b44-4ca0-93a2-bb1b8851127f">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216dcb7f79948829a9e8c0013253508_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtOC0xLTEtMA_ae2cc0a2-7459-473c-85c7-2ce627da847d">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38621f45cc7c42abb0b3b65928e20ac1_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTAtMS0xLTA_c2454c9e-9abe-4b1f-b11f-499fe7d386e8">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a4279f407d406cb284cc2edc96ad1a_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTItMS0xLTA_de962d96-dd7f-42c8-84d5-97de185fcd85">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82688362eef04085b653508050f8f422_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTQtMS0xLTA_02f99ef2-2264-4a63-95ab-fd08ac3ac4c3">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d0a82cc5d540e987b6673d38b892bd_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTYtMS0xLTA_376060f0-ff81-48c4-bb5b-c7a8cde98b2a">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ledipasvir/Sofosbuvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14da41d357c4519ad6e0f90343d204c_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMi0xLTEtMA_5d034298-c23a-4978-8433-9df619bf975d">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97ad43f65774b7094b3a379df786172_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtNC0xLTEtMA_5a24d976-d9b5-4215-a9c3-46a766f22772">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3bf3186cb94890a8c57a6616584439_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtNi0xLTEtMA_1bf335bd-f2a2-4d33-a50c-d12ea635d101">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia45b3f782eb04b7e861b03896b46c351_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtOC0xLTEtMA_ed856631-36f9-4a13-885f-abe5e395496a">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03eef6be4f4649c3a18607489e2d41fc_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTAtMS0xLTA_2b2e7231-fcdb-42e5-9254-a7c052629118">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b54e6960b4405f8590d818220a3f95_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTItMS0xLTA_5976e243-b361-4dfb-b4b1-1ba12b43a577">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd48fdbbda9146a484254f1e767cc90c_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTQtMS0xLTA_89b691b5-a4cc-4ee8-b68b-84edf1ea7287">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883550dc5b2e40a5bbb96599635c444b_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTYtMS0xLTA_88615243-a59e-4d3e-a8fc-e193ba80e9b6">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letairis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf480b492bf4fe09ebf0fc197965303_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMi0xLTEtMA_0c7a6c92-70bc-4f30-b853-c5572933a0b5">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9bb91712e39437b936294b2735c13d6_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtNC0xLTEtMA_e71a4b4e-d925-463d-8195-69755f519b56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5b7f7113df4f099c265bb2954a56eb_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtNi0xLTEtMA_8c4d7807-fe07-4e19-ad38-7f7974a0e67c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3484e902294670acc409da1ba4e0d4_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtOC0xLTEtMA_9c237e08-a59c-427d-8710-38b874cdae7f">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2641a1a842544e209516e50ec96c27b0_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTAtMS0xLTA_4d6b4ee7-088c-42c7-aaa9-95ff2fc93fec"><ix:nonFraction unitRef="usd" contextRef="i2e6404156b2847f181b5d1bd7b274323_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTAtMS0xLTA_d48d4b25-da98-4b8f-95c7-72f68e7d9138">522</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770bcef54ce64fe388b602f9e6584063_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTItMS0xLTA_3f06a69d-ed2f-4883-a14a-be4b96ea789c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dac5ce142294efdb06ad2c8c9ec3cea_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTQtMS0xLTA_acc2b82d-e5cd-43be-8ae2-40fc906d6cda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2641a1a842544e209516e50ec96c27b0_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTYtMS0xLTA_4d6b4ee7-088c-42c7-aaa9-95ff2fc93fec"><ix:nonFraction unitRef="usd" contextRef="i2e6404156b2847f181b5d1bd7b274323_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTYtMS0xLTA_d48d4b25-da98-4b8f-95c7-72f68e7d9138">522</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ranexa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc1d1479cd648439d07c37d2ab148bb_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMi0xLTEtMA_39d416f6-5374-4957-80f9-2a4a3c657e82">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b4d4435c8a4f83a0f27f31211068c5_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtNC0xLTEtMA_39f08de2-2411-4ea3-8c60-d664e04859c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e0424cfa2f4e97b30415fd7e13e4f2_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtNi0xLTEtMA_77a3ff52-68d5-48d7-8754-38cb74dad3f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a3c4e259bef48d08c592ec5a9e88090_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtOC0xLTEtMA_3875eadf-7018-4690-8909-ec47e765d757">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fdd8a2b3e147d395c164637e7427f9_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTAtMS0xLTA_56d37787-4e27-41de-9f92-4ea0091a2ceb">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0fee0ad1ea8468fa383b85fe7b7143b_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTItMS0xLTA_53c4c8e5-e602-4dee-90a1-58e87321b203">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d935f01a0e4ce7af8e635a7a172ab9_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTQtMS0xLTA_ff782473-8f4f-4d0c-90f0-9a66bcc729a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eec3ec224342aba0682ca3a09c4082_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTYtMS0xLTA_f7625ce2-dbd1-4597-a02d-3725c4d3baea">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sofosbuvir/Velpatasvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28996bf75474bb6b566e27bdb76a76d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMi0xLTEtMA_d3a7912f-25dc-477e-a4b1-328d52813855">646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i168a1ac690494b26a0ffda594222e1bf_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctNC0xLTEtMA_7104a493-12f7-4548-b4bd-aead59c4454e">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4480c0b7198d4340abbdea40d9168391_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctNi0xLTEtMA_bfe1ea89-2214-4442-89c5-361564467b4c">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i255cdd4a6e2745f6b4c4695c024a26b5_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctOC0xLTEtMA_4edf42e1-6ed7-4fd0-95b2-4a6e21737524">1,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i813e081e9063466a97d1059c75816be2_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTAtMS0xLTA_7fc5efac-be92-4f46-833e-ad7eb908a0d6">731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6244d0354fb04ecd8098b5e3bac74231_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTItMS0xLTA_cf62d66b-8e57-4a1e-bba8-97472e5a6860">428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1edb8c2b0045c7973d66c486950a77_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTQtMS0xLTA_45409e05-91bb-471a-89cb-8f60e50bff36">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if758b0a643444e158af4faf00dabffcb_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTYtMS0xLTA_6aaf973b-c899-4f98-8434-2eaef911eaa6">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e47efb0a051404592f124c05e259845_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMi0xLTEtMTUxNA_5d023f41-0df3-4c02-997e-411348366343">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43df52b49eec4fd985700ab74700f187_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNC0xLTEtMTUxOA_e92b5f25-ab30-493f-a5e7-d413ea67652f">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ecda589633462d9718e5074b78e1f6_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNi0xLTEtMTUyMg_a43ea6aa-be28-4993-9a52-65b127464a21">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if14a0f64631c43c587d9d721103ee2c3_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtOC0xLTEtMTUyNw_4b3b0076-45e2-4797-ba51-86d235c434b8">873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i174b7d15e02f410b8f1d31ccdc7a13ff_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTAtMS0xLTE1MzA_01cda4a4-7962-4397-91fa-539cbf84d972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844571eb2df140729ef8179477274f42_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTItMS0xLTE1MzQ_e2e63ef0-0925-4feb-bb6f-4d956d0e97f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28663efe02324a84b779525d9431c777_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTQtMS0xLTE1Mzg_5e0cfca7-e01e-4d37-8f4f-80fbe1c7cce8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15345e0a267842739752f2512f08855f_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTYtMS0xLTE1NDI_2fb31a49-ad4a-4335-9430-5b0fce8cfbda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vemlidy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12734f9dde1a41feb3c30e72d478860c_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMi0xLTEtMA_9eb111a4-2ae9-4ef3-a865-cc805bc6b531">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60ae20d01ab4ca884b6a676ad457b13_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNC0xLTEtMA_080aee2d-1049-4c40-92a2-43b90409e9ef">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f201861e937474292f64e97131f815c_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNi0xLTEtMA_7a70880f-5377-4636-bc25-bc801e14db45">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41acb1f4c6d84c1c8cbda1fd11bba630_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtOC0xLTEtMA_021fcea3-8dc8-490f-93ec-f5b64f4154f3">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2acca92b854994b32a72c07a2aed73_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTAtMS0xLTA_2f647c23-9208-4c41-9e45-e899ed1a23c8">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95cfac35a9a4dfaa8213afe8cf1742a_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTItMS0xLTA_0deec2ef-ce4f-4a61-9925-df4781e45731">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide92661b1b6740029933d532260622e8_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTQtMS0xLTA_892175d4-5a1f-4ac7-9201-74b7f92e9ed2">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5d9b5844fdb44dca1c2ccd68053d3ab_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTYtMS0xLTA_64321be7-f226-4127-9dc7-d57d8acb346d">351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viread</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4924f62835d947d593de516d3eb5bd4b_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMi0xLTEtMA_b18c597f-7a03-49b0-84d2-8f0f17737cab">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b19822d0cfa438e89b18807a9cf9e85_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktNC0xLTEtMA_25e2f2bd-4786-4e62-9dab-b3a8492ef73a">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bbfe6897734d888e60bf1689e0476a_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktNi0xLTEtMA_518db2ac-d518-4134-800d-d411eec4954c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7c3fa3e98e64124ab3a4e81c8b27cfb_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktOC0xLTEtMA_1ada29da-d688-4daa-a09a-04d8ee3e357d">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffcf254dcfa549e8af3b55df2a518bb5_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTAtMS0xLTA_0ca2d531-b70e-4234-995b-acbe49d2985c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaef6b26552d46d1a943326e4f631348_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTItMS0xLTA_fcc3327f-81db-4c25-80fd-d9a6b911659a">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia091375d714a4af68c9a4c3286c57151_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTQtMS0xLTA_42a65600-c914-4073-9f3b-45577176469a">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i469fb002cdb84ed4a5287f8c3a0c82f0_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTYtMS0xLTA_4b16eca6-f0f2-4af3-8f52-ae081a6ed1f3">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vosevi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie801464f2af24b6db9580bcc799e8ed0_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMi0xLTEtMA_9cb7d776-7596-4564-9271-364033a0bba3">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e28ff274164fa5873e4f98ae0032eb_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtNC0xLTEtMA_32a400c4-84a1-4bce-b05b-ed27c6ea4272">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a8067a5b7a4233a4795cf8b3a1e2de_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtNi0xLTEtMA_93c5e933-7b60-4d7d-bd42-3e46ed428877">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640acf012c444e8896d04840405bc26d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtOC0xLTEtMA_fab68834-9e7b-402f-a696-dec9aa9a5a30">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6189e39123304106b05d084b2f10f2eb_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTAtMS0xLTA_6e11d85b-43ff-4fb6-9c90-c71bd8ba7074">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369c0f4c20b2434ab53ae12dfd9718fe_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTItMS0xLTA_edbde77a-a975-4e5b-81c1-fba64e88ff11">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0609460d710a44d795a4a5b9718c88ca_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTQtMS0xLTA_bf663492-4719-40ca-afaa-56d73acfa84b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2525996f7074ffe8fed7cbd90a965d4_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTYtMS0xLTA_e769d1c5-dbeb-46ab-a39a-5fb15fa133a0">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yescarta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b971cbacba4ffcbe41b30a57c4ada5_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMi0xLTEtMA_e96f3282-0f66-4cd1-bd76-6c8fa2fa8307">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf5589198704a3a9eaf1b0b016c3346_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtNC0xLTEtMA_6b539b97-c22b-4e12-9d50-d50839b4712a">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a49d3ca5034dc399ac09438153fe99_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtNi0xLTEtMA_86872d9d-1a2f-4b73-ac8f-8098b992233c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074bdcf660fb4535964c4423fbe341ef_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtOC0xLTEtMA_bc3934ec-980c-4008-aa5d-843d568d05ba">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1ec0d72918417a956f0174b7d3c346_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTAtMS0xLTA_84240f6c-82e6-429b-83b2-fd2225b96ce8">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1824caa947414b7096f32b2b67d14786_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTItMS0xLTA_0124f270-966c-4b47-b0a9-bdad4536c946">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a83c69b2be54c018955d99da45844b7_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTQtMS0xLTA_2cd433c5-5d7f-4ee5-a838-89bfeba6a9fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe54791ae9241c4aa29ddeb88cf9d1e_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTYtMS0xLTA_8c3f20f2-2e31-4fbd-a046-629436a215df">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydelig</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251385f2e42b4b1aa5d365acc3ea9c9c_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMi0xLTEtMA_1eefaaa4-8c66-4341-9cd6-88ebc6b03212">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b331bf063c54bfabd806c7596fc3c27_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItNC0xLTEtMA_649a7788-c34d-48aa-8714-8e20122395de">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ef2dad4ad2412486b5ea11f53023fa_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItNi0xLTEtMA_2f39b011-5e64-481b-9f0a-092a0dc1f95e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98a59cc78974919ba762eeec3eb216d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItOC0xLTEtMA_2d574580-d943-4b00-ac3b-e93315c83ce8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997559821d1a4a16a73dd88830cf5174_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTAtMS0xLTA_e2d5f0a1-2528-4513-8465-0a9dd2f1c9e4">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ec3d326d4242959cc35197614e8409_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTItMS0xLTA_97e59b1c-ae87-4cb5-94d0-983600433c33">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af4b394c8b54e37830a1db47238b3ce_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTQtMS0xLTA_005c1402-19a3-47f8-a515-79c992da08d1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2247de6dfc784a9b868f0819caf83870_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTYtMS0xLTA_61b73c9a-fae6-4825-af4d-512cda70e56f">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6b25963e724b4e9173371c02a0efb8_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMi0xLTEtMA_8ed9f0c0-310e-41e0-a8a6-40b109dc399a">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d2cfbbe26ee4febb9b48574fd162233_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtNC0xLTEtMA_bf82c950-b659-4fbf-8c29-29129eba72e5">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8060638d08784ee0a62d3f6ca7218aa3_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtNi0xLTEtMA_15af2e94-c693-4b46-82e0-573e7dd75dd7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63441ce40ba84fa7ba414d3c9f749407_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtOC0xLTEtMA_1f8939de-dde5-4759-b790-604a73181cc5">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e8741122cb4adb92eba65068bc4aa2_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTAtMS0xLTA_9c83ec10-ad85-4211-ad23-8ca4eab6d44a">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie92e99fb19404d699c9090195126fcbe_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTItMS0xLTA_10539d7f-37f9-4a5b-80ab-85001c2768a0">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i985de888cc224fff89bc3914c4f615ce_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTQtMS0xLTA_10c8def6-2e55-4c6d-90f4-ed079b06466a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6064ee7dedd34944b949c382cdd8cdbb_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTYtMS0xLTA_19345913-55a4-4202-82b4-7028a66a0fe3">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc19fdfb19b8400abf3317f7988947dd_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMi0xLTEtMA_c17a9f24-a7a6-4f56-9d25-1728891d6e7a">12,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c2677c28fa40e08640a377bf09b729_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtNC0xLTEtMA_fd7b4c68-13ff-45c6-8ea9-77128d1e6958">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad7b65bb41c9454391dd5c4c5f30cdd3_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtNi0xLTEtMA_f9092df1-7d0a-4f43-882d-e82ca1076c0a">1,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia542ffe4c807464b9cb360eb9f6c08b4_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtOC0xLTEtMA_3250a92f-6353-4fc4-b7c2-91a0ceab8e8f">17,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87253831ae434b6c84a09a210ade93fd_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTAtMS0xLTA_85178e7b-93a4-409a-866d-efae242cfb38">12,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70a1a73cd2a4d09bbcea125f90ccdb6_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTItMS0xLTA_2591f618-8cff-4fc6-86a2-19ecf2e77755">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aaac2bc6875471f9ceeb394f6c3798e_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTQtMS0xLTA_d7709e46-d82c-4155-83bb-f79edc69bb6f">1,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ab6f6260e54f569438ef8ea0ff6cd6_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTYtMS0xLTA_e19933b8-31ac-4710-ace6-4107167b22f8">16,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1822fe145b174f858d3559312d4b8f07_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMi0xLTEtMA_c30c27a5-a2d5-4e6c-8171-59c7069ea9c2">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e63b6b02edb4668bfc3e4cf5963b880_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtNC0xLTEtMA_3890c1a3-4c7e-4ec9-98a2-93f6ce62342b">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b020739eb14d59b3f71d4b1dbff8fa_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtNi0xLTEtMA_d6528aa2-26e9-4270-8771-6457ec053a4c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaad7749126c4b9a9ca4c44b1cff7a4f_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtOC0xLTEtMA_943e6a8f-82ef-4520-adf8-12f7746c920e">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c3814004476430eb98633e8d57f0ec4_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTAtMS0xLTA_c0a30d73-0f15-4585-ba43-d81663a55c1d">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581d05693e9a4a06b56980cfd2f297a6_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTItMS0xLTA_2ebee9ab-0527-42e0-9842-fe2f045044c6">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida77997dde894ccf8cb1e4b0f492b8a3_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTQtMS0xLTA_9a2c3ed5-3836-4236-b244-82dc73589913">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6e106923dd4893989458d5e54fa96b_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTYtMS0xLTA_ed723cb0-9978-4f57-8538-734a9e685d13">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74680bc621445ff90e26deda6b247a0_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMi0xLTEtMA_2b3d6a4a-ecba-4f4f-b278-80a7caef53ce">12,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c7d640e5a74988b2acbeca36e215a4_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtNC0xLTEtMA_f9149608-130e-4b23-8dce-4eeb3b6af322">2,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9ba585026444bda0371b5c9792d66c_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtNi0xLTEtMA_c991f986-f6c0-41ad-bed7-5a38c06e0eab">1,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtOC0xLTEtMA_02a4d319-5388-412a-9e2d-a42e727e3448">17,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7edbbe0058498ba07f1c694f172ae5_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTAtMS0xLTA_417f6f18-bb1d-4bbd-93d9-8003a73c1e28">12,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae67afc268c481189809b0cb77b19b0_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTItMS0xLTA_32e7d593-a204-488e-989e-b79ac35426a7">2,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d15d27b4f1147e9a39d0edfa87476a6_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTQtMS0xLTA_f624efdf-6331-4259-a371-6351b06936a5">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTYtMS0xLTA_e0ef9620-c040-487e-bd8e-5eb3c92df675">16,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Emtriva and Tybost.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents our revenue from cobicistat (C), emtricitabine (FTC) and tenofovir alafenamide (TAF) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland UC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Harvoni and the authorized generic version of Harvoni sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Cayston, Hepsera, Sovaldi and Tecartus. Europe product sales included unfavorable adjustments recorded in 2019 for statutory rebates related to sales of Sovaldi made in prior years.</span></div></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues from Major Customers</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTI0OA_658a9d08-008d-4f14-9d07-63f4cfae1969" escape="true"><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmerisourceBergen Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib51bea2a549043ccb4d2d8b9b4e6f2fd_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy0yLTEtMS0w_cff9618a-a014-4662-96f2-afe3e202c858">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d4f1c22279841b1bc41d5c7af3e12f3_D20190701-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy00LTEtMS0w_7bf7ef64-c906-4d6a-801f-c7e521ebad03">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdf756e786804feaac25586f0993f6ad_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy02LTEtMS0w_bb2b5d98-935b-470f-9118-d7f6170a44ec">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0344ff608be498d82fb0639f25f1fbb_D20190101-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy04LTEtMS0w_1cd6519c-9bdf-4d0f-8891-be296003bbc0">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5e4c86e2a164127b1e60622b100f769_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC0yLTEtMS0w_32dd2612-4d53-4948-986d-5ef1c4140711">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3351e615eb324ecfbe90c19cb5ed63af_D20190701-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC00LTEtMS0w_15fa8c62-f755-4a88-b17c-8a1c63b7ca5d">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6cabee79f5b442639e665379940075f6_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC02LTEtMS0w_81502c34-2d15-4229-a381-1a60c5365d58">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2d001f2fdfb4dd69dbbf58a803cf0b1_D20190101-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC04LTEtMS0w_b73fabf8-ad54-4691-9a44-6ea42a08cd32">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd52bba8c8b746ceb4390db580f35332_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS0yLTEtMS0w_f8393fef-a54e-49d0-9629-928aa47129dc">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3a8e91519874ec798163966b238f366_D20190701-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS00LTEtMS0w_ffdc854a-9b7a-481d-87e1-d5066b317a15">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i493449153f79453f9dfe0eacaa0db3b2_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS02LTEtMS0w_640c2db3-f3be-4efc-bf96-bb3e8575cc16">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id668da46343f4db6a7137fe89d885862_D20190101-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS04LTEtMS0w_f0c41565-92f7-4e46-91c2-23a1423df1a8">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues Recognized from Performance Obligations Satisfied in Prior Periods </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from performance obligations satisfied in prior years related to royalties for licenses of our intellectual property were </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjUw_a0b9d552-a2f4-4b1c-9438-956bd7350179">206</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjU3_b5e51674-b557-4b04-b934-1d2cec199ee7">618</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the three and nine months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjkw_c08980ea-ebbe-47d9-9f44-ed9c1a1636fe">201</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjk3_478b9f6d-9728-4c2d-934e-8d698038233b">527</ix:nonFraction> million for the three and nine months ended September 30, 2019, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i5b75b49baa8848c4b2642ffe845ed2dc"><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable consideration is included in the net sales price only to the extent a significant reversal in the amount of cumulative revenue recognized is not probable of occurring when the uncertainty associated with the variable consideration is subsequently resolved. Estimates are assessed each period and updated to reflect current information. Changes in estimates for variable consideration related to sales made in prior years resulted in a $<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODI1_898b6731-44d6-49e4-93a5-1df4bb33c1a5">13</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODMy_30ba220a-54b2-48ad-a6ae-d1869975fa07">94</ix:nonFraction> million increase in revenues for the three and nine months ended September 30, 2020, respectively, and a $<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODg4_7a342115-2f3d-4389-bae4-89deaecf4737">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODk1_c6dd233c-6fca-4e4f-a52c-320963f4ccbf">309</ix:nonFraction> million increase in revenues for the three and nine months ended September 30, 2019, respectively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets, which consist of unbilled amounts primarily from arrangements where the licensing of intellectual property is the only or predominant performance obligation, totaled $<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTE1Mg_5799806a-1fa2-4e73-bcad-e35fab2f5ee3">186</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTE1OQ_bfd74ac0-ff2c-4c44-96e8-595d36bce616">144</ix:nonFraction> million as of September&#160;30, 2020 and December&#160;31, 2019, respectively. Contract liabilities, which generally result from receipt of advance payment before our performance under the contract, were $<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTA5OTUxMTYzMjM1MQ_1e42d762-d762-473b-b1c4-fec9edaade50">103</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTA5OTUxMTYzMjM1OA_8abbe923-5112-4647-985e-b0be9cac7264">45</ix:nonFraction>&#160;million as of September&#160;30, 2020 and December&#160;31, 2019. During the three and nine months ended September 30, 2020 and 2019, revenue recognized that was included in the contract liability balance as of the beginning of the respective years was not material. Revenue expected to be recognized in the future from contract liabilities as the related performance obligations are satisfied is not expected to be material in any one year.</span></div></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_40"></div><div style="margin-top:16.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg3NQ_6591e167-fd29-4579-8800-6b23c1ece789" continuedAt="i536cb8f2106f44ee9585db496c41b9d7" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i536cb8f2106f44ee9585db496c41b9d7" continuedAt="id8d9f229e31d42e9a7dd7c2ae3e42052"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg2Mw_698db302-766a-4c9c-b93b-47d6e832c9fd" continuedAt="if9b6543441824e72acca449bbdb801bb" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of financial and non-financial assets and liabilities using the fair value hierarchy, which establishes three levels of inputs that may be used to measure fair value, as follows:</span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 1 inputs include quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 2 inputs include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For our marketable securities, we review trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and </span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 3 inputs include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Our Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. </span></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if9b6543441824e72acca449bbdb801bb">Our financial instruments consist primarily of cash and cash equivalents, marketable debt securities, accounts receivable, foreign currency exchange contracts, equity securities, accounts payable and short-term and long-term debt. Cash and cash equivalents, marketable debt securities, certain equity securities and foreign currency exchange contracts are reported at their respective fair values in our Condensed Consolidated Balance Sheets. Equity securities without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. Short-term and long-term debt are reported at their amortized costs in our Condensed Consolidated Balance Sheets. The remaining financial instruments are reported in our Condensed Consolidated Balance Sheets at amounts that approximate current fair values.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id8d9f229e31d42e9a7dd7c2ae3e42052" continuedAt="i212d820e11884debb9c7cae6df87cb32"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg4MA_2b4fe557-3fdc-4ea2-a64a-7a3e01c49989" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6441f2721574eb2b066460bd0098a33_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xLTEtMS0w_a2814abf-b7bb-4b18-830e-a7bed58047c4">2,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea4251592be4a09bb586ecf7b0877b6_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0zLTEtMS0w_be26339f-1968-429c-adfb-47bf6b39c70b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cc122877ef421aa55fd71bb8bc36aa_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC01LTEtMS0w_daf82902-83e8-426e-b5da-ee1e2524b91f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e9a07c98224bbaaaf8f40807d0e83c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC03LTEtMS0w_e5a4fec3-ca82-4f10-b2e0-32065ecbf5a9">2,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i016620e60b0e45a2b86d94e4bedcd1d4_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC05LTEtMS0w_281e1b61-99a3-430c-845e-4b909aab1077">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0f034dcaa0404585e485dfbb6d10e3_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xMS0xLTEtMA_0906dc17-0990-49aa-bde7-d58db5f26626">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65f5244a5e8f4ed5b372521b97d023cb_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xMy0xLTEtMA_1757ef5b-82c4-4ed1-9f37-0283586d54a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4ed4d70910c4494a6240e2ac85171eb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xNS0xLTEtMA_b195ed81-dd16-41f3-aaf9-5f53ac905afa">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda5ed87da74c01ab8c6f23f4b7f768_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xLTEtMS0w_d0b33c74-7af0-413e-83b0-f965c03e6831">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c6e23a89e1448f9ed6fbf3ca90c206_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0zLTEtMS0w_f4209c7b-5ffa-429b-b11e-e1d63fe59114">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5b88ed58b34df29d8e5cad8f3c7ef6_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS01LTEtMS0w_402c4fff-a346-4559-9bd0-93e7cdd4019b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffb351639be43d6ba1030c106ff8eb8_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS03LTEtMS0w_66087a72-4e32-4cf6-9598-33c6e02133dc">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c7b09230e8405fb21eb18f3e0dfae7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS05LTEtMS0w_eda564f2-ff0f-4f86-92c8-8fa13f451d08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb611e0fbed54ad5968a92550e95897b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xMS0xLTEtMA_d42e0ebc-e10f-467e-8f5e-bd678f384a0b">3,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75300f98c39f4d63a888fcd33da6f547_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xMy0xLTEtMA_893aa2d9-3c46-42eb-bb39-a31b1f54e68b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae90ac2d91e4170b23f8a6a66efc12f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xNS0xLTEtMA_071b40ce-a739-4b18-a7e2-2080141908e2">3,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b24cc4056cf47e784957e18bd3d8fef_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xLTEtMS0w_f04ce90e-649b-45e8-9e6a-816859ac5b57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08217eba7b4040989c8927514a8e4667_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0zLTEtMS0w_d811ea8f-98ae-498c-b8c5-273c8af7230b">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic06f0fae2eba4968aaef1e5ccbb6b62c_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi01LTEtMS0w_02fb8312-12e6-4693-a780-12ae6ea82ae4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ff3da4637496c978fdba31ede1851_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi03LTEtMS0w_dbaf7ba5-a275-43f3-9d53-619dcedd1428">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7cfa70f7d44abeb0a42230869dd083_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi05LTEtMS0w_6dc71d86-b1f8-4abe-b618-73cab829683c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93f2ac2c6184cdc88f83b027e6b6987_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xMS0xLTEtMA_124960ff-4992-459b-acf5-34733020a606">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0205ea3174f84373ad0b7317fb14ee43_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xMy0xLTEtMA_4ac717f2-70b3-46aa-847a-79a745443917">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2175ecdb247344f380a11e6cc2fff2c0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xNS0xLTEtMA_33296d2f-f7d7-41b3-bb00-5e13ad34b49d">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8d2177f2e648dbbf9fb7e466067dd7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xLTEtMS0w_8274e599-bf05-432c-9e04-daca74af3594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic455f28a60e74c3fb60fa85587a50d84_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0zLTEtMS0w_2b00fcfd-0e0f-4207-968e-f6df8d67d006">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3eca0222a334fe6a0daa4b5b8dab50f_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy01LTEtMS0w_c2bdb6fe-ae3d-43e6-b936-8399ce018e87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c28da23233147d9b46404d8348cc986_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy03LTEtMS0w_f93e8359-7e95-4726-a4f7-c5258ee29736">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacec8636d81c4ccca6752cd4f9295732_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy05LTEtMS0w_f5fd0e2d-ce13-4296-8d64-b6aab30abe78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a82defc66745f690df80e8668e890c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xMS0xLTEtMA_9905858a-4ffc-4a21-b815-55d277595f89">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2762aff7213c485a9bd438bb60c288d0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xMy0xLTEtMA_0c621a0c-b843-4740-b9cf-d4b2129e9126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ed3d6b01754487a4a76050317ca559_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xNS0xLTEtMA_f833090d-4600-4d37-a93a-e375e52362b2">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ddeab33a06c4acf87407a2dd4a0fa57_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xLTEtMS0w_848b0428-1439-4466-b3d8-8491c85e8344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb532ca82c864b69bcefe78f95dbff76_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0zLTEtMS0w_135a6914-5475-43c6-a48a-7eff1351c494">7,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba47020efd0947a3a230d76409764d71_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC01LTEtMS0w_609e6e91-57a9-489a-8e07-338f2a753034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e91ec83eb244499df3127b2b341240_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC03LTEtMS0w_a0a713fd-53ed-4125-a4c1-1f4b42732526">7,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b5ab6cbfea4b5ba7e0e248c8955c25_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC05LTEtMS0w_bdc197be-11c0-4f55-905f-86be68facd8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc3256a0924126aa99e6bbeadc7d47_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xMS0xLTEtMA_bd5c17be-e4f7-4d6f-ab4b-d2953d7bfd6f">9,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346980582de5432fab397590fe91e43e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xMy0xLTEtMA_4be9c909-eea4-42dc-a104-c00a13cf824a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc2a2681941419293fadf9296a83636_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xNS0xLTEtMA_7039eef1-37ca-495a-a0ce-0daa354b2f6c">9,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a2dbe200754e44ba989b4ac9964ff1_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xLTEtMS0w_9aa23c06-d0d4-4bab-a3d4-855cf14ef418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6341635988148b8ae35b14f5506e068_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0zLTEtMS0w_68916f76-775f-4e6b-9b45-bc96adae2d30">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia390b9822bae42bb96393b307440c66b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS01LTEtMS0w_2f6d2a38-898a-46f6-801d-06394112772a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c74ca81b25645129c007d405131d946_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS03LTEtMS0w_643e8bb1-0d34-4883-b9f2-c01771af2f54">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8446aa5e56ad47e4866b4ffd7bc9103d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS05LTEtMS0w_4f778f06-be12-4835-849a-bcfe45787867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i256bfd9c10a3491e8671599c334071c0_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xMS0xLTEtMA_6c5eaa17-ac1c-4978-9dea-b4b085d320da">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebfc4a0cc6a403fb9a858f1755f42fe_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xMy0xLTEtMA_107b9660-0cc0-4b06-a11c-b502a2724113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb62bb7ec71e4bdab398215247c43327_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xNS0xLTEtMA_ff48bae8-e122-4d85-bbe9-562e3964b903">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment in Galapagos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80339bdd09004325869ace1cd2d34105_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMS0xLTEtMA_4d8aaa8e-b4cd-44b8-897b-1dcac9ffcb81">2,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef34b5a375d4d90a234962b99965328_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMy0xLTEtMA_4fd1359f-da3a-4149-9342-90dd3a87f630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f736d48d424b4bb10af44ec2c200c5_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtNS0xLTEtMA_1a8b5d7d-c595-4c3c-9ba9-500392154091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ed5764050847e49062635ab01cae21_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtNy0xLTEtMA_4bb02c68-8c0e-4327-b748-08fdc6bdccde">2,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e8c6f47d2041209000d04abb655b79_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtOS0xLTEtMA_68135894-a9e6-46da-becb-97fbc3fe747b">3,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6533f6ca1a8499c9911c6c29ec5e81d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMTEtMS0xLTA_674bcbdf-e05b-4fe5-a80b-433e7a346e9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ae46288d7648bc98a7b52b5e2a2e94_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMTMtMS0xLTA_f48b0dcf-b5b9-42c9-9ade-d58a270b6682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic990aad2d80c4f41a16acb8758ad9e39_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMTUtMS0xLTA_e5d60757-75f8-439a-a23c-adfdb906cf00">3,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7457789a3f89476fa8de57c200293d14_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMS0xLTEtMA_fbe145b5-6413-41b4-9842-2ade070b944d">11,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fb86f9d78a402a80e9cf34ac4e8cd6_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMy0xLTEtMA_b1d60d0e-feda-415d-9f5b-4760aa7872c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49cf4dabb9324f5d8ca59ddfb2c21457_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItNS0xLTEtMA_acd4c1ff-13ef-4b17-8948-fc1213908eec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f94575eafb6420daedc818f3fbaaf52_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItNy0xLTEtMA_f415b752-942f-4228-90fe-5f09d59ad727">11,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96baf7453ec488d8b4ee4a49d5a698d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItOS0xLTEtMA_e31a0ce4-84a2-4a5f-9ff3-eed36d081496">7,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e53a276f8f04098947f2d530352c0c1_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMTEtMS0xLTA_e146ed1a-f937-4519-a9c4-a95eb2a453c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2514dcd1744c42d99689f65cf992ea80_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMTMtMS0xLTA_29d6d6cd-77b2-4af0-a3e2-a1109107b19b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ebf1e84f3954ab8a1cc2392c6e28569_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMTUtMS0xLTA_8ee099b4-98b0-4b8d-9bac-7c22e4ba103f">7,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other publicly traded equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8598034c1a26461fb3d885c48a66e8ac_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMS0xLTEtMA_1e4ee118-2d43-4929-add8-959f5920d377">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3836c33667544e528fc4feb3ed36fc42_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMy0xLTEtMA_db857bfb-510f-40d1-82f7-36e7c8a9ff7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a034e702f740f381d179248d096442_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtNS0xLTEtMA_dbba2dbd-5612-4ba0-8f65-9484dc00ec6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf34775baa8f4d23afc2547f765fed5d_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtNy0xLTEtMA_3a513762-68ea-49ee-9690-17e064a18292">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22107d806154b21b150e48b8ced2120_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtOS0xLTEtMA_fb680474-3d50-4f45-ba45-93b9155aa1c4">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332100bf65a74c73b78f88558ca64905_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMTEtMS0xLTA_9cf4f544-ac7b-4267-b8be-77114a70a6bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3a038de51d492da6acb057be109969_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMTMtMS0xLTA_7db7e4d9-7f40-4781-8038-8501ffd10859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca554c2c1754c65b519605f1694f915_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMTUtMS0xLTA_892c7d69-e4b7-4dd9-ac16-a5a6bb14fcbb">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16bea56fb72747d698df8fbf549baa95_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMS0xLTEtMA_e4b1b04b-b486-410d-a1fa-a4ac0ded602a">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9c716a8e98448eb4565f3e04a28ebf_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMy0xLTEtMA_3700bb0c-35ef-4ca9-b6e3-0622e0a1f73e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2836e0ba225f4e40aaa8bf556a63e011_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtNS0xLTEtMA_63b1ac89-0277-4241-b347-584f7d7cad95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fd4965df6c4aba98b90509f6af2d11_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtNy0xLTEtMA_1a1c3504-0758-4861-9ea2-fe04b192d59b">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3680162306264834bb21711e1ff3044a_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtOS0xLTEtMA_8e622be0-2c24-4395-90c1-8d42b9468ab8">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ecb4569c8314f7c8e009e95c3628aa7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMTEtMS0xLTA_cd123e89-0853-46d2-bd4c-36f43b685d0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343a612674094b2083c8d08bac298824_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMTMtMS0xLTA_0efca191-def6-4356-a4ca-080dd6b44a92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86851181e3a487098e2236460b2dada_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMTUtMS0xLTA_1d33b869-303a-4e6e-9a61-c9a42adc0df9">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency derivative contracts </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6d3cfa89a44fc4b021c0457c085a5f_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMS0xLTEtMA_2eabcc4a-4691-474a-a2a7-47acf7382a06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3fcb255d1824b2288a9ce395b9da146_I20200930" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMy0xLTEtMA_3a5e4916-0bed-4902-b8c7-554d3e189bfb">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15165eda3c9345ff8f6ae2cebaafe873_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtNS0xLTEtMA_e3d7fd1a-8678-49e8-b414-a09a632bc1b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1832e7b713ea47d0a15518b89e0f27bb_I20200930" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtNy0xLTEtMA_dd508fd6-f374-4e4d-b72b-5f56f4501835">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bf9c41df7549ccae89be301ed3f03b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtOS0xLTEtMA_b35ad794-8cb8-4d84-a411-dffb5c2db411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia379b9e5e4e84e8b9e9aa4b43ba92bdf_I20191231" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMTEtMS0xLTA_b0dab716-35a6-4b2d-ba73-31a01206cd2f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife8fdfe82c0246158810b46b13c00e97_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMTMtMS0xLTA_c3c09a15-ab36-4778-a944-ef7317646347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ef925d0d174ed992b1c8c45928db38_I20191231" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMTUtMS0xLTA_765b430c-b387-4263-9c78-5c6e7240a08e">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcbde7b6799451db4c9c818cfeead67_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMS0xLTEtMA_b78a80f0-0232-4e79-87e1-49dbd51bccfd">16,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93eadd341c934b73a3e6940d3f6413a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMy0xLTEtMA_3a346aec-9995-4b88-90a6-3c85ffe51a47">11,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic41b4012b457481dbffd93eb9153e360_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtNS0xLTEtMA_4744a7e8-6920-434b-8213-a5b124d87e08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5e4a50b9284e4d9af880ee03a84122_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtNy0xLTEtMA_99dc0543-4884-4129-9477-17a421e5263c">28,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76f2122a7b7462cb1fc9f410f396ff4_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtOS0xLTEtMA_4bc85cf0-1d85-4914-8809-02f647e97135">13,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9219113fc2d041d29935ac7469176613_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMTEtMS0xLTA_e7da08c8-d00b-48db-bbd9-162e58f73dd1">14,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a61c55dc4b4663867980b24fdcb0a1_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMTMtMS0xLTA_961923d7-7784-4119-a75e-6f7b98f6c19f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1fdb77ea804ee193031561a281a198_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMTUtMS0xLTA_bd676286-8f00-4eb5-b2c7-5b8b049a26e1">27,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16bea56fb72747d698df8fbf549baa95_I20200930" decimals="-6" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMS0xLTEtMA_c09cdcd7-4441-4502-b89c-da64a5b59ee0">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9c716a8e98448eb4565f3e04a28ebf_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMy0xLTEtMA_1cba6716-7f15-4401-bb0d-6788c2c5b7b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2836e0ba225f4e40aaa8bf556a63e011_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtNS0xLTEtMA_da3ace92-c47f-408b-b828-640a816936e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fd4965df6c4aba98b90509f6af2d11_I20200930" decimals="-6" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtNy0xLTEtMA_9372dae2-ec2f-4d1f-b692-4107f7783282">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3680162306264834bb21711e1ff3044a_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtOS0xLTEtMA_afc5978c-94f4-47dd-a594-b1f330763432">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ecb4569c8314f7c8e009e95c3628aa7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMTEtMS0xLTA_af160dc3-b750-4ba8-8ca5-c745da15edc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343a612674094b2083c8d08bac298824_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMTMtMS0xLTA_0d91b29b-fe40-4394-b0a9-9d0f9a7f1868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86851181e3a487098e2236460b2dada_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMTUtMS0xLTA_4717e295-0f74-4df6-ac56-1c2413496e53">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency derivative contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6d3cfa89a44fc4b021c0457c085a5f_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMS0xLTEtMA_606b571d-01e3-41d1-b26c-ebd51c6afc5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3fcb255d1824b2288a9ce395b9da146_I20200930" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMy0xLTEtMA_62d41f89-49ce-4b33-992b-07a039ac16bc">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15165eda3c9345ff8f6ae2cebaafe873_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktNS0xLTEtMA_e4ba8555-ac84-4649-bf5a-314a29459f76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1832e7b713ea47d0a15518b89e0f27bb_I20200930" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktNy0xLTEtMA_b80f2ebe-d3f0-4896-9f16-0a9c1286bafe">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bf9c41df7549ccae89be301ed3f03b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktOS0xLTEtMA_fe73ec48-3b01-414b-87aa-4c72fd096065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia379b9e5e4e84e8b9e9aa4b43ba92bdf_I20191231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMTEtMS0xLTA_463f234b-346e-4e91-861d-89634d2043fa">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife8fdfe82c0246158810b46b13c00e97_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMTMtMS0xLTA_3ddd6cda-1bd7-42df-b066-f318e7996fe6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ef925d0d174ed992b1c8c45928db38_I20191231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMTUtMS0xLTA_ae88486c-3af0-4e90-9a1b-dc2950fb1e4a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcbde7b6799451db4c9c818cfeead67_I20200930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMS0xLTEtMA_ff6f0678-edec-4373-8012-388fe6281c56">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93eadd341c934b73a3e6940d3f6413a4_I20200930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMy0xLTEtMA_0ceae389-8969-4e39-87f7-3aaa22a80d11">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic41b4012b457481dbffd93eb9153e360_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtNS0xLTEtMA_5d21c509-53db-46fa-8950-1b062eb9b237">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5e4a50b9284e4d9af880ee03a84122_I20200930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtNy0xLTEtMA_1d13b8da-104f-4252-8688-eb977f58c9fc">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76f2122a7b7462cb1fc9f410f396ff4_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtOS0xLTEtMA_5fc59343-3e3f-40c6-b196-684c71b11a90">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9219113fc2d041d29935ac7469176613_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMTEtMS0xLTA_baa3f167-c9ce-4b4e-9f3b-70480f1d3e86">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a61c55dc4b4663867980b24fdcb0a1_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMTMtMS0xLTA_9d2188fa-7888-4b3f-a8bb-49d188300a48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1fdb77ea804ee193031561a281a198_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMTUtMS0xLTA_e3f09abb-3a4a-4faf-86d9-464f76e73d00">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of equity securities resulted in net unrealized losses of $<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjYzMA_71485cbe-8571-4494-a636-8b30da770190">964</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjY2MA_19cad957-873d-4aa6-99a3-a6afdabd6748">1,046</ix:nonFraction> million for the three and nine months ended September 30, 2020, respectively, and net unrealized gains of $<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjcxNw_002113e4-1d5b-4375-b56d-40952f180205">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjcyNA_a27e0b55-d4ba-495d-93b8-261a9020d193">312</ix:nonFraction> million for the three and nine months ended September 30, 2019, respectively, which were included in Other income (expense), net on our Condensed Consolidated Statements of Operations.</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg4NA_bfa6a8cf-0f90-4a12-bad0-1dca2c84ca66" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of our equity securities in our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:11pt;margin-top:9.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bd59bb3d5a446c898736046871d68f_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMS0xLTEtMS0w_295f0b5b-1676-4b03-87ff-936c19cf899b">11,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202d8dd34b4048a6a70528355ccc07d7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMS0zLTEtMS0w_06806a5f-aeff-4a77-94aa-8fc61fc150f3">7,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aad028e1dd94922b809346982b70e6f_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMi0xLTEtMS0w_fb400701-9aca-46dc-8ed1-439260741a42">986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63529910aec24b4797650b819a035d38_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMi0zLTEtMS0w_79b4c0ec-7713-4af4-a16a-2d97c5515556">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id95a598ab9ac4ba38343c2442e163984_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMy0xLTEtMS0w_d84c504f-0638-4788-ae2a-0ed03b5250ab">2,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf8f6a568ff4422830e566cac20c2b1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMy0zLTEtMS0w_bf0cef09-3ba0-4045-a13f-f8e11602a016">3,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973aae8a8cc74f1285d8fcfa96228c98_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfNC0xLTEtMS0w_bbdc236e-7293-421c-8f35-0572c73111ab">14,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f86e6b410fe461e99132bb73eb20f07_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfNC0zLTEtMS0w_d8d716a3-2746-40ab-ba56-bad5f1bbe927">11,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our available-for-sale debt securities are classified as cash equivalents, short-term marketable securities and long-term marketable securities in our Condensed Consolidated Balance Sheets. See Note 4. Available-For-Sale Debt Securities for additional information. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6. Acquisitions, Collaborations and Other Arrangements for additional information on our equity investment in Galapagos NV (&#8220;Galapagos&#8221;).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 Inputs</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair values of Level 2 instruments by taking into consideration valuations obtained from third-party pricing services. The pricing services utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate the fair value. These inputs include reported trades of and broker/dealer quotes on the same or similar securities, issuer credit spreads, benchmark securities, prepayment/default projections based on historical data and other observable inputs.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i212d820e11884debb9c7cae6df87cb32"><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our foreign currency derivative contracts have maturities within an 18-month time horizon and all are with counterparties that have a minimum credit rating of A- or equivalent by S&amp;P Global Ratings, Moody&#8217;s Investors Service, Inc. or Fitch Ratings, Inc. We estimate the fair values of these contracts by taking into consideration the valuations obtained from a third-party valuation service that utilizes an income-based industry standard valuation model for which all significant inputs are observable, either directly or indirectly. These inputs include foreign currency exchange rates, London Interbank Offered Rates and swap rates. These inputs, where applicable, are observable at commonly quoted intervals.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total estimated fair values of our aggregate short-term and long-term debt, determined using Level 2 inputs based on their quoted market values, were approximately $<ix:nonFraction unitRef="usd" contextRef="i3f57c5401fe14752b2128178cf57b7b8_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDc0NA_b23981cd-608b-454a-8fd0-0d8043598873">33.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib076e25c99fb466c9bc9ec757f4c69ba_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDc1MQ_18ac93f8-1d51-4e0e-8946-fbf28a3f8bce">27.3</ix:nonFraction> billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively, and the carrying values were $<ix:nonFraction unitRef="usd" contextRef="i1fd39ebfac5e489099472ca928286c5d_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDgxNA_3ef93fdd-dbad-470d-a194-823cd946d2c7">29.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i152b037ec98d48b8b0f21c10881726a8_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDgyMQ_eca48778-7b9b-490a-be2b-f129a3c488e0">24.6</ix:nonFraction> billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively.</span></div></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_43"></div><div style="margin-top:16.5pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMwNA_496d41bc-f5f7-4185-b091-fe93d137eff6" continuedAt="i113c98ff2e8640e5b8327aee69eba681" escape="true">AVAILABLE-FOR-SALE DEBT SECURITIES</ix:nonNumeric></span></div><ix:continuation id="i113c98ff2e8640e5b8327aee69eba681" continuedAt="ic8a215741ea14582aaec20887722707f"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMyMg_ef10da42-4595-423c-ab4e-04409facd78b" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab61524bb61c418da02f67470629315a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0yLTEtMS0w_88d7838d-0824-4c24-a528-d9b91c92b4e1">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab61524bb61c418da02f67470629315a_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi00LTEtMS0w_0e0ed200-a983-410e-9c1a-16a2a58a1534">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab61524bb61c418da02f67470629315a_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi02LTEtMS0w_4e52606e-4fce-4852-9c1c-90b25d6d499e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab61524bb61c418da02f67470629315a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi04LTEtMS0w_9dcff39f-f7e0-431a-bd28-a2e98f9e3701">2,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xMC0xLTEtMA_d19c2252-0c22-4174-a247-51f6ab9dbca9">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xMi0xLTEtMA_cfc0910f-2d99-453e-aea7-66371b83f533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xNC0xLTEtMA_c5d6a038-7700-4ab9-bb76-d6b70124d04e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xNi0xLTEtMA_8bbb86a0-bc7f-447d-a0ee-2133ec92997b">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed486534dc045088bf927345ba227e0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0yLTEtMS0w_532daedd-4e43-4773-99a6-42bcd3e69214">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed486534dc045088bf927345ba227e0_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy00LTEtMS0w_8da112e2-d9b7-4500-ba6a-c1713c093d51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed486534dc045088bf927345ba227e0_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy02LTEtMS0w_19c7a933-81a7-44bf-a6ea-5c1ee30de8c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed486534dc045088bf927345ba227e0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy04LTEtMS0w_0240821c-a487-47a6-8819-eba224d3844a">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280f5420541248679b56a8d625ccd64a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xMC0xLTEtMA_4f4d10de-cef7-4536-bb7a-f323093218ac">3,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280f5420541248679b56a8d625ccd64a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xMi0xLTEtMA_a251f64a-d168-4694-b510-f125cfef9f0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280f5420541248679b56a8d625ccd64a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xNC0xLTEtMA_5ec195ee-e4cd-4784-96a3-f46c2d8c324e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280f5420541248679b56a8d625ccd64a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xNi0xLTEtMA_6e2c5f4d-3767-4368-a434-fb38e3855e9f">3,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i915f187c67784380afcab80212da1735_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0yLTEtMS0w_e778f6fa-d8f4-42fe-a6ec-ef5e48aa6556">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i915f187c67784380afcab80212da1735_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC00LTEtMS0w_12c2caa8-27bc-43fb-8adb-873924c79382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i915f187c67784380afcab80212da1735_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC02LTEtMS0w_0536b894-0c54-4518-aa42-337cf61b869f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i915f187c67784380afcab80212da1735_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC04LTEtMS0w_ec883757-6877-4ee7-a4c7-04865a43990b">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xMC0xLTEtMA_4fe1e556-ecee-40b3-b1e4-0f4e5463f3f1">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xMi0xLTEtMA_764e6e41-3687-43dc-b890-d22f9034ff3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xNC0xLTEtMA_c28efff7-0658-45d0-be5e-6a22e766677c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xNi0xLTEtMA_41141639-4c30-452f-bbf9-fe0985261249">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44901ae9d576485b846e66590a5145bb_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0yLTEtMS0w_5c46e247-cbb0-4c80-92cb-62c22d9ed581">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44901ae9d576485b846e66590a5145bb_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS00LTEtMS0w_ad748d90-a462-4d99-930e-ee1d52142403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44901ae9d576485b846e66590a5145bb_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS02LTEtMS0w_1f37e273-82a3-4533-8325-cbd65c9423c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44901ae9d576485b846e66590a5145bb_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS04LTEtMS0w_8937ec2e-371f-4f0a-985a-3d4e52c1ee8b">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xMC0xLTEtMA_2eef2858-29bc-42b8-83d1-4773863f5076">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xMi0xLTEtMA_36f60bb3-ad2b-49ab-96a3-30693684f7c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xNC0xLTEtMA_fd94099e-ced2-4e29-b37b-19a820c5771c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xNi0xLTEtMA_27f8af8f-d932-410a-ae2b-3aee21ad91a3">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0yLTEtMS0w_ec0ecac0-3fe5-4f3f-ae02-c00dfb91a134">7,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi00LTEtMS0w_36382d98-4f6d-44bd-bc5d-9d3fce58b3ab">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi02LTEtMS0w_f044e870-6533-411f-8db9-4b3871c06738">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi04LTEtMS0w_48f84d24-a133-4a66-9ac7-0a9c3e6b0062">7,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xMC0xLTEtMA_8302f62a-75d6-43b4-b5ec-966a9ed7e1ff">9,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xMi0xLTEtMA_909e5270-e3a8-43f7-9e16-fc19f5549f41">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xNC0xLTEtMA_465a45cf-1bc4-417d-bfc8-ab2c34f35f8e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xNi0xLTEtMA_30ef7278-68a6-40e3-bdc0-9561f2018f6e">9,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage and asset-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0yLTEtMS0w_8a683228-247a-4666-a6bb-3db18640c912">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy00LTEtMS0w_3f62e0cc-6e9b-4667-a279-7c827a988531">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy02LTEtMS0w_82cf4b64-6079-4391-8c44-834f04d43e4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy04LTEtMS0w_67e33824-316c-465b-8c13-60da74576d94">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xMC0xLTEtMA_6e860b27-3919-4a52-86a6-7cf1d4d86b62">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xMi0xLTEtMA_3d552b8e-d115-42ff-ae80-04cde15ccf5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xNC0xLTEtMA_27d5eb54-6d0d-403e-9dcc-346e6385c38a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xNi0xLTEtMA_25c11a38-2881-405e-a319-9c011cd55f59">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0yLTEtMS0w_9c94422d-1115-45fa-a907-ab116e334f38">13,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC00LTEtMS0w_903eb647-92e5-4aef-a5c7-e0f1bf911ed9">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC02LTEtMS0w_11747adb-c484-4b16-918b-1ef021f8283d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC04LTEtMS0w_0cf8ab3f-2a78-49a8-a1b4-750ac5fef770">13,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xMC0xLTEtMA_4eccedbc-fd17-4eca-9ce9-1f627214a134">16,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xMi0xLTEtMA_87909408-34a2-4513-a5c1-9f8668acdc46">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xNC0xLTEtMA_8459623e-b445-4074-ac8f-1711e7c31de2">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xNi0xLTEtMA_8291ff7b-cf90-4af7-8b79-31289fb24a7e">16,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMyMA_86f73fa5-e727-4c01-a2b6-fd860a847bf8" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e30f2b68c584a1cae64f4692423ac60_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMS0yLTEtMS0w_10018885-c3a0-452c-b82c-b14f3a6f5747">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if077c28b2a3549009e4351063889daee_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMS00LTEtMS0w_6cabf54f-2acb-4a84-8a52-cec36280919a">2,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb967509b8d4595b980817e4efe72c4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMi0yLTEtMS0w_05d5e5ae-8285-43cb-9c0a-ff06c15e47d3">11,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0649099fa908450db840cbbb3e57fe0b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMi00LTEtMS0w_8cdbee75-efe2-4c6a-98b4-c617682fbd1f">12,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ac5e322d254b9da70701bbc22881e2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMy0yLTEtMS0w_4af95004-cb9d-495b-af91-c8eebf4c9c18">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9901b9b6eb08420fbd35a1817088ca98_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMy00LTEtMS0w_891130f2-a8f4-4fbc-947a-e2316801a541">1,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfNC0yLTEtMS0w_447f3b8b-570e-45e5-b85c-4dc331c03d0b">13,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfNC00LTEtMS0w_7f145d1c-94f8-4259-aa9e-f6a080586fbd">16,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest receivable excluded from both the fair value and amortized cost basis of the available-for-sale debt securities was $<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzUx_b9885200-aa38-4e85-84c9-172257c4eebf">49</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzU4_7492ad6e-6389-4235-a8cb-309804849ea3">37</ix:nonFraction> million as of September&#160;30, 2020 and December&#160;31, 2019, respectively, and is recorded in Prepaid and other current assets on our Condensed Consolidated Balance Sheets. There were <ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="gild:Writeoffsinaccruedinterestreceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzg0ODI5MDcwMDEyOQ_1612028f-d412-4632-be60-207b06b1428b"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="gild:Writeoffsinaccruedinterestreceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzg0ODI5MDcwMDEyOQ_56832d7e-d4f4-4a2c-9214-98591439b909">no</ix:nonFraction></ix:nonFraction> write-offs of accrued interest receivable during the three and nine months ended September 30, 2020.</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMxMg_b8de82e6-67d4-4f6c-b0ad-92e29a86ff6d" escape="true"><div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in millions): </span></div><div style="margin-bottom:6pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within one year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMi0yLTEtMS0w_e3cf649b-d968-417e-a888-3dcecc2f9273">11,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMi00LTEtMS0w_1e69a2c5-a8c3-4b42-8797-4becd2811cc3">11,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMy0yLTEtMS0w_6c7f7895-357f-4a00-bc52-e540625fb6ea">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMy00LTEtMS0w_8e1200e4-87d9-44e7-97ee-669223988924">1,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNC0yLTEtMS0w_15212464-4cb8-4a99-b4fe-c4cef905916e">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNC00LTEtMS0w_f347d5e4-5855-481c-b6b8-85584945df4f">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNS0yLTEtMS0w_a9539405-9540-492c-b41f-11c09e64861d">13,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNS00LTEtMS0w_dce8b61e-6e2d-42dd-bac4-8378f8ec2b2a">13,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic8a215741ea14582aaec20887722707f"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTI5Nw_5b0f1947-cccd-4bda-8ea8-3fc079383898" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#acacac;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy0yLTEtMS0w_2da1dae7-68b0-4698-b544-2af90300aa6e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy00LTEtMS0w_f5233c90-3711-4e56-8ddb-ff104ce475fd">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy02LTEtMS0w_706589e5-f5e1-4fa6-beb9-0178057ade65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy04LTEtMS0w_4ad53fec-618b-47b1-8049-e9717b92db5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy0xMC0xLTEtMA_213be6f6-7308-4278-b84a-9808708fd808">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy0xMi0xLTEtMA_5272ef2a-76a8-4071-8b26-11f56f5ca854">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS0yLTEtMS0w_cba2469c-faa8-4f38-a132-27ead3a80498">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS00LTEtMS0w_3e5a9946-0d86-4ee0-8b9d-bbdf46a82f00">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS02LTEtMS0w_307be479-ae6a-4e43-aeda-bef798625b03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS04LTEtMS0w_02d08960-3138-45e0-a94b-ce0ecbe94e64">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS0xMC0xLTEtMA_74354299-83dc-42c7-8f23-5fb52655f4df">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS0xMi0xLTEtMA_89399969-ac86-4b17-a95c-a56590dc8ca2">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held a total of <ix:nonFraction unitRef="position" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfOTM4_98104235-6333-4a1d-9505-8793e70502ef">208</ix:nonFraction> positions which were in an unrealized loss position as of September&#160;30, 2020. The unrealized losses are largely due to changes in interest rates. Aggregated gross unrealized losses on available-for-sale corporate debt securities were not material, and accordingly, <ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTI0Mw_7e16d16e-df51-4d21-aed6-b93671a000b8"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTI0Mw_ebcccf3c-c918-4cf8-95b8-073c40ff70f5">no</ix:nonFraction></ix:nonFraction> impairments were recognized for the three and nine months ended September 30, 2020.</span></div></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_46"></div><div style="margin-top:16.5pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM2OA_73f18a8d-cf04-4d7b-976f-a46965e9183d" continuedAt="i923a1f895465495abb26610df17b399e" escape="true">DERIVATIVE FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i923a1f895465495abb26610df17b399e" continuedAt="i8b472698cb1d46158fc8132c0850be98"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in foreign countries expose us to market risk associated with foreign currency exchange rate fluctuations between the U.S. dollar and various foreign currencies, primarily the Euro. To manage this risk, we may hedge a portion of our foreign currency exposures related to outstanding monetary assets and liabilities as well as forecasted product sales using foreign currency exchange forward or option contracts. In general, the market risk related to these contracts is offset by corresponding gains and losses on the hedged transactions. The credit risk associated with these contracts is driven by changes in interest and currency exchange rates and, as a result, varies over time. By working only with major banks and closely monitoring current market conditions, we seek to limit the risk that counterparties to these contracts may be unable to perform. We also seek to limit our risk of loss by entering into contracts that permit net settlement at maturity. Therefore, our overall risk of loss in the event of a counterparty default is limited to the amount of any unrealized gains on outstanding contracts (i.e., those contracts that have a positive fair value) at the date of default. We do not enter into derivative contracts for trading purposes. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge our exposure to foreign currency exchange rate fluctuations for certain monetary assets and liabilities that are denominated in a non-functional currency. The derivative instruments we use to hedge this exposure are not designated as hedges and, as a result, changes in their fair value are recorded in Other income (expense), net on our Condensed Consolidated Statements of Operations. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge our exposure to foreign currency exchange rate fluctuations for forecasted product sales that are denominated in a non-functional currency. The derivative instruments we use to hedge this exposure are designated as cash flow hedges and have maturities of <ix:nonNumeric contextRef="i885c8e3d7c564884960c80c8d85d08fd_D20200701-20200930" format="ixt-sec:durmonth" name="us-gaap:DerivativeRemainingMaturity1" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMTg3Ng_c8818cd3-4dbb-4a11-a209-a75d493b97a2">18</ix:nonNumeric> months or less. Upon executing a hedging contract and quarterly thereafter, we assess hedge effectiveness using regression analysis. The unrealized gains or losses in Accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;AOCI&#8221;) are reclassified into product sales when the respective hedged transactions affect earnings. The majority of gains and losses related to the hedged forecasted transactions reported in AOCI as of September&#160;30, 2020 are expected to be reclassified to product sales within <ix:nonNumeric contextRef="i885c8e3d7c564884960c80c8d85d08fd_D20200701-20200930" format="ixt-sec:durmonth" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMjM0MQ_8943b0b5-626f-4fe1-990e-fb3ba39e3230">12</ix:nonNumeric> months.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flow effects of our derivative contracts for the nine months ended September 30, 2020 and 2019 were included within Net cash provided by operating activities on our Condensed Consolidated Statements of Cash Flows.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had notional amounts on foreign currency exchange contracts outstanding of $<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMjU2NQ_b1b753e9-201c-404d-ade7-f5d59d02c8e3">2.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMTcwNDI0MzAyMzM5MzE_8d562474-17e4-4893-8adf-1079dc4802f4">2.9</ix:nonFraction> billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8b472698cb1d46158fc8132c0850be98" continuedAt="i1af64b0ad6ff448382328e270b36cf6d"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While all our derivative contracts allow us the right to offset assets and liabilities, we have presented amounts on a gross basis. <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM0MA_81f71090-ae5e-4aef-8678-acbf9d275758" continuedAt="i2fb018de10d041e094d57ecabc631d80" escape="true">The following table summarizes the classification and fair values of derivative instruments in our Condensed Consolidated Balance Sheets (in millions):</ix:nonNumeric></span></div><ix:continuation id="i2fb018de10d041e094d57ecabc631d80"><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:33.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a333aeeecec4ed9b2e05cc1f18eca61_I20200930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNC00LTEtMS0w_7c69303b-e4f5-4850-b1ee-d440a45b6f12">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;accrued&#160;liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dd9abcdf6fa4e63ac008c910c2064e7_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNC04LTEtMS0w_ef7b4d2d-09cc-434c-9a0f-e36442eba4a0">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcad679966294ff2a2a4a7fce703e297_I20200930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNS00LTEtMS0w_13f65908-ac3d-44e6-af2f-da430b100070">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if94c93bbf7284ee089c617ef366c010b_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNS04LTEtMS0w_46856dad-a582-4962-8fe5-0797e9876e6b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3441f3a2b4f440a8bc916049c259e00f_I20200930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNi00LTEtMS0w_11763140-1559-4391-bc5a-785eee54ddce">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3441f3a2b4f440a8bc916049c259e00f_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNi04LTEtMS0w_fc92f9dd-4a2a-4f3a-baa1-02e8f3d5591e">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727aeb50823e469a9b8a9e02739b65d8_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOC00LTEtMS0w_5d47f63f-0aa2-4250-9ab4-caa57d7adecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36e630b95ff54a039e3b28faf946f40d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOC04LTEtMS0w_d757988f-c8f8-4f54-8413-1c95498caa94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69bdaf8a67d84555bf6582631022fc61_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOS00LTEtMS0w_a298aeb7-9a17-4f5d-8a01-7eb4c3b60240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69bdaf8a67d84555bf6582631022fc61_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOS04LTEtMS0w_552f063a-b24c-4e91-8ded-125bbe0286e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfMTAtNC0xLTEtMA_37545e4f-f812-4f74-be6a-bb7300c422f4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfMTAtOC0xLTEtMA_a22df877-8817-4f43-957a-d5e52dd1c813">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i778d229a5af747b7afc0e73451dbaca6_I20191231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNC00LTEtMS0w_09bc61cd-f450-4fab-a35c-4e7d1b186222">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;accrued&#160;liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41cf8059cc904b458c6aeb8f0e345448_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNC04LTEtMS0w_ae260316-bb7e-41ed-a516-18a2c75457ba">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia63da40b12964679bd495e281370437e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNS00LTEtMS0w_790dcd0a-e65f-4bd5-8340-ebef5343c0d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3bada8f952b40819bd558e693f22b13_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNS04LTEtMS0w_e0808ff4-6ac5-45a7-81ca-b4866bd5d938">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48fffe834ce34e46a02a3296f02cfe58_I20191231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNi00LTEtMS0w_4a3f6e6d-9ce6-4fb9-9f49-d60d556de0c6">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48fffe834ce34e46a02a3296f02cfe58_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNi04LTEtMS0w_915cefaa-4a0d-455e-aa2c-b686ddf250a3">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093f149708bc438285250a031a978d87_I20191231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOC00LTEtMS0w_aefbf0ea-7a57-4e16-b5c9-89b539a8aab7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fca64d1acd048958ee9a481adb0d0ab_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOC04LTEtMS0w_8a1be679-1615-49bf-8cac-f483cf4e2257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b6a29b0c8f4d5fae00186fc6544d94_I20191231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOS00LTEtMS0w_26b5670a-d610-4de1-b842-73ce2f768203">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b6a29b0c8f4d5fae00186fc6544d94_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOS04LTEtMS0w_6cb05199-b5c1-4413-a4cf-4b65390878a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfMTAtNC0xLTEtMA_6485b1f9-16f5-4a34-8a18-1b7c247d24b1">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfMTAtOC0xLTEtMA_2342dd0b-474d-42c2-82a8-876d633e404a">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM3MA_b84110f5-9686-49aa-b9b9-90e4c0fb7f51" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of our foreign currency exchange contracts on our Condensed Consolidated Financial Statements (in millions): </span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) recognized in AOCI </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC0yLTEtMS0w_a12c2399-704f-4b45-8162-f5c4629858f9">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC00LTEtMS0w_7931b53e-0dd5-427f-952c-b1429654f279">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC02LTEtMS0w_1f9dfb15-d501-439a-9376-3fc403035032">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC04LTEtMS0w_6255adab-aa94-4be2-87f6-43504bfd2754">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains reclassified from AOCI into product sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS0yLTEtMS0w_582602db-34cb-4b1f-b6ed-fc1fd2d8529d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS00LTEtMS0w_0c3ae987-def5-4b92-8a69-c421c18fc14d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS02LTEtMS0w_bfb272be-0ae4-4510-8461-3cc15d2a1362">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS04LTEtMS0w_28213f2a-e9a2-4f20-bcba-2361ecb83189">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) recognized in Other income (expense), net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy0yLTEtMS0w_af9b465c-8570-48b5-b350-6b1331ac09f6">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy00LTEtMS0w_4059eca0-d74f-4b94-8bb3-5189a175f477">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy02LTEtMS0w_804548e4-955d-4213-9c68-9d8948a3fc55">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy04LTEtMS0w_5ed5c413-580b-4966-80e6-40252b085aaa">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may discontinue cash flow hedges and, as a result, record related amounts in Other income (expense), net on our Condensed Consolidated Statements of Operations. There were <ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_078103af-6d5b-4dd0-b7a0-24aadc4cbd1f"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_843ecc1d-4114-40ec-8a1f-059cee53a150"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_a4b80256-16f7-4a91-9ca8-10e6a567d89f"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_f6d01f90-070f-4d19-a081-a84df18e28b1">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> discontinuances of cash flow hedges for the three and nine months ended September 30, 2020 and 2019. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1af64b0ad6ff448382328e270b36cf6d"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and December&#160;31, 2019, we only held foreign currency exchange contracts. <ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM1Mw_5a59ff7b-8db9-451b-ae6a-3c2dd96f210f" continuedAt="i1b794736944a4b02ae001e1bca2714f8" escape="true">The following table summarizes the potential effect of offsetting our foreign currency exchange contracts on our Condensed Consolidated Balance Sheets (in millions):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"><ix:continuation id="i1b794736944a4b02ae001e1bca2714f8"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:22.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts Not Offset <br/>on our Condensed <br/>Consolidated Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts<br/> of Recognized <br/>Assets/Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts<br/> Offset on our <br/>Condensed <br/>Consolidated <br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amounts of Assets/Liabilities Presented<br/> on our Condensed Consolidated<br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Derivative <br/>Financial <br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash Collateral <br/>Received/<br/>Pledged</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net Amount<br/> (Legal Offset)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">As of September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC0yLTEtMS0w_5a0f855b-dd6a-41a9-8ca7-6c81f0b0f528">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC00LTEtMS0w_b8aa8868-3e6d-4fc1-9f7f-0f272a39e27b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC02LTEtMS0w_79299a51-7288-4a24-9015-108edc63a33f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC04LTEtMS0w_8a6235b4-1c53-4659-bfec-3e10003c87c6">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC0xMC0xLTEtMA_3f5c3339-6356-42b5-bc96-4d06e2b25d72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC0xMi0xLTEtMA_e77b30c9-0bdb-4db3-aebf-695aabdd67a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS0yLTEtMS0w_85fa617c-e8fc-4e63-8575-93b3aff8a5a7">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS00LTEtMS0w_93aee8fd-c146-45c8-8b81-df961d4bc53e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS02LTEtMS0w_633e75cf-b7ce-4056-b8b1-2b5046d372e7">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS04LTEtMS0w_7ef5467d-7199-499e-9d76-d43971dcf698">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS0xMC0xLTEtMA_1d910126-4f99-4bc8-943f-6bdaa828e613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS0xMi0xLTEtMA_5be00b6c-dcc4-4387-97d4-ec532f49ada0">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">As of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy0yLTEtMS0w_95caf579-28e3-4e50-86e4-74cee17d5227">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy00LTEtMS0w_a719c55f-1387-4efa-aab5-ed6351b0381d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy02LTEtMS0w_a3cd7de1-fd76-4671-9dbb-b6472595b75c">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy04LTEtMS0w_a4ffddd8-4547-49df-ac55-6f98a87ebb35">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy0xMC0xLTEtMA_ca661bee-f0af-4f6f-9615-dfbd5e77b802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy0xMi0xLTEtMA_ba20bb6b-b87f-4543-ab0a-9ba66a68bbdf">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC0yLTEtMS0w_0b0db519-7983-4244-bcd9-b91905924e10">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC00LTEtMS0w_01c1b9df-9052-4a24-b8ae-a1f86d796987">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC02LTEtMS0w_bf77cfe7-97b2-4a65-b8e0-8fa0b44dd572">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC04LTEtMS0w_3aadf4dc-754d-435d-a7cd-466bf32d2b0a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC0xMC0xLTEtMA_05e64b52-bfa8-4726-bc93-f8c045e52436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC0xMi0xLTEtMA_8dc5ec4f-62de-42ca-958d-b256c452a288">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_49"></div><div style="margin-top:16.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="gild:AcquisitionCollaborationsandOtherArrangementsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfOTQwMA_4f3b13a7-ad31-4a96-bed9-1ed2d909385a" continuedAt="i79d6d294fc0f4263a7c3f058f8777f8a" escape="true">ACQUISITIONS, COLLABORATIONS AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><ix:continuation id="i79d6d294fc0f4263a7c3f058f8777f8a" continuedAt="ib76d078de7124415b4cced588e378376"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to pursue acquisitions, licensing and strategic collaborations and other similar arrangements including equity investments with third parties for the development and commercialization of certain products and product candidates. These arrangements may include non-refundable upfront payments, expense reimbursements or payments by us for options to acquire certain rights, contingent obligations by us for potential development and regulatory milestone payments and/or sales-based milestone payments, royalty payments, revenue or profit-sharing arrangements and cost-sharing arrangements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:150%">Forty Seven, Inc. (&#8220;Forty Seven&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On&#160;April 7, 2020, we acquired all of the then issued and outstanding common stock of Forty Seven, a clinical-stage immuno-oncology company focused on developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches, for a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic81637a074d1401ba756b4140e12c426_I20200407" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0Mjc4Mw_082f4689-e6e1-4455-ba41-4eda37a424aa">95.50</ix:nonFraction> per share in cash, for total consideration of $<ix:nonFraction unitRef="usd" contextRef="ic81637a074d1401ba756b4140e12c426_I20200407" decimals="-8" format="ixt:numdotdecimal" name="gild:AssetAcquisitionCashOutflowNetOfCashAcquired" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MjgzMw_52318e23-1b83-4981-a97f-8738e5f89475">4.7</ix:nonFraction> billion, net of acquired cash. As a result, Forty Seven became our wholly-owned subsidiary. Forty Seven&#8217;s lead program, magrolimab, is an investigational monoclonal antibody in clinical development for the treatment of myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma and solid tumors. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the transaction as an asset acquisition since the lead asset, magrolimab, represented substantially all the fair value of the gross assets acquired. At the acquisition date, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i71639a47b1bd4ad797ffe29d99a1a286_D20200407-20200407" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MzM0Mw_47df4ca3-b288-4e65-8fe1-db3048a875fa">4.5</ix:nonFraction> billion charge representing an acquired IPR&amp;D asset with no alternative future use in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. In connection with this acquisition, we recorded $<ix:nonFraction unitRef="usd" contextRef="i71639a47b1bd4ad797ffe29d99a1a286_D20200407-20200407" decimals="-6" format="ixt:numdotdecimal" name="gild:AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MzQ5MA_e7437848-71a9-4421-84c3-e46271ad4e15">202</ix:nonFraction> million of assets acquired primarily consisting of deferred tax assets. Liabilities assumed were not material. During the three months ended June 30, 2020, we also recorded share-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i17d546d74ae148b5a021eb383025f81b_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MzY5NQ_906c6c6b-3a6d-4b01-abfd-f984cabf3dea">144</ix:nonFraction> million related to the cash settlement of unvested Forty Seven employee stock awards attributable to post-acquisition services, which was primarily recorded in Research and development expenses on our Condensed Consolidated Statements of Operations. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:150%">Immunomedics, Inc. (&#8220;Immunomedics&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 13, 2020, we entered into an agreement and plan of merger (&#8220;Agreement and Plan of Merger&#8221;) to acquire Immunomedics, a company focused on the development of antibody-drug conjugate (&#8220;ADC&#8221;) technology. Immunomedics researches and develops biopharmaceutical products, particularly antibody-based products for patients with solid tumors and blood cancers, and manufactures and markets Trodelvy. Trodelvy, a Trop-2-directed ADC, developed by Immunomedics is the first ADC that the U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved for the treatment of adult patients with metastatic triple-negative breast cancer.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 24, 2020, under the terms of the Agreement and Plan of Merger, we commenced a tender offer (&#8220;Offer&#8221;) to acquire all of the outstanding shares of common stock of Immunomedics for approximately $<ix:nonFraction unitRef="usd" contextRef="icd56ba38aa8046bba054f36afeef99eb_D20200924-20200924" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMTY0OTI2NzUyODc1Mg_26763a1b-2c36-40f8-b3ae-c06f25a965d2">21</ix:nonFraction> billion (at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia0f837e863ae43748f6f3d4be7b759a9_I20200924" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzI5Mw_255b2bf0-e42c-42bb-9b2f-3a5da8f942c0">88.00</ix:nonFraction> per share), net in cash, without interest and subject to any withholding of taxes. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib76d078de7124415b4cced588e378376" continuedAt="ie7b4c3394fa541cda6626e05274fce38"><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an event subsequent to September 30, 2020, on October 23, 2020, we completed the Offer for all outstanding shares of common stock of Immunomedics and accepted all shares validly tendered and not withdrawn as of the expiration time of the Offer. Following the Offer, we also acquired all remaining shares not tendered at Offer pursuant to the merger contemplated by the Agreement and Plan of Merger. As a result, the acquisition was completed and Immunomedics became a wholly owned subsidiary of Gilead. The financial results of Immunomedics will be included in our consolidated financial results for the year ending December 31, 2020 from the date of completion of the acquisition. We financed the acquisition with the majority of the proceeds from the September 2020 senior unsecured notes offering, an additional $<ix:nonFraction unitRef="usd" contextRef="ib8a8484ba93b4e959a292d7acd17712e_D20201023-20201023" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMTY0OTI2NzUyMjAwMQ_777c18cd-441a-4997-82a7-971028c90c86">1.0</ix:nonFraction> billion borrowing under a new senior unsecured term loan facility and the balance with cash on hand. See Note 9. Debt and Credit Facilities for additional information.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our acquisition of Immunomedics will be accounted for as a business combination using the acquisition method of accounting in the fourth quarter of 2020. Given the recent timing of the transaction close, we are in the process of estimating fair values of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assets acquired and liabilities assumed in the business combination.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we are currently unable to provide preliminary allocation of purchase consideration based on the acquisition date fair values of the assets acquired and liabilities assumed as well as other related information, but we will disclose such information in our Annual Report on Form 10-K for the year ending December 31, 2020. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaborations and Other Arrangements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arcus Biosciences, Inc. (&#8220;Arcus&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 29, 2020, we acquired <ix:nonFraction unitRef="shares" contextRef="i10ded791c9da4652a9c01c141f86a369_I20200529" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentOwnedBalanceShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjEzNA_d09a516f-59b9-44d4-ab7a-63be9afee11a">2.2</ix:nonFraction>&#160;million shares of the common stock of Arcus, a publicly traded oncology-focused biopharmaceutical company, for approximately $<ix:nonFraction unitRef="usd" contextRef="i10ded791c9da4652a9c01c141f86a369_I20200529" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjI1NA_2c03aa8a-8092-4313-b056-11596da653bf">61</ix:nonFraction> million in a secondary equity offering. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, on&#160;May 27, 2020, we entered into a transaction with Arcus, which included entry into an option, license and collaboration agreement (the &#8220;Collaboration Agreement&#8221;) and a common stock purchase agreement and an investor rights agreement (together, the &#8220;Stock Purchase Agreements&#8221;). </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Collaboration Agreement and Stock Purchase Agreements, on July 13, 2020, we made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjY5Ng_61f4a2c2-62cd-401f-b6ff-cd32da309d0e">175</ix:nonFraction> million and acquired approximately <ix:nonFraction unitRef="shares" contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:InvestmentOwnedBalanceAdditionalShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjcyNg_6f267e01-38f3-41f1-a49e-208077d56ab5">6</ix:nonFraction>&#160;million additional shares of Arcus&#8217; common stock for $<ix:nonFraction unitRef="usd" contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjc3NA_727b5fd1-970f-46a2-b727-1c9e964fa5bc">200</ix:nonFraction> million in accordance with the terms of the Collaboration Agreement and the Stock Purchase Agreements. Of the total $<ix:nonFraction unitRef="usd" contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:TotalUpfrontPaymentsMade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQwMg_37f01e53-48ab-4218-b597-ee4aa2d6a74f">391</ix:nonFraction> million initial cash payments made under the agreements and direct transactional costs, we recorded $<ix:nonFraction unitRef="usd" contextRef="i052a9ab163094c12a8e0e749e1a27ad0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQyMA_337cd120-ce26-4d09-a5a9-e230f76a6e12">135</ix:nonFraction> million as an equity investment, which was calculated based on Arcus&#8217; closing stock price of $<ix:nonFraction unitRef="eurPerShare" contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQzMg_175853da-9aff-4c9f-b221-4ea94dfb8c60">22.67</ix:nonFraction> on the closing date of the transaction. As a result, combined with our existing share holdings, we own <ix:nonFraction unitRef="shares" contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentOwnedBalanceShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ0Ng_2bd89057-b8da-490f-878f-27ed36e2a54b">8.2</ix:nonFraction>&#160;million shares of Arcus, representing approximately <ix:nonFraction unitRef="number" contextRef="iae7c61328cd345d19182e7d8c3116c73_I20200713" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjkwNg_1a627b68-8e3f-4612-82ea-fb3fe62fb4b9">13</ix:nonFraction>% of the issued and outstanding voting stock of Arcus immediately following the closing of the transaction. We recorded our equity investments in Arcus in Other long-term assets on our Condensed Consolidated Balance Sheets as the investments are subject to contractual lock-up provisions for a period up to 2 years from the closing date of the agreements, subject to certain conditions. We account for our equity investment in Arcus at fair value with changes in fair value recognized in Other income (expense), net for each reporting period. The remaining $<ix:nonFraction unitRef="usd" contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ2NA_ef0c14cc-43de-4c57-9829-a979d5a58e16">256</ix:nonFraction> million was attributed to the acquired license and option rights of $<ix:nonFraction unitRef="usd" contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ4Mg_fc816af0-adbc-4cc9-b1ca-43f92e23da71">175</ix:nonFraction> million representing IPR&amp;D assets with no alternative future use, $<ix:nonFraction unitRef="usd" contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713" decimals="-6" sign="-" format="ixt:numdotdecimal" name="gild:IssuanceDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ5OQ_9e0eab99-0acd-4800-9f46-8c34948f5f0c">65</ix:nonFraction> million of an issuance premium for the equity purchase and $<ix:nonFraction unitRef="usd" contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:PaymentsForDirectTransactionalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc3ODA3OA_2a15f5b5-e10b-4b2e-a1c9-80991f384546">16</ix:nonFraction> million of direct transactional costs. These amounts were expensed as Acquired in-process research and development expenses during the three months ended September 30, 2020 on our Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gilead has the right to opt-in to all current and future investigational product candidates that emerge from Arcus&#8217; research portfolio for the ten years following the closing of the transaction. Upon our exercise of an option for a program, unless Arcus opts out according to the terms of the Collaboration Agreement, the companies will co-develop and share global development costs and co-commercialize and share profits in the U.S. We will obtain exclusive rights to commercialize any optioned programs outside of the U.S., subject to any rights of Arcus&#8217; existing partners, for which we will pay to Arcus tiered royalties ranging from the high teens to the low twenties on net sales. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Collaboration Agreement, subject to certain limited exceptions, we are required to provide $<ix:nonFraction unitRef="usd" contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjU5NzA2OTg0NDg1OQ_489f4a65-0b4d-49be-8351-6cbe431d5567">100</ix:nonFraction>&#160;million to Arcus on the second anniversary of the agreement and may pay an additional $<ix:nonFraction unitRef="usd" contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzUzNQ_0c117b5a-9031-4a69-b835-a1bb79b79f74">100</ix:nonFraction> million at our option on each of the fourth, sixth, and eighth anniversaries of the agreement, unless terminated early, as ongoing research and development support to extend our collaboration term to up to <ix:nonNumeric contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713" format="ixt-sec:durwordsen" name="gild:CollaborativeArrangementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfOTQwNA_896188c4-99a6-4a12-bed2-0e9416896cb0">10-years</ix:nonNumeric>. Accordingly, during the three months ended September 30, 2020, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i3562638e6f29454e9b2073af015cfd17_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzU1NA_7f022ddd-b8b4-484c-be6b-55e233906cee">100</ix:nonFraction> million charge representing the contractually committed payment in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Collaboration Agreement, we will potentially provide up to $<ix:nonFraction unitRef="usd" contextRef="ia3d27c4b18e74db390be0856717db477_I20200713" decimals="-8" format="ixt:numdotdecimal" name="gild:EquitySecuritiesFVNIFutureMaximumMilestonePayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDE0Mg_e673c9af-890b-4fae-a88a-9d27614dc679">1.2</ix:nonFraction> billion in opt-in and milestone payments with respect to current clinical product candidates, if and when such payments are triggered under the Collaboration Agreement. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie7b4c3394fa541cda6626e05274fce38" continuedAt="i6697bdb7afd34df18e1a71ee622b4053"><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stock Purchase Agreements, we have the right to purchase additional shares of Arcus from Arcus over the next <ix:nonNumeric contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713" format="ixt-sec:durwordsen" name="gild:EquitySecuritiesFVNIPurchasePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDQxNQ_6319738f-0906-44c1-b352-c48c0504ef1f">five years</ix:nonNumeric>, up to a maximum of <ix:nonFraction unitRef="number" contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713" decimals="2" name="gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDQzOA_f5a19cf7-44e0-414a-bd55-8942ba66cdcc">35</ix:nonFraction>% of the outstanding voting stock. We are subject to a <ix:nonNumeric contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713" format="ixt-sec:durwordsen" name="gild:EquitySecuritiesFVNIRestrictionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfOTM5OA_7fb55139-89f4-4a29-860c-6f26989f123f">three-year</ix:nonNumeric> standstill restricting our ability to acquire voting stock of Arcus exceeding more than <ix:nonFraction unitRef="number" contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713" decimals="2" name="gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDU5MA_f5a19cf7-44e0-414a-bd55-8942ba66cdcc">35</ix:nonFraction>% of the then issued and outstanding voting stock of Arcus, subject to certain exceptions. Additionally, we agreed not to dispose of any equity securities of Arcus prior to the second anniversary of the closing of the Stock Purchase Agreements without the prior consent of Arcus, subject to certain exceptions. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pionyr Immunotherapeutics, Inc. (&#8220;Pionyr&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2020, we entered into a transaction with Pionyr, a privately held company pursuing novel biology in the field of immuno-oncology, which included entry into <ix:nonFraction unitRef="agreement" contextRef="i17375473d31a4fa98457488c706cd582_I20200619" decimals="INF" format="ixt-sec:numwordsen" name="gild:NumberOfAgreements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTA4Mw_a585ac1d-453d-439e-97f6-f02900dc9ee2">two</ix:nonFraction> separate merger agreements, one contemplating the initial acquisition of <ix:nonFraction unitRef="number" contextRef="i17375473d31a4fa98457488c706cd582_I20200619" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTE1OQ_297ba64b-afa8-4e9c-87f8-7967bf59b8db">49.9</ix:nonFraction>% equity interest in Pionyr, and the other providing us the exclusive option, subject to certain terms and conditions, to acquire the remaining outstanding capital stock of Pionyr (together, the &#8220;Pionyr Merger and Option Agreements&#8221;) and a research and development service agreement. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2020, we closed the transaction with Pionyr and paid $<ix:nonFraction unitRef="usd" contextRef="i211cbe851f934c1b9e00538e84f893fc_D20200713-20200713" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTUzNQ_66534bd6-80ed-4ec6-a224-094f17b42a75">269</ix:nonFraction> million in cash and accrued an additional $<ix:nonFraction unitRef="usd" contextRef="i211cbe851f934c1b9e00538e84f893fc_D20200713-20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:InvestmentOwnedBalanceAdditionalPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzU2Nw_5ff922ce-3d57-4623-b4a6-5721eee644f4">6</ix:nonFraction> million payable, subject to certain customary adjustments, to Pionyr&#8217;s shareholders in accordance with the terms of the Pionyr Merger and Option Agreements. We account for our investment in Pionyr using the equity method of accounting because our equity interest provides us with the ability to exercise significance influence over Pionyr. Our investment in Pionyr, consisting of the transaction price noted above and transaction costs, exceeded our pro-rata portion of Pionyr's net assets at transaction closing. We determined that the resulting basis difference primarily relates to Pionyr&#8217;s IPR&amp;D which has no alternative future use and that Pionyr is not a business as defined in ASC 805, &#8220;Business Combinations.&#8221; As a result, we immediately recorded a charge for this basis difference of $<ix:nonFraction unitRef="usd" contextRef="ied8aaf6ee07c4c68b0c9d4a257521bf3_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzU4Ng_7ad49937-45da-49bd-8b8c-4d581dd2ca27">215</ix:nonFraction> million in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our exclusive option to acquire the remaining outstanding capital stock of Pionyr is approximately $<ix:nonFraction unitRef="usd" contextRef="i665e017e6d564f3f848b9735e5795f2f_I20200713" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzYwMw_e3b5477c-b9ca-480a-a3c2-2a0de96acfd2">70</ix:nonFraction> million based on a probability weighted option pricing model and recorded in Other long-term assets on our Condensed Consolidated Balance Sheet. From the first anniversary of the closing date, we may choose to exercise our exclusive option to purchase the remaining equity interest from Pionyr&#8217;s current shareholders for a $<ix:nonFraction unitRef="usd" contextRef="i665e017e6d564f3f848b9735e5795f2f_I20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:EquityMethodInvestmentOptionExerciseFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTkzNA_42766079-ea2b-43bd-8eff-9b726afda318">315</ix:nonFraction> million option exercise fee and up to $<ix:nonFraction unitRef="usd" contextRef="i665e017e6d564f3f848b9735e5795f2f_I20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:PotentialFutureMaximumMilestonePayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTk2Nw_5f6348cf-81ce-4b35-95b3-66949abb5b31">1.2</ix:nonFraction> billion in potential future milestone payments upon achievement of certain development and regulatory milestones, in each case subject to certain negotiated adjustments. Such option to purchase will expire following the earliest occurrence of specified events, including the delivery of data following completion of certain Phase 1b trials by Pionyr. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the research and development service agreement, we made an initial cash funding of $<ix:nonFraction unitRef="usd" contextRef="i2823e599701c40b09d1834198af15d61_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjQwNw_98768072-53c4-4a0b-989a-92f4376d9352">80</ix:nonFraction> million and recorded a charge in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020. We will provide additional payments of up to $<ix:nonFraction unitRef="usd" contextRef="i5669c974fb37460591c74bfced921611_I20200713" decimals="-6" format="ixt:numdotdecimal" name="gild:ResearchAndDevelopmentFutureMaximumPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjQ1Ng_bf81814b-cfa9-4870-a0d4-28b1acaf712c">115</ix:nonFraction> million to Pionyr upon achievement of certain development milestones. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tizona Therapeutics, Inc. (&#8220;Tizona&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2020, we entered into a transaction with Tizona, a privately held company developing cancer immunotherapies, which included entry into <ix:nonFraction unitRef="agreement" contextRef="ia7c901a1a55647e6ba26816eb4351009_I20200717" decimals="INF" format="ixt-sec:numwordsen" name="gild:NumberOfAgreements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjc2MA_4c3f00eb-49ef-4c80-8d1d-2a89a8ac8b53">two</ix:nonFraction> separate merger agreements, one contemplating the initial acquisition of a <ix:nonFraction unitRef="number" contextRef="ia7c901a1a55647e6ba26816eb4351009_I20200717" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjgzOA_ba2679ac-cbad-4640-b4a8-00f2ba370093">49.9</ix:nonFraction>% equity interest in Tizona, and the other providing us the exclusive option, subject to certain terms and conditions, to acquire the remaining outstanding capital stock of Tizona (together, the &#8220;Tizona Merger and Option Agreements&#8221;) and a development agreement. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2020, we closed the transaction with Tizona and paid $<ix:nonFraction unitRef="usd" contextRef="ib29eaffb63144ef9be056132abb82695_D20200825-20200825" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNzMyMQ_e7c0abbd-8bf5-4d26-aa84-d3434ac0a8d1">302</ix:nonFraction> million in cash to Tizona&#8217;s shareholders in accordance with the terms of the Tizona Merger and Option Agreements. We account for our investment in Tizona using the equity method of accounting because our equity interest provides us with the ability to exercise significance influence over Tizona. Our investment in Tizona, consisting of the transaction price noted above and transaction costs, exceeded our pro-rata portion of Tizona&#8217;s net assets at transaction closing. We determined that the resulting basis difference primarily relates to Tizona&#8217;s IPR&amp;D with no alternative future use and that Tizona is not a business as defined in ASC 805, &#8220;Business Combinations.&#8221; As a result, during the three months ended September 30, 2020, we immediately recorded this basis difference of $<ix:nonFraction unitRef="usd" contextRef="iabe5bc9211f04bfa9c594ba7cff3169b_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzYyMQ_60a1f887-d26f-4553-9aa0-48d0b3d39a93">272</ix:nonFraction> million in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our exclusive option to acquire Tizona is approximately $<ix:nonFraction unitRef="usd" contextRef="i23962171ea454e2fa69a3ea748b90d4c_I20200825" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzYzOQ_40e44310-0edb-4a35-a3a7-d7e104b455e2">41</ix:nonFraction> million based on a probability weighted option pricing model and recorded in Other long-term assets on our Condensed Consolidated Balance Sheet. From the first anniversary of the closing date, we may choose to exercise our exclusive option to purchase the remaining equity interest from Tizona&#8217;s current shareholders for up to $<ix:nonFraction unitRef="usd" contextRef="i23962171ea454e2fa69a3ea748b90d4c_I20200825" decimals="-8" format="ixt:numdotdecimal" name="gild:EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNzcyNA_190fd565-00c1-4d62-a0a7-7995ec664c4b">1.3</ix:nonFraction> billion, including an option fee and potential future milestone payments upon achievement of certain development and regulatory milestones, in each case subject to certain negotiated adjustments. Such option to purchase will expire following the earliest occurrence of specified events, including the delivery of data following completion of certain Phase 1b trials by Tizona. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6697bdb7afd34df18e1a71ee622b4053" continuedAt="i003d6347a32a4b6297b470e54f678ff0"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the development agreement, we committed to provide funding to Tizona of $<ix:nonFraction unitRef="usd" contextRef="if8210403301349c7b8277961e43603dc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzY1OA_ad4177cc-cc9d-4804-b2a9-af1a43d4c09a">115</ix:nonFraction> million, which was recorded in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tango Therapeutics, Inc. (&#8220;Tango&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2020, we entered into a transaction with Tango, a privately held company pursuing innovative targeted immune evasion therapies for patients with cancer through its proprietary, CRISPR-enabled functional genomics target discovery platform, which included entry into an amended and restated research collaboration and license agreement and a stock purchase agreement (together, the &#8220;Collaboration and Stock Purchase Agreements&#8221;). </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon entering into this transaction, we made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzczMQ_7dc1184a-ce8b-4a61-b6b3-dfc9623d0e35">125</ix:nonFraction> million and a $<ix:nonFraction unitRef="usd" contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817" decimals="-6" format="ixt:numdotdecimal" name="gild:CashPaymentsMadeRelatedToEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzc0OQ_a1ac24b4-e379-4f4d-9141-52e6ba6e6e6a">20</ix:nonFraction> million equity investment in Tango, representing approximately <ix:nonFraction unitRef="number" contextRef="if6a49596afb64be2a40ce0133770c139_I20200817" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU5NDIxMw_9e28e51c-594b-477e-a90c-f1f34b427f04">7</ix:nonFraction>% of the issued and outstanding voting stock of Tango immediately following the transaction, in accordance with the terms of the Collaboration and Stock Purchase Agreements. During the three months ended September 30, 2020, we recorded the $<ix:nonFraction unitRef="usd" contextRef="i6d1c0da9b7b548618507b7b986013f51_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc4MDYxMg_e7186c25-2761-4fa8-a84d-993a99e9ffba">125</ix:nonFraction> million upfront expense in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. Our equity investment in Tango is recorded at cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of Tango.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Collaboration and Stock Purchase Agreements, Gilead has the right to option up to <ix:nonFraction unitRef="program" contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817" decimals="INF" name="gild:NumberOfPrograms" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjU5NzA2OTgyOTU4Nw_d094f6cc-a762-4941-9d34-441d5ec65807">15</ix:nonFraction> programs over the <ix:nonNumeric contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817" format="ixt-sec:durwordsen" name="gild:CollaborativeArrangementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjU5NzA2OTg0NDg5OA_47df5d8d-b6c5-4694-8303-d540c01e15a7">seven-year</ix:nonNumeric> collaboration for up to $<ix:nonFraction unitRef="usd" contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817" decimals="-6" format="ixt:numdotdecimal" name="gild:EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzc4Mw_ddfbd56a-852a-4f33-9ba9-867b8d5e9b0a">410</ix:nonFraction> million per program in opt-in, extension and milestone payments. The parties will equally split profits and losses, as well as development costs in the U.S., for the products that Tango opts to co-develop and co-promote. We will provide Tango milestone payments and royalties on sales outside of the U.S. For products that Tango does not opt to co-develop and co-promote, we will pay Tango up to low double digit tiered royalties on net sales. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jounce Therapeutics, Inc. (&#8220;Jounce&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2020, we entered into a transaction with Jounce, a publicly traded company developing novel cancer immunotherapies, which included entry into license, registration rights and stock purchase agreements (together, &#8220;License and Stock Purchase Agreement&#8221;). In an event subsequent to September 30, 2020, in October 2020, we closed this transaction and made a total payment of $<ix:nonFraction unitRef="usd" contextRef="i291a141ad60a40e18d8e16c054569bd6_D20201001-20201031" decimals="-6" format="ixt:numdotdecimal" name="gild:TotalUpfrontPaymentsMade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM4MjM5OQ_1f1f4e00-8500-4aec-b313-e998ea8c7c99">120</ix:nonFraction> million in accordance with the terms of the License and Stock Purchase Agreement and recorded $<ix:nonFraction unitRef="usd" contextRef="i291a141ad60a40e18d8e16c054569bd6_D20201001-20201031" decimals="-6" format="ixt:numdotdecimal" name="gild:CashPaymentsMadeRelatedToEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM4MjY0Mg_99ac7857-0915-44c2-bbfc-cb6ca14fdb29">56</ix:nonFraction> million as an equity investment, representing approximately <ix:nonFraction unitRef="number" contextRef="ibb7dec07426445a0b61fd7ee1c436ae5_I20201031" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU5NDIxOQ_3f85749a-9d79-4245-bc97-869ac62d6956">14</ix:nonFraction>% of the issued and outstanding voting stock of Jounce immediately following the transaction, which was calculated based on Jounce&#8217;s closing stock price of $<ix:nonFraction unitRef="eurPerShare" contextRef="ic2051ed6e5a04c058e858df3aa244c5b_I20201031" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM4MjYyOA_ceed35fd-b39c-42d7-aefb-b03df85cf743">10.06</ix:nonFraction> on the closing date of the transaction. In addition, we will provide up to $<ix:nonFraction unitRef="usd" contextRef="ic2051ed6e5a04c058e858df3aa244c5b_I20201031" decimals="-6" format="ixt:numdotdecimal" name="gild:ResearchAndDevelopmentFutureMaximumPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzgzOA_24bc46df-c3c2-4a8b-85bd-d79e615f06fa">685</ix:nonFraction> million in future potential clinical, regulatory and commercial milestone payments upon achievement of certain milestones, and pay Jounce royalties ranging from high single digit to mid-teens based upon worldwide sales, subject to certain adjustments. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Galapagos </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we closed an option, license and collaboration agreement (the &#8220;Collaboration Agreement&#8221;) and a subscription agreement (the &#8220;Subscription Agreement&#8221;), each with Galapagos, pursuant to which the parties entered into a global collaboration that covers Galapagos&#8217; current and future product portfolio (other than filgotinib). Upon closing, we paid $<ix:nonFraction unitRef="usd" contextRef="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831" decimals="-8" format="ixt:numdotdecimal" name="gild:PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzg1Nw_716cc30e-7c73-4f81-a04e-e34344c4d596">5.1</ix:nonFraction>&#160;billion for the license and option rights and <ix:nonFraction unitRef="shares" contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831" decimals="-5" format="ixt:numdotdecimal" name="gild:InvestmentOwnedBalanceAdditionalShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzg3Ng_9e97e370-e9c2-4b64-82c3-1722cae4ef98">6.8</ix:nonFraction>&#160;million new ordinary shares of Galapagos at a subscription price of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzg4OQ_8daa2a27-569c-41b1-974a-18868f9b7aa8">140.59</ix:nonFraction> per share. As a result, combined with our then existing share holdings, we owned <ix:nonFraction unitRef="shares" contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentOwnedBalanceShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzkwNg_12484348-4214-4f91-a66d-de92f1391e37">13.6</ix:nonFraction>&#160;million ordinary shares of Galapagos, representing approximately <ix:nonFraction unitRef="number" contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzkxNQ_12074afd-8010-4d9e-8259-fd95e92864cf">22</ix:nonFraction>% of the issued and outstanding voting securities of Galapagos at the closing of the Collaboration Agreement and Subscription Agreement. The parties also amended certain terms relating to the development and commercialization of filgotinib pursuant to the license and collaboration agreement previously entered into between Gilead and Galapagos in 2015.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected the fair value option to account for our equity investment in Galapagos whereby the investment is marked to market through earnings in each reporting period based on the market price of Galapagos shares. We believe the fair value option best reflects the underlying economics of the investment. The $<ix:nonFraction unitRef="usd" contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzkzMA_37b55609-878a-4db8-99c8-b86eb81f347c">1.1</ix:nonFraction>&#160;billion equity investment, which included an issuance discount of $<ix:nonFraction unitRef="usd" contextRef="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="gild:IssuanceDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzk0Nw_7a0d2720-ea12-48a1-8496-c515deb71e52">63</ix:nonFraction> million calculated based on Galapagos&#8217; closing stock price on the date of closing of the Subscription Agreement and the subscription price of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzk2NQ_8daa2a27-569c-41b1-974a-18868f9b7aa8">140.59</ix:nonFraction> per share, and our existing equity investment in Galapagos was recorded in Other long-term assets on our Condensed Consolidated Balance Sheets as our equity investment in Galapagos is subject to contractual lock-up provisions for a period up to 5 years from the closing date of the Subscription Agreement. The remaining $<ix:nonFraction unitRef="usd" contextRef="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzk4MA_30093069-8ead-4e23-954f-e8ca2ee45fea">3.9</ix:nonFraction>&#160;billion of the payment was recorded in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, as the initial contractual lock-up provision for certain Galapagos shares will expire in August 2021, the corresponding equity investment balance of $<ix:nonFraction unitRef="usd" contextRef="i22eab18f188d4327810ed03862e4e414_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc1MTI0Ng_e3d78231-3530-4d4e-9556-c640c291c4a8">505</ix:nonFraction> million was reclassified to Prepaid and other current assets from Other long-term assets on our Condensed Consolidated Balance Sheets. During the three months ended September 30, 2020, we recorded a pre-tax unrealized loss of $<ix:nonFraction unitRef="usd" contextRef="ic68ebf48645046309e24289804996aac_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc1MDI1OQ_758328f0-9162-482c-9335-47b36d24c942">923</ix:nonFraction>&#160;million related to our investment in Galapagos in Other income (expense), net on our Condensed Consolidated Statement of Operations due to a decline in Galapagos&#8217; stock price. See Note 3. Fair Value Measurements for additional information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><ix:continuation id="i003d6347a32a4b6297b470e54f678ff0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gadeta B.V. (&#8220;Gadeta&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2018, we entered into a collaboration arrangement with Gadeta and made a purchase of equity in Gadeta from Gadeta&#8217;s shareholders. We determined that Gadeta was a VIE, and we were its primary beneficiary because we had the power to direct the activities of Gadeta that most significantly impact its economic performance. Upon the initial consolidation of Gadeta, we recorded $<ix:nonFraction unitRef="usd" contextRef="if0c15f0a4bf24e5faedca42d6ccbed3f_I20180731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestInVariableInterestEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc3NjM5OA_14e0f8a1-aa3d-4901-8f02-a69dc77bd4ee">82</ix:nonFraction> million to Noncontrolling interest, primarily reflecting acquired intangible assets related to IPR&amp;D on our Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, we effectively terminated the agreement with Gadeta. Upon the effective termination, we ceased to have a controlling interest and deconsolidated this VIE by removing the related net assets and noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="i55b9f2307b7d494fb84ae4a2f95e61ff_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestInVariableInterestEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc4MDU4MA_4c5ead7b-f848-42ea-8b0e-e8cd91c97305">82</ix:nonFraction> million from our Condensed Consolidated Balance Sheets. The net loss from the deconsolidation was not material.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2020 and 2019, we entered into several collaborative, equity investments and licensing arrangements as well as other similar arrangements that we do not consider to be individually material. We recorded upfront collaboration expenses related to these arrangements of $<ix:nonFraction unitRef="usd" contextRef="i1624c0037f5a41c4bfefb2aab54ddab5_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODQ3Mw_ba9731c9-0b14-450c-987e-67b0a5b8ab49">7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib97742c494394b88bc0725331e447507_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODQ4MA_73b06ce4-3f1d-4491-bae7-816ea6be5a67">129</ix:nonFraction> million for the three and nine months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="iad7fd7f958c54653849a9d5ba294d69c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODUxMw_4f58d224-2992-4d21-b6c4-60cb037d7b28">40</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i26766cda4c294fe982cb31efc05bed10_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODUyMA_f29a0e83-a54c-4667-9263-3dbe0b6a8e9d">331</ix:nonFraction> million for the three and nine months ended September 30, 2019, respectively, within Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. Cash payments made related to our equity investments for the three and nine months ended September 30, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i1624c0037f5a41c4bfefb2aab54ddab5_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:CashPaymentsMadeRelatedToEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM3ODA0NQ_fbee12f2-9e7d-469c-ab9b-13d5ddef1ed1">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib97742c494394b88bc0725331e447507_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:CashPaymentsMadeRelatedToEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM3ODA1Mw_fd9dbdb1-2b99-4012-9450-50f7635b57d8">61</ix:nonFraction> million, respectively, and totaled $<ix:nonFraction unitRef="usd" contextRef="iad7fd7f958c54653849a9d5ba294d69c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="gild:CashPaymentsMadeRelatedToEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc1MjYwMA_c7eb332b-e648-49d5-95a4-2b3dd5fe8dc5">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i26766cda4c294fe982cb31efc05bed10_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="gild:CashPaymentsMadeRelatedToEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODY3Mg_f2aa9f5f-528e-4ae9-8ead-b77ba7198a84">119</ix:nonFraction> million for the three and nine months ended September 30, 2019, respectively, which were primarily recorded within Prepaid and other current assets and Other long-term assets on our Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the financial terms of these arrangements, we may be required to make payments upon achievement of developmental, regulatory and commercial milestones, which could be significant. Future milestone payments, if any, will be reflected in our Condensed Consolidated Statements of Operations when the corresponding events become probable. In addition, we may be required to pay significant royalties on future sales if products related to these arrangements are commercialized. The payment of these amounts, however, is contingent upon the occurrence of various future events, which have a high degree of uncertainty of occurrence.</span></div></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_52"></div><div style="margin-top:13.5pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RleHRyZWdpb246YTVmNWRkYTUzOTJhNDg2NGI2YWNiN2E3N2M2OTJjNzdfMTg1_e97664d5-eb59-43a3-bded-4d2dc2caa1cd" continuedAt="i7d4a272b8ab04bc1a86898e8b8b718da" escape="true">OTHER FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i7d4a272b8ab04bc1a86898e8b8b718da"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RleHRyZWdpb246YTVmNWRkYTUzOTJhNDg2NGI2YWNiN2E3N2M2OTJjNzdfMTc2_e41efe52-a1f9-462d-98c9-6912a80e81e8" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our Inventories (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMS0yLTEtMS0w_4c060190-1b31-4345-8623-d05c4e85af40">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMS00LTEtMS0w_19552bb8-3363-4ef6-9448-9847a9aaf8a9">1,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMi0yLTEtMS0w_9a4597f6-439d-48c0-9fbb-d2f2e5a2b663">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMi00LTEtMS0w_733cf98d-1fbd-4a2f-9123-dfc16b3b6a19">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMy0yLTEtMS0w_71dc9056-9d1d-4a52-8f08-ecd192a58c7a">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMy00LTEtMS0w_0d27770b-b0b9-4cd1-9147-5ab4b84a9f3d">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:InventoryNetAndInventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNC0yLTEtMS0w_fcd4423f-be81-44af-aa7c-5ab548db065e">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="gild:InventoryNetAndInventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNC00LTEtMS0w_bd26d1fb-ae12-442d-b005-9490784b2013">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNy0yLTEtMS0w_b3c0c200-aa69-4ad7-b5e0-d2f5ca8f66ef">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNy00LTEtMS0w_40b354c7-c91e-410b-af7b-50ea9d59be66">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOC0yLTEtMS0w_8530a2a1-789e-4af6-8acb-d09a8cc23131">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOC00LTEtMS0w_6d4c1300-3209-428e-acc9-73a0dcb2c6d4">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:InventoryNetAndInventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOS0yLTEtMS0w_51119b6e-8349-467f-8339-e5c54795c628">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="gild:InventoryNetAndInventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOS00LTEtMS0w_9a3ffe29-8d0b-4872-8de2-3c0ac81c3273">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:0.1%"></td><td style="width:2.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts primarily consist of raw materials.</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Accrued Liabilities </span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RleHRyZWdpb246YTVmNWRkYTUzOTJhNDg2NGI2YWNiN2E3N2M2OTJjNzdfMTg0_b84ea6ab-8e81-47e2-bacf-45a24a0fb690" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of Other accrued liabilities (in millions):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMS0yLTEtMS0w_86bc3798-05b3-45f8-862b-e5e254a046b2">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMS00LTEtMS0w_d18df827-9b95-401c-bc07-64afdf76b623">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMi0yLTEtMS0w_f3bf55de-793d-4ee5-96d5-64a263284f65">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMi00LTEtMS0w_f9aadaae-855b-4e74-b1b0-691fae2b4f6d">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMy0yLTEtMS0w_d47d06d8-c689-4acf-80c5-11acc8817a65">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMy00LTEtMS0w_51152680-e011-4a59-9443-4fad03191349">2,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfNC0yLTEtMS0w_3904a82c-f681-4bd1-8e22-183477f42b7e">4,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfNC00LTEtMS0w_75d6d5d7-f19d-4cc5-af56-0ec367e0c1f9">3,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:16.5pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDMy_0c6a6397-5a20-4132-b7f1-ade47182bb39" continuedAt="ifa311c8c683943bf9f656b2fdd0d8626" escape="true">INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ifa311c8c683943bf9f656b2fdd0d8626"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDQ1_e62c6336-4315-4928-b182-9da00928ba7f" escape="true"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDY0_b7c770b9-b173-4e0f-b0b1-dd598ff1df63" escape="true"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our intangible assets, net (in millions): </span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:22.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.524%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.524%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finite-lived assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - sofosbuvir</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecca81affd53498284282e31cecf32f7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0yLTEtMS0w_43e6ab37-9745-4f8f-87a9-5691e583938b">10,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecca81affd53498284282e31cecf32f7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy00LTEtMS0w_254c8f5d-bdd6-420c-b40c-ef8a0804c98f">4,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecca81affd53498284282e31cecf32f7_I20200930" decimals="-6" format="ixt:zerodash" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy02LTEtMS0w_c371d6d3-91a5-40a3-a569-342c742866cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecca81affd53498284282e31cecf32f7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy04LTEtMS0w_8397f30a-9169-4f94-8602-e56ad320bc7d">5,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a84de8a34fb438289702707097480b8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xMC0xLTEtMA_2f70d2d2-3bcc-4ce2-a064-d8feeebbf1cc">10,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a84de8a34fb438289702707097480b8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xMi0xLTEtMA_057acb39-94ce-4765-9cf1-210eb6ba3a41">4,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a84de8a34fb438289702707097480b8_I20191231" decimals="-6" format="ixt:zerodash" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xNC0xLTEtMA_6751ab12-ae4d-4436-9a4a-4dd116e3fe24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a84de8a34fb438289702707097480b8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xNi0xLTEtMA_11e5d17b-ac34-4aec-a0cd-30fea33f2d89">6,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - axicabtagene ciloleucel</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0yLTEtMS0w_449f4675-3804-4316-8ce3-94f635ed4986">6,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC00LTEtMS0w_27193d44-3baa-4a4a-8bac-85c113736fef">1,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930" decimals="-6" format="ixt:zerodash" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC02LTEtMS0w_9a704326-f462-4799-a1c5-5217ce3e3c5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC04LTEtMS0w_18362524-d63f-4377-aa56-d81a14a01cc4">5,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xMC0xLTEtMA_3a6b9eeb-ddca-4e8c-a969-f02cc09c1e94">6,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xMi0xLTEtMA_e9a2b24b-4837-49f1-9093-76e1f46e29ef">761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231" decimals="-6" format="ixt:zerodash" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xNC0xLTEtMA_ae9e3103-d9d4-4b1e-b23c-cc18321a3297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xNi0xLTEtMA_d60b0d95-b213-4e4a-93b9-1da85200b08c">5,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0yLTEtMS0w_b0e0a9c5-c0f0-4a87-9bbd-a0037196b6ae">1,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS00LTEtMS0w_7bd4877b-f088-4c06-a60a-8a6bba082e46">516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930" decimals="-6" sign="-" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS02LTEtMS0w_a86996b8-d81d-4e62-91f9-43d7762062a7">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS04LTEtMS0w_5d44df43-3823-4e4b-94b7-c113c1c31c4d">685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xMC0xLTEtMA_d6d150ff-6bc3-4285-99b5-6091176370a2">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xMi0xLTEtMA_478debd0-2068-462c-82fb-1a5ebacbe536">454</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231" decimals="-6" sign="-" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xNC0xLTEtMA_c88b4856-7662-4c4d-a105-6cdcb71d39fa">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xNi0xLTEtMA_37f9cefb-c2d4-4b66-a765-837c2fce445e">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0yLTEtMS0w_374015ce-c7ba-44d5-a715-a5585c110439">18,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi00LTEtMS0w_ebe4ce67-0dc8-4cb0-89fe-7d0806dde205">6,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" sign="-" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi02LTEtMS0w_c220d986-5984-4ffc-8fc4-850578ded980">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi04LTEtMS0w_94830913-3674-49cd-abae-3d215b66e41c">11,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xMC0xLTEtMA_ec7a5e4b-6f1c-4496-92e7-a284e7379808">18,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xMi0xLTEtMA_87006bd0-560b-49f7-940b-d449a0d4288a">5,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" sign="-" name="gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xNC0xLTEtMA_41284a66-7f6c-4470-b99f-8f9af5aeb139">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xNi0xLTEtMA_6911abeb-372b-4076-b3ec-c08b025a215c">12,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived assets - IPR&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0440dbc560c34febb8b14b9e45c4454d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0yLTEtMS0w_3b6eec7f-274d-4e5a-a7ef-e2944830fdd0">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0440dbc560c34febb8b14b9e45c4454d_I20200930" decimals="-6" format="ixt:zerodash" name="gild:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy02LTEtMS0w_af972984-4d76-45b8-bf02-3239b6e14664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0440dbc560c34febb8b14b9e45c4454d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy04LTEtMS0w_9f694a59-b98f-4551-a79f-7dbe665f6aa1">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957437a2c5fb481fbc92c780ca815df7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0xMC0xLTEtMA_9d381afa-9d14-4061-8130-f99c03d3c431">1,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i957437a2c5fb481fbc92c780ca815df7_I20191231" decimals="-6" sign="-" name="gild:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0xNC0xLTEtMA_0989a680-0e4b-428d-8b8d-303abbdcb75e">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957437a2c5fb481fbc92c780ca815df7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="gild:TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0xNi0xLTEtMA_e9f38c86-4838-4394-957b-8110fe27f49f">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0yLTEtMS0w_3d6259d1-b114-4bbd-9ca3-a2d49ffaa975">19,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC00LTEtMS0w_2ff10bb0-7ab3-450a-b2e0-6085570aa7bc">6,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" sign="-" name="gild:FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC02LTEtMS0w_f09cb295-800c-4700-9c93-9db8bd8beb5f">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC04LTEtMS0w_b8cbac6e-4718-486e-9928-cc42309b8693">12,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xMC0xLTEtMA_fa582978-0d8f-41b0-80e0-760007425141">19,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xMi0xLTEtMA_3763e302-7847-40d2-85a9-9938512e0acc">5,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" sign="-" name="gild:FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xNC0xLTEtMA_f6a9ec67-ba9d-41ec-b938-203f33e5b992">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xNi0xLTEtMA_2c765257-86b1-4a67-85e4-4e909e169e22">13,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate amortization expense related to finite-lived intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMTY1_9e31f617-fef1-4409-92b2-7c5b00911e58">281</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMTcy_0f8b01a1-5196-407e-afbe-055f83394d51">844</ix:nonFraction> million for the three and nine months ended September 30, 2020, respectively, $<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMjAx_a1b621bf-38ce-4575-9c7b-0b9f210e454b">281</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMjA4_b1aa57d3-5d84-4575-8c93-485b62ca698c">868</ix:nonFraction> million for the three and nine months ended September 30, 2019, respectively, and was primarily included in Cost of goods sold on our Condensed Consolidated Statements of Operations.</span><span style="color:#b6b6b6;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDQ2_75f4a6da-e9d7-4724-acb1-7594192fee58" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of September&#160;30, 2020 (in millions):</span></div><div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:86.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfMS0yLTEtMS0w_d1e3f68a-d879-4adf-a909-2eeba853f872">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfMi0yLTEtMS0w_b077b9ed-462d-4ad9-b7e1-687c012d1652">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfMy0yLTEtMS0w_3a3793db-12b6-49a3-a4c7-28c23c6d40bb">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNC0yLTEtMS0w_1f9be901-dba9-457d-a576-c6b3cce183f2">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNS0yLTEtMS0w_d5c995cc-d73c-4c0e-b8d6-2b67649ce943">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNi0yLTEtMS0w_75cb9aeb-b7ef-4eaf-97ac-5c8ce5041683">6,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNy0yLTEtMS0w_42c27dd5-080e-4f7b-b8b3-0f57fd29beb0">11,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:4.5pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i9a5d0989150642c5998d2a345ad46d37_58"></div><div style="margin-top:16.5pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgyMzU1Ng_18d5168c-080f-4031-a7ce-35ebae8e01d2" continuedAt="if48b26ad7dc24e699fdeb2177c883773" escape="true">DEBT AND CREDIT FACILITIES</ix:nonNumeric></span></div><ix:continuation id="if48b26ad7dc24e699fdeb2177c883773" continuedAt="ia1edec20a56d4ee0b524672b532b4509"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Unsecured Notes</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTU1NA_e2c30e99-7fac-4797-9b75-64599467623e" escape="true"><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our borrowings under our senior unsecured notes (in millions):</span></div><div style="margin-bottom:11pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3160daa24dd5457a91283b0e02bb2b28_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMi00LTEtMS0w_52feec6a-e274-483a-a39d-3a0ef1f679dc">2.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3160daa24dd5457a91283b0e02bb2b28_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMi02LTEtMS0w_bd2bbe95-868b-44c4-acf3-682f81b14c81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b3518888b6449e28a4dd8a1ebb01448_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMi04LTEtMS0w_93ddbeb1-58a9-4908-8b95-fcc8d8bce5cd">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c5233e0d1e34dc1b9b616c2b9958ae9_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMy00LTEtMS0w_15372c45-765c-430c-9753-280ff80209cd">2.55</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5233e0d1e34dc1b9b616c2b9958ae9_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMy02LTEtMS0w_ef985bcb-b4aa-4101-9211-1285ffecb744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323f9eee9390464fb82fbcab9d0a9a54_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMy04LTEtMS0w_f503291f-55ec-4e08-93fc-d83a170301c3">1,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7bd2f1324bbe4577aaaa0b02e886a09d_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNC00LTEtMS0w_8e8ea4fe-f5a5-44f6-8a40-769af82726c2">4.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd2f1324bbe4577aaaa0b02e886a09d_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNC02LTEtMS0w_62744910-2377-481a-9a3e-74da76bfea23">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f678f93d81402b94b3fe583ae53808_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNC04LTEtMS0w_9e518046-f27f-43c3-ab05-ba40c202efd0">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-month LIBOR + <ix:nonFraction unitRef="number" contextRef="i076a134b65754ba59bc1587c4dba35f0_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS00LTEtMS04MjAyL3RleHRyZWdpb246NTliY2UxMjQ2YTgzNGMzNWE2YTYwODNkNWRlNzMyMzlfMTA5OTUxMTYyNzgwNg_5f9ffec1-5400-45bc-9152-f36547c88c70">0.15</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b6a868c97f4d47b86b691b5a97102c_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS02LTEtMS0zMjMz_5d02325c-2313-4f48-8ef4-af17e9aacccd">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff5c939d7a664dbcaa1fe8a25b93b1e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS04LTEtMS0zMjMz_9f1a47a0-b684-443f-ac72-9840a1887f4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cfd9d16d0134db083a80208f18fb127_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS00LTEtMS0w_c0e1aa6d-44dc-400c-9ed8-44cba294050e">4.40</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfd9d16d0134db083a80208f18fb127_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS02LTEtMS0w_161fd37a-241f-4891-b684-da4712d52f32">1,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b49b10ace4044ddb35f895db112ee9b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS04LTEtMS0w_20e4a2cf-adb0-4025-8e4b-d6c0815e16fb">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f3d085128dc47ddbc2b7e8c7b158013_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNi00LTEtMS0w_78de0def-263a-4ab6-b74a-e7cc349acf93">1.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3d085128dc47ddbc2b7e8c7b158013_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNi02LTEtMS0w_946fe99f-163a-4315-a46a-af007e7817a4">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943f74870a1242a68086cfeba9802e0e_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNi04LTEtMS0w_7907651f-02a8-40d7-a505-c6185a10a306">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib7115ef027e1437da78e8c0e4770de11_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNy00LTEtMS0w_d37f5fa9-7f0d-4d0c-9492-7e4d2e8656d4">3.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7115ef027e1437da78e8c0e4770de11_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNy02LTEtMS0w_6ef4d8b8-ab92-4155-adb0-adb52d96362f">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4445c6b7b641c6ac7e8571db780c2e_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNy04LTEtMS0w_ea59b451-03c1-4d21-9787-ac28c1c3caef">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice6ce99e645641b1b447d7873df500b8_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOC00LTEtMS0w_72ca6269-d4d6-4353-a0b4-523b2c9734dc">2.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6ce99e645641b1b447d7873df500b8_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOC02LTEtMS0w_04fce8b6-51a3-4964-9d3e-ceff3efac558">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i034bc53776884c94ae8a3268988a8403_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOC04LTEtMS0w_d2a52f27-4847-4c56-b61d-91066e3c647d">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-month LIBOR + <ix:nonFraction unitRef="number" contextRef="ifa3287ce6d5c46038d6d90283ff80eeb_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNC0xLTEtODIwNC90ZXh0cmVnaW9uOjA0ZGQ4NjAxMDEyODQ3NzU5MGQyZTg5NDY1MjJjNzQ3XzEwOTk1MTE2Mjc4MDY_da6a5064-8a70-4150-a9ef-11bb32c34c0c">0.52</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i024047c0ec56431f91c17a86fae8c5fc_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNi0xLTEtMzIzNg_1deca093-b6b3-4b0c-9332-6a3391c425ed">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb855db743fc4e4d8bfeb913a9465b4b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtOC0xLTEtMzIzNg_16ea1c16-2e83-4460-9e63-b720bac9de09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNC0xLTEtODE4OQ_5a811fd2-7583-44a8-8f69-9837ac44cd08">0.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNi0xLTEtMzIzNg_1465689f-8701-4009-ad4d-ed2a4d1152b4">1,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1740f93795744755a3ee51a0609192ff_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtOC0xLTEtMzIzNg_ab89615d-abee-405e-bbe4-f4e1cf589ddb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53f786cdbfbe4e19a3f79eb22d33def6_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOS00LTEtMS0w_a5179945-58ef-42c1-9a54-13fe1fc5f1e4">3.70</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f786cdbfbe4e19a3f79eb22d33def6_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOS02LTEtMS0w_5044f8cb-d2b3-4c0b-8cb7-36d169f9c49e">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830b9fd58a46421ca2f14073652a8b07_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOS04LTEtMS0w_0e2b0687-62ab-4308-9747-b27fc80f74e1">1,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69184deceb83472e87a54770bd526907_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNC0xLTEtMA_da253860-867c-4160-8cd8-42132675ed3b">3.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69184deceb83472e87a54770bd526907_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNi0xLTEtMA_cc893293-1719-46ff-ad75-1e70efc4fbb3">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08649fd40b64b78a3ac992ce45ffe51_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtOC0xLTEtMA_0e04f0a8-60ce-408d-9774-256a09070c34">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3db367e747ab469885d1e740050763a3_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNC0xLTEtMA_e5fbb185-080c-4d13-9521-0fd82e56c73d">3.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db367e747ab469885d1e740050763a3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNi0xLTEtMA_6bdee1fd-7851-473e-93f6-6dbcd410ed3d">2,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9037d73ce3734b9781f89c898abc8331_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtOC0xLTEtMA_54185139-ece6-4f21-96cf-ce97701f0606">2,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i819d350aa46949b1927defb662d03b4a_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTItNC0xLTEtMA_7ead8c60-ebfd-4335-86d7-d33827227435">2.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819d350aa46949b1927defb662d03b4a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTItNi0xLTEtMA_f9c901ff-6679-4ee6-ae11-8d96bfa6c491">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9543cb5e44cf49dc9f987a6ce144eb4d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTItOC0xLTEtMA_6bee6f89-3f1f-45bf-ae5b-87ff770be426">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNC0xLTEtODE5Mw_ce54adb2-3941-4e1d-8bc5-773a4e854359">1.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNi0xLTEtMzIzOQ_bcc78140-5d45-4cf3-8057-0b3055d862d0">745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a72c53bb76412d862e75ceca21ea29_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtOC0xLTEtMzIzOQ_67413b31-49f8-4fba-a2ca-b5de03ce4913">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f72724ee7414879a83048bd3532f197_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNC0xLTEtODE5Mw_cce3054b-7eee-42a7-9df6-b047c8354230">1.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f72724ee7414879a83048bd3532f197_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNi0xLTEtMzIzOQ_8fbaddb6-d770-4672-bf47-61612ec47545">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if172b80ce0344955a3bae899f1aef873_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctOC0xLTEtMzIzOQ_0cfde10e-1146-4987-95b9-72d5b5421e9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27ddc1e9a89a48ae9793e4c7f3c3ee5e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTMtNC0xLTEtMA_49e361ab-037b-4de7-8918-0b57043209cf">4.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ddc1e9a89a48ae9793e4c7f3c3ee5e_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTMtNi0xLTEtMA_b4b14a32-89bd-4dd6-b2b2-b44c70196ce1">991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc4618a73204298852a45480a01610f_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTMtOC0xLTEtMA_cdcbe2ff-e8b9-4452-ace4-3ae74018e181">991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie746e67ba8d64af0b6434070b1135780_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTQtNC0xLTEtMA_3d3d20be-a3d0-4999-9e32-979b1ad015e7">4.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie746e67ba8d64af0b6434070b1135780_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTQtNi0xLTEtMA_37f2426d-0ed7-4ed8-9219-36e0eb26bc14">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i917d5ae043a6482ea2fe51d188f57fdd_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTQtOC0xLTEtMA_5d140f5a-5358-497a-bc9c-4507571808b6">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtNC0xLTEtODE5NQ_917b7168-7b6e-432c-a55d-4a1b62d9b808">2.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtNi0xLTEtMzI0Mg_21721800-fd89-4ec5-a9c8-364186ee411a">986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29e93986f134ebcadfa3bf09afe5797_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtOC0xLTEtMzI0OQ_493cdc59-03b4-4ef5-b87e-1ebed34cbaa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2041</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idfec6ce2d495407e91872cb50eb1d277_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTUtNC0xLTEtMA_27eab932-f4f3-4d94-b4cd-c102dfb6ee0d">5.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfec6ce2d495407e91872cb50eb1d277_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTUtNi0xLTEtMA_4039b493-7021-4c64-b365-e2fab14ee53b">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65e28716f114e31bb0b12b21ca5d7b3_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTUtOC0xLTEtMA_0bbbc5a6-de49-45ec-bd95-e0e1ba0cbd46">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i916f791cc0b141c9acf5ce3bcf4af863_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNC0xLTEtMA_7de655f7-5712-4ac7-9917-dd6b651d034b">4.80</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i916f791cc0b141c9acf5ce3bcf4af863_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNi0xLTEtMA_8d83be07-0300-4d01-8394-432c76a93630">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516c59fe4fdb420fa10752e3f879ee6a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtOC0xLTEtMA_02035841-9ccb-4ea7-9232-4b64cc342553">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2045</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd8ad038d121413794732443f43b0dd4_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNC0xLTEtMA_5c94afec-a38b-402b-ac3f-2d8f3257eb28">4.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8ad038d121413794732443f43b0dd4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNi0xLTEtMA_f0bf25a5-56dc-42c7-8263-ae8a97b2f2a1">1,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id493a8861f6f49eebbc2bfe998aabff2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctOC0xLTEtMA_542d8a85-ebd2-4af7-8008-5741689507e4">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2046</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i924d914a188c41fabc11cc7f15cdc373_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTgtNC0xLTEtMA_dccd4ef2-56c4-4589-bff3-e0bcde22c2ea">4.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i924d914a188c41fabc11cc7f15cdc373_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTgtNi0xLTEtMA_4c240fa6-b3e9-4c74-9b48-67d9f269586b">2,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f55700d855e42528ccc24cdf5849a69_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTgtOC0xLTEtMA_81ae9972-e66c-4589-9f9c-7ce49683b62d">2,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2047</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04dd812e93aa44c9a770b8e0110ad89d_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTktNC0xLTEtMA_26352176-d61f-47d0-ab13-925e2d733d6a">4.15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04dd812e93aa44c9a770b8e0110ad89d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTktNi0xLTEtMA_079aa6e1-3ab2-4af3-871a-dd4fa807314a">1,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffee9b8a237845ffb486442200c4c758_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTktOC0xLTEtMA_0e89e5e6-2013-46cd-a858-d48145175e25">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjYtNC0xLTEtODE5Nw_f0be2aea-9855-488d-b92d-a22036139aca">2.80</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjYtNi0xLTEtMzI0NQ_602b3702-31dd-4451-8b4d-a07a21346b64">1,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic09bf1bed99a4abc8990ec17f2674ada_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjYtOC0xLTEtMzI0NQ_5eaf6556-5053-4517-8700-3dfaa9bfe543">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtNi0xLTEtMA_48a3ac8d-225b-460b-9261-ef2c2a1cf165">29,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtOC0xLTEtMA_03064761-7448-4e0e-bc57-2e73e122887f">24,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt 2px 42pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjEtNi0xLTEtMA_ab98df47-1874-4a01-b3ba-1455d5dcb88d">1,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjEtOC0xLTEtMA_2a5d9287-f1ec-4fd8-a392-a4141a133351">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjItNi0xLTEtMA_c0e893a1-e887-44d6-9781-b81c7f76ee0d">27,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjItOC0xLTEtMA_5129342b-22c0-4153-a012-0f7328a2e17e">22,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes Offering</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we issued $<ix:nonFraction unitRef="usd" contextRef="i732e6064e491434f97f7abba277ffc08_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2Mjk3NQ_7cdca5c9-af46-40f9-9503-fefd1f0feb8b">7.25</ix:nonFraction> billion aggregate principal amount of senior unsecured notes consisting of (i) $<ix:nonFraction unitRef="usd" contextRef="i78b6a868c97f4d47b86b691b5a97102c_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2Mjk1OQ_46cffe76-01b5-44a4-91b4-b9187cbe1581">500</ix:nonFraction> million principal amount of floating rate notes due September 2021 and $<ix:nonFraction unitRef="usd" contextRef="i024047c0ec56431f91c17a86fae8c5fc_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2Mjk5OA_f1ff7704-3de2-4138-8817-69e81d18fb1e">500</ix:nonFraction> million principal amount of floating rate notes due September 2023 (together, the &#8220;Floating Rate Notes&#8221;); and (ii) $<ix:nonFraction unitRef="usd" contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzAxMw_97a9a7e7-2d9c-42b0-9e26-0fe048b193ba">2.0</ix:nonFraction> billion principal amount of <ix:nonFraction unitRef="number" contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgwMg_f29cbf55-d326-48c8-91e9-ed4e6fc9faa1">0.75</ix:nonFraction>% senior notes due September 2023, $<ix:nonFraction unitRef="usd" contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzAyOA_5ce8e87a-3c1b-40af-9045-e753ef5a1ad1">750</ix:nonFraction> million principal amount of <ix:nonFraction unitRef="number" contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgxMA_c6c7cfdb-3adf-437a-90c1-bfe519ad8eb2">1.20</ix:nonFraction>% senior notes due October 2027, $<ix:nonFraction unitRef="usd" contextRef="i0f72724ee7414879a83048bd3532f197_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzA0Mw_e390cc1c-c37c-4d52-a66c-f5e447feb91e">1.0</ix:nonFraction> billion principal amount of <ix:nonFraction unitRef="number" contextRef="i0f72724ee7414879a83048bd3532f197_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgxOA_903ba683-01eb-46f3-bfff-3436044373c8">1.65</ix:nonFraction>% senior notes due October 2030, $<ix:nonFraction unitRef="usd" contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzA1OA_f6a1152f-0b50-40ea-bfe7-f9aa678c985d">1.0</ix:nonFraction> billion principal amount of <ix:nonFraction unitRef="number" contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgyNg_09d5fbbc-74fe-4005-b26f-d04f6ab95a52">2.60</ix:nonFraction>% senior notes due October 2040 and $<ix:nonFraction unitRef="usd" contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzA3Mw_cae1cb2d-29c7-4164-93bd-e4f2e2bfed6b">1.5</ix:nonFraction> billion principal amount of <ix:nonFraction unitRef="number" contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgzNA_721c02a4-009b-4de2-b62b-1031c2e8be6b">2.80</ix:nonFraction>% senior notes due October 2050 (together, the &#8220;Fixed Rate Notes&#8221; and, together the Floating Rate Notes, the &#8220;2020 Senior Notes&#8221;), the terms of which are summarized in the table above. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia1edec20a56d4ee0b524672b532b4509"><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed Rate Notes may be redeemed at our option at a redemption price equal to the greater of (i) <ix:nonFraction unitRef="number" contextRef="i7ff2cdfdf7c743e5a3c192c472818845_D20200901-20200930" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIxMw_4c06cc80-09ac-4cff-b738-dde25ab3ebe8">100</ix:nonFraction>% of the principal amount of the Fixed Rate Notes to be redeemed and (ii) the sum, as determined by an independent investment banker, of the present values of the remaining scheduled payments of principal and interest on the Fixed Rate Notes to be redeemed (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semiannual basis at the treasury rate, plus <ix:nonFraction unitRef="number" contextRef="i6942d430090747b99d43a27db7846096_D20200901-20200930" decimals="INF" name="gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUwOA_3bbb961d-7aea-4f25-803a-cb00933007a3">10</ix:nonFraction> basis points in the case of the 2023 fixed rate notes, <ix:nonFraction unitRef="number" contextRef="i5d133b8c794a496097f8802c3cee3c74_D20200901-20200930" decimals="INF" name="gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUxNw_230ffee9-ad60-4054-8871-fb9217c4a7c4">12.5</ix:nonFraction> basis points in the case of the 2027 fixed rates notes, <ix:nonFraction unitRef="number" contextRef="ia93111f675b84d0185cffe796ba9ad0f_D20200901-20200930" decimals="INF" name="gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUyNg_05f09f7e-ae7f-4f3a-ab1f-2dc03779cd5b">15</ix:nonFraction> basis points in the case of the 2030 fixed rate notes, <ix:nonFraction unitRef="number" contextRef="i0af1b61d1bd24f02bcf41645b802cfef_D20200901-20200930" decimals="INF" name="gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUzMw_eda5a18a-b738-4f40-9c4e-cb3e10cdc5e6">20</ix:nonFraction> basis points in the case of the 2040 fixed notes and <ix:nonFraction unitRef="number" contextRef="ib35e51d4a6e5413d804346c20c4d645d_D20200901-20200930" decimals="INF" name="gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDU0MA_41467b7f-cb54-414b-8aa3-360487e19b97">25</ix:nonFraction> basis points in the case of the 2050 fixed rate notes, plus any accrued and unpaid interest on the Fixed Rate Notes to be redeemed to, but excluding, the date of redemption. The Fixed Rate Notes also have a call feature, exercisable at our option, to redeem the notes at par in whole, or in part, on dates ranging from <ix:nonNumeric contextRef="ie2873f7c29354cc8a00cc6b3eadad4b9_D20200901-20200930" format="ixt-sec:durwordsen" name="gild:DebtInstrumentCallFeaturePeriodBeforeMaturity" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDU2Mg_52c0e139-9b38-4fd0-8286-14f6fac932d4">two months</ix:nonNumeric> to <ix:nonNumeric contextRef="i332b81acd0e34cb68ce82c944141e308_D20200901-20200930" format="ixt-sec:durwordsen" name="gild:DebtInstrumentCallFeaturePeriodBeforeMaturity" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDU4MA_a9ad9214-7190-436f-9392-61bdff6f05cf">two years</ix:nonNumeric> prior to maturity. In each case, accrued and unpaid interest is also required to be redeemed to the date of redemption. The September 2023 floating rate notes also have a call feature, exercisable at our option, to redeem the notes at par, in whole, or in part, approximately <ix:nonNumeric contextRef="ie5f98f733a534405a4a7aceadcbae8db_D20200901-20200930" format="ixt-sec:durwordsen" name="gild:DebtInstrumentCallFeaturePeriodBeforeMaturity" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgyMzcyMQ_49dcacca-8c9f-4ff8-943e-1fa90c1052bc">two years</ix:nonNumeric> prior to maturity.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of the occurrence of a change in control and a downgrade in the rating of the 2020 Senior Notes below investment grade by Moody&#8217;s Investors Service, Inc. and S&amp;P Global Ratings, the holders may require us to purchase all or a portion of their notes at a price equal to <ix:nonFraction unitRef="number" contextRef="ifebe1e104a53429d9f4985f21acfcf6f_D20200901-20200930" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIxOQ_205977b8-ac7e-49cf-af3c-3bd56d0e3d44">101</ix:nonFraction>% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest to the date of repurchase.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to comply with certain covenants under our note indentures governing our senior unsecured notes. As of September&#160;30, 2020, we were in compliance with all covenants.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes Repayments</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, we repaid $<ix:nonFraction unitRef="usd" contextRef="i8c112e7007ab4912b6828d7439e90eed_D20200201-20200229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfUnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTYx_52979457-1bdc-430f-9ba4-49b35a9ae4d7">500</ix:nonFraction> million of our senior unsecured notes upon maturity. In September 2020, we repaid $<ix:nonFraction unitRef="usd" contextRef="if350b42852dd44f48da9f53e1b8ff9e9_D20200901-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfUnsecuredDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTY0OTI2NzQ5NDg2Ng_514a5a7f-ae78-421b-aed0-4be2b4de7709">2.0</ix:nonFraction> billion of our senior unsecured notes upon maturity.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Facility</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a commitment letter with a group of institutional lenders to provide for a <ix:nonNumeric contextRef="id43f9dfea2c7418cb87a1a84ccc9a37e_D20200901-20200930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxOTc0OA_d012b62c-b1b9-4835-8367-4baa4be71e36">three-year</ix:nonNumeric> senior unsecured term loan facility (the &#8220;Term Loan Facility&#8221;) in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i66ad83bd55674a5489ec01dc33324735_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDg0OQ_108deeab-6083-4941-b01f-d4120365552c">1.0</ix:nonFraction> billion. As of September&#160;30, 2020, there were <ix:nonFraction unitRef="usd" contextRef="i66ad83bd55674a5489ec01dc33324735_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIyOA_045d589a-9664-404f-a1d1-485f3035dfc6">no</ix:nonFraction> borrowings outstanding. In an event subsequent to September&#160;30, 2020, on October 23, 2020, we entered into a term loan credit agreement under the Term Loan Facility and borrowed an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i05c93da51a924b19ae6284b9a552e965_I20201023" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIzMw_f08ca5b2-3454-493c-87a7-d217833ad8e7">1.0</ix:nonFraction>&#160;billion.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan Facility contains customary representations, warranties, affirmative and negative covenants and events of default. The Term Loan Facility bears interest at 3-month LIBOR plus the Applicable Percentage as defined in the Term Loan Facility credit agreement. We may terminate or reduce the amount borrowed under the Term Loan Facility in whole or in part at any time without premium or penalty.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving Credit Facilities</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we terminated our $<ix:nonFraction unitRef="usd" contextRef="i1bfe479f1cd340f3a96f534ba41654ad_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNDE2_7db32e1c-fcfd-483b-9804-36da1409d4e4">2.5</ix:nonFraction> billion revolving credit facility maturing in May 2021 (the &#8220;2016 Revolving Credit Facility&#8221;) and entered into a new $<ix:nonFraction unitRef="usd" contextRef="i345776f175ba45628e7886736d46d225_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNTI4_e748075d-7cee-40d8-9f8a-cc7e3a75b928">2.5</ix:nonFraction> billion revolving credit facility maturing in June 2025 (the &#8220;2020 Revolving Credit Facility&#8221;), which has terms substantially similar to the 2016 Revolving Credit Facility. The 2020 Revolving Credit Facility can be used for working capital requirements and for general corporate purposes, including, without limitation, acquisitions. As of September&#160;30, 2020 and December&#160;31, 2019, there were <ix:nonFraction unitRef="usd" contextRef="ifda8f675af864a82a9abe9b9a27454d7_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfODg1_3a735a28-7912-4742-b17e-f55c9cd9cf4e"><ix:nonFraction unitRef="usd" contextRef="ic3c8da64f2584082a30059c2ef0db569_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfODg1_3accfb16-0080-4ab9-a8e0-038e18b1b111">no</ix:nonFraction></ix:nonFraction> amounts outstanding under these revolving credit facilities.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Revolving Credit Facility contains customary representations, warranties, affirmative and negative covenants and events of default. At September&#160;30, 2020, we were in compliance with all covenants. Loans under the 2020 Revolving Credit Facility bear interest at either (i) the Eurodollar Rate plus the Applicable Percentage, or (ii) the Base Rate plus the Applicable Percentage, each as defined in the 2020 Revolving Credit Facility agreement. We may terminate or reduce the commitments, and may prepay any loans under the new credit facility in whole or in part at any time without premium or penalty.</span></div></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_61"></div><div style="margin-top:16.5pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfMjQxODM_9a2b541e-cb57-4c8b-acbf-8154e7d57f0d" continuedAt="i3e41297950294fe79d0807f8ce31c5eb" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i3e41297950294fe79d0807f8ce31c5eb" continuedAt="ie76b5fefffcf416bb9742df64d63d1ee"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to various legal actions. The most significant of these are described below. We recognize accruals for such actions to the extent that we conclude that a loss is both probable and reasonably estimable. We accrue for the best estimate of a loss within a range; however, if no estimate in the range is better than any other, then we accrue the minimum amount in the range. If we determine that a material loss is reasonably possible and the loss or range of loss can be estimated, we disclose the possible loss. Unless otherwise noted, it is not possible to determine the outcome of these matters or the outcome (including in excess of any accrual) is not expected to be material, and we cannot reasonably estimate the maximum potential exposure or the range of possible loss.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie76b5fefffcf416bb9742df64d63d1ee" continuedAt="ifa40608794474796ba2aa88273ba8b84"><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any material accruals for the matters described below in our Condensed Consolidated Balance Sheets as of September&#160;30, 2020 and December&#160;31, 2019. </span></div><div style="margin-bottom:5pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Related to Sofosbuvir</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, we acquired Pharmasset, Inc. Through the acquisition, we acquired sofosbuvir, a nucleotide analog that acts to inhibit the replication of the hepatitis C virus (&#8220;HCV&#8221;). In 2013, we received approval from FDA for sofosbuvir, now known commercially as Sovaldi. Sofosbuvir is also included in all of our marketed HCV products. We have received a number of litigation claims regarding sofosbuvir. While we have carefully considered these claims both prior to and following the acquisition and believe they are without merit, we cannot predict the ultimate outcome of such claims or range of loss.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are aware of patents and patent applications owned by third parties that have been or may in the future be alleged by such parties to cover the use of our HCV products. If third parties obtain valid and enforceable patents, and successfully prove infringement of those patents by our HCV products, we could be required to pay significant monetary damages. We cannot predict the ultimate outcome of intellectual property claims related to our HCV products. We have spent, and will continue to spend, significant resources defending against these claims.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Litigation with Idenix Pharmaceuticals, Inc. (&#8220;Idenix&#8221;), Universita Degli Studi di Cagliari (&#8220;UDSG&#8221;), Centre National de la Recherche Scientifique and L&#8217;Universit&#233; Montpellier II</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2013, Idenix, UDSG, Centre National de la Recherche Scientifique and L&#8217;Universit&#233; Montpellier II sued us in the U.S. District Court for the District of Delaware alleging that the commercialization of sofosbuvir infringes U.S. Patent No. 7,608,600 (the &#8220;&#8217;600 patent&#8221;). We prevailed at all phases of litigation concerning the &#8217;600 patent, and in 2018, the U.S. Supreme Court denied Idenix&#8217;s petition for certiorari. Also in 2013, Idenix and UDSG sued us in the U.S. District Court for the District of Massachusetts alleging that the commercialization of sofosbuvir infringes U.S. Patent Nos. 6,914,054 (the &#8220;&#8217;054 patent&#8221;) and 7,608,597 (the &#8220;&#8217;597 patent&#8221;). In 2014, the court transferred the Massachusetts litigation to the U.S. District Court for the District of Delaware.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to trial in 2016, Idenix committed to give us a covenant not to sue with respect to any claims arising out of the &#8217;054 patent related to sofosbuvir and withdrew that patent from the trial. A jury trial was held in 2016 on the &#8217;597 patent, and the jury found that we willfully infringed the asserted claims of the &#8217;597 patent and awarded Idenix $<ix:nonFraction unitRef="usd" contextRef="iadae1c7466ea41e990dd30ccf69b5887_D20161201-20161231" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfMzQ3Mg_e7644ee9-18ad-421c-a692-84f3880b161c">2.54</ix:nonFraction> billion in past damages. In 2018, the judge invalidated Idenix&#8217;s &#8217;597 patent and vacated the jury&#8217;s award of $<ix:nonFraction unitRef="usd" contextRef="ib20b3c03bc154daba1331e8af30fdb76_D20180101-20181231" decimals="-7" format="ixt:numdotdecimal" name="gild:LossContingencyMotionInvalidatedForPastDamagesValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfMzU3Ng_a857cc5d-8495-454f-bbe6-da9af41d413d">2.54</ix:nonFraction> billion in past damages. Idenix appealed this decision to the U.S. Court of Appeals for the Federal Circuit (&#8220;CAFC&#8221;), and in October 2019, the CAFC issued an opinion affirming the trial court&#8217;s decision that the &#8217;597 patent is invalid. In April 2020, the CAFC denied Idenix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s petition for rehearing en banc. Idenix has sought review by the U.S. Supreme Court. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Litigation with the University of Minnesota</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The University of Minnesota (the &#8220;University&#8221;) has obtained U.S. Patent No. 8,815,830 (the &#8220;&#8217;830 patent&#8221;), which purports to broadly cover nucleosides with antiviral and anticancer activity.&#160;In 2016, the University filed a lawsuit against us in the U.S. District Court for the District of Minnesota, alleging that the commercialization of sofosbuvir-containing products infringes the &#8217;830 patent.&#160;We believe the &#8217;830 patent is invalid and will not be infringed by the continued commercialization of sofosbuvir. In 2017, the court granted our motion to transfer the case to California. We have also filed petitions for inter partes review with the U.S. Patent and Trademark Office Patent Trial and Appeal Board (&#8220;PTAB&#8221;) alleging that all asserted claims are invalid for anticipation and obviousness, and the PTAB instituted one of these petitions. In 2018, the U.S. District Court for the Northern District of California stayed the litigation until after the PTAB concludes the inter partes review that it has initiated, which we expect will occur by 2021.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Related to Axicabtagene Ciloleucel</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own patents and patent applications that protect our axicabtagene ciloleucel chimeric DNA segments. Third parties may have, or may obtain rights to, patents that could allegedly be used to prevent or attempt to prevent us from commercializing axicabtagene ciloleucel or to require us to obtain a license in order to commercialize axicabtagene ciloleucel. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno Therapeutics, Inc. and Sloan Kettering Cancer Center (collectively, &#8220;Juno&#8221;) filed a lawsuit against us in the U.S. District Court for the Central District of California, alleging that the commercialization of axicabtagene ciloleucel, sold commercially as Yescarta, infringes on U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 patent&#8221;). A jury trial was held on the &#8217;190 patent, and in December 2019, the jury found that the asserted claims of the &#8217;190 patent were valid, and that we willfully infringed the asserted claims of the &#8217;190 patent. The jury also awarded Juno damages in amounts of $<ix:nonFraction unitRef="usd" contextRef="i375f4aa83089473d80f0894376a87131_D20191201-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjA1Mg_854ecec1-d518-4eaf-9483-6e06d5b6c90f">585</ix:nonFraction> million in an up-front payment and a <ix:nonFraction unitRef="number" contextRef="i375f4aa83089473d80f0894376a87131_D20191201-20191231" decimals="3" name="gild:JudgmentRoyaltyRateFromOctober2017" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjA4NA_9eb72da1-3e27-4866-8410-dbc866d156d7">27.6</ix:nonFraction>% running royalty from October 2017 through the date of the jury&#8217;s verdict. The parties filed post-trial motions in the first quarter of 2020, and the trial judge entered a judgment in April 2020. The trial judge affirmed the jury&#8217;s verdict, enhanced the past damages by <ix:nonFraction unitRef="number" contextRef="i3b9e6e8a3097447b8a5306434ceee570_I20200430" decimals="2" name="gild:JudgmentEnhancedDamagesonPastSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjM1Ng_41e3b9ae-9e14-4814-a02d-36e4301c9024">50</ix:nonFraction>% and maintained the royalties on future Yescarta sales at <ix:nonFraction unitRef="number" contextRef="i3b9e6e8a3097447b8a5306434ceee570_I20200430" decimals="3" name="gild:JudgmentRoyaltyRateOnFutureSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjQxNg_0eef38f4-fad8-4410-82da-05f0ad65dc54">27.6</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifa40608794474796ba2aa88273ba8b84" continuedAt="i3198a54f0774461c8c9a88df965007a0"><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing whether we should accrue a liability for this litigation in our consolidated financial statements, we considered various factors, including the legal and factual circumstances of the case, the jury&#8217;s verdict, the district court&#8217;s pre- and post-trial orders, the current status of the proceedings, applicable law, the views of legal counsel and the likelihood that the judgment will be upheld on appeal. As a result of this review, we have determined, in accordance with applicable accounting standards, that it is not probable that we will incur a material loss as a result of this litigation. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the judgment is reversed on appeal, the loss is expected to be <ix:nonFraction unitRef="usd" contextRef="i81637e03a86945a093db345c6214f5d9_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzA4NA_4e8f87be-5408-414c-94b4-b5630d819e70">zero</ix:nonFraction>. If the judgment is upheld in its entirety on appeal, we estimate a loss through the third quarter of 2020 to be approximately $<ix:nonFraction unitRef="usd" contextRef="ie7181038d12c4972b2d35c23670305e2_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzIxNQ_b3ab7248-5bf2-44e1-b03f-a44cf43daf89">1.3</ix:nonFraction>&#160;billion, which consists of (i) approximately $<ix:nonFraction unitRef="usd" contextRef="i61fb468d46454c35be375b3bf645c786_I20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:LossContingencyEstimateofPossibleLossPastSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzI1NQ_b2a59f27-d5ac-4647-8b07-33f9829c921b">811</ix:nonFraction> million, which represents damages on Yescarta revenues through December 12, 2019, and prejudgment interest thereon, (ii) approximately $<ix:nonFraction unitRef="usd" contextRef="i61fb468d46454c35be375b3bf645c786_I20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzM4NQ_b304b1d6-fb6d-44fc-8610-9b7b07dbf69c">389</ix:nonFraction> million, which represents a <ix:nonFraction unitRef="number" contextRef="i3b9e6e8a3097447b8a5306434ceee570_I20200430" decimals="2" name="gild:JudgmentEnhancedDamagesonPastSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzQwOA_41e3b9ae-9e14-4814-a02d-36e4301c9024">50</ix:nonFraction>% enhancement of past damages and (iii) approximately $<ix:nonFraction unitRef="usd" contextRef="i61fb468d46454c35be375b3bf645c786_I20200930" decimals="-6" format="ixt:numdotdecimal" name="gild:LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjA0NzMxNDAwMDM3NA_4591b38a-60db-49cb-b775-6a4cb1570679">128</ix:nonFraction> million for royalties and prejudgment interest on Yescarta revenues from December 13, 2019 to September&#160;30, 2020. Although we cannot predict with certainty the ultimate outcome of this litigation on appeal, we believe the jury&#8217;s verdict and the judgment to be in error. In April 2020, we filed an appeal seeking to reverse the judgment or obtain a new trial due to errors made by the trial judge.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Related to Bictegravir</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, ViiV Healthcare Company (&#8220;ViiV&#8221;) filed a lawsuit against us in the U.S. District Court of Delaware, alleging that the commercialization of bictegravir, sold commercially in combination with tenofovir alafenamide and emtricitabine as Biktarvy, infringes ViiV&#8217;s U.S. Patent No. 8,129,385 (the &#8220;&#8217;385 patent&#8221;) covering ViiV&#8217;s dolutegravir. Bictegravir is structurally different from dolutegravir, and we believe that bictegravir does not infringe the sole asserted claim of the &#8217;385 patent. The court has set a trial date of March 2021 for this lawsuit.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, ViiV also filed a lawsuit against us in the Federal Court of Canada, alleging that our activities relating to our bictegravir compound have infringed ViiV&#8217;s Canadian Patent No. 2,606,282 (the &#8220;&#8217;282 patent&#8221;), which was issued to Shionogi &amp; Co. Ltd. and ViiV. The &#8217;282 patent is the compound patent covering ViiV&#8217;s dolutegravir. We believe that bictegravir does not infringe the claims of the &#8217;282 patent. In January 2020, the court held a summary trial to assess ViiV&#8217;s infringement allegations. In April 2020, the court determined that bictegravir does not infringe the claims of the &#8217;282 patent and dismissed the case. ViiV has appealed this decision.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November and December 2019, ViiV filed lawsuits in France, Germany, Ireland and the UK asserting the relevant national designations of European Patent No. 3 045 206 (&#8220;EP &#8217;206&#8221;); in Australia asserting Australian Patent No. 2006239177; in Japan asserting Japanese Patent No. 4295353; and in Korea asserting Korean Patent Nos. 1848819 and 1363875. These patents all relate to molecules which ViiV claims would act as integrase inhibitors. We believe that bictegravir does not infringe the claims of any of ViiV&#8217;s patents. In 2019, we filed an opposition in the European Patent Office (&#8220;EPO&#8221;) requesting revocation of EP &#8217;206. The EPO hearing is scheduled for 2021. In all jurisdictions, to the extent that the claims of ViiV&#8217;s patents are interpreted to cover bictegravir, we believe that those claims are invalid. We cannot predict the ultimate outcome of intellectual property claims related to bictegravir. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Relating to Pre-Exposure Prophylaxis</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we filed petitions requesting inter partes review of U.S. Patent Nos. 9,044,509, 9,579,333, 9,937,191 and 10,335,423 (collectively, &#8220;HHS Patents&#8221;) by PTAB. The HHS Patents are assigned to the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) and purport to claim a process of protecting a primate host from infection by an immunodeficiency retrovirus by administering a combination of emtricitabine and tenofovir or TDF prior to exposure of the host to the immunodeficiency retrovirus, a process commonly known as pre-exposure prophylaxis (&#8220;PrEP&#8221;). In November 2019, the U.S. Department of Justice filed a lawsuit against us in the U.S. District Court of Delaware, alleging that the sale of Truvada and Descovy for use as PrEP infringes the HHS Patents. In February 2020, PTAB declined to institute our petitions for inter partes review of the HHS Patents. In April 2020, we filed a breach of contract lawsuit against the U.S. federal government in the Court of Federal Claims, alleging violations of four material transfer agreements (&#8220;MTAs&#8221;) related to the research underlying the HHS Patents and a clinical trial agreement (&#8220;CTA&#8221;) by the U.S. Centers for Disease Control and Prevention related to PrEP research. Although we cannot predict with certainty the ultimate outcome of these litigation matters, we believe that the U.S. federal government breached the MTAs and CTA, that Truvada and Descovy do not infringe the HHS Patents and that the HHS Patents are invalid over prior art descriptions of Truvada&#8217;s use for PrEP and post-exposure prophylaxis as well because physicians and patients were using the claimed methods years before HHS filed the applications for the patents. A trial date for the lawsuit in the District Court of Delaware has been set for May 2023.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3198a54f0774461c8c9a88df965007a0" continuedAt="i6ede9c6184c449b5a0bd31132c5a478f"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation with Generic Manufacturers</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the approval process for some of our products, FDA granted us a New Chemical Entity (&#8220;NCE&#8221;) exclusivity period during which other manufacturers&#8217; applications for approval of generic versions of our product will not be approved. Generic manufacturers may challenge the patents protecting products that have been granted NCE exclusivity one year prior to the end of the NCE exclusivity period. Generic manufacturers have sought and may continue to seek FDA approval for a similar or identical drug through an abbreviated new drug application (&#8220;ANDA&#8221;), the application form typically used by manufacturers seeking approval of a generic drug. The sale of generic versions of our products earlier than their patent expiration would have a significant negative effect on our revenues and results of operations. To seek approval for a generic version of a product having NCE status, a generic company may submit its ANDA to FDA four years after the branded product&#8217;s approval.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting in December 2019, we received letters from Lupin Ltd., Apotex Inc., Shilpa Medicare Ltd., Sunshine Lake Pharma Co. Ltd., Laurus Labs, Natco Pharma Ltd., Macleods Pharma Ltd., Hetero Labs Ltd. and Cipla Ltd. (collectively, &#8220;generic manufacturers&#8221;) indicating that they have submitted ANDAs to FDA requesting permission to market and manufacture generic versions of certain of our tenofovir alafenamide (&#8220;TAF&#8221;)-containing products. Between them, these generic manufacturers seek to market generic versions of Odefsey, Descovy and Vemlidy. Some generic manufacturers have challenged the validity of four patents listed on the Orange Book and associated with TAF, while others have challenged the validity of two of our Orange Book-listed patents associated with TAF. We filed lawsuits against the generic manufacturers, and we intend to enforce and defend our intellectual property.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Patent Claims</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, several parties filed oppositions in the EPO requesting revocation of one of our granted European patents covering sofosbuvir that expires in 2028. In 2016, the EPO upheld the validity of certain claims of our sofosbuvir patent. We have appealed this decision, seeking to restore all of the original claims, and several of the original opposing parties have also appealed, requesting full revocation. The appeal hearing is scheduled for July 2021.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, several parties filed oppositions in the EPO requesting revocation of our granted European patent relating to sofosbuvir that expires in 2024. The EPO conducted an oral hearing for this opposition in 2018 and upheld the claims. Two of the original opposing parties have appealed, requesting full revocation. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, several parties filed oppositions in the EPO requesting revocation of our granted European patent covering TAF that expires in 2026. In 2017, the EPO upheld the validity of the claims of our TAF patent. Three parties have appealed this decision. The appeal hearing is scheduled for March 2021.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, several parties filed oppositions in the EPO requesting revocation of our granted European patent relating to TAF hemifumarate that expires in 2032. In 2019, the EPO upheld the validity of the claims of our TAF hemifumarate patent. Three parties have appealed this decision. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, three parties filed oppositions in the EPO requesting revocation of our granted European patent covering cobicistat that expires in 2027. In 2017, the EPO upheld the validity of the claims of our cobicistat patent. Two parties have appealed this decision. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The appeal process may take several years for all EPO opposition proceedings. While we are confident in the strength of our patents, we cannot predict the ultimate outcome of these oppositions. If we are unsuccessful in defending these oppositions, some or all of our patent claims may be narrowed or revoked and the patent protection for sofosbuvir, TAF, TAF hemifumarate and cobicistat in the European Union could be substantially shortened or eliminated entirely. If our patents are revoked, and no other European patents are granted covering these compounds, our exclusivity may be based entirely on regulatory exclusivity granted by the European Medicines Agency. If we lose patent protection for any of these compounds, our revenues and results of operations could be negatively impacted for the years including and succeeding the year in which such exclusivity is lost.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Investigations and Related Litigation</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2011, we received a subpoena from the U.S. Attorney&#8217;s Office for the Northern District of California requesting documents related to the manufacture, quality and distribution practices of Complera, Atripla, Truvada, Viread, Emtriva, Hepsera and Letairis. We cooperated with the government&#8217;s inquiry. In 2014, the U.S. Department of Justice informed us that it had declined to intervene in a False Claims Act lawsuit filed by two former employees. In 2019, the District Court granted the Department of Justice&#8217;s motion to dismiss plaintiffs&#8217; federal claims. In April 2020, plaintiffs refiled their California False Claims Act and California retaliation claims in the Superior Court of California, County of San Mateo. In July 2020, the California Attorney General declined to intervene in the case, and the state court complaint was unsealed. In September 2020, we filed a demurrer requesting that the Superior Court dismiss plaintiffs&#8217; claims, and we expect the court to rule on our demurrer before the end of the year. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit and we intend to vigorously defend against it.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6ede9c6184c449b5a0bd31132c5a478f" continuedAt="ie81f52b889b047af94654802e192a386"><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, we received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts requesting documents related to our support of 501(c)(3) organizations that provide financial assistance to patients and documents concerning our provision of financial assistance to patients for our HCV products. In 2020, the matter was resolved through settlement. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts requesting documents related to our copay coupon program and Medicaid price reporting methodology. We cooperated with this inquiry, and in July 2020, the government notified us that it was closed.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we received a voluntary request for information from the U.S. Attorney&#8217;s Office for the Eastern District of Pennsylvania requesting information related to our reimbursement support offerings, clinical education programs and interactions with specialty pharmacies for Sovaldi and Harvoni. In 2018, we received another voluntary request for information related to our speaker programs and advisory boards for our HCV and hepatitis B virus (&#8220;HBV&#8221;) products. We cooperated with these voluntary requests. In October 2019, the government informed us that, following an investigation, it declined to intervene in two False Claims Act lawsuits against us relating to HCV reimbursement support and clinical education programs and hepatitis B speaker programs and advisory boards, respectively. Notwithstanding the government&#8217;s declination, two plaintiffs have continued to pursue the lawsuit relating to HBV speaker programs and advisory boards and served us with the Second Amended Complaint in November 2019. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit and we intend to vigorously defend against it.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we received a subpoena from the California Department of Insurance and the Alameda County District Attorney&#8217;s Office requesting documents related to our marketing activities, reimbursement support offerings, clinical education programs and interactions with specialty pharmacies for Harvoni and Sovaldi.&#160;In August 2020, we were informed that the government had closed this matter.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we also received a subpoena from the U.S. Attorney&#8217;s Office for the Southern District of New York requesting documents related to our promotional speaker programs for HIV. We are cooperating with this inquiry.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, Health Choice Advocates, LLC (&#8220;Health Choice Advocates&#8221;) filed a qui tam lawsuit against us under seal in New Jersey state court alleging violations of the New Jersey False Claims Act through our clinical education programs for Sovaldi and Harvoni and our HCV and HIV patient access programs. In July 2020, the New Jersey Attorney General&#8217;s Office declined to intervene in the lawsuit and the complaint was unsealed. In May 2020, Health Choice Advocates filed a qui tam lawsuit under seal against us in Texas state court making similar allegations. In October 2020, the Texas Attorney General&#8217;s Office declined to intervene in the lawsuit and the complaint was unsealed. Health Choice Advocates previously filed a lawsuit making similar allegations in federal court in the Eastern District of Texas in June 2017 and the court entered an order dismissing that matter without prejudice in July 2018. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been named as a defendant in two class action lawsuits and various product liability lawsuits related to Viread, Truvada, Atripla, Complera and Stribild.&#160;Plaintiffs allege that Viread, Truvada, Atripla, Complera and/or Stribild caused them to experience kidney, bone and/or tooth injuries. The lawsuits, which are pending in state or federal court in California, Delaware, Florida, New Jersey and Missouri, involve more than <ix:nonFraction unitRef="plaintiff" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzE0NjgyNTY1NjMwMw_95d7bd1a-1c52-4a6c-a3f4-0c6967f9b830">19,000</ix:nonFraction> plaintiffs.&#160;Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. We intend to vigorously defend ourselves in these actions. While we believe these cases are without merit, we cannot predict the ultimate outcome. If plaintiffs are successful in their claims, we could be required to pay significant monetary damages.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Antitrust and Consumer Protection</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We (along with Japan Tobacco Inc. (&#8220;Japan Tobacco&#8221;), Bristol-Myers Squibb Company and Johnson &amp; Johnson, Inc.) have been named as defendants in class action lawsuits filed in 2019 and 2020 related to various drugs used to treat HIV, including drugs used in combination antiretroviral therapy.&#160;Japan Tobacco was dismissed from the lawsuit after a favorable court ruling on the defendants&#8217; motion to dismiss. Plaintiffs allege that we (and the other remaining defendants) engaged in various conduct to restrain competition in violation of federal and state antitrust laws and state consumer protection laws.&#160;The lawsuits, which have been or may be consolidated, are all pending in the U.S. District Court for the Northern District of California. The lawsuits seek to bring claims on behalf of two nationwide classes - one of direct purchasers consisting largely of wholesales, and another of end-payor purchasers, including health insurers and individual patients.&#160;Plaintiffs seek damages, permanent injunctive relief and other relief.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we along with generic manufacturers Cipla Ltd. and Cipla USA Inc. (&#8220;Cipla&#8221;) were named as defendants in a class action lawsuit filed by Jacksonville Police Officers and Fire Fighters Health Insurance Trust (&#8220;Jacksonville Trust&#8221;) on behalf of end-payor purchasers. Jacksonville Trust claims that the 2014 settlement agreement between us and Cipla, which settled a patent dispute relating to patents covering our Emtriva, Truvada, and Atripla products and permitted generic entry prior to patent expiry, violates certain federal and state antitrust and consumer protection laws.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie81f52b889b047af94654802e192a386"><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe these cases are without merit, we cannot predict the ultimate outcome.&#160;If plaintiffs are successful in their claims, we could be required to pay significant monetary damages or could be subject to permanent injunctive relief awarded in favor of plaintiffs.&#160;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to various legal actions that arose in the ordinary course of our business. We do not believe that these other legal actions will have a material adverse impact on our consolidated business, financial position or results of operations.</span></div></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_64"></div><div style="margin-top:16.5pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMTYxMA_cf2e5c06-9555-462e-95a5-e1039e52f8e6" continuedAt="i8c5d0d47549e4011bd9f9357904810ef" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i8c5d0d47549e4011bd9f9357904810ef"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2016, our Board of Directors authorized a $<ix:nonFraction unitRef="usd" contextRef="i83dbde55d11d4cca843046da3156ede0_I20160128" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMTA0_231358a0-74bb-4ad3-b78e-cce9bcac326c">12.0</ix:nonFraction> billion stock repurchase program (&#8220;2016 Program&#8221;) under which repurchases may be made in the open market or in privately negotiated transactions. We started repurchases under the 2016 Program in April 2016. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, our Board of Directors authorized a new $<ix:nonFraction unitRef="usd" contextRef="i8e803091b7ae47a28cf31980b4e75241_I20200129" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzU3_3d4f2519-396d-4b18-883d-c9d830f1828c">5.0</ix:nonFraction> billion&#160;stock repurchase program (&#8220;2020 Program&#8221;), which will commence upon the completion of the&#160;2016 Program. Purchases under the 2020 Program may be made in the open market or in privately negotiated transactions.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2020, we repurchased and retired <ix:nonFraction unitRef="shares" contextRef="i2f8986f71eb946ce91a3ac37191c811a_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMjkzNA_9a67c86b-8280-4846-9743-d44575d13ca1">3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i2c72d335e955423da6fa2cc5ce0ca6a9_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMjk2NA_b150f0d9-f86e-4309-ba11-e1a1fee86362">22</ix:nonFraction> million shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="i2f8986f71eb946ce91a3ac37191c811a_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMjk5Ng_1539574e-f091-46e2-9679-e0fd92cb8093">201</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2c72d335e955423da6fa2cc5ce0ca6a9_D20200101-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMzAyNg_93ff5987-bfa3-4fb9-9083-5fd6c20b235a">1.6</ix:nonFraction> billion, respectively, through open market transactions under the 2016 Program. During the three and nine months ended September 30, 2019, we repurchased and retired <ix:nonFraction unitRef="shares" contextRef="i5f6d71b9595c455b91d1695466faaa46_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODg1MA_776608a0-9822-4c36-ba07-b0615394c87d">3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i9c5133b40b7348ee9a886cf367a8c92a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODg5NQ_25fe3418-b7f8-4abe-bfd2-2996ab045a57">25</ix:nonFraction> million shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="i5f6d71b9595c455b91d1695466faaa46_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODk0Mw_8a7929de-caac-4309-8248-a027f755ecc6">223</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9c5133b40b7348ee9a886cf367a8c92a_D20190101-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODk5Mw_d9c8c895-2c8f-4f6e-836c-83b07369c78e">1.6</ix:nonFraction> billion, respectively, through open market transactions under the 2016 Program. As of September&#160;30, 2020, the remaining authorized repurchase amount under both programs was $<ix:nonFraction unitRef="usd" contextRef="i8428dd318d974b2db41a333de386ece2_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMzA1OA_5cd1dc66-f951-4f0f-a31d-e5a1f551fc0f">6.8</ix:nonFraction> billion.</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMTYwNw_cf96bd2c-9561-4ad5-a1da-d35ce56ff05a" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in AOCI by component, net of tax (in millions):</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126913deb985494cbae4e16c0eefaaa0_I20191231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS0yLTEtMS0w_aa26253b-f5c8-4132-8696-7cff55b2132f">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31e50be0c1b8444dac6878e054031f95_I20191231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS00LTEtMS0w_b2fc035b-0c0d-4884-9c85-90477fe8167a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92120c1df08941c0baa875930620ab7b_I20191231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS02LTEtMS0w_4459620b-f413-45ed-815a-ab73fa261662">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i697547cbd3024af6ab47310c99aecd30_I20191231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS04LTEtMS0w_764ba89c-52fa-4682-bbe9-da3c68f08183">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi0yLTEtMS0w_46115c3f-b617-4eb9-b240-e2cae4490940">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2d992fc41144e698540022573aae90_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi00LTEtMS0w_3ed5d647-e708-4c22-abc3-1ef7e055cf43">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi02LTEtMS0w_6f06a302-8a6d-4a62-946e-90d9f16f49cc">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi04LTEtMS0w_b0f4f02b-6915-4965-b176-a6fba3811fc5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy0yLTEtMS0w_760b3898-818d-4926-a249-243e7f43efc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c2d992fc41144e698540022573aae90_D20200101-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy00LTEtMS0w_2e7c9bef-6b26-4cc5-9abd-4e1e270117b8">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy02LTEtMS0w_eeb46c1e-e88a-4ee7-ab71-7b506e82f746">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy04LTEtMS0w_afe3c3cc-5302-4390-a010-623981e00b99">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC0yLTEtMS0w_8c90c302-003c-40eb-a421-7396bed55a27">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2d992fc41144e698540022573aae90_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC00LTEtMS0w_d8b1e6bd-286e-40a9-b5a6-c424c031c319">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC02LTEtMS0w_8860e8bb-ee09-406b-8997-62809723c05d">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC04LTEtMS0w_cb14cf32-3128-4afd-90fd-57bcc706f120">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa15a6a2044f4dffbdd84d9bd4107466_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS0yLTEtMS0w_ab0daffa-12cb-4138-9add-e576003b2781">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf3701a61048ce98060b964e89b9d6_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS00LTEtMS0w_3a3362bf-2dd8-4aa9-91c1-7d85f470f4e9">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3ea6d768f5a439a8c7671f8e1b2734e_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS02LTEtMS0w_d7405359-39e7-4ef8-af7b-72d8f31343af">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20a282f852c4c7dbb87cc18035c48ad_I20200930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS04LTEtMS0w_248606de-08ab-455d-8d6e-e0c5de2d461b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:11pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931ba07aa5b84693bb30002c9e25ba8f_I20181231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS0yLTEtMS0w_2a699d06-af39-4b1b-85e1-bbdef5ced9de">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc9ff79601b7441a89cc4803200d5db3_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS00LTEtMS0w_8261bfb8-9ac5-4c7c-8b47-66c2f09407e1">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21170d6027749b8ac405fbc5d0c14f3_I20181231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS02LTEtMS0w_948df819-e857-4798-956e-0e9166952ff9">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d14e1d51864d97b88c87da0f398d28_I20181231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS04LTEtMS0w_4aef999d-0a1c-4366-b82a-8385910e7fd8">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i032461dad5024966ae092159c3844bbf_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi0yLTEtMS0w_73e48e2f-ed85-4a24-b66a-2b7d75e64cf9">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi00LTEtMS0w_4afb5eaa-b62f-4e91-afce-85844811a0c5">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5caf79123df745c29fab67273cf54adf_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi02LTEtMS0w_cdea34bd-592d-4ba3-8c9d-0ec92aa5d2c8">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi04LTEtMS0w_01f30488-32dc-468c-a2e7-4bbb5ab95d41">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032461dad5024966ae092159c3844bbf_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy0yLTEtMS0w_7f5925f7-c9a8-4da2-8193-e17a5a80e3f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy00LTEtMS0w_855faf74-99f7-4f16-ac9a-e1bffc7b85a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5caf79123df745c29fab67273cf54adf_D20190101-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy02LTEtMS0w_8d672b6b-0e18-4956-b1a7-2caf25eeda61">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy04LTEtMS0w_879bcbd4-866a-4ebf-ac92-c706477094ff">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i032461dad5024966ae092159c3844bbf_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC0yLTEtMS0w_a6372ce3-8c07-4ca6-b134-989a7c14d856">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC00LTEtMS0w_5d19a2a7-d452-4626-b16f-305c7e271b6a">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5caf79123df745c29fab67273cf54adf_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC02LTEtMS0w_95a29b94-d2e8-4efb-bb12-63dc8b0e903b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC04LTEtMS0w_6d06ca8f-b809-4873-88b1-d1a08a95d152">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646702f3b9c14ffda1e398222e462a80_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS0yLTEtMS0w_3661f18e-2227-41d0-b288-3ce1357664f0">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27914e2a7fbd4b0dbcc730cd7b58c33c_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS00LTEtMS0w_06ea2540-9f41-45b1-a930-91f7e3644fb7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16228b8cf344fd0b17a751f84856174_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS02LTEtMS0w_d310db2f-28ce-4a68-b15c-1e6c93a71469">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d3e46703834e0098456a41f5ef8be5_I20190930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS04LTEtMS0w_70b2f150-a498-41c7-8788-f82b98c98629">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts reclassified to net income for gains and losses on cash flow hedges are recorded as part of Product sales on our Condensed Consolidated Statements of Operations. See Note 5. Derivative Financial Instruments for additional information. The amounts reclassified to net income for gains and losses on available-for-sale debt securities are recorded as part of Other income (expense), net on our Condensed Consolidated Statements of Operations. Gross realized gains and losses on available-for-sale debt securities were not material for the nine months ended September 30, 2020 and 2019. The income tax impact allocated to each component of other comprehensive income (loss) was not material for the periods presented.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:16.5pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTA1OQ_6e1ed379-356f-4cd2-acdc-30abfa8c2d1f" continuedAt="iaf902fda6f2e4cefa817320002c1dddf" escape="true">NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO GILEAD COMMON STOCKHOLDERS</ix:nonNumeric></span></div><ix:continuation id="iaf902fda6f2e4cefa817320002c1dddf"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share attributable to Gilead common stockholders is calculated based on the weighted average number of shares of our common stock outstanding during the period. Diluted net income (loss) per share attributable to Gilead common stockholders is calculated based on the weighted average number of shares of our common stock and other dilutive securities outstanding during the period. The potentially dilutive shares of our common stock resulting from the assumed exercise of outstanding stock options and equivalents were determined under the treasury stock metho</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential shares of common stock excluded from the computation of diluted net income (loss) per share attributable to Gilead common stockholders because their effect would have been antidilutive were <ix:nonFraction unitRef="shares" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE3MA_b24e8dc5-aa3a-483a-8147-09b0050b07f8">13</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE3NA_551770e0-252a-4831-b02f-4124d537fcb5">38</ix:nonFraction> million for the three and nine months ended September 30, 2020, respectively, and <ix:nonFraction unitRef="shares" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE3OA_153bf480-ee3e-4b05-84f9-2b722fdefbac">40</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE4Mg_221e17d5-a67d-4cf7-a116-95db52ac416a">14</ix:nonFraction> million, for the three and nine months ended September 30, 2019, respectively.</span></div><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTA2Nw_ebbdeb6b-fc30-4f7c-8cf3-17d0a55b79f2" escape="true"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the calculation of basic and diluted net income (loss) per share attributable to Gilead common stockholders (in millions, except per share amounts):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy0yLTEtMS0w_35172059-0623-4939-a2ab-2632005c8bb4">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy00LTEtMS0w_b825f899-78bc-4a82-b89c-3f4464b98d9d">1,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy02LTEtMS0w_6500a031-b81e-4f80-bb64-23b105f26df9">1,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy04LTEtMS0w_7795d942-fd0c-473a-b45c-6a949ce99ce6">2,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC0yLTEtMS0w_52f495ba-4ba7-496a-baee-5a5e772277c6">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC00LTEtMS0w_5b9c0625-0f25-4fab-a21f-3ebb4a84b582">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC02LTEtMS0w_eecf04e5-e225-4177-af46-2140f3356814">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC04LTEtMS0w_9a572ba2-9d10-4a2b-8be7-cb3daab3a267">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS0yLTEtMS0w_c316eb8a-c8bb-4446-8073-bf418cae7f04">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS00LTEtMS0w_dcaaaa79-1536-4aa5-bb33-01595673c51d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS02LTEtMS0w_f9dac7d6-48fc-434e-ba0d-ff2b413f1822">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS04LTEtMS0w_5e47a675-4c1b-4583-89f5-4a0665b2f836">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi0yLTEtMS0w_455a2ddc-4c6c-49d8-b208-2a0f6bca5d02">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi00LTEtMS0w_647686b9-d5b9-469b-9cc4-91b0e9e4f4f7">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi02LTEtMS0w_2f31f061-4b2d-441f-b835-c051458d2b86">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi04LTEtMS0w_017ea0e0-d07e-4442-9ae5-6f9c648d7019">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC0yLTEtMS0w_fe324573-1663-48c1-a7c1-717efedb6f15">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC00LTEtMS0w_9cb4a5ed-8e68-45f7-bb7d-7395eacd649e">0.92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC02LTEtMS0w_43b6c3d9-202b-4afc-9154-a8add711692b">1.14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC04LTEtMS0w_6bad210f-e526-4d86-9189-525d142e876a">2.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS0yLTEtMS0w_d586c26d-20dc-4f6b-8b01-4e24eec59f66">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS00LTEtMS0w_38044d96-ccbc-4ec2-8a92-f681f5981a36">0.92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS02LTEtMS0w_69f8cefb-0962-47c3-a1af-11617c333981">1.14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS04LTEtMS0w_886b01a4-0200-4bec-bf1b-f9799b41c169">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9a5d0989150642c5998d2a345ad46d37_70"></div><div style="margin-top:16.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMjA1OA_7a5a2a34-c693-485e-81b8-307fdb456af2" continuedAt="ia217aaa4cd764244bc865e2ba05976f1" escape="true">INCOME TAXES </ix:nonNumeric></span></div><ix:continuation id="ia217aaa4cd764244bc865e2ba05976f1" continuedAt="ib5ab918067d744d185ff8e171ff61c1b"><ix:nonNumeric contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMjA2OQ_de794d49-ef66-464b-bbf8-27472137ad06" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our income tax expense (benefit) (in millions, except percentages):</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy0yLTEtMS0w_9742a7e4-140b-416e-a118-16631ee731bc"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy0yLTEtMS0w_b3f64fc1-fbb2-49b0-95d9-7549807af89c">825</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy00LTEtMS0w_1ba1953b-aaff-4d24-8527-3f9e84027b35"><ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy00LTEtMS0w_a031a6ca-aa2b-452c-befc-bcd0160841a2">1,501</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy02LTEtMS0w_0b03bae9-1848-49be-a617-4053a01ee632"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy02LTEtMS0w_4ac698fd-868e-4df6-9489-a7c61046caf3">145</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy04LTEtMS0w_18763f2a-5869-4244-90b5-87294d8830f5"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy04LTEtMS0w_fdb3fd5d-e46c-4cfd-8ac4-41ca0dd9a05a">3,259</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC0yLTEtMS0w_cfb44b27-6daf-4df4-8d37-7106b8d9fe62">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC00LTEtMS0w_a1d14eed-d1c4-44fd-9143-f8a1c8033bc4">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC02LTEtMS0w_59cde5c8-9ce9-4adb-9d44-3fd1ddd2c0d6">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC04LTEtMS0w_251a80f4-aba4-4073-839b-4facf066efe6">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS0yLTEtMS0w_456a2914-203f-46c9-af97-50452c7cb019">57.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS00LTEtMS0w_467e631d-e61d-4b07-ab35-b9e672961e1c">22.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS02LTEtMS0w_ad72b523-59da-4a7f-88a9-baac9c96c3e2">903.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS04LTEtMS0w_e46d1faf-e919-4b79-937c-5eb81e1998f3">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of <ix:nonFraction unitRef="number" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTQ3_456a2914-203f-46c9-af97-50452c7cb019">57.2</ix:nonFraction>% for the three months ended September 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to $<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTA5OTUxMTYzMTU3Mg_1a68006b-f871-426d-8b73-99fb72d51c53">511</ix:nonFraction> million of certain acquired IPR&amp;D charges and $<ix:nonFraction unitRef="usd" contextRef="ic68ebf48645046309e24289804996aac_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTA5OTUxMTYzMTQyMQ_758328f0-9162-482c-9335-47b36d24c942">923</ix:nonFraction> million of unfavorable changes in the fair value of our equity investments in Galapagos that are non-deductible for income tax purposes. The three months ended September 30, 2020 also included a $<ix:nonFraction unitRef="usd" contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTA5OTUxMTYzMTQwNQ_c6ec6b7d-a92a-4df4-90e1-6671576d7c36">91</ix:nonFraction> million net discrete tax benefit related to a settlement with a taxing authority. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of (<ix:nonFraction unitRef="number" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfNjU5NzA2OTc3MDgyMQ_a3d063f4-5690-4518-950a-bcb5126b67b4">903.4</ix:nonFraction>)% for the nine months ended September 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to a non-deductible $<ix:nonFraction unitRef="usd" contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMjY5_b13325fa-5538-414f-988b-cc414aa9c507">4.5</ix:nonFraction> billion IPR&amp;D charge recorded in connection with our acquisition of Forty Seven, in addition to the above mentioned amounts for the three months ended September 30, 2020. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of <ix:nonFraction unitRef="number" contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfNDY0_467e631d-e61d-4b07-ab35-b9e672961e1c">22.2</ix:nonFraction>% for the three months ended September 30, 2019 differed from the U.S. federal statutory rate of 21% primarily due to the Global Intangible Low-Taxed Income (&#8220;GILTI&#8221;) tax, state taxes and our portion of the non-deductible branded prescription drug (&#8220;BPD&#8221;) fee, partially offset by research tax credits and earnings from non-U.S. subsidiaries that operate in jurisdictions with lower tax rates than the United States.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of <ix:nonFraction unitRef="number" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfODU0_e46d1faf-e919-4b79-937c-5eb81e1998f3">17.9</ix:nonFraction>% for the nine months ended September 30, 2019 differed from the U.S. federal statutory rate of 21% primarily due to a $<ix:nonFraction unitRef="usd" contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfOTM5_ba8f4643-c9e0-4a31-b337-9b9f2d4c6722">119</ix:nonFraction> million tax benefit related to settlements with taxing authorities, research tax credits and earnings from non-U.S. subsidiaries that operate in jurisdictions with lower tax rates than the United States, partially offset by the GILTI tax, state taxes and our portion of the non-deductible BPD fee.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib5ab918067d744d185ff8e171ff61c1b">We are currently under examination by the U.S. Internal Revenue Service for the tax years from 2013 to 2015 and by various state and foreign jurisdictions. There are differing interpretations of tax laws and regulations, and as a result, significant disputes may arise with these tax authorities involving issues of the timing and amount of deductions and allocations of income among various tax jurisdictions. We regularly evaluate our exposures associated with our tax filing positions to determine our assessment of unrecognized tax benefits in accordance with the income tax guidance which clarifies the accounting for uncertainty in income taxes.</ix:continuation></span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13.5pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. The forward-looking statements are contained principally in this section entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Risk Factors.&#8221; Words such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;target,&#8221; &#8220;goal,&#8221; &#8220;project,&#8221; &#8220;hope,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;might,&#8221; and variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, any statements other than statements of historical fact are forward-looking statements, including statements regarding overall trends, operating cost and revenue trends, liquidity and capital needs, collaboration and licensing arrangements, ongoing litigation and investigation matters, statements regarding the anticipated future impact on our business of the ongoing coronavirus disease 2019 (&#8220;COVID-19&#8221;) and related public health measures, statements regarding the development, manufacturing and distribution of Veklury as a treatment for COVID-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends and similar expressions. We have based these forward-looking statements on our current expectations about future events. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Our actual results may differ materially from those suggested by these forward-looking statements for various reasons, including those identified below under Risk Factors. Given these risks and uncertainties, you are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements included in this report are made only as of the date hereof unless otherwise specified. Except as required under federal securities laws and the rules and regulations of the Securities and Exchange Commission, we do not undertake and specifically decline any obligation to update any of these statements or to publicly announce the results of any revisions to any forward-looking statements after the distribution of this report, whether as a result of new information, future events, changes in assumptions or otherwise. In evaluating our business, you should carefully consider the risks described in the section entitled Risk Factors under Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019 and Part II of our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020 and this Quarterly Report on Form 10-Q Part II, Item&#160;1A in addition to the other information in this Quarterly Report on Form&#160;10-Q. Any of the risks contained herein could materially and adversely affect our business, results of operations and financial condition.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read the following management&#8217;s discussion and analysis of our financial condition and results of operations in conjunction with our audited Consolidated Financial Statements and related notes thereto included as part of our <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000006/0000882095-20-000006-index.htm">Annual Report on Form 10-K</a> for the year ended December&#160;31, 2019 and our unaudited Condensed Consolidated Financial Statements for the nine months ended September 30, 2020 and other disclosures (including the disclosures under Part II, Item&#160;1A, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) included in this Quarterly Report on Form&#160;10-Q. Our Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles and are presented in U.S. dollars.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT OVERVIEW</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gilead Sciences, Inc. (&#8220;Gilead&#8221;, &#8220;we&#8221;, &#8220;our&#8221; or &#8220;us&#8221;), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. We have operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead&#8217;s primary areas of focus include viral diseases, inflammatory diseases and oncology. We seek to add to our existing portfolio of products and product candidates through our internal discovery and clinical development programs, acquisitions, in-licensing, options and other strategic collaborations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of marketed products includes AmBisome</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Atripla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Biktarvy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Cayston</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Complera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/Eviplera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Descovy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Descovy for PrEP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Emtriva</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Epclusa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Genvoya</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Harvoni</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Hepsera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Jyseleca</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Letairis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Odefsey</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Ranexa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Sovaldi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Stribild</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Tecartus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Trodelvy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Truvada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Truvada for PrEP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Tybost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Veklury</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Vemlidy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Viread</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Vosevi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Zydelig</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval status of Jyseleca varies worldwide, and Jyseleca is not approved in the United States. We also sell and distribute authorized generic versions of Epclusa and Harvoni in the United States through our separate subsidiary, Asegua Therapeutics, LLC. In addition, we sell and distribute certain products through our corporate partners under collaborative agreements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Highlights</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, we made important strides in advancing work across each of the three long-term ambitions laid out in our corporate strategy: (i) to bring 10+ transformative therapies to patients by 2030; (ii) to be the biotech employer and partner of choice; and (iii) to deliver shareholder value in a sustainable and responsible manner. This progress occurred as we continued efforts to enhance our understanding of remdesivir&#8217;s role in treating COVID-19 and rapidly expand access for patients worldwide. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Development:</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We significantly accelerated the buildout of our oncology portfolio and expertise during the three months ended September 30, 2020 by announcing the acquisition of Immunomedics, Inc. (&#8220;Immunomedics&#8221;). This transaction, our thirteenth in oncology in the last two years, brings a foundational product to our oncology franchise, broadening and deepening our solid tumor pipeline and building on current marketed products and late-stage clinical candidates for patients with hematologic malignances.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September, we agreed to acquire Immunomedics for approximately $21 billion. In an event subsequent to September 30, 2020, on October 23, 2020, we closed the transaction and gained Trodelvy, a first-in-class Trop-2-directed antibody-drug conjugate. Trodelvy was granted accelerated approval by the U.S. Food and Drug Administration (&#8220;FDA&#8221;) in April for the treatment of adult patients with metastatic triple-negative breast cancer (&#8220;mTNBC&#8221;) who have received at least two prior therapies for metastatic disease. Beyond mTNBC, Trodelvy is being studied as a monotherapy and combination agent for additional tumor types, including HR+/HER2- breast cancer, bladder cancer, non-small cell lung cancer and other solid tumors. At the ESMO Virtual Congress 2020, Immunomedics presented new data on Trodelvy, including detailed results from the Phase 3 ASCENT study in mTNBC and additional clinical data in bladder cancer and other solid tumors. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, we also entered into several additional agreements to advance our emerging and complementary oncology portfolio:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We completed our transaction with Arcus Biosciences, Inc. (&#8220;Arcus&#8221;) to enter into a 10-year partnership. Gilead and Arcus will co-develop and co-commercialize next generation cancer immunotherapies, including investigational products that target important mechanisms involved in tumor evasion of the immune system and cell-intrinsic pathways important for cancer growth and metastasis.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Kite Pharma Inc. (&#8220;Kite&#8221;), a Gilead Company, entered into a two-year research collaboration and license agreement with HiFiBiO Therapeutics (&#8220;HiFiBiO&#8221;). HiFiBiO will use its proprietary technology platforms to identify novel acute myeloid leukemia (&#8220;AML&#8221;) targets and anti-AML specific antibodies for Kite&#8217;s use in cell therapies, and Kite will have an exclusive option to opt in on any targets discovered through the collaboration.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We announced an agreement with Jounce Therapeutics, Inc. (&#8220;Jounce&#8221;) to exclusively license JTX-1811, Jounce&#8217;s monoclonal antibody designed to selectively deplete immunosuppressive tumor-infiltrating T regulatory cells. Jounce will lead development of JTX-1811 through investigational new drug clearance, and thereafter, we will have the sole right to develop the compound. In an event subsequent to September 30, 2020, in October, this transaction was completed. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We acquired a 49.9% equity interest in Pionyr Immunotherapeutics, Inc. (&#8220;Pionyr&#8221;), as well as an exclusive option to acquire the remainder of Pionyr following the readout of a Phase 1b study of Pionyr&#8217;s investigational antibodies, PY314 and PY159, or earlier. Pionyr&#8217;s Myeloid Tuning&#8482; therapies have the potential to treat patients who currently do not benefit from checkpoint inhibitor therapies. PY314 and PY159 are first-in-class antibodies designed to remove or reprogram, respectively, the immune suppressive cells in the tumor microenvironment and thereby enhance anti-tumor immunity.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We acquired a 49.9% equity interest in Tizona Therapeutics, Inc. (&#8220;Tizona&#8221;), as well as an exclusive option to acquire the remainder of Tizona following the readout of a Phase 1b study of Tizona&#8217;s investigational antibody, TTX-080, or earlier. TTX-080 is a potential first-in-class medicine that targets HLA-G, a novel and emerging immune checkpoint expressed across multiple tumor types.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expanded our multi-year collaboration with Tango Therapeutics (&#8220;Tango&#8221;). Tango will continue to leverage its proprietary, CRISPR-enabled functional genomics target discovery platform to identify novel immune evasion targets. The number of targets covered will expand from five to 15.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remdesivir and Ongoing COVID-19 Pandemic Response:</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ensuring Broader Access to Veklury:</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, additional regulatory authorizations for the treatment of COVID-19 facilitated broader access to Veklury. Additionally, we continued to collaborate with industry partners and thought leaders to support efforts to systematically address the impact of COVID-19 on minority communities and ensure affordable supply of therapy for people worldwide.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October and July, Veklury became the first approved treatment for COVID-19 in the United States and European Union, respectively. FDA granted full approval to Veklury for the treatment of patients with COVID-19, and the European Commission (&#8220;EC&#8221;) granted conditional Marketing Authorization for the treatment of COVID-19.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As previously discussed in our second quarter of 2020 earnings press release, we executed process improvements to shorten the manufacturing time and expanded our manufacturing capacity globally to supply remdesivir broadly. As a result, we have been meeting real-time demand for Veklury in the United States since the beginning of October and now meet global demand for Veklury, even in the event of potential future surges of COVID-19.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October, we began distributing Veklury in the United States upon conclusion of the previous distribution agreement with the U.S. Federal government. To ensure stable management of drug supply in the near-term, AmerisourceBergen will continue to serve as the sole U.S. distributor of Veklury through the end of 2020 and will sell the product directly to hospitals. This distribution model closely reflects the traditional model hospitals use to procure medicines. Hospitals will control the quantity of Veklury that they order, enabling them to have ample, predictable supply of Veklury in advance of any anticipated increase in COVID-19 incidence.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October, Gilead and the EC signed a joint procurement agreement (&#8220;JPA&#8221;) that will enable rapid and equitable access to Veklury. The JPA enables participating countries in the European Union and the European Economic Area and the United Kingdom to purchase Veklury for both real-time demand and stockpiling needs, coordinated by the EC. The agreement covers purchases of Veklury for a six-month period and has the option to be extended. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advancing Remdesivir Clinical Development:</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to make rapid progress advancing remdesivir as a treatment for COVID-19. During the three months ended September 30, 2020, additional data were released that further enhance the understanding of remdesivir and point to its important role in treating patients with COVID-19, and new clinical trials were initiated to assess remdesivir&#8217;s safety and efficacy in additional patient populations. </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July, we presented new data at the 23rd International AIDS Conference, including a comparative analysis of the Phase 3 SIMPLE-Severe trial and a real-world retrospective of a cohort of patients with severe COVID-19. The analysis demonstrated that remdesivir was associated with an improvement in clinical recovery and a 62 percent reduction in the risk of mortality compared with the standard of care. Separate subgroup analyses from the Phase 3 SIMPLE-severe trial found that traditionally marginalized racial or ethnic groups treated with remdesivir experienced similar clinical outcomes as the overall patient population in the study. </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July, we announced the initiation of a Phase 1a clinical study to evaluate the safety, tolerability and pharmacokinetics of an investigational, inhaled solution of remdesivir in healthy volunteers. We also announced plans for trials using intravenous infusions in outpatient settings such as infusion centers and nursing homes, trials evaluating remdesivir in combination with the JAK inhibitor, baricitinib, and the IL-6 receptor antagonist tocilizumab; and trials including vulnerable patient populations, such as children, pregnant women, and patients with end-stage renal disease. </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October, the New England Journal of Medicine published the final results from the National Institute of Allergy and Infectious Diseases&#8217; Phase 3 ACTT-1 trial in adults hospitalized with mild-moderate or severe COVID-19. The final ACTT-1 study results showed that treatment with Veklury resulted in consistent, clinically meaningful improvements across multiple outcome assessments compared with placebo in COVID-19 patients. The final results also demonstrate that treatment with Veklury resulted in a faster time to recovery than previously reported. Overall, treatment with Veklury resulted in five days faster recovery and reduced disease progression compared with placebo. Veklury reduced mortality by 70 percent at day 29 in patients on low-flow oxygen at baseline in a post-hoc analysis.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Pipeline Updates: </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Viral Diseases:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July, new data across our HIV franchise were presented at the 23rd International AIDS Conference. The presentations included a new clinical study data for a sustained-delivery subcutaneous formulation of our novel investigational HIV-1 capsid inhibitor lenacapavir; additional data evaluating the safety and efficacy of Biktarvy as a treatment for HIV in adults aged 65 or older; data from the DISCOVER trial indicating no increase in sexual health risk behavior among those taking Descovy for PrEP or Truvada for PrEP, and an update on our cure research strategy through data on dose-dependent immune responses with vesatolimod, an investigational toll-like receptor 7 agonist.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August, the China National Medical Products Administration approved a PrEP indication for Truvada. Truvada is the first medicine approved for HIV prevention in China. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August, new data showcasing the breadth of our research in viral hepatitis were presented at the Digital International Liver Congress&#8482; 2020. The presentations included data reinforcing the effectiveness of Epclusa for hepatitis C virus (&#8220;HCV&#8221;) in key underserved populations, as well as new data demonstrating the durable renal and bone safety benefit of Vemlidy for hepatitis B virus (&#8220;HBV&#8221;) and supporting the further evaluation of selgantolimod as part of a combination approach to a functional cure for HBV.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October, new data for Biktarvy were presented at HIV Glasgow 2020. The presentations included long-term study results from multiple switch studies, in which treatment with Biktarvy continued to demonstrate durable efficacy with an established safety profile in a broad range of people living with HIV, as well as data from the observational, real-world, global BICSTaR study, which showed consistent therapeutic effectiveness and long-term safety in real-world practice settings.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inflammatory Diseases:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August, Gilead and Galapagos NV (&#8220;Galapagos&#8221;) announced that FDA issued a complete response letter for the New Drug Application for filgotinib, an investigational treatment for moderately to severely active rheumatoid arthritis (&#8220;RA&#8221;). Gilead will meet with FDA and determine next steps in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August, new data highlighting our research in nonalcoholic steatohepatitis (&#8220;NASH&#8221;) and primary sclerosing cholangitis (&#8220;PSC&#8221;) were presented at the Digital International Liver Congress&#8482; 2020. The presentations included the full results from the Phase 2 ATLAS study, which demonstrate the potential for combination approaches for the treatment of people with advanced fibrosis due to NASH, as well as new data describing the utility of machine learning approaches to evaluate liver histology, identify histologic features associated with disease progression in NASH and PSC, and assess the impact of treatment with tenofovir disoproxil fumarate (&#8220;TDF&#8221;) in chronic HBV.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September, Gilead and Eisai Co., Ltd., announced that the Japanese Ministry of Health, Labour and Welfare granted regulatory approval of Jyseleca for the treatment of RA in patients who have had an inadequate response to conventional therapies, including the prevention of structural joint damage.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September, Gilead and Galapagos announced that EC granted marketing authorization for Jyseleca for the treatment of adults with moderate to severe active RA who have responded inadequately to, or are intolerant to, one or more disease modifying anti-rheumatic drugs. Under the marketing authorization, Jyseleca may be used as monotherapy or in combination with methotrexate. The EC&#8217;s decision follows a positive opinion from the European Medicines Agency&#8217;s (&#8220;EMA&#8221;) Committee for Medicine Products for Human Use (&#8220;CHMP&#8221;), which was announced in July. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October, Gilead and Galapagos presented new data at the 2020 United European Gastroenterology Week Virtual Meeting, including late-breaking data from the Phase 2b/3 SELECTION trial evaluating filgotinib for the treatment of moderately to severely active ulcerative colitis. The data showed that a significantly higher proportion of patients treated with filgotinib 200 mg, versus placebo, achieved clinical remission at Week 10 and maintained remission through Week 58. In addition, significantly more patients achieved six-month corticosteroid-free remission.</span></div><div style="margin-bottom:4.5pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Oncology:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July, FDA granted accelerated approval to Tecartus, the first and only approved chimeric antigen receptor (&#8220;CAR&#8221;) T cell therapy for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September, Kite announced the submission of a supplemental Biologics License Application to FDA for Yescarta for the treatment of relapsed or refractory follicular lymphoma and marginal zone lymphoma after two or more prior lines of systemic therapy. If approved, Yescarta would be the first CAR T cell therapy approved for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September, we announced that FDA granted Breakthrough Therapy designation for magrolimab, a first-in-class, investigational, monoclonal antibody for the treatment of newly diagnosed myelodysplastic syndrome (&#8220;MDS&#8221;). The Breakthrough Therapy designation was based on positive results from the ongoing Phase 1b study evaluating magrolimab in combination with azacitidine in previously untreated intermediate, high and very high-risk MDS.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October, Kite announced that the EMA Committee for CHMP has issued a positive opinion on its Marketing Authorization Application for KTE-X19, a CAR T cell therapy, for the treatment of relapsed or refractory mantle cell lymphoma. In recognition of its potential to benefit patients with significant unmet medical need, KTE-X19 was granted Priority Medicines designation by the EMA. </span></div><div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Unsecured Notes Offering: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September, we issued $7.25 billion aggregate principal amount of senior unsecured notes, in an underwritten, registered public offering, consisting of seven tranches.</span></div><div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan Facility:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In September 2020, we entered into a commitment letter with a group of institutional lenders to provide for a three-year senior unsecured term loan facility (the &#8220;Term Loan Facility&#8221;) in an aggregate principal amount of $1.0 billion. In an event subsequent to September 30, 2020, on October 23, 2020, we entered into a term loan credit agreement under the Term Loan Facility and borrowed an aggregate principal amount of $1.0&#160;billion.</span></div><div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Appointment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October 2020, Anthony Welters, who retired in 2016 as Senior Adviser to the Office of the Chief Executive Officer of UnitedHealth Group Inc., joined our Board of Directors. With his extensive experience in the health insurance and managed care industry, Mr. Welters will bring important perspective to our Board of Directors as we continue our work to deliver transformational medicines to patients.</span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Highlights</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Gilead</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">________________________________</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">NM - Not Meaningful</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues increased by 17% to $6.6 billion for the three months ended September 30, 2020, compared to $5.6 billion for the same period in 2019, due to higher product sales of both Veklury and our HIV products, which was driven by higher volume as channel inventory continues to normalize in the United States, as well as stronger patient demand, including the continued patient uptake of Biktarvy and growth of Descovy for PrEP. The increases were partially offset by lower sales volume of our Truvada (emtricitabine (&#8220;FTC&#8221;) and TDF)-based products and lower sales of HCV products. As expected, revenues for the three months ended September 30, 2020 reflect the continued impact from the COVID-19 pandemic on HCV and pre-exposure prophylaxis (&#8220;PrEP&#8221;). </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Gilead was $360 million,&#160;or $0.29 per diluted share, for the three months ended September 30, 2020, compared to net loss attributable to Gilead of $(1.2) billion, or $(0.92) per diluted share, for the same period in 2019. The three months ended September 30, 2020 included acquired in-process research and development (&#8220;IPR&amp;D&#8221;) expenses totaling $1.2&#160;billion related to our collaborations and other investments we entered into during the quarter as well as a $923 million unrealized loss from changes in the fair value of our equity investments in Galapagos. The three months ended September 30, 2019 included $4.0 billion acquired IPR&amp;D charges primarily related to our global research and development collaboration agreement with Galapagos. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had $26.0 billion of cash, cash equivalents and marketable debt securities compared to $25.8 billion as of December&#160;31, 2019. During the three months ended September 30, 2020, we generated $2.25 billion in operating cash flow, issued senior unsecured notes in an aggregate principal amount of $7.25 billion, repaid $2.0 billion of debt upon maturity, utilized $1.0 billion on acquisitions, net of cash acquired (including IPR&amp;D), paid cash dividends of $861 million and utilized $201 million on repurchases of our common stock. In an event subsequent to September 30, 2020, on October 23, 2020, we financed the acquisition of Immunomedics with the majority of the proceeds from the September 2020 senior unsecured notes offering, an additional $1.0 billion borrowing under the Term Loan Facility and the balance with cash on hand.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Revenues</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our revenues:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product Sales:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIV Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCV Products</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cell Therapy Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Product Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,493&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,516&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,577&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,268&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">________________________________</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">NM - Not Meaningful</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Sales</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For the three months ended September 30, 2020 compared to the three months ended September 30, 2019</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total product sales increased by 18% to $6.5 billion for the three months ended September 30, 2020, compared to $5.5 billion for the same period in 2019, primarily</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to higher sales of both Veklury and our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> HIV products, which was driven by higher volume as channel inventory continues to normalize in the United States, as well as stronger patient demand, including the continued patient uptake of Biktarvy and growth of Descovy for PrEP. The increases were partially offset by lower sales </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">volume of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Truvada (FTC/TDF)-based products, lower HCV sales volumes due to the COVID-19 pandemic and lower average HCV net selling price.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIV product sales increased by 8% to $4.5 billion for the three months ended September 30, 2020, compared to $4.2 billion for the same period in 2019, primarily due to our core HIV business driven by higher volume as channel inventory continues to normalize in the United States following the second quarter consumption of the stockpiling from the first quarter of 2020, as well as stronger patient demand, including the continued patient uptake of Biktarvy and growth of Descovy for PrEP. The increases were partially offset by lower sales volume of our Truvada (FTC/TDF)-based products and lower average net selling price, including the effect of unfavorable payer mix. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HCV product sales decreased by 31% to $464 million for the three months ended September 30, 2020, compared to $674 million for the same period in 2019, primarily due to lower sales volume driven by lower patient starts in the United States and Europe attributable to a decrease in healthcare provider (&#8220;HCP&#8221;) visits and screenings due to the COVID-19 pandemic and lower average net selling price.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cell therapy product sales, which include Yescarta and Tecartus, increased by 25% to $147 million for the three months ended September 30, 2020, compared to $118 million for the same period in 2019, primarily due to the continued uptake and expansion of Yescarta in Europe. Tecartus was approved by FDA during three months ended September 30, 2020.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Veklury generated $873 million in sales for the three months ended September 30, 2020. Veklury revenue is generated in a highly dynamic and complex global environment, which continues to evolve. As a result, Veklury revenue is subject to significant volatility and uncertainty. Future product demand will depend on the nature of the COVID-19 pandemic, including duration of the pandemic, infection rates, hospitalizations, and availability of alternative therapies and vaccines being developed.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other product sales, which include Vemlidy, Viread, Letairis, Ranexa, Zydelig, AmBisome and Cayston, decreased by 11% to $462 million for the three months ended September 30, 2020, compared to $522 million for the same period in 2019, primarily due to the expected declines in sales of Letairis and Ranexa after generic entries in the first half of 2019.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Sales by Geographic Area:</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of our total product sales, 22% and 24% were generated outside the United States for the three months ended September 30, 2020 and 2019, respectively. We faced exposure to movements in foreign currency exchange rates, primarily in the Euro. We used foreign currency exchange contracts to hedge a portion of our foreign currency exposure. Foreign currency exchange, net of hedges, had an immaterial impact on our product sales for the three months ended September 30, 2020, based on a comparison using foreign currency exchange rates from the three months ended September 30, 2019.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales in the United States increased by 21% to $5.1 billion for the three months ended September 30, 2020, compared to $4.2 billion for the same period in 2019, primarily due to Veklury sales of $785 million and our core HIV products, which was driven by higher volume as channel inventory continues to normalize in the United States following the second quarter consumption of the stockpiling from the first quarter of 2020, as well as stronger patient demand, including the continued patient uptake of Biktarvy and growth of Descovy for PrEP. The increases were partially offset by lower sales volume of our HCV products driven by lower patient starts attributable to a decrease in HCP visits and screenings due to the COVID-19 pandemic and lower sales of Letairis and Ranexa after generic entries in the first half of 2019.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales in Europe increased by 9% to $877 million for the three months ended September 30, 2020, compared to $804 million for the same period in 2019, primarily due to Veklury sales of $60 million and higher sales of Yescarta and our HIV products, partially offset by lower sales volume of our HCV products driven by lower patient starts due to the COVID-19 pandemic.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales in other locations increased by 5% to $540 million for the three months ended September 30, 2020, compared to $513 million for the same period in 2019, primarily due to higher sales volumes of Biktarvy and Vemlidy, partially offset by lower average net selling price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total product sales increased by 4% to $17.0 billion for the nine months ended September 30, 2020, compared to $16.3 billion for the same period in 2019, primarily due to sales of Veklury, the continued patient uptake of Biktarvy and growth of Descovy for PrEP. The increase was partially offset by lower sales </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">volume of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Truvada (FTC/TDF)-based products and lower HCV sales due to lower average HCV net selling price and lower patient starts attributable to a decrease in HCP visits and screenings due to the COVID-19 pandemic, and lower sales of Letairis and Ranexa. Total product sales for the nine months ended September 30, 2019 included $309 million of favorable net adjustments primarily due to government rebates and discounts related to sales made in prior years.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIV product sales increased by 7% to $12.7 billion for the nine months ended September 30, 2020, compared to $11.9 billion for the same period in 2019, primarily due to the continued patient uptake of Biktarvy and growth of Descovy for PrEP, partially offset by lower sales volume of our Truvada (FTC/TDF)-based products and lower average net selling price. HIV product sales for the nine months ended September 30, 2019 included favorable net adjustments primarily due to government rebates and discounts. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HCV product sales decreased by 29% to $1.6 billion for the nine months ended September 30, 2020, compared to $2.3 billion for the same period in 2019, primarily due to lower sales volume driven by lower patient starts in the United States and Europe attributable to the COVID-19 pandemic and lower average net selling price. HCV product sales for the nine months ended September 30, 2019 included favorable net adjustments primarily due to government rebates and discounts.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Veklury generated $873 million</span><span style="color:#b3b3b3;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in sales during the nine months ended September 30, 2020</span><span style="color:#b3b3b3;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cell therapy product sales increased by 33% to $444 million for the nine months ended September 30, 2020, compared to $334 million for the same period in 2019, primarily due to the continued uptake and expansion of Yescarta in Europe.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other product sales, which include Vemlidy, Viread, Letairis, Ranexa, Zydelig, AmBisome and Cayston, decreased by 24% to $1.4 billion for the nine months ended September 30, 2020, compared to $1.8 billion for the same period in 2019, primarily due to the expected declines in sales of Letairis and Ranexa.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Sales by Geographic Area:</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of our total product sales, 25% and 26% were generated outside the United States for the nine months ended September 30, 2020 and 2019, respectively. We faced exposure to movements in foreign currency exchange rates, primarily in the Euro. We used foreign currency exchange contracts to hedge a portion of our foreign currency exposure. Foreign currency exchange, net of hedges, had an unfavorable impact on our product sales of $63 million for the nine months ended September 30, 2020, based on a comparison using foreign currency exchange rates from the nine months ended September 30, 2019.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales in the United States increased by 7% to $12.8 billion for the nine months ended September 30, 2020, compared to $12.0 billion for the same period in 2019, primarily due to sales of Veklury, the continued patient uptake of Biktarvy and growth of Descovy for PrEP, partially offset by decreases in sales of Truvada (FTC/TDF)-based products. The increase was also partially offset by lower sales of our HCV products and lower sales volume of Letairis and Ranexa. The decrease in sales of our HCV products was primarily due to lower average net selling price, and lower sales volume as a result of lower patient starts attributable to a decrease in HCP visits and screenings due to the COVID-19 pandemic. Product sales in the United States for the nine months ended September 30, 2019 included favorable net adjustments primarily due to government rebates and discounts.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales in Europe decreased by 7% to $2.5 billion for the nine months ended September 30, 2020, compared to $2.7 billion for the same period in 2019, primarily due to a lower sales volume of our HCV products driven by lower patient starts due to COVID-19 and lower average net selling price. The decreases were partially offset by the continued patient uptake of Biktarvy and higher sales of Yescarta. Product sales in Europe for the nine months ended September 30, 2019 included favorable net adjustments primarily due to government rebates and discounts.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales in other locations increased by 8% to $1.7 billion for the nine months ended September 30, 2020, compared to $1.5 billion for the same period in 2019, primarily due to higher sales volumes of Biktarvy and Vemlidy, partially offset by lower average net selling price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">HIV and HCV Product Sales by Geographic Area:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an additional discussion of the sales of our HIV and HCV products:</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Descovy (&#8220;FTC/TAF&#8221;)-based products: Biktarvy, Descovy, Genvoya, Odefsey and Revenue Share - Symtuza</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our sales of Descovy (FTC/TAF)-based products:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,855&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other locations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of HIV product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Descovy (FTC/TAF)-based product sales in the United States increased for both the three and nine months ended September 30, 2020, compared to the same periods in 2019, primarily due to the continued patient uptake of Biktarvy and higher sales volume of Descovy driven by patients switching to Descovy for PrEP from Truvada for PrEP.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Descovy (FTC/TAF)-based product sales in Europe and other international locations increased for both the three and nine months ended September 30, 2020 compared to the same periods in 2019, primarily due to higher sales volume of Biktarvy, partially offset by lower sales volume of Genvoya.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Truvada (FTC/TDF)-based products: Atripla, Complera/Eviplera, Stribild and Truvada</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our sales of Truvada (FTC/TDF)-based products:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other locations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Truvada (FTC/TDF)-based product sales in the United States decreased for both the three and nine months ended September 30, 2020, compared to the same periods in 2019, primarily due to lower sales volume as a result of patients switching to regimens containing FTC/TAF. We expect a significant decline in our sales of Truvada as the first generic version of Truvada became available in the United States on October 2, 2020.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Truvada (FTC/TDF)-based product sales in Europe decreased for both the three and nine months ended September 30, 2020, compared to the same periods in 2019, primarily due to lower sales volume as a result of the broader availability of generic versions of Truvada and patients switching to regimens containing FTC/TAF.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">HCV products: Epclusa, Harvoni, Sovaldi, Vosevi and Authorized Generics of Epclusa and Harvoni</span></div><div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our sales of HCV products:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other locations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HCV product sales in the United States decreased for both the three and nine months ended September 30, 2020, compared to the same periods in 2019, primarily due to lower patient starts attributable to a decrease in HCP visits and screenings due to the COVID-19 pandemic and lower average net selling price.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HCV product sales in Europe decreased for both the three and nine months ended September 30, 2020, compared to the same periods in 2019, primarily due to lower patient starts attributable to a decrease in HCP visits and screenings due to the COVID-19 pandemic. The decrease was also impacted by favorable net adjustments primarily due to government rebates and discounts during the nine months ended September 30, 2019, which did not reoccur in 2020.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HCV product sales in other international locations decreased for both the three and nine months ended September 30, 2020, compared to the same periods in 2019, primarily due to lower average net selling price partially offset by higher sales volume of Epclusa.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Sales by Product:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our product sales:</span></div><div style="margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atripla</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biktarvy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complera/Eviplera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Descovy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genvoya</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Odefsey</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stribild</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other HIV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue share &#8211; Symtuza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total HIV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmBisome</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ledipasvir/Sofosbuvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letairis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ranexa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sofosbuvir/Velpatasvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vemlidy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viread</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vosevi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yescarta</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zydelig</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,493&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,027&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,323&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Emtriva and Tybost.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents our revenue from cobicistat (&#8220;C&#8221;), emtricitabine (&#8220;FTC&#8221;) and tenofovir alafenamide (&#8220;TAF&#8221;) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland UC.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Harvoni and the authorized generic version of Harvoni sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Cayston, Hepsera, Sovaldi and Tecartus. Europe product sales included unfavorable adjustments recorded in 2019 for statutory rebates related to sales of Sovaldi made in prior years.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Percentage is greater than 100%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Costs and Expenses</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our costs and expenses:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product gross margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">120bps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(30)bps</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development (&#8220;R&amp;D&#8221;) expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Goods Sold and Product Gross Margin</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold for the three and nine months ended September 30, 2020 increased by $106 million and $182 million, or 10% and 6%, respectively, compared to the same periods in 2019, primarily due to higher sales volumes driven by Veklury, partially offset by lower royalty expenses. In addition, the increase in cost of goods sold for the nine months ended September 30, 2020 was impacted by higher sales volume of Biktarvy, compared to same period in 2019. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross margin for the three months ended September 30, 2020 increased, compared to the same period in 2019, primarily due to Veklury sales and lower inventory reserves, partially offset by overall lower product mix.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross margin for the nine months ended September 30, 2020 decreased, compared to the same period in 2019, primarily due to overall lower product mix, partially offset by Veklury sales. </span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses consist primarily of clinical studies performed by contract research organizations, materials and supplies, payments under collaborative and other arrangements, including milestone payments, licenses and fees, as well as expense reimbursements to the collaboration partners, personnel costs, including salaries, benefits and stock-based compensation expense, and overhead allocations consisting of various support and infrastructure costs.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not track total R&amp;D expenses by product candidate, therapeutic area or development phase. However, we manage our R&amp;D expenses by identifying the R&amp;D activities we anticipate will be performed during a given period and then prioritizing efforts based on scientific data, probability of technical and regulatory successful development, market potential, available human and capital resources and other considerations. We continually review our R&amp;D projects based on unmet medical need and, as necessary, reallocate resources among our internal R&amp;D portfolio and external opportunities that we believe will best support the long-term growth of our business.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses for the three months ended September 30, 2020 increased by $128 million, or 12%, compared to the same period in 2019, primarily due to higher clinical trial expenses related to remdesivir and higher investments in our oncology programs including magrolimab, partially offset by lower costs as a result of our pause or postponement of certain clinical trials due to the COVID-19 pandemic. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses for the nine months ended September 30, 2020 increased by $505 million, or 17%, compared to the same period in 2019, primarily due to higher clinical trial expenses related to remdesivir including material costs, acquisition related expenses in connection with our acquisition of Forty Seven and higher investments in oncology programs including magrolimab, partially offset by lower clinical trial expenses from completion of certain inflammation research programs. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquired In-Process Research and Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D expenses reflect IPR&amp;D impairments as well as the initial costs of externally developed IPR&amp;D projects, acquired directly in a transaction other than a business combination, that do not have an alternative future use, including upfront payments related to various collaborations and the initial costs of rights to IPR&amp;D projects. Beginning in the second quarter of 2020, acquired IPR&amp;D expenses were reported separately from Research and development expenses on our Condensed Consolidated Statements of Operations. IPR&amp;D assets capitalized are tested for impairment in the fourth quarter of each year, or earlier if impairment indicators exist. No IPR&amp;D impairment charges were recorded for the three and nine months ended September 30, 2020 and 2019.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D expenses of $1.2&#160;billion for the three months ended September 30, 2020, included charges related to our collaborations and other investments we entered into during the quarter with Arcus, Pionyr, Tango and Tizona. Acquired IPR&amp;D expenses of $5.8&#160;billion for the nine months ended September 30, 2020 also included a $4.5 billion charge recorded in connection with the second quarter 2020 acquisition of Forty Seven.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPR&amp;D expenses of $4.0&#160;billion and $4.3&#160;billion for the three and nine months ended September 30, 2019, were primarily related to our global research and development collaboration agreement with Galapagos. </span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses relate to sales and marketing, finance, human resources, legal and other administrative activities. Expenses consist primarily of personnel costs, facilities and overhead costs, outside marketing, advertising and legal expenses and other general and administrative costs. SG&amp;A expenses also include the Branded Prescription Drug fee. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses for the three months ended September 30, 2020 increased by $54 million or 5%, compared to the same period in 2019, primarily due to higher expenses driven by headcount growth, partially offset by lower marketing and other spend due to the COVID-19 pandemic.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses for the nine months ended September 30, 2020 increased by $244 million or 8%, compared to the same period in 2019, primarily due to a $97 million accrual related to a previously disclosed U.S. Department of Justice investigation, $89 million of expenses associated with our acquisition of Forty Seven, certain remdesivir donations and higher expenses driven by headcount growth, partially offset by lower marketing and other spend due to the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our Other income (expense), net:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(940)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(848)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">________________________________</span></div><div style="margin-bottom:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">NM - Not Meaningful</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net for the three and nine months ended September 30, 2020 decreased compared to the same periods in 2019, primarily due to unfavorable changes in the fair value of our equity investments in Galapagos and lower interest income. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the period-over-period changes in our income tax expense (benefit):</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,501)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(3,404)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(921.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate and provision increased for the three months ended September 30, 2020, compared to the same period in 2019, primarily due to $511 million of certain acquired IPR&amp;D charges and $923 million of unfavorable changes in the fair value of our equity investments in Galapagos that are non-deductible for income tax purposes. The three months ended September 30, 2020 also included a $91 million net discrete tax benefit related to a settlement with a taxing authority.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate and provision differed for the nine months ended September 30, 2020, compared to the same period in 2019, primarily due to a non-deductible $4.5 billion IPR&amp;D charge recorded in connection with our acquisition of Forty Seven, in addition to the above mentioned amounts for the three months ended September 30, 2020. </span></div><div id="i9a5d0989150642c5998d2a345ad46d37_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing capital resources, supplemented by our cash flows generated from operating activities, will be adequate to satisfy our capital needs for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash, cash equivalents and marketable debt securities and working capital:</span></div><div style="margin-bottom:11pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and marketable debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Marketable Debt Securities</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and marketable debt securities increased by $209 million, or 1%, compared to December&#160;31, 2019. During the nine months ended September 30, 2020, we generated $6.3 billion in operating cash flows, issued senior unsecured notes in an aggregate principal amount of $7.25 billion in September 2020, repaid $2.5 billion of debt upon maturity, utilized $5.8 billion on acquisitions, net of cash acquired (including IPR&amp;D), paid cash dividends of $2.6 billion and repurchased 22 million shares of our common stock for $1.6 billion through open market transactions.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an event subsequent to September 30, 2020, on October 23, 2020, we financed the acquisition of Immunomedics with the majority of the proceeds from the September 2020 senior unsecured notes offering, an additional $1.0 billion borrowing under the Term Loan Facility and the balance with cash on hand. See Note 6. Acquisitions, Collaborations and Other Arrangements and Note 9. Debt and Credit Facilities of the Notes to Condensed Consolidated Financial Statements included in Part I, Item I of this Quarterly Report on Form 10-Q for additional information relating to the acquisition of Immunomedics.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital increased by $880 million, or 4%, compared to December&#160;31, 2019, primarily due to reclassifications of senior unsecured notes and certain portion of our Galapagos equity investment from Long-term debt, net and Other long-term assets, respectively, and the factors noted above under the heading Cash, Cash Equivalents and Marketable Debt Securities, partially offset by lower short-term marketable debt securities resulting from a shift in our investment strategy to investing in longer dated securities. We expect our working capital to decrease in the fourth quarter of 2020 as a result of our approximately $21 billion acquisition of Immunomedics.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable increased by $331 million, compared to December&#160;31, 2019, primarily due to Veklury sales during the three months ended September 30, 2020. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities increased by $1.1 billion compared to December&#160;31, 2019, primarily due to a reclassification from long-term income taxes payable for certain tax payments expected to be made within a year, sales return liability and accruals for certain milestone payments.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flow activities:</span></div><div style="margin-bottom:11pt;margin-top:9.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used in):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,738)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Provided by Operating Activities</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities represents the cash receipts and disbursements related to all activities other than investing and financing activities. Operating cash flow is derived by adjusting our net income for non-cash items and changes in operating assets and liabilities. Cash provided by operating activities decreased by $312 million to $6.3 billion for the nine months ended September 30, 2020 compared to the same period in 2019. The decrease was primarily the result of changes in operating assets and liabilities.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Used in Investing Activities</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities primarily consists of purchases, sales and maturities of our marketable debt securities, capital expenditures, acquisitions, net of cash acquired (including IPR&amp;D), purchases of equity securities and other investments. Cash used in investing activities decreased compared to the prior year primarily due to lower net purchases of marketable debt securities, partially offset by lower proceeds from maturities of marketable debt securities and higher payments related to acquisitions, net of cash acquired (including IPR&amp;D).</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Provided by (Used in) Financing Activities</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in cash provided by (used in) financing activities was primarily due to $7.2 billion in proceeds from the September 2020 senior unsecured notes offering, net of issuance costs, and $250 million lower repayments of debt during the nine months ended September 30, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and Credit Facilities</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our borrowings under various financing arrangement is included in Note 9. Debt and Credit Facilities of the Notes to Condensed Consolidated Financial Statements included in Part I, Item I of this Quarterly Report on Form 10-Q for additional information.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes Offering</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we issued $7.25 billion aggregate principal amount of senior unsecured notes consisting of (i) $500 million principal amount of floating rate notes due September 2021 and $500 million principal amount of floating rate notes due September 2023 and (ii) $2.0 billion principal amount of 0.75% senior notes due September 2023, $750 million principal amount of 1.20% senior notes due October 2027, $1.0 billion principal amount of 1.65% senior notes due October 2030, $1.0 billion principal amount of 2.60% senior notes due October 2040 and $1.5 billion principal amount of 2.80% senior notes due October 2050 (the &#8220;2020 Senior Notes&#8221;).</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes Repayments</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, we repaid $500 million of our senior unsecured notes upon maturity that were issued in November 2014. In September 2020, we repaid $2.0 billion of our senior unsecured notes upon maturity that were issued in September 2015.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan Facility</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an event subsequent to September 30, 2020, on October 23, 2020, we borrowed an aggregate principal amount of $1.0&#160;billion under the Term Loan Facility.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facility</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we terminated our $2.5 billion revolving credit facility maturing in May 2021 (the &#8220;2016 Revolving Credit Facility&#8221;) and entered into a new $2.5 billion revolving credit facility maturing in June 2025 (the &#8220;2020 Revolving Credit Facility&#8221;), which had terms substantially similar to the 2016 Revolving Credit Facility. The 2020 Revolving Credit Facility can be used for working capital requirements and for general corporate purposes, including, without limitation, acquisitions. As of September&#160;30, 2020 and December&#160;31, 2019, there were no amounts outstanding under these revolving credit facilities. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing of Immunomedics</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an event subsequent to September 30, 2020, on October 23, 2020, we financed the acquisition of Immunomedics with the majority of the proceeds from the 2020 Senior Notes, an additional $1.0 billion borrowing under the Term Loan Facility and the balance with cash on hand. </span></div><div id="i9a5d0989150642c5998d2a345ad46d37_85"></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES, ESTIMATES AND JUDGMENTS</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts in the financial statements and related disclosures. On an ongoing basis, we evaluate our significant accounting policies and estimates. We base our estimates on historical experience and on various market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent COVID-19 pandemic could have on our significant accounting estimates. Actual results may differ significantly from these estimates. A summary of our critical accounting policies and estimates is presented in Part II, Item 7 of our <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000006/0000882095-20-000006-index.htm">Annual Report on Form 10-K</a> for the year ended December&#160;31, 2019. There were no material changes to our critical accounting policies and estimates during the nine months ended September 30, 2020.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_88"></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OFF-BALANCE SHEET ARRANGEMENTS</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1. Summary Of Significant Accounting Policies of the Notes to Condensed Consolidated Financial Statements included in Part I, Item I of this Quarterly Report on Form 10-Q for additional information.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_94"></div><div style="margin-top:16.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our market risk during the three and nine months ended September 30, 2020 compared to the disclosures in Part II, Item 7A of our <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000006/0000882095-20-000006-index.htm">Annual Report on Form 10-K</a> for the year ended December&#160;31, 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:16.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation as of September&#160;30, 2020 was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our &#8220;disclosure controls and procedures,&#8221; which are defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act), as controls and other procedures of a company that are designed to ensure that the information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September&#160;30, 2020.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and Chief Financial Officer, has evaluated any changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2020, and has concluded that there was no change during such quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations on the Effectiveness of Controls</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. Accordingly, our disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our disclosure control system are met and, as set forth above, our Chief Executive Officer and Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this report, that our disclosure controls and procedures were effective to provide reasonable assurance that the objectives of our disclosure control system were met.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_103"></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of our significant pending legal proceedings, please see Note 10. Commitments and Contingencies of the Notes to Condensed Consolidated Financial Statements included in Part I, Item I of this Quarterly Report on Form 10-Q. </span></div><div id="i9a5d0989150642c5998d2a345ad46d37_106"></div><div style="margin-top:16.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. &#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, except as previously disclosed in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020, and as set forth below.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business has been, and may in the future be, adversely affected by outbreaks of epidemic, pandemic or contagious diseases, including the recent coronavirus disease 2019 (&#8220;COVID-19&#8221;) outbreak.</span></div><div style="margin-bottom:4pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual or threatened outbreaks of epidemic, pandemic or contagious diseases, such as COVID-19, may significantly disrupt our global operations and adversely affect our business, financial condition and results of operations. In March 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic, and COVID-19 continues to spread throughout the world. The spread of this pandemic has caused significant volatility and uncertainty in U.S. and international markets and has resulted in increased risks to our operations. In addition to the developments discussed in Part I, Item 2 &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations,&#8221; we are monitoring a number of risks related to this pandemic, including the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Supply Chain: While to date we have not experienced significant disruptions in our supply chain and distribution, an extended duration of this pandemic could result in disruptions in the future. For example, quarantines, shelter-in-place and other governmental orders and policies, travel restrictions, airline capacity and route reductions, safety guidelines and health impacts of the COVID-19 pandemic, could impact the availability or productivity of products and personnel at third-party manufacturers, distributors, freight carriers and other necessary components of our supply chain. In addition, there may be unfavorable changes in the availability or cost of raw materials, intermediates and other materials necessary for production, which may result in disruptions in our supply chain and adversely affect our ability to distribute certain of our products or product candidates for commercial or clinical supply. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Clinical Trials: This pandemic has adversely affected and may continue to adversely affect certain of our clinical trials, including our ability to initiate and complete our clinical trials within the anticipated timelines. For ongoing trials, clinical trial sites have imposed restrictions on patient visits to limit risks of possible COVID-19 exposure, and we may experience issues with participant compliance with clinical trial protocols as a result of quarantines, travel restrictions and interruptions to healthcare services. Due to the decreased site and participant availability during the pandemic resulting from adherence with applicable pandemic-related guidance and restrictions, we have experienced delays with new subject enrollment for most clinical trials. Although we continue enrollment at open sites, there is a risk that closures may be necessary as the pandemic and related guidance and restrictions continue to evolve, which may result in overall delays. There is also the risk of biased data collection if only certain clinical trial sites remain open. The current pressures on medical systems and the prioritization of healthcare resources toward the COVID-19 pandemic have also resulted in interruptions in data collection and submissions for certain clinical trials and delayed starts for certain planned studies. As a result, our anticipated filing and marketing timelines may be adversely impacted.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulatory Reviews: The operations of the U.S. Food and Drug Administration (&#8220;FDA&#8221;), European Medicines Agency (&#8220;EMA&#8221;) or other regulatory agencies may be adversely affected. There is the possibility that we may experience delays with our New Drug Application (&#8220;NDA&#8221;) for filgotinib for the treatment of rheumatoid arthritis filed with FDA and our Marketing Authorization Application for KTE-X19 for the treatment of relapsed or refractory mantle cell lymphoma filed with EMA. We may also experience delays in necessary interactions with regulatory authorities around the world, including with respect to any anticipated filings. Our ability to launch new commercial products may be impacted by any such delays and other factors resulting from the pandemic, such as adverse market conditions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patient Access: The COVID-19 pandemic has limited patients&#8217; ability or willingness to access and seek care from healthcare providers and initiate new therapies, which has resulted in lower demand for our products, particularly with respect to HIV prevention and hepatitis C virus (&#8220;HCV&#8221;) treatment. For example, we have seen a reduction in prescription refills for HIV prevention as a result of higher discontinuations. In addition, with the rising unemployment, we have experienced a shift in payer mix towards more government-funded coverage and the uninsured segment, which has an adverse impact on revenues.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Employees: We face risks related to the health, safety, morale and productivity of our employees, including the safe occupancy of our sites during the pandemic. Currently, most Gilead sites are requiring flexible location employees to work from home while physical location dependent workers and mixed location workers may need to work on Gilead sites. Site enhancements and risk protocols that we have implemented in response to the COVID-19 pandemic, including health screenings and COVID-19 testing, do not guarantee that we can maintain the safe occupancy of our sites. On-site employees testing positive for COVID-19 could lead to mandatory quarantines and potential site shutdowns, which may adversely affect our business operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Financial: The COVID-19 pandemic has had and may continue to have an adverse financial impact in the short-term and potentially beyond. As a result of reduced patient access and a shift in payer mix, our HCV treatment and HIV prevention businesses have been adversely impacted, and we may continue to experience lower revenues from these businesses during the course of this pandemic. We have also experienced, and may continue to experience, volatility in our short-term revenues due to fluctuations in inventory channel purchases during this pandemic. We also have higher research and development expenses in 2020, primarily related to our continued investment in remdesivir, which we expect will continue through 2021 and beyond, subject to clinical data and regulatory outcomes, and we could have additional unexpected expenses related to the pandemic, which may require us to prioritize our investments. The short-term revenue and expense variations, as well as the overall uncertainty and disruption caused by the pandemic, could result in increased volatility and decreased predictability in our results of operations as well as volatility in our working capital, including the possibility of an increase in the days sales outstanding as accounts receivable.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing risks have had or may have an adverse effect on our overall business, financial condition, results of operations and our stock price. Additionally, the ongoing COVID-19 pandemic may also affect our operating and financial results in a manner that is not presently known to us or that we currently do not consider as significant risks to our operations. This pandemic may also amplify many of the other risks described throughout the &#8220;Risk Factors&#8221; section of our Annual Report on Form 10-K for the year ended December 31, 2019, as updated in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020, and as set forth in this Quarterly Report on Form 10-Q. Any resulting financial impact cannot be reasonably estimated at this time. The extent to which the COVID-19 pandemic impacts our business and results will depend on future developments, which are uncertain and cannot be predicted with confidence, including the duration and scope of the outbreak, any potential future waves of the pandemic, new information which may emerge concerning the severity of COVID-19 and the ongoing and future actions to contain it or treat its impact, among others.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We face risks related to the development, manufacturing and distribution of Veklury (remdesivir) as a treatment for COVID-19.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We face risks related to our significant investment in the rapid development, manufacturing and distribution of Veklury (remdesivir), which was approved by the FDA in October 2020 as a treatment for hospitalized patients with COVID-19. Given the severity and urgency of the COVID-19 pandemic, we have committed significant capital and resources for clinical trials and the scale-up of the production of remdesivir, which involves a complex manufacturing process that is both resource- and time-sensitive. By the end of 2020, we expect our investment in the development and manufacture of remdesivir to exceed $1 billion, and we expect our investment will continue through 2021 and beyond, as we continue to evaluate the safety and efficacy of remdesivir for the treatment of COVID-19 in different patient populations, formulations and in combinations with other therapies. If we are not successful in the commercialization of remdesivir, we will be unable to recoup the significant expenses incurred to date and in the future related to the development and production of remdesivir. We are unable to predict future demand for Veklury and the amount and timing of future Veklury revenues, which will depend on the duration and scope of the COVID-19 pandemic, the availability and effectiveness of alternative treatments and vaccines for COVID-19 and other uncertainties. If we are unable to accurately forecast demand or manufacture Veklury at levels to meet actual demand, then this may result in shortages or excess inventory that we may need to later write off. We also may be unable to effectively manage the global supply and distribution of Veklury. In addition, as a result of the emergency situations in many countries, there is a heightened risk that Veklury may be subject to adverse governmental actions in certain countries, including intellectual property expropriation, intellectual property challenges, compulsory licenses, strict price controls or other actions. Such actions may limit our ability to recoup our significant current and future expenses. Further, given that COVID-19 has been designated as a pandemic and represents an urgent public health crisis, we have observed and are likely to continue to face significant public attention and scrutiny over the complex decisions made regarding the allocation, business models and pricing decisions with respect to Veklury, which has caused significant volatility in our stock price. In addition, as we and third parties continue to evaluate the safety and efficacy of remdesivir, there is no assurance of favorable results from any ongoing or future clinical studies. Any perceived or actual inconsistency of data from such studies could lead to a public debate about the costs and benefits of Veklury, which may adversely impact demand for Veklury and also result in reputational harm. If we are unable to successfully manage these risks, we could face significant reputational harm, which could negatively affect our stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our results of operations may be adversely affected by current and potential future healthcare legislative and regulatory actions.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Legislative and regulatory actions affecting government prescription drug procurement and reimbursement programs occur relatively frequently. In the United States, a challenge to the Affordable Care Act (&#8220;ACA&#8221;) is currently pending before the U.S. Supreme Court, which has resulted in uncertainty regarding the ACA&#8217;s future viability and destabilization of the health insurance market. The resulting impact on our business is uncertain and could be material.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Efforts to control prescription drug prices could also have a material adverse effect on our business. In September 2020, President Trump announced an executive order that would require the U.S. Department of Health and Human Services to test payment models under which Medicare would pay no more for Part B drugs and for</span><span style="background-color:#ffffff;color:#293340;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Part D drugs than certain other countries pay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This executive order will require rulemaking or satisfaction of other requirements before it can be implemented. In September 2020, FDA issued a final rule and final guidance implementing two pathways for the legal importation of certain prescription drugs from Canada and prescription drugs that are FDA-approved, manufactured abroad, authorized for sale in a foreign country and originally intended for sale in that foreign country. The volume of drug pricing-related bills also has dramatically increased under the current Congress. For example, Congress has proposed bills to change the Medicare Part D benefit to impose an inflation-based rebate when list prices for drugs grow faster than inflation and to increase manufacturer contributions in some or all of the benefit phases.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, many state legislatures are considering, or have already passed into law, legislation that seeks to indirectly or directly regulate pharmaceutical drug pricing, such as requiring manufacturers to publicly report proprietary pricing information, creating review boards for prices to state agencies, and encouraging the use of generic drugs. Such initiatives and legislation may cause added pricing pressures on our products, and the resulting impact on our business is uncertain and could be material.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes to the Medicaid program at the federal or state level could also have a material adverse effect on our business. For example, in June 2020, the Centers for Medicare and Medicaid Services issued a proposed rule that would make certain changes to the calculation of rebates under the Medicaid Drug Rebate Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Among other changes, the proposed rule would promulgate a new definition of a line extension drug and change the requirements for excluding manufacturer co-pay coupons from the Medicaid &#8220;best price.&#8221; If finalized, these changes could substantially increase our Medicaid rebate obligations and decrease the prices.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other proposed regulatory actions affecting manufacturers could have a material adverse effect on our business. It is difficult to predict the impact, if any, of any such proposed legislative and regulatory actions or resulting state actions on the use and reimbursement of our products in the United States, but such actions may adversely affect our results of operations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many countries outside the United States, including the European Union member states, have established complex and lengthy procedures to obtain price approvals, coverage reimbursement and periodically review their pricing and reimbursement decisions. The outcome of this review cannot be predicted and could have an adverse effect on the pricing and reimbursement of our medicinal products in the European Union member states. Reductions in the pricing of our medicinal products in one member state could affect the price in other member states and have a negative impact on our financial results. </span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:16.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our stock repurchase activity for the three months ended September 30, 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of Shares&#160;Purchased (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average&#160;Price&#160;Paid per Share (in dollars) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;Total Number of Shares Purchased as Part of Publicly Announced Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum&#160;Approximate Dollar&#160;Value of&#160;Shares that&#160;May&#160;Yet&#160;Be Purchased&#160;Under the Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"> (in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - July 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 - August 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 - September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">In the first quarter of 2016, our Board of Directors authorized a $12.0 billion share repurchase program (&#8220;2016 Program&#8221;). Shares purchased during the period were made under the 2016 Program. In January 2020, our Board of Directors authorized a new $5.0 billion stock repurchase program (&#8220;2020 Program&#8221;), which will commence upon the completion of the 2016 Program. Share repurchases under both programs may be made in the open market or in privately negotiated transactions. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">The difference between the total number of shares purchased and the total number of shares purchased as part of a publicly announced program is due to shares of common stock withheld by us from employee restricted stock awards in order to satisfy applicable tax withholding obligations.</span></div></td></tr></table></div><div id="i9a5d0989150642c5998d2a345ad46d37_112"></div><div style="margin-top:16.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_115"></div><div style="margin-top:16.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_118"></div><div style="margin-top:16.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i9a5d0989150642c5998d2a345ad46d37_121"></div><div style="margin-top:16.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the Exhibit Index included herein.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Index</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.898%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.618%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Exhibit<br/>Footnote</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Description of Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000110465919028215/a19-9678_1ex3d2.htm">Restated Certificate of Incorporation of Registrant</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000110465919028215/a19-9678_1ex3d3.htm">Amended and Restated Bylaws of Registrant</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Reference is made to Exhibit 3.1 and Exhibit 3.2</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312511086814/dex41.htm">Indenture related to Senior Notes, dated as of March&#160;30, 2011, between Registrant and Wells Fargo, National Association, as Trustee</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312511086814/dex42.htm">First Supplemental Indenture related to Senior Notes, dated as of March 30, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including form of Senior Notes)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312511339157/d269235dex41.htm">Second Supplemental Indenture related to Senior Notes, dated as of December 13, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2021 Note, Form of 2041 Note)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312514089047/d688498dex41.htm">Third Supplemental Indenture related to Senior Notes, dated as of March 7, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2024 Note, Form of 2044 Note)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312514415184/d821656dex41.htm">Fourth Supplemental Indenture related to Senior Notes, dated as of November 17, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2020 Note, Form of 2025 Note, Form of 2045 Note)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312515319560/d68529dex41.htm">Fifth Supplemental Indenture, dated as of September 14, 2015, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2020 Note, Form of 2022 Note, Form of 2026 Note, Form of 2035 Note and Form of 2046 Note)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312516714926/d259911dex41.htm">Sixth Supplemental Indenture, dated as of September 20, 2016, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2022 Note, Form of 2023 Note, Form of 2027 Note, Form of 2036 Note and Form of 2047 Note)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Eighth Supplemental Indenture, dated as of September 30, 2020, between the Company and Wells Fargo Bank, National Association, as Trustee (including form of notes)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000006/gild2019form10-kex49.htm">Description of Registrant&#8217;s Securities</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(10)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312517168672/d396034dex101.htm">Gilead Sciences, Inc. 2004 Equity Incentive Plan, amended and restated May 10, 2017</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(11)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312511132405/dex1042.htm">Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants made in 2011 through 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex104.htm">Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants made in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(13)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000027/gildq32019ex105.htm">Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2019)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex105.htm">Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(15)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312509165506/dex1019.htm">Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants made in 2009 through 2012)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(16)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209513000038/gildq21310-qex1043.htm">Form of non-employee director stock option agreement (U.S.) under 2004 Equity Incentive Plan (for grants made in 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(16)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209513000038/gildq21310-qex1044.htm">Form of non-employee director stock option agreement (non-U.S.) under 2004 Equity Incentive Plan (for grants made in 2013)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(17)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209514000038/ex1045-stockoptionagreement.htm">Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants made in 2014 through 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex109.htm">Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex109.htm">made</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex109.htm"> in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000019/gildq22020ex10112020no.htm">Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants commencing in 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(19)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209516000046/gildq12016ex1041.htm">Form of performance share award agreement - TSR Goals (U.S.) with Director Retirement Provisions under 2004 Equity Incentive Plan (for grants made in 2016 through 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1012.htm">Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants made in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1013.htm">Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2020)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(19)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209516000046/gildq12016ex1043.htm">Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants made in 2016 through 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(19)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209516000046/gildq12016ex1044.htm">Form of performance share award agreement - Revenue Goals (U.S.) with Director Retirement Provisions under 2004 Equity Incentive Plan (for grants made in 2016 through 2018)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.17*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1015.htm">Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants made in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1017.htm">Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2020)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(11)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312511132405/dex1057.htm">Form of employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants made in 2011 through 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1017.htm">Form of employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants made in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(13)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000027/gildq32019ex1019.htm">Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (3 year vest) (for grants made in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(13)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000027/gildq32019ex1020.htm">Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants made in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.23*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1018.htm">Form of non-employee director restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants made in 2019)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.898%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.618%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.24*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1023.htm">Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (3 year vest) (for grants commencing in 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.25*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1024.htm">Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(18)</span></div></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.26*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000019/gildq22020ex10262020no.htm">Form of non-employee director restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants commencing in 2020)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000019/gildq22020ex10272018eq.htm">Gilead Sciences, Inc. 2018 Equity Incentive Plan, amended and restated April 7, 2020</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(21) </span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.28*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209515000015/exhibit101-espp.htm">Gilead Sciences, Inc. Employee Stock Purchase Plan, amended and restated January 22, 2015</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.29*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1020.htm">Gilead Sciences, Inc. 2005 Deferred Compensation Plan, amended and restated April 19, 2016</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000019/gildq22020ex1030severa.htm">Gilead Sciences, Inc. Severance Plan, amended and restated May 5, 2020</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.31*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1028.htm">Gilead Sciences, Inc. Corporate Annual Incentive Plan, amended and restated January 1, 2020</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(22)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.32*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209518000029/gildq32018ex1028.htm">Gilead Sciences, Inc. Retention Program for Executive Officers</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.33*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1030.htm">Gilead Sciences, Inc. Retention Program for Senior Vice Presidents and Executive Vice Presidents</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000006/gild2019form10-kex1029.htm">Severance and General Release Agreement between Registration and Laura Hamill, dated June 6, 2019</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(13)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.35*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000027/gildq32019ex1030.htm">Transition and Severance Agreement between Registrant and Gregg Alton, dated July 15, 2019</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(13)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.36*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000027/gildq32019ex1031.htm">Transition and Severance Agreement between Registrant and John McHutchison, dated July 15, 2019</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(23)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.37*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000110465918072098/a18-41320_1ex99d2.htm">Offer Letter between Registrant and Daniel O&#8217;Day, dated November 30, 2018</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.38*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1027.htm">Stock option agreement for Daniel O&#8217;Day under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.39*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1028.htm">Performance share award agreement for Daniel O&#8217;Day (for TSR Goals in 2019) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.40*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1029.htm">Performance share award agreement for Daniel O&#8217;Day (for Revenue Goals in 2019) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.41*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1029.htm">Form of restricted stock unit issuance agreement for Daniel O&#8217;Day (in 2019) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.42*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000020/gildq22019ex1026.htm">Offer Letter between Registrant and Johanna Mercier, dated May 21, 2019</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.43*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000019/gildq22020ex1043housin.htm">Letter Agreement between Registrant and Johanna Mercier, dated May 4, 2020</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.44*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1040.htm">Global stock option agreement for Johanna Mercier (in 2019) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.45*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1041.htm">Restricted stock unit issuance agreement for Johanna Mercier (for Performance Objectives in 2019-2020) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.46*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1042.htm">Global restricted stock unit issuance agreement for Johanna Mercier (in 2019) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.47*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1043.htm">Offer Letter between Registrant and Merdad Parsey, dated September 29, 2019</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.48*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1044.htm">Global stock option agreement for Merdad Parsey (in 2019) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.49*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209520000013/gildq12020ex1045.htm">Global restricted stock unit issuance agreement for Merdad Parsey (in 2019) under 2004 Equity Incentive Plan</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(24)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.50*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Form of Indemnity Agreement entered into between Registrant and its directors and executive officers</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(24)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.51*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Form of Employee Proprietary Information and Invention Agreement entered into between Registrant and certain of its officers and key employees</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(25)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.52*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312507041203/dex103.htm">Form of Employee Proprietary Information and Invention Agreement entered into between Registrant and certain of its officers and key employees (revised September&#160;2006)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(26)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.53</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Amendment Agreement, dated October&#160;25, 1993, between Registrant, the Institute of Organic Chemistry and Biochemistry (IOCB) and Rega Stichting v.z.w. (REGA), together with the following exhibits: the License Agreement, dated December&#160;15, 1991, between Registrant, IOCB and REGA (the 1991 License Agreement); the License Agreement, dated October&#160;15, 1992, between Registrant, IOCB and REGA (the October 1992 License Agreement); and the License Agreement, dated December&#160;1, 1992, between Registrant, IOCB and REGA (the December 1992 License Agreement)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(27)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000091205701007841/a2041233zex-10_13.txt">Amendment Agreement between Registrant and IOCB/REGA, dated December&#160;27, 2000, amending the 1991 License Agreement and the December 1992 License Agreement</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(28)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312506223996/dex103.htm">Sixth Amendment Agreement to the License Agreement, between IOCB/REGA and Registrant, dated August&#160;18, 2006, amending the October 1992 License Agreement and the December 1992 License Agreement</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(29)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209513000046/q313form10-qxexhibit1078.htm">Seventh Amendment Agreement to the License Agreement, between IOCB/REGA and Registrant, dated July 1, 2013, amending the October 1992 License Agreement and the December 1992 License Agreement</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(30)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.57</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022622/000091205799003190/0000912057-99-003190.txt">Exclusive License Agreement by and between Registrant (as successor to Triangle Pharmaceuticals, Inc.), Glaxo Group Limited, The Wellcome Foundation Limited, Glaxo Wellcome Inc. and Emory University, dated May&#160;6, 1999</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(31)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.58</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312505216649/dex102.htm">Royalty Sale Agreement by and among Registrant, Emory University and Investors Trust &amp; Custodial Services (Ireland) Limited, solely in its capacity as Trustee of Royalty Pharma, dated July&#160;18, 2005</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(31)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.59</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000119312505216649/dex102.htm">Amended and Restated License Agreement by and between Registrant, Emory University and Investors Trust &amp; Custodial Services (Ireland) Limited, solely in its capacity as Trustee of Royalty Pharma, dated July&#160;21, 2005</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;++(32)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000008/gild2018form10-kaexhibit1042.htm">Amended and Restated EVG License Agreement by and between Japan Tobacco Inc. and Registrant, dated November 29, 2018</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.898%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.618%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;++(32)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000008/gild2018form10-kaexhibit1043.htm">Master Agreement by and between Registrant, Gilead Sciences K.K. and Japan Tobacco Inc., dated November 29, 2018</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(33)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209515000008/ex1076-arcollaborationagre.htm">Amended and Restated Collaboration Agreement by and among Registrant, Gilead Sciences Ireland UC (formerly Gilead Sciences Limited) and Janssen R&amp;D Ireland, dated December 23, 2014</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;+(34)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1510580/000119312514239257/d705296dex1017.htm">License Agreement by and among Kite Pharma, Inc., Cabaret Biotech Ltd. and Dr. Zelig Eshhar, dated December 12, 2013</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">&#160;++(13)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.64</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/882095/000088209519000027/gildq32019ex1050.htm">Option, License and Collaboration Agreement by and between Galapagos NV and Registrant, dated July 14, 2019</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">(35)</span></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">10.65</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated September 13, 2020, among Immunomedics, Inc., Gilead Sciences, Inc. and Maui Merger Sub, Inc.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">31.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="gildq32020ex311.htm">Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">31.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="gildq32020ex312.htm">Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">32***</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="gildq32020ex32.htm">Certifications of Chief Executive Officer and Chief Financial Officer, as required by Rule 13a-14(b) or Rule&#160;15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101.INS**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101.SCH**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101.CAL**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101.DEF**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101.LAB**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">101.PRE**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">Cover Page Interactive Data File, formatted in Inline XBRL (included as Exhibit 101)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on May 9, 2019, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on April&#160;1, 2011, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on December 13, 2011, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on March 7, 2014, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on November 17, 2014, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on September 14, 2015, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on September 20, 2016, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on September 30, 2020, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(10)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on May 12, 2017, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(11)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2011, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(12)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2019, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(13)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(14)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(15)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2009, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(16)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, and incorporated herein by reference</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(17)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(18)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(19)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2016, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(20)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on May 8, 2015, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(21)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(22)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(23)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on December 10, 2018, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(24)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Registration Statement on Form S-1 (No. 33-55680), as amended, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(25)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(26)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended March&#160;31, 1994, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(27)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2000, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(28)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2006, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(29)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(30)&#160;&#160;&#160;&#160;Filed as an exhibit to Triangle Pharmaceuticals, Inc.&#8217;s Quarterly Report on Form 10-Q/A filed on November&#160;3, 1999, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(31)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2005, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(32)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Amendment No. 1 to Annual Report on Form 10-K/A filed on April 18, 2019, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(33)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2014, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(34)&#160;&#160;&#160;&#160;Filed as an exhibit to Kite Pharma, Inc.&#8217;s Registration Statement on Form S-1/A (No. 333-196081) filed on June 17, 2014, and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(35)&#160;&#160;&#160;&#160;Filed as an exhibit to Registrant&#8217;s Current Report on Form 8-K filed on September 14, 2020, and incorporated herein by reference.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensatory plan or arrangement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">***&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Certain confidential portions of this Exhibit were omitted by means of marking such portions with an asterisk (the Mark). This Exhibit has been filed separately with the Secretary of the Securities and Exchange Commission without the Mark pursuant to Registrant&#8217;s Application Requesting Confidential Treatment under Rule 24b-2 under the Securities Exchange Act of 1934, as amended.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">++&#160;&#160;&#160;&#160;Certain confidential portions of this Exhibit were omitted by means of marking such portions with the Mark because the identified confidential portions are (i) not material and (ii) would be competitively harmful if publicly disclosed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i9a5d0989150642c5998d2a345ad46d37_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GILEAD SCIENCES, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DANIEL P. O&#8217;DAY</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Daniel P. O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Day</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman and Chief Executive Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Executive Officer)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ANDREW D. DICKINSON</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew D. Dickinson<br/>Executive Vice President and Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>gildq32020ex311.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i0f4c57abf1754775b9f92e9dadd4d91e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel P. O&#8217;Day, certify that&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Gilead Sciences, Inc.&#59;</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;3, 2020 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:8pt;padding-left:288pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:41.959%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;DANIEL P. O&#8217;DAY</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Daniel P. O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Day</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Chairman and Chief Executive Officer</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>gildq32020ex312.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ib7fa62bb354f490bafe9c1284e1c1de7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Andrew D. Dickinson, certify that&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Gilead Sciences, Inc.&#59;</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;3, 2020 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:11pt;padding-left:252pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:48.391%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;ANDREW D. DICKINSON</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Andrew D. Dickinson<br>Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>gildq32020ex32.htm
<DESCRIPTION>SECTION 906 CERTIFICATIONS
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ie64dd2578b324e0397f05b07b56bc10e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. &#167; 1350, as adopted), Daniel P. O&#8217;Day, the Chairman and Chief Executive Officer of Gilead Sciences, Inc. (the Company), and Andrew D. Dickinson, the Executive Vice President and Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2020 (the Report) fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;3, 2020</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:17pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;DANIEL P. O&#8217;DAY</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;ANDREW D. DICKINSON</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Daniel P. O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Day</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Chairman and Chief Executive Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Andrew D. Dickinson<br>Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>gild-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dd71f5ae-c8d4-497f-83ec-41f4a56b820c,g:fe07381a-9620-491b-af7b-d6c30510011c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gild="http://www.gilead.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gilead.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gild-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.gilead.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>1006007 - Statement - Consolidated Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails" roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails">
        <link:definition>2403401 - Disclosure - Summary of Significant Accounting Policies Additional Details (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.gilead.com/role/Revenues">
        <link:definition>2104102 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesTables" roleURI="http://www.gilead.com/role/RevenuesTables">
        <link:definition>2305301 - Disclosure - Revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDisaggregationofRevenuesDetails" roleURI="http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails">
        <link:definition>2406402 - Disclosure - Revenues - Disaggregation of Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesRevenuesfromMajorCustomersDetails" roleURI="http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails">
        <link:definition>2407403 - Disclosure - Revenues - Revenues from Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesAdditionalInformationDetails" roleURI="http://www.gilead.com/role/RevenuesAdditionalInformationDetails">
        <link:definition>2408404 - Disclosure - Revenues - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.gilead.com/role/FairValueMeasurements">
        <link:definition>2109103 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.gilead.com/role/FairValueMeasurementsTables">
        <link:definition>2310302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails">
        <link:definition>2411405 - Disclosure - Fair Value Measurements Summary of Assets and Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails">
        <link:definition>2412406 - Disclosure - Fair Value Measurements Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails" roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails">
        <link:definition>2413407 - Disclosure - Fair Value Measurements Summary of Classification of Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleDebtSecurities" roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecurities">
        <link:definition>2114104 - Disclosure - Available-for-Sale Debt Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleDebtSecuritiesTables" roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables">
        <link:definition>2315303 - Disclosure - Available-for-Sale Debt Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails" roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails">
        <link:definition>2416408 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities at Estimated Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails" roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails">
        <link:definition>2417409 - Disclosure - Available-for-Sale Debt Securities - Summary of the Balance Sheet Classification of Available-for-Sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleDebtSecuritiesAdditionalInformationDetails" roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails">
        <link:definition>2418410 - Disclosure - Available-for-Sale Debt Securities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2419411 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails" roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails">
        <link:definition>2420412 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities in a Continuous Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.gilead.com/role/DerivativeFinancialInstruments">
        <link:definition>2121105 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>2322304 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsAdditionalInformationDetails" roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails">
        <link:definition>2423413 - Disclosure - Derivative Financial Instruments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails" roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails">
        <link:definition>2424414 - Disclosure - Derivative Financial Instruments - Summary of Classification and Fair Value of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails" roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails">
        <link:definition>2425415 - Disclosure - Derivative Financial Instruments - Summary of Effect of Foreign Currency Exchange Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails" roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails">
        <link:definition>2426416 - Disclosure - Derivative Financial Instruments - Summary of Potential Effect of Offsetting Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsCollaborationsandOtherArrangements" roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements">
        <link:definition>2127106 - Disclosure - Acquisitions, Collaborations and Other Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsCollaborationsandOtherArrangementsDetails" roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails">
        <link:definition>2428417 - Disclosure - Acquisitions, Collaborations and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherFinancialInformation" roleURI="http://www.gilead.com/role/OtherFinancialInformation">
        <link:definition>2129107 - Disclosure - Other Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherFinancialInformationTables" roleURI="http://www.gilead.com/role/OtherFinancialInformationTables">
        <link:definition>2330305 - Disclosure - Other Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherFinancialInformationInventoriesDetails" roleURI="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails">
        <link:definition>2431418 - Disclosure - Other Financial Information Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherFinancialInformationInventoriesDetails_1" roleURI="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1">
        <link:definition>2431418 - Disclosure - Other Financial Information Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherFinancialInformationOtherAccruedLiabilitiesDetails" roleURI="http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails">
        <link:definition>2432419 - Disclosure - Other Financial Information Other Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.gilead.com/role/IntangibleAssets">
        <link:definition>2133108 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.gilead.com/role/IntangibleAssetsTables">
        <link:definition>2334306 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsSummaryofIntangibleAssetsDetails" roleURI="http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails">
        <link:definition>2435420 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAdditionalInformationDetails" roleURI="http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails">
        <link:definition>2436421 - Disclosure - Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails" roleURI="http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails">
        <link:definition>2437422 - Disclosure - Intangible Assets - Schedule of Estimated Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilities" roleURI="http://www.gilead.com/role/DebtandCreditFacilities">
        <link:definition>2138109 - Disclosure - Debt and Credit Facilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesTables" roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesTables">
        <link:definition>2339307 - Disclosure - Debt and Credit Facilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails" roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails">
        <link:definition>2440423 - Disclosure - Debt and Credit Facilities - Summary of Debt Carrying Amount (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesAdditionalInformationDetails" roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails">
        <link:definition>2441424 - Disclosure - Debt and Credit Facilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.gilead.com/role/CommitmentsandContingencies">
        <link:definition>2142110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetails" roleURI="http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails">
        <link:definition>2443425 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.gilead.com/role/StockholdersEquity">
        <link:definition>2144111 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.gilead.com/role/StockholdersEquityTables">
        <link:definition>2345308 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAdditionalInformationDetails" roleURI="http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails">
        <link:definition>2446426 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2447427 - Disclosure - Stockholders' Equity - Summary of Changes in Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareAttributabletoGileadCommonStockholders" roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders">
        <link:definition>2148112 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables" roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables">
        <link:definition>2349309 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails" roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails">
        <link:definition>2450428 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails" roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails">
        <link:definition>2451429 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Schedule of the Calculation of Basic and Diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.gilead.com/role/IncomeTaxes">
        <link:definition>2152113 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.gilead.com/role/IncomeTaxesTables">
        <link:definition>2353310 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails" roleURI="http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails">
        <link:definition>2454430 - Disclosure - Income Taxes - Summary of the Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>2455431 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="gild_A475SeniorUnsecuredNotesDueMarch2046Member" abstract="true" name="A475SeniorUnsecuredNotesDueMarch2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OtherEquitySecuritiesMember" abstract="true" name="OtherEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OtherInternationalMember" abstract="true" name="OtherInternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" abstract="false" name="FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" abstract="false" name="EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_OtherCollaborationArrangementsMember" abstract="true" name="OtherCollaborationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A280SeniorUnsecuredNotesDueOctober2050Member" abstract="true" name="A280SeniorUnsecuredNotesDueOctober2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_ImmunomedicsIncMember" abstract="true" name="ImmunomedicsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_TangoTherapeuticsIncMember" abstract="true" name="TangoTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_EquityinvestmentinGalapagosMember" abstract="true" name="EquityinvestmentinGalapagosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember" abstract="true" name="LicenseRegistrationRightsAndStockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A2016StockRepurchaseProgramMember" abstract="true" name="A2016StockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_FortySevenIncMember" abstract="true" name="FortySevenIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_COVID19ProductsVekluryMember" abstract="true" name="COVID19ProductsVekluryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AssetAcquisitionDomain" abstract="true" name="AssetAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_MarketableSecuritiesCurrentMember" abstract="true" name="MarketableSecuritiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_ProductsOtherHIVMember" abstract="true" name="ProductsOtherHIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" abstract="false" name="LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_SeniorUnsecuredNoteIssuedSeptember2015Member" abstract="true" name="SeniorUnsecuredNoteIssuedSeptember2015Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" abstract="false" name="EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_JudgmentRoyaltyRateFromOctober2017" abstract="false" name="JudgmentRoyaltyRateFromOctober2017" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="gild_A165SeniorUnsecuredNotesDueOctober2030Member" abstract="true" name="A165SeniorUnsecuredNotesDueOctober2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_DeferredCompensationPlanMember" abstract="true" name="DeferredCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A415SeniorUnsecuredNotesDueMarch2047Member" abstract="true" name="A415SeniorUnsecuredNotesDueMarch2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A120SeniorUnsecuredNotesDueOctober2027Member" abstract="true" name="A120SeniorUnsecuredNotesDueOctober2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OtherProductsVemlidyMember" abstract="true" name="OtherProductsVemlidyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_ForeignCurrencyDerivativeContractsMember" abstract="true" name="ForeignCurrencyDerivativeContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A235SeniorUnsecuredNotesDueFebruary2020Member" abstract="true" name="A235SeniorUnsecuredNotesDueFebruary2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AcquisitionCollaborationsAndOtherArrangementsTable" abstract="true" name="AcquisitionCollaborationsAndOtherArrangementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gild_A565SeniorUnsecuredNotesDueDecember2041Member" abstract="true" name="A565SeniorUnsecuredNotesDueDecember2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AcquisitionCollaborationsAndOtherArrangementsLineItems" abstract="true" name="AcquisitionCollaborationsAndOtherArrangementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gild_TizonaMergerAndOptionAgreementsMember" abstract="true" name="TizonaMergerAndOptionAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_CashPaymentsMadeRelatedToEquityInvestments" abstract="false" name="CashPaymentsMadeRelatedToEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" abstract="false" name="Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_AllowanceforAccountsReceivableandChargebacks" abstract="false" name="AllowanceforAccountsReceivableandChargebacks" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_GadetaBVCollaborationArrangementMember" abstract="true" name="GadetaBVCollaborationArrangementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_ProductsRevenueShareSymtuzaMember" abstract="true" name="ProductsRevenueShareSymtuzaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract" abstract="true" name="AcquisitionsCollaborationsAndOtherArrangementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gild_RoyaltyContractAndOtherMember" abstract="true" name="RoyaltyContractAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AssetAcquisitionAxis" abstract="true" name="AssetAcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="gild_A400SeniorUnsecuredNotesDueSeptember2036Member" abstract="true" name="A400SeniorUnsecuredNotesDueSeptember2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_JounceTherapeuticsIncMember" abstract="true" name="JounceTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_SeniorUnsecuredNoteIssuedSeptember2020Member" abstract="true" name="SeniorUnsecuredNoteIssuedSeptember2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_CollaborativeArrangementTerm" abstract="false" name="CollaborativeArrangementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gild_Accruedgovernmentandotherrebates" abstract="false" name="Accruedgovernmentandotherrebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_A440SeniorUnsecuredNotesDueDecember2021Member" abstract="true" name="A440SeniorUnsecuredNotesDueDecember2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_TizonaTherapeuticsIncMember" abstract="true" name="TizonaTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_Writeoffsinaccruedinterestreceivable" abstract="false" name="Writeoffsinaccruedinterestreceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_A2020StockRepurchaseProgramMember" abstract="true" name="A2020StockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" abstract="false" name="PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_DebtInstrumentCallFeaturePeriodBeforeMaturity" abstract="false" name="DebtInstrumentCallFeaturePeriodBeforeMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" abstract="false" name="EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" abstract="false" name="LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" abstract="true" name="CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_NumberOfAgreements" abstract="false" name="NumberOfAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gild_OtherProductsLetairisMember" abstract="true" name="OtherProductsLetairisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_MarketableSecuritiesNoncurrentMember" abstract="true" name="MarketableSecuritiesNoncurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_EquityMethodInvestmentOptionExerciseFee" abstract="false" name="EquityMethodInvestmentOptionExerciseFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_ResearchAndDevelopmentServiceAgreementMember" abstract="true" name="ResearchAndDevelopmentServiceAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" abstract="true" name="A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments" abstract="false" name="EquitySecuritiesFVNIFutureMaximumMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_ArcusBiosciencesIncMember" abstract="true" name="ArcusBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_PionyrMergerAndOptionAgreementsMember" abstract="true" name="PionyrMergerAndOptionAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_ResidentialMortgageAndAssetBackedSecuritiesMember" abstract="true" name="ResidentialMortgageAndAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A365SeniorUnsecuredNotesDueMarch2026Member" abstract="true" name="A365SeniorUnsecuredNotesDueMarch2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A350SeniorUnsecuredNotesDueFebruary2025Member" abstract="true" name="A350SeniorUnsecuredNotesDueFebruary2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_PotentialFutureMaximumMilestonePayments" abstract="false" name="PotentialFutureMaximumMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_MckessonCorpMember" abstract="true" name="MckessonCorpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_ResearchAndDevelopmentFutureMaximumPayments" abstract="false" name="ResearchAndDevelopmentFutureMaximumPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_InvestmentOwnedBalanceAdditionalPayable" abstract="false" name="InvestmentOwnedBalanceAdditionalPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_HIVProductsGenvoyaMember" abstract="true" name="HIVProductsGenvoyaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_EquitySecuritiesFVNIRestrictionPeriod" abstract="false" name="EquitySecuritiesFVNIRestrictionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gild_AssetAcquisitionCashOutflowNetOfCashAcquired" abstract="false" name="AssetAcquisitionCashOutflowNetOfCashAcquired" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_A480SeniorUnsecuredNotesDueApril2044Member" abstract="true" name="A480SeniorUnsecuredNotesDueApril2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_JudgmentEnhancedDamagesonPastSales" abstract="false" name="JudgmentEnhancedDamagesonPastSales" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="gild_CreditFacilityDueJune2025Member" abstract="true" name="CreditFacilityDueJune2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_PaymentsForDirectTransactionalExpense" abstract="false" name="PaymentsForDirectTransactionalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_IssuanceDiscountPremium" abstract="false" name="IssuanceDiscountPremium" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_AmerisourcebergenCorpMember" abstract="true" name="AmerisourcebergenCorpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A195SeniorUnsecuredNotesDueMarch2022Member" abstract="true" name="A195SeniorUnsecuredNotesDueMarch2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_TotalUpfrontPaymentsMade" abstract="false" name="TotalUpfrontPaymentsMade" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_HIVProductsAtriplaMember" abstract="true" name="HIVProductsAtriplaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_HCVProductsSofosbuvirVelpatasvirMember" abstract="true" name="HCVProductsSofosbuvirVelpatasvirMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember" abstract="true" name="ThreeYearSeniorUnsecuredTermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_IndenixMember" abstract="true" name="IndenixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OtherProductsZydeligMember" abstract="true" name="OtherProductsZydeligMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OtherFinancialInformationAbstract" abstract="true" name="OtherFinancialInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" abstract="false" name="EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_OtherProductsAmBisomeMember" abstract="true" name="OtherProductsAmBisomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A295SeniorUnsecuredNotesDueMarch2027Member" abstract="true" name="A295SeniorUnsecuredNotesDueMarch2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" abstract="true" name="FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" abstract="true" name="OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_NumberOfPrograms" abstract="false" name="NumberOfPrograms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gild_HIVProductsOdefseyMember" abstract="true" name="HIVProductsOdefseyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" abstract="true" name="OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_LossContingencyEstimateofPossibleLossPastSales" abstract="false" name="LossContingencyEstimateofPossibleLossPastSales" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" abstract="false" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" abstract="false" name="DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="gild_HIVProductsDescovyMember" abstract="true" name="HIVProductsDescovyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_HCVProductsLedipasvirSofosbuvirMember" abstract="true" name="HCVProductsLedipasvirSofosbuvirMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_SeniorUnsecuredNoteIssuedNovember2014Member" abstract="true" name="SeniorUnsecuredNoteIssuedNovember2014Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_HIVProductsBiktarvyMember" abstract="true" name="HIVProductsBiktarvyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_CardinalHealthIncMember" abstract="true" name="CardinalHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A450SeniorUnsecuredNotesDueApril2021Member" abstract="true" name="A450SeniorUnsecuredNotesDueApril2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" abstract="true" name="AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_CreditFacilityDueMay2021Member" abstract="true" name="CreditFacilityDueMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OtherProductsVireadMember" abstract="true" name="OtherProductsVireadMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_JunoMember" abstract="true" name="JunoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" abstract="false" name="IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" abstract="false" name="EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_LossContingencyMotionInvalidatedForPastDamagesValue" abstract="false" name="LossContingencyMotionInvalidatedForPastDamagesValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_OtherProductsOtherMember" abstract="true" name="OtherProductsOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_PionyrImmunotherapeuticsIncMember" abstract="true" name="PionyrImmunotherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_IntangibleAssetSofosbuvirMember" abstract="true" name="IntangibleAssetSofosbuvirMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_DevelopmentAgreementMember" abstract="true" name="DevelopmentAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A250SeniorUnsecuredNotesDueSeptember2023Member" abstract="true" name="A250SeniorUnsecuredNotesDueSeptember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A450SeniorUnsecuredNotesDueFebruary2045Member" abstract="true" name="A450SeniorUnsecuredNotesDueFebruary2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_InvestmentOwnedBalanceAdditionalShares" abstract="false" name="InvestmentOwnedBalanceAdditionalShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gild_HIVProductsStribildMember" abstract="true" name="HIVProductsStribildMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" abstract="false" name="TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_AxicabtageneciloleucelDLBCLMember" abstract="true" name="AxicabtageneciloleucelDLBCLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A260SeniorUnsecuredNotesDueOctober2040Member" abstract="true" name="A260SeniorUnsecuredNotesDueOctober2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AcquisitionCollaborationsandOtherArrangementsTextBlock" abstract="false" name="AcquisitionCollaborationsandOtherArrangementsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="gild_A325SeniorUnsecuredNotesDueSeptember2022Member" abstract="true" name="A325SeniorUnsecuredNotesDueSeptember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_HIVProductsCompleraEvipleraMember" abstract="true" name="HIVProductsCompleraEvipleraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A255SeniorUnsecuredNotesDueSeptember2020Member" abstract="true" name="A255SeniorUnsecuredNotesDueSeptember2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_JudgmentRoyaltyRateOnFutureSales" abstract="false" name="JudgmentRoyaltyRateOnFutureSales" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="gild_A460SeniorUnsecuredNotesDueSeptember2035Member" abstract="true" name="A460SeniorUnsecuredNotesDueSeptember2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A075SeniorUnsecuredNotesDueSeptember2023Member" abstract="true" name="A075SeniorUnsecuredNotesDueSeptember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" abstract="true" name="A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_GalapagosMember" abstract="true" name="GalapagosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_EquitySecuritiesFVNIPurchasePeriod" abstract="false" name="EquitySecuritiesFVNIPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="gild_OtherProductsYescartaMember" abstract="true" name="OtherProductsYescartaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_HIVProductsTruvadaMember" abstract="true" name="HIVProductsTruvadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_A370SeniorUnsecuredNotesDueApril2024Member" abstract="true" name="A370SeniorUnsecuredNotesDueApril2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_OtherProductsRanexaMember" abstract="true" name="OtherProductsRanexaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_InventoryNetAndInventoryNoncurrent" abstract="false" name="InventoryNetAndInventoryNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" abstract="false" name="UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gild_OptionLicenseAndCollaborationAgreementMember" abstract="true" name="OptionLicenseAndCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_HCVProductsVoseviMember" abstract="true" name="HCVProductsVoseviMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="gild_AdditionalInformationAbstract" abstract="true" name="AdditionalInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" abstract="false" name="AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>gild-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dd71f5ae-c8d4-497f-83ec-41f4a56b820c,g:fe07381a-9620-491b-af7b-d6c30510011c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gilead.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="gild-20200930.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DocumentandEntityInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3744992-25ae-4ec2-9965-79952a60278a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_75d6d21a-52c1-430c-b99b-f3eb3696e1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3744992-25ae-4ec2-9965-79952a60278a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_75d6d21a-52c1-430c-b99b-f3eb3696e1ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_594a1d90-6260-479d-ad96-d2bb7c5c0a18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3744992-25ae-4ec2-9965-79952a60278a" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_594a1d90-6260-479d-ad96-d2bb7c5c0a18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_76b69df7-f4e1-4b42-94bc-735c487ece5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3744992-25ae-4ec2-9965-79952a60278a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_76b69df7-f4e1-4b42-94bc-735c487ece5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c05da37a-0f93-44cf-b2e6-7b6380bea16d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3744992-25ae-4ec2-9965-79952a60278a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c05da37a-0f93-44cf-b2e6-7b6380bea16d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf1bd6e-c762-4b0c-a21f-3049bf554a6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3744992-25ae-4ec2-9965-79952a60278a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf1bd6e-c762-4b0c-a21f-3049bf554a6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6b3b87f4-b3e8-4c1e-aebf-11c26b0f4d39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3744992-25ae-4ec2-9965-79952a60278a" xlink:to="loc_us-gaap_LiabilitiesCurrent_6b3b87f4-b3e8-4c1e-aebf-11c26b0f4d39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7c620f92-13e0-40a7-93b4-8916a8fc66c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_05618f82-961e-48b6-a0a9-9cced80a9cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7c620f92-13e0-40a7-93b4-8916a8fc66c1" xlink:to="loc_us-gaap_AccountsPayableCurrent_05618f82-961e-48b6-a0a9-9cced80a9cf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_Accruedgovernmentandotherrebates_ffbddaf9-b6ad-414a-b1ef-4b5f468a29a0" xlink:href="gild-20200930.xsd#gild_Accruedgovernmentandotherrebates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7c620f92-13e0-40a7-93b4-8916a8fc66c1" xlink:to="loc_gild_Accruedgovernmentandotherrebates_ffbddaf9-b6ad-414a-b1ef-4b5f468a29a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_755444c7-be78-46e2-bf84-e422401fe695" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7c620f92-13e0-40a7-93b4-8916a8fc66c1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_755444c7-be78-46e2-bf84-e422401fe695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_7dc42445-b781-459d-be8b-9555278d153b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7c620f92-13e0-40a7-93b4-8916a8fc66c1" xlink:to="loc_us-gaap_DebtCurrent_7dc42445-b781-459d-be8b-9555278d153b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1eed71bb-a920-4f1f-9fb1-352fdda6e55c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_119bed3d-9110-437f-b4bb-0993c0caf7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1eed71bb-a920-4f1f-9fb1-352fdda6e55c" xlink:to="loc_us-gaap_PreferredStockValue_119bed3d-9110-437f-b4bb-0993c0caf7ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f242bbad-2598-4df7-9b20-e3072c1e66c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1eed71bb-a920-4f1f-9fb1-352fdda6e55c" xlink:to="loc_us-gaap_CommonStockValue_f242bbad-2598-4df7-9b20-e3072c1e66c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_94fe6043-2186-42f3-a7d8-43bf30ee9c18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1eed71bb-a920-4f1f-9fb1-352fdda6e55c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_94fe6043-2186-42f3-a7d8-43bf30ee9c18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_df0ffc13-d03b-41a9-9be9-3db88dac789e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1eed71bb-a920-4f1f-9fb1-352fdda6e55c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_df0ffc13-d03b-41a9-9be9-3db88dac789e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_af278d5c-9665-4331-8fcd-a6a04d72fae4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1eed71bb-a920-4f1f-9fb1-352fdda6e55c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_af278d5c-9665-4331-8fcd-a6a04d72fae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_99d6050d-fea8-42f3-a1f8-d747192e1769" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6978c115-3d75-4890-9e4b-7a9053e4f861" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_99d6050d-fea8-42f3-a1f8-d747192e1769" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6978c115-3d75-4890-9e4b-7a9053e4f861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4327cbfe-f12f-48f3-b896-7ec9f944bdc5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_99d6050d-fea8-42f3-a1f8-d747192e1769" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4327cbfe-f12f-48f3-b896-7ec9f944bdc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_204520ca-e61b-4f09-bc1f-2ed7427b4c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_99d6050d-fea8-42f3-a1f8-d747192e1769" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_204520ca-e61b-4f09-bc1f-2ed7427b4c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2cf69d1d-c3d8-4d53-91b2-2653f5017c27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_99d6050d-fea8-42f3-a1f8-d747192e1769" xlink:to="loc_us-gaap_InventoryNet_2cf69d1d-c3d8-4d53-91b2-2653f5017c27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4cddb3d0-6baa-426e-bd2d-2eae35760e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_99d6050d-fea8-42f3-a1f8-d747192e1769" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4cddb3d0-6baa-426e-bd2d-2eae35760e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3556959-6505-441c-9eac-05aceffbb258" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_581e7434-8547-4718-a2cb-3a66c57b6f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3556959-6505-441c-9eac-05aceffbb258" xlink:to="loc_us-gaap_StockholdersEquity_581e7434-8547-4718-a2cb-3a66c57b6f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_6adea8a3-eee4-44aa-8ee0-aea1edf4a1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3556959-6505-441c-9eac-05aceffbb258" xlink:to="loc_us-gaap_MinorityInterest_6adea8a3-eee4-44aa-8ee0-aea1edf4a1f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d2c60754-d2b6-45fd-b113-7d43d67d7dde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_40c79899-b5b4-40f2-bb22-0f4fa9e7a86a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2c60754-d2b6-45fd-b113-7d43d67d7dde" xlink:to="loc_us-gaap_AssetsCurrent_40c79899-b5b4-40f2-bb22-0f4fa9e7a86a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1fb5bd8-706c-4bc2-acdd-fe58a4bbe356" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2c60754-d2b6-45fd-b113-7d43d67d7dde" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a1fb5bd8-706c-4bc2-acdd-fe58a4bbe356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_2cb4e7a4-eab2-4b3b-b445-5da28017fc2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2c60754-d2b6-45fd-b113-7d43d67d7dde" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_2cb4e7a4-eab2-4b3b-b445-5da28017fc2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_421150b5-5ceb-4db0-b98f-464fdd92fbf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2c60754-d2b6-45fd-b113-7d43d67d7dde" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_421150b5-5ceb-4db0-b98f-464fdd92fbf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a0245016-74cd-47d9-8b2b-e75157019de7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2c60754-d2b6-45fd-b113-7d43d67d7dde" xlink:to="loc_us-gaap_Goodwill_a0245016-74cd-47d9-8b2b-e75157019de7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0edc9142-05bc-4e71-97d2-e8d1ade5c93f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2c60754-d2b6-45fd-b113-7d43d67d7dde" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0edc9142-05bc-4e71-97d2-e8d1ade5c93f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fc4b318f-c2bc-4e9b-9dcb-91ea082bb5ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_975b52fd-6eb7-44a8-a3ea-a6be9aa1365a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fc4b318f-c2bc-4e9b-9dcb-91ea082bb5ea" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_975b52fd-6eb7-44a8-a3ea-a6be9aa1365a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_45290c4e-ec37-4e9e-bcc7-7d63505efcb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fc4b318f-c2bc-4e9b-9dcb-91ea082bb5ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_45290c4e-ec37-4e9e-bcc7-7d63505efcb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1e046504-4a9a-4af2-920a-2b8e1cff3940" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_204ffbe5-5d84-472a-b94e-5622ca921632" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1e046504-4a9a-4af2-920a-2b8e1cff3940" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_204ffbe5-5d84-472a-b94e-5622ca921632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_71a83d04-517e-4f0a-b0df-468d7a61fcc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1e046504-4a9a-4af2-920a-2b8e1cff3940" xlink:to="loc_us-gaap_ProfitLoss_71a83d04-517e-4f0a-b0df-468d7a61fcc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b954821-7d5d-42d1-9b7d-267ada4cc081" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f766d522-2f3d-427b-8cbf-162e2275a139" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b954821-7d5d-42d1-9b7d-267ada4cc081" xlink:to="loc_us-gaap_OperatingIncomeLoss_f766d522-2f3d-427b-8cbf-162e2275a139" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2e731c00-53e9-42b5-9972-4f7423611f96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b954821-7d5d-42d1-9b7d-267ada4cc081" xlink:to="loc_us-gaap_InterestExpense_2e731c00-53e9-42b5-9972-4f7423611f96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_43d21660-f05c-4c5d-99e7-a2ac984efa77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4b954821-7d5d-42d1-9b7d-267ada4cc081" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_43d21660-f05c-4c5d-99e7-a2ac984efa77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9944f54b-8ae9-4c37-a88b-3ac324dc98b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_54ce1475-1c32-4b09-ba0d-6cae51034628" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9944f54b-8ae9-4c37-a88b-3ac324dc98b0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_54ce1475-1c32-4b09-ba0d-6cae51034628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9338dd20-bfc5-47c1-9c69-104ae4a18646" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9944f54b-8ae9-4c37-a88b-3ac324dc98b0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9338dd20-bfc5-47c1-9c69-104ae4a18646" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_7ce2ffed-7069-47f3-aa58-b03f45c2d675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9944f54b-8ae9-4c37-a88b-3ac324dc98b0" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_7ce2ffed-7069-47f3-aa58-b03f45c2d675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7c212e17-b2bc-4b6d-bf3a-a275d8034cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9944f54b-8ae9-4c37-a88b-3ac324dc98b0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7c212e17-b2bc-4b6d-bf3a-a275d8034cf4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9db90531-c28a-4b36-a312-1308068b6219" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_dac61197-a152-4542-8555-7558bd3eb270" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9db90531-c28a-4b36-a312-1308068b6219" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_dac61197-a152-4542-8555-7558bd3eb270" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5c672cc0-9f5d-4e30-822f-50f41952d0f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9db90531-c28a-4b36-a312-1308068b6219" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5c672cc0-9f5d-4e30-822f-50f41952d0f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_981693b0-7579-4504-b7d7-37185b355e57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d95c42d1-a90e-44c2-b7d7-bd5c54e74aff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_981693b0-7579-4504-b7d7-37185b355e57" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d95c42d1-a90e-44c2-b7d7-bd5c54e74aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b1b0300f-5a84-4cfa-90a3-32dcb61f86a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_981693b0-7579-4504-b7d7-37185b355e57" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b1b0300f-5a84-4cfa-90a3-32dcb61f86a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6d3f90ce-20fb-4ced-b259-00f8bd5e2d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_68500f28-34f8-4ed6-ac88-23b3f288e2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6d3f90ce-20fb-4ced-b259-00f8bd5e2d1d" xlink:to="loc_us-gaap_ProfitLoss_68500f28-34f8-4ed6-ac88-23b3f288e2ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_55f78443-5479-49ca-bd04-a1579307a4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6d3f90ce-20fb-4ced-b259-00f8bd5e2d1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_55f78443-5479-49ca-bd04-a1579307a4a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_492beb35-96ae-4e38-9491-f9a4ae892b56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1ae75eeb-8917-4c3f-9774-6fb2838add2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_492beb35-96ae-4e38-9491-f9a4ae892b56" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1ae75eeb-8917-4c3f-9774-6fb2838add2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7afe37db-c0ae-4e86-aad6-adb3676df345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_492beb35-96ae-4e38-9491-f9a4ae892b56" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7afe37db-c0ae-4e86-aad6-adb3676df345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b6990281-67b2-40bb-a67b-70da8edf5d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_492beb35-96ae-4e38-9491-f9a4ae892b56" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b6990281-67b2-40bb-a67b-70da8edf5d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_970513c9-2cbc-46df-b144-1e7268fd9741" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_8acb6e15-923f-4ac6-b2ba-d11c81456b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_970513c9-2cbc-46df-b144-1e7268fd9741" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_8acb6e15-923f-4ac6-b2ba-d11c81456b8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_457e9b66-4ca5-4944-a382-a90f95cdae5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_970513c9-2cbc-46df-b144-1e7268fd9741" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_457e9b66-4ca5-4944-a382-a90f95cdae5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="gild-20200930.xsd#ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_d99616d6-46fd-4433-b654-fa34b66112d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_d99616d6-46fd-4433-b654-fa34b66112d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_644f9c37-8744-44fe-99ab-b59500293d15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_644f9c37-8744-44fe-99ab-b59500293d15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_dc914c55-cc9b-4379-b9b8-aa8fb53ad04e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_dc914c55-cc9b-4379-b9b8-aa8fb53ad04e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_67034810-213d-4f76-8faa-073adda47055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_AdjustmentForAmortization_67034810-213d-4f76-8faa-073adda47055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_813f3108-96f0-4e70-9d0b-67401b6a4703" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_813f3108-96f0-4e70-9d0b-67401b6a4703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2fc05201-47d2-497e-8bdb-1fc86141585c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2fc05201-47d2-497e-8bdb-1fc86141585c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_434f1b08-d497-427e-a02c-9f06ab062d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_Depreciation_434f1b08-d497-427e-a02c-9f06ab062d38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c7bd4168-f34f-4a70-966b-5ae10267ff78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_ShareBasedCompensation_c7bd4168-f34f-4a70-966b-5ae10267ff78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8f2d9e13-81dc-4eb0-a282-f0114b9178a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8f2d9e13-81dc-4eb0-a282-f0114b9178a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc96c88b-6ec7-4eb7-bfa9-0e65a5d7955c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc96c88b-6ec7-4eb7-bfa9-0e65a5d7955c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dc6fba8b-494a-4c2e-8038-bf76b2e6a721" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_ProfitLoss_dc6fba8b-494a-4c2e-8038-bf76b2e6a721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_35c4315a-2571-44d2-ad68-62742581b22a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_35c4315a-2571-44d2-ad68-62742581b22a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9e6a59d7-956d-4151-b37c-6cdf770622e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9e6a59d7-956d-4151-b37c-6cdf770622e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_a7c3496b-9861-4133-aefa-0b3916a2e4fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_75809134-a657-453a-8ba6-f23a0b3d2939" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_a7c3496b-9861-4133-aefa-0b3916a2e4fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_76c747b4-f0fb-4bdc-a62c-f63b16d7421a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_76c747b4-f0fb-4bdc-a62c-f63b16d7421a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_83be9eea-28c8-4e73-8ac3-527bdeec7589" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_83be9eea-28c8-4e73-8ac3-527bdeec7589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e770ac7a-8f4c-40f7-8204-2a7770eaf5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e770ac7a-8f4c-40f7-8204-2a7770eaf5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_9a72244c-52a4-41e0-9ab5-11a92df97822" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_9a72244c-52a4-41e0-9ab5-11a92df97822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f41a9876-10b5-4fb6-b02e-99788a58029f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f41a9876-10b5-4fb6-b02e-99788a58029f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_ec7a3ba4-c895-4ada-88c1-112ae5de4e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_ec7a3ba4-c895-4ada-88c1-112ae5de4e6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_0ec85fca-66b0-4347-b42e-0fe0c44e1b17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_460ba931-632f-4cfa-919d-6d7b4e7ef7f9" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_0ec85fca-66b0-4347-b42e-0fe0c44e1b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6363f09e-d6cd-4cc5-90ca-22ba88583e82" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_08c8fdab-8a83-4bf4-afb2-3deb0a15c06b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6363f09e-d6cd-4cc5-90ca-22ba88583e82" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_08c8fdab-8a83-4bf4-afb2-3deb0a15c06b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dbd43626-89c7-4f6c-bae5-a111cb7f55e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6363f09e-d6cd-4cc5-90ca-22ba88583e82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dbd43626-89c7-4f6c-bae5-a111cb7f55e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7704a0f9-e7fd-43cd-8ac7-f5036c08b8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6363f09e-d6cd-4cc5-90ca-22ba88583e82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7704a0f9-e7fd-43cd-8ac7-f5036c08b8a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2b68fdd3-dc51-43ae-8fba-58ef0dfeae1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6363f09e-d6cd-4cc5-90ca-22ba88583e82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2b68fdd3-dc51-43ae-8fba-58ef0dfeae1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7762fc8-8f09-45cd-9905-8205c6f36afd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_a35de59c-9b8f-4e06-b3de-36ba1c8a236b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7762fc8-8f09-45cd-9905-8205c6f36afd" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_a35de59c-9b8f-4e06-b3de-36ba1c8a236b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a454c0d1-88f0-47c9-b32d-993688f4544b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7762fc8-8f09-45cd-9905-8205c6f36afd" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a454c0d1-88f0-47c9-b32d-993688f4544b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_99220a2d-16ed-47bc-98fd-28041a66c3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7762fc8-8f09-45cd-9905-8205c6f36afd" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_99220a2d-16ed-47bc-98fd-28041a66c3ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_22d1c529-d4b7-4f43-a31f-4d76d02d893d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7762fc8-8f09-45cd-9905-8205c6f36afd" xlink:to="loc_us-gaap_RepaymentsOfDebt_22d1c529-d4b7-4f43-a31f-4d76d02d893d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_c794a860-69b6-4af0-a005-7f987e38f4e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7762fc8-8f09-45cd-9905-8205c6f36afd" xlink:to="loc_us-gaap_PaymentsOfDividends_c794a860-69b6-4af0-a005-7f987e38f4e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_32a8faa4-e5f8-43cc-8a25-cd5f3fba756b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7762fc8-8f09-45cd-9905-8205c6f36afd" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_32a8faa4-e5f8-43cc-8a25-cd5f3fba756b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/Revenues" xlink:type="simple" xlink:href="gild-20200930.xsd#Revenues"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/Revenues" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/RevenuesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesDisaggregationofRevenuesDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesRevenuesfromMajorCustomersDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/RevenuesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_15e3eecb-869c-4525-9af8-5296461a1895" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_59edb03e-f3ad-44a3-af65-a946d3842dd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_15e3eecb-869c-4525-9af8-5296461a1895" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_59edb03e-f3ad-44a3-af65-a946d3842dd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f109ff9a-380d-4049-8ad0-234678e28702" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_15e3eecb-869c-4525-9af8-5296461a1895" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f109ff9a-380d-4049-8ad0-234678e28702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9339dbf9-db55-47af-b08f-b5244e570688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_15e3eecb-869c-4525-9af8-5296461a1895" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9339dbf9-db55-47af-b08f-b5244e570688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_dfa134ee-d32f-4a76-bc65-2b0f2e2675ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_800302dd-3465-48d1-921b-86c70c5eb3e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_dfa134ee-d32f-4a76-bc65-2b0f2e2675ad" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_800302dd-3465-48d1-921b-86c70c5eb3e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_ed8a734c-921e-4d8c-8a59-40678d001bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_dfa134ee-d32f-4a76-bc65-2b0f2e2675ad" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_ed8a734c-921e-4d8c-8a59-40678d001bdc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecurities" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecurities"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d04841e2-a980-405d-9cbb-c265db620c14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1b0ea31a-554d-4441-8114-6bb0be193cae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d04841e2-a980-405d-9cbb-c265db620c14" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1b0ea31a-554d-4441-8114-6bb0be193cae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6a57f2a0-4324-43b6-9f3a-6f08d8b11ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d04841e2-a980-405d-9cbb-c265db620c14" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6a57f2a0-4324-43b6-9f3a-6f08d8b11ec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fd4ef84e-a594-4af0-9a72-e4589f01d3ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d04841e2-a980-405d-9cbb-c265db620c14" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fd4ef84e-a594-4af0-9a72-e4589f01d3ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9b0e72c5-8068-495c-86e8-29a06bb0ee4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f73ba4b4-ce67-4379-a57f-6e04a92bdf9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9b0e72c5-8068-495c-86e8-29a06bb0ee4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f73ba4b4-ce67-4379-a57f-6e04a92bdf9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bc726133-eee5-456e-b885-dd56afb81ade" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9b0e72c5-8068-495c-86e8-29a06bb0ee4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bc726133-eee5-456e-b885-dd56afb81ade" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_2eb01965-73d2-4bf5-a0a8-13d742945d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9b0e72c5-8068-495c-86e8-29a06bb0ee4d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_2eb01965-73d2-4bf5-a0a8-13d742945d3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeb578fe-9545-4774-9530-3dd7672f66ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1d3f5f92-d0c9-490f-b0b0-e8f794a5d9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeb578fe-9545-4774-9530-3dd7672f66ee" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1d3f5f92-d0c9-490f-b0b0-e8f794a5d9bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_56e11378-244e-45ee-b498-6851bc38ff0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeb578fe-9545-4774-9530-3dd7672f66ee" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_56e11378-244e-45ee-b498-6851bc38ff0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_368fa0f0-cd93-43ce-bffb-5293a61c2777" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeb578fe-9545-4774-9530-3dd7672f66ee" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_368fa0f0-cd93-43ce-bffb-5293a61c2777" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1aba7828-584f-4358-af71-068d4f942445" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_de2a3024-174f-4395-bf7f-dbb86c5c4b21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1aba7828-584f-4358-af71-068d4f942445" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_de2a3024-174f-4395-bf7f-dbb86c5c4b21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6d9cb5ca-cdf4-49a5-b746-9cc1bcaabdf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1aba7828-584f-4358-af71-068d4f942445" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6d9cb5ca-cdf4-49a5-b746-9cc1bcaabdf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f2530e6e-38e6-4db1-87ba-f8bcf20adeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_5b7b9794-adcf-499c-954a-6d69cd19f427" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f2530e6e-38e6-4db1-87ba-f8bcf20adeb4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_5b7b9794-adcf-499c-954a-6d69cd19f427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_ddb93176-16c9-444b-8de1-e685915d594d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f2530e6e-38e6-4db1-87ba-f8bcf20adeb4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_ddb93176-16c9-444b-8de1-e685915d594d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_3d2b2d47-a22a-4dab-b781-0a46df06b547" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d424fbf3-44e5-43c5-8423-562b2b50425f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_3d2b2d47-a22a-4dab-b781-0a46df06b547" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d424fbf3-44e5-43c5-8423-562b2b50425f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_e8d4c9e4-3400-4cf4-89f5-96665dc275c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_3d2b2d47-a22a-4dab-b781-0a46df06b547" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_e8d4c9e4-3400-4cf4-89f5-96665dc275c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c4bb3e84-7554-4b04-8563-04c0374dbd76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1aac97a3-2f9d-4526-99fe-bbce1c0f1d63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_c4bb3e84-7554-4b04-8563-04c0374dbd76" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1aac97a3-2f9d-4526-99fe-bbce1c0f1d63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_1032b490-b40c-460e-b1ae-3846c35eb8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_c4bb3e84-7554-4b04-8563-04c0374dbd76" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_1032b490-b40c-460e-b1ae-3846c35eb8f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9e1d5860-08ea-4966-b831-221abe2ca645" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_bb4ec160-085d-4ea1-8f14-d7b874909e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9e1d5860-08ea-4966-b831-221abe2ca645" xlink:to="loc_us-gaap_DerivativeAssets_bb4ec160-085d-4ea1-8f14-d7b874909e9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_5c57d0c1-3796-4467-90c5-664b7b6c7621" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9e1d5860-08ea-4966-b831-221abe2ca645" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_5c57d0c1-3796-4467-90c5-664b7b6c7621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_ebafe5e9-141e-422f-8486-dcaf8367ae91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9e1d5860-08ea-4966-b831-221abe2ca645" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_ebafe5e9-141e-422f-8486-dcaf8367ae91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_2b6c757d-32b2-4b82-ab8d-aed4c5038acb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_50cda076-13ba-44b8-b2a2-c9056e90f7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_2b6c757d-32b2-4b82-ab8d-aed4c5038acb" xlink:to="loc_us-gaap_DerivativeLiabilities_50cda076-13ba-44b8-b2a2-c9056e90f7c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_b8067b99-572d-4015-85a0-0b0353717a19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_2b6c757d-32b2-4b82-ab8d-aed4c5038acb" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_b8067b99-572d-4015-85a0-0b0353717a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_49322807-4e02-43c7-9295-248e1aa07ea9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_2b6c757d-32b2-4b82-ab8d-aed4c5038acb" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_49322807-4e02-43c7-9295-248e1aa07ea9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements" xlink:type="simple" xlink:href="gild-20200930.xsd#AcquisitionsCollaborationsandOtherArrangements"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AcquisitionsCollaborationsandOtherArrangementsDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformation" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformation"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationTables" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_InventoryNetAndInventoryNoncurrent_c357f92b-b913-4360-850b-4dbbc76ce713" xlink:href="gild-20200930.xsd#gild_InventoryNetAndInventoryNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_799646df-5755-48d8-acb5-bd3f73943633" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_InventoryNetAndInventoryNoncurrent_c357f92b-b913-4360-850b-4dbbc76ce713" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_799646df-5755-48d8-acb5-bd3f73943633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b01905e4-5b3a-4ea2-b42d-f86300f413a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_InventoryNetAndInventoryNoncurrent_c357f92b-b913-4360-850b-4dbbc76ce713" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b01905e4-5b3a-4ea2-b42d-f86300f413a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8652c38c-3eb4-4145-a2aa-141cad042597" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_InventoryNetAndInventoryNoncurrent_c357f92b-b913-4360-850b-4dbbc76ce713" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8652c38c-3eb4-4145-a2aa-141cad042597" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationInventoriesDetails_1"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_InventoryNetAndInventoryNoncurrent_2269d181-326c-4765-9fa1-f846e47f7902" xlink:href="gild-20200930.xsd#gild_InventoryNetAndInventoryNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ab5920e7-9620-4058-90e6-8db0da638013" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_InventoryNetAndInventoryNoncurrent_2269d181-326c-4765-9fa1-f846e47f7902" xlink:to="loc_us-gaap_InventoryNet_ab5920e7-9620-4058-90e6-8db0da638013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_1aeaca42-e9e5-4dd8-9f48-364df84ea1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_InventoryNetAndInventoryNoncurrent_2269d181-326c-4765-9fa1-f846e47f7902" xlink:to="loc_us-gaap_InventoryNoncurrent_1aeaca42-e9e5-4dd8-9f48-364df84ea1eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationOtherAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f88a38d8-bfe1-4601-b33d-a452a64dc87a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_97b90fa1-0143-418f-98ef-fba2e04e975f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f88a38d8-bfe1-4601-b33d-a452a64dc87a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_97b90fa1-0143-418f-98ef-fba2e04e975f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1470a244-4df7-446c-894c-fbc3fde1a814" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f88a38d8-bfe1-4601-b33d-a452a64dc87a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1470a244-4df7-446c-894c-fbc3fde1a814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_045edc27-35c7-48f2-b000-733a76b04770" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f88a38d8-bfe1-4601-b33d-a452a64dc87a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_045edc27-35c7-48f2-b000-733a76b04770" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssets" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_072ede67-d952-48a6-b01c-8460ea3f3955" xlink:href="gild-20200930.xsd#gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_02d09e8f-5ae1-420c-985a-842ad98f481d" xlink:href="gild-20200930.xsd#gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_072ede67-d952-48a6-b01c-8460ea3f3955" xlink:to="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_02d09e8f-5ae1-420c-985a-842ad98f481d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_84216772-ee4a-4841-b5bf-18ed76f0fbd8" xlink:href="gild-20200930.xsd#gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_072ede67-d952-48a6-b01c-8460ea3f3955" xlink:to="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_84216772-ee4a-4841-b5bf-18ed76f0fbd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_723ca731-3517-488c-9a61-95bcd3e6a187" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a99588c5-9e55-4781-bb68-c98c4fdd6cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_723ca731-3517-488c-9a61-95bcd3e6a187" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a99588c5-9e55-4781-bb68-c98c4fdd6cd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_3dde83d1-2060-414a-bad1-c5ee01d8d33b" xlink:href="gild-20200930.xsd#gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_723ca731-3517-488c-9a61-95bcd3e6a187" xlink:to="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_3dde83d1-2060-414a-bad1-c5ee01d8d33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cdd69572-eaed-4f88-9651-0111ef994ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cda99f3b-bb12-4cc4-8a7b-e72000df229e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cdd69572-eaed-4f88-9651-0111ef994ff4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cda99f3b-bb12-4cc4-8a7b-e72000df229e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_1d09fba2-d1c6-45c0-ab16-71f84ae3e4e2" xlink:href="gild-20200930.xsd#gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cdd69572-eaed-4f88-9651-0111ef994ff4" xlink:to="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_1d09fba2-d1c6-45c0-ab16-71f84ae3e4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_789b8514-6ddc-42e4-a601-361c3dfdde93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cdd69572-eaed-4f88-9651-0111ef994ff4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_789b8514-6ddc-42e4-a601-361c3dfdde93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_444cdc4f-8eef-42a3-bbb5-183f4b645efa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_556e638c-a026-4e43-a3a8-597e04be7239" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_444cdc4f-8eef-42a3-bbb5-183f4b645efa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_556e638c-a026-4e43-a3a8-597e04be7239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_deab1238-2307-4464-8460-204b5bfb2220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_444cdc4f-8eef-42a3-bbb5-183f4b645efa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_deab1238-2307-4464-8460-204b5bfb2220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_4d4264cb-7487-4aa8-8a3a-75ee6b027509" xlink:href="gild-20200930.xsd#gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_013027b5-bdab-455e-8596-bd5c839a0e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_4d4264cb-7487-4aa8-8a3a-75ee6b027509" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_013027b5-bdab-455e-8596-bd5c839a0e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_97c27fa5-b871-4085-bf0a-425243699b13" xlink:href="gild-20200930.xsd#gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_4d4264cb-7487-4aa8-8a3a-75ee6b027509" xlink:to="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_97c27fa5-b871-4085-bf0a-425243699b13" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilities" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilities"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c3304fc1-62a0-468c-af8d-6df1061e9d48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9442d0b5-5c10-4067-b9c0-d182c1a69cf6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c3304fc1-62a0-468c-af8d-6df1061e9d48" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9442d0b5-5c10-4067-b9c0-d182c1a69cf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ed385f4a-5dfb-4cbe-841c-3805f4a11367" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_c3304fc1-62a0-468c-af8d-6df1061e9d48" xlink:to="loc_us-gaap_LongTermDebtCurrent_ed385f4a-5dfb-4cbe-841c-3805f4a11367" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="gild-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquity" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholders"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c90a1b76-cf24-4725-be12-3929674705ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b11efbe-b2a8-4f04-ad56-feb01b5edb2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c90a1b76-cf24-4725-be12-3929674705ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b11efbe-b2a8-4f04-ad56-feb01b5edb2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e2e2eca0-b505-4651-b317-6b1a13d4feec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c90a1b76-cf24-4725-be12-3929674705ff" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e2e2eca0-b505-4651-b317-6b1a13d4feec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxes" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>gild-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dd71f5ae-c8d4-497f-83ec-41f4a56b820c,g:fe07381a-9620-491b-af7b-d6c30510011c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="gild-20200930.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DocumentandEntityInformation" xlink:type="extended" id="i4e555cc5408d4752aa80e63879d9bfdf_DocumentandEntityInformation"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i205bf23545cc4db1aaef3829cbd78387_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i55e620fc7364462a9a5e6261edf8ca15_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i26998cdd6dd04285b7117c0ad7bc9783_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_8ed20105-0b05-4fcd-bd15-140806f45c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_RevenuesAbstract_8ed20105-0b05-4fcd-bd15-140806f45c5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_beaee5a9-b3d2-4917-9fcf-090cc396d22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_8ed20105-0b05-4fcd-bd15-140806f45c5f" xlink:to="loc_us-gaap_Revenues_beaee5a9-b3d2-4917-9fcf-090cc396d22e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3463c80f-e3de-465d-ae00-b8500371319f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3463c80f-e3de-465d-ae00-b8500371319f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ef95093a-8239-4281-811b-75ca3037cca1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ef95093a-8239-4281-811b-75ca3037cca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_51b6abbe-9c11-4ec9-8dff-64a73a8b18aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_51b6abbe-9c11-4ec9-8dff-64a73a8b18aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2a5eea1-aed0-4d44-b7e2-7c7671010948" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2a5eea1-aed0-4d44-b7e2-7c7671010948" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b170ad2b-f8be-4330-8e41-c1359ca78cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_CostsAndExpenses_b170ad2b-f8be-4330-8e41-c1359ca78cc2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0e4249c0-e2d0-495a-b3df-5b090c87e2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_OperatingIncomeLoss_0e4249c0-e2d0-495a-b3df-5b090c87e2ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_eb85ea68-14ea-4a96-9ead-643248367aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_InterestExpense_eb85ea68-14ea-4a96-9ead-643248367aaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_be3ebaaf-70aa-4b8a-8fe2-d0d6ccec675b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_be3ebaaf-70aa-4b8a-8fe2-d0d6ccec675b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba5e0906-fbec-4e73-8ad6-c2f25b63b8f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba5e0906-fbec-4e73-8ad6-c2f25b63b8f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a0942560-3e36-4436-97e5-f5cd70dcbcd2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a0942560-3e36-4436-97e5-f5cd70dcbcd2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89663507-4f88-4e39-ad53-052f362e252f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_ProfitLoss_89663507-4f88-4e39-ad53-052f362e252f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_960c18b8-d0ae-4722-90da-4085c07b036c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_960c18b8-d0ae-4722-90da-4085c07b036c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_edbafad2-af5d-40e1-b928-47a40a8e9e18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_NetIncomeLoss_edbafad2-af5d-40e1-b928-47a40a8e9e18" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f3ff58ee-1ebb-4b83-926f-b1cba7033f56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_EarningsPerShareBasic_f3ff58ee-1ebb-4b83-926f-b1cba7033f56" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be1ab335-e591-4770-bd23-466984e2b6d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be1ab335-e591-4770-bd23-466984e2b6d6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8e71457f-2cbc-410b-ae90-1befcb247c87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8e71457f-2cbc-410b-ae90-1befcb247c87" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ada297ee-cda3-4314-982a-1188aa0c3eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ada297ee-cda3-4314-982a-1188aa0c3eb1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_79b6e65f-234a-480b-b71e-5d3599d5f849" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_StatementTable_79b6e65f-234a-480b-b71e-5d3599d5f849" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_79b6e65f-234a-480b-b71e-5d3599d5f849" xlink:to="loc_srt_ProductOrServiceAxis_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb" xlink:to="loc_srt_ProductsAndServicesDomain_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb" xlink:to="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_33b4f478-7b0e-4ec2-bdeb-bce1dcbbbcac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:to="loc_us-gaap_ProductMember_33b4f478-7b0e-4ec2-bdeb-bce1dcbbbcac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_RoyaltyContractAndOtherMember_d4f07eaa-09e5-403b-b950-7a8b329e77b7" xlink:href="gild-20200930.xsd#gild_RoyaltyContractAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:to="loc_gild_RoyaltyContractAndOtherMember_d4f07eaa-09e5-403b-b950-7a8b329e77b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="id762d97f91024c9aa52500516eac78c6_CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="ic2cb5324bb0c424a9f08f60d3d359f6a_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c3c46a15-f54f-43d4-b712-ae62a4a8f20d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c3c46a15-f54f-43d4-b712-ae62a4a8f20d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_02d8796f-2abc-4039-9f6f-d28456510989" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_02d8796f-2abc-4039-9f6f-d28456510989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b55495b-ff20-4e68-8ddb-e6963709787c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b55495b-ff20-4e68-8ddb-e6963709787c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_4a238123-01e3-4c3b-963b-238288ac0b4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_4a238123-01e3-4c3b-963b-238288ac0b4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_2aaeac1f-9f4d-40b2-84c9-ad0154b57e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_2aaeac1f-9f4d-40b2-84c9-ad0154b57e9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8026fb17-02bc-4d14-826e-df5efbdd4473" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_ProfitLoss_8026fb17-02bc-4d14-826e-df5efbdd4473" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7bfd50d0-5e4a-4d71-aa57-6436114146f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7bfd50d0-5e4a-4d71-aa57-6436114146f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6f5de74f-527a-4157-a29e-3b5c87e7688d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6f5de74f-527a-4157-a29e-3b5c87e7688d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0a2cc89b-70f2-4804-b521-b9b86aa5473c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0a2cc89b-70f2-4804-b521-b9b86aa5473c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0aeafb9e-fc00-451a-ae99-3749ee474e97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0aeafb9e-fc00-451a-ae99-3749ee474e97" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_61431368-ea6d-4ce9-ad9a-bf7522577668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_61431368-ea6d-4ce9-ad9a-bf7522577668" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_42bc4c18-986d-42f6-84a0-c756a7bcce10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_42bc4c18-986d-42f6-84a0-c756a7bcce10" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0b9a2c33-e39f-4a44-831b-0a5f449ca7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0b9a2c33-e39f-4a44-831b-0a5f449ca7cf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_de2895df-ee99-4b7f-87ce-a0963029bd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_de2895df-ee99-4b7f-87ce-a0963029bd1d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_368ae622-82d7-4bf4-a366-1477a89b4127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_Dividends_368ae622-82d7-4bf4-a366-1477a89b4127" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4bdca590-d51f-475d-af77-9d0502706388" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71798a5f-327e-4ba0-bcae-0572f1c39fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c3c46a15-f54f-43d4-b712-ae62a4a8f20d" xlink:to="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba6b96b0-f7b1-4a40-b926-9f7110defbef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba6b96b0-f7b1-4a40-b926-9f7110defbef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ba6b96b0-f7b1-4a40-b926-9f7110defbef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba6b96b0-f7b1-4a40-b926-9f7110defbef" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ba6b96b0-f7b1-4a40-b926-9f7110defbef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba6b96b0-f7b1-4a40-b926-9f7110defbef" xlink:to="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_365aec93-69c2-40fa-b66f-186af6a54b43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_365aec93-69c2-40fa-b66f-186af6a54b43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_c1f658ff-d114-422c-93ab-af8ea136dc41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_c1f658ff-d114-422c-93ab-af8ea136dc41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_89dcc4a1-a2fc-4152-9343-44495dd02718" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_89dcc4a1-a2fc-4152-9343-44495dd02718" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_89dcc4a1-a2fc-4152-9343-44495dd02718_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89dcc4a1-a2fc-4152-9343-44495dd02718" xlink:to="loc_us-gaap_EquityComponentDomain_89dcc4a1-a2fc-4152-9343-44495dd02718_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89dcc4a1-a2fc-4152-9343-44495dd02718" xlink:to="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_870d7f12-6a72-4ea1-a6c0-506b1c42cb66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_CommonStockMember_870d7f12-6a72-4ea1-a6c0-506b1c42cb66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e2b692f0-95e8-4526-9445-8c5740e95336" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e2b692f0-95e8-4526-9445-8c5740e95336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c35b05a-e189-4efd-be20-6d718515d8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c35b05a-e189-4efd-be20-6d718515d8a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5ecd8937-b419-4447-aabf-bf5feeddfe33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_RetainedEarningsMember_5ecd8937-b419-4447-aabf-bf5feeddfe33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5213c695-9058-46c1-8815-1cbd7c2963b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5213c695-9058-46c1-8815-1cbd7c2963b3" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="gild-20200930.xsd#ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended" id="ide1115b934374ab0bb98afd721f90517_ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="ib9f2d47ee9724b1d8b4c77aa221da5ca_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="i07b4b959d134451ead44d59844e44612_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i753e55505f494d6996d16c6e018d10ef_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails" xlink:type="extended" id="i68be57fca68c4f39bff3ddc1ab79cf42_SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/Revenues" xlink:type="simple" xlink:href="gild-20200930.xsd#Revenues"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/Revenues" xlink:type="extended" id="ie4bb8842c5784f54869d70d881c9d691_Revenues"/>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/RevenuesTables" xlink:type="extended" id="i8f20e5f78b544716aa310966d671f3fe_RevenuesTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesDisaggregationofRevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails" xlink:type="extended" id="i00453251c1f54123a0a03a99744d9567_RevenuesDisaggregationofRevenuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_de78d166-d5db-495c-93b2-ec8ae0ca94a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_de78d166-d5db-495c-93b2-ec8ae0ca94a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d5ebb2d2-a0da-4681-ae8b-683610478568" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:to="loc_us-gaap_Revenues_d5ebb2d2-a0da-4681-ae8b-683610478568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:to="loc_srt_ProductOrServiceAxis_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9" xlink:to="loc_srt_ProductsAndServicesDomain_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9" xlink:to="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsAtriplaMember_af27eabc-8010-4a90-99fb-d39e3fd181c1" xlink:href="gild-20200930.xsd#gild_HIVProductsAtriplaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsAtriplaMember_af27eabc-8010-4a90-99fb-d39e3fd181c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsBiktarvyMember_4450cc8d-4506-4cd6-a7e3-877899dd62ad" xlink:href="gild-20200930.xsd#gild_HIVProductsBiktarvyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsBiktarvyMember_4450cc8d-4506-4cd6-a7e3-877899dd62ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsCompleraEvipleraMember_ef66abfd-d8b9-4e94-b61a-23a84fcfcd6f" xlink:href="gild-20200930.xsd#gild_HIVProductsCompleraEvipleraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsCompleraEvipleraMember_ef66abfd-d8b9-4e94-b61a-23a84fcfcd6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsDescovyMember_68ba8567-e055-4ac1-a361-5973336d1108" xlink:href="gild-20200930.xsd#gild_HIVProductsDescovyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsDescovyMember_68ba8567-e055-4ac1-a361-5973336d1108" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsGenvoyaMember_8adeaa07-c382-44c4-a5f2-e828019cfc0c" xlink:href="gild-20200930.xsd#gild_HIVProductsGenvoyaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsGenvoyaMember_8adeaa07-c382-44c4-a5f2-e828019cfc0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsOdefseyMember_5f42ac7b-f545-46dd-9b79-4ecaae98f448" xlink:href="gild-20200930.xsd#gild_HIVProductsOdefseyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsOdefseyMember_5f42ac7b-f545-46dd-9b79-4ecaae98f448" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsStribildMember_0ba82d37-2691-4f03-b1e9-48a6537b3a25" xlink:href="gild-20200930.xsd#gild_HIVProductsStribildMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsStribildMember_0ba82d37-2691-4f03-b1e9-48a6537b3a25" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsTruvadaMember_efd4c404-022d-4896-9766-34cb00920176" xlink:href="gild-20200930.xsd#gild_HIVProductsTruvadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsTruvadaMember_efd4c404-022d-4896-9766-34cb00920176" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ProductsOtherHIVMember_9ac45b78-3811-4cf7-b06c-33a88b9a68b1" xlink:href="gild-20200930.xsd#gild_ProductsOtherHIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_ProductsOtherHIVMember_9ac45b78-3811-4cf7-b06c-33a88b9a68b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ProductsRevenueShareSymtuzaMember_b3a06060-f853-439e-a093-a676dcb9854c" xlink:href="gild-20200930.xsd#gild_ProductsRevenueShareSymtuzaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_ProductsRevenueShareSymtuzaMember_b3a06060-f853-439e-a093-a676dcb9854c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsAmBisomeMember_a9eed381-4b1e-4368-8997-6b8a49aa4b05" xlink:href="gild-20200930.xsd#gild_OtherProductsAmBisomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsAmBisomeMember_a9eed381-4b1e-4368-8997-6b8a49aa4b05" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsLedipasvirSofosbuvirMember_ab81997b-3783-4763-bf0f-f111efe452b9" xlink:href="gild-20200930.xsd#gild_HCVProductsLedipasvirSofosbuvirMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HCVProductsLedipasvirSofosbuvirMember_ab81997b-3783-4763-bf0f-f111efe452b9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsLetairisMember_aab2e22d-3118-490e-938d-687e959621d2" xlink:href="gild-20200930.xsd#gild_OtherProductsLetairisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsLetairisMember_aab2e22d-3118-490e-938d-687e959621d2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsRanexaMember_7b4b8732-39c6-4e23-b916-0c7a5f8de5dc" xlink:href="gild-20200930.xsd#gild_OtherProductsRanexaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsRanexaMember_7b4b8732-39c6-4e23-b916-0c7a5f8de5dc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsSofosbuvirVelpatasvirMember_3c2c5823-ef04-49c0-91aa-9b4793a11a4a" xlink:href="gild-20200930.xsd#gild_HCVProductsSofosbuvirVelpatasvirMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HCVProductsSofosbuvirVelpatasvirMember_3c2c5823-ef04-49c0-91aa-9b4793a11a4a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_COVID19ProductsVekluryMember_d271422f-e6d7-44e9-ade9-a978211282a8" xlink:href="gild-20200930.xsd#gild_COVID19ProductsVekluryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_COVID19ProductsVekluryMember_d271422f-e6d7-44e9-ade9-a978211282a8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsVemlidyMember_12a2ff64-7e8e-456d-b311-7a0fe31760d6" xlink:href="gild-20200930.xsd#gild_OtherProductsVemlidyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsVemlidyMember_12a2ff64-7e8e-456d-b311-7a0fe31760d6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsVireadMember_d4b81e08-403b-4aeb-a1db-f6d4abc08e8c" xlink:href="gild-20200930.xsd#gild_OtherProductsVireadMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsVireadMember_d4b81e08-403b-4aeb-a1db-f6d4abc08e8c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsVoseviMember_0fca19c0-7d1d-411e-ba80-f1dd6d7712b2" xlink:href="gild-20200930.xsd#gild_HCVProductsVoseviMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HCVProductsVoseviMember_0fca19c0-7d1d-411e-ba80-f1dd6d7712b2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsYescartaMember_3a18ccac-f221-4cf5-a38d-3f42c83cec6a" xlink:href="gild-20200930.xsd#gild_OtherProductsYescartaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsYescartaMember_3a18ccac-f221-4cf5-a38d-3f42c83cec6a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsZydeligMember_92c918c6-4337-414b-8466-a1a9d88c6878" xlink:href="gild-20200930.xsd#gild_OtherProductsZydeligMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsZydeligMember_92c918c6-4337-414b-8466-a1a9d88c6878" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsOtherMember_157ba7ee-cc3d-461d-b4c1-ef36a55a2264" xlink:href="gild-20200930.xsd#gild_OtherProductsOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsOtherMember_157ba7ee-cc3d-461d-b4c1-ef36a55a2264" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_5cc26d51-4add-4b47-9fb3-1bbdfcd0c239" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_us-gaap_ProductMember_5cc26d51-4add-4b47-9fb3-1bbdfcd0c239" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_RoyaltyContractAndOtherMember_d9e71c6b-b103-4171-bf00-564d02a3a15d" xlink:href="gild-20200930.xsd#gild_RoyaltyContractAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_RoyaltyContractAndOtherMember_d9e71c6b-b103-4171-bf00-564d02a3a15d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_89d7c3d2-5bf9-4568-b061-0af393a4d8e7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:to="loc_srt_StatementGeographicalAxis_89d7c3d2-5bf9-4568-b061-0af393a4d8e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_89d7c3d2-5bf9-4568-b061-0af393a4d8e7_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_89d7c3d2-5bf9-4568-b061-0af393a4d8e7" xlink:to="loc_srt_SegmentGeographicalDomain_89d7c3d2-5bf9-4568-b061-0af393a4d8e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_89d7c3d2-5bf9-4568-b061-0af393a4d8e7" xlink:to="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_024d6799-94b2-40d2-affb-c4776c76494c" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:to="loc_country_US_024d6799-94b2-40d2-affb-c4776c76494c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_06007d27-6607-4c22-a7a6-5e21f63a724c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:to="loc_srt_EuropeMember_06007d27-6607-4c22-a7a6-5e21f63a724c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherInternationalMember_ca5b2fee-4b24-4a46-89b5-92f8caa2414c" xlink:href="gild-20200930.xsd#gild_OtherInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:to="loc_gild_OtherInternationalMember_ca5b2fee-4b24-4a46-89b5-92f8caa2414c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesRevenuesfromMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails" xlink:type="extended" id="ib8fcc221e54043e49f3cdf2acbfbf9ef_RevenuesRevenuesfromMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_ccdb8c32-687b-415f-87ee-18591b7ae4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d400ecfa-867e-4254-b9c8-890d3657e01f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_ccdb8c32-687b-415f-87ee-18591b7ae4ee" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d400ecfa-867e-4254-b9c8-890d3657e01f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_ccdb8c32-687b-415f-87ee-18591b7ae4ee" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_67d52586-9637-436e-911f-5e8af454f7e0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:to="loc_srt_MajorCustomersAxis_67d52586-9637-436e-911f-5e8af454f7e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_67d52586-9637-436e-911f-5e8af454f7e0_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_67d52586-9637-436e-911f-5e8af454f7e0" xlink:to="loc_srt_NameOfMajorCustomerDomain_67d52586-9637-436e-911f-5e8af454f7e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_67d52586-9637-436e-911f-5e8af454f7e0" xlink:to="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AmerisourcebergenCorpMember_968dc5fe-7470-478f-a4e5-b87fc6977608" xlink:href="gild-20200930.xsd#gild_AmerisourcebergenCorpMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:to="loc_gild_AmerisourcebergenCorpMember_968dc5fe-7470-478f-a4e5-b87fc6977608" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CardinalHealthIncMember_8bc48a34-c356-4a0b-baa2-804e89a2c2fd" xlink:href="gild-20200930.xsd#gild_CardinalHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:to="loc_gild_CardinalHealthIncMember_8bc48a34-c356-4a0b-baa2-804e89a2c2fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MckessonCorpMember_8db89a12-fdc6-4a07-a1dd-5cdb17bff17e" xlink:href="gild-20200930.xsd#gild_MckessonCorpMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:to="loc_gild_MckessonCorpMember_8db89a12-fdc6-4a07-a1dd-5cdb17bff17e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_47d06d12-9502-4859-9c22-551300bae76d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_47d06d12-9502-4859-9c22-551300bae76d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_62dd4c2d-26e8-40cf-b516-d32686fc7720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_47d06d12-9502-4859-9c22-551300bae76d" xlink:to="loc_us-gaap_SalesRevenueNetMember_62dd4c2d-26e8-40cf-b516-d32686fc7720" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_65a6a78f-a324-4adc-97dc-540e4e2b0222" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_65a6a78f-a324-4adc-97dc-540e4e2b0222" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_65a6a78f-a324-4adc-97dc-540e4e2b0222_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_65a6a78f-a324-4adc-97dc-540e4e2b0222" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_65a6a78f-a324-4adc-97dc-540e4e2b0222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c03cdbb4-9c8f-4048-bf40-34d65a93c02e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_65a6a78f-a324-4adc-97dc-540e4e2b0222" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c03cdbb4-9c8f-4048-bf40-34d65a93c02e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5e14b6f2-b2b3-4f15-b4c0-77efe737e3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c03cdbb4-9c8f-4048-bf40-34d65a93c02e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5e14b6f2-b2b3-4f15-b4c0-77efe737e3c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/RevenuesAdditionalInformationDetails" xlink:type="extended" id="i3835074b2a4942898cc16f5b150e8a6d_RevenuesAdditionalInformationDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/FairValueMeasurements" xlink:type="extended" id="i578e2ea5847b49b4bcbfb83a67c5697d_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsTables" xlink:type="extended" id="ic9d74ce7dcf64b42b3605dccf0a78dec_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended" id="icb8effc1183e4eb5b89dce8bd5b66afd_FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71c52e84-7c6d-44b1-9144-9112a5771030" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71c52e84-7c6d-44b1-9144-9112a5771030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_af19bd58-3eb3-4790-bc19-1c3229b342f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_af19bd58-3eb3-4790-bc19-1c3229b342f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b4ea6ef3-2801-4e02-aca1-2b645fa27525" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b4ea6ef3-2801-4e02-aca1-2b645fa27525" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b53f3433-5396-4776-b4b8-f14e9a51665c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b53f3433-5396-4776-b4b8-f14e9a51665c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_74459101-5a7d-4ec0-9243-fe19143f1cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_74459101-5a7d-4ec0-9243-fe19143f1cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_8d989218-eca4-43da-b602-dec243e7fb5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_8d989218-eca4-43da-b602-dec243e7fb5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_87b3efd5-7327-4f1a-8031-405ca33844f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_87b3efd5-7327-4f1a-8031-405ca33844f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3059e42d-d6c9-4055-a330-e066e8c8ad84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3059e42d-d6c9-4055-a330-e066e8c8ad84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b36c24fa-2980-4ab8-ad2c-5fd4e10a9406" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3059e42d-d6c9-4055-a330-e066e8c8ad84" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b36c24fa-2980-4ab8-ad2c-5fd4e10a9406" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb7c1220-aedc-483b-8585-821904b8c896" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb7c1220-aedc-483b-8585-821904b8c896" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb7c1220-aedc-483b-8585-821904b8c896_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb7c1220-aedc-483b-8585-821904b8c896" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb7c1220-aedc-483b-8585-821904b8c896_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb7c1220-aedc-483b-8585-821904b8c896" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_05450955-5ff9-41e8-95eb-acc3e38daa25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_05450955-5ff9-41e8-95eb-acc3e38daa25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6f0174e6-aaa1-4f2c-ad89-d92b76e83917" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6f0174e6-aaa1-4f2c-ad89-d92b76e83917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b5d306d6-44de-4947-a35c-03356caa7fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b5d306d6-44de-4947-a35c-03356caa7fa8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d03eb3d9-fe8b-4a57-9d8d-5f9f5a858046" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d03eb3d9-fe8b-4a57-9d8d-5f9f5a858046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18223d3c-e935-4ff5-afb7-cac4621e654d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d03eb3d9-fe8b-4a57-9d8d-5f9f5a858046" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18223d3c-e935-4ff5-afb7-cac4621e654d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_265dfb98-7061-4d75-ad75-8ed904ebf0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18223d3c-e935-4ff5-afb7-cac4621e654d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_265dfb98-7061-4d75-ad75-8ed904ebf0d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b6c603f3-5587-4c0a-bf8f-18c393c6f5db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b6c603f3-5587-4c0a-bf8f-18c393c6f5db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b6c603f3-5587-4c0a-bf8f-18c393c6f5db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b6c603f3-5587-4c0a-bf8f-18c393c6f5db" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b6c603f3-5587-4c0a-bf8f-18c393c6f5db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b6c603f3-5587-4c0a-bf8f-18c393c6f5db" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_787e13ff-1c17-4d0d-95ff-27fedf0252d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_787e13ff-1c17-4d0d-95ff-27fedf0252d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_50145975-80b4-4bf5-9df2-73c1429912c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_CertificatesOfDepositMember_50145975-80b4-4bf5-9df2-73c1429912c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3c307e38-88ad-404a-a8d6-cda990a3418a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3c307e38-88ad-404a-a8d6-cda990a3418a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_d672854b-c663-42cc-9c25-f76c8085e6f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_d672854b-c663-42cc-9c25-f76c8085e6f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ba0bbbf7-216e-4589-a208-cf2c846b52f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ba0bbbf7-216e-4589-a208-cf2c846b52f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_13304443-23ea-4b5d-b342-18e7dd0f0f14" xlink:href="gild-20200930.xsd#gild_ResidentialMortgageAndAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_13304443-23ea-4b5d-b342-18e7dd0f0f14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityinvestmentinGalapagosMember_33eda92f-7271-47dd-8827-18608aea6d11" xlink:href="gild-20200930.xsd#gild_EquityinvestmentinGalapagosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_EquityinvestmentinGalapagosMember_33eda92f-7271-47dd-8827-18608aea6d11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_b945abb3-49b7-42d2-b57a-20b47935f012" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_MoneyMarketFundsMember_b945abb3-49b7-42d2-b57a-20b47935f012" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c5b044f5-7d9b-4d12-85e0-59d2b418143a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_EquitySecuritiesMember_c5b044f5-7d9b-4d12-85e0-59d2b418143a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DeferredCompensationPlanMember_63a000e6-5977-47fe-b141-5939a4779510" xlink:href="gild-20200930.xsd#gild_DeferredCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_DeferredCompensationPlanMember_63a000e6-5977-47fe-b141-5939a4779510" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ForeignCurrencyDerivativeContractsMember_95465838-e8ed-41e1-a30c-73b26c54c277" xlink:href="gild-20200930.xsd#gild_ForeignCurrencyDerivativeContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_ForeignCurrencyDerivativeContractsMember_95465838-e8ed-41e1-a30c-73b26c54c277" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" id="i4334e68f797f4bfeafc401d46dd2aa70_FairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_296b3f79-ee0f-4323-9d30-9f59c84af51f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_296b3f79-ee0f-4323-9d30-9f59c84af51f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_4766151a-819b-44fa-9424-ba8da90ba355" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_4766151a-819b-44fa-9424-ba8da90ba355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_b458fc23-4bed-4723-b5e5-8ca85945db52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_LongTermDebtFairValue_b458fc23-4bed-4723-b5e5-8ca85945db52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2e7b07e3-a36c-441a-91f0-5a10920a8e66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2e7b07e3-a36c-441a-91f0-5a10920a8e66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d275fea5-449f-495a-90c6-b909ae933f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d275fea5-449f-495a-90c6-b909ae933f74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d275fea5-449f-495a-90c6-b909ae933f74_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d275fea5-449f-495a-90c6-b909ae933f74" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d275fea5-449f-495a-90c6-b909ae933f74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ed0ec741-e9bb-4c55-8e0d-d39a24b40aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d275fea5-449f-495a-90c6-b909ae933f74" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ed0ec741-e9bb-4c55-8e0d-d39a24b40aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ed0ec741-e9bb-4c55-8e0d-d39a24b40aa2" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_debbe427-8198-48df-98b6-70e435b4a120" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_debbe427-8198-48df-98b6-70e435b4a120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8f5670d0-f991-480a-9597-ecb11acf7e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8f5670d0-f991-480a-9597-ecb11acf7e3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f54d192-50b6-4370-9a2c-fc99f458ee54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f54d192-50b6-4370-9a2c-fc99f458ee54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f54d192-50b6-4370-9a2c-fc99f458ee54_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f54d192-50b6-4370-9a2c-fc99f458ee54" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f54d192-50b6-4370-9a2c-fc99f458ee54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b55adbdb-df59-4fb9-bcc1-519af826787e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f54d192-50b6-4370-9a2c-fc99f458ee54" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b55adbdb-df59-4fb9-bcc1-519af826787e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d8737b73-bad8-432b-96b4-ef6c6aa87f95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b55adbdb-df59-4fb9-bcc1-519af826787e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d8737b73-bad8-432b-96b4-ef6c6aa87f95" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails" xlink:type="extended" id="i95653cc47a6545fe87809f6872b7f001_FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7ce35e89-0a37-41fe-afe3-a68067dd5701" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7ce35e89-0a37-41fe-afe3-a68067dd5701" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_471c318e-5125-4082-9734-90d1a6a877fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_471c318e-5125-4082-9734-90d1a6a877fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1134d489-97ad-42f8-af06-b41b95700ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1134d489-97ad-42f8-af06-b41b95700ff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1134d489-97ad-42f8-af06-b41b95700ff9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1134d489-97ad-42f8-af06-b41b95700ff9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1134d489-97ad-42f8-af06-b41b95700ff9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d364b338-3795-40f8-b6b2-ca85867d6f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1134d489-97ad-42f8-af06-b41b95700ff9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d364b338-3795-40f8-b6b2-ca85867d6f3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherEquitySecuritiesMember_a87709aa-105f-40f8-8099-1fbfeb94b9a3" xlink:href="gild-20200930.xsd#gild_OtherEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d364b338-3795-40f8-b6b2-ca85867d6f3b" xlink:to="loc_gild_OtherEquitySecuritiesMember_a87709aa-105f-40f8-8099-1fbfeb94b9a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_13f68fb3-a96a-4eda-872d-153fe5c8e60e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_13f68fb3-a96a-4eda-872d-153fe5c8e60e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a997caf4-34fa-4f4a-87ee-f289f5c692f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a997caf4-34fa-4f4a-87ee-f289f5c692f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_9d647e86-30fa-47dc-aa17-bed28574a622" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_9d647e86-30fa-47dc-aa17-bed28574a622" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecurities" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecurities"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecurities" xlink:type="extended" id="i95b754fbf8b44468b5eeb448f9d03af0_AvailableforSaleDebtSecurities"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables" xlink:type="extended" id="i7dec2f7d017647dd8ed8b4e67cf913ae_AvailableforSaleDebtSecuritiesTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails" xlink:type="extended" id="i1dab7791baa24ead88df11ff09870aa6_AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b58bb041-ca9c-4f18-95ac-32c7eaeb5a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b58bb041-ca9c-4f18-95ac-32c7eaeb5a5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_15051e71-7a65-4b84-a90c-834f921d08a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_15051e71-7a65-4b84-a90c-834f921d08a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d57d08df-4402-4d7a-85e8-4f63854cfceb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d57d08df-4402-4d7a-85e8-4f63854cfceb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9bf02515-94fb-4f1d-8d03-f3f43cc2bf3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9bf02515-94fb-4f1d-8d03-f3f43cc2bf3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_db38b87c-5b5f-4a7a-94ba-c36218584e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_db38b87c-5b5f-4a7a-94ba-c36218584e9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_98b82141-16c5-4964-9454-34c798126f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_db38b87c-5b5f-4a7a-94ba-c36218584e9d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_98b82141-16c5-4964-9454-34c798126f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_98b82141-16c5-4964-9454-34c798126f5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98b82141-16c5-4964-9454-34c798126f5c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_98b82141-16c5-4964-9454-34c798126f5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98b82141-16c5-4964-9454-34c798126f5c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_eeb3a71d-d3b0-40ae-900e-9a8cdb7f11f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_eeb3a71d-d3b0-40ae-900e-9a8cdb7f11f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_d06e605b-9fb7-40b4-924a-f79e72a25b08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_CertificatesOfDepositMember_d06e605b-9fb7-40b4-924a-f79e72a25b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c739e270-1609-4040-97eb-381f15a4b4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c739e270-1609-4040-97eb-381f15a4b4ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_7eb7fb2b-5bc7-409b-bde8-c29f68019225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_7eb7fb2b-5bc7-409b-bde8-c29f68019225" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e2e3aff9-6103-445d-a5d9-07d7af88ff79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e2e3aff9-6103-445d-a5d9-07d7af88ff79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_9c35afd1-f8ee-49ec-b0be-883391666c23" xlink:href="gild-20200930.xsd#gild_ResidentialMortgageAndAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_9c35afd1-f8ee-49ec-b0be-883391666c23" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails" xlink:type="extended" id="idec5bb5015104c09a24987023c5952a3_AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8948d6b2-a1b6-4923-af79-61c3d2399f90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b74226a-febf-47c8-a4cc-0d5bf834a41c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8948d6b2-a1b6-4923-af79-61c3d2399f90" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b74226a-febf-47c8-a4cc-0d5bf834a41c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bd016e7-1373-4d51-a0b6-fde7651813c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8948d6b2-a1b6-4923-af79-61c3d2399f90" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bd016e7-1373-4d51-a0b6-fde7651813c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3e16149-e2d9-4eaa-a555-49424fc36ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bd016e7-1373-4d51-a0b6-fde7651813c1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3e16149-e2d9-4eaa-a555-49424fc36ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3e16149-e2d9-4eaa-a555-49424fc36ec3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3e16149-e2d9-4eaa-a555-49424fc36ec3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3e16149-e2d9-4eaa-a555-49424fc36ec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3e16149-e2d9-4eaa-a555-49424fc36ec3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_8882d0e0-5bf1-4ac7-a38d-e3477ef353f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_8882d0e0-5bf1-4ac7-a38d-e3477ef353f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MarketableSecuritiesCurrentMember_73c55312-5270-4e23-afc9-35665f34065e" xlink:href="gild-20200930.xsd#gild_MarketableSecuritiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:to="loc_gild_MarketableSecuritiesCurrentMember_73c55312-5270-4e23-afc9-35665f34065e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MarketableSecuritiesNoncurrentMember_58a6ea1c-7fdb-40f8-9124-708b71911149" xlink:href="gild-20200930.xsd#gild_MarketableSecuritiesNoncurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:to="loc_gild_MarketableSecuritiesNoncurrentMember_58a6ea1c-7fdb-40f8-9124-708b71911149" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails" xlink:type="extended" id="ie551ee586d234cadb1270b15f0717d95_AvailableforSaleDebtSecuritiesAdditionalInformationDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended" id="i0ea9945366b7476dbdb6fb19f5916624_AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails" xlink:type="extended" id="i45c2db35db3649e39247ec356b67af09_AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ebcf5357-5fcb-4699-a0de-31e2ccb6e9de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ebcf5357-5fcb-4699-a0de-31e2ccb6e9de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_79b272ca-554a-4a65-9a5f-9ef0d2653eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_79b272ca-554a-4a65-9a5f-9ef0d2653eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_78e12a2a-ada1-43cb-beb9-7480a6f34f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_78e12a2a-ada1-43cb-beb9-7480a6f34f74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_35fbd3a1-c0ba-45df-a04b-d3f572286d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_35fbd3a1-c0ba-45df-a04b-d3f572286d0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8c2dd5f7-b10a-457e-9500-4ef95a78d0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8c2dd5f7-b10a-457e-9500-4ef95a78d0a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7d3af41a-2304-4c8f-86ca-027378645160" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7d3af41a-2304-4c8f-86ca-027378645160" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16b7c6ed-3eb5-44cd-8569-7d25edbdb8dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16b7c6ed-3eb5-44cd-8569-7d25edbdb8dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2f14081f-3ac8-44e7-9d01-20d380a6349f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16b7c6ed-3eb5-44cd-8569-7d25edbdb8dd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2f14081f-3ac8-44e7-9d01-20d380a6349f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2f14081f-3ac8-44e7-9d01-20d380a6349f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2f14081f-3ac8-44e7-9d01-20d380a6349f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2f14081f-3ac8-44e7-9d01-20d380a6349f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6db3bdfe-848c-4e1d-8936-91d11683b0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2f14081f-3ac8-44e7-9d01-20d380a6349f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6db3bdfe-848c-4e1d-8936-91d11683b0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_10a65e75-f8fc-41eb-a49a-1cfbf86dd0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6db3bdfe-848c-4e1d-8936-91d11683b0b1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_10a65e75-f8fc-41eb-a49a-1cfbf86dd0a1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstruments" xlink:type="extended" id="i1ea611e9b8c54a7187021dbef20b448c_DerivativeFinancialInstruments"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended" id="id6385d5d8c994fadb0b183c80c983f4e_DerivativeFinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails" xlink:type="extended" id="i70909fe0e79c4528b6de993a34544a1c_DerivativeFinancialInstrumentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_8b32a493-39da-48a4-9852-e1721dfc4594" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_8b32a493-39da-48a4-9852-e1721dfc4594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1_fc610b41-1ae1-4de8-bd8e-f6829302c104" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1_fc610b41-1ae1-4de8-bd8e-f6829302c104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7a756a67-cf07-408a-ae7e-ab6e36552696" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7a756a67-cf07-408a-ae7e-ab6e36552696" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet_2ca069fc-0bd9-4a7f-b69a-edab6dc47ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet_2ca069fc-0bd9-4a7f-b69a-edab6dc47ebb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2abf522-7907-47a1-bd24-1d25a9f421d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_DerivativeTable_b2abf522-7907-47a1-bd24-1d25a9f421d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be8200d6-9477-46cd-910c-0af9db7357d9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2abf522-7907-47a1-bd24-1d25a9f421d2" xlink:to="loc_srt_RangeAxis_be8200d6-9477-46cd-910c-0af9db7357d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_be8200d6-9477-46cd-910c-0af9db7357d9_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_be8200d6-9477-46cd-910c-0af9db7357d9" xlink:to="loc_srt_RangeMember_be8200d6-9477-46cd-910c-0af9db7357d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29a30449-8214-48b7-9c20-73224981ca97" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_be8200d6-9477-46cd-910c-0af9db7357d9" xlink:to="loc_srt_RangeMember_29a30449-8214-48b7-9c20-73224981ca97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_45d1282d-1e81-4681-a128-487c988ed5e1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29a30449-8214-48b7-9c20-73224981ca97" xlink:to="loc_srt_MaximumMember_45d1282d-1e81-4681-a128-487c988ed5e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails" xlink:type="extended" id="iee80e1d19afc4c5d9ebadb9aa969581c_DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_3c3ffee9-b3bf-47b0-8ce7-99fbf929264c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_3c3ffee9-b3bf-47b0-8ce7-99fbf929264c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_9d04b3a1-d001-4327-8fc8-e681836c4fde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_9d04b3a1-d001-4327-8fc8-e681836c4fde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_49633e40-cd7f-4fcf-b85b-ff2527bccd33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:to="loc_us-gaap_HedgingDesignationAxis_49633e40-cd7f-4fcf-b85b-ff2527bccd33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_49633e40-cd7f-4fcf-b85b-ff2527bccd33_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_49633e40-cd7f-4fcf-b85b-ff2527bccd33" xlink:to="loc_us-gaap_HedgingDesignationDomain_49633e40-cd7f-4fcf-b85b-ff2527bccd33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_49633e40-cd7f-4fcf-b85b-ff2527bccd33" xlink:to="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02b726a0-6ab0-4d85-903a-0bde9dccf552" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02b726a0-6ab0-4d85-903a-0bde9dccf552" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ccc2bc3a-4812-41b8-ac53-154f06b3b6fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:to="loc_us-gaap_NondesignatedMember_ccc2bc3a-4812-41b8-ac53-154f06b3b6fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f4c6004c-37a1-425e-8209-a67d362f0d26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f4c6004c-37a1-425e-8209-a67d362f0d26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_23bcaa86-6c8b-4c0c-a731-b2f27da42bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_23bcaa86-6c8b-4c0c-a731-b2f27da42bdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_40852004-3727-4ec5-8aef-b1f84d8d8cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_40852004-3727-4ec5-8aef-b1f84d8d8cc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_047be6f4-d3b8-4b29-afb2-62ba48e3d2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_047be6f4-d3b8-4b29-afb2-62ba48e3d2c9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails" xlink:type="extended" id="i0e70c6418cf5423c91d6e95afa93beef_DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails" xlink:type="extended" id="i2282914397754df7a6de193ea4600f58_DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements" xlink:type="simple" xlink:href="gild-20200930.xsd#AcquisitionsCollaborationsandOtherArrangements"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements" xlink:type="extended" id="i675d4f09b804405ab15d3f60e0c40e72_AcquisitionsCollaborationsandOtherArrangements"/>
  <link:roleRef roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AcquisitionsCollaborationsandOtherArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails" xlink:type="extended" id="iefe3bc5a3b3f4dc2ae13c4fae773a376_AcquisitionsCollaborationsandOtherArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsAndOtherArrangementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_eec30562-0684-4606-b684-cba55b252618" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_SharePrice_eec30562-0684-4606-b684-cba55b252618" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionCashOutflowNetOfCashAcquired_27c330c9-9ca2-41fb-8b26-17bad6142198" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionCashOutflowNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_AssetAcquisitionCashOutflowNetOfCashAcquired_27c330c9-9ca2-41fb-8b26-17bad6142198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_a5ddb414-1a03-49c3-8b9e-28ea97d62951" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_a5ddb414-1a03-49c3-8b9e-28ea97d62951" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash_8c805f97-5d90-4e36-b8f1-158e080d8dc5" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash_8c805f97-5d90-4e36-b8f1-158e080d8dc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e9633b2f-25a4-44ce-b65e-1364fab8a0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_ShareBasedCompensation_e9633b2f-25a4-44ce-b65e-1364fab8a0aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4928749f-def1-4a11-9af4-aa90f85a39ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4928749f-def1-4a11-9af4-aa90f85a39ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_798d2ec6-19ac-4a99-ab28-7ecdf89e739a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_798d2ec6-19ac-4a99-ab28-7ecdf89e739a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b3b7ea25-0501-46f7-ba02-af12b3ed90df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b3b7ea25-0501-46f7-ba02-af12b3ed90df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_cefb379f-0dbe-448b-a973-b7499f4e91e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_cefb379f-0dbe-448b-a973-b7499f4e91e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_c4f3dfe4-e518-428e-a4df-29c3d96cf49e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_c4f3dfe4-e518-428e-a4df-29c3d96cf49e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_808cc78e-2ef9-4098-b906-8f9b1003e7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_808cc78e-2ef9-4098-b906-8f9b1003e7c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalUpfrontPaymentsMade_6800d22e-3ad6-4298-8e02-05fad808fd7e" xlink:href="gild-20200930.xsd#gild_TotalUpfrontPaymentsMade"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_TotalUpfrontPaymentsMade_6800d22e-3ad6-4298-8e02-05fad808fd7e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InvestmentOwnedBalanceAdditionalShares_425f34ae-0389-424e-8135-f59bd8eb8719" xlink:href="gild-20200930.xsd#gild_InvestmentOwnedBalanceAdditionalShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_InvestmentOwnedBalanceAdditionalShares_425f34ae-0389-424e-8135-f59bd8eb8719" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_edb2a386-7d73-459e-8594-78ccec0f27b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_edb2a386-7d73-459e-8594-78ccec0f27b6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_f45a1ca3-1c19-42b5-838a-c9c7fd1d79a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_f45a1ca3-1c19-42b5-838a-c9c7fd1d79a7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IssuanceDiscountPremium_825e54fd-50eb-4bba-aef2-0297205b5efa" xlink:href="gild-20200930.xsd#gild_IssuanceDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_IssuanceDiscountPremium_825e54fd-50eb-4bba-aef2-0297205b5efa" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PaymentsForDirectTransactionalExpense_e3826dcf-d153-4af3-a3fc-f58153f216c8" xlink:href="gild-20200930.xsd#gild_PaymentsForDirectTransactionalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_PaymentsForDirectTransactionalExpense_e3826dcf-d153-4af3-a3fc-f58153f216c8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary_dcc15957-a94f-4464-a016-fd1f08d79215" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary_dcc15957-a94f-4464-a016-fd1f08d79215" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries_c670ceec-2369-44d4-aecd-83220a8c5393" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries_c670ceec-2369-44d4-aecd-83220a8c5393" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CollaborativeArrangementTerm_362867ad-dcd2-4b93-822c-0be813710314" xlink:href="gild-20200930.xsd#gild_CollaborativeArrangementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_CollaborativeArrangementTerm_362867ad-dcd2-4b93-822c-0be813710314" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments_6b275161-37c3-45e1-86fe-0d41a0078812" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments_6b275161-37c3-45e1-86fe-0d41a0078812" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIPurchasePeriod_78269b1f-d3d0-4790-ba65-a04845071d77" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIPurchasePeriod_78269b1f-d3d0-4790-ba65-a04845071d77" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased_d67a8db4-d4c3-42af-853c-b77824253a66" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased_d67a8db4-d4c3-42af-853c-b77824253a66" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIRestrictionPeriod_b003b038-df08-42a1-a27b-8dbc996b251b" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIRestrictionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIRestrictionPeriod_b003b038-df08-42a1-a27b-8dbc996b251b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_NumberOfAgreements_8777e1c7-774d-450f-a902-c0f1d177d37b" xlink:href="gild-20200930.xsd#gild_NumberOfAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_NumberOfAgreements_8777e1c7-774d-450f-a902-c0f1d177d37b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006a5817-a109-4ae0-8215-29db5c348087" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006a5817-a109-4ae0-8215-29db5c348087" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InvestmentOwnedBalanceAdditionalPayable_f29ad146-23e7-4961-8142-b43c7c359b9e" xlink:href="gild-20200930.xsd#gild_InvestmentOwnedBalanceAdditionalPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_InvestmentOwnedBalanceAdditionalPayable_f29ad146-23e7-4961-8142-b43c7c359b9e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_dc7507b2-7f0a-4ee1-91a3-c3818fe2a688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_dc7507b2-7f0a-4ee1-91a3-c3818fe2a688" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityMethodInvestmentOptionExerciseFee_f18379af-2eb3-40b8-ada4-c273c91de309" xlink:href="gild-20200930.xsd#gild_EquityMethodInvestmentOptionExerciseFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquityMethodInvestmentOptionExerciseFee_f18379af-2eb3-40b8-ada4-c273c91de309" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PotentialFutureMaximumMilestonePayments_fc086551-e673-4a8a-8846-da10c9bfbe67" xlink:href="gild-20200930.xsd#gild_PotentialFutureMaximumMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_PotentialFutureMaximumMilestonePayments_fc086551-e673-4a8a-8846-da10c9bfbe67" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments_98949a9e-fe6a-4858-9b56-40dbde3da5c1" xlink:href="gild-20200930.xsd#gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments_98949a9e-fe6a-4858-9b56-40dbde3da5c1" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResearchAndDevelopmentFutureMaximumPayments_3ff2d190-a672-44d7-ad44-0eb7bc8d81f9" xlink:href="gild-20200930.xsd#gild_ResearchAndDevelopmentFutureMaximumPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_ResearchAndDevelopmentFutureMaximumPayments_3ff2d190-a672-44d7-ad44-0eb7bc8d81f9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments_df59001c-b41f-4257-9094-ed2ec0d1a4b2" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments_df59001c-b41f-4257-9094-ed2ec0d1a4b2" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_NumberOfPrograms_4c80ed2f-d71b-45d8-a25e-e8a4b2cf556a" xlink:href="gild-20200930.xsd#gild_NumberOfPrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_NumberOfPrograms_4c80ed2f-d71b-45d8-a25e-e8a4b2cf556a" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing_d8955e07-16ca-4704-a6a7-1c42e0d4e554" xlink:href="gild-20200930.xsd#gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing_d8955e07-16ca-4704-a6a7-1c42e0d4e554" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd8d852f-58fa-4bd7-b013-b4bde8e3177b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd8d852f-58fa-4bd7-b013-b4bde8e3177b" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_405c782d-dc00-4f7c-9f8a-833aec9d0de9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquityMethodInvestments_405c782d-dc00-4f7c-9f8a-833aec9d0de9" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_99715e3a-8651-451b-8c9b-7c8b39737e50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_99715e3a-8651-451b-8c9b-7c8b39737e50" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_c4e31d66-3447-47dc-8d6f-f8fb3df0a623" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_c4e31d66-3447-47dc-8d6f-f8fb3df0a623" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_ca99d8f8-b5e1-4b8c-b531-062208701c88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_ca99d8f8-b5e1-4b8c-b531-062208701c88" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements_2d7a2f96-4429-43b6-bdc3-1817bde0dfcd" xlink:href="gild-20200930.xsd#gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements_2d7a2f96-4429-43b6-bdc3-1817bde0dfcd" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CashPaymentsMadeRelatedToEquityInvestments_286c713c-47b2-4d80-9083-f9af3ea23917" xlink:href="gild-20200930.xsd#gild_CashPaymentsMadeRelatedToEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_CashPaymentsMadeRelatedToEquityInvestments_286c713c-47b2-4d80-9083-f9af3ea23917" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsAndOtherArrangementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionAxis_eed9ce2b-e326-4108-800a-99f459e8c412" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_gild_AssetAcquisitionAxis_eed9ce2b-e326-4108-800a-99f459e8c412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionDomain_eed9ce2b-e326-4108-800a-99f459e8c412_default" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_gild_AssetAcquisitionAxis_eed9ce2b-e326-4108-800a-99f459e8c412" xlink:to="loc_gild_AssetAcquisitionDomain_eed9ce2b-e326-4108-800a-99f459e8c412_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionDomain_d01c2a4d-0b6e-4b29-b35d-c0a72c993681" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_gild_AssetAcquisitionAxis_eed9ce2b-e326-4108-800a-99f459e8c412" xlink:to="loc_gild_AssetAcquisitionDomain_d01c2a4d-0b6e-4b29-b35d-c0a72c993681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FortySevenIncMember_a5a20bd1-beca-4368-b268-3933f4130fe7" xlink:href="gild-20200930.xsd#gild_FortySevenIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gild_AssetAcquisitionDomain_d01c2a4d-0b6e-4b29-b35d-c0a72c993681" xlink:to="loc_gild_FortySevenIncMember_a5a20bd1-beca-4368-b268-3933f4130fe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ada12055-0afa-4ad6-b5fc-3ca936b67607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ada12055-0afa-4ad6-b5fc-3ca936b67607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ImmunomedicsIncMember_ac8eb6f8-362c-420c-8e3d-0afa508a76c0" xlink:href="gild-20200930.xsd#gild_ImmunomedicsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ada12055-0afa-4ad6-b5fc-3ca936b67607" xlink:to="loc_gild_ImmunomedicsIncMember_ac8eb6f8-362c-420c-8e3d-0afa508a76c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c302c4e3-b91b-476b-8e0c-950db6425597" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c302c4e3-b91b-476b-8e0c-950db6425597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_afdf3dce-1c22-41cc-ae04-1eef01d822a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c302c4e3-b91b-476b-8e0c-950db6425597" xlink:to="loc_us-gaap_SubsequentEventMember_afdf3dce-1c22-41cc-ae04-1eef01d822a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_69e90452-1850-4a00-9582-0c80eeb3e463" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_DebtInstrumentAxis_69e90452-1850-4a00-9582-0c80eeb3e463" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69e90452-1850-4a00-9582-0c80eeb3e463_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_69e90452-1850-4a00-9582-0c80eeb3e463" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69e90452-1850-4a00-9582-0c80eeb3e463_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_98febcca-39c0-4a94-baeb-66178f0e3da8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_69e90452-1850-4a00-9582-0c80eeb3e463" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_98febcca-39c0-4a94-baeb-66178f0e3da8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_8d0abd6d-edde-4c77-ac71-cdd6e1e10c23" xlink:href="gild-20200930.xsd#gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_98febcca-39c0-4a94-baeb-66178f0e3da8" xlink:to="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_8d0abd6d-edde-4c77-ac71-cdd6e1e10c23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_33e42cb5-94a6-455e-854c-ef4266da4be6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_33e42cb5-94a6-455e-854c-ef4266da4be6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_33e42cb5-94a6-455e-854c-ef4266da4be6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_33e42cb5-94a6-455e-854c-ef4266da4be6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_33e42cb5-94a6-455e-854c-ef4266da4be6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9322620c-1474-4c40-b454-eb0c4eebd0db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_33e42cb5-94a6-455e-854c-ef4266da4be6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9322620c-1474-4c40-b454-eb0c4eebd0db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_92b1ea4f-4f10-486c-885b-b0bdb99ced7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9322620c-1474-4c40-b454-eb0c4eebd0db" xlink:to="loc_us-gaap_MediumTermNotesMember_92b1ea4f-4f10-486c-885b-b0bdb99ced7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3f4bc994-3c66-479e-b012-a903bfb6b7f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_3f4bc994-3c66-479e-b012-a903bfb6b7f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f4bc994-3c66-479e-b012-a903bfb6b7f4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3f4bc994-3c66-479e-b012-a903bfb6b7f4" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3f4bc994-3c66-479e-b012-a903bfb6b7f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3f4bc994-3c66-479e-b012-a903bfb6b7f4" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember_12e19058-c8a9-47af-a328-aa136f0754af" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember_12e19058-c8a9-47af-a328-aa136f0754af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementMember_f51d7f8b-dec7-43bf-b256-efc7e250ce32" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OptionLicenseAndCollaborationAgreementMember_f51d7f8b-dec7-43bf-b256-efc7e250ce32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember_c3b090ea-b7ef-4510-8597-99114cc8390a" xlink:href="gild-20200930.xsd#gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember_c3b090ea-b7ef-4510-8597-99114cc8390a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PionyrMergerAndOptionAgreementsMember_08618a15-5ec6-4e74-a037-be3a9aca4a4a" xlink:href="gild-20200930.xsd#gild_PionyrMergerAndOptionAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_PionyrMergerAndOptionAgreementsMember_08618a15-5ec6-4e74-a037-be3a9aca4a4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResearchAndDevelopmentServiceAgreementMember_81b7c3b3-8215-4847-b260-92a5db8f2963" xlink:href="gild-20200930.xsd#gild_ResearchAndDevelopmentServiceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_ResearchAndDevelopmentServiceAgreementMember_81b7c3b3-8215-4847-b260-92a5db8f2963" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TizonaMergerAndOptionAgreementsMember_2a66aa82-f83a-48df-bc9e-81a8aee14610" xlink:href="gild-20200930.xsd#gild_TizonaMergerAndOptionAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_TizonaMergerAndOptionAgreementsMember_2a66aa82-f83a-48df-bc9e-81a8aee14610" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DevelopmentAgreementMember_9c902915-27d7-4afa-b169-a07b341039cb" xlink:href="gild-20200930.xsd#gild_DevelopmentAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_DevelopmentAgreementMember_9c902915-27d7-4afa-b169-a07b341039cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember_d2333fba-276d-4a09-a83d-13dc4d266bf1" xlink:href="gild-20200930.xsd#gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember_d2333fba-276d-4a09-a83d-13dc4d266bf1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember_e74d2808-9d61-4d52-b90e-315b9e92d400" xlink:href="gild-20200930.xsd#gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember_e74d2808-9d61-4d52-b90e-315b9e92d400" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember_4e044d87-921c-4705-9302-9c8604f138f6" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember_4e044d87-921c-4705-9302-9c8604f138f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_GadetaBVCollaborationArrangementMember_3438014f-97f0-4add-8122-90b70fb47335" xlink:href="gild-20200930.xsd#gild_GadetaBVCollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_GadetaBVCollaborationArrangementMember_3438014f-97f0-4add-8122-90b70fb47335" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherCollaborationArrangementsMember_62d00d62-2ee1-4679-9f3e-08790e6f56b0" xlink:href="gild-20200930.xsd#gild_OtherCollaborationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OtherCollaborationArrangementsMember_62d00d62-2ee1-4679-9f3e-08790e6f56b0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f617cc8-62d1-4fdf-b963-ac77850b0d64" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f617cc8-62d1-4fdf-b963-ac77850b0d64" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1f617cc8-62d1-4fdf-b963-ac77850b0d64_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f617cc8-62d1-4fdf-b963-ac77850b0d64" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1f617cc8-62d1-4fdf-b963-ac77850b0d64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f617cc8-62d1-4fdf-b963-ac77850b0d64" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ArcusBiosciencesIncMember_b6ad7936-59c0-4f6b-85d9-50f830115874" xlink:href="gild-20200930.xsd#gild_ArcusBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_ArcusBiosciencesIncMember_b6ad7936-59c0-4f6b-85d9-50f830115874" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PionyrImmunotherapeuticsIncMember_6de478fb-1aaa-4d4b-ab3d-a458f2cf1358" xlink:href="gild-20200930.xsd#gild_PionyrImmunotherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_PionyrImmunotherapeuticsIncMember_6de478fb-1aaa-4d4b-ab3d-a458f2cf1358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TizonaTherapeuticsIncMember_b28fa8fb-0da4-4de0-b974-5648e6067140" xlink:href="gild-20200930.xsd#gild_TizonaTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_TizonaTherapeuticsIncMember_b28fa8fb-0da4-4de0-b974-5648e6067140" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TangoTherapeuticsIncMember_35f5d802-946b-4a8b-bf36-52f1f8664e8d" xlink:href="gild-20200930.xsd#gild_TangoTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_TangoTherapeuticsIncMember_35f5d802-946b-4a8b-bf36-52f1f8664e8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JounceTherapeuticsIncMember_f4d7e6c9-bc8a-44da-9be0-8ae52a23a1bc" xlink:href="gild-20200930.xsd#gild_JounceTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_JounceTherapeuticsIncMember_f4d7e6c9-bc8a-44da-9be0-8ae52a23a1bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_GalapagosMember_75ce27d0-6c66-49a2-98f3-96d7614c8fd2" xlink:href="gild-20200930.xsd#gild_GalapagosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_GalapagosMember_75ce27d0-6c66-49a2-98f3-96d7614c8fd2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_srt_OwnershipAxis_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc" xlink:to="loc_srt_OwnershipDomain_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc" xlink:to="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ArcusBiosciencesIncMember_3b9a387a-5326-4f3f-a5e0-814bcd91fa5a" xlink:href="gild-20200930.xsd#gild_ArcusBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:to="loc_gild_ArcusBiosciencesIncMember_3b9a387a-5326-4f3f-a5e0-814bcd91fa5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TangoTherapeuticsIncMember_4accac99-8e96-4427-9c8b-072ad671745a" xlink:href="gild-20200930.xsd#gild_TangoTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:to="loc_gild_TangoTherapeuticsIncMember_4accac99-8e96-4427-9c8b-072ad671745a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JounceTherapeuticsIncMember_ef950756-0c46-49cd-8c6c-35c11a298d35" xlink:href="gild-20200930.xsd#gild_JounceTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:to="loc_gild_JounceTherapeuticsIncMember_ef950756-0c46-49cd-8c6c-35c11a298d35" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformation" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformation"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/OtherFinancialInformation" xlink:type="extended" id="i79b28832713b4d13a5afd101a3812199_OtherFinancialInformation"/>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationTables" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationTables" xlink:type="extended" id="i2d5f4bd0115546f691bcf4355236e94a_OtherFinancialInformationTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationInventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails" xlink:type="extended" id="i8790503bebad4c598e190011becf248a_OtherFinancialInformationInventoriesDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationOtherAccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails" xlink:type="extended" id="i7ff1c9c1589d4a13980edaac358b937b_OtherFinancialInformationOtherAccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssets" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IntangibleAssets" xlink:type="extended" id="i7c0f96ceed4d4e159a4f9ed2f6970fce_IntangibleAssets"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IntangibleAssetsTables" xlink:type="extended" id="i779c8130ad88492f9a69d9a548060b58_IntangibleAssetsTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended" id="if82ab7d2edc44a1994cdc5f5163bebb6_IntangibleAssetsSummaryofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c290ac7b-a0eb-4022-b4c6-d85547c10882" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c290ac7b-a0eb-4022-b4c6-d85547c10882" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbeac1da-5adc-4fa4-a376-a2476d6007fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbeac1da-5adc-4fa4-a376-a2476d6007fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_d7bd549e-8d8e-4406-925c-d1f0563a03cb" xlink:href="gild-20200930.xsd#gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_d7bd549e-8d8e-4406-925c-d1f0563a03cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94142f67-3e3d-4f74-b25e-24f1890db47d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94142f67-3e3d-4f74-b25e-24f1890db47d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4a2bec04-94ee-49bc-ad34-9a124f40ef55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4a2bec04-94ee-49bc-ad34-9a124f40ef55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4a2bec04-94ee-49bc-ad34-9a124f40ef55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IntangibleAssetSofosbuvirMember_7338366d-daef-47fe-be67-d802e159b2fe" xlink:href="gild-20200930.xsd#gild_IntangibleAssetSofosbuvirMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:to="loc_gild_IntangibleAssetSofosbuvirMember_7338366d-daef-47fe-be67-d802e159b2fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AxicabtageneciloleucelDLBCLMember_842174b3-3098-4b69-9b30-ad2b7145f671" xlink:href="gild-20200930.xsd#gild_AxicabtageneciloleucelDLBCLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:to="loc_gild_AxicabtageneciloleucelDLBCLMember_842174b3-3098-4b69-9b30-ad2b7145f671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_18253c89-af4b-418e-956c-fe320d31b810" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_18253c89-af4b-418e-956c-fe320d31b810" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97305c0a-51b8-481b-abe6-6bc2dfff5e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97305c0a-51b8-481b-abe6-6bc2dfff5e6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_0c228a74-7d7c-410d-b63e-54e077d92eb2" xlink:href="gild-20200930.xsd#gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:to="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_0c228a74-7d7c-410d-b63e-54e077d92eb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_e0197911-569a-4256-bf08-242ee1f71a51" xlink:href="gild-20200930.xsd#gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:to="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_e0197911-569a-4256-bf08-242ee1f71a51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c3922fd5-abbc-4dc9-8d47-9f9cea176362" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c3922fd5-abbc-4dc9-8d47-9f9cea176362" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c3922fd5-abbc-4dc9-8d47-9f9cea176362" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae7ed464-5f27-4dfc-993d-c9a609696fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae7ed464-5f27-4dfc-993d-c9a609696fa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6d3dcbd4-177f-4dda-b545-bba69ad21f11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae7ed464-5f27-4dfc-993d-c9a609696fa2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6d3dcbd4-177f-4dda-b545-bba69ad21f11" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="extended" id="i8c825b45e1534aef949698e0837efc9a_IntangibleAssetsAdditionalInformationDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="extended" id="id26b2eb28c4044c5b02487537d310b52_IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilities" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilities"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilities" xlink:type="extended" id="i2b46c2d583cf43cfb4eb03347ec0c6eb_DebtandCreditFacilities"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesTables" xlink:type="extended" id="i3c2b78f6d35740c0bac7f13e75a5a351_DebtandCreditFacilitiesTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails" xlink:type="extended" id="i1368e8b1aa834ae28d8bc4c9427b9a46_DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49b74b4f-ae0d-4c2a-a227-dc1205a1cc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49b74b4f-ae0d-4c2a-a227-dc1205a1cc8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_830bd5e3-6d80-4e63-bd21-aebc4189077f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_830bd5e3-6d80-4e63-bd21-aebc4189077f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5d0403a3-fc30-4399-a034-26be7dab51d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_LongTermDebt_5d0403a3-fc30-4399-a034-26be7dab51d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_62a627c9-8fc2-4698-a6ee-29e892298f73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_62a627c9-8fc2-4698-a6ee-29e892298f73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_59ed4074-1ffa-49ab-84c2-83a4eab99971" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_LongTermDebtCurrent_59ed4074-1ffa-49ab-84c2-83a4eab99971" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a798c005-aadd-4b18-9602-9a9307575a47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a798c005-aadd-4b18-9602-9a9307575a47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bd159c6-57df-400f-8c65-24c3b2280e23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bd159c6-57df-400f-8c65-24c3b2280e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bd159c6-57df-400f-8c65-24c3b2280e23_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bd159c6-57df-400f-8c65-24c3b2280e23" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bd159c6-57df-400f-8c65-24c3b2280e23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3b3b47e9-167b-49ab-b288-295d82317641" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bd159c6-57df-400f-8c65-24c3b2280e23" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3b3b47e9-167b-49ab-b288-295d82317641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7d88ddc8-f4c8-41af-b65f-77424b135130" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3b3b47e9-167b-49ab-b288-295d82317641" xlink:to="loc_us-gaap_SeniorNotesMember_7d88ddc8-f4c8-41af-b65f-77424b135130" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bc259ddc-190f-453a-9bda-7d43e98c12cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:to="loc_us-gaap_DebtInstrumentAxis_bc259ddc-190f-453a-9bda-7d43e98c12cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc259ddc-190f-453a-9bda-7d43e98c12cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bc259ddc-190f-453a-9bda-7d43e98c12cd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc259ddc-190f-453a-9bda-7d43e98c12cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bc259ddc-190f-453a-9bda-7d43e98c12cd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A235SeniorUnsecuredNotesDueFebruary2020Member_956d846d-83ee-440f-86e3-8ebd3f148ae1" xlink:href="gild-20200930.xsd#gild_A235SeniorUnsecuredNotesDueFebruary2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A235SeniorUnsecuredNotesDueFebruary2020Member_956d846d-83ee-440f-86e3-8ebd3f148ae1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A255SeniorUnsecuredNotesDueSeptember2020Member_837141ed-bd1c-4343-9803-a9bc2fe5d62a" xlink:href="gild-20200930.xsd#gild_A255SeniorUnsecuredNotesDueSeptember2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A255SeniorUnsecuredNotesDueSeptember2020Member_837141ed-bd1c-4343-9803-a9bc2fe5d62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A450SeniorUnsecuredNotesDueApril2021Member_df836dd8-97d3-4225-88e3-0487770330dd" xlink:href="gild-20200930.xsd#gild_A450SeniorUnsecuredNotesDueApril2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A450SeniorUnsecuredNotesDueApril2021Member_df836dd8-97d3-4225-88e3-0487770330dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_a70d2254-b509-41c4-871d-2788f6953035" xlink:href="gild-20200930.xsd#gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_a70d2254-b509-41c4-871d-2788f6953035" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A440SeniorUnsecuredNotesDueDecember2021Member_ed6a1ba0-f337-4b2a-ad7c-618c9ffde015" xlink:href="gild-20200930.xsd#gild_A440SeniorUnsecuredNotesDueDecember2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A440SeniorUnsecuredNotesDueDecember2021Member_ed6a1ba0-f337-4b2a-ad7c-618c9ffde015" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A195SeniorUnsecuredNotesDueMarch2022Member_3f3ab69d-a2bf-410f-930f-46e7d469daac" xlink:href="gild-20200930.xsd#gild_A195SeniorUnsecuredNotesDueMarch2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A195SeniorUnsecuredNotesDueMarch2022Member_3f3ab69d-a2bf-410f-930f-46e7d469daac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A325SeniorUnsecuredNotesDueSeptember2022Member_c551c945-c094-4535-88c7-40f96014d9c4" xlink:href="gild-20200930.xsd#gild_A325SeniorUnsecuredNotesDueSeptember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A325SeniorUnsecuredNotesDueSeptember2022Member_c551c945-c094-4535-88c7-40f96014d9c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A250SeniorUnsecuredNotesDueSeptember2023Member_ef05c0aa-d502-4b14-87a4-75ce20d40eb6" xlink:href="gild-20200930.xsd#gild_A250SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A250SeniorUnsecuredNotesDueSeptember2023Member_ef05c0aa-d502-4b14-87a4-75ce20d40eb6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_a6710a53-5d81-47e9-bf87-45c491f213c1" xlink:href="gild-20200930.xsd#gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_a6710a53-5d81-47e9-bf87-45c491f213c1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_f6339a9c-5047-419d-96fc-578cf58f051c" xlink:href="gild-20200930.xsd#gild_A075SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_f6339a9c-5047-419d-96fc-578cf58f051c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A370SeniorUnsecuredNotesDueApril2024Member_478cb758-f024-4c3a-8ee3-041481e23c46" xlink:href="gild-20200930.xsd#gild_A370SeniorUnsecuredNotesDueApril2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A370SeniorUnsecuredNotesDueApril2024Member_478cb758-f024-4c3a-8ee3-041481e23c46" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A350SeniorUnsecuredNotesDueFebruary2025Member_51c0fee7-74a0-4ba2-9fc1-16cda7691cc7" xlink:href="gild-20200930.xsd#gild_A350SeniorUnsecuredNotesDueFebruary2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A350SeniorUnsecuredNotesDueFebruary2025Member_51c0fee7-74a0-4ba2-9fc1-16cda7691cc7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A365SeniorUnsecuredNotesDueMarch2026Member_3985fa4f-12af-4608-a9dd-2d4d00cc8308" xlink:href="gild-20200930.xsd#gild_A365SeniorUnsecuredNotesDueMarch2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A365SeniorUnsecuredNotesDueMarch2026Member_3985fa4f-12af-4608-a9dd-2d4d00cc8308" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A295SeniorUnsecuredNotesDueMarch2027Member_ba789b56-d82e-4428-b929-ecf68e19b4f9" xlink:href="gild-20200930.xsd#gild_A295SeniorUnsecuredNotesDueMarch2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A295SeniorUnsecuredNotesDueMarch2027Member_ba789b56-d82e-4428-b929-ecf68e19b4f9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_e6eb0e1b-a7cd-4175-ab2e-74b2bdb3546d" xlink:href="gild-20200930.xsd#gild_A120SeniorUnsecuredNotesDueOctober2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_e6eb0e1b-a7cd-4175-ab2e-74b2bdb3546d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_06af5cb4-3064-42a3-a115-8617a07c17d9" xlink:href="gild-20200930.xsd#gild_A165SeniorUnsecuredNotesDueOctober2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_06af5cb4-3064-42a3-a115-8617a07c17d9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A460SeniorUnsecuredNotesDueSeptember2035Member_b2bbf53e-03dc-47a0-ac7f-3016da1c67eb" xlink:href="gild-20200930.xsd#gild_A460SeniorUnsecuredNotesDueSeptember2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A460SeniorUnsecuredNotesDueSeptember2035Member_b2bbf53e-03dc-47a0-ac7f-3016da1c67eb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A400SeniorUnsecuredNotesDueSeptember2036Member_9ea86750-971e-4f82-b3c8-7884600e8e5e" xlink:href="gild-20200930.xsd#gild_A400SeniorUnsecuredNotesDueSeptember2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A400SeniorUnsecuredNotesDueSeptember2036Member_9ea86750-971e-4f82-b3c8-7884600e8e5e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_cdc9ed91-4842-4ea0-bd7f-5dc33b2fe116" xlink:href="gild-20200930.xsd#gild_A260SeniorUnsecuredNotesDueOctober2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_cdc9ed91-4842-4ea0-bd7f-5dc33b2fe116" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A565SeniorUnsecuredNotesDueDecember2041Member_d8317b0b-443b-4337-846c-18a78583cd15" xlink:href="gild-20200930.xsd#gild_A565SeniorUnsecuredNotesDueDecember2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A565SeniorUnsecuredNotesDueDecember2041Member_d8317b0b-443b-4337-846c-18a78583cd15" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A480SeniorUnsecuredNotesDueApril2044Member_bb0c97b7-7d7c-4eb6-bb5f-af5bdef4f8d6" xlink:href="gild-20200930.xsd#gild_A480SeniorUnsecuredNotesDueApril2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A480SeniorUnsecuredNotesDueApril2044Member_bb0c97b7-7d7c-4eb6-bb5f-af5bdef4f8d6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A450SeniorUnsecuredNotesDueFebruary2045Member_ef0195ec-9a82-4fc3-8832-728202fae552" xlink:href="gild-20200930.xsd#gild_A450SeniorUnsecuredNotesDueFebruary2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A450SeniorUnsecuredNotesDueFebruary2045Member_ef0195ec-9a82-4fc3-8832-728202fae552" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A475SeniorUnsecuredNotesDueMarch2046Member_360afd0b-e3c8-4f13-8cab-6127c28d0790" xlink:href="gild-20200930.xsd#gild_A475SeniorUnsecuredNotesDueMarch2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A475SeniorUnsecuredNotesDueMarch2046Member_360afd0b-e3c8-4f13-8cab-6127c28d0790" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A415SeniorUnsecuredNotesDueMarch2047Member_6c39d623-4ea8-42f7-99df-e04ce5fdca96" xlink:href="gild-20200930.xsd#gild_A415SeniorUnsecuredNotesDueMarch2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A415SeniorUnsecuredNotesDueMarch2047Member_6c39d623-4ea8-42f7-99df-e04ce5fdca96" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_17d4ac33-5593-4182-9245-ab0f71d163fb" xlink:href="gild-20200930.xsd#gild_A280SeniorUnsecuredNotesDueOctober2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_17d4ac33-5593-4182-9245-ab0f71d163fb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f7a5abca-4aae-400a-a323-0acb8a57d1be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:to="loc_us-gaap_VariableRateAxis_f7a5abca-4aae-400a-a323-0acb8a57d1be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f7a5abca-4aae-400a-a323-0acb8a57d1be_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f7a5abca-4aae-400a-a323-0acb8a57d1be" xlink:to="loc_us-gaap_VariableRateDomain_f7a5abca-4aae-400a-a323-0acb8a57d1be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9ec32d63-c95c-4742-98f0-848f4c6c7e80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f7a5abca-4aae-400a-a323-0acb8a57d1be" xlink:to="loc_us-gaap_VariableRateDomain_9ec32d63-c95c-4742-98f0-848f4c6c7e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd086723-4e71-4438-9509-e31aae165299" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9ec32d63-c95c-4742-98f0-848f4c6c7e80" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd086723-4e71-4438-9509-e31aae165299" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails" xlink:type="extended" id="i7b94833cb9d64760baaa61574e1424f6_DebtandCreditFacilitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7182a4a3-22f6-4fad-ba8d-de7b0335df12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7182a4a3-22f6-4fad-ba8d-de7b0335df12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3e5465b3-e051-45fc-81c6-a160045d41c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3e5465b3-e051-45fc-81c6-a160045d41c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_7f11b24c-cb47-471f-8bf5-453eaf1ef125" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_7f11b24c-cb47-471f-8bf5-453eaf1ef125" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments_d373e6ec-d051-4844-8ba1-a4c35fa3e7a2" xlink:href="gild-20200930.xsd#gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments_d373e6ec-d051-4844-8ba1-a4c35fa3e7a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity_06b7f260-2cd9-4483-a7d9-06bf38a73346" xlink:href="gild-20200930.xsd#gild_DebtInstrumentCallFeaturePeriodBeforeMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity_06b7f260-2cd9-4483-a7d9-06bf38a73346" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt_4d14e918-0547-4a1f-b50f-7d2f97e2265b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_RepaymentsOfUnsecuredDebt_4d14e918-0547-4a1f-b50f-7d2f97e2265b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_024425c9-9506-4290-98b3-da906393d057" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentTerm_024425c9-9506-4290-98b3-da906393d057" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91a11503-1f7e-467c-be6d-e403ab8ed028" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91a11503-1f7e-467c-be6d-e403ab8ed028" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a45cc26a-50e3-4e54-90a2-3d3675e51505" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_LongTermDebt_a45cc26a-50e3-4e54-90a2-3d3675e51505" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_3fd43e42-1ea1-4d7a-a5f2-acb86e74177c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_LineOfCredit_3fd43e42-1ea1-4d7a-a5f2-acb86e74177c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_989159ce-4aec-4a22-858f-726ba0eeac75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_989159ce-4aec-4a22-858f-726ba0eeac75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_989159ce-4aec-4a22-858f-726ba0eeac75_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_989159ce-4aec-4a22-858f-726ba0eeac75" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_989159ce-4aec-4a22-858f-726ba0eeac75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_989159ce-4aec-4a22-858f-726ba0eeac75" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_39c632d4-e94f-4910-bdd0-6db62e6d13ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:to="loc_us-gaap_SeniorNotesMember_39c632d4-e94f-4910-bdd0-6db62e6d13ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_722b4425-e3a3-4056-a424-bc257ad6fa54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:to="loc_us-gaap_MediumTermNotesMember_722b4425-e3a3-4056-a424-bc257ad6fa54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2a5d62ee-bf88-4307-83ab-e60baaaf9838" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_CreditFacilityAxis_2a5d62ee-bf88-4307-83ab-e60baaaf9838" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2a5d62ee-bf88-4307-83ab-e60baaaf9838_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2a5d62ee-bf88-4307-83ab-e60baaaf9838" xlink:to="loc_us-gaap_CreditFacilityDomain_2a5d62ee-bf88-4307-83ab-e60baaaf9838_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d599758a-8469-4344-80b5-b5aec6a09421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2a5d62ee-bf88-4307-83ab-e60baaaf9838" xlink:to="loc_us-gaap_CreditFacilityDomain_d599758a-8469-4344-80b5-b5aec6a09421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17e13074-229c-4f9c-a67c-4c6badf2a7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d599758a-8469-4344-80b5-b5aec6a09421" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17e13074-229c-4f9c-a67c-4c6badf2a7f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2e19c5e0-6313-40d3-81d4-b216ba3bfecc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_DebtInstrumentAxis_2e19c5e0-6313-40d3-81d4-b216ba3bfecc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2e19c5e0-6313-40d3-81d4-b216ba3bfecc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2e19c5e0-6313-40d3-81d4-b216ba3bfecc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2e19c5e0-6313-40d3-81d4-b216ba3bfecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2e19c5e0-6313-40d3-81d4-b216ba3bfecc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedSeptember2020Member_69ff6686-d401-496d-9caf-ec1fcc94ac79" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedSeptember2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_SeniorUnsecuredNoteIssuedSeptember2020Member_69ff6686-d401-496d-9caf-ec1fcc94ac79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_61a4577f-8839-4270-8412-f96bb5df5e74" xlink:href="gild-20200930.xsd#gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_61a4577f-8839-4270-8412-f96bb5df5e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_03fdac44-e899-4893-8dc6-82aecece4e12" xlink:href="gild-20200930.xsd#gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_03fdac44-e899-4893-8dc6-82aecece4e12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_84386571-bf40-4a9a-b671-7102765457f0" xlink:href="gild-20200930.xsd#gild_A075SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_84386571-bf40-4a9a-b671-7102765457f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_85cf70af-ee96-4a2d-bd77-e06c4450ffa9" xlink:href="gild-20200930.xsd#gild_A120SeniorUnsecuredNotesDueOctober2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_85cf70af-ee96-4a2d-bd77-e06c4450ffa9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_0c4acd89-0806-4c84-ae83-980703eba46d" xlink:href="gild-20200930.xsd#gild_A165SeniorUnsecuredNotesDueOctober2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_0c4acd89-0806-4c84-ae83-980703eba46d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_8cda564b-5110-442d-89b2-c233c8c53d60" xlink:href="gild-20200930.xsd#gild_A260SeniorUnsecuredNotesDueOctober2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_8cda564b-5110-442d-89b2-c233c8c53d60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_30ce8572-da83-46c0-85a6-746987b0a8b0" xlink:href="gild-20200930.xsd#gild_A280SeniorUnsecuredNotesDueOctober2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_30ce8572-da83-46c0-85a6-746987b0a8b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member_fc930d09-b5cb-4044-9c8e-8fa7c6038620" xlink:href="gild-20200930.xsd#gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member_fc930d09-b5cb-4044-9c8e-8fa7c6038620" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedNovember2014Member_f3f74d6e-e62c-4373-9f48-1c56d48b61ed" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedNovember2014Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_SeniorUnsecuredNoteIssuedNovember2014Member_f3f74d6e-e62c-4373-9f48-1c56d48b61ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedSeptember2015Member_9239da4f-d094-4505-83af-338fdc94d1d0" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedSeptember2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_SeniorUnsecuredNoteIssuedSeptember2015Member_9239da4f-d094-4505-83af-338fdc94d1d0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_b44c0d23-9209-4b58-b66f-80abc49d3131" xlink:href="gild-20200930.xsd#gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_b44c0d23-9209-4b58-b66f-80abc49d3131" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CreditFacilityDueMay2021Member_07fd7e4b-66f7-4324-9816-bab9bf2b4b4c" xlink:href="gild-20200930.xsd#gild_CreditFacilityDueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_CreditFacilityDueMay2021Member_07fd7e4b-66f7-4324-9816-bab9bf2b4b4c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CreditFacilityDueJune2025Member_ec2c00ef-8267-4985-be25-87f53d78c07d" xlink:href="gild-20200930.xsd#gild_CreditFacilityDueJune2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_CreditFacilityDueJune2025Member_ec2c00ef-8267-4985-be25-87f53d78c07d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e4bf8dd2-12c0-4b14-864d-422418e521ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_VariableRateAxis_e4bf8dd2-12c0-4b14-864d-422418e521ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e4bf8dd2-12c0-4b14-864d-422418e521ce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e4bf8dd2-12c0-4b14-864d-422418e521ce" xlink:to="loc_us-gaap_VariableRateDomain_e4bf8dd2-12c0-4b14-864d-422418e521ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7fa1cd2a-3921-4885-bbac-8cf260b5e4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e4bf8dd2-12c0-4b14-864d-422418e521ce" xlink:to="loc_us-gaap_VariableRateDomain_7fa1cd2a-3921-4885-bbac-8cf260b5e4e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_55753d9d-a5e8-46de-92f0-b4df3de26563" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7fa1cd2a-3921-4885-bbac-8cf260b5e4e6" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_55753d9d-a5e8-46de-92f0-b4df3de26563" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a08c0da-ecc7-4a8d-8126-7955a669f650" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_srt_RangeAxis_7a08c0da-ecc7-4a8d-8126-7955a669f650" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7a08c0da-ecc7-4a8d-8126-7955a669f650_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7a08c0da-ecc7-4a8d-8126-7955a669f650" xlink:to="loc_srt_RangeMember_7a08c0da-ecc7-4a8d-8126-7955a669f650_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7a08c0da-ecc7-4a8d-8126-7955a669f650" xlink:to="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5e07ccc5-c9fc-465f-9084-3a0168fde498" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:to="loc_srt_MinimumMember_5e07ccc5-c9fc-465f-9084-3a0168fde498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b8af2ac3-0f61-4bbc-8e31-045ed5a88fe2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:to="loc_srt_MaximumMember_b8af2ac3-0f61-4bbc-8e31-045ed5a88fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_195e2bf8-4908-41fc-aec1-b5f279c8fa46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_195e2bf8-4908-41fc-aec1-b5f279c8fa46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_86160105-e586-4515-8909-765169357d76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_195e2bf8-4908-41fc-aec1-b5f279c8fa46" xlink:to="loc_us-gaap_SubsequentEventMember_86160105-e586-4515-8909-765169357d76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e615ac83-4378-46a7-bf89-35a684ca8e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e615ac83-4378-46a7-bf89-35a684ca8e6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e615ac83-4378-46a7-bf89-35a684ca8e6b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e615ac83-4378-46a7-bf89-35a684ca8e6b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e615ac83-4378-46a7-bf89-35a684ca8e6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dd531fa-d1e2-46e2-9c63-677955d12306" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e615ac83-4378-46a7-bf89-35a684ca8e6b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dd531fa-d1e2-46e2-9c63-677955d12306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ImmunomedicsIncMember_327442df-adbf-498f-a4ea-1cbf428dc1c6" xlink:href="gild-20200930.xsd#gild_ImmunomedicsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dd531fa-d1e2-46e2-9c63-677955d12306" xlink:to="loc_gild_ImmunomedicsIncMember_327442df-adbf-498f-a4ea-1cbf428dc1c6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="gild-20200930.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CommitmentsandContingencies" xlink:type="extended" id="ibe7890e69d3449268e486f2121dd7d28_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended" id="ica60bec27ff249cfba6cbe1986941682_CommitmentsandContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_582db721-b52a-4321-9b54-85e2eeb3f9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_582db721-b52a-4321-9b54-85e2eeb3f9ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyMotionInvalidatedForPastDamagesValue_b3137f02-ce14-48c3-9706-541c6ddc8156" xlink:href="gild-20200930.xsd#gild_LossContingencyMotionInvalidatedForPastDamagesValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyMotionInvalidatedForPastDamagesValue_b3137f02-ce14-48c3-9706-541c6ddc8156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentRoyaltyRateFromOctober2017_f22debd9-8e99-48b5-ae43-ab39b1df7a6c" xlink:href="gild-20200930.xsd#gild_JudgmentRoyaltyRateFromOctober2017"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_JudgmentRoyaltyRateFromOctober2017_f22debd9-8e99-48b5-ae43-ab39b1df7a6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentEnhancedDamagesonPastSales_af2b09e4-67b2-43a4-93f0-01eb1a368b2d" xlink:href="gild-20200930.xsd#gild_JudgmentEnhancedDamagesonPastSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_JudgmentEnhancedDamagesonPastSales_af2b09e4-67b2-43a4-93f0-01eb1a368b2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentRoyaltyRateOnFutureSales_20d41f77-b8f9-46a6-966e-fec5939b260d" xlink:href="gild-20200930.xsd#gild_JudgmentRoyaltyRateOnFutureSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_JudgmentRoyaltyRateOnFutureSales_20d41f77-b8f9-46a6-966e-fec5939b260d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_1173b043-4b16-4ad9-9d5b-2d56e5d42353" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_1173b043-4b16-4ad9-9d5b-2d56e5d42353" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLossPastSales_9ca3a570-6769-4c52-a904-57004a2281db" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLossPastSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyEstimateofPossibleLossPastSales_9ca3a570-6769-4c52-a904-57004a2281db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages_15d6c53d-7cdc-4ba9-b811-f896d58a456a" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages_15d6c53d-7cdc-4ba9-b811-f896d58a456a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest_5b968b5f-6fb8-45a6-bc42-736afd96f069" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest_5b968b5f-6fb8-45a6-bc42-736afd96f069" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_63898735-195e-4342-a59f-78b7a18a41e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_63898735-195e-4342-a59f-78b7a18a41e2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9e5b4aa6-1eb4-4f06-b158-c17250b17709" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:to="loc_srt_LitigationCaseAxis_9e5b4aa6-1eb4-4f06-b158-c17250b17709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9e5b4aa6-1eb4-4f06-b158-c17250b17709_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9e5b4aa6-1eb4-4f06-b158-c17250b17709" xlink:to="loc_srt_LitigationCaseTypeDomain_9e5b4aa6-1eb4-4f06-b158-c17250b17709_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9e5b4aa6-1eb4-4f06-b158-c17250b17709" xlink:to="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndenixMember_699100d4-8d4c-4b01-936e-cf3e883a66c6" xlink:href="gild-20200930.xsd#gild_IndenixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:to="loc_gild_IndenixMember_699100d4-8d4c-4b01-936e-cf3e883a66c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JunoMember_ad2f9e04-94c9-47aa-89bd-0ed3e44948eb" xlink:href="gild-20200930.xsd#gild_JunoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:to="loc_gild_JunoMember_ad2f9e04-94c9-47aa-89bd-0ed3e44948eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89654bb6-b552-4fa0-bce0-fc09ad716713" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:to="loc_srt_RangeAxis_89654bb6-b552-4fa0-bce0-fc09ad716713" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_89654bb6-b552-4fa0-bce0-fc09ad716713_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_89654bb6-b552-4fa0-bce0-fc09ad716713" xlink:to="loc_srt_RangeMember_89654bb6-b552-4fa0-bce0-fc09ad716713_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_89654bb6-b552-4fa0-bce0-fc09ad716713" xlink:to="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c1a40eb8-8fde-4d71-ad70-6f307654dd8d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:to="loc_srt_MinimumMember_c1a40eb8-8fde-4d71-ad70-6f307654dd8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0f3da065-a3e0-4735-b865-e70e0f5b4e35" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:to="loc_srt_MaximumMember_0f3da065-a3e0-4735-b865-e70e0f5b4e35" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquity" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/StockholdersEquity" xlink:type="extended" id="i9e033f32098a456382e3a9ffeefdf1b3_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/StockholdersEquityTables" xlink:type="extended" id="ic1ba5be39679424bbc44c933107cd907_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended" id="i922d35a0cf584fafaf1bc028c0b60efc_StockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_6ce1f154-7866-4d3d-95a8-0c86f41627d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_6ce1f154-7866-4d3d-95a8-0c86f41627d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20212901-6c57-46c3-b036-afbe20ff17d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20212901-6c57-46c3-b036-afbe20ff17d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e26ee781-61e8-4665-9c31-25b288620987" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e26ee781-61e8-4665-9c31-25b288620987" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f58f146f-443d-43bb-a856-61267e739b20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f58f146f-443d-43bb-a856-61267e739b20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8e89c19f-aed5-4f47-85bc-124169cc918d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8e89c19f-aed5-4f47-85bc-124169cc918d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8e89c19f-aed5-4f47-85bc-124169cc918d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8e89c19f-aed5-4f47-85bc-124169cc918d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8e89c19f-aed5-4f47-85bc-124169cc918d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8e89c19f-aed5-4f47-85bc-124169cc918d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A2016StockRepurchaseProgramMember_82bc9dcd-080f-4b9f-bf1c-650766eef5b9" xlink:href="gild-20200930.xsd#gild_A2016StockRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:to="loc_gild_A2016StockRepurchaseProgramMember_82bc9dcd-080f-4b9f-bf1c-650766eef5b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A2020StockRepurchaseProgramMember_03c53527-8e4d-46b8-a187-a362f8269176" xlink:href="gild-20200930.xsd#gild_A2020StockRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:to="loc_gild_A2020StockRepurchaseProgramMember_03c53527-8e4d-46b8-a187-a362f8269176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2" xlink:to="loc_us-gaap_ClassOfStockDomain_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fdc59149-676f-4569-b02f-9699600a541c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2" xlink:to="loc_us-gaap_ClassOfStockDomain_fdc59149-676f-4569-b02f-9699600a541c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i44247160dc4b4651b807d228f85b13cf_StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_07cbcc26-ad44-44cd-9045-107bdf080fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_07cbcc26-ad44-44cd-9045-107bdf080fc9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_76bc11e6-508c-4638-b22d-20ff66e88e95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_StockholdersEquity_76bc11e6-508c-4638-b22d-20ff66e88e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_47b4904c-978b-4839-963e-92e65de8dd8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_47b4904c-978b-4839-963e-92e65de8dd8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_db823ff6-74f3-44ed-9c60-8ed48029cfbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_db823ff6-74f3-44ed-9c60-8ed48029cfbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3af184bd-75c4-4014-9c95-bddc3634b7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3af184bd-75c4-4014-9c95-bddc3634b7bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3e2d3bb6-80be-4da0-84f4-7210c8999bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d81e4e04-2062-4a7f-b926-d8aacdfabb57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_07cbcc26-ad44-44cd-9045-107bdf080fc9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d81e4e04-2062-4a7f-b926-d8aacdfabb57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3e38f25c-b9c1-42ee-9283-438101aae168" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d81e4e04-2062-4a7f-b926-d8aacdfabb57" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3e38f25c-b9c1-42ee-9283-438101aae168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3e38f25c-b9c1-42ee-9283-438101aae168_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3e38f25c-b9c1-42ee-9283-438101aae168" xlink:to="loc_us-gaap_EquityComponentDomain_3e38f25c-b9c1-42ee-9283-438101aae168_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3e38f25c-b9c1-42ee-9283-438101aae168" xlink:to="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6763d9c5-5788-43a4-92c6-b2c7be06a6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6763d9c5-5788-43a4-92c6-b2c7be06a6b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0b94b215-2ad6-4738-803a-d48b8695cb5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0b94b215-2ad6-4738-803a-d48b8695cb5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c598aaab-6678-4d6a-bdcf-338298373d30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c598aaab-6678-4d6a-bdcf-338298373d30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4092607-59d7-4d43-9988-32adafcdf764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4092607-59d7-4d43-9988-32adafcdf764" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholders"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders" xlink:type="extended" id="i0c367cf764f541e0b2580c09c98c9f1c_NetIncomeLossPerShareAttributabletoGileadCommonStockholders"/>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables" xlink:type="extended" id="i5b08048b04b945898eb06b0b835fa7c7_NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails" xlink:type="extended" id="ib85356fe9ac849289937e78967783130_NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails" xlink:type="extended" id="i95bcf316f2934c209eb9fd3e58eacc74_NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxes" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IncomeTaxes" xlink:type="extended" id="i6a3cf48f73c24232a6cb3b45ac528ded_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IncomeTaxesTables" xlink:type="extended" id="i339ca02a987146279d0746d97b3f925e_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails" xlink:type="extended" id="ia82b6bb8e2ff477f8917244111818a9f_IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended" id="i29e409e0d4004c869e701c208bcc47e3_IncomeTaxesAdditionalInformationDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>gild-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dd71f5ae-c8d4-497f-83ec-41f4a56b820c,g:fe07381a-9620-491b-af7b-d6c30510011c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_gild_IntangibleAssetSofosbuvirMember_fcf51bf7-483e-45e1-be6d-83edfc07f2e7_terseLabel_en-US" xlink:label="lab_gild_IntangibleAssetSofosbuvirMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset - sofosbuvir</link:label>
    <link:label id="lab_gild_IntangibleAssetSofosbuvirMember_label_en-US" xlink:label="lab_gild_IntangibleAssetSofosbuvirMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset - Sofosbuvir [Member]</link:label>
    <link:label id="lab_gild_IntangibleAssetSofosbuvirMember_documentation_en-US" xlink:label="lab_gild_IntangibleAssetSofosbuvirMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sofosbuvir [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IntangibleAssetSofosbuvirMember" xlink:href="gild-20200930.xsd#gild_IntangibleAssetSofosbuvirMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_IntangibleAssetSofosbuvirMember" xlink:to="lab_gild_IntangibleAssetSofosbuvirMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_13cfeda1-6782-4b6d-b4f0-d49ed264d59a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_304bc2cc-cf2b-4a38-9442-459054b2ce21_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8857d0e3-446d-4d8e-b295-dd350c17b419_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a1ce6e34-1910-4c4f-a256-31147affc604_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b6451011-e3d0-4d05-9c85-dc985dd416f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) reclassified from AOCI into product sales</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_302f45fb-33b2-4294-98cc-0302454aef77_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts outstanding under revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity_cca079a3-7c69-4e78-aeba-326b59418dfa_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest in VIE</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:to="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0b0f13e3-dba8-42b1-a6e8-f531b36e20da_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e62889ad-a924-474f-b491-09eb3ec7406d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_JudgmentRoyaltyRateOnFutureSales_ea1ad947-7d5e-4373-85f4-c71dc5a645ca_terseLabel_en-US" xlink:label="lab_gild_JudgmentRoyaltyRateOnFutureSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Running royalty rate on future sales</link:label>
    <link:label id="lab_gild_JudgmentRoyaltyRateOnFutureSales_label_en-US" xlink:label="lab_gild_JudgmentRoyaltyRateOnFutureSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment: Royalty Rate on Future Sales</link:label>
    <link:label id="lab_gild_JudgmentRoyaltyRateOnFutureSales_documentation_en-US" xlink:label="lab_gild_JudgmentRoyaltyRateOnFutureSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment: Royalty Rate on Future Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentRoyaltyRateOnFutureSales" xlink:href="gild-20200930.xsd#gild_JudgmentRoyaltyRateOnFutureSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_JudgmentRoyaltyRateOnFutureSales" xlink:to="lab_gild_JudgmentRoyaltyRateOnFutureSales" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing_c6fe0157-2883-48fb-a8c4-9ffc8293d356_terseLabel_en-US" xlink:label="lab_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and option rights paid upon closing</link:label>
    <link:label id="lab_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing_label_en-US" xlink:label="lab_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for License and Option Rights for Equity Investments Upon Closing</link:label>
    <link:label id="lab_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing_documentation_en-US" xlink:label="lab_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for license and option rights for equity investments upon closing of collaboration agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" xlink:href="gild-20200930.xsd#gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" xlink:to="lab_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_aa868002-3fe0-403e-a53c-33b3367da85a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, indefinite-lived assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_eeeee6bc-0f8e-4225-a036-dc7455cae43f_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborations and Other Arrangements [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_c03f2232-60a1-422f-8a93-7a839397023d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A2020StockRepurchaseProgramMember_bc6fdaa4-3910-4a19-8b56-cc5a4d7417b8_terseLabel_en-US" xlink:label="lab_gild_A2020StockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Repurchase Program</link:label>
    <link:label id="lab_gild_A2020StockRepurchaseProgramMember_label_en-US" xlink:label="lab_gild_A2020StockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Repurchase Program [Member]</link:label>
    <link:label id="lab_gild_A2020StockRepurchaseProgramMember_documentation_en-US" xlink:label="lab_gild_A2020StockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A2020StockRepurchaseProgramMember" xlink:href="gild-20200930.xsd#gild_A2020StockRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A2020StockRepurchaseProgramMember" xlink:to="lab_gild_A2020StockRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_35201e31-bc91-4ad2-af73-bc5d671566b6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_40d4568d-f714-46d1-8b03-8fe4ce957865_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsYescartaMember_25b9efd5-8ce2-416d-87cf-b52b89c46aac_terseLabel_en-US" xlink:label="lab_gild_OtherProductsYescartaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yescarta</link:label>
    <link:label id="lab_gild_OtherProductsYescartaMember_label_en-US" xlink:label="lab_gild_OtherProductsYescartaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Yescarta [Member]</link:label>
    <link:label id="lab_gild_OtherProductsYescartaMember_documentation_en-US" xlink:label="lab_gild_OtherProductsYescartaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Yescarta [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsYescartaMember" xlink:href="gild-20200930.xsd#gild_OtherProductsYescartaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsYescartaMember" xlink:to="lab_gild_OtherProductsYescartaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9f566eca-febb-44f7-8d6a-01ce39ef6159_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_994f04f6-0133-41f3-8505-16e5ebc71651_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_2d039b57-dd8b-49ba-be45-78000816afa1_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f235da7d-6d1d-4bff-9a81-1dd78a233970_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_ef64bf78-ac5b-43d2-b854-c73266474256_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2c2c11e7-0729-4b7b-849f-3038f989648f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in per share calculation - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ab03388-7b2a-4318-8a8a-7ef4726d9f29_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in per share calculation - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2793a88f-9b77-4a20-ac65-0f054fcf0c51_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_da998f44-1ab4-4e89-a41b-52ceb796a1b4_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_677fceb8-f0e0-4f2a-9b4d-e51d8b3875ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Classification of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_895d8bdb-e675-49db-b784-f5e1bc03fd64_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_3f155913-e7ed-4ccd-9fe2-491efa5302d3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities owned (in shares)</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:to="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b64a9936-0858-4ab6-95e8-5b9c10de3267_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_c2b7b4ff-f406-4de4-9325-868b52a90c1e_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_5a3bfc17-82b8-4bff-8e1c-461239815243_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0b36ed23-a9d8-4bdd-a211-2900531826cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a9380976-9f7f-452c-82fd-4b3e3171391e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4b34babb-6edd-4288-880e-37906ad228cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a44b98c8-2d9a-4512-bfc5-50e5ed642e90_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f1bb43d3-e893-4500-93b5-26724b838309_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_db2418e0-d2db-46f9-8e81-7efd0c478932_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9bd03eb6-1e16-4454-8778-86a27d4e3ea1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ResearchAndDevelopmentFutureMaximumPayments_776bba3c-5338-4e34-92bc-e850d8aa4cf4_terseLabel_en-US" xlink:label="lab_gild_ResearchAndDevelopmentFutureMaximumPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential maximum future milestone payments</link:label>
    <link:label id="lab_gild_ResearchAndDevelopmentFutureMaximumPayments_label_en-US" xlink:label="lab_gild_ResearchAndDevelopmentFutureMaximumPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Future Maximum Payments</link:label>
    <link:label id="lab_gild_ResearchAndDevelopmentFutureMaximumPayments_documentation_en-US" xlink:label="lab_gild_ResearchAndDevelopmentFutureMaximumPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Future Maximum Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResearchAndDevelopmentFutureMaximumPayments" xlink:href="gild-20200930.xsd#gild_ResearchAndDevelopmentFutureMaximumPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ResearchAndDevelopmentFutureMaximumPayments" xlink:to="lab_gild_ResearchAndDevelopmentFutureMaximumPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_df849770-562c-4cac-9a5c-55b9b4b2fb89_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsAmBisomeMember_b63c5d71-7818-4c24-b19c-80c0cbb78031_terseLabel_en-US" xlink:label="lab_gild_OtherProductsAmBisomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmBisome</link:label>
    <link:label id="lab_gild_OtherProductsAmBisomeMember_label_en-US" xlink:label="lab_gild_OtherProductsAmBisomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, AmBisome [Member]</link:label>
    <link:label id="lab_gild_OtherProductsAmBisomeMember_documentation_en-US" xlink:label="lab_gild_OtherProductsAmBisomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, AmBisome [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsAmBisomeMember" xlink:href="gild-20200930.xsd#gild_OtherProductsAmBisomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsAmBisomeMember" xlink:to="lab_gild_OtherProductsAmBisomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquityinvestmentinGalapagosMember_269e33e5-1c82-450d-95c2-633caca6dff4_terseLabel_en-US" xlink:label="lab_gild_EquityinvestmentinGalapagosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment in Galapagos</link:label>
    <link:label id="lab_gild_EquityinvestmentinGalapagosMember_label_en-US" xlink:label="lab_gild_EquityinvestmentinGalapagosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment in Galapagos [Member]</link:label>
    <link:label id="lab_gild_EquityinvestmentinGalapagosMember_documentation_en-US" xlink:label="lab_gild_EquityinvestmentinGalapagosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment in Galapagos [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityinvestmentinGalapagosMember" xlink:href="gild-20200930.xsd#gild_EquityinvestmentinGalapagosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquityinvestmentinGalapagosMember" xlink:to="lab_gild_EquityinvestmentinGalapagosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c9576405-a996-4aad-adfd-c84eb289ac1f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_bc6ea045-6186-4364-a73d-100d54e37bc8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity_0e3f86a7-e8f1-4531-8b31-7d26936114b2_terseLabel_en-US" xlink:label="lab_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call feature, period prior to maturity</link:label>
    <link:label id="lab_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity_label_en-US" xlink:label="lab_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Call Feature, Period Before Maturity</link:label>
    <link:label id="lab_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity_documentation_en-US" xlink:label="lab_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Call Feature, Period Before Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity" xlink:href="gild-20200930.xsd#gild_DebtInstrumentCallFeaturePeriodBeforeMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity" xlink:to="lab_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_e00207dc-9342-43e6-bc2a-b75bff08ef3d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedSeptember2020Member_37dcff69-b2d5-4203-8fca-80d1ee933cbe_terseLabel_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "2020 Senior Notes"</link:label>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedSeptember2020Member_label_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note Issued September 2020 [Member]</link:label>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedSeptember2020Member_documentation_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note Issued September 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedSeptember2020Member" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedSeptember2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_SeniorUnsecuredNoteIssuedSeptember2020Member" xlink:to="lab_gild_SeniorUnsecuredNoteIssuedSeptember2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_7d8dd0a6-0fcb-42c9-a475-2acd0fce7aa5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_8c8c7fe5-86fe-4304-9f76-89f86c11c6f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_67e210be-46a5-4233-8e6a-bcadab1c21fc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9f302af4-083c-4e4f-bbab-de02726c6bd4_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount (Legal Offset)</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:to="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_537da4a0-10cc-4544-b364-fde051891f49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_88f8ebea-334b-472f-b06a-24225a86c166_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5155ffea-98c3-4809-af79-640062d834e3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_75a6221c-692e-42bf-a05d-d05dfa6941a3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_9484d9f5-d300-4016-a6d1-73142b6a4d80_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. government securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_391dd4dc-1654-42e9-8e2d-657f7adbafb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 Months or greater, gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_5ab3a2e0-3fba-43bb-b22a-116e3f1d69e1_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A365SeniorUnsecuredNotesDueMarch2026Member_53f9be39-b7c8-4170-bb6c-55c9c66562d7_terseLabel_en-US" xlink:label="lab_gild_A365SeniorUnsecuredNotesDueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Senior Unsecured Notes Due March 2026</link:label>
    <link:label id="lab_gild_A365SeniorUnsecuredNotesDueMarch2026Member_label_en-US" xlink:label="lab_gild_A365SeniorUnsecuredNotesDueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Senior Unsecured Notes Due March 2026 [Member]</link:label>
    <link:label id="lab_gild_A365SeniorUnsecuredNotesDueMarch2026Member_documentation_en-US" xlink:label="lab_gild_A365SeniorUnsecuredNotesDueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Senior Unsecured Notes Due March 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A365SeniorUnsecuredNotesDueMarch2026Member" xlink:href="gild-20200930.xsd#gild_A365SeniorUnsecuredNotesDueMarch2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A365SeniorUnsecuredNotesDueMarch2026Member" xlink:to="lab_gild_A365SeniorUnsecuredNotesDueMarch2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_caa087d0-1acf-4dfc-bda8-6ccb48f99740_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment recognized</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e58080e2-ee4e-4671-a488-ba3451f7a940_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b11e5b9a-679f-4d06-b62a-38e794f5ef24_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_CollaborativeArrangementTerm_d6f06f93-f9ef-45a1-b6d7-ec04c12edad5_terseLabel_en-US" xlink:label="lab_gild_CollaborativeArrangementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative term</link:label>
    <link:label id="lab_gild_CollaborativeArrangementTerm_label_en-US" xlink:label="lab_gild_CollaborativeArrangementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term</link:label>
    <link:label id="lab_gild_CollaborativeArrangementTerm_documentation_en-US" xlink:label="lab_gild_CollaborativeArrangementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CollaborativeArrangementTerm" xlink:href="gild-20200930.xsd#gild_CollaborativeArrangementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_CollaborativeArrangementTerm" xlink:to="lab_gild_CollaborativeArrangementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_b5d1b822-7736-467a-adf9-fa49aa9e0640_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A400SeniorUnsecuredNotesDueSeptember2036Member_0da321d2-d092-4543-b086-8d65322b3e04_terseLabel_en-US" xlink:label="lab_gild_A400SeniorUnsecuredNotesDueSeptember2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Senior Unsecured Notes Due September 2036</link:label>
    <link:label id="lab_gild_A400SeniorUnsecuredNotesDueSeptember2036Member_label_en-US" xlink:label="lab_gild_A400SeniorUnsecuredNotesDueSeptember2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Senior Unsecured Notes Due September 2036 [Member]</link:label>
    <link:label id="lab_gild_A400SeniorUnsecuredNotesDueSeptember2036Member_documentation_en-US" xlink:label="lab_gild_A400SeniorUnsecuredNotesDueSeptember2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Senior Unsecured Notes Due September 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A400SeniorUnsecuredNotesDueSeptember2036Member" xlink:href="gild-20200930.xsd#gild_A400SeniorUnsecuredNotesDueSeptember2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A400SeniorUnsecuredNotesDueSeptember2036Member" xlink:to="lab_gild_A400SeniorUnsecuredNotesDueSeptember2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e610090f-e603-4f1a-8e4d-21e602a8f1b9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_54c56fcb-560f-487e-b5b6-d38b9e5fdcbe_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_8e1f1e1d-8363-4222-8b4b-1b6340adf93e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e75e0e63-44ee-4e29-9cfc-5fb6ffceb37a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsRanexaMember_751496c9-0f03-4446-bb56-2dc151b25cc7_terseLabel_en-US" xlink:label="lab_gild_OtherProductsRanexaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranexa</link:label>
    <link:label id="lab_gild_OtherProductsRanexaMember_label_en-US" xlink:label="lab_gild_OtherProductsRanexaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Ranexa [Member]</link:label>
    <link:label id="lab_gild_OtherProductsRanexaMember_documentation_en-US" xlink:label="lab_gild_OtherProductsRanexaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Ranexa [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsRanexaMember" xlink:href="gild-20200930.xsd#gild_OtherProductsRanexaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsRanexaMember" xlink:to="lab_gild_OtherProductsRanexaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_162e2274-0f33-4edd-a849-bd3f099121da_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_MckessonCorpMember_74d9bfe3-5031-4a36-8a70-d7cd2d8204ea_terseLabel_en-US" xlink:label="lab_gild_MckessonCorpMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation</link:label>
    <link:label id="lab_gild_MckessonCorpMember_label_en-US" xlink:label="lab_gild_MckessonCorpMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corp [Member]</link:label>
    <link:label id="lab_gild_MckessonCorpMember_documentation_en-US" xlink:label="lab_gild_MckessonCorpMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corp [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MckessonCorpMember" xlink:href="gild-20200930.xsd#gild_MckessonCorpMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_MckessonCorpMember" xlink:to="lab_gild_MckessonCorpMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea9aa833-3f2c-47a5-8e1c-3c4c3194d24e_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02b6d31a-5f88-4478-9e5b-2bba3f213adb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_06cc3a63-c35d-4ecf-a58f-09d96fe42127_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_8655c732-7045-44ce-b3b2-3e162ff373ad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_292a5da5-1e9b-4b16-9677-0816e883821b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount under stock repurchase programs</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b444462a-d25b-4314-bb8a-f474fa4d153d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_e0d613d0-b31c-497b-88fb-bdcec119d78f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_4aa9fc1e-3fc8-4b86-865b-54d91e9330b5_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1_f2154396-8d94-48a9-9e92-0a0f417d0f20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time estimate for gains (losses) to be reclassified from AOCI to product sales</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimate of Time to Transfer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fd5f5680-5db3-4417-ab07-0aefd9dfb3a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_11848a4b-1888-4627-bc71-b2fc69692fda_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition share price (usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8a472f3c-171e-4afc-9748-55582bf7da68_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A195SeniorUnsecuredNotesDueMarch2022Member_7d848ded-4da9-4d46-b210-2ed99d4c095b_terseLabel_en-US" xlink:label="lab_gild_A195SeniorUnsecuredNotesDueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.95% Senior Unsecured Notes Due March 2022</link:label>
    <link:label id="lab_gild_A195SeniorUnsecuredNotesDueMarch2022Member_label_en-US" xlink:label="lab_gild_A195SeniorUnsecuredNotesDueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.95% Senior Unsecured Notes Due March 2022 [Member]</link:label>
    <link:label id="lab_gild_A195SeniorUnsecuredNotesDueMarch2022Member_documentation_en-US" xlink:label="lab_gild_A195SeniorUnsecuredNotesDueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.95% Senior Unsecured Notes Due March 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A195SeniorUnsecuredNotesDueMarch2022Member" xlink:href="gild-20200930.xsd#gild_A195SeniorUnsecuredNotesDueMarch2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A195SeniorUnsecuredNotesDueMarch2022Member" xlink:to="lab_gild_A195SeniorUnsecuredNotesDueMarch2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_848bdd62-03c5-467a-9f1e-26abf49cd1c2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquitySecuritiesFVNIRestrictionPeriod_64a87045-25ec-4eb3-8149-bf9009893139_terseLabel_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIRestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction period</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIRestrictionPeriod_label_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIRestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Restriction Period</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIRestrictionPeriod_documentation_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIRestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Restriction Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIRestrictionPeriod" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIRestrictionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquitySecuritiesFVNIRestrictionPeriod" xlink:to="lab_gild_EquitySecuritiesFVNIRestrictionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_IndenixMember_dbf2e26d-318e-4035-b4a5-449dc050b7a7_terseLabel_en-US" xlink:label="lab_gild_IndenixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indenix</link:label>
    <link:label id="lab_gild_IndenixMember_label_en-US" xlink:label="lab_gild_IndenixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indenix [Member]</link:label>
    <link:label id="lab_gild_IndenixMember_documentation_en-US" xlink:label="lab_gild_IndenixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indenix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndenixMember" xlink:href="gild-20200930.xsd#gild_IndenixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_IndenixMember" xlink:to="lab_gild_IndenixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_ee990a64-3db3-4213-bb34-7c96003d505b_terseLabel_en-US" xlink:label="lab_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment, indefinite-lived assets</link:label>
    <link:label id="lab_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_label_en-US" xlink:label="lab_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</link:label>
    <link:label id="lab_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_documentation_en-US" xlink:label="lab_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:href="gild-20200930.xsd#gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:to="lab_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_a8bfa354-cfa1-4817-b409-5dc8ce7272f2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_0e46c32d-f61f-4631-9328-5587504729b3_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect from the adoption of new accounting standard</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_a8af25a9-d56d-4e25-8334-16d499099fa4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_086ee833-d8de-4622-9888-d3aca161fa46_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AmerisourcebergenCorpMember_9f8b1b6f-504a-47db-bc0f-c95dc6ee6786_terseLabel_en-US" xlink:label="lab_gild_AmerisourcebergenCorpMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmerisourceBergen Corporation</link:label>
    <link:label id="lab_gild_AmerisourcebergenCorpMember_label_en-US" xlink:label="lab_gild_AmerisourcebergenCorpMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmerisourceBergen Corp [Member]</link:label>
    <link:label id="lab_gild_AmerisourcebergenCorpMember_documentation_en-US" xlink:label="lab_gild_AmerisourcebergenCorpMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmerisourceBergen Corp [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AmerisourcebergenCorpMember" xlink:href="gild-20200930.xsd#gild_AmerisourcebergenCorpMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AmerisourcebergenCorpMember" xlink:to="lab_gild_AmerisourcebergenCorpMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsGenvoyaMember_9a6c241a-3b51-4ac7-ba5e-8ae32a1b612e_terseLabel_en-US" xlink:label="lab_gild_HIVProductsGenvoyaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genvoya</link:label>
    <link:label id="lab_gild_HIVProductsGenvoyaMember_label_en-US" xlink:label="lab_gild_HIVProductsGenvoyaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Genvoya [Member]</link:label>
    <link:label id="lab_gild_HIVProductsGenvoyaMember_documentation_en-US" xlink:label="lab_gild_HIVProductsGenvoyaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Genvoya [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsGenvoyaMember" xlink:href="gild-20200930.xsd#gild_HIVProductsGenvoyaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsGenvoyaMember" xlink:to="lab_gild_HIVProductsGenvoyaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_927b974f-c898-461b-8393-fde7fc670892_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances under equity incentive plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_838fdc80-2af1-4311-8ce7-dd8c70544aef_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_720a0eac-ee54-4077-a4e4-195faaac47a5_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications to net income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_d3203140-9ba9-4dec-8d61-8fdaf784b832_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_eab3f65e-8c01-44a6-8104-6e7f2ed1f1d9_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsOtherMember_eade15cd-e80f-4742-891a-4377440ec4a0_terseLabel_en-US" xlink:label="lab_gild_OtherProductsOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_gild_OtherProductsOtherMember_label_en-US" xlink:label="lab_gild_OtherProductsOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Other [Member]</link:label>
    <link:label id="lab_gild_OtherProductsOtherMember_documentation_en-US" xlink:label="lab_gild_OtherProductsOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsOtherMember" xlink:href="gild-20200930.xsd#gild_OtherProductsOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsOtherMember" xlink:to="lab_gild_OtherProductsOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementMember_a7a7a189-7e48-4c8e-876f-bdc6a84ea692_terseLabel_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the &#8220;Collaboration Agreement"</link:label>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementMember_label_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option, License and Collaboration Agreement [Member]</link:label>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementMember_documentation_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option, License and Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementMember" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OptionLicenseAndCollaborationAgreementMember" xlink:to="lab_gild_OptionLicenseAndCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_baf48092-e579-4f94-9b1c-9f35918bc159_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_70b19122-ba11-485f-a6cb-a579e44fd8a4_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member_9122d4f1-20e8-4cf9-aa87-78e9be80526b_terseLabel_en-US" xlink:label="lab_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "2020 Fixed Rate Notes"</link:label>
    <link:label id="lab_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member_label_en-US" xlink:label="lab_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate Senior Unsecured Note Issued September 2020 [Member]</link:label>
    <link:label id="lab_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member_documentation_en-US" xlink:label="lab_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate Senior Unsecured Note Issued September 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" xlink:href="gild-20200930.xsd#gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" xlink:to="lab_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_29e69a1e-7dc1-4f26-88eb-ab44f3565818_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6d834f15-b4ba-4972-918d-c9f8ebbe9ad6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_71736fbc-bba3-4de4-b7b7-822052f3c89a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_25c0f672-bb75-4f9c-9163-3ef1ee2a1976_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b00bf77d-949c-4df2-8673-7e2a627739d7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_dc0679aa-dda5-446b-a864-6299fa587c6b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenues</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_05184dd9-1a94-4a25-a388-58439fe64337_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_55388eb8-9060-4a83-8e6f-97ac7b3d0b3c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_6a82368f-89ba-45f3-8703-f0fe7c51958c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_7110390f-4fe2-4528-ad1a-91c8a2236f6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_35930113-6550-4e60-9cd8-91f23caf7d74_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share attributable to Gilead common stockholders - basic (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b7dee292-85d9-4b65-8932-5367d3b23584_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Gilead common stockholders - basic (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_7aee5e85-04b7-4a5b-a929-33322cae7433_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividends declared (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6332e280-0a5f-4b49-bead-c6f52af3b6f3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to Gilead</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A370SeniorUnsecuredNotesDueApril2024Member_00dd9b83-1221-438d-9bf5-b76dd27086e1_terseLabel_en-US" xlink:label="lab_gild_A370SeniorUnsecuredNotesDueApril2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Senior Unsecured Notes Due April 2024</link:label>
    <link:label id="lab_gild_A370SeniorUnsecuredNotesDueApril2024Member_label_en-US" xlink:label="lab_gild_A370SeniorUnsecuredNotesDueApril2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Senior Unsecured Notes Due April 2024 [Member]</link:label>
    <link:label id="lab_gild_A370SeniorUnsecuredNotesDueApril2024Member_documentation_en-US" xlink:label="lab_gild_A370SeniorUnsecuredNotesDueApril2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Senior Unsecured Notes Due April 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A370SeniorUnsecuredNotesDueApril2024Member" xlink:href="gild-20200930.xsd#gild_A370SeniorUnsecuredNotesDueApril2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A370SeniorUnsecuredNotesDueApril2024Member" xlink:to="lab_gild_A370SeniorUnsecuredNotesDueApril2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_cae54853-7120-4220-8d29-874780e7a027_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_cf236dca-77b6-42c2-8ec5-767f23851f14_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A165SeniorUnsecuredNotesDueOctober2030Member_d59c3d6f-dafe-4a4b-b413-4ec89f274540_terseLabel_en-US" xlink:label="lab_gild_A165SeniorUnsecuredNotesDueOctober2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.65% Senior Unsecured Notes Due October 2030</link:label>
    <link:label id="lab_gild_A165SeniorUnsecuredNotesDueOctober2030Member_label_en-US" xlink:label="lab_gild_A165SeniorUnsecuredNotesDueOctober2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.65% Senior Unsecured Notes Due October 2030 [Member]</link:label>
    <link:label id="lab_gild_A165SeniorUnsecuredNotesDueOctober2030Member_documentation_en-US" xlink:label="lab_gild_A165SeniorUnsecuredNotesDueOctober2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.65% Senior Unsecured Notes Due October 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member" xlink:href="gild-20200930.xsd#gild_A165SeniorUnsecuredNotesDueOctober2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member" xlink:to="lab_gild_A165SeniorUnsecuredNotesDueOctober2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_626aed3f-cae3-4431-a81f-f056b5a2e9f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts Offset on our Condensed Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:to="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_5f10b81f-3e69-4b1d-8e5b-4c07b67ca53a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_48d9ad1f-1468-4039-8443-96e38611f4bb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9c2682be-3e9e-4bb9-a2e9-309f023dc320_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e7bb49b0-d74f-4378-b44c-e51086026386_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_165da71c-9996-47fa-8b17-b00a7226704d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1de02223-a001-46c6-9306-af4d1775e58b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_6d36fa54-1591-4e34-8e14-ca3aee35ead2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa96113c-aa22-4008-a8c9-d3451b3e51aa_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c3ca18bc-dc39-4a6a-bbed-4037a3aa240b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_99c2013e-7b0a-4e29-83f0-699b10b22369_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_df48ca42-2ea9-4bfb-8b23-9a5f470a471e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_72a7e486-eb4a-4e7f-a8cd-df53ffdf44be_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4fc19a0f-8062-4ecf-a9d5-22c0ba61d754_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_0fa4823b-324b-4d7d-b131-b250c8469a01_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_0ad6ab2a-4f17-4a44-8e59-cf0f6f0e6476_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_4387a667-ab6b-470a-a317-9bc3ac39a9f8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_PaymentsForDirectTransactionalExpense_a43bbeec-8e68-4b61-8dcc-c444969a82b9_terseLabel_en-US" xlink:label="lab_gild_PaymentsForDirectTransactionalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for direct transactional costs</link:label>
    <link:label id="lab_gild_PaymentsForDirectTransactionalExpense_label_en-US" xlink:label="lab_gild_PaymentsForDirectTransactionalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Direct Transactional Expense</link:label>
    <link:label id="lab_gild_PaymentsForDirectTransactionalExpense_documentation_en-US" xlink:label="lab_gild_PaymentsForDirectTransactionalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Direct Transactional Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PaymentsForDirectTransactionalExpense" xlink:href="gild-20200930.xsd#gild_PaymentsForDirectTransactionalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_PaymentsForDirectTransactionalExpense" xlink:to="lab_gild_PaymentsForDirectTransactionalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f402e4bc-2dc6-4ac5-b35c-1ac361e34956_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A460SeniorUnsecuredNotesDueSeptember2035Member_e9c5ed77-5485-41f1-981e-393a5fb6004f_terseLabel_en-US" xlink:label="lab_gild_A460SeniorUnsecuredNotesDueSeptember2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.60% Senior Unsecured Notes Due September 2035</link:label>
    <link:label id="lab_gild_A460SeniorUnsecuredNotesDueSeptember2035Member_label_en-US" xlink:label="lab_gild_A460SeniorUnsecuredNotesDueSeptember2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.60% Senior Unsecured Notes Due September 2035 [Member]</link:label>
    <link:label id="lab_gild_A460SeniorUnsecuredNotesDueSeptember2035Member_documentation_en-US" xlink:label="lab_gild_A460SeniorUnsecuredNotesDueSeptember2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.60% Senior Unsecured Notes Due September 2035</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A460SeniorUnsecuredNotesDueSeptember2035Member" xlink:href="gild-20200930.xsd#gild_A460SeniorUnsecuredNotesDueSeptember2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A460SeniorUnsecuredNotesDueSeptember2035Member" xlink:to="lab_gild_A460SeniorUnsecuredNotesDueSeptember2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_acff9d66-652f-45e3-9bff-8daaf98f1148_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_20749099-8c34-40bf-971d-2984d0155103_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies, Estimates and Judgments</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4e71530a-76f2-499c-ac31-4290d29d6485_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_064c564f-cca5-47fc-bc98-3e792bef3a8d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_fc307912-5187-4d1c-a116-d5caabbfb63c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_05336086-f591-4d8e-ad0e-4597dce67693_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_2cedbca7-8a8c-4de1-bc60-300a75a36ab6_terseLabel_en-US" xlink:label="lab_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment, finite-lived assets</link:label>
    <link:label id="lab_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_label_en-US" xlink:label="lab_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</link:label>
    <link:label id="lab_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_documentation_en-US" xlink:label="lab_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:href="gild-20200930.xsd#gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:to="lab_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_adcea699-2772-4146-8c04-5c0887b5602d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $714 and $758, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AllowanceforAccountsReceivableandChargebacks_ea17d929-5946-49d9-a529-5be763469132_terseLabel_en-US" xlink:label="lab_gild_AllowanceforAccountsReceivableandChargebacks" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable</link:label>
    <link:label id="lab_gild_AllowanceforAccountsReceivableandChargebacks_label_en-US" xlink:label="lab_gild_AllowanceforAccountsReceivableandChargebacks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Accounts Receivable and Chargebacks</link:label>
    <link:label id="lab_gild_AllowanceforAccountsReceivableandChargebacks_documentation_en-US" xlink:label="lab_gild_AllowanceforAccountsReceivableandChargebacks" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable and other receivables not elsewhere defined in the taxonomy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AllowanceforAccountsReceivableandChargebacks" xlink:href="gild-20200930.xsd#gild_AllowanceforAccountsReceivableandChargebacks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AllowanceforAccountsReceivableandChargebacks" xlink:to="lab_gild_AllowanceforAccountsReceivableandChargebacks" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember_d699e060-d9d9-4816-a2d2-d54ff02a1121_terseLabel_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the &#8220;Collaboration Agreement" and the &#8220;Stock Purchase Agreements&#8221;</link:label>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember_label_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option, License and Collaboration Agreement and Common Stock Purchase Agreement and Investor Rights Agreement [Member]</link:label>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember_documentation_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An option, license and collaboration agreement (the &#8220;Collaboration Agreement&#8221;) and a common stock purchase agreement and an investor rights agreement (together, the &#8220;Stock Purchase Agreements&#8221;).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:to="lab_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_a18fb67e-4801-43a9-a5b3-feefaa5bc050_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8b4264e1-d394-4a93-b9cc-e0251a9ec19a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_2f7c59f5-0f6a-423e-a2ac-d42d75bfed7c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_b4c86030-d9b9-484f-80d3-05da937f2fbf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_61704df6-3ee0-4850-ad4d-c9701a570f8f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other publicly traded equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ProductsRevenueShareSymtuzaMember_452d148e-4a5c-4a52-ab47-3751492e57a7_terseLabel_en-US" xlink:label="lab_gild_ProductsRevenueShareSymtuzaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue share - Symtuza</link:label>
    <link:label id="lab_gild_ProductsRevenueShareSymtuzaMember_label_en-US" xlink:label="lab_gild_ProductsRevenueShareSymtuzaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products, Revenue Share-Symtuza [Member]</link:label>
    <link:label id="lab_gild_ProductsRevenueShareSymtuzaMember_documentation_en-US" xlink:label="lab_gild_ProductsRevenueShareSymtuzaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products, Revenue Share-Symtuza [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ProductsRevenueShareSymtuzaMember" xlink:href="gild-20200930.xsd#gild_ProductsRevenueShareSymtuzaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ProductsRevenueShareSymtuzaMember" xlink:to="lab_gild_ProductsRevenueShareSymtuzaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d950217f-7862-4a9f-affe-ccec36c12e96_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherInternationalMember_17208a9f-8b8d-4364-8b82-e69139816cac_terseLabel_en-US" xlink:label="lab_gild_OtherInternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International</link:label>
    <link:label id="lab_gild_OtherInternationalMember_label_en-US" xlink:label="lab_gild_OtherInternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International [Member]</link:label>
    <link:label id="lab_gild_OtherInternationalMember_documentation_en-US" xlink:label="lab_gild_OtherInternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherInternationalMember" xlink:href="gild-20200930.xsd#gild_OtherInternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherInternationalMember" xlink:to="lab_gild_OtherInternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_788ec6bf-3da4-4ad7-b5d6-a07383de4d2e_negatedLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to settlements with taxing authorities</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_14016283-0dce-443d-9029-15812a3b2059_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive (loss) attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_797e8dab-bebd-45c6-b4cc-127f64e73078_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods_6e1ee651-11be-45c5-a526-5ff50fc9dcd8_terseLabel_en-US" xlink:label="lab_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues recognized from performance obligations satisfied in prior periods</link:label>
    <link:label id="lab_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods_label_en-US" xlink:label="lab_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues recognized from performance obligations satisfied in previous periods</link:label>
    <link:label id="lab_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods_documentation_en-US" xlink:label="lab_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues recognized from performance obligations satisfied in previous periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" xlink:href="gild-20200930.xsd#gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" xlink:to="lab_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_dcacfb20-ed90-4500-a55b-6ae35a377571_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs involved</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_06e33a8b-0b03-453f-885d-cea555698b8a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_24641a54-7595-489f-9a2a-f3ab17682477_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_672e44b9-2d1d-4374-807f-af905d5d37f3_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract_6892784f-b985-40fb-ada4-e85dad9dbfd0_terseLabel_en-US" xlink:label="lab_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract_label_en-US" xlink:label="lab_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Collaborations and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract_documentation_en-US" xlink:label="lab_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Collaborations and Other Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract" xlink:href="gild-20200930.xsd#gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract" xlink:to="lab_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_607c877b-de46-4626-a334-3e7023cf6bc3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsTruvadaMember_67b8867a-d608-40c7-a0cb-97323d449ae3_terseLabel_en-US" xlink:label="lab_gild_HIVProductsTruvadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truvada</link:label>
    <link:label id="lab_gild_HIVProductsTruvadaMember_label_en-US" xlink:label="lab_gild_HIVProductsTruvadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Truvada [Member]</link:label>
    <link:label id="lab_gild_HIVProductsTruvadaMember_documentation_en-US" xlink:label="lab_gild_HIVProductsTruvadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Truvada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsTruvadaMember" xlink:href="gild-20200930.xsd#gild_HIVProductsTruvadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsTruvadaMember" xlink:to="lab_gild_HIVProductsTruvadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8db76486-2bdd-445e-a7d2-1ee5525fe2f7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_dd7fbfc5-b42c-46ba-83d5-ab303a078b24_terseLabel_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Rate</link:label>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_label_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:to="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_604f893a-6533-4c2c-9f89-fc86a4521446_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Gilead</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_365648f8-f08d-4fd6-9ce2-e4c4f9205001_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Gilead</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_Accruedgovernmentandotherrebates_f90a5ffa-20fe-46f0-a745-a95eb695095a_terseLabel_en-US" xlink:label="lab_gild_Accruedgovernmentandotherrebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued government and other rebates</link:label>
    <link:label id="lab_gild_Accruedgovernmentandotherrebates_label_en-US" xlink:label="lab_gild_Accruedgovernmentandotherrebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued government and other rebates</link:label>
    <link:label id="lab_gild_Accruedgovernmentandotherrebates_documentation_en-US" xlink:label="lab_gild_Accruedgovernmentandotherrebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued government and other rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_Accruedgovernmentandotherrebates" xlink:href="gild-20200930.xsd#gild_Accruedgovernmentandotherrebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_Accruedgovernmentandotherrebates" xlink:to="lab_gild_Accruedgovernmentandotherrebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_c351d9f3-d577-464d-b96b-d468e2b3117d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_80059264-530b-4dbb-879b-c723c9543e50_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock&#160;</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_a93c61cd-c04e-48a4-accb-435aae1ac994_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments_79770f0e-68c7-455d-9a82-b6c82bad6a9b_terseLabel_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future maximum milestone payments</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments_label_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Future Maximum Milestone Payments</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments_documentation_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Future Maximum Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments" xlink:to="lab_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_TizonaMergerAndOptionAgreementsMember_162c7082-ef35-45c1-8963-e93bc8a69b92_terseLabel_en-US" xlink:label="lab_gild_TizonaMergerAndOptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "Tizona Merger and Option Agreements"</link:label>
    <link:label id="lab_gild_TizonaMergerAndOptionAgreementsMember_label_en-US" xlink:label="lab_gild_TizonaMergerAndOptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tizona Merger and Option Agreements [Member]</link:label>
    <link:label id="lab_gild_TizonaMergerAndOptionAgreementsMember_documentation_en-US" xlink:label="lab_gild_TizonaMergerAndOptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tizona Merger and Option Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TizonaMergerAndOptionAgreementsMember" xlink:href="gild-20200930.xsd#gild_TizonaMergerAndOptionAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_TizonaMergerAndOptionAgreementsMember" xlink:to="lab_gild_TizonaMergerAndOptionAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember_a4ea06d9-fe27-48c9-b7ec-5e2ee4d9f8cf_terseLabel_en-US" xlink:label="lab_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the &#8220;Stock Purchase Agreements&#8221;</link:label>
    <link:label id="lab_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember_label_en-US" xlink:label="lab_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchase Agreement and Investor Rights Agreement [Member]</link:label>
    <link:label id="lab_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember_documentation_en-US" xlink:label="lab_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchase Agreement and Investor Rights Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:href="gild-20200930.xsd#gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:to="lab_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_189a76b1-5108-4fa4-8311-a19928619184_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_9a5e71ba-f3a5-425f-998c-d5915e6a8e57_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities in offering</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Equity Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_6590fba2-2f60-4c3a-997a-67dfe028c932_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_4a59eff3-77d9-4c7b-99c7-6446b0fdd9a5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_47cdf75f-16f1-4ae3-9bc6-0c812855ebb5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_d9f712b8-b5fd-4a44-a010-431d4ec24cb5_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A260SeniorUnsecuredNotesDueOctober2040Member_97997926-483f-41b9-9716-4d5b4968cbb3_terseLabel_en-US" xlink:label="lab_gild_A260SeniorUnsecuredNotesDueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.60% Senior Unsecured Notes Due October 2040</link:label>
    <link:label id="lab_gild_A260SeniorUnsecuredNotesDueOctober2040Member_label_en-US" xlink:label="lab_gild_A260SeniorUnsecuredNotesDueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.60% Senior Unsecured Notes Due October 2040 [Member]</link:label>
    <link:label id="lab_gild_A260SeniorUnsecuredNotesDueOctober2040Member_documentation_en-US" xlink:label="lab_gild_A260SeniorUnsecuredNotesDueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.60% Senior Unsecured Notes Due October 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member" xlink:href="gild-20200930.xsd#gild_A260SeniorUnsecuredNotesDueOctober2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member" xlink:to="lab_gild_A260SeniorUnsecuredNotesDueOctober2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_47b66e97-8dec-49bd-8b44-037565280d72_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_48f039e5-7bbb-4e10-a1e4-a64710344c8d_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_bed0ed5d-6c45-4adb-9c0d-f77cc152c3c5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_07ebec2e-29bd-457a-a8ee-5a0862e47e69_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f98bd451-921b-4bec-a313-63737e11627a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_33d14d8c-c754-44c5-92a1-17ba61f53cd4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized&#160;Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1dab836d-be19-44c9-a7da-48420f531d94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_3694a68e-7754-4507-b39d-6568d4b79a05_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherEquitySecuritiesMember_163f7fdd-c9bb-4ed8-ade0-76e1f0802606_terseLabel_en-US" xlink:label="lab_gild_OtherEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Equity Securities</link:label>
    <link:label id="lab_gild_OtherEquitySecuritiesMember_label_en-US" xlink:label="lab_gild_OtherEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Equity Securities [Member]</link:label>
    <link:label id="lab_gild_OtherEquitySecuritiesMember_documentation_en-US" xlink:label="lab_gild_OtherEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherEquitySecuritiesMember" xlink:href="gild-20200930.xsd#gild_OtherEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherEquitySecuritiesMember" xlink:to="lab_gild_OtherEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_7344e9c3-fa20-4527-aa3b-4bd17ec8a5f1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A250SeniorUnsecuredNotesDueSeptember2023Member_d50071fc-f58a-4ce0-ad54-4e9501a9794b_terseLabel_en-US" xlink:label="lab_gild_A250SeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.50% Senior Unsecured Notes Due September 2023</link:label>
    <link:label id="lab_gild_A250SeniorUnsecuredNotesDueSeptember2023Member_label_en-US" xlink:label="lab_gild_A250SeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.50% Senior Unsecured Notes Due September 2023 [Member]</link:label>
    <link:label id="lab_gild_A250SeniorUnsecuredNotesDueSeptember2023Member_documentation_en-US" xlink:label="lab_gild_A250SeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.50% Senior Unsecured Notes Due September 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A250SeniorUnsecuredNotesDueSeptember2023Member" xlink:href="gild-20200930.xsd#gild_A250SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A250SeniorUnsecuredNotesDueSeptember2023Member" xlink:to="lab_gild_A250SeniorUnsecuredNotesDueSeptember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_c9328020-4170-45e9-b6bc-27e6c09c3889_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_c74d1d92-03c5-473c-b65f-a65b6cfb7e2f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2461180f-390e-4982-9275-325aefebe013_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9d1ccef1-2c03-4830-b578-9aa010fff22a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_8dfb28c1-e2bd-41f0-8062-2697a2873b6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_InvestmentOwnedBalanceAdditionalPayable_442adab5-0605-49d5-9b6b-4532a380aee5_terseLabel_en-US" xlink:label="lab_gild_InvestmentOwnedBalanceAdditionalPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional payable accrued</link:label>
    <link:label id="lab_gild_InvestmentOwnedBalanceAdditionalPayable_label_en-US" xlink:label="lab_gild_InvestmentOwnedBalanceAdditionalPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Additional Payable</link:label>
    <link:label id="lab_gild_InvestmentOwnedBalanceAdditionalPayable_documentation_en-US" xlink:label="lab_gild_InvestmentOwnedBalanceAdditionalPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Additional Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InvestmentOwnedBalanceAdditionalPayable" xlink:href="gild-20200930.xsd#gild_InvestmentOwnedBalanceAdditionalPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_InvestmentOwnedBalanceAdditionalPayable" xlink:to="lab_gild_InvestmentOwnedBalanceAdditionalPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_5246a33a-0a15-40b7-809e-07370da34a43_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of effect of foreign currency exchange contracts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_cc34bdcd-8c4a-488a-bad7-a601e853174e_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_9bab9b43-fb73-45df-a509-c20442d02b6d_verboseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_9e2ccb3b-9920-4d92-a3d6-e98a05e3b232_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_313b0025-319f-407e-90d6-e2f7ce8ecbdb_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency derivative contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_bda683de-63e5-4a63-8498-687ab238d89f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_06a2013b-779a-424b-8f40-843c92cbb663_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_8b0bf25a-c649-43c5-a85a-cb03eee96325_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_90c16ac5-b6bf-4523-b7c9-db7c46152873_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_bb91bef1-523f-4ab2-bf6b-6a1965fd3bfc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_f5bbbfdc-6d03-4cb4-98eb-52fc5d2aab87_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_a82a8100-791a-41a8-abe5-e7bbc8766c6e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_590f398a-f6a8-4f21-bdca-0bb67b3065c4_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_75e812c5-b2dd-43fd-8be8-1c1813b30c8a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain on investment of equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_0d5e6108-8662-4258-b919-33c6faaee7b1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_1aed0ae8-6d27-47b0-8d4b-18d90ffb46c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_c1412a37-d470-4197-b6be-b2b01f4f6506_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_5257e6fc-460c-47da-b3aa-45c3f9a0c028_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of classification of equity securities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_243f858a-384c-4204-863b-76e2f03ef30d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of Assets/Liabilities Presented on our Condensed Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_211ba465-2066-45e6-8976-c552b175c3c4_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross&#160; Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_3910c369-4790-4166-8019-fb753a760944_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_30e181fd-0776-44b0-b314-32e788c380ac_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_5a8d8b2a-3f3b-4bb3-8af4-6af9fcf98bf3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock_fdf65555-a51f-4f2b-bbf6-eaef6e94eb29_terseLabel_en-US" xlink:label="lab_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Collaborations and Other Arrangements</link:label>
    <link:label id="lab_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock_label_en-US" xlink:label="lab_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Text Block]</link:label>
    <link:label id="lab_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock_documentation_en-US" xlink:label="lab_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaboratiions and Other Arrangements [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsandOtherArrangementsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock" xlink:to="lab_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsAtriplaMember_8cb9e8f0-727b-45b9-aaba-e6c9b897ffe2_terseLabel_en-US" xlink:label="lab_gild_HIVProductsAtriplaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Atripla</link:label>
    <link:label id="lab_gild_HIVProductsAtriplaMember_label_en-US" xlink:label="lab_gild_HIVProductsAtriplaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Atripla [Member]</link:label>
    <link:label id="lab_gild_HIVProductsAtriplaMember_documentation_en-US" xlink:label="lab_gild_HIVProductsAtriplaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Atripla [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsAtriplaMember" xlink:href="gild-20200930.xsd#gild_HIVProductsAtriplaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsAtriplaMember" xlink:to="lab_gild_HIVProductsAtriplaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_2674893d-29a2-4da5-b2ef-db5be44ee0b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A565SeniorUnsecuredNotesDueDecember2041Member_3857868e-e6a5-4a6a-a22e-c4ca59794340_terseLabel_en-US" xlink:label="lab_gild_A565SeniorUnsecuredNotesDueDecember2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.65% Senior Unsecured Notes Due December 204</link:label>
    <link:label id="lab_gild_A565SeniorUnsecuredNotesDueDecember2041Member_label_en-US" xlink:label="lab_gild_A565SeniorUnsecuredNotesDueDecember2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.65% Senior Unsecured Notes Due December 2041 [Member]</link:label>
    <link:label id="lab_gild_A565SeniorUnsecuredNotesDueDecember2041Member_documentation_en-US" xlink:label="lab_gild_A565SeniorUnsecuredNotesDueDecember2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.65% Senior Unsecured Notes Due December 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A565SeniorUnsecuredNotesDueDecember2041Member" xlink:href="gild-20200930.xsd#gild_A565SeniorUnsecuredNotesDueDecember2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A565SeniorUnsecuredNotesDueDecember2041Member" xlink:to="lab_gild_A565SeniorUnsecuredNotesDueDecember2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_LossContingencyMotionInvalidatedForPastDamagesValue_da45c9f3-512b-4656-97b4-f49578264239_terseLabel_en-US" xlink:label="lab_gild_LossContingencyMotionInvalidatedForPastDamagesValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Past damages vacated</link:label>
    <link:label id="lab_gild_LossContingencyMotionInvalidatedForPastDamagesValue_label_en-US" xlink:label="lab_gild_LossContingencyMotionInvalidatedForPastDamagesValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Motion Invalidated For Past Damages, Value</link:label>
    <link:label id="lab_gild_LossContingencyMotionInvalidatedForPastDamagesValue_documentation_en-US" xlink:label="lab_gild_LossContingencyMotionInvalidatedForPastDamagesValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Motion Invalidated For Past Damages, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyMotionInvalidatedForPastDamagesValue" xlink:href="gild-20200930.xsd#gild_LossContingencyMotionInvalidatedForPastDamagesValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_LossContingencyMotionInvalidatedForPastDamagesValue" xlink:to="lab_gild_LossContingencyMotionInvalidatedForPastDamagesValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_10de4ef8-e49f-424e-a564-d527255fa782_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing from senior unsecured term loan facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_a1c0778c-36e8-47f8-8b28-904b730e4665_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt financing, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A235SeniorUnsecuredNotesDueFebruary2020Member_98739e18-94af-48ef-b1e0-a7acafc95e75_terseLabel_en-US" xlink:label="lab_gild_A235SeniorUnsecuredNotesDueFebruary2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.35% Senior Unsecured Notes Due February 2020</link:label>
    <link:label id="lab_gild_A235SeniorUnsecuredNotesDueFebruary2020Member_label_en-US" xlink:label="lab_gild_A235SeniorUnsecuredNotesDueFebruary2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.35% Senior Unsecured Notes Due February 2020 [Member]</link:label>
    <link:label id="lab_gild_A235SeniorUnsecuredNotesDueFebruary2020Member_documentation_en-US" xlink:label="lab_gild_A235SeniorUnsecuredNotesDueFebruary2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.35% Senior Unsecured Notes Due February 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A235SeniorUnsecuredNotesDueFebruary2020Member" xlink:href="gild-20200930.xsd#gild_A235SeniorUnsecuredNotesDueFebruary2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A235SeniorUnsecuredNotesDueFebruary2020Member" xlink:to="lab_gild_A235SeniorUnsecuredNotesDueFebruary2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_0dde9009-47b6-446a-8900-6f1bd7712ae8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts Offset on our Condensed Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_aecc7b14-f748-4d9d-a848-82a68a0acc08_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_dc3306c9-5da2-4975-8133-bc054b91daee_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss on investment of equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_62cf6b26-4436-43d8-9f44-8989df77d69e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_dbf82b25-f809-47d9-b4d1-9cf11de64157_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_InventoryNetAndInventoryNoncurrent_bcf32efc-9a06-44c4-8ff9-44c5f3bffdbb_totalLabel_en-US" xlink:label="lab_gild_InventoryNetAndInventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_gild_InventoryNetAndInventoryNoncurrent_label_en-US" xlink:label="lab_gild_InventoryNetAndInventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Net And Inventory Noncurrent</link:label>
    <link:label id="lab_gild_InventoryNetAndInventoryNoncurrent_documentation_en-US" xlink:label="lab_gild_InventoryNetAndInventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Net And Inventory Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InventoryNetAndInventoryNoncurrent" xlink:href="gild-20200930.xsd#gild_InventoryNetAndInventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_InventoryNetAndInventoryNoncurrent" xlink:to="lab_gild_InventoryNetAndInventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_73fdc7a9-8552-49a8-8f43-5e5f0a3eaf6e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2963e380-5927-49bd-b2c8-9cdea0e1824e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_b3ecef0f-d536-42c6-872d-63552ffd3b44_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet_6ddb5106-16dd-4a5e-93b7-624f3423aea8_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinuances of cash flow hedges</link:label>
    <link:label id="lab_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet_label_en-US" xlink:label="lab_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Discontinuation of Foreign Currency Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" xlink:to="lab_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A450SeniorUnsecuredNotesDueFebruary2045Member_7d413055-1a63-4a1f-be2c-5dc2257a78e2_terseLabel_en-US" xlink:label="lab_gild_A450SeniorUnsecuredNotesDueFebruary2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Senior Unsecured Notes Due February 2045</link:label>
    <link:label id="lab_gild_A450SeniorUnsecuredNotesDueFebruary2045Member_label_en-US" xlink:label="lab_gild_A450SeniorUnsecuredNotesDueFebruary2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Senior Unsecured Notes Due February 2045 [Member]</link:label>
    <link:label id="lab_gild_A450SeniorUnsecuredNotesDueFebruary2045Member_documentation_en-US" xlink:label="lab_gild_A450SeniorUnsecuredNotesDueFebruary2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Senior Unsecured Notes Due February 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A450SeniorUnsecuredNotesDueFebruary2045Member" xlink:href="gild-20200930.xsd#gild_A450SeniorUnsecuredNotesDueFebruary2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A450SeniorUnsecuredNotesDueFebruary2045Member" xlink:to="lab_gild_A450SeniorUnsecuredNotesDueFebruary2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_320b6ac1-964f-4fa1-baf4-b23b0b861eb5_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_63f5b25a-d99d-4e3a-b599-1bed0f3719bc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash_d08091bf-83b8-4803-8825-c947b1651a0d_terseLabel_en-US" xlink:label="lab_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired, net of cash</link:label>
    <link:label id="lab_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash_label_en-US" xlink:label="lab_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Net of Cash</link:label>
    <link:label id="lab_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash_documentation_en-US" xlink:label="lab_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Net of Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" xlink:to="lab_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a658d6fc-bd98-4eb8-9da2-c0ba1d38156b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_IssuanceDiscountPremium_6571909d-edb1-4e02-8d8e-8b87f440f0cd_terseLabel_en-US" xlink:label="lab_gild_IssuanceDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance discount (premium)</link:label>
    <link:label id="lab_gild_IssuanceDiscountPremium_label_en-US" xlink:label="lab_gild_IssuanceDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Discount (Premium)</link:label>
    <link:label id="lab_gild_IssuanceDiscountPremium_documentation_en-US" xlink:label="lab_gild_IssuanceDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IssuanceDiscountPremium" xlink:href="gild-20200930.xsd#gild_IssuanceDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_IssuanceDiscountPremium" xlink:to="lab_gild_IssuanceDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_718467aa-2bdc-46ca-9297-e51ad45fc342_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_014706af-d556-491b-9430-e078f90bee65_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfUnsecuredDebt_3c05dd15-665d-4798-86fa-ebf4d5e46cc7_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of senior unsecured notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfUnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfUnsecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_59467fe1-33c4-464f-b5d3-623b37157198_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_b18edafd-0ee7-4274-9893-0d321274be07_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A325SeniorUnsecuredNotesDueSeptember2022Member_c22b5da3-7a9f-4484-8d9e-870aacc9f733_terseLabel_en-US" xlink:label="lab_gild_A325SeniorUnsecuredNotesDueSeptember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% Senior Unsecured Notes Due September 2022</link:label>
    <link:label id="lab_gild_A325SeniorUnsecuredNotesDueSeptember2022Member_label_en-US" xlink:label="lab_gild_A325SeniorUnsecuredNotesDueSeptember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% Senior Unsecured Notes Due September 2022 [Member]</link:label>
    <link:label id="lab_gild_A325SeniorUnsecuredNotesDueSeptember2022Member_documentation_en-US" xlink:label="lab_gild_A325SeniorUnsecuredNotesDueSeptember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% Senior Unsecured Notes Due September 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A325SeniorUnsecuredNotesDueSeptember2022Member" xlink:href="gild-20200930.xsd#gild_A325SeniorUnsecuredNotesDueSeptember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A325SeniorUnsecuredNotesDueSeptember2022Member" xlink:to="lab_gild_A325SeniorUnsecuredNotesDueSeptember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_e8465a44-1cfa-464e-9477-680d0eadfd71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_MarketableSecuritiesCurrentMember_e4adc1b1-6f40-4ddb-9a81-ee0e7d1b58e7_terseLabel_en-US" xlink:label="lab_gild_MarketableSecuritiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_gild_MarketableSecuritiesCurrentMember_label_en-US" xlink:label="lab_gild_MarketableSecuritiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current [Member]</link:label>
    <link:label id="lab_gild_MarketableSecuritiesCurrentMember_documentation_en-US" xlink:label="lab_gild_MarketableSecuritiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MarketableSecuritiesCurrentMember" xlink:href="gild-20200930.xsd#gild_MarketableSecuritiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_MarketableSecuritiesCurrentMember" xlink:to="lab_gild_MarketableSecuritiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_NumberOfAgreements_75805dd2-60ca-4b7c-927b-d2072b197f64_terseLabel_en-US" xlink:label="lab_gild_NumberOfAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of agreements</link:label>
    <link:label id="lab_gild_NumberOfAgreements_label_en-US" xlink:label="lab_gild_NumberOfAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Agreements</link:label>
    <link:label id="lab_gild_NumberOfAgreements_documentation_en-US" xlink:label="lab_gild_NumberOfAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_NumberOfAgreements" xlink:href="gild-20200930.xsd#gild_NumberOfAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_NumberOfAgreements" xlink:to="lab_gild_NumberOfAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_5dacf2a8-1d42-4c07-818e-dae40658b437_totalLabel_en-US" xlink:label="lab_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount, indefinite-lived assets</link:label>
    <link:label id="lab_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Indefinite Lived Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_documentation_en-US" xlink:label="lab_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total carrying amount of assets (excluding financial assets) that lack physical substance, excluding goodwill, having a projected indefinite period of benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="gild-20200930.xsd#gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_fc6b82c6-0599-4750-a3b2-1343a497048d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AssetAcquisitionAxis_d2dc2473-a501-4b9f-92c2-1c0abd5e93a7_terseLabel_en-US" xlink:label="lab_gild_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_gild_AssetAcquisitionAxis_label_en-US" xlink:label="lab_gild_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_gild_AssetAcquisitionAxis_documentation_en-US" xlink:label="lab_gild_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionAxis" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AssetAcquisitionAxis" xlink:to="lab_gild_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_ea9ec8de-5490-4644-b33b-4184a0d72834_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, performance obligation satisfied in previous period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c1eafbd4-7a9f-44e0-a937-cfc4ad6cb4e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of assets and liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6810d73f-af48-42bb-9544-44fc4d14c63f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_e020cc93-da07-4701-805b-2dd2aef658ac_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_b62ee208-3324-42ce-adbb-7b330ee60ff1_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HCVProductsVoseviMember_adc76921-475f-48f0-93a3-8cc30162d59f_terseLabel_en-US" xlink:label="lab_gild_HCVProductsVoseviMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vosevi</link:label>
    <link:label id="lab_gild_HCVProductsVoseviMember_label_en-US" xlink:label="lab_gild_HCVProductsVoseviMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCV Products, Vosevi [Member]</link:label>
    <link:label id="lab_gild_HCVProductsVoseviMember_documentation_en-US" xlink:label="lab_gild_HCVProductsVoseviMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCV Products, Vosevi [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsVoseviMember" xlink:href="gild-20200930.xsd#gild_HCVProductsVoseviMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HCVProductsVoseviMember" xlink:to="lab_gild_HCVProductsVoseviMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_ae66160f-4a87-45bf-aade-d089ee144776_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_FortySevenIncMember_5cc8c77d-58ea-4fdc-82e3-6293e2b5f506_terseLabel_en-US" xlink:label="lab_gild_FortySevenIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forty Seven</link:label>
    <link:label id="lab_gild_FortySevenIncMember_label_en-US" xlink:label="lab_gild_FortySevenIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forty Seven, Inc. [Member]</link:label>
    <link:label id="lab_gild_FortySevenIncMember_documentation_en-US" xlink:label="lab_gild_FortySevenIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forty Seven, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FortySevenIncMember" xlink:href="gild-20200930.xsd#gild_FortySevenIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_FortySevenIncMember" xlink:to="lab_gild_FortySevenIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_MarketableSecuritiesNoncurrentMember_ea260f91-fe3e-4166-9ce4-5650859db270_terseLabel_en-US" xlink:label="lab_gild_MarketableSecuritiesNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable securities</link:label>
    <link:label id="lab_gild_MarketableSecuritiesNoncurrentMember_label_en-US" xlink:label="lab_gild_MarketableSecuritiesNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent [Member]</link:label>
    <link:label id="lab_gild_MarketableSecuritiesNoncurrentMember_documentation_en-US" xlink:label="lab_gild_MarketableSecuritiesNoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MarketableSecuritiesNoncurrentMember" xlink:href="gild-20200930.xsd#gild_MarketableSecuritiesNoncurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_MarketableSecuritiesNoncurrentMember" xlink:to="lab_gild_MarketableSecuritiesNoncurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_22a25466-b0fd-4992-87fe-61291c7b1975_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_4bf70dc6-955e-4126-b532-444eb0d65be8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_eb60cf3d-194a-4e38-8463-147954e269ae_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dba75541-d64f-4460-abf9-ca191d64a15d_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e691950a-3c91-4669-90fe-ad5119f57551_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value&#160;</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1bedf704-4044-479f-a1a5-6ccc160fbd90_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_ba278af1-88ca-4bb2-a140-ed3f844f4bc3_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount (Legal Offset)</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A440SeniorUnsecuredNotesDueDecember2021Member_29bfe8bf-90fb-43dd-8d9e-9b5150223d77_terseLabel_en-US" xlink:label="lab_gild_A440SeniorUnsecuredNotesDueDecember2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.40% Senior Unsecured Notes Due December 2021</link:label>
    <link:label id="lab_gild_A440SeniorUnsecuredNotesDueDecember2021Member_label_en-US" xlink:label="lab_gild_A440SeniorUnsecuredNotesDueDecember2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.40% Senior Unsecured Notes Due December 2021 [Member]</link:label>
    <link:label id="lab_gild_A440SeniorUnsecuredNotesDueDecember2021Member_documentation_en-US" xlink:label="lab_gild_A440SeniorUnsecuredNotesDueDecember2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.40% Senior Unsecured Notes Due December 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A440SeniorUnsecuredNotesDueDecember2021Member" xlink:href="gild-20200930.xsd#gild_A440SeniorUnsecuredNotesDueDecember2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A440SeniorUnsecuredNotesDueDecember2021Member" xlink:to="lab_gild_A440SeniorUnsecuredNotesDueDecember2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_8b17083c-81f8-443f-8e4f-bdd63b40e2d6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Available-for-Sale Debt Securities in a Continuous Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_53ba4318-b52e-406a-86e0-015c4c033b82_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a4130b4c-a63e-4606-ba1d-ade9d35f3bb6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_91610a87-bcf0-4636-864b-de8c60896fef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_99773350-5a6b-4737-94af-57b2a453c3a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ProductsOtherHIVMember_7b1e8e9c-f073-4200-8b0d-89acc4fd6edb_terseLabel_en-US" xlink:label="lab_gild_ProductsOtherHIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other HIV</link:label>
    <link:label id="lab_gild_ProductsOtherHIVMember_label_en-US" xlink:label="lab_gild_ProductsOtherHIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products, Other HIV [Member]</link:label>
    <link:label id="lab_gild_ProductsOtherHIVMember_documentation_en-US" xlink:label="lab_gild_ProductsOtherHIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products, Other HIV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ProductsOtherHIVMember" xlink:href="gild-20200930.xsd#gild_ProductsOtherHIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ProductsOtherHIVMember" xlink:to="lab_gild_ProductsOtherHIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_84b30a92-a958-4a63-bcc9-a1cb0709cd71_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_962111bf-b8e4-4ce2-a170-d41e3bfcf8d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_3294ed3f-7bc6-4f2c-aa79-d50e2370bb3b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8bbd7ca5-3c77-4070-8884-6f9042d0b3e2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share attributable to Gilead common stockholders - diluted (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fefe3ad0-8b7e-458f-aa92-6cf4fed7f90d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Gilead common stockholders - diluted (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A2016StockRepurchaseProgramMember_eda9f5c1-d8bf-487a-8106-66eb4743e1a1_terseLabel_en-US" xlink:label="lab_gild_A2016StockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Stock Repurchase Program</link:label>
    <link:label id="lab_gild_A2016StockRepurchaseProgramMember_label_en-US" xlink:label="lab_gild_A2016StockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Stock Repurchase Program [Member]</link:label>
    <link:label id="lab_gild_A2016StockRepurchaseProgramMember_documentation_en-US" xlink:label="lab_gild_A2016StockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Stock Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A2016StockRepurchaseProgramMember" xlink:href="gild-20200930.xsd#gild_A2016StockRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A2016StockRepurchaseProgramMember" xlink:to="lab_gild_A2016StockRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_44e69a1f-e6c2-44b9-a9eb-2d72dfed8fe2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_e41bbc78-25e7-4c02-864a-ab508eccf74b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsZydeligMember_3f57a90e-2041-40e1-ab5b-1e80b089d429_terseLabel_en-US" xlink:label="lab_gild_OtherProductsZydeligMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zydelig</link:label>
    <link:label id="lab_gild_OtherProductsZydeligMember_label_en-US" xlink:label="lab_gild_OtherProductsZydeligMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Zydelig [Member]</link:label>
    <link:label id="lab_gild_OtherProductsZydeligMember_documentation_en-US" xlink:label="lab_gild_OtherProductsZydeligMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Zydelig [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsZydeligMember" xlink:href="gild-20200930.xsd#gild_OtherProductsZydeligMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsZydeligMember" xlink:to="lab_gild_OtherProductsZydeligMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments_59f2b69e-50c9-4fc4-88c6-c6c88d2ef757_terseLabel_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opt-in, extension and milestone payments</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments_label_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Option Opt-in, Extension and Milestone Payments</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments_documentation_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Option Opt-in, Extension and Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" xlink:to="lab_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_73c737f7-f98c-4e61-9f9b-d108b1db8e1a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_af7b0f17-dd28-4fc3-b518-2b66c1e37930_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_418bd72a-920a-40d0-ae3d-8d284b9b8c13_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_b66b6ad5-edcd-4c0f-9ab4-70d9bc7bc2a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fd738afd-2b6d-4537-ad26-e8d61efdf7d5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember_9d0cc140-eabb-410d-86b6-0128e4fb1bb0_terseLabel_en-US" xlink:label="lab_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the &#8220;Collaboration and Stock Purchase Agreements&#8221;</link:label>
    <link:label id="lab_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember_label_en-US" xlink:label="lab_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Research Collaboration and License Agreement and Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Research Collaboration and License Agreement and Stock Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" xlink:href="gild-20200930.xsd#gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" xlink:to="lab_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_4e433715-4eaa-4d13-846e-fe8ae88d4881_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, including in-process research and development, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_5b4fb8b7-c32b-4fd7-87e1-073b3fa41ab3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire in process research and development</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a8bb8cdb-ec34-4a27-b234-329db93b4bcd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign currency translation gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_2b1315c6-e1d8-4c81-91b6-5d52a917e193_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_2039d9cc-3084-4fa1-bb51-4e893e44d1f5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements_c801e777-0af4-4c57-ae6f-b59e3138379f_terseLabel_en-US" xlink:label="lab_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront collaboration expenses related to other collaborative arrangements</link:label>
    <link:label id="lab_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements_label_en-US" xlink:label="lab_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Collaboration Expenses Related to Other Collaborative Arrangements</link:label>
    <link:label id="lab_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements_documentation_en-US" xlink:label="lab_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Collaboration Expenses Related to Other Collaborative Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" xlink:href="gild-20200930.xsd#gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" xlink:to="lab_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_91588bec-65bc-4019-95c7-a541cf19b439_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A480SeniorUnsecuredNotesDueApril2044Member_c9789986-a092-4c94-abf3-521b3fbb1fe2_terseLabel_en-US" xlink:label="lab_gild_A480SeniorUnsecuredNotesDueApril2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.80% Senior Unsecured Notes Due April 2044</link:label>
    <link:label id="lab_gild_A480SeniorUnsecuredNotesDueApril2044Member_label_en-US" xlink:label="lab_gild_A480SeniorUnsecuredNotesDueApril2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.80% Senior Unsecured Notes Due April 2044 [Member]</link:label>
    <link:label id="lab_gild_A480SeniorUnsecuredNotesDueApril2044Member_documentation_en-US" xlink:label="lab_gild_A480SeniorUnsecuredNotesDueApril2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.80% Senior Unsecured Notes Due April 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A480SeniorUnsecuredNotesDueApril2044Member" xlink:href="gild-20200930.xsd#gild_A480SeniorUnsecuredNotesDueApril2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A480SeniorUnsecuredNotesDueApril2044Member" xlink:to="lab_gild_A480SeniorUnsecuredNotesDueApril2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_CreditFacilityDueJune2025Member_28571bea-9b20-466d-9b60-74a2af3ad43f_terseLabel_en-US" xlink:label="lab_gild_CreditFacilityDueJune2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "2020 Revolving Credit Facility"</link:label>
    <link:label id="lab_gild_CreditFacilityDueJune2025Member_label_en-US" xlink:label="lab_gild_CreditFacilityDueJune2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Due June 2025 [Member]</link:label>
    <link:label id="lab_gild_CreditFacilityDueJune2025Member_documentation_en-US" xlink:label="lab_gild_CreditFacilityDueJune2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Due June 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CreditFacilityDueJune2025Member" xlink:href="gild-20200930.xsd#gild_CreditFacilityDueJune2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_CreditFacilityDueJune2025Member" xlink:to="lab_gild_CreditFacilityDueJune2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_962acfe8-a5d0-40c1-bc4d-06586ee5ca48_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8b86ae5e-8349-4438-acdc-2f608915a7b2_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_060a6015-a18f-45bc-b559-e57b138914e3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_8475419a-9696-46a4-916d-ae20d8ab063b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ffc7330-6331-4456-8733-e5d83f2e5012_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AdditionalInformationAbstract_39641939-1114-4619-a28b-6d43b3eed8c6_terseLabel_en-US" xlink:label="lab_gild_AdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information [Abstract]</link:label>
    <link:label id="lab_gild_AdditionalInformationAbstract_label_en-US" xlink:label="lab_gild_AdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information [Abstract]</link:label>
    <link:label id="lab_gild_AdditionalInformationAbstract_documentation_en-US" xlink:label="lab_gild_AdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AdditionalInformationAbstract" xlink:href="gild-20200930.xsd#gild_AdditionalInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AdditionalInformationAbstract" xlink:to="lab_gild_AdditionalInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_f928cf1b-7845-471c-ab6c-073c2ce14d92_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_91d290c9-dbc7-4ccf-8960-b501c1ed01b4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e171e669-fe86-4485-a0ec-d542079d45b3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2f42228f-0a48-4fc7-b465-c5fc4799a368_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_53692781-b780-4b41-a003-08552c8b4242_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications to net income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_0b1a8625-0ae2-4067-8db5-884fcf487023_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allocated and Single Maturity Date, Maturity, after 10 Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments_5b11bc50-696d-420a-8cc1-5c53479e1874_terseLabel_en-US" xlink:label="lab_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate to discount remaining payments</link:label>
    <link:label id="lab_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments_label_en-US" xlink:label="lab_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Basis Spread On Variable Rate To Discount Remaining Payments</link:label>
    <link:label id="lab_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments_documentation_en-US" xlink:label="lab_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Basis Spread On Variable Rate To Discount Remaining Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" xlink:href="gild-20200930.xsd#gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" xlink:to="lab_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7f4889d1-527d-4013-8442-ad14bbdb39ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts of Recognized Assets/Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_846e66ca-292a-4aad-9429-34f61c95d92a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c467d530-77e0-4dd5-ac55-a92ed5de5174_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term obligations</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d0bd94f0-a7f7-4ca5-a467-2bf908878365_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2404699e-8c62-48b7-b772-6270e5fa3d4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fcd9bd6-df50-40c7-9e53-166e0c065fe3_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_fc619f4f-c1de-4c63-b672-1711534e0393_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6811c7b9-837e-41c4-a8c0-aea3da36d3f1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_JunoMember_03374361-be92-4071-92c6-cefb17bb2239_terseLabel_en-US" xlink:label="lab_gild_JunoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Juno</link:label>
    <link:label id="lab_gild_JunoMember_label_en-US" xlink:label="lab_gild_JunoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Juno [Member]</link:label>
    <link:label id="lab_gild_JunoMember_documentation_en-US" xlink:label="lab_gild_JunoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Juno [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JunoMember" xlink:href="gild-20200930.xsd#gild_JunoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_JunoMember" xlink:to="lab_gild_JunoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6f10b544-af78-4b4e-a1af-2498a8c942ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e02063a5-f64b-4e4e-9355-7897f54ab786_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_1410875c-a904-4267-8f46-9c0b6af6508d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivableCurrent" xlink:to="lab_us-gaap_InterestReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_df7d9641-1a9d-4f63-bfef-64f60ab417e9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_776a006a-bc60-4e8e-bbff-e5e95c30bded_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dad014c6-b299-479a-ab09-2beb1da1e1aa_verboseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_70500a74-8172-4211-a946-14a694510752_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries_d38f7cae-b055-4cf3-befd-e7ce2f80af45_terseLabel_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional option fee on 4th, 6th, and 8th anniversaries</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries_label_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Additional Option Fee on Fourth, Sixth, and Eighth Anniversaries</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries_documentation_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Additional Option Fee on Fourth, Sixth, and Eighth Anniversaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" xlink:to="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_026415d5-6d63-4cbf-9b18-1b0b7392d642_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_102eba0e-263e-4538-bb25-42c96131be20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d595c746-b02d-4346-99d8-e29f541bc864_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_4f56172b-ac31-4c1d-9463-a64e14447acc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equity securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_568b579a-36c8-460a-9c48-e0d9eae6b121_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions held in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_b08ae066-e1bd-4f11-af1e-bbfceade8e9e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_9568472f-e241-406e-a46c-afa762dfe5fe_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_e0984ab4-1184-4a42-9654-6b3fa9ac1f6d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da03b144-8526-412f-811a-4136d4e94e03_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_54bf2e67-acfa-4aae-8273-9387d5723f83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary_8528af59-dafd-4b91-b542-2052b42865c2_terseLabel_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional option fee on second anniversary</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary_label_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Additional Option Fee on Second Anniversary</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary_documentation_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Additional Option Fee on Second Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" xlink:to="lab_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_55e1c98d-283e-4e1c-b0f1-cb6ec60d6754_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_973af902-3233-4fde-9b81-e81435d1c53f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3a10b743-9434-430d-a52f-8c64f453abec_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AssetAcquisitionDomain_6af11ee1-979d-4e8a-9de3-7728e778cc13_terseLabel_en-US" xlink:label="lab_gild_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_gild_AssetAcquisitionDomain_label_en-US" xlink:label="lab_gild_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_gild_AssetAcquisitionDomain_documentation_en-US" xlink:label="lab_gild_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionDomain" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AssetAcquisitionDomain" xlink:to="lab_gild_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ff0ddd4d-4f7d-4ded-8c1b-ce8866865495_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0f6f0845-05a1-4233-aa5a-42eecff32b55_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_e0d4eff3-8fe6-4aa5-a71e-048cca07cf84_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncontrolling interest (Note 6)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_3f31cf8c-83ac-48bc-b406-b1ee5b7afc15_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (gain) loss from equity securities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_dbf1da10-b8bb-4194-b81a-a321db1b192a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a4501fa3-be4d-49a2-abb6-14c0415941e3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_31d1d551-ba95-483b-be51-b6e22498c4e7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember_1c20137a-ee33-41ed-91c5-c58fcd466d8a_terseLabel_en-US" xlink:label="lab_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "License and Stock Purchase Agreement"</link:label>
    <link:label id="lab_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember_label_en-US" xlink:label="lab_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License, Registration Rights and Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License, Registration Rights and Stock Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember" xlink:href="gild-20200930.xsd#gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember" xlink:to="lab_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_30eb3d16-be19-44a9-9a3a-76ba2b116542_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Collateral Received/ Pledged</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Collateral, Obligation to Return Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:to="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_PotentialFutureMaximumMilestonePayments_b0f79d6c-69ed-49b1-a855-379c55eb147f_terseLabel_en-US" xlink:label="lab_gild_PotentialFutureMaximumMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential future maximum milestone payments</link:label>
    <link:label id="lab_gild_PotentialFutureMaximumMilestonePayments_label_en-US" xlink:label="lab_gild_PotentialFutureMaximumMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Maximum Milestone Payments</link:label>
    <link:label id="lab_gild_PotentialFutureMaximumMilestonePayments_documentation_en-US" xlink:label="lab_gild_PotentialFutureMaximumMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Maximum Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PotentialFutureMaximumMilestonePayments" xlink:href="gild-20200930.xsd#gild_PotentialFutureMaximumMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_PotentialFutureMaximumMilestonePayments" xlink:to="lab_gild_PotentialFutureMaximumMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_800224ae-fae2-4bec-afaf-e263cace0fd2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_af0ee433-4f04-4204-9252-0074f339af7b_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_ba0f1aed-92c3-424a-a7ad-466be30629de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_0edc23bd-46a1-45e2-b4bc-42557588dedf_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt and other obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest_c99bee1d-72e3-4a9c-a275-a0517b79d7de_terseLabel_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss representing royalties and prejudgment interest</link:label>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest_label_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss (Royalties and Prejudgment Interest)</link:label>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest_documentation_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss (Royalties and Prejudgment Interest)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" xlink:to="lab_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_164f1b0d-014c-4d60-baef-aff4964c9e20_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount, finite-lived assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_89a92db2-9b89-4a0f-a3e7-309c705fb6fb_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_label_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeRemainingMaturity1" xlink:to="lab_us-gaap_DerivativeRemainingMaturity1" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased_dd8cfa39-c7db-4040-8054-5f218ba89fc0_terseLabel_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum percentage of outstanding stock allowed to be purchased</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased_label_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Percentage Of Outstanding Stock Allowed To Be Purchased</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased_documentation_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Percentage Of Outstanding Stock Allowed To Be Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" xlink:to="lab_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_9e250825-2b8e-4f04-8361-1acb339a69da_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_edf2ae0c-6bbe-4a60-ba77-43bef20c09ec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c86b4041-d3b8-4ce3-98d5-5a611593f7ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherFinancialInformationAbstract_d54e1b92-29d4-4091-b722-bda1abfaaa9e_terseLabel_en-US" xlink:label="lab_gild_OtherFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Information [Abstract]</link:label>
    <link:label id="lab_gild_OtherFinancialInformationAbstract_label_en-US" xlink:label="lab_gild_OtherFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Information [Abstract]</link:label>
    <link:label id="lab_gild_OtherFinancialInformationAbstract_documentation_en-US" xlink:label="lab_gild_OtherFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherFinancialInformationAbstract" xlink:href="gild-20200930.xsd#gild_OtherFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherFinancialInformationAbstract" xlink:to="lab_gild_OtherFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_077c893f-badf-4703-8767-a2d91af109ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_85026642-353d-4b92-a659-199a6b9ed41d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsCompleraEvipleraMember_a0a28702-b15e-4e4f-930d-854a2c83bbb2_terseLabel_en-US" xlink:label="lab_gild_HIVProductsCompleraEvipleraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complera/Eviplera</link:label>
    <link:label id="lab_gild_HIVProductsCompleraEvipleraMember_label_en-US" xlink:label="lab_gild_HIVProductsCompleraEvipleraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Complera/Eviplera [Member]</link:label>
    <link:label id="lab_gild_HIVProductsCompleraEvipleraMember_documentation_en-US" xlink:label="lab_gild_HIVProductsCompleraEvipleraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Complera/Eviplera [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsCompleraEvipleraMember" xlink:href="gild-20200930.xsd#gild_HIVProductsCompleraEvipleraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsCompleraEvipleraMember" xlink:to="lab_gild_HIVProductsCompleraEvipleraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e57bea36-aa21-47ae-8f22-d1fe6f2481b9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_2ac3e858-4e9f-4168-8802-d38b4d63c229_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_5c63da42-8c71-4e06-9012-a92ec32ff926_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_989e32a0-b8ff-43b3-b1dc-d4b985eb1805_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 Months or greater, fair value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquitySecuritiesFVNIPurchasePeriod_ffd3975a-ddad-475d-afb4-fe30df6bd7b1_terseLabel_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase period</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIPurchasePeriod_label_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Purchase Period</link:label>
    <link:label id="lab_gild_EquitySecuritiesFVNIPurchasePeriod_documentation_en-US" xlink:label="lab_gild_EquitySecuritiesFVNIPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIPurchasePeriod" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquitySecuritiesFVNIPurchasePeriod" xlink:to="lab_gild_EquitySecuritiesFVNIPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_TangoTherapeuticsIncMember_8bcc97db-d107-4ab0-863c-ab11c7cece8c_terseLabel_en-US" xlink:label="lab_gild_TangoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tango</link:label>
    <link:label id="lab_gild_TangoTherapeuticsIncMember_label_en-US" xlink:label="lab_gild_TangoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tango Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_gild_TangoTherapeuticsIncMember_documentation_en-US" xlink:label="lab_gild_TangoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tango Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TangoTherapeuticsIncMember" xlink:href="gild-20200930.xsd#gild_TangoTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_TangoTherapeuticsIncMember" xlink:to="lab_gild_TangoTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2a9b8fd2-532d-4b72-9bdb-253b9b0313c2_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_JudgmentRoyaltyRateFromOctober2017_ff3767c3-ac9a-40aa-a9bd-c52909cbeebd_terseLabel_en-US" xlink:label="lab_gild_JudgmentRoyaltyRateFromOctober2017" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Running royalty rate from October 2017</link:label>
    <link:label id="lab_gild_JudgmentRoyaltyRateFromOctober2017_label_en-US" xlink:label="lab_gild_JudgmentRoyaltyRateFromOctober2017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment: Royalty Rate from October 2017</link:label>
    <link:label id="lab_gild_JudgmentRoyaltyRateFromOctober2017_documentation_en-US" xlink:label="lab_gild_JudgmentRoyaltyRateFromOctober2017" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment: Royalty Rate from October 2017</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentRoyaltyRateFromOctober2017" xlink:href="gild-20200930.xsd#gild_JudgmentRoyaltyRateFromOctober2017"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_JudgmentRoyaltyRateFromOctober2017" xlink:to="lab_gild_JudgmentRoyaltyRateFromOctober2017" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_53f3b648-d464-40a6-ae39-67720b0ccfe5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6fc1d614-0bba-4d7b-95ed-710bf2b4a879_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_29769ae9-83fa-42f7-8c5f-5c9e452ec77a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_a2f68346-4b74-475e-bdfc-24756958d396_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, redemption percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_ae18260d-6d8d-4899-8645-d514df4e3fd3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_a2dc6a35-94d1-485a-9fb7-a99d62dd0ca2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e0a7ebbe-c536-41ec-8339-7197a7b00a1f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_a742bfcb-cab7-4316-9cf5-9f493f68d796_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_954070fd-95c2-455d-9edb-61ebeb1bf566_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Credit Facilities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_4c861120-889d-4dbd-86a9-7bc8846e8b3e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs charged against allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6cb98294-9005-4023-a23d-109de7950754_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_COVID19ProductsVekluryMember_be4a49b8-6eb7-4bf3-a6d6-0a81a822c1e9_terseLabel_en-US" xlink:label="lab_gild_COVID19ProductsVekluryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Veklury</link:label>
    <link:label id="lab_gild_COVID19ProductsVekluryMember_label_en-US" xlink:label="lab_gild_COVID19ProductsVekluryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Products, Veklury [Member]</link:label>
    <link:label id="lab_gild_COVID19ProductsVekluryMember_documentation_en-US" xlink:label="lab_gild_COVID19ProductsVekluryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Products, Veklury</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_COVID19ProductsVekluryMember" xlink:href="gild-20200930.xsd#gild_COVID19ProductsVekluryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_COVID19ProductsVekluryMember" xlink:to="lab_gild_COVID19ProductsVekluryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_11a7f341-e270-467e-abe1-09cf0dfd55f4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value to acquire equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e53b3081-ee0a-4685-af7f-774ff7219414_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_11b72307-3405-475d-b773-d07a3343595f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4710e652-bbab-4c13-a934-e054d59f2ada_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization, finite-lived assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4cc0f21b-f295-409a-b897-2bf600a1cc8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e87e9de4-b2a0-4981-85a0-f99a78e721e1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1407dae4-48e0-4e4e-ad03-435f92567c16_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a1a1242b-3e36-4570-b670-f2c74c58a56d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_fa33a0d3-a349-4661-a255-9929a4566d63_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_b7983502-3563-410c-9cf2-a747589e539d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_9c2bb211-c7a0-4e50-a486-52d2717b2d05_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_52b9315c-d7a9-43e5-af64-7345c3ddb4aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6f4b0229-0fba-4067-a238-901efd9fe85e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_70c275ba-7189-43d1-a79b-f95ad8c9e882_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the Calculation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5662c7aa-debf-4712-b3af-ff4e6a816b2f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7516cb06-1079-4221-8aad-d07b6a8098cb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_f68da206-a9ca-4f0b-8923-fc8356dd2edd_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_51552494-e8d6-441f-a55c-ff92270c71ae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_2f26c777-b5b5-4bf4-b56e-b819a24c47b8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AcquisitionCollaborationsAndOtherArrangementsTable_30dcb3d6-b992-4226-a66b-c8d1ff527dc6_terseLabel_en-US" xlink:label="lab_gild_AcquisitionCollaborationsAndOtherArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Table]</link:label>
    <link:label id="lab_gild_AcquisitionCollaborationsAndOtherArrangementsTable_label_en-US" xlink:label="lab_gild_AcquisitionCollaborationsAndOtherArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Table]</link:label>
    <link:label id="lab_gild_AcquisitionCollaborationsAndOtherArrangementsTable_documentation_en-US" xlink:label="lab_gild_AcquisitionCollaborationsAndOtherArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsAndOtherArrangementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable" xlink:to="lab_gild_AcquisitionCollaborationsAndOtherArrangementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_e291eb17-fa82-4f8d-9081-f9169e974710_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_a8145537-ff35-449c-8308-6b56bf07a3a2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c6fed82e-79c0-46e0-ba28-722ebe3fb592_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_225e8484-3a37-492c-a026-f87c5cdf3b47_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_b88afba7-76bb-40d8-ab88-44760ef94cd0_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsVireadMember_06718919-8570-4743-a94d-2a8156fada28_terseLabel_en-US" xlink:label="lab_gild_OtherProductsVireadMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viread</link:label>
    <link:label id="lab_gild_OtherProductsVireadMember_label_en-US" xlink:label="lab_gild_OtherProductsVireadMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Viread [Member]</link:label>
    <link:label id="lab_gild_OtherProductsVireadMember_documentation_en-US" xlink:label="lab_gild_OtherProductsVireadMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Viread [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsVireadMember" xlink:href="gild-20200930.xsd#gild_OtherProductsVireadMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsVireadMember" xlink:to="lab_gild_OtherProductsVireadMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ArcusBiosciencesIncMember_1d9ceb68-8e43-49e3-a532-2cffc952dc44_terseLabel_en-US" xlink:label="lab_gild_ArcusBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arcus</link:label>
    <link:label id="lab_gild_ArcusBiosciencesIncMember_label_en-US" xlink:label="lab_gild_ArcusBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arcus Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_gild_ArcusBiosciencesIncMember_documentation_en-US" xlink:label="lab_gild_ArcusBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arcus Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ArcusBiosciencesIncMember" xlink:href="gild-20200930.xsd#gild_ArcusBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ArcusBiosciencesIncMember" xlink:to="lab_gild_ArcusBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_344fa871-c2b6-4805-a292-3a7507269203_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6a5b9f0a-19fa-401a-b71a-adfb5f9f707c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsDescovyMember_ec0fef24-6e5b-4618-b087-3af2b5f83a36_terseLabel_en-US" xlink:label="lab_gild_HIVProductsDescovyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Descovy</link:label>
    <link:label id="lab_gild_HIVProductsDescovyMember_label_en-US" xlink:label="lab_gild_HIVProductsDescovyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Descovy [Member]</link:label>
    <link:label id="lab_gild_HIVProductsDescovyMember_documentation_en-US" xlink:label="lab_gild_HIVProductsDescovyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Descovy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsDescovyMember" xlink:href="gild-20200930.xsd#gild_HIVProductsDescovyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsDescovyMember" xlink:to="lab_gild_HIVProductsDescovyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_TotalUpfrontPaymentsMade_95fd99c0-b4c7-4dbb-8330-d1e54234a6e6_terseLabel_en-US" xlink:label="lab_gild_TotalUpfrontPaymentsMade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total upfront payments made</link:label>
    <link:label id="lab_gild_TotalUpfrontPaymentsMade_label_en-US" xlink:label="lab_gild_TotalUpfrontPaymentsMade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Upfront Payments Made</link:label>
    <link:label id="lab_gild_TotalUpfrontPaymentsMade_documentation_en-US" xlink:label="lab_gild_TotalUpfrontPaymentsMade" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Upfront Payments Made</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalUpfrontPaymentsMade" xlink:href="gild-20200930.xsd#gild_TotalUpfrontPaymentsMade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_TotalUpfrontPaymentsMade" xlink:to="lab_gild_TotalUpfrontPaymentsMade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_ca0c8c8f-44b3-4923-9be2-eb6deb98ebf6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_08977e76-2943-46be-9625-02dbcaf94454_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember_c9b0ae61-c151-45a9-a0fc-9c0e52bbbbbb_terseLabel_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "Collaboration Agreement" and "Subscription Agreement"</link:label>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember_label_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option License and Collaboration Agreement and Subscription Agreement [Member]</link:label>
    <link:label id="lab_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember_documentation_en-US" xlink:label="lab_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An option, license and collaboration Agreement (the &#8220;Collaboration Agreement&#8221;) and a Subscription Agreement (the &#8220;Subscription Agreement&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" xlink:to="lab_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ImmunomedicsIncMember_5dee76c1-49c8-4b29-9d9a-1f5ae5e44b97_terseLabel_en-US" xlink:label="lab_gild_ImmunomedicsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunomedics</link:label>
    <link:label id="lab_gild_ImmunomedicsIncMember_label_en-US" xlink:label="lab_gild_ImmunomedicsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunomedics, Inc. [Member]</link:label>
    <link:label id="lab_gild_ImmunomedicsIncMember_documentation_en-US" xlink:label="lab_gild_ImmunomedicsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunomedics, Inc. (&#8220;Immunomedics&#8221;), a leading company in antibody-drug conjugate (&#8220;ADC&#8221;) technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ImmunomedicsIncMember" xlink:href="gild-20200930.xsd#gild_ImmunomedicsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ImmunomedicsIncMember" xlink:to="lab_gild_ImmunomedicsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ee4aeb63-6d11-4bbf-a815-3ea3a20ecfba_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_15b37dcc-78ba-42b2-87cc-b77c5af4196c_verboseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_cf70f7e7-76f0-49e7-a847-b5c5e5f9d590_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_874f3d48-eb1e-4bae-9346-fe71b8fa2ca8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_cb4a9d76-e35b-437c-96ac-d19327470976_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquityMethodInvestmentOptionExerciseFee_7ddb3921-339c-4d16-84a7-a9fca6fb19bf_terseLabel_en-US" xlink:label="lab_gild_EquityMethodInvestmentOptionExerciseFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option exercise fee</link:label>
    <link:label id="lab_gild_EquityMethodInvestmentOptionExerciseFee_label_en-US" xlink:label="lab_gild_EquityMethodInvestmentOptionExerciseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Option Exercise Fee</link:label>
    <link:label id="lab_gild_EquityMethodInvestmentOptionExerciseFee_documentation_en-US" xlink:label="lab_gild_EquityMethodInvestmentOptionExerciseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Option Exercise Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityMethodInvestmentOptionExerciseFee" xlink:href="gild-20200930.xsd#gild_EquityMethodInvestmentOptionExerciseFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquityMethodInvestmentOptionExerciseFee" xlink:to="lab_gild_EquityMethodInvestmentOptionExerciseFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_cc21f73a-ebed-4ceb-9b02-f28c819c7dd2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance under equity incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_011ec4ba-d420-410f-82d6-3f4775cff35a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_63811c0e-3948-4205-9b8e-b23e7ce6d76a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a98db339-9a61-4020-83f0-4a23410f591a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_60f83da1-06e9-4da8-bc58-cdc4cebb8b44_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0328feb9-0236-4612-b5c0-43da5e403ec8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9f07d86e-85f0-4749-af0a-6c9b9049ffec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_cc8e6668-cc1f-4a3c-abb1-aa9552c18d48_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_4f237ccf-ec92-421d-92d0-d15ef388f53c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_9c599af7-9151-4b57-ae04-1cc3879754e6_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_ff650e69-ba7d-4203-901d-436fd61e7605_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 (remaining three months)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b13aaf38-c41b-4e8f-a57f-60bbd73c0485_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d4c5b72d-71a1-416b-b6ab-606a617984c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_fd9d5bfc-1f43-49dc-baef-33b85f009cc1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_102fab41-f384-49f2-86cb-b6b7086d06a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5cf836f6-e904-40e8-a910-3bb7d3ae804d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ResearchAndDevelopmentServiceAgreementMember_b26605d7-07c7-41f3-bb7e-3e840adc3ccb_terseLabel_en-US" xlink:label="lab_gild_ResearchAndDevelopmentServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Service Agreement</link:label>
    <link:label id="lab_gild_ResearchAndDevelopmentServiceAgreementMember_label_en-US" xlink:label="lab_gild_ResearchAndDevelopmentServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Service Agreement [Member]</link:label>
    <link:label id="lab_gild_ResearchAndDevelopmentServiceAgreementMember_documentation_en-US" xlink:label="lab_gild_ResearchAndDevelopmentServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Service Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResearchAndDevelopmentServiceAgreementMember" xlink:href="gild-20200930.xsd#gild_ResearchAndDevelopmentServiceAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ResearchAndDevelopmentServiceAgreementMember" xlink:to="lab_gild_ResearchAndDevelopmentServiceAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages_1b31ed2f-0e6d-41d6-832a-8f6f2aaa1a3f_terseLabel_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss representing enhancement of past damages</link:label>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages_label_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss (50% Enhancement of Past Damages)</link:label>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages_documentation_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss (50% Enhancement of Past Damages)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" xlink:to="lab_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_DevelopmentAgreementMember_1e97c812-f3d4-4c18-a6f4-014e986fb031_terseLabel_en-US" xlink:label="lab_gild_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement</link:label>
    <link:label id="lab_gild_DevelopmentAgreementMember_label_en-US" xlink:label="lab_gild_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement [Member]</link:label>
    <link:label id="lab_gild_DevelopmentAgreementMember_documentation_en-US" xlink:label="lab_gild_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DevelopmentAgreementMember" xlink:href="gild-20200930.xsd#gild_DevelopmentAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_DevelopmentAgreementMember" xlink:to="lab_gild_DevelopmentAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_a94a158f-b1f9-40bc-a421-edfe1a71c3b1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:to="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f048c97b-f547-4a87-bd1d-9d5c25262e04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of classification and fair value of derivative instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_PionyrImmunotherapeuticsIncMember_8e6c7a89-c915-4294-a3d3-daf5cd5e2d25_terseLabel_en-US" xlink:label="lab_gild_PionyrImmunotherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pionyr</link:label>
    <link:label id="lab_gild_PionyrImmunotherapeuticsIncMember_label_en-US" xlink:label="lab_gild_PionyrImmunotherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pionyr Immunotherapeutics, Inc. [Member]</link:label>
    <link:label id="lab_gild_PionyrImmunotherapeuticsIncMember_documentation_en-US" xlink:label="lab_gild_PionyrImmunotherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pionyr Immunotherapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PionyrImmunotherapeuticsIncMember" xlink:href="gild-20200930.xsd#gild_PionyrImmunotherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_PionyrImmunotherapeuticsIncMember" xlink:to="lab_gild_PionyrImmunotherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_bc099de4-91b9-4e72-97e1-54ea938c705d_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of Assets/Liabilities Presented on our Condensed Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_JounceTherapeuticsIncMember_56187f5b-ca76-4653-afe8-e18608312fde_terseLabel_en-US" xlink:label="lab_gild_JounceTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jounce</link:label>
    <link:label id="lab_gild_JounceTherapeuticsIncMember_label_en-US" xlink:label="lab_gild_JounceTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jounce Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_gild_JounceTherapeuticsIncMember_documentation_en-US" xlink:label="lab_gild_JounceTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jounce Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JounceTherapeuticsIncMember" xlink:href="gild-20200930.xsd#gild_JounceTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_JounceTherapeuticsIncMember" xlink:to="lab_gild_JounceTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A255SeniorUnsecuredNotesDueSeptember2020Member_fc936c09-e84b-4e97-b6c5-6a27642ff1a5_terseLabel_en-US" xlink:label="lab_gild_A255SeniorUnsecuredNotesDueSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.55% Senior Unsecured Notes Due September 2020</link:label>
    <link:label id="lab_gild_A255SeniorUnsecuredNotesDueSeptember2020Member_label_en-US" xlink:label="lab_gild_A255SeniorUnsecuredNotesDueSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.55% Senior Unsecured Notes Due September 2020 [Member]</link:label>
    <link:label id="lab_gild_A255SeniorUnsecuredNotesDueSeptember2020Member_documentation_en-US" xlink:label="lab_gild_A255SeniorUnsecuredNotesDueSeptember2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.55% Senior Unsecured Notes Due September 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A255SeniorUnsecuredNotesDueSeptember2020Member" xlink:href="gild-20200930.xsd#gild_A255SeniorUnsecuredNotesDueSeptember2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A255SeniorUnsecuredNotesDueSeptember2020Member" xlink:to="lab_gild_A255SeniorUnsecuredNotesDueSeptember2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c69a3259-f7b4-45a2-adb0-63dde5edbac5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A295SeniorUnsecuredNotesDueMarch2027Member_8d9c65c1-2738-4a74-b1e8-01aa201cea9d_terseLabel_en-US" xlink:label="lab_gild_A295SeniorUnsecuredNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Senior Unsecured Notes Due March 2027</link:label>
    <link:label id="lab_gild_A295SeniorUnsecuredNotesDueMarch2027Member_label_en-US" xlink:label="lab_gild_A295SeniorUnsecuredNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Senior Unsecured Notes Due March 2027 [Member]</link:label>
    <link:label id="lab_gild_A295SeniorUnsecuredNotesDueMarch2027Member_documentation_en-US" xlink:label="lab_gild_A295SeniorUnsecuredNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Senior Unsecured Notes Due March 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A295SeniorUnsecuredNotesDueMarch2027Member" xlink:href="gild-20200930.xsd#gild_A295SeniorUnsecuredNotesDueMarch2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A295SeniorUnsecuredNotesDueMarch2027Member" xlink:to="lab_gild_A295SeniorUnsecuredNotesDueMarch2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_10b5edaa-e591-4b88-b3bb-35ac5e1be878_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6219c3be-93e1-47d7-93f6-b90f42f445cd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_e372d842-a7db-4ba5-84fd-4c06a7d54e30_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e968663f-bede-4838-b743-69376f6cf3f6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares repurchased and retired</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_e44d4016-46da-40b4-8947-d41a0bc607d6_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_55418c65-d0f0-4df7-940b-504ae0b5cebf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_61941a14-288b-4f7c-ba5d-da5591e2adcd_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ForeignCurrencyDerivativeContractsMember_35dc8c15-3cdf-42af-925f-375251080d2b_terseLabel_en-US" xlink:label="lab_gild_ForeignCurrencyDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency derivative contracts</link:label>
    <link:label id="lab_gild_ForeignCurrencyDerivativeContractsMember_label_en-US" xlink:label="lab_gild_ForeignCurrencyDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Contracts [Member]</link:label>
    <link:label id="lab_gild_ForeignCurrencyDerivativeContractsMember_documentation_en-US" xlink:label="lab_gild_ForeignCurrencyDerivativeContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ForeignCurrencyDerivativeContractsMember" xlink:href="gild-20200930.xsd#gild_ForeignCurrencyDerivativeContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ForeignCurrencyDerivativeContractsMember" xlink:to="lab_gild_ForeignCurrencyDerivativeContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_11d98b23-650c-4dc0-a5a7-8f949a1e19c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_6226d7ea-f13c-4a3c-80b6-dcf6c3a69b0d_terseLabel_en-US" xlink:label="lab_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.52% LIBOR Senior Unsecured Notes Due September 2023</link:label>
    <link:label id="lab_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_label_en-US" xlink:label="lab_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.52% LIBOR Senior Unsecured Notes Due September 2023 [Member]</link:label>
    <link:label id="lab_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_documentation_en-US" xlink:label="lab_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.52% LIBOR Senior Unsecured Notes Due September 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" xlink:href="gild-20200930.xsd#gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" xlink:to="lab_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3ff711ee-10b8-4616-99e7-a585e1a785d0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A120SeniorUnsecuredNotesDueOctober2027Member_dadfb3a5-ae4a-45bd-a15c-bb0f988f4dc2_terseLabel_en-US" xlink:label="lab_gild_A120SeniorUnsecuredNotesDueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.20% Senior Unsecured Notes Due October 2027</link:label>
    <link:label id="lab_gild_A120SeniorUnsecuredNotesDueOctober2027Member_label_en-US" xlink:label="lab_gild_A120SeniorUnsecuredNotesDueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.20% Senior Unsecured Notes Due October 2027 [Member]</link:label>
    <link:label id="lab_gild_A120SeniorUnsecuredNotesDueOctober2027Member_documentation_en-US" xlink:label="lab_gild_A120SeniorUnsecuredNotesDueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.20% Senior Unsecured Notes Due October 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member" xlink:href="gild-20200930.xsd#gild_A120SeniorUnsecuredNotesDueOctober2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member" xlink:to="lab_gild_A120SeniorUnsecuredNotesDueOctober2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_NumberOfPrograms_8079f2c7-1885-473c-ba9a-82d95b2e622d_terseLabel_en-US" xlink:label="lab_gild_NumberOfPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of programs</link:label>
    <link:label id="lab_gild_NumberOfPrograms_label_en-US" xlink:label="lab_gild_NumberOfPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Programs</link:label>
    <link:label id="lab_gild_NumberOfPrograms_documentation_en-US" xlink:label="lab_gild_NumberOfPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_NumberOfPrograms" xlink:href="gild-20200930.xsd#gild_NumberOfPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_NumberOfPrograms" xlink:to="lab_gild_NumberOfPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_9c9c9afe-3867-4700-8a9c-cb847cf2e307_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6329ee66-a84a-4657-aac7-9cb88f1f3fa1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_45ac0a3e-df0d-484e-9977-fb7c80cea9a7_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_994aeb07-1825-4b62-a6c9-cbe1cba572f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#160;long-term&#160;obligations</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a31cf07f-3240-4f4f-8552-267ae8088917_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications to net income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_eafc24e2-2081-458e-9772-6e993b9c7afc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_34af70e4-0ae7-4328-86b8-336945c0524e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_fb8395af-b8b9-4468-87d2-6b461ca6c4ab_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_36144b44-108a-4773-8f11-eded0db41c57_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Available-for-Sale Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_f86015f1-0bb0-4f23-8566-9cdff8737b6a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A450SeniorUnsecuredNotesDueApril2021Member_8b77a8e5-3bf0-4706-a4de-1712e549c3f7_terseLabel_en-US" xlink:label="lab_gild_A450SeniorUnsecuredNotesDueApril2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Senior Unsecured Notes Due April 2021</link:label>
    <link:label id="lab_gild_A450SeniorUnsecuredNotesDueApril2021Member_label_en-US" xlink:label="lab_gild_A450SeniorUnsecuredNotesDueApril2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Senior Unsecured Notes Due April 2021 [Member]</link:label>
    <link:label id="lab_gild_A450SeniorUnsecuredNotesDueApril2021Member_documentation_en-US" xlink:label="lab_gild_A450SeniorUnsecuredNotesDueApril2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Senior Unsecured Notes Due April 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A450SeniorUnsecuredNotesDueApril2021Member" xlink:href="gild-20200930.xsd#gild_A450SeniorUnsecuredNotesDueApril2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A450SeniorUnsecuredNotesDueApril2021Member" xlink:to="lab_gild_A450SeniorUnsecuredNotesDueApril2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_8b1f3f65-ca52-4655-b44c-ef47ba764903_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months, gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7805b69-1b89-46dc-8250-5a0945335930_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedSeptember2015Member_fb8a4754-b054-4db1-8baf-b451b3fea3f0_terseLabel_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedSeptember2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "2015 Senior Notes"</link:label>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedSeptember2015Member_label_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedSeptember2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note Issued September 2015 [Member]</link:label>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedSeptember2015Member_documentation_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedSeptember2015Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note Issued September 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedSeptember2015Member" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedSeptember2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_SeniorUnsecuredNoteIssuedSeptember2015Member" xlink:to="lab_gild_SeniorUnsecuredNoteIssuedSeptember2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b6fcf56d-7bee-4758-91ef-0f1a63d4a142_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_8a596664-5dee-4ec6-a1df-b323350c5fd7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_73247f8b-ce3f-4dce-8d92-d4112165d679_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7e107b4a-e238-491f-a446-0ad0bacd1f19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of potential effect of offsetting derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c167e1f0-67a0-442f-b4e5-41068e613610_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_DeferredCompensationPlanMember_689cdc23-13fa-4e6c-9599-caf5ca6683a0_terseLabel_en-US" xlink:label="lab_gild_DeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan</link:label>
    <link:label id="lab_gild_DeferredCompensationPlanMember_label_en-US" xlink:label="lab_gild_DeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan [Member]</link:label>
    <link:label id="lab_gild_DeferredCompensationPlanMember_documentation_en-US" xlink:label="lab_gild_DeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DeferredCompensationPlanMember" xlink:href="gild-20200930.xsd#gild_DeferredCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_DeferredCompensationPlanMember" xlink:to="lab_gild_DeferredCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_PionyrMergerAndOptionAgreementsMember_a31c95a3-7acc-470f-ab92-d9beca420264_terseLabel_en-US" xlink:label="lab_gild_PionyrMergerAndOptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "Pionyr Merger and Option Agreements"</link:label>
    <link:label id="lab_gild_PionyrMergerAndOptionAgreementsMember_label_en-US" xlink:label="lab_gild_PionyrMergerAndOptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pionyr Merger and Option Agreements [Member]</link:label>
    <link:label id="lab_gild_PionyrMergerAndOptionAgreementsMember_documentation_en-US" xlink:label="lab_gild_PionyrMergerAndOptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pionyr Merger and Option Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PionyrMergerAndOptionAgreementsMember" xlink:href="gild-20200930.xsd#gild_PionyrMergerAndOptionAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_PionyrMergerAndOptionAgreementsMember" xlink:to="lab_gild_PionyrMergerAndOptionAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_89e0b66a-928f-47f7-8e23-4ae0003d1b45_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_31fc08ea-28d3-42a8-be25-7f7945c211c2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_6670c504-ad34-4f2c-8db2-343c896e6be6_terseLabel_en-US" xlink:label="lab_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Line Items]</link:label>
    <link:label id="lab_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_label_en-US" xlink:label="lab_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Line Items]</link:label>
    <link:label id="lab_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_documentation_en-US" xlink:label="lab_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, Collaborations and Other Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsAndOtherArrangementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems" xlink:to="lab_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherCollaborationArrangementsMember_e065bf2b-5a0e-49b9-bdfd-a9b8e3d43a7d_terseLabel_en-US" xlink:label="lab_gild_OtherCollaborationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Arrangements</link:label>
    <link:label id="lab_gild_OtherCollaborationArrangementsMember_label_en-US" xlink:label="lab_gild_OtherCollaborationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Collaboration Arrangements [Member]</link:label>
    <link:label id="lab_gild_OtherCollaborationArrangementsMember_documentation_en-US" xlink:label="lab_gild_OtherCollaborationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Collaboration Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherCollaborationArrangementsMember" xlink:href="gild-20200930.xsd#gild_OtherCollaborationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherCollaborationArrangementsMember" xlink:to="lab_gild_OtherCollaborationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_cf44989b-15d0-4abb-a392-c5b75a22021b_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_2bd90364-e12a-4b21-b023-5369aca73c12_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_79075a1a-ca67-4a80-aa2d-c7d334fc870b_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsStribildMember_cb61d13b-923a-4ae1-b62d-d5214ce84eab_terseLabel_en-US" xlink:label="lab_gild_HIVProductsStribildMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stribild</link:label>
    <link:label id="lab_gild_HIVProductsStribildMember_label_en-US" xlink:label="lab_gild_HIVProductsStribildMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Stribild [Member]</link:label>
    <link:label id="lab_gild_HIVProductsStribildMember_documentation_en-US" xlink:label="lab_gild_HIVProductsStribildMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Stribild [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsStribildMember" xlink:href="gild-20200930.xsd#gild_HIVProductsStribildMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsStribildMember" xlink:to="lab_gild_HIVProductsStribildMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c302bbdc-9995-4791-b09f-97c26df2f4c5_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_7f868635-8444-48d4-a61e-87f6bed266d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7e14a639-2033-4fc1-9e6d-6c773437d598_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ffb40cb3-4c18-46c2-ac38-d8a59b7a5d8b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b4ad7420-e6d7-4fec-b6b3-a5c49cb23a33_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_cd4c63c5-bc98-4d55-bb5c-c2a210f1737a_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7d2481d7-aa1d-46aa-a951-7a809ae7f3ea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsBiktarvyMember_8bf405ef-3414-4d8a-9ad0-fe210a3ac5eb_terseLabel_en-US" xlink:label="lab_gild_HIVProductsBiktarvyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biktarvy</link:label>
    <link:label id="lab_gild_HIVProductsBiktarvyMember_label_en-US" xlink:label="lab_gild_HIVProductsBiktarvyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Biktarvy [Member]</link:label>
    <link:label id="lab_gild_HIVProductsBiktarvyMember_documentation_en-US" xlink:label="lab_gild_HIVProductsBiktarvyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Biktarvy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsBiktarvyMember" xlink:href="gild-20200930.xsd#gild_HIVProductsBiktarvyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsBiktarvyMember" xlink:to="lab_gild_HIVProductsBiktarvyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_91349cf5-46dc-4e2b-a8c5-bb3f9291859a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible IPR&amp;D charges</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_67b3e4bd-8e3f-4ffc-88fe-7230109a479f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_49e47c55-0f55-4f00-b355-37397f7b1f3d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_GalapagosMember_85fe64f0-5cd1-4432-9228-6fc22bddc70e_terseLabel_en-US" xlink:label="lab_gild_GalapagosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Galapagos</link:label>
    <link:label id="lab_gild_GalapagosMember_label_en-US" xlink:label="lab_gild_GalapagosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Galapagos [Member]</link:label>
    <link:label id="lab_gild_GalapagosMember_documentation_en-US" xlink:label="lab_gild_GalapagosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Galapagos [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_GalapagosMember" xlink:href="gild-20200930.xsd#gild_GalapagosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_GalapagosMember" xlink:to="lab_gild_GalapagosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5663fa57-2b1f-4e49-84c4-d610b3425a91_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_0e3ac2ab-b4a7-4d1e-b0b3-b6b30c99f6b3_terseLabel_en-US" xlink:label="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage and asset-backed securities</link:label>
    <link:label id="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_c267a0f5-b645-4ae1-91ce-3e7a40641efc_verboseLabel_en-US" xlink:label="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage and asset-backed securities</link:label>
    <link:label id="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage And Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage And Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember" xlink:href="gild-20200930.xsd#gild_ResidentialMortgageAndAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember" xlink:to="lab_gild_ResidentialMortgageAndAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_a35eecb3-d884-4235-8d74-b9c9df5e7395_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_bf6577b0-4c4b-4f4f-927c-d8c750776f81_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_8d0d931a-36e7-4f11-bd6b-3ba92f4e7447_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share Attributable to Gilead Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_CreditFacilityDueMay2021Member_0e15fc3b-6eec-4279-88bc-59f54b2b110c_terseLabel_en-US" xlink:label="lab_gild_CreditFacilityDueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "2016 Revolving Credit Facility"</link:label>
    <link:label id="lab_gild_CreditFacilityDueMay2021Member_label_en-US" xlink:label="lab_gild_CreditFacilityDueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Due May 2021 [Member]</link:label>
    <link:label id="lab_gild_CreditFacilityDueMay2021Member_documentation_en-US" xlink:label="lab_gild_CreditFacilityDueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Due May 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CreditFacilityDueMay2021Member" xlink:href="gild-20200930.xsd#gild_CreditFacilityDueMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_CreditFacilityDueMay2021Member" xlink:to="lab_gild_CreditFacilityDueMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_e942ea2c-f8d4-4585-81e1-c172740285bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HIVProductsOdefseyMember_9e145ce4-bd10-40c2-881e-ad91b4eec4ef_terseLabel_en-US" xlink:label="lab_gild_HIVProductsOdefseyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Odefsey</link:label>
    <link:label id="lab_gild_HIVProductsOdefseyMember_label_en-US" xlink:label="lab_gild_HIVProductsOdefseyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Odefsey [Member]</link:label>
    <link:label id="lab_gild_HIVProductsOdefseyMember_documentation_en-US" xlink:label="lab_gild_HIVProductsOdefseyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIV Products, Odefsey [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsOdefseyMember" xlink:href="gild-20200930.xsd#gild_HIVProductsOdefseyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HIVProductsOdefseyMember" xlink:to="lab_gild_HIVProductsOdefseyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0b2c0611-3156-45b6-90cb-a5c474be68ac_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_a7bdc020-f76f-4aa6-847e-44c181bb751c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4a2a0ae7-548b-4bd1-867f-7702d27e70a5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_d2c72768-daac-4425-9e26-4aa21b94c499_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency derivative contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_dd43710a-184c-403b-89f4-c5639805650c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_Writeoffsinaccruedinterestreceivable_48485358-bae8-4877-b82d-4d6189d1e841_terseLabel_en-US" xlink:label="lab_gild_Writeoffsinaccruedinterestreceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs of accrued interest receivable</link:label>
    <link:label id="lab_gild_Writeoffsinaccruedinterestreceivable_label_en-US" xlink:label="lab_gild_Writeoffsinaccruedinterestreceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs in accrued interest receivable</link:label>
    <link:label id="lab_gild_Writeoffsinaccruedinterestreceivable_documentation_en-US" xlink:label="lab_gild_Writeoffsinaccruedinterestreceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off in accrued interest receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_Writeoffsinaccruedinterestreceivable" xlink:href="gild-20200930.xsd#gild_Writeoffsinaccruedinterestreceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_Writeoffsinaccruedinterestreceivable" xlink:to="lab_gild_Writeoffsinaccruedinterestreceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_CardinalHealthIncMember_2a24f838-090a-4a19-b6d4-e65d12064344_terseLabel_en-US" xlink:label="lab_gild_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health, Inc.</link:label>
    <link:label id="lab_gild_CardinalHealthIncMember_label_en-US" xlink:label="lab_gild_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health Inc [Member]</link:label>
    <link:label id="lab_gild_CardinalHealthIncMember_documentation_en-US" xlink:label="lab_gild_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CardinalHealthIncMember" xlink:href="gild-20200930.xsd#gild_CardinalHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_CardinalHealthIncMember" xlink:to="lab_gild_CardinalHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_45c54029-a51f-4774-b0d9-c863714dcdee_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_742cfde7-f6a9-4609-aa2b-a1b646fcaee2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_4cd28a09-800b-4e2f-9b4c-7ccd75c31be5_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_260c8a41-1809-4ad2-aaa5-2ca940ad2352_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedNovember2014Member_a12f3cc7-6337-485a-b87c-988febfa536f_terseLabel_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedNovember2014Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the "2014 Senior Notes"</link:label>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedNovember2014Member_label_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedNovember2014Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note Issued November 2014 [Member]</link:label>
    <link:label id="lab_gild_SeniorUnsecuredNoteIssuedNovember2014Member_documentation_en-US" xlink:label="lab_gild_SeniorUnsecuredNoteIssuedNovember2014Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note Issued November 2014</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedNovember2014Member" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedNovember2014Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_SeniorUnsecuredNoteIssuedNovember2014Member" xlink:to="lab_gild_SeniorUnsecuredNoteIssuedNovember2014Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d00e383c-a0ec-496b-b0a8-57e9dce761d2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bcb96f50-9a3e-4f28-b954-94f3a416c137_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_4d0bf21b-5940-4b6b-9dcf-8aae99825c39_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HCVProductsLedipasvirSofosbuvirMember_6838094f-6b51-4533-8152-c45e8a1be622_terseLabel_en-US" xlink:label="lab_gild_HCVProductsLedipasvirSofosbuvirMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ledipasvir/Sofosbuvir</link:label>
    <link:label id="lab_gild_HCVProductsLedipasvirSofosbuvirMember_label_en-US" xlink:label="lab_gild_HCVProductsLedipasvirSofosbuvirMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCV Products, Ledipasvir/Sofosbuvir [Member]</link:label>
    <link:label id="lab_gild_HCVProductsLedipasvirSofosbuvirMember_documentation_en-US" xlink:label="lab_gild_HCVProductsLedipasvirSofosbuvirMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCV Products, Ledipasvir/Sofosbuvir</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsLedipasvirSofosbuvirMember" xlink:href="gild-20200930.xsd#gild_HCVProductsLedipasvirSofosbuvirMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HCVProductsLedipasvirSofosbuvirMember" xlink:to="lab_gild_HCVProductsLedipasvirSofosbuvirMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_172d6ad6-011f-412c-95c6-d5a119c78d4a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ab9e3e3f-dcde-46da-a528-2f7a462dbf7b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e4b6be9-4184-41cc-bb6a-e2ac127767a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_0252167d-e8f7-4769-843a-90259c357813_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_498f2775-f627-4059-bc83-d906361bff2a_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_bbd63b57-6a81-4193-994d-cc70d0eb1ee2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001 per share; 5,600 shares authorized; 1,253 and 1,266 shares issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A280SeniorUnsecuredNotesDueOctober2050Member_4ca7522d-600e-40f3-87f6-a6befc7c83f4_terseLabel_en-US" xlink:label="lab_gild_A280SeniorUnsecuredNotesDueOctober2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.80% Senior Unsecured Notes Due October 2050</link:label>
    <link:label id="lab_gild_A280SeniorUnsecuredNotesDueOctober2050Member_label_en-US" xlink:label="lab_gild_A280SeniorUnsecuredNotesDueOctober2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.80% Senior Unsecured Notes Due October 2050 [Member]</link:label>
    <link:label id="lab_gild_A280SeniorUnsecuredNotesDueOctober2050Member_documentation_en-US" xlink:label="lab_gild_A280SeniorUnsecuredNotesDueOctober2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.80% Senior Unsecured Notes Due October 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member" xlink:href="gild-20200930.xsd#gild_A280SeniorUnsecuredNotesDueOctober2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member" xlink:to="lab_gild_A280SeniorUnsecuredNotesDueOctober2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3f4494c6-2408-41d8-a0bd-22e6883d62db_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_JudgmentEnhancedDamagesonPastSales_52b4e4a9-05b3-41f9-8567-6c268549fb35_terseLabel_en-US" xlink:label="lab_gild_JudgmentEnhancedDamagesonPastSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enhancement rate on past damages</link:label>
    <link:label id="lab_gild_JudgmentEnhancedDamagesonPastSales_label_en-US" xlink:label="lab_gild_JudgmentEnhancedDamagesonPastSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment: Enhanced Damages on Past Sales</link:label>
    <link:label id="lab_gild_JudgmentEnhancedDamagesonPastSales_documentation_en-US" xlink:label="lab_gild_JudgmentEnhancedDamagesonPastSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment: Enhanced Damages on Past Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentEnhancedDamagesonPastSales" xlink:href="gild-20200930.xsd#gild_JudgmentEnhancedDamagesonPastSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_JudgmentEnhancedDamagesonPastSales" xlink:to="lab_gild_JudgmentEnhancedDamagesonPastSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9bcc8e1d-32ab-45e1-a1cf-fd5c42786ae5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_f72ce381-f313-4219-ab50-4703bc4b61e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsVemlidyMember_bcb905d1-155f-4f4e-8738-ed279fbc007d_terseLabel_en-US" xlink:label="lab_gild_OtherProductsVemlidyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vemlidy</link:label>
    <link:label id="lab_gild_OtherProductsVemlidyMember_label_en-US" xlink:label="lab_gild_OtherProductsVemlidyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Vemlidy [Member]</link:label>
    <link:label id="lab_gild_OtherProductsVemlidyMember_documentation_en-US" xlink:label="lab_gild_OtherProductsVemlidyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Vemlidy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsVemlidyMember" xlink:href="gild-20200930.xsd#gild_OtherProductsVemlidyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsVemlidyMember" xlink:to="lab_gild_OtherProductsVemlidyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_336ae5a6-324c-4e7e-90d6-140655d040b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of stock options and equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A475SeniorUnsecuredNotesDueMarch2046Member_971707a1-2374-43ee-bc97-a123a00ea343_terseLabel_en-US" xlink:label="lab_gild_A475SeniorUnsecuredNotesDueMarch2046Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Senior Unsecured Notes Due March 2046</link:label>
    <link:label id="lab_gild_A475SeniorUnsecuredNotesDueMarch2046Member_label_en-US" xlink:label="lab_gild_A475SeniorUnsecuredNotesDueMarch2046Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Senior Unsecured Notes Due March 2046 [Member]</link:label>
    <link:label id="lab_gild_A475SeniorUnsecuredNotesDueMarch2046Member_documentation_en-US" xlink:label="lab_gild_A475SeniorUnsecuredNotesDueMarch2046Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Senior Unsecured Notes Due March 2046 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A475SeniorUnsecuredNotesDueMarch2046Member" xlink:href="gild-20200930.xsd#gild_A475SeniorUnsecuredNotesDueMarch2046Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A475SeniorUnsecuredNotesDueMarch2046Member" xlink:to="lab_gild_A475SeniorUnsecuredNotesDueMarch2046Member" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_TizonaTherapeuticsIncMember_789bd77b-cbc8-499b-abc1-897a6aa19908_terseLabel_en-US" xlink:label="lab_gild_TizonaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tizona</link:label>
    <link:label id="lab_gild_TizonaTherapeuticsIncMember_label_en-US" xlink:label="lab_gild_TizonaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tizona Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_gild_TizonaTherapeuticsIncMember_documentation_en-US" xlink:label="lab_gild_TizonaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tizona Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TizonaTherapeuticsIncMember" xlink:href="gild-20200930.xsd#gild_TizonaTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_TizonaTherapeuticsIncMember" xlink:to="lab_gild_TizonaTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_InvestmentOwnedBalanceAdditionalShares_6e0d5293-2395-4019-b04f-d5f20805fdf5_terseLabel_en-US" xlink:label="lab_gild_InvestmentOwnedBalanceAdditionalShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity securities owned (in shares)</link:label>
    <link:label id="lab_gild_InvestmentOwnedBalanceAdditionalShares_label_en-US" xlink:label="lab_gild_InvestmentOwnedBalanceAdditionalShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Additional Shares</link:label>
    <link:label id="lab_gild_InvestmentOwnedBalanceAdditionalShares_documentation_en-US" xlink:label="lab_gild_InvestmentOwnedBalanceAdditionalShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Additional Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InvestmentOwnedBalanceAdditionalShares" xlink:href="gild-20200930.xsd#gild_InvestmentOwnedBalanceAdditionalShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_InvestmentOwnedBalanceAdditionalShares" xlink:to="lab_gild_InvestmentOwnedBalanceAdditionalShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_26f9ba32-20c2-4265-9359-4552f6207f5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months, fair value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_10d79e24-bb59-459f-8659-ab78de9ff59a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in per share calculation - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9abbff01-c6ad-46a0-b155-9f761125fab6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in per share calculation - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_ec98c784-910c-4162-babc-cbe1710b5eaf_terseLabel_en-US" xlink:label="lab_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Senior Term Loan Facility</link:label>
    <link:label id="lab_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_label_en-US" xlink:label="lab_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year Senior Unsecured Term Loan Facility [Member]</link:label>
    <link:label id="lab_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_documentation_en-US" xlink:label="lab_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year Senior Unsecured Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember" xlink:href="gild-20200930.xsd#gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember" xlink:to="lab_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_3660a084-8454-4f13-b556-3771febf5fd0_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c6a14dee-352d-46ca-8ea7-3b2b07c5ef98_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_4295d577-2fa7-491a-ae2a-244735453c51_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_1b5d6587-317e-449a-8e9c-1d388ab7f26a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_OtherProductsLetairisMember_09586c23-9d17-4049-b711-150c9d226390_terseLabel_en-US" xlink:label="lab_gild_OtherProductsLetairisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letairis</link:label>
    <link:label id="lab_gild_OtherProductsLetairisMember_label_en-US" xlink:label="lab_gild_OtherProductsLetairisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Letairis [Member]</link:label>
    <link:label id="lab_gild_OtherProductsLetairisMember_documentation_en-US" xlink:label="lab_gild_OtherProductsLetairisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products, Letairis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsLetairisMember" xlink:href="gild-20200930.xsd#gild_OtherProductsLetairisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_OtherProductsLetairisMember" xlink:to="lab_gild_OtherProductsLetairisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_CashPaymentsMadeRelatedToEquityInvestments_55ae1857-7a01-40de-9204-ee463305c6db_terseLabel_en-US" xlink:label="lab_gild_CashPaymentsMadeRelatedToEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments made related to equity investments</link:label>
    <link:label id="lab_gild_CashPaymentsMadeRelatedToEquityInvestments_label_en-US" xlink:label="lab_gild_CashPaymentsMadeRelatedToEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payments Made Related to Equity Investments</link:label>
    <link:label id="lab_gild_CashPaymentsMadeRelatedToEquityInvestments_documentation_en-US" xlink:label="lab_gild_CashPaymentsMadeRelatedToEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payments Made Related to Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CashPaymentsMadeRelatedToEquityInvestments" xlink:href="gild-20200930.xsd#gild_CashPaymentsMadeRelatedToEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_CashPaymentsMadeRelatedToEquityInvestments" xlink:to="lab_gild_CashPaymentsMadeRelatedToEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_dcf15a3a-00db-48d6-9caa-104a13b125b0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Gilead stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2787cb92-6ce0-4b23-ad1a-a8d846acf545_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_206dc817-8e63-4e98-99a6-94d36a45eef2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_dfb0e0b3-3a7c-49fa-83a3-7a775e9d821c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amortization expense related to finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_9fb6e828-4032-4cfa-9ab1-b13f0b8dc1cc_terseLabel_en-US" xlink:label="lab_gild_A075SeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.75% Senior Unsecured Notes Due September 2023</link:label>
    <link:label id="lab_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_label_en-US" xlink:label="lab_gild_A075SeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.75% Senior Unsecured Notes Due September 2023 [Member]</link:label>
    <link:label id="lab_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_documentation_en-US" xlink:label="lab_gild_A075SeniorUnsecuredNotesDueSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.75% Senior Unsecured Notes Due in September 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member" xlink:href="gild-20200930.xsd#gild_A075SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member" xlink:to="lab_gild_A075SeniorUnsecuredNotesDueSeptember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_74facc73-c262-4dee-a555-d4534909c7d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_d2b02cc5-3d1a-4223-979e-7b7f0d0b0f9e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_03757a54-8e4d-4cb9-94a5-054262ed8535_terseLabel_en-US" xlink:label="lab_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.15% LIBOR Senior Unsecured Notes Due September 2021</link:label>
    <link:label id="lab_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_label_en-US" xlink:label="lab_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.15% LIBOR Senior Unsecured Notes Due September 2021 [Member]</link:label>
    <link:label id="lab_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_documentation_en-US" xlink:label="lab_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.15% LIBOR Senior Unsecured Notes Due September 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" xlink:href="gild-20200930.xsd#gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" xlink:to="lab_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7313c204-f8fc-4477-a4d5-1bd029681fd9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recognized in Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_37f7167e-b374-49eb-afb2-4a6d108202c7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_80b4bf94-879f-4ab7-9afe-52339213e005_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_ebfb5716-436f-47ea-896f-f87aa5467fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_582ea6db-fef0-48fb-b86a-8a17ceac94f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_08e02b71-42a5-4d97-8d7f-ad50e3ca212c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_38e2b76c-adaf-4d1b-91b9-071e7de901fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_75ca7cb7-8787-4348-8c74-72913c90e802_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived assets - IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_70b82697-8c5e-43d8-be4e-a457edfddd4a_totalLabel_en-US" xlink:label="lab_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_label_en-US" xlink:label="lab_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</link:label>
    <link:label id="lab_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_documentation_en-US" xlink:label="lab_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:href="gild-20200930.xsd#gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:to="lab_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_da792d5b-a48a-4925-8c4f-e8ebd2dceb12_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborations and Other Arrangements [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_cbe1b763-7112-47b5-818a-4597a73e49e9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, finite-lived assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_74b7c648-aee3-4707-8f4f-3a0c61fafffc_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_5cf27490-7745-43cc-ba3e-b564fb126e22_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from Major Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b73ced7e-08cf-4853-9c31-dfa0a3e907e9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_b754b8cf-908f-4cb2-9b43-6b80f714c452_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_962ad5b7-521d-4fab-99fe-066937fad9c7_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AssetAcquisitionCashOutflowNetOfCashAcquired_5aa16a30-d33d-4e42-bfab-875b5a0f1a6a_terseLabel_en-US" xlink:label="lab_gild_AssetAcquisitionCashOutflowNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration, net of acquired cash</link:label>
    <link:label id="lab_gild_AssetAcquisitionCashOutflowNetOfCashAcquired_label_en-US" xlink:label="lab_gild_AssetAcquisitionCashOutflowNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Cash Outflow Net Of Cash Acquired</link:label>
    <link:label id="lab_gild_AssetAcquisitionCashOutflowNetOfCashAcquired_documentation_en-US" xlink:label="lab_gild_AssetAcquisitionCashOutflowNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Cash Outflow Net Of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionCashOutflowNetOfCashAcquired" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionCashOutflowNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AssetAcquisitionCashOutflowNetOfCashAcquired" xlink:to="lab_gild_AssetAcquisitionCashOutflowNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_abf4a0ef-b6c3-4f49-8869-6499f70e88ba_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_be6e411f-8887-4f98-96ea-9b7c6935b9ff_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from earnings per share computation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_AxicabtageneciloleucelDLBCLMember_8ffb66b7-120c-42e2-8872-d8427044db4e_terseLabel_en-US" xlink:label="lab_gild_AxicabtageneciloleucelDLBCLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset - axicabtagene ciloleucel</link:label>
    <link:label id="lab_gild_AxicabtageneciloleucelDLBCLMember_label_en-US" xlink:label="lab_gild_AxicabtageneciloleucelDLBCLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">axicabtagene ciloleucel (DLBCL) [Member]</link:label>
    <link:label id="lab_gild_AxicabtageneciloleucelDLBCLMember_documentation_en-US" xlink:label="lab_gild_AxicabtageneciloleucelDLBCLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">axicabtagene ciloleucel (DLBCL) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AxicabtageneciloleucelDLBCLMember" xlink:href="gild-20200930.xsd#gild_AxicabtageneciloleucelDLBCLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_AxicabtageneciloleucelDLBCLMember" xlink:to="lab_gild_AxicabtageneciloleucelDLBCLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_ae9de6d6-1213-4828-9456-fba2369e3cb5_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_22a351b8-fce0-4993-bea8-e38d6c33ea10_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A415SeniorUnsecuredNotesDueMarch2047Member_0ec3dcfb-b423-45a3-8e51-7f24b0de734b_terseLabel_en-US" xlink:label="lab_gild_A415SeniorUnsecuredNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.15% Senior Unsecured Notes Due March 2047</link:label>
    <link:label id="lab_gild_A415SeniorUnsecuredNotesDueMarch2047Member_label_en-US" xlink:label="lab_gild_A415SeniorUnsecuredNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.15% Senior Unsecured Notes Due March 2047 [Member]</link:label>
    <link:label id="lab_gild_A415SeniorUnsecuredNotesDueMarch2047Member_documentation_en-US" xlink:label="lab_gild_A415SeniorUnsecuredNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.15% Senior Unsecured Notes Due March 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A415SeniorUnsecuredNotesDueMarch2047Member" xlink:href="gild-20200930.xsd#gild_A415SeniorUnsecuredNotesDueMarch2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A415SeniorUnsecuredNotesDueMarch2047Member" xlink:to="lab_gild_A415SeniorUnsecuredNotesDueMarch2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_3e50c770-bf38-4e93-8ac8-ebf2d02fd2cf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8c61c350-8dd1-4296-9ea6-d3c649e60714_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_beab45d0-47d0-464f-b167-b056db3564ee_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8935be4b-e5d0-4930-a307-abb399045f0c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c2da91f8-5f14-45c4-881e-cd423b21ef92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Available-for-Sale Debt Securities from Cost Basis to Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8caee141-cf33-43e4-8a5a-a6e7ecdb3414_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_HCVProductsSofosbuvirVelpatasvirMember_14c7b7ce-7cb3-4c0e-b727-cacd6cb4e3d4_terseLabel_en-US" xlink:label="lab_gild_HCVProductsSofosbuvirVelpatasvirMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sofosbuvir/Velpatasvir</link:label>
    <link:label id="lab_gild_HCVProductsSofosbuvirVelpatasvirMember_label_en-US" xlink:label="lab_gild_HCVProductsSofosbuvirVelpatasvirMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCV Products, Sofosbuvir/Velpatasvir [Member]</link:label>
    <link:label id="lab_gild_HCVProductsSofosbuvirVelpatasvirMember_documentation_en-US" xlink:label="lab_gild_HCVProductsSofosbuvirVelpatasvirMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCV Products, Sofosbuvir/Velpatasvir</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsSofosbuvirVelpatasvirMember" xlink:href="gild-20200930.xsd#gild_HCVProductsSofosbuvirVelpatasvirMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_HCVProductsSofosbuvirVelpatasvirMember" xlink:to="lab_gild_HCVProductsSofosbuvirVelpatasvirMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0c888472-e864-428c-8f46-8510f2dafd67_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_d3acb90f-85c3-475a-b3ae-b18d7b80e59a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#160;accrued&#160;liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_92b97e39-174b-4bfd-954b-b736c7ff94cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Collateral Received/ Pledged</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Collateral, Right to Reclaim Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:to="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_GadetaBVCollaborationArrangementMember_37207c39-e41c-4a10-a20a-764f6c792e9d_terseLabel_en-US" xlink:label="lab_gild_GadetaBVCollaborationArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gadeta Collaboration Arrangement</link:label>
    <link:label id="lab_gild_GadetaBVCollaborationArrangementMember_label_en-US" xlink:label="lab_gild_GadetaBVCollaborationArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gadeta B.V. Collaboration Arrangement [Member]</link:label>
    <link:label id="lab_gild_GadetaBVCollaborationArrangementMember_documentation_en-US" xlink:label="lab_gild_GadetaBVCollaborationArrangementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gadeta B.V. Collaboration Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_GadetaBVCollaborationArrangementMember" xlink:href="gild-20200930.xsd#gild_GadetaBVCollaborationArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_GadetaBVCollaborationArrangementMember" xlink:to="lab_gild_GadetaBVCollaborationArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLossPastSales_3589adbb-9c5a-4023-a473-a30ffa1d44a0_terseLabel_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLossPastSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss representing past sales</link:label>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLossPastSales_label_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLossPastSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss (Past Sales)</link:label>
    <link:label id="lab_gild_LossContingencyEstimateofPossibleLossPastSales_documentation_en-US" xlink:label="lab_gild_LossContingencyEstimateofPossibleLossPastSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss (Past Sales)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLossPastSales" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLossPastSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_LossContingencyEstimateofPossibleLossPastSales" xlink:to="lab_gild_LossContingencyEstimateofPossibleLossPastSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_567ba57c-a1c2-4f12-9d83-9e23687c734a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5ea4b3a3-c0ad-4b91-887f-f4beb644d627_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized amount under stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_d084eb1a-1542-4f60-88f5-9613b7cbde9d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_4c3b8ccc-3a21-4ebc-92d9-ac48f46fafa0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_A350SeniorUnsecuredNotesDueFebruary2025Member_05d9de7d-4262-4e99-894f-f0382dbb46c2_terseLabel_en-US" xlink:label="lab_gild_A350SeniorUnsecuredNotesDueFebruary2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.50% Senior Unsecured Notes Due February 2025</link:label>
    <link:label id="lab_gild_A350SeniorUnsecuredNotesDueFebruary2025Member_label_en-US" xlink:label="lab_gild_A350SeniorUnsecuredNotesDueFebruary2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.50% Senior Unsecured Notes Due February 2025 [Member]</link:label>
    <link:label id="lab_gild_A350SeniorUnsecuredNotesDueFebruary2025Member_documentation_en-US" xlink:label="lab_gild_A350SeniorUnsecuredNotesDueFebruary2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.50% Senior Unsecured Notes Due February 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A350SeniorUnsecuredNotesDueFebruary2025Member" xlink:href="gild-20200930.xsd#gild_A350SeniorUnsecuredNotesDueFebruary2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_A350SeniorUnsecuredNotesDueFebruary2025Member" xlink:to="lab_gild_A350SeniorUnsecuredNotesDueFebruary2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_8189a94d-e491-444f-9318-a51d940f6ab6_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0fa5e45f-dc62-4c7f-a132-a7460e15541c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_RoyaltyContractAndOtherMember_0f13d5aa-c458-4bc3-8348-96d801ad1849_terseLabel_en-US" xlink:label="lab_gild_RoyaltyContractAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, contract and other revenues</link:label>
    <link:label id="lab_gild_RoyaltyContractAndOtherMember_label_en-US" xlink:label="lab_gild_RoyaltyContractAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Contract, And Other [Member]</link:label>
    <link:label id="lab_gild_RoyaltyContractAndOtherMember_documentation_en-US" xlink:label="lab_gild_RoyaltyContractAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Contract, And Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_RoyaltyContractAndOtherMember" xlink:href="gild-20200930.xsd#gild_RoyaltyContractAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_RoyaltyContractAndOtherMember" xlink:to="lab_gild_RoyaltyContractAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments_598e4dbe-ac49-4a0e-bb96-f4bcd16ae928_terseLabel_en-US" xlink:label="lab_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option fee and potential future milestone payments</link:label>
    <link:label id="lab_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments_label_en-US" xlink:label="lab_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Option Fee And Potential Future Milestone Payments</link:label>
    <link:label id="lab_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments_documentation_en-US" xlink:label="lab_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Option Fee And Potential Future Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" xlink:href="gild-20200930.xsd#gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" xlink:to="lab_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_73dedf28-0bab-4f3b-9338-1caf18ea170a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts of Recognized Assets/Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_693a9e40-94b3-413c-aa56-799b17ba94e8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>gild-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dd71f5ae-c8d4-497f-83ec-41f4a56b820c,g:fe07381a-9620-491b-af7b-d6c30510011c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gilead.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="gild-20200930.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_dca58540-4e5e-4d64-9ceb-222a8d53c566" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityInteractiveDataCurrent_dca58540-4e5e-4d64-9ceb-222a8d53c566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2f190b89-1ce7-45b4-8fff-c2f6846adfcc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityAddressAddressLine1_2f190b89-1ce7-45b4-8fff-c2f6846adfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_69480c96-0754-4cca-bd10-1b1a918e4deb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_Security12bTitle_69480c96-0754-4cca-bd10-1b1a918e4deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_632ba448-75e5-46ea-8382-6c73d7ae4810" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityIncorporationStateCountryCode_632ba448-75e5-46ea-8382-6c73d7ae4810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_62a17153-72bf-403b-b7a8-9326791c34ba" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_DocumentTransitionReport_62a17153-72bf-403b-b7a8-9326791c34ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_19a0d438-695e-452d-9dac-f163a978014f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_DocumentQuarterlyReport_19a0d438-695e-452d-9dac-f163a978014f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_32bef90b-0902-4dea-b899-454392b03512" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityRegistrantName_32bef90b-0902-4dea-b899-454392b03512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_829151aa-4946-4633-aed5-ab4838ae9669" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityCentralIndexKey_829151aa-4946-4633-aed5-ab4838ae9669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c314990e-c2bd-4067-8673-c474b09e2043" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_CurrentFiscalYearEndDate_c314990e-c2bd-4067-8673-c474b09e2043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c96d169b-bfaa-49b9-bc68-6ee33abe7684" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityFilerCategory_c96d169b-bfaa-49b9-bc68-6ee33abe7684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4ecc94e0-f155-46a2-bba4-255b11e0f14f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_DocumentType_4ecc94e0-f155-46a2-bba4-255b11e0f14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4d22db80-07b6-4a7d-a8d9-374a3a5371f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_DocumentPeriodEndDate_4d22db80-07b6-4a7d-a8d9-374a3a5371f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4fa29a99-af41-4731-bf68-59e852ea4364" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityFileNumber_4fa29a99-af41-4731-bf68-59e852ea4364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_17801947-be79-43e3-8031-5d082b921a02" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_DocumentFiscalYearFocus_17801947-be79-43e3-8031-5d082b921a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_defc285e-766a-4a24-955a-a6eb3166ce9d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_DocumentFiscalPeriodFocus_defc285e-766a-4a24-955a-a6eb3166ce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5865730f-98e0-4159-88cf-cbc7c41e8a67" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_AmendmentFlag_5865730f-98e0-4159-88cf-cbc7c41e8a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c135009e-669f-44e7-a8f4-7097e3bc2dcb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityEmergingGrowthCompany_c135009e-669f-44e7-a8f4-7097e3bc2dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_83f1890c-88b4-481c-891d-fdbff4675e49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntitySmallBusiness_83f1890c-88b4-481c-891d-fdbff4675e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_51538a2e-a0d1-41fd-95fc-c8ca9f3ad048" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_51538a2e-a0d1-41fd-95fc-c8ca9f3ad048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_beec5b0d-286a-4213-a36c-118375d95b77" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityCurrentReportingStatus_beec5b0d-286a-4213-a36c-118375d95b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_980d46b9-92c4-4dbb-b79c-9eb1504221db" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityShellCompany_980d46b9-92c4-4dbb-b79c-9eb1504221db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8b40165e-74c6-4af0-bed1-6da88c16aea8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityTaxIdentificationNumber_8b40165e-74c6-4af0-bed1-6da88c16aea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_aa2226a2-86c7-4815-b0ca-213d95297d40" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_TradingSymbol_aa2226a2-86c7-4815-b0ca-213d95297d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3bb73da5-8048-4d7d-815e-800b2a6fb65a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_SecurityExchangeName_3bb73da5-8048-4d7d-815e-800b2a6fb65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a7785787-6224-4582-8142-5616cf68b1c8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityAddressCityOrTown_a7785787-6224-4582-8142-5616cf68b1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b3ebb7d4-4b14-4cd6-af87-e97b0ffab291" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityAddressStateOrProvince_b3ebb7d4-4b14-4cd6-af87-e97b0ffab291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2a8c2685-9b09-45f3-8d00-a1290c849f02" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_EntityAddressPostalZipCode_2a8c2685-9b09-45f3-8d00-a1290c849f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_be938aea-a58c-4bda-a6b8-bf3d1157467b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_CityAreaCode_be938aea-a58c-4bda-a6b8-bf3d1157467b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_00758c0b-ce1c-4763-941d-9666f0f11fd3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_de4aa524-fce8-418b-85ab-6eb0773bbe33" xlink:to="loc_dei_LocalPhoneNumber_00758c0b-ce1c-4763-941d-9666f0f11fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6cdaee36-11a5-411f-b6a7-54849fca0154" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6cdaee36-11a5-411f-b6a7-54849fca0154" xlink:to="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d3877e68-b378-43a8-ba62-9416c9d4270e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d3877e68-b378-43a8-ba62-9416c9d4270e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e8b8ac98-d419-425c-a292-7deb8ef8e686" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e8b8ac98-d419-425c-a292-7deb8ef8e686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6ffbcf79-a54f-4f54-88f2-5bcbd4723460" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6ffbcf79-a54f-4f54-88f2-5bcbd4723460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1ded7614-87e7-4fd9-8d32-19b11626591e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:to="loc_us-gaap_InventoryNet_1ded7614-87e7-4fd9-8d32-19b11626591e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d5dfc4f9-2d7e-452c-a5a1-6b35923f6d92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d5dfc4f9-2d7e-452c-a5a1-6b35923f6d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6e29b988-0931-4dc5-bccb-c889b15c01c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a0e51a6e-e419-4505-b93b-6618525918d4" xlink:to="loc_us-gaap_AssetsCurrent_6e29b988-0931-4dc5-bccb-c889b15c01c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_69d4c637-25e7-462d-8566-01dde31009ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_69d4c637-25e7-462d-8566-01dde31009ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_e7b43ccf-11fd-4108-ad8f-c092e1155e45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_e7b43ccf-11fd-4108-ad8f-c092e1155e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_51b73d37-9a78-40cc-867e-deba5e4c942b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_51b73d37-9a78-40cc-867e-deba5e4c942b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1a3fe1b-bf43-4d15-b42f-0289d9587816" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:to="loc_us-gaap_Goodwill_d1a3fe1b-bf43-4d15-b42f-0289d9587816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_11663c36-1cac-41fd-bc54-50022a26f361" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_11663c36-1cac-41fd-bc54-50022a26f361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a8cd33b9-3e81-4398-9ca5-c5e656c4926d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e5bbe580-517e-48f0-a556-8b602051e434" xlink:to="loc_us-gaap_Assets_a8cd33b9-3e81-4398-9ca5-c5e656c4926d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6cdaee36-11a5-411f-b6a7-54849fca0154" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b49d3985-ac76-46b6-90d8-c1d4ad50173a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b49d3985-ac76-46b6-90d8-c1d4ad50173a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_774e73c9-667f-475f-aa82-667a48a39504" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b49d3985-ac76-46b6-90d8-c1d4ad50173a" xlink:to="loc_us-gaap_AccountsPayableCurrent_774e73c9-667f-475f-aa82-667a48a39504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_Accruedgovernmentandotherrebates_07b10b37-df0a-4677-baed-ff9133d52128" xlink:href="gild-20200930.xsd#gild_Accruedgovernmentandotherrebates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b49d3985-ac76-46b6-90d8-c1d4ad50173a" xlink:to="loc_gild_Accruedgovernmentandotherrebates_07b10b37-df0a-4677-baed-ff9133d52128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_65c5a374-d3f6-4dd2-b8de-06ed023ed7e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b49d3985-ac76-46b6-90d8-c1d4ad50173a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_65c5a374-d3f6-4dd2-b8de-06ed023ed7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2da864af-3a86-40a0-bf1b-2b3472e08156" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b49d3985-ac76-46b6-90d8-c1d4ad50173a" xlink:to="loc_us-gaap_DebtCurrent_2da864af-3a86-40a0-bf1b-2b3472e08156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_98b8c587-8305-43e3-8acc-ecc02f791539" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b49d3985-ac76-46b6-90d8-c1d4ad50173a" xlink:to="loc_us-gaap_LiabilitiesCurrent_98b8c587-8305-43e3-8acc-ecc02f791539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2166c0c1-1925-4d30-be26-edf96d3ad99d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2166c0c1-1925-4d30-be26-edf96d3ad99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_58bdc8f7-a9a6-4f27-a1bd-b1fd45a35c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_58bdc8f7-a9a6-4f27-a1bd-b1fd45a35c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1daf071f-8d95-418a-924c-956dfc9f8c9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1daf071f-8d95-418a-924c-956dfc9f8c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_849e0216-b56b-462a-9830-c68ab725003a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:to="loc_us-gaap_CommitmentsAndContingencies_849e0216-b56b-462a-9830-c68ab725003a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0010c1d1-3d13-4f53-82f2-921e331de937" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_PreferredStockValue_0010c1d1-3d13-4f53-82f2-921e331de937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b3e04298-4bc2-40df-bfaa-15dab0af5592" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_CommonStockValue_b3e04298-4bc2-40df-bfaa-15dab0af5592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_80b2eb5d-2a4b-4475-adb6-3663631fc28f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_80b2eb5d-2a4b-4475-adb6-3663631fc28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a3749f18-38e0-40c1-a824-fe4ea2db01cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a3749f18-38e0-40c1-a824-fe4ea2db01cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c6207e3-2571-41a2-9112-6327f16a7f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c6207e3-2571-41a2-9112-6327f16a7f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0cbe4a7f-b81e-42c4-a726-bccfbbe507f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_StockholdersEquity_0cbe4a7f-b81e-42c4-a726-bccfbbe507f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_aacc9a3e-eb7c-47c3-a2e3-d7c14d820a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_MinorityInterest_aacc9a3e-eb7c-47c3-a2e3-d7c14d820a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ba3a31c6-95b7-458b-a8b9-72012c7b3e57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9bbf7530-2ad7-4764-bacf-9818a79443f3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ba3a31c6-95b7-458b-a8b9-72012c7b3e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f7a545a-6565-47d7-b7e6-d841f9204fca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_91c9b377-590d-487c-8ffb-d77987cd3593" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f7a545a-6565-47d7-b7e6-d841f9204fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AllowanceforAccountsReceivableandChargebacks_dab5fa25-99f9-402a-9839-81ba3862b963" xlink:href="gild-20200930.xsd#gild_AllowanceforAccountsReceivableandChargebacks"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_gild_AllowanceforAccountsReceivableandChargebacks_dab5fa25-99f9-402a-9839-81ba3862b963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f2c205f0-7b4e-4401-ba76-895069eaa479" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f2c205f0-7b4e-4401-ba76-895069eaa479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4c1cffb4-382e-4d2f-b5fc-8dfa8d568e94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4c1cffb4-382e-4d2f-b5fc-8dfa8d568e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f078e577-e98d-44c5-86cb-d254184548f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f078e577-e98d-44c5-86cb-d254184548f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ac14dc20-2f80-4179-9065-fe8f1014ac6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ac14dc20-2f80-4179-9065-fe8f1014ac6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a8b52da1-a517-44d0-bd2c-3efa249a77f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a8b52da1-a517-44d0-bd2c-3efa249a77f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_59fba2a1-34d8-4c09-830e-83a8035b557b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_us-gaap_CommonStockSharesIssued_59fba2a1-34d8-4c09-830e-83a8035b557b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0609591e-c774-45f3-a63a-6ddaaeea7463" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64fa4be6-8860-4820-91a5-955174db43b6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0609591e-c774-45f3-a63a-6ddaaeea7463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f364aa07-3f5d-472d-a7d5-71f7d98a03cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_79b6e65f-234a-480b-b71e-5d3599d5f849" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f364aa07-3f5d-472d-a7d5-71f7d98a03cd" xlink:to="loc_us-gaap_StatementTable_79b6e65f-234a-480b-b71e-5d3599d5f849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79b6e65f-234a-480b-b71e-5d3599d5f849" xlink:to="loc_srt_ProductOrServiceAxis_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_26fa74ea-1c92-4247-a4fe-e3a94de9eaeb" xlink:to="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_33b4f478-7b0e-4ec2-bdeb-bce1dcbbbcac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:to="loc_us-gaap_ProductMember_33b4f478-7b0e-4ec2-bdeb-bce1dcbbbcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_RoyaltyContractAndOtherMember_d4f07eaa-09e5-403b-b950-7a8b329e77b7" xlink:href="gild-20200930.xsd#gild_RoyaltyContractAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2054a0a7-2002-4f31-973e-f6e84f1ac258" xlink:to="loc_gild_RoyaltyContractAndOtherMember_d4f07eaa-09e5-403b-b950-7a8b329e77b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79b6e65f-234a-480b-b71e-5d3599d5f849" xlink:to="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_8ed20105-0b05-4fcd-bd15-140806f45c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_RevenuesAbstract_8ed20105-0b05-4fcd-bd15-140806f45c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_beaee5a9-b3d2-4917-9fcf-090cc396d22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_8ed20105-0b05-4fcd-bd15-140806f45c5f" xlink:to="loc_us-gaap_Revenues_beaee5a9-b3d2-4917-9fcf-090cc396d22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3463c80f-e3de-465d-ae00-b8500371319f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3463c80f-e3de-465d-ae00-b8500371319f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ef95093a-8239-4281-811b-75ca3037cca1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ef95093a-8239-4281-811b-75ca3037cca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_51b6abbe-9c11-4ec9-8dff-64a73a8b18aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_51b6abbe-9c11-4ec9-8dff-64a73a8b18aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2a5eea1-aed0-4d44-b7e2-7c7671010948" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2a5eea1-aed0-4d44-b7e2-7c7671010948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b170ad2b-f8be-4330-8e41-c1359ca78cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_48f4cc4e-5b77-4d4f-8692-8c1d7fad7539" xlink:to="loc_us-gaap_CostsAndExpenses_b170ad2b-f8be-4330-8e41-c1359ca78cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0e4249c0-e2d0-495a-b3df-5b090c87e2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_OperatingIncomeLoss_0e4249c0-e2d0-495a-b3df-5b090c87e2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_eb85ea68-14ea-4a96-9ead-643248367aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_InterestExpense_eb85ea68-14ea-4a96-9ead-643248367aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_be3ebaaf-70aa-4b8a-8fe2-d0d6ccec675b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_be3ebaaf-70aa-4b8a-8fe2-d0d6ccec675b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba5e0906-fbec-4e73-8ad6-c2f25b63b8f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba5e0906-fbec-4e73-8ad6-c2f25b63b8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a0942560-3e36-4436-97e5-f5cd70dcbcd2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a0942560-3e36-4436-97e5-f5cd70dcbcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89663507-4f88-4e39-ad53-052f362e252f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_ProfitLoss_89663507-4f88-4e39-ad53-052f362e252f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_960c18b8-d0ae-4722-90da-4085c07b036c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_960c18b8-d0ae-4722-90da-4085c07b036c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_edbafad2-af5d-40e1-b928-47a40a8e9e18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_NetIncomeLoss_edbafad2-af5d-40e1-b928-47a40a8e9e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f3ff58ee-1ebb-4b83-926f-b1cba7033f56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_EarningsPerShareBasic_f3ff58ee-1ebb-4b83-926f-b1cba7033f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be1ab335-e591-4770-bd23-466984e2b6d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be1ab335-e591-4770-bd23-466984e2b6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8e71457f-2cbc-410b-ae90-1befcb247c87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8e71457f-2cbc-410b-ae90-1befcb247c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ada297ee-cda3-4314-982a-1188aa0c3eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67b8e436-5ec7-4327-bfbe-33843faf8097" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ada297ee-cda3-4314-982a-1188aa0c3eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_02fa64e1-108f-4889-aace-907f0bc5aec3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5643eafb-74db-4d09-9880-1a9e9bc06d12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_02fa64e1-108f-4889-aace-907f0bc5aec3" xlink:to="loc_us-gaap_ProfitLoss_5643eafb-74db-4d09-9880-1a9e9bc06d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b0bd55d4-deb2-4c9f-8f46-36704357b992" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_02fa64e1-108f-4889-aace-907f0bc5aec3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b0bd55d4-deb2-4c9f-8f46-36704357b992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1b0c10ed-d881-4971-beb7-f5ca638a31f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b0bd55d4-deb2-4c9f-8f46-36704357b992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1b0c10ed-d881-4971-beb7-f5ca638a31f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_12934c4d-8055-47d0-89fb-b5582a509d05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b0bd55d4-deb2-4c9f-8f46-36704357b992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_12934c4d-8055-47d0-89fb-b5582a509d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_80a18e6a-344a-4887-a048-37a4652964ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_12934c4d-8055-47d0-89fb-b5582a509d05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_80a18e6a-344a-4887-a048-37a4652964ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_e26a5590-e282-4acd-a727-cfbd91b56aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_12934c4d-8055-47d0-89fb-b5582a509d05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_e26a5590-e282-4acd-a727-cfbd91b56aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9c4e08e7-33aa-4293-8ebb-05a44713b663" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_12934c4d-8055-47d0-89fb-b5582a509d05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9c4e08e7-33aa-4293-8ebb-05a44713b663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_42723e3e-a543-4009-bb2c-7da86c324832" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b0bd55d4-deb2-4c9f-8f46-36704357b992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_42723e3e-a543-4009-bb2c-7da86c324832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_772a4ae7-6fb3-4739-8575-e8a35f5c4c27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_42723e3e-a543-4009-bb2c-7da86c324832" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_772a4ae7-6fb3-4739-8575-e8a35f5c4c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e95d192c-6f45-42d5-bbca-ec1339ea0a06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_42723e3e-a543-4009-bb2c-7da86c324832" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e95d192c-6f45-42d5-bbca-ec1339ea0a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_dbca09d3-ac48-48f4-b158-a41d83337ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_42723e3e-a543-4009-bb2c-7da86c324832" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_dbca09d3-ac48-48f4-b158-a41d83337ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4ea21a85-6adc-46ce-950d-d60dd075f11f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b0bd55d4-deb2-4c9f-8f46-36704357b992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4ea21a85-6adc-46ce-950d-d60dd075f11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cd3887e2-67ca-4189-af7b-eca05fc17a1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_02fa64e1-108f-4889-aace-907f0bc5aec3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cd3887e2-67ca-4189-af7b-eca05fc17a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1f6194db-7238-4c3a-986c-1e9dc0704972" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_02fa64e1-108f-4889-aace-907f0bc5aec3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1f6194db-7238-4c3a-986c-1e9dc0704972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_341244c7-8319-4c2b-92d0-fe3d7d4c6e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_02fa64e1-108f-4889-aace-907f0bc5aec3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_341244c7-8319-4c2b-92d0-fe3d7d4c6e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_dfd90433-d388-400e-8090-ec59ac387290" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_dfd90433-d388-400e-8090-ec59ac387290" xlink:to="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba6b96b0-f7b1-4a40-b926-9f7110defbef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba6b96b0-f7b1-4a40-b926-9f7110defbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba6b96b0-f7b1-4a40-b926-9f7110defbef" xlink:to="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_365aec93-69c2-40fa-b66f-186af6a54b43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_365aec93-69c2-40fa-b66f-186af6a54b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_c1f658ff-d114-422c-93ab-af8ea136dc41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_94f95994-aa66-4c52-b4fb-0f4f50554583" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_c1f658ff-d114-422c-93ab-af8ea136dc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_89dcc4a1-a2fc-4152-9343-44495dd02718" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_89dcc4a1-a2fc-4152-9343-44495dd02718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89dcc4a1-a2fc-4152-9343-44495dd02718" xlink:to="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_870d7f12-6a72-4ea1-a6c0-506b1c42cb66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_CommonStockMember_870d7f12-6a72-4ea1-a6c0-506b1c42cb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e2b692f0-95e8-4526-9445-8c5740e95336" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e2b692f0-95e8-4526-9445-8c5740e95336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c35b05a-e189-4efd-be20-6d718515d8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c35b05a-e189-4efd-be20-6d718515d8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5ecd8937-b419-4447-aabf-bf5feeddfe33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_RetainedEarningsMember_5ecd8937-b419-4447-aabf-bf5feeddfe33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5213c695-9058-46c1-8815-1cbd7c2963b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bad574bf-1c41-45ce-8663-8b4fa1c6e5d7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5213c695-9058-46c1-8815-1cbd7c2963b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c3c46a15-f54f-43d4-b712-ae62a4a8f20d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c13073b6-8177-4c1a-8705-e27b6fe1cd76" xlink:to="loc_us-gaap_StatementLineItems_c3c46a15-f54f-43d4-b712-ae62a4a8f20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c3c46a15-f54f-43d4-b712-ae62a4a8f20d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_02d8796f-2abc-4039-9f6f-d28456510989" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_02d8796f-2abc-4039-9f6f-d28456510989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b55495b-ff20-4e68-8ddb-e6963709787c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3b55495b-ff20-4e68-8ddb-e6963709787c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_4a238123-01e3-4c3b-963b-238288ac0b4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_4a238123-01e3-4c3b-963b-238288ac0b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_2aaeac1f-9f4d-40b2-84c9-ad0154b57e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_2aaeac1f-9f4d-40b2-84c9-ad0154b57e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8026fb17-02bc-4d14-826e-df5efbdd4473" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_ProfitLoss_8026fb17-02bc-4d14-826e-df5efbdd4473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7bfd50d0-5e4a-4d71-aa57-6436114146f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7bfd50d0-5e4a-4d71-aa57-6436114146f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6f5de74f-527a-4157-a29e-3b5c87e7688d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6f5de74f-527a-4157-a29e-3b5c87e7688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0a2cc89b-70f2-4804-b521-b9b86aa5473c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0a2cc89b-70f2-4804-b521-b9b86aa5473c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0aeafb9e-fc00-451a-ae99-3749ee474e97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0aeafb9e-fc00-451a-ae99-3749ee474e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_61431368-ea6d-4ce9-ad9a-bf7522577668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_61431368-ea6d-4ce9-ad9a-bf7522577668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_42bc4c18-986d-42f6-84a0-c756a7bcce10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_42bc4c18-986d-42f6-84a0-c756a7bcce10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0b9a2c33-e39f-4a44-831b-0a5f449ca7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0b9a2c33-e39f-4a44-831b-0a5f449ca7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_de2895df-ee99-4b7f-87ce-a0963029bd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_de2895df-ee99-4b7f-87ce-a0963029bd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_368ae622-82d7-4bf4-a366-1477a89b4127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_Dividends_368ae622-82d7-4bf4-a366-1477a89b4127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4bdca590-d51f-475d-af77-9d0502706388" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4bdca590-d51f-475d-af77-9d0502706388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71798a5f-327e-4ba0-bcae-0572f1c39fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2a96e7ad-8128-4f2d-9c0a-4dac04117d02" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71798a5f-327e-4ba0-bcae-0572f1c39fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="gild-20200930.xsd#ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_82793863-eb4a-49e5-bd4f-f6dabc1fbd24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_91e74852-c95f-4df9-89a5-721398c4b048" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_82793863-eb4a-49e5-bd4f-f6dabc1fbd24" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_91e74852-c95f-4df9-89a5-721398c4b048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="gild-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_008c49e5-b4f3-4234-b692-a452daaa800f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_008c49e5-b4f3-4234-b692-a452daaa800f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4379f2fd-9831-48b7-b53f-2b6989232126" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_008c49e5-b4f3-4234-b692-a452daaa800f" xlink:to="loc_us-gaap_ProfitLoss_4379f2fd-9831-48b7-b53f-2b6989232126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_008c49e5-b4f3-4234-b692-a452daaa800f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6559438a-77c4-4ae7-a437-6dbb3387173f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:to="loc_us-gaap_Depreciation_6559438a-77c4-4ae7-a437-6dbb3387173f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_220a3c67-810b-467d-b24f-bfd36aa8ac85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:to="loc_us-gaap_AdjustmentForAmortization_220a3c67-810b-467d-b24f-bfd36aa8ac85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ef8b9218-7ef2-47b6-9e83-2c9a258b1b76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:to="loc_us-gaap_ShareBasedCompensation_ef8b9218-7ef2-47b6-9e83-2c9a258b1b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_03d15398-6e1a-4f86-90c4-a305d9c0af1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_03d15398-6e1a-4f86-90c4-a305d9c0af1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9e5d7546-894a-41bd-8578-b525362d75e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9e5d7546-894a-41bd-8578-b525362d75e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_edf62a9b-b995-41fd-b885-136b3e7289d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_edf62a9b-b995-41fd-b885-136b3e7289d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8d3c3e3c-15e2-4593-8dfb-b986a8510bde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_251cfd51-b1b2-498d-ae36-7698f0f3c6f9" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8d3c3e3c-15e2-4593-8dfb-b986a8510bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_008c49e5-b4f3-4234-b692-a452daaa800f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6c0dbd3a-6b24-4007-80a9-030f4ac7ebb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6c0dbd3a-6b24-4007-80a9-030f4ac7ebb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e834c38b-7440-4298-a76f-f14ed8d747f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e834c38b-7440-4298-a76f-f14ed8d747f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_03605a97-8a43-4b71-a1bc-fdd2d782bd4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_03605a97-8a43-4b71-a1bc-fdd2d782bd4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_77243b32-072b-42ad-9df9-9bfc463e76f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_77243b32-072b-42ad-9df9-9bfc463e76f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_92c02d9d-63ab-4dc8-a675-123166b0d40d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_92c02d9d-63ab-4dc8-a675-123166b0d40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_376589cc-5ab7-49cf-8d9a-ec9fcb5336d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c9338af0-5c56-4f62-b927-1470f1ae0760" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_376589cc-5ab7-49cf-8d9a-ec9fcb5336d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_989e74e8-ee76-4947-90b0-130be2964478" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_008c49e5-b4f3-4234-b692-a452daaa800f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_989e74e8-ee76-4947-90b0-130be2964478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_f3472a48-d78c-49a5-94d8-3b16d4c755a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecurities_f3472a48-d78c-49a5-94d8-3b16d4c755a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_b061d40c-de5a-45be-a2ec-d78b05395dd2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_b061d40c-de5a-45be-a2ec-d78b05395dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_89de2d85-6765-4469-bf5c-31b0bb7aa0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_89de2d85-6765-4469-bf5c-31b0bb7aa0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_0eca13d8-d35d-4bb9-8722-27f7d71f8b90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_0eca13d8-d35d-4bb9-8722-27f7d71f8b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_d8c1cf63-9dac-4cc1-9cbf-3aa2d3ba7cef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_d8c1cf63-9dac-4cc1-9cbf-3aa2d3ba7cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11d80471-8a3e-4633-8642-cb524d192856" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11d80471-8a3e-4633-8642-cb524d192856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c0498b46-a4b9-4093-9d3e-b863da7a1826" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c0498b46-a4b9-4093-9d3e-b863da7a1826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63d7df09-5043-4b21-a69a-e2aa38e8f6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ecaa8e9d-998b-4d5a-9080-92e7d0713bb0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63d7df09-5043-4b21-a69a-e2aa38e8f6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_86916126-5477-4153-9e04-e3f79b3e8b73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_86916126-5477-4153-9e04-e3f79b3e8b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_89514da5-890c-4d92-ba02-bc43287354c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_89514da5-890c-4d92-ba02-bc43287354c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09cc62df-b3a6-4689-81fe-3fea98848bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_09cc62df-b3a6-4689-81fe-3fea98848bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_03e7fde4-463d-4c07-8865-d3a6490ca68e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:to="loc_us-gaap_RepaymentsOfDebt_03e7fde4-463d-4c07-8865-d3a6490ca68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_2980772f-ec54-47f4-9ee7-90016417b9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:to="loc_us-gaap_PaymentsOfDividends_2980772f-ec54-47f4-9ee7-90016417b9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c87720d8-efd8-4bdc-96fe-73bdb9a3158b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c87720d8-efd8-4bdc-96fe-73bdb9a3158b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_315ab909-2968-40ac-8f8d-7a4f1b438664" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e8c31e25-6274-4e9e-b3f8-c1bdaaf12fba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_315ab909-2968-40ac-8f8d-7a4f1b438664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_965cba48-801a-4f66-8e6f-1dd067f60a0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_965cba48-801a-4f66-8e6f-1dd067f60a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a929b4c3-3edf-44b6-a89b-f017f624332f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a929b4c3-3edf-44b6-a89b-f017f624332f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7042457f-afd6-45b1-af8d-42554185417a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7042457f-afd6-45b1-af8d-42554185417a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d8541d9-787e-4ef7-8e8e-480b3f2c54c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_63966ce8-eaae-4904-ab19-2d74d2fc80f3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d8541d9-787e-4ef7-8e8e-480b3f2c54c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_42b338fc-5c46-48ed-8270-a1add188e4b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_5fa8fb8e-14de-46cc-b3e5-442048d1012b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_42b338fc-5c46-48ed-8270-a1add188e4b1" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_5fa8fb8e-14de-46cc-b3e5-442048d1012b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_efbfcc1c-0834-4309-84c1-bac91e93e05f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_efbfcc1c-0834-4309-84c1-bac91e93e05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9a9ef05e-03b6-4faa-ba1b-81a1d7ea70af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9a9ef05e-03b6-4faa-ba1b-81a1d7ea70af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_ce69a599-6cb3-4764-9cd6-6270a4b1afb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:to="loc_us-gaap_UseOfEstimates_ce69a599-6cb3-4764-9cd6-6270a4b1afb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d0d15d87-a4c5-4c75-8e5e-de69319f20de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d0d15d87-a4c5-4c75-8e5e-de69319f20de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_8036ee1b-3866-458c-9f5a-2d9e520c1166" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_8036ee1b-3866-458c-9f5a-2d9e520c1166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8d97c5ed-2e19-4e99-9ae5-403b6ec3fbd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8d97c5ed-2e19-4e99-9ae5-403b6ec3fbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_60ed6643-2387-42fb-ab4d-1895874b686d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_76b4a04e-6fa6-43ee-a610-a57833a7affa" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_60ed6643-2387-42fb-ab4d-1895874b686d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0bb8d6b3-ee4b-4c48-8dc4-37de8dac5220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b0eb7afd-cfe3-4ac8-baba-d60a4032bd8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0bb8d6b3-ee4b-4c48-8dc4-37de8dac5220" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b0eb7afd-cfe3-4ac8-baba-d60a4032bd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5034cf0c-988d-42f2-9e46-888cec9f0fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0bb8d6b3-ee4b-4c48-8dc4-37de8dac5220" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5034cf0c-988d-42f2-9e46-888cec9f0fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_86070f53-e0d5-42c7-999a-519a6e5ae1ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0bb8d6b3-ee4b-4c48-8dc4-37de8dac5220" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_86070f53-e0d5-42c7-999a-519a6e5ae1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/Revenues" xlink:type="simple" xlink:href="gild-20200930.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c0ebd17-35e5-4000-ae14-b26b5314c64e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_b6365fe9-4e54-4a30-82bb-6e881ed1ad55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c0ebd17-35e5-4000-ae14-b26b5314c64e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_b6365fe9-4e54-4a30-82bb-6e881ed1ad55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/RevenuesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9509ab40-6999-4553-b11b-b5fdc676efcf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_856a1aed-c9d6-45c0-a311-16de79746fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9509ab40-6999-4553-b11b-b5fdc676efcf" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_856a1aed-c9d6-45c0-a311-16de79746fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_3c3f29b6-94d6-4e74-b2b2-b0b371e32a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9509ab40-6999-4553-b11b-b5fdc676efcf" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_3c3f29b6-94d6-4e74-b2b2-b0b371e32a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesDisaggregationofRevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a7531d00-34e9-4640-8ab3-02221dbd0a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a7531d00-34e9-4640-8ab3-02221dbd0a05" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:to="loc_srt_ProductOrServiceAxis_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f3d0ed78-c91d-4e45-9e12-ec90df90f0c9" xlink:to="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsAtriplaMember_af27eabc-8010-4a90-99fb-d39e3fd181c1" xlink:href="gild-20200930.xsd#gild_HIVProductsAtriplaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsAtriplaMember_af27eabc-8010-4a90-99fb-d39e3fd181c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsBiktarvyMember_4450cc8d-4506-4cd6-a7e3-877899dd62ad" xlink:href="gild-20200930.xsd#gild_HIVProductsBiktarvyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsBiktarvyMember_4450cc8d-4506-4cd6-a7e3-877899dd62ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsCompleraEvipleraMember_ef66abfd-d8b9-4e94-b61a-23a84fcfcd6f" xlink:href="gild-20200930.xsd#gild_HIVProductsCompleraEvipleraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsCompleraEvipleraMember_ef66abfd-d8b9-4e94-b61a-23a84fcfcd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsDescovyMember_68ba8567-e055-4ac1-a361-5973336d1108" xlink:href="gild-20200930.xsd#gild_HIVProductsDescovyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsDescovyMember_68ba8567-e055-4ac1-a361-5973336d1108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsGenvoyaMember_8adeaa07-c382-44c4-a5f2-e828019cfc0c" xlink:href="gild-20200930.xsd#gild_HIVProductsGenvoyaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsGenvoyaMember_8adeaa07-c382-44c4-a5f2-e828019cfc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsOdefseyMember_5f42ac7b-f545-46dd-9b79-4ecaae98f448" xlink:href="gild-20200930.xsd#gild_HIVProductsOdefseyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsOdefseyMember_5f42ac7b-f545-46dd-9b79-4ecaae98f448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsStribildMember_0ba82d37-2691-4f03-b1e9-48a6537b3a25" xlink:href="gild-20200930.xsd#gild_HIVProductsStribildMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsStribildMember_0ba82d37-2691-4f03-b1e9-48a6537b3a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HIVProductsTruvadaMember_efd4c404-022d-4896-9766-34cb00920176" xlink:href="gild-20200930.xsd#gild_HIVProductsTruvadaMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HIVProductsTruvadaMember_efd4c404-022d-4896-9766-34cb00920176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ProductsOtherHIVMember_9ac45b78-3811-4cf7-b06c-33a88b9a68b1" xlink:href="gild-20200930.xsd#gild_ProductsOtherHIVMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_ProductsOtherHIVMember_9ac45b78-3811-4cf7-b06c-33a88b9a68b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ProductsRevenueShareSymtuzaMember_b3a06060-f853-439e-a093-a676dcb9854c" xlink:href="gild-20200930.xsd#gild_ProductsRevenueShareSymtuzaMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_ProductsRevenueShareSymtuzaMember_b3a06060-f853-439e-a093-a676dcb9854c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsAmBisomeMember_a9eed381-4b1e-4368-8997-6b8a49aa4b05" xlink:href="gild-20200930.xsd#gild_OtherProductsAmBisomeMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsAmBisomeMember_a9eed381-4b1e-4368-8997-6b8a49aa4b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsLedipasvirSofosbuvirMember_ab81997b-3783-4763-bf0f-f111efe452b9" xlink:href="gild-20200930.xsd#gild_HCVProductsLedipasvirSofosbuvirMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HCVProductsLedipasvirSofosbuvirMember_ab81997b-3783-4763-bf0f-f111efe452b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsLetairisMember_aab2e22d-3118-490e-938d-687e959621d2" xlink:href="gild-20200930.xsd#gild_OtherProductsLetairisMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsLetairisMember_aab2e22d-3118-490e-938d-687e959621d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsRanexaMember_7b4b8732-39c6-4e23-b916-0c7a5f8de5dc" xlink:href="gild-20200930.xsd#gild_OtherProductsRanexaMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsRanexaMember_7b4b8732-39c6-4e23-b916-0c7a5f8de5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsSofosbuvirVelpatasvirMember_3c2c5823-ef04-49c0-91aa-9b4793a11a4a" xlink:href="gild-20200930.xsd#gild_HCVProductsSofosbuvirVelpatasvirMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HCVProductsSofosbuvirVelpatasvirMember_3c2c5823-ef04-49c0-91aa-9b4793a11a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_COVID19ProductsVekluryMember_d271422f-e6d7-44e9-ade9-a978211282a8" xlink:href="gild-20200930.xsd#gild_COVID19ProductsVekluryMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_COVID19ProductsVekluryMember_d271422f-e6d7-44e9-ade9-a978211282a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsVemlidyMember_12a2ff64-7e8e-456d-b311-7a0fe31760d6" xlink:href="gild-20200930.xsd#gild_OtherProductsVemlidyMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsVemlidyMember_12a2ff64-7e8e-456d-b311-7a0fe31760d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsVireadMember_d4b81e08-403b-4aeb-a1db-f6d4abc08e8c" xlink:href="gild-20200930.xsd#gild_OtherProductsVireadMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsVireadMember_d4b81e08-403b-4aeb-a1db-f6d4abc08e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_HCVProductsVoseviMember_0fca19c0-7d1d-411e-ba80-f1dd6d7712b2" xlink:href="gild-20200930.xsd#gild_HCVProductsVoseviMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_HCVProductsVoseviMember_0fca19c0-7d1d-411e-ba80-f1dd6d7712b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsYescartaMember_3a18ccac-f221-4cf5-a38d-3f42c83cec6a" xlink:href="gild-20200930.xsd#gild_OtherProductsYescartaMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsYescartaMember_3a18ccac-f221-4cf5-a38d-3f42c83cec6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsZydeligMember_92c918c6-4337-414b-8466-a1a9d88c6878" xlink:href="gild-20200930.xsd#gild_OtherProductsZydeligMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsZydeligMember_92c918c6-4337-414b-8466-a1a9d88c6878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherProductsOtherMember_157ba7ee-cc3d-461d-b4c1-ef36a55a2264" xlink:href="gild-20200930.xsd#gild_OtherProductsOtherMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_OtherProductsOtherMember_157ba7ee-cc3d-461d-b4c1-ef36a55a2264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_5cc26d51-4add-4b47-9fb3-1bbdfcd0c239" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_us-gaap_ProductMember_5cc26d51-4add-4b47-9fb3-1bbdfcd0c239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_RoyaltyContractAndOtherMember_d9e71c6b-b103-4171-bf00-564d02a3a15d" xlink:href="gild-20200930.xsd#gild_RoyaltyContractAndOtherMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ddff4286-3a06-426d-978c-1599360d93d8" xlink:to="loc_gild_RoyaltyContractAndOtherMember_d9e71c6b-b103-4171-bf00-564d02a3a15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_89d7c3d2-5bf9-4568-b061-0af393a4d8e7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:to="loc_srt_StatementGeographicalAxis_89d7c3d2-5bf9-4568-b061-0af393a4d8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_89d7c3d2-5bf9-4568-b061-0af393a4d8e7" xlink:to="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_024d6799-94b2-40d2-affb-c4776c76494c" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:to="loc_country_US_024d6799-94b2-40d2-affb-c4776c76494c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_06007d27-6607-4c22-a7a6-5e21f63a724c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:to="loc_srt_EuropeMember_06007d27-6607-4c22-a7a6-5e21f63a724c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherInternationalMember_ca5b2fee-4b24-4a46-89b5-92f8caa2414c" xlink:href="gild-20200930.xsd#gild_OtherInternationalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a65927e-8881-41aa-8f42-01fa637215cb" xlink:to="loc_gild_OtherInternationalMember_ca5b2fee-4b24-4a46-89b5-92f8caa2414c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd0c57c6-0fd2-4155-950b-892894855af8" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_de78d166-d5db-495c-93b2-ec8ae0ca94a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_de78d166-d5db-495c-93b2-ec8ae0ca94a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d5ebb2d2-a0da-4681-ae8b-683610478568" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b7d34679-230e-4dc6-96b9-105f3792f304" xlink:to="loc_us-gaap_Revenues_d5ebb2d2-a0da-4681-ae8b-683610478568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesRevenuesfromMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_71b42e2d-6c76-49d7-a6a1-5df115e0344e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_71b42e2d-6c76-49d7-a6a1-5df115e0344e" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_67d52586-9637-436e-911f-5e8af454f7e0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:to="loc_srt_MajorCustomersAxis_67d52586-9637-436e-911f-5e8af454f7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_67d52586-9637-436e-911f-5e8af454f7e0" xlink:to="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AmerisourcebergenCorpMember_968dc5fe-7470-478f-a4e5-b87fc6977608" xlink:href="gild-20200930.xsd#gild_AmerisourcebergenCorpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:to="loc_gild_AmerisourcebergenCorpMember_968dc5fe-7470-478f-a4e5-b87fc6977608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CardinalHealthIncMember_8bc48a34-c356-4a0b-baa2-804e89a2c2fd" xlink:href="gild-20200930.xsd#gild_CardinalHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:to="loc_gild_CardinalHealthIncMember_8bc48a34-c356-4a0b-baa2-804e89a2c2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MckessonCorpMember_8db89a12-fdc6-4a07-a1dd-5cdb17bff17e" xlink:href="gild-20200930.xsd#gild_MckessonCorpMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_aaacef72-2867-40a8-917a-198ce1e5c23a" xlink:to="loc_gild_MckessonCorpMember_8db89a12-fdc6-4a07-a1dd-5cdb17bff17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_47d06d12-9502-4859-9c22-551300bae76d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84cb3305-1e9e-44f4-a7d2-0ae10ea89e75" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_47d06d12-9502-4859-9c22-551300bae76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_62dd4c2d-26e8-40cf-b516-d32686fc7720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_47d06d12-9502-4859-9c22-551300bae76d" xlink:to="loc_us-gaap_SalesRevenueNetMember_62dd4c2d-26e8-40cf-b516-d32686fc7720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_65a6a78f-a324-4adc-97dc-540e4e2b0222" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_65a6a78f-a324-4adc-97dc-540e4e2b0222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c03cdbb4-9c8f-4048-bf40-34d65a93c02e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_65a6a78f-a324-4adc-97dc-540e4e2b0222" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c03cdbb4-9c8f-4048-bf40-34d65a93c02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5e14b6f2-b2b3-4f15-b4c0-77efe737e3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c03cdbb4-9c8f-4048-bf40-34d65a93c02e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5e14b6f2-b2b3-4f15-b4c0-77efe737e3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_ccdb8c32-687b-415f-87ee-18591b7ae4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d43e4647-6700-478d-a223-9e8d802e9607" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_ccdb8c32-687b-415f-87ee-18591b7ae4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d400ecfa-867e-4254-b9c8-890d3657e01f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_ccdb8c32-687b-415f-87ee-18591b7ae4ee" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d400ecfa-867e-4254-b9c8-890d3657e01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/RevenuesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#RevenuesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/RevenuesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ddc9ae90-be2a-47b3-aeba-d7d2b0ba68e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods_53d9916d-586a-4265-86c0-4457ce3b78eb" xlink:href="gild-20200930.xsd#gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ddc9ae90-be2a-47b3-aeba-d7d2b0ba68e9" xlink:to="loc_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods_53d9916d-586a-4265-86c0-4457ce3b78eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_d9db5652-1089-49a7-b0b7-284b93d655ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ddc9ae90-be2a-47b3-aeba-d7d2b0ba68e9" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_d9db5652-1089-49a7-b0b7-284b93d655ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_26c207d6-e0a5-407a-93f8-9f1e679b4ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ddc9ae90-be2a-47b3-aeba-d7d2b0ba68e9" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_26c207d6-e0a5-407a-93f8-9f1e679b4ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_def35d18-9de0-49a2-ab92-b006dbb0265c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ddc9ae90-be2a-47b3-aeba-d7d2b0ba68e9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_def35d18-9de0-49a2-ab92-b006dbb0265c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4b62cd3c-f5be-4403-b49e-816986a7c5a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d73ad177-9f1d-4673-a4ee-535b2b117da2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4b62cd3c-f5be-4403-b49e-816986a7c5a4" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d73ad177-9f1d-4673-a4ee-535b2b117da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f93b9470-20be-4611-ba5e-7ffdd6b5553e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5945229b-2db4-4e5a-8a84-1ad8942623ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f93b9470-20be-4611-ba5e-7ffdd6b5553e" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5945229b-2db4-4e5a-8a84-1ad8942623ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_46877739-bfea-415c-b0dc-304b38697055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f93b9470-20be-4611-ba5e-7ffdd6b5553e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_46877739-bfea-415c-b0dc-304b38697055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_33a25192-4755-4b38-bf71-cbfd1370c803" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33a25192-4755-4b38-bf71-cbfd1370c803" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3059e42d-d6c9-4055-a330-e066e8c8ad84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28ad5abb-973e-43cc-a2fb-9c2b7bde15ad" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3059e42d-d6c9-4055-a330-e066e8c8ad84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b36c24fa-2980-4ab8-ad2c-5fd4e10a9406" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3059e42d-d6c9-4055-a330-e066e8c8ad84" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b36c24fa-2980-4ab8-ad2c-5fd4e10a9406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb7c1220-aedc-483b-8585-821904b8c896" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb7c1220-aedc-483b-8585-821904b8c896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eb7c1220-aedc-483b-8585-821904b8c896" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_05450955-5ff9-41e8-95eb-acc3e38daa25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_05450955-5ff9-41e8-95eb-acc3e38daa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6f0174e6-aaa1-4f2c-ad89-d92b76e83917" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6f0174e6-aaa1-4f2c-ad89-d92b76e83917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b5d306d6-44de-4947-a35c-03356caa7fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5857096-6619-4d44-817c-cc702c7e4eae" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b5d306d6-44de-4947-a35c-03356caa7fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d03eb3d9-fe8b-4a57-9d8d-5f9f5a858046" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_eefc48f6-c5b1-4e89-bd2e-af73aa6c6694" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d03eb3d9-fe8b-4a57-9d8d-5f9f5a858046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18223d3c-e935-4ff5-afb7-cac4621e654d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d03eb3d9-fe8b-4a57-9d8d-5f9f5a858046" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18223d3c-e935-4ff5-afb7-cac4621e654d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_265dfb98-7061-4d75-ad75-8ed904ebf0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18223d3c-e935-4ff5-afb7-cac4621e654d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_265dfb98-7061-4d75-ad75-8ed904ebf0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b6c603f3-5587-4c0a-bf8f-18c393c6f5db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b6c603f3-5587-4c0a-bf8f-18c393c6f5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b6c603f3-5587-4c0a-bf8f-18c393c6f5db" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_787e13ff-1c17-4d0d-95ff-27fedf0252d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_787e13ff-1c17-4d0d-95ff-27fedf0252d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_50145975-80b4-4bf5-9df2-73c1429912c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_CertificatesOfDepositMember_50145975-80b4-4bf5-9df2-73c1429912c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3c307e38-88ad-404a-a8d6-cda990a3418a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3c307e38-88ad-404a-a8d6-cda990a3418a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_d672854b-c663-42cc-9c25-f76c8085e6f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_d672854b-c663-42cc-9c25-f76c8085e6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ba0bbbf7-216e-4589-a208-cf2c846b52f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ba0bbbf7-216e-4589-a208-cf2c846b52f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_13304443-23ea-4b5d-b342-18e7dd0f0f14" xlink:href="gild-20200930.xsd#gild_ResidentialMortgageAndAssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_13304443-23ea-4b5d-b342-18e7dd0f0f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityinvestmentinGalapagosMember_33eda92f-7271-47dd-8827-18608aea6d11" xlink:href="gild-20200930.xsd#gild_EquityinvestmentinGalapagosMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_EquityinvestmentinGalapagosMember_33eda92f-7271-47dd-8827-18608aea6d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_b945abb3-49b7-42d2-b57a-20b47935f012" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_MoneyMarketFundsMember_b945abb3-49b7-42d2-b57a-20b47935f012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c5b044f5-7d9b-4d12-85e0-59d2b418143a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_us-gaap_EquitySecuritiesMember_c5b044f5-7d9b-4d12-85e0-59d2b418143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DeferredCompensationPlanMember_63a000e6-5977-47fe-b141-5939a4779510" xlink:href="gild-20200930.xsd#gild_DeferredCompensationPlanMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_DeferredCompensationPlanMember_63a000e6-5977-47fe-b141-5939a4779510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ForeignCurrencyDerivativeContractsMember_95465838-e8ed-41e1-a30c-73b26c54c277" xlink:href="gild-20200930.xsd#gild_ForeignCurrencyDerivativeContractsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e223ce87-8e32-4612-9386-96745f664bf8" xlink:to="loc_gild_ForeignCurrencyDerivativeContractsMember_95465838-e8ed-41e1-a30c-73b26c54c277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_12151af4-0ddc-4276-9b39-078e1d230c5a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71c52e84-7c6d-44b1-9144-9112a5771030" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_71c52e84-7c6d-44b1-9144-9112a5771030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_af19bd58-3eb3-4790-bc19-1c3229b342f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_af19bd58-3eb3-4790-bc19-1c3229b342f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b4ea6ef3-2801-4e02-aca1-2b645fa27525" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b4ea6ef3-2801-4e02-aca1-2b645fa27525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b53f3433-5396-4776-b4b8-f14e9a51665c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_57fba287-11fa-45cb-b4c7-eb825c3e13a6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b53f3433-5396-4776-b4b8-f14e9a51665c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3017bb19-9247-4381-9931-ef8f158b7f93" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_74459101-5a7d-4ec0-9243-fe19143f1cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_74459101-5a7d-4ec0-9243-fe19143f1cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_8d989218-eca4-43da-b602-dec243e7fb5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_8d989218-eca4-43da-b602-dec243e7fb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_87b3efd5-7327-4f1a-8031-405ca33844f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_350e6081-4297-41ca-b972-2871888fded7" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_87b3efd5-7327-4f1a-8031-405ca33844f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_27015c41-f339-40b7-934d-2b1a6a718348" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27015c41-f339-40b7-934d-2b1a6a718348" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d275fea5-449f-495a-90c6-b909ae933f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d275fea5-449f-495a-90c6-b909ae933f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ed0ec741-e9bb-4c55-8e0d-d39a24b40aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d275fea5-449f-495a-90c6-b909ae933f74" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ed0ec741-e9bb-4c55-8e0d-d39a24b40aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ed0ec741-e9bb-4c55-8e0d-d39a24b40aa2" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_debbe427-8198-48df-98b6-70e435b4a120" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_debbe427-8198-48df-98b6-70e435b4a120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8f5670d0-f991-480a-9597-ecb11acf7e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7ae4f629-f242-42b0-85ed-1c3e7d1f5b2c" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8f5670d0-f991-480a-9597-ecb11acf7e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f54d192-50b6-4370-9a2c-fc99f458ee54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f54d192-50b6-4370-9a2c-fc99f458ee54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b55adbdb-df59-4fb9-bcc1-519af826787e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f54d192-50b6-4370-9a2c-fc99f458ee54" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b55adbdb-df59-4fb9-bcc1-519af826787e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d8737b73-bad8-432b-96b4-ef6c6aa87f95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b55adbdb-df59-4fb9-bcc1-519af826787e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d8737b73-bad8-432b-96b4-ef6c6aa87f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aa0f157c-0247-4f34-94d8-54d8bc2a3979" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_296b3f79-ee0f-4323-9d30-9f59c84af51f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_296b3f79-ee0f-4323-9d30-9f59c84af51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_4766151a-819b-44fa-9424-ba8da90ba355" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_4766151a-819b-44fa-9424-ba8da90ba355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_b458fc23-4bed-4723-b5e5-8ca85945db52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_LongTermDebtFairValue_b458fc23-4bed-4723-b5e5-8ca85945db52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2e7b07e3-a36c-441a-91f0-5a10920a8e66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428b823-24a4-4b81-8ed1-67b2de2b5fa0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2e7b07e3-a36c-441a-91f0-5a10920a8e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a5439742-e488-4f2e-8eaf-56f039ff42a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5439742-e488-4f2e-8eaf-56f039ff42a5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1134d489-97ad-42f8-af06-b41b95700ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1134d489-97ad-42f8-af06-b41b95700ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d364b338-3795-40f8-b6b2-ca85867d6f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1134d489-97ad-42f8-af06-b41b95700ff9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d364b338-3795-40f8-b6b2-ca85867d6f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherEquitySecuritiesMember_a87709aa-105f-40f8-8099-1fbfeb94b9a3" xlink:href="gild-20200930.xsd#gild_OtherEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d364b338-3795-40f8-b6b2-ca85867d6f3b" xlink:to="loc_gild_OtherEquitySecuritiesMember_a87709aa-105f-40f8-8099-1fbfeb94b9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9284ef4a-abf9-4d77-b6b9-30d2f0fdd2f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_13f68fb3-a96a-4eda-872d-153fe5c8e60e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_13f68fb3-a96a-4eda-872d-153fe5c8e60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a997caf4-34fa-4f4a-87ee-f289f5c692f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a997caf4-34fa-4f4a-87ee-f289f5c692f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_9d647e86-30fa-47dc-aa17-bed28574a622" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ff61ba5c-edd9-4b5d-b6f5-b5def5b904df" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_9d647e86-30fa-47dc-aa17-bed28574a622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0dd0180f-abdd-4cca-8937-50507080fbbe" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7ce35e89-0a37-41fe-afe3-a68067dd5701" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7ce35e89-0a37-41fe-afe3-a68067dd5701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_471c318e-5125-4082-9734-90d1a6a877fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ed518a8c-b00d-45b5-8843-f0e35b90b6d7" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_471c318e-5125-4082-9734-90d1a6a877fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecurities" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecurities"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_4cc5d77e-8f06-4f0c-9f32-d42692171aec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2237e8e4-fe4e-4ec2-b74a-ae5297261c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_4cc5d77e-8f06-4f0c-9f32-d42692171aec" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2237e8e4-fe4e-4ec2-b74a-ae5297261c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_1bf631c0-50a9-47d7-a88a-f64d4743ff31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_ba914bc6-b4f8-49e8-971a-b03431c7de7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_1bf631c0-50a9-47d7-a88a-f64d4743ff31" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_ba914bc6-b4f8-49e8-971a-b03431c7de7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_40986e53-1e34-42b0-ba69-eb537166bc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_1bf631c0-50a9-47d7-a88a-f64d4743ff31" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_40986e53-1e34-42b0-ba69-eb537166bc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_bb65c12d-ae01-4e31-b111-8f870eaf8500" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_1bf631c0-50a9-47d7-a88a-f64d4743ff31" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_bb65c12d-ae01-4e31-b111-8f870eaf8500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_e6367d70-8209-4525-b08a-cbc2017311b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_1bf631c0-50a9-47d7-a88a-f64d4743ff31" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_e6367d70-8209-4525-b08a-cbc2017311b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0cc6f9fc-cf48-4c16-b8a7-79a940b4bd06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_db38b87c-5b5f-4a7a-94ba-c36218584e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_0cc6f9fc-cf48-4c16-b8a7-79a940b4bd06" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_db38b87c-5b5f-4a7a-94ba-c36218584e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_98b82141-16c5-4964-9454-34c798126f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_db38b87c-5b5f-4a7a-94ba-c36218584e9d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_98b82141-16c5-4964-9454-34c798126f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98b82141-16c5-4964-9454-34c798126f5c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_eeb3a71d-d3b0-40ae-900e-9a8cdb7f11f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_eeb3a71d-d3b0-40ae-900e-9a8cdb7f11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_d06e605b-9fb7-40b4-924a-f79e72a25b08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_CertificatesOfDepositMember_d06e605b-9fb7-40b4-924a-f79e72a25b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c739e270-1609-4040-97eb-381f15a4b4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c739e270-1609-4040-97eb-381f15a4b4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_7eb7fb2b-5bc7-409b-bde8-c29f68019225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_7eb7fb2b-5bc7-409b-bde8-c29f68019225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e2e3aff9-6103-445d-a5d9-07d7af88ff79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e2e3aff9-6103-445d-a5d9-07d7af88ff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_9c35afd1-f8ee-49ec-b0be-883391666c23" xlink:href="gild-20200930.xsd#gild_ResidentialMortgageAndAssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0be710ed-e5f2-403c-a9c2-caaad0e34d6a" xlink:to="loc_gild_ResidentialMortgageAndAssetBackedSecuritiesMember_9c35afd1-f8ee-49ec-b0be-883391666c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_db38b87c-5b5f-4a7a-94ba-c36218584e9d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b58bb041-ca9c-4f18-95ac-32c7eaeb5a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b58bb041-ca9c-4f18-95ac-32c7eaeb5a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_15051e71-7a65-4b84-a90c-834f921d08a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_15051e71-7a65-4b84-a90c-834f921d08a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d57d08df-4402-4d7a-85e8-4f63854cfceb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d57d08df-4402-4d7a-85e8-4f63854cfceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9bf02515-94fb-4f1d-8d03-f3f43cc2bf3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5fcd2347-94c3-486b-b529-55dc9c6c3228" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9bf02515-94fb-4f1d-8d03-f3f43cc2bf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_8cddde15-6b25-4cc1-a139-3c195539a186" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bd016e7-1373-4d51-a0b6-fde7651813c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_8cddde15-6b25-4cc1-a139-3c195539a186" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bd016e7-1373-4d51-a0b6-fde7651813c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3e16149-e2d9-4eaa-a555-49424fc36ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bd016e7-1373-4d51-a0b6-fde7651813c1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3e16149-e2d9-4eaa-a555-49424fc36ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3e16149-e2d9-4eaa-a555-49424fc36ec3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_8882d0e0-5bf1-4ac7-a38d-e3477ef353f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_8882d0e0-5bf1-4ac7-a38d-e3477ef353f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MarketableSecuritiesCurrentMember_73c55312-5270-4e23-afc9-35665f34065e" xlink:href="gild-20200930.xsd#gild_MarketableSecuritiesCurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:to="loc_gild_MarketableSecuritiesCurrentMember_73c55312-5270-4e23-afc9-35665f34065e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_MarketableSecuritiesNoncurrentMember_58a6ea1c-7fdb-40f8-9124-708b71911149" xlink:href="gild-20200930.xsd#gild_MarketableSecuritiesNoncurrentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a62eb605-93ee-42c4-9850-ca0648b3381c" xlink:to="loc_gild_MarketableSecuritiesNoncurrentMember_58a6ea1c-7fdb-40f8-9124-708b71911149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8948d6b2-a1b6-4923-af79-61c3d2399f90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1bd016e7-1373-4d51-a0b6-fde7651813c1" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8948d6b2-a1b6-4923-af79-61c3d2399f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b74226a-febf-47c8-a4cc-0d5bf834a41c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8948d6b2-a1b6-4923-af79-61c3d2399f90" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b74226a-febf-47c8-a4cc-0d5bf834a41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2c0bfad7-cb9a-42eb-acf8-d474d57c66b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_676422ca-0a8c-4adc-af2e-c03248fdb296" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2c0bfad7-cb9a-42eb-acf8-d474d57c66b4" xlink:to="loc_us-gaap_InterestReceivableCurrent_676422ca-0a8c-4adc-af2e-c03248fdb296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_Writeoffsinaccruedinterestreceivable_91262382-aa50-4cfa-9e1c-ec889834562d" xlink:href="gild-20200930.xsd#gild_Writeoffsinaccruedinterestreceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2c0bfad7-cb9a-42eb-acf8-d474d57c66b4" xlink:to="loc_gild_Writeoffsinaccruedinterestreceivable_91262382-aa50-4cfa-9e1c-ec889834562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_5b069f90-eedf-4e0c-ad3e-31dff6a93f12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2c0bfad7-cb9a-42eb-acf8-d474d57c66b4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_5b069f90-eedf-4e0c-ad3e-31dff6a93f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_22291461-d20f-4ca2-8822-7daa7dc34c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2c0bfad7-cb9a-42eb-acf8-d474d57c66b4" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_22291461-d20f-4ca2-8822-7daa7dc34c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_c9519c45-6e1f-4f99-9aff-0e8f46ae46c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_f886dfa0-95f2-47f1-b641-0cca60e562f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_c9519c45-6e1f-4f99-9aff-0e8f46ae46c7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_f886dfa0-95f2-47f1-b641-0cca60e562f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_a1d3a1a2-d0fa-4201-a6b9-c47b1e475a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_f886dfa0-95f2-47f1-b641-0cca60e562f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_a1d3a1a2-d0fa-4201-a6b9-c47b1e475a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_48c8a753-e6e8-4f8d-84a0-677f827eb774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_f886dfa0-95f2-47f1-b641-0cca60e562f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_48c8a753-e6e8-4f8d-84a0-677f827eb774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_faa2150b-4038-4b7a-938b-4be0bdb762e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_f886dfa0-95f2-47f1-b641-0cca60e562f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_faa2150b-4038-4b7a-938b-4be0bdb762e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fd14a66e-88b8-4efd-9251-152a4ae61f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_f886dfa0-95f2-47f1-b641-0cca60e562f0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fd14a66e-88b8-4efd-9251-152a4ae61f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6bef9e5c-cb6f-4e8f-85bb-41bd34a636e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_c9519c45-6e1f-4f99-9aff-0e8f46ae46c7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6bef9e5c-cb6f-4e8f-85bb-41bd34a636e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_bf942b9d-5111-4d87-9e8c-534126f53858" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6bef9e5c-cb6f-4e8f-85bb-41bd34a636e5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_bf942b9d-5111-4d87-9e8c-534126f53858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_04f8c869-0bca-4733-b8b1-00df510d2c56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6bef9e5c-cb6f-4e8f-85bb-41bd34a636e5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_04f8c869-0bca-4733-b8b1-00df510d2c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_484f3532-c402-4e20-a33b-2864d878aa68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6bef9e5c-cb6f-4e8f-85bb-41bd34a636e5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_484f3532-c402-4e20-a33b-2864d878aa68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9cd6c853-9a03-4e08-a6cb-22535acc0f64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6bef9e5c-cb6f-4e8f-85bb-41bd34a636e5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9cd6c853-9a03-4e08-a6cb-22535acc0f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_71019e61-4470-4f3a-8c60-d862f0dc3538" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16b7c6ed-3eb5-44cd-8569-7d25edbdb8dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_71019e61-4470-4f3a-8c60-d862f0dc3538" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16b7c6ed-3eb5-44cd-8569-7d25edbdb8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2f14081f-3ac8-44e7-9d01-20d380a6349f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16b7c6ed-3eb5-44cd-8569-7d25edbdb8dd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2f14081f-3ac8-44e7-9d01-20d380a6349f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6db3bdfe-848c-4e1d-8936-91d11683b0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2f14081f-3ac8-44e7-9d01-20d380a6349f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6db3bdfe-848c-4e1d-8936-91d11683b0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_10a65e75-f8fc-41eb-a49a-1cfbf86dd0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6db3bdfe-848c-4e1d-8936-91d11683b0b1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_10a65e75-f8fc-41eb-a49a-1cfbf86dd0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16b7c6ed-3eb5-44cd-8569-7d25edbdb8dd" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ebcf5357-5fcb-4699-a0de-31e2ccb6e9de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ebcf5357-5fcb-4699-a0de-31e2ccb6e9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_79b272ca-554a-4a65-9a5f-9ef0d2653eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_79b272ca-554a-4a65-9a5f-9ef0d2653eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_78e12a2a-ada1-43cb-beb9-7480a6f34f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_78e12a2a-ada1-43cb-beb9-7480a6f34f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_35fbd3a1-c0ba-45df-a04b-d3f572286d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_35fbd3a1-c0ba-45df-a04b-d3f572286d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8c2dd5f7-b10a-457e-9500-4ef95a78d0a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8c2dd5f7-b10a-457e-9500-4ef95a78d0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7d3af41a-2304-4c8f-86ca-027378645160" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5e07b5-6d67-46ff-90da-75e96cbfab9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7d3af41a-2304-4c8f-86ca-027378645160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f4121f2-667d-4a1a-a036-4ec0d2591542" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4cef2fa5-a563-4db7-a543-1ca9801f2820" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f4121f2-667d-4a1a-a036-4ec0d2591542" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4cef2fa5-a563-4db7-a543-1ca9801f2820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_563be137-92da-4c13-a9f9-56073b2ada6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d752c2ca-989f-4f85-bf9d-cf8e5eb9143b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_563be137-92da-4c13-a9f9-56073b2ada6e" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d752c2ca-989f-4f85-bf9d-cf8e5eb9143b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_dc34018d-a855-4799-b67a-9616ca675548" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_563be137-92da-4c13-a9f9-56073b2ada6e" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_dc34018d-a855-4799-b67a-9616ca675548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7de57d9a-13e2-4e75-acf6-6d14c35e1f17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_563be137-92da-4c13-a9f9-56073b2ada6e" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7de57d9a-13e2-4e75-acf6-6d14c35e1f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6cf90d19-7a15-410f-bd1e-cbd967dd55bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2abf522-7907-47a1-bd24-1d25a9f421d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6cf90d19-7a15-410f-bd1e-cbd967dd55bf" xlink:to="loc_us-gaap_DerivativeTable_b2abf522-7907-47a1-bd24-1d25a9f421d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be8200d6-9477-46cd-910c-0af9db7357d9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2abf522-7907-47a1-bd24-1d25a9f421d2" xlink:to="loc_srt_RangeAxis_be8200d6-9477-46cd-910c-0af9db7357d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29a30449-8214-48b7-9c20-73224981ca97" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_be8200d6-9477-46cd-910c-0af9db7357d9" xlink:to="loc_srt_RangeMember_29a30449-8214-48b7-9c20-73224981ca97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_45d1282d-1e81-4681-a128-487c988ed5e1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29a30449-8214-48b7-9c20-73224981ca97" xlink:to="loc_srt_MaximumMember_45d1282d-1e81-4681-a128-487c988ed5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2abf522-7907-47a1-bd24-1d25a9f421d2" xlink:to="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_8b32a493-39da-48a4-9852-e1721dfc4594" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_8b32a493-39da-48a4-9852-e1721dfc4594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1_fc610b41-1ae1-4de8-bd8e-f6829302c104" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1_fc610b41-1ae1-4de8-bd8e-f6829302c104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7a756a67-cf07-408a-ae7e-ab6e36552696" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7a756a67-cf07-408a-ae7e-ab6e36552696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet_2ca069fc-0bd9-4a7f-b69a-edab6dc47ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2ba2dcc3-3a93-405c-be89-d97a45ed8159" xlink:to="loc_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet_2ca069fc-0bd9-4a7f-b69a-edab6dc47ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_394b8cc5-974f-49aa-bfb9-9cb7a4d20609" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_394b8cc5-974f-49aa-bfb9-9cb7a4d20609" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_49633e40-cd7f-4fcf-b85b-ff2527bccd33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:to="loc_us-gaap_HedgingDesignationAxis_49633e40-cd7f-4fcf-b85b-ff2527bccd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_49633e40-cd7f-4fcf-b85b-ff2527bccd33" xlink:to="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02b726a0-6ab0-4d85-903a-0bde9dccf552" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_02b726a0-6ab0-4d85-903a-0bde9dccf552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ccc2bc3a-4812-41b8-ac53-154f06b3b6fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_52279849-bcd6-4544-ada8-dba9f4ce525f" xlink:to="loc_us-gaap_NondesignatedMember_ccc2bc3a-4812-41b8-ac53-154f06b3b6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ed05c1b0-723f-4aa7-8e6c-c92dcddb66a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f4c6004c-37a1-425e-8209-a67d362f0d26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f4c6004c-37a1-425e-8209-a67d362f0d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_23bcaa86-6c8b-4c0c-a731-b2f27da42bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_23bcaa86-6c8b-4c0c-a731-b2f27da42bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_40852004-3727-4ec5-8aef-b1f84d8d8cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_40852004-3727-4ec5-8aef-b1f84d8d8cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_047be6f4-d3b8-4b29-afb2-62ba48e3d2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d78bbd6d-d2b3-40c1-a553-37f81ab3122b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_047be6f4-d3b8-4b29-afb2-62ba48e3d2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9a5b5e0b-e445-4bb4-a149-9fa646b718ee" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_3c3ffee9-b3bf-47b0-8ce7-99fbf929264c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_3c3ffee9-b3bf-47b0-8ce7-99fbf929264c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_9d04b3a1-d001-4327-8fc8-e681836c4fde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_63c43409-aa31-46f6-9b80-5713fc991efe" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_9d04b3a1-d001-4327-8fc8-e681836c4fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d1574fe9-31d6-4937-b5ee-f2baa1ed5ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fa9f1a33-9572-446d-95e8-3a85b29b6605" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d1574fe9-31d6-4937-b5ee-f2baa1ed5ab1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fa9f1a33-9572-446d-95e8-3a85b29b6605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c6b5606a-3e73-4318-958c-eb795dfc596a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d1574fe9-31d6-4937-b5ee-f2baa1ed5ab1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c6b5606a-3e73-4318-958c-eb795dfc596a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c209c98c-682a-4bd0-ae3a-af749ff142ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d1574fe9-31d6-4937-b5ee-f2baa1ed5ab1" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c209c98c-682a-4bd0-ae3a-af749ff142ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7754e454-0974-4208-ba46-db8aed610671" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7754e454-0974-4208-ba46-db8aed610671" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e9b509da-01b7-49b2-a9b7-078d33760142" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e9b509da-01b7-49b2-a9b7-078d33760142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_ec20fb3c-9a87-47d3-91f2-82c8d7fa0f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_ec20fb3c-9a87-47d3-91f2-82c8d7fa0f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_88bfcf81-3f4f-407e-923a-a22868006dce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:to="loc_us-gaap_DerivativeAssets_88bfcf81-3f4f-407e-923a-a22868006dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_465e5d71-6147-4d9d-a52b-aec2fb0bfdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_465e5d71-6147-4d9d-a52b-aec2fb0bfdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_3c35348c-ba21-4e5a-826d-196079a9b0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_3c35348c-ba21-4e5a-826d-196079a9b0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_001bf038-86eb-4c7b-bf33-a156e30f1be8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_cae64e76-f561-410e-9485-e4c9da03a1ae" xlink:to="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_001bf038-86eb-4c7b-bf33-a156e30f1be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7754e454-0974-4208-ba46-db8aed610671" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ddd61107-4ab8-4723-b093-f206b26126e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ddd61107-4ab8-4723-b093-f206b26126e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_772e94d9-bd7d-4c39-8b87-d2f8666e2cb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_772e94d9-bd7d-4c39-8b87-d2f8666e2cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_f198d219-d87e-4bc1-b2f0-aa15ab0a3f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:to="loc_us-gaap_DerivativeLiabilities_f198d219-d87e-4bc1-b2f0-aa15ab0a3f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_a3e50364-7231-4ede-b419-4abc46168a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_a3e50364-7231-4ede-b419-4abc46168a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_76c51f34-174c-4de2-90c2-727d1e47b015" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_76c51f34-174c-4de2-90c2-727d1e47b015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_130a4776-0396-4c09-9bf1-17db67cbfb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_14434104-6e78-4b17-bfb3-d2100627f53e" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_130a4776-0396-4c09-9bf1-17db67cbfb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements" xlink:type="simple" xlink:href="gild-20200930.xsd#AcquisitionsCollaborationsandOtherArrangements"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract_91f95423-de04-474c-b353-ef12d8c2ab0e" xlink:href="gild-20200930.xsd#gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock_53f94722-7c86-403d-97d9-e0b3576022e0" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsandOtherArrangementsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract_91f95423-de04-474c-b353-ef12d8c2ab0e" xlink:to="loc_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock_53f94722-7c86-403d-97d9-e0b3576022e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#AcquisitionsCollaborationsandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract_cd5c202e-0468-484b-a3cb-741269f38a9c" xlink:href="gild-20200930.xsd#gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsAndOtherArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract_cd5c202e-0468-484b-a3cb-741269f38a9c" xlink:to="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionAxis_eed9ce2b-e326-4108-800a-99f459e8c412" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_gild_AssetAcquisitionAxis_eed9ce2b-e326-4108-800a-99f459e8c412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionDomain_d01c2a4d-0b6e-4b29-b35d-c0a72c993681" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AssetAcquisitionAxis_eed9ce2b-e326-4108-800a-99f459e8c412" xlink:to="loc_gild_AssetAcquisitionDomain_d01c2a4d-0b6e-4b29-b35d-c0a72c993681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FortySevenIncMember_a5a20bd1-beca-4368-b268-3933f4130fe7" xlink:href="gild-20200930.xsd#gild_FortySevenIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AssetAcquisitionDomain_d01c2a4d-0b6e-4b29-b35d-c0a72c993681" xlink:to="loc_gild_FortySevenIncMember_a5a20bd1-beca-4368-b268-3933f4130fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ada12055-0afa-4ad6-b5fc-3ca936b67607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e38bc971-01f6-4bb7-9e1e-3ec1f25f9f26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ada12055-0afa-4ad6-b5fc-3ca936b67607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ImmunomedicsIncMember_ac8eb6f8-362c-420c-8e3d-0afa508a76c0" xlink:href="gild-20200930.xsd#gild_ImmunomedicsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ada12055-0afa-4ad6-b5fc-3ca936b67607" xlink:to="loc_gild_ImmunomedicsIncMember_ac8eb6f8-362c-420c-8e3d-0afa508a76c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c302c4e3-b91b-476b-8e0c-950db6425597" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b1ae5a4d-52a4-45a7-b2f5-d4c4115ab668" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c302c4e3-b91b-476b-8e0c-950db6425597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_afdf3dce-1c22-41cc-ae04-1eef01d822a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c302c4e3-b91b-476b-8e0c-950db6425597" xlink:to="loc_us-gaap_SubsequentEventMember_afdf3dce-1c22-41cc-ae04-1eef01d822a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_69e90452-1850-4a00-9582-0c80eeb3e463" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_DebtInstrumentAxis_69e90452-1850-4a00-9582-0c80eeb3e463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_98febcca-39c0-4a94-baeb-66178f0e3da8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_69e90452-1850-4a00-9582-0c80eeb3e463" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_98febcca-39c0-4a94-baeb-66178f0e3da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_8d0abd6d-edde-4c77-ac71-cdd6e1e10c23" xlink:href="gild-20200930.xsd#gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_98febcca-39c0-4a94-baeb-66178f0e3da8" xlink:to="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_8d0abd6d-edde-4c77-ac71-cdd6e1e10c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_33e42cb5-94a6-455e-854c-ef4266da4be6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_33e42cb5-94a6-455e-854c-ef4266da4be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9322620c-1474-4c40-b454-eb0c4eebd0db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_33e42cb5-94a6-455e-854c-ef4266da4be6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9322620c-1474-4c40-b454-eb0c4eebd0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_92b1ea4f-4f10-486c-885b-b0bdb99ced7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9322620c-1474-4c40-b454-eb0c4eebd0db" xlink:to="loc_us-gaap_MediumTermNotesMember_92b1ea4f-4f10-486c-885b-b0bdb99ced7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3f4bc994-3c66-479e-b012-a903bfb6b7f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_3f4bc994-3c66-479e-b012-a903bfb6b7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3f4bc994-3c66-479e-b012-a903bfb6b7f4" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember_12e19058-c8a9-47af-a328-aa136f0754af" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember_12e19058-c8a9-47af-a328-aa136f0754af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementMember_f51d7f8b-dec7-43bf-b256-efc7e250ce32" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OptionLicenseAndCollaborationAgreementMember_f51d7f8b-dec7-43bf-b256-efc7e250ce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember_c3b090ea-b7ef-4510-8597-99114cc8390a" xlink:href="gild-20200930.xsd#gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember_c3b090ea-b7ef-4510-8597-99114cc8390a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PionyrMergerAndOptionAgreementsMember_08618a15-5ec6-4e74-a037-be3a9aca4a4a" xlink:href="gild-20200930.xsd#gild_PionyrMergerAndOptionAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_PionyrMergerAndOptionAgreementsMember_08618a15-5ec6-4e74-a037-be3a9aca4a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResearchAndDevelopmentServiceAgreementMember_81b7c3b3-8215-4847-b260-92a5db8f2963" xlink:href="gild-20200930.xsd#gild_ResearchAndDevelopmentServiceAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_ResearchAndDevelopmentServiceAgreementMember_81b7c3b3-8215-4847-b260-92a5db8f2963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TizonaMergerAndOptionAgreementsMember_2a66aa82-f83a-48df-bc9e-81a8aee14610" xlink:href="gild-20200930.xsd#gild_TizonaMergerAndOptionAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_TizonaMergerAndOptionAgreementsMember_2a66aa82-f83a-48df-bc9e-81a8aee14610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DevelopmentAgreementMember_9c902915-27d7-4afa-b169-a07b341039cb" xlink:href="gild-20200930.xsd#gild_DevelopmentAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_DevelopmentAgreementMember_9c902915-27d7-4afa-b169-a07b341039cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember_d2333fba-276d-4a09-a83d-13dc4d266bf1" xlink:href="gild-20200930.xsd#gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember_d2333fba-276d-4a09-a83d-13dc4d266bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember_e74d2808-9d61-4d52-b90e-315b9e92d400" xlink:href="gild-20200930.xsd#gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember_e74d2808-9d61-4d52-b90e-315b9e92d400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember_4e044d87-921c-4705-9302-9c8604f138f6" xlink:href="gild-20200930.xsd#gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember_4e044d87-921c-4705-9302-9c8604f138f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_GadetaBVCollaborationArrangementMember_3438014f-97f0-4add-8122-90b70fb47335" xlink:href="gild-20200930.xsd#gild_GadetaBVCollaborationArrangementMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_GadetaBVCollaborationArrangementMember_3438014f-97f0-4add-8122-90b70fb47335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherCollaborationArrangementsMember_62d00d62-2ee1-4679-9f3e-08790e6f56b0" xlink:href="gild-20200930.xsd#gild_OtherCollaborationArrangementsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_57a0bf41-a860-4f1a-9f03-47c3e050f6ab" xlink:to="loc_gild_OtherCollaborationArrangementsMember_62d00d62-2ee1-4679-9f3e-08790e6f56b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f617cc8-62d1-4fdf-b963-ac77850b0d64" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f617cc8-62d1-4fdf-b963-ac77850b0d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1f617cc8-62d1-4fdf-b963-ac77850b0d64" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ArcusBiosciencesIncMember_b6ad7936-59c0-4f6b-85d9-50f830115874" xlink:href="gild-20200930.xsd#gild_ArcusBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_ArcusBiosciencesIncMember_b6ad7936-59c0-4f6b-85d9-50f830115874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PionyrImmunotherapeuticsIncMember_6de478fb-1aaa-4d4b-ab3d-a458f2cf1358" xlink:href="gild-20200930.xsd#gild_PionyrImmunotherapeuticsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_PionyrImmunotherapeuticsIncMember_6de478fb-1aaa-4d4b-ab3d-a458f2cf1358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TizonaTherapeuticsIncMember_b28fa8fb-0da4-4de0-b974-5648e6067140" xlink:href="gild-20200930.xsd#gild_TizonaTherapeuticsIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_TizonaTherapeuticsIncMember_b28fa8fb-0da4-4de0-b974-5648e6067140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TangoTherapeuticsIncMember_35f5d802-946b-4a8b-bf36-52f1f8664e8d" xlink:href="gild-20200930.xsd#gild_TangoTherapeuticsIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_TangoTherapeuticsIncMember_35f5d802-946b-4a8b-bf36-52f1f8664e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JounceTherapeuticsIncMember_f4d7e6c9-bc8a-44da-9be0-8ae52a23a1bc" xlink:href="gild-20200930.xsd#gild_JounceTherapeuticsIncMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_JounceTherapeuticsIncMember_f4d7e6c9-bc8a-44da-9be0-8ae52a23a1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_GalapagosMember_75ce27d0-6c66-49a2-98f3-96d7614c8fd2" xlink:href="gild-20200930.xsd#gild_GalapagosMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5f8896c0-85c0-48a1-b29a-4e5f9e8b6fcd" xlink:to="loc_gild_GalapagosMember_75ce27d0-6c66-49a2-98f3-96d7614c8fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_srt_OwnershipAxis_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_ad17ea54-221c-47f3-bb9d-4e6d64fb96dc" xlink:to="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ArcusBiosciencesIncMember_3b9a387a-5326-4f3f-a5e0-814bcd91fa5a" xlink:href="gild-20200930.xsd#gild_ArcusBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:to="loc_gild_ArcusBiosciencesIncMember_3b9a387a-5326-4f3f-a5e0-814bcd91fa5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TangoTherapeuticsIncMember_4accac99-8e96-4427-9c8b-072ad671745a" xlink:href="gild-20200930.xsd#gild_TangoTherapeuticsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:to="loc_gild_TangoTherapeuticsIncMember_4accac99-8e96-4427-9c8b-072ad671745a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JounceTherapeuticsIncMember_ef950756-0c46-49cd-8c6c-35c11a298d35" xlink:href="gild-20200930.xsd#gild_JounceTherapeuticsIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_eae00b4e-f0c0-45cc-9f0a-b4fdb3e19a05" xlink:to="loc_gild_JounceTherapeuticsIncMember_ef950756-0c46-49cd-8c6c-35c11a298d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:href="gild-20200930.xsd#gild_AcquisitionCollaborationsAndOtherArrangementsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsTable_a92d1bb9-7bbc-460f-b30b-096fdb862ee6" xlink:to="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_eec30562-0684-4606-b684-cba55b252618" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_SharePrice_eec30562-0684-4606-b684-cba55b252618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionCashOutflowNetOfCashAcquired_27c330c9-9ca2-41fb-8b26-17bad6142198" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionCashOutflowNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_AssetAcquisitionCashOutflowNetOfCashAcquired_27c330c9-9ca2-41fb-8b26-17bad6142198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_a5ddb414-1a03-49c3-8b9e-28ea97d62951" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_a5ddb414-1a03-49c3-8b9e-28ea97d62951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash_8c805f97-5d90-4e36-b8f1-158e080d8dc5" xlink:href="gild-20200930.xsd#gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash_8c805f97-5d90-4e36-b8f1-158e080d8dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e9633b2f-25a4-44ce-b65e-1364fab8a0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_ShareBasedCompensation_e9633b2f-25a4-44ce-b65e-1364fab8a0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4928749f-def1-4a11-9af4-aa90f85a39ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4928749f-def1-4a11-9af4-aa90f85a39ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_798d2ec6-19ac-4a99-ab28-7ecdf89e739a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_798d2ec6-19ac-4a99-ab28-7ecdf89e739a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b3b7ea25-0501-46f7-ba02-af12b3ed90df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b3b7ea25-0501-46f7-ba02-af12b3ed90df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_cefb379f-0dbe-448b-a973-b7499f4e91e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_cefb379f-0dbe-448b-a973-b7499f4e91e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_c4f3dfe4-e518-428e-a4df-29c3d96cf49e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent_c4f3dfe4-e518-428e-a4df-29c3d96cf49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_808cc78e-2ef9-4098-b906-8f9b1003e7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_808cc78e-2ef9-4098-b906-8f9b1003e7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalUpfrontPaymentsMade_6800d22e-3ad6-4298-8e02-05fad808fd7e" xlink:href="gild-20200930.xsd#gild_TotalUpfrontPaymentsMade"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_TotalUpfrontPaymentsMade_6800d22e-3ad6-4298-8e02-05fad808fd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InvestmentOwnedBalanceAdditionalShares_425f34ae-0389-424e-8135-f59bd8eb8719" xlink:href="gild-20200930.xsd#gild_InvestmentOwnedBalanceAdditionalShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_InvestmentOwnedBalanceAdditionalShares_425f34ae-0389-424e-8135-f59bd8eb8719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_edb2a386-7d73-459e-8594-78ccec0f27b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_edb2a386-7d73-459e-8594-78ccec0f27b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_f45a1ca3-1c19-42b5-838a-c9c7fd1d79a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_f45a1ca3-1c19-42b5-838a-c9c7fd1d79a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IssuanceDiscountPremium_825e54fd-50eb-4bba-aef2-0297205b5efa" xlink:href="gild-20200930.xsd#gild_IssuanceDiscountPremium"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_IssuanceDiscountPremium_825e54fd-50eb-4bba-aef2-0297205b5efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PaymentsForDirectTransactionalExpense_e3826dcf-d153-4af3-a3fc-f58153f216c8" xlink:href="gild-20200930.xsd#gild_PaymentsForDirectTransactionalExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_PaymentsForDirectTransactionalExpense_e3826dcf-d153-4af3-a3fc-f58153f216c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary_dcc15957-a94f-4464-a016-fd1f08d79215" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary_dcc15957-a94f-4464-a016-fd1f08d79215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries_c670ceec-2369-44d4-aecd-83220a8c5393" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries_c670ceec-2369-44d4-aecd-83220a8c5393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CollaborativeArrangementTerm_362867ad-dcd2-4b93-822c-0be813710314" xlink:href="gild-20200930.xsd#gild_CollaborativeArrangementTerm"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_CollaborativeArrangementTerm_362867ad-dcd2-4b93-822c-0be813710314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments_6b275161-37c3-45e1-86fe-0d41a0078812" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments_6b275161-37c3-45e1-86fe-0d41a0078812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIPurchasePeriod_78269b1f-d3d0-4790-ba65-a04845071d77" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIPurchasePeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIPurchasePeriod_78269b1f-d3d0-4790-ba65-a04845071d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased_d67a8db4-d4c3-42af-853c-b77824253a66" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased_d67a8db4-d4c3-42af-853c-b77824253a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIRestrictionPeriod_b003b038-df08-42a1-a27b-8dbc996b251b" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIRestrictionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIRestrictionPeriod_b003b038-df08-42a1-a27b-8dbc996b251b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_NumberOfAgreements_8777e1c7-774d-450f-a902-c0f1d177d37b" xlink:href="gild-20200930.xsd#gild_NumberOfAgreements"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_NumberOfAgreements_8777e1c7-774d-450f-a902-c0f1d177d37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006a5817-a109-4ae0-8215-29db5c348087" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006a5817-a109-4ae0-8215-29db5c348087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InvestmentOwnedBalanceAdditionalPayable_f29ad146-23e7-4961-8142-b43c7c359b9e" xlink:href="gild-20200930.xsd#gild_InvestmentOwnedBalanceAdditionalPayable"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_InvestmentOwnedBalanceAdditionalPayable_f29ad146-23e7-4961-8142-b43c7c359b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_dc7507b2-7f0a-4ee1-91a3-c3818fe2a688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_dc7507b2-7f0a-4ee1-91a3-c3818fe2a688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityMethodInvestmentOptionExerciseFee_f18379af-2eb3-40b8-ada4-c273c91de309" xlink:href="gild-20200930.xsd#gild_EquityMethodInvestmentOptionExerciseFee"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquityMethodInvestmentOptionExerciseFee_f18379af-2eb3-40b8-ada4-c273c91de309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PotentialFutureMaximumMilestonePayments_fc086551-e673-4a8a-8846-da10c9bfbe67" xlink:href="gild-20200930.xsd#gild_PotentialFutureMaximumMilestonePayments"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_PotentialFutureMaximumMilestonePayments_fc086551-e673-4a8a-8846-da10c9bfbe67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments_98949a9e-fe6a-4858-9b56-40dbde3da5c1" xlink:href="gild-20200930.xsd#gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments_98949a9e-fe6a-4858-9b56-40dbde3da5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ResearchAndDevelopmentFutureMaximumPayments_3ff2d190-a672-44d7-ad44-0eb7bc8d81f9" xlink:href="gild-20200930.xsd#gild_ResearchAndDevelopmentFutureMaximumPayments"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_ResearchAndDevelopmentFutureMaximumPayments_3ff2d190-a672-44d7-ad44-0eb7bc8d81f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments_df59001c-b41f-4257-9094-ed2ec0d1a4b2" xlink:href="gild-20200930.xsd#gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments_df59001c-b41f-4257-9094-ed2ec0d1a4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_NumberOfPrograms_4c80ed2f-d71b-45d8-a25e-e8a4b2cf556a" xlink:href="gild-20200930.xsd#gild_NumberOfPrograms"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_NumberOfPrograms_4c80ed2f-d71b-45d8-a25e-e8a4b2cf556a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing_d8955e07-16ca-4704-a6a7-1c42e0d4e554" xlink:href="gild-20200930.xsd#gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing_d8955e07-16ca-4704-a6a7-1c42e0d4e554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd8d852f-58fa-4bd7-b013-b4bde8e3177b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd8d852f-58fa-4bd7-b013-b4bde8e3177b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_405c782d-dc00-4f7c-9f8a-833aec9d0de9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquityMethodInvestments_405c782d-dc00-4f7c-9f8a-833aec9d0de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_99715e3a-8651-451b-8c9b-7c8b39737e50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_99715e3a-8651-451b-8c9b-7c8b39737e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_c4e31d66-3447-47dc-8d6f-f8fb3df0a623" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_c4e31d66-3447-47dc-8d6f-f8fb3df0a623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_ca99d8f8-b5e1-4b8c-b531-062208701c88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_ca99d8f8-b5e1-4b8c-b531-062208701c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements_2d7a2f96-4429-43b6-bdc3-1817bde0dfcd" xlink:href="gild-20200930.xsd#gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements_2d7a2f96-4429-43b6-bdc3-1817bde0dfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CashPaymentsMadeRelatedToEquityInvestments_286c713c-47b2-4d80-9083-f9af3ea23917" xlink:href="gild-20200930.xsd#gild_CashPaymentsMadeRelatedToEquityInvestments"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems_b5f5fea0-37c2-4b73-86fa-8742abb76e11" xlink:to="loc_gild_CashPaymentsMadeRelatedToEquityInvestments_286c713c-47b2-4d80-9083-f9af3ea23917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformation" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherFinancialInformationAbstract_9a711b10-3faf-4af5-90aa-7f01abb4ad5e" xlink:href="gild-20200930.xsd#gild_OtherFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_5a21895b-ae29-43a8-9767-0aea087db30e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_9a711b10-3faf-4af5-90aa-7f01abb4ad5e" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_5a21895b-ae29-43a8-9767-0aea087db30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationTables" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherFinancialInformationAbstract_1c6f7f12-23d4-4f58-9ef3-2af24f274cdc" xlink:href="gild-20200930.xsd#gild_OtherFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5d22325f-2a95-449d-95ba-c2521ff8a15f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_1c6f7f12-23d4-4f58-9ef3-2af24f274cdc" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5d22325f-2a95-449d-95ba-c2521ff8a15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_378ef514-d475-4c29-b2ad-d72a5f272c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_1c6f7f12-23d4-4f58-9ef3-2af24f274cdc" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_378ef514-d475-4c29-b2ad-d72a5f272c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherFinancialInformationAbstract_005ec625-4062-4578-8e2f-24ec70cbaef7" xlink:href="gild-20200930.xsd#gild_OtherFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_73c85f44-25e1-4bb6-a590-28bf83115a23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_005ec625-4062-4578-8e2f-24ec70cbaef7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_73c85f44-25e1-4bb6-a590-28bf83115a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_05d96330-23fd-4a1f-8a9b-95a6704ac872" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_005ec625-4062-4578-8e2f-24ec70cbaef7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_05d96330-23fd-4a1f-8a9b-95a6704ac872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1a685e91-e87d-4ab3-81f1-7aa731f95a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_005ec625-4062-4578-8e2f-24ec70cbaef7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1a685e91-e87d-4ab3-81f1-7aa731f95a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InventoryNetAndInventoryNoncurrent_e971a0a3-2e4b-450a-8b97-14e477203af8" xlink:href="gild-20200930.xsd#gild_InventoryNetAndInventoryNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_005ec625-4062-4578-8e2f-24ec70cbaef7" xlink:to="loc_gild_InventoryNetAndInventoryNoncurrent_e971a0a3-2e4b-450a-8b97-14e477203af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c5f9ff94-e2bd-4414-adda-9fb6c2e6b7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_005ec625-4062-4578-8e2f-24ec70cbaef7" xlink:to="loc_us-gaap_InventoryNet_c5f9ff94-e2bd-4414-adda-9fb6c2e6b7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_36a8a878-0d34-4100-9ec1-a6b292d62747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_005ec625-4062-4578-8e2f-24ec70cbaef7" xlink:to="loc_us-gaap_InventoryNoncurrent_36a8a878-0d34-4100-9ec1-a6b292d62747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_InventoryNetAndInventoryNoncurrent_776dd443-9649-42a2-a60f-e8490e7823e5" xlink:href="gild-20200930.xsd#gild_InventoryNetAndInventoryNoncurrent"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationInventoriesDetails_1"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#OtherFinancialInformationOtherAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_OtherFinancialInformationAbstract_5c3f2854-e8a7-4cab-bdfd-d806d054d8cb" xlink:href="gild-20200930.xsd#gild_OtherFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_166db26e-b775-4053-b80d-1643c9baaae6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_5c3f2854-e8a7-4cab-bdfd-d806d054d8cb" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_166db26e-b775-4053-b80d-1643c9baaae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_c4d97e37-0d6d-4459-9ee2-3e58e6fdabc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_5c3f2854-e8a7-4cab-bdfd-d806d054d8cb" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_c4d97e37-0d6d-4459-9ee2-3e58e6fdabc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d3f8e06a-2245-4173-a361-2152d9e969cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_5c3f2854-e8a7-4cab-bdfd-d806d054d8cb" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d3f8e06a-2245-4173-a361-2152d9e969cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f9ddc34f-aadf-4f24-a74d-7c04893df68d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_OtherFinancialInformationAbstract_5c3f2854-e8a7-4cab-bdfd-d806d054d8cb" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f9ddc34f-aadf-4f24-a74d-7c04893df68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssets" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_de29f4d4-df3e-45d0-822a-e89b3f784e35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_d33fa6dc-2345-46df-a087-32efaf522e03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_de29f4d4-df3e-45d0-822a-e89b3f784e35" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_d33fa6dc-2345-46df-a087-32efaf522e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_03e171f4-1e61-4ed1-ac61-9e085daace0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_769f8f25-f492-4c31-919f-c290024b7af5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_03e171f4-1e61-4ed1-ac61-9e085daace0c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_769f8f25-f492-4c31-919f-c290024b7af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_ff5e202b-4762-4d44-862d-c163a58c7aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_03e171f4-1e61-4ed1-ac61-9e085daace0c" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_ff5e202b-4762-4d44-862d-c163a58c7aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3ee6b9a2-b64a-471f-9948-575c438a18cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_03e171f4-1e61-4ed1-ac61-9e085daace0c" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3ee6b9a2-b64a-471f-9948-575c438a18cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06b43ad8-4dd7-42e8-adee-33e94abe7801" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4a2bec04-94ee-49bc-ad34-9a124f40ef55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06b43ad8-4dd7-42e8-adee-33e94abe7801" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4a2bec04-94ee-49bc-ad34-9a124f40ef55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4a2bec04-94ee-49bc-ad34-9a124f40ef55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fac2f4e6-6ddb-4d7b-9e96-663a93942fe4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IntangibleAssetSofosbuvirMember_7338366d-daef-47fe-be67-d802e159b2fe" xlink:href="gild-20200930.xsd#gild_IntangibleAssetSofosbuvirMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:to="loc_gild_IntangibleAssetSofosbuvirMember_7338366d-daef-47fe-be67-d802e159b2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_AxicabtageneciloleucelDLBCLMember_842174b3-3098-4b69-9b30-ad2b7145f671" xlink:href="gild-20200930.xsd#gild_AxicabtageneciloleucelDLBCLMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:to="loc_gild_AxicabtageneciloleucelDLBCLMember_842174b3-3098-4b69-9b30-ad2b7145f671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_18253c89-af4b-418e-956c-fe320d31b810" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_626f3cde-2044-410d-9056-139133c5e11b" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_18253c89-af4b-418e-956c-fe320d31b810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4a2bec04-94ee-49bc-ad34-9a124f40ef55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c290ac7b-a0eb-4022-b4c6-d85547c10882" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c290ac7b-a0eb-4022-b4c6-d85547c10882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbeac1da-5adc-4fa4-a376-a2476d6007fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bbeac1da-5adc-4fa4-a376-a2476d6007fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_d7bd549e-8d8e-4406-925c-d1f0563a03cb" xlink:href="gild-20200930.xsd#gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_d7bd549e-8d8e-4406-925c-d1f0563a03cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94142f67-3e3d-4f74-b25e-24f1890db47d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_faa8140b-22f0-42aa-acbd-ac7ed1785b1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_94142f67-3e3d-4f74-b25e-24f1890db47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c3922fd5-abbc-4dc9-8d47-9f9cea176362" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06b43ad8-4dd7-42e8-adee-33e94abe7801" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c3922fd5-abbc-4dc9-8d47-9f9cea176362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c3922fd5-abbc-4dc9-8d47-9f9cea176362" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae7ed464-5f27-4dfc-993d-c9a609696fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a3ed52af-1012-48a5-b4d3-6f2ea62b9f6c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae7ed464-5f27-4dfc-993d-c9a609696fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6d3dcbd4-177f-4dda-b545-bba69ad21f11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae7ed464-5f27-4dfc-993d-c9a609696fa2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6d3dcbd4-177f-4dda-b545-bba69ad21f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_c3922fd5-abbc-4dc9-8d47-9f9cea176362" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97305c0a-51b8-481b-abe6-6bc2dfff5e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_97305c0a-51b8-481b-abe6-6bc2dfff5e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_0c228a74-7d7c-410d-b63e-54e077d92eb2" xlink:href="gild-20200930.xsd#gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:to="loc_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_0c228a74-7d7c-410d-b63e-54e077d92eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_e0197911-569a-4256-bf08-242ee1f71a51" xlink:href="gild-20200930.xsd#gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_a2dd3765-7237-44f5-9e98-f772331da6c4" xlink:to="loc_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill_e0197911-569a-4256-bf08-242ee1f71a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7857ac3e-e82d-41de-a979-17c6375fd60e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06b43ad8-4dd7-42e8-adee-33e94abe7801" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7857ac3e-e82d-41de-a979-17c6375fd60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c0f4a5fc-6e20-40b4-850a-f48ed93b8f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06b43ad8-4dd7-42e8-adee-33e94abe7801" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c0f4a5fc-6e20-40b4-850a-f48ed93b8f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_abe273c5-ecb0-4580-b2d0-bbefd3db0529" xlink:href="gild-20200930.xsd#gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06b43ad8-4dd7-42e8-adee-33e94abe7801" xlink:to="loc_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss_abe273c5-ecb0-4580-b2d0-bbefd3db0529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c6009c59-1154-4057-903e-24675bed6220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_06b43ad8-4dd7-42e8-adee-33e94abe7801" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c6009c59-1154-4057-903e-24675bed6220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_4095452a-f874-4fdd-ac31-3711d3fd2e15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a0e6cd5e-9400-4230-a38e-e8542f45afa7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_4095452a-f874-4fdd-ac31-3711d3fd2e15" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a0e6cd5e-9400-4230-a38e-e8542f45afa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_63afdc85-04b1-4bc4-90aa-df88c509991e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_63afdc85-04b1-4bc4-90aa-df88c509991e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33a174e6-9212-4126-83c1-95de1f9ef0d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33a174e6-9212-4126-83c1-95de1f9ef0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_562d5b68-ce69-4a97-9b73-9685d8613010" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_562d5b68-ce69-4a97-9b73-9685d8613010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_be3b001a-d76d-44fc-b7ff-d634d1cedae4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_be3b001a-d76d-44fc-b7ff-d634d1cedae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_df9d1ecc-b207-4c2f-9e15-079d1fb0c80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_df9d1ecc-b207-4c2f-9e15-079d1fb0c80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a3e47b81-e109-48d2-9330-ab9b69e0ee00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a3e47b81-e109-48d2-9330-ab9b69e0ee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c57f92dd-c6d0-47fc-a0b9-27d6159f5825" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_eebefd64-263d-4b95-b5da-bccb007c4605" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c57f92dd-c6d0-47fc-a0b9-27d6159f5825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilities" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fcf54aa8-dc84-4283-bd23-17d7ebc457d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_b311cbc6-952c-417f-bd80-5b43728822b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fcf54aa8-dc84-4283-bd23-17d7ebc457d7" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_b311cbc6-952c-417f-bd80-5b43728822b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c6606d48-a4f6-4c7e-b98f-5fdd849b75ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_41dfa638-c9b2-457c-894f-bdf72ad52790" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c6606d48-a4f6-4c7e-b98f-5fdd849b75ed" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_41dfa638-c9b2-457c-894f-bdf72ad52790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3aded9bb-26b1-48e7-9da3-6c6181c7748d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3aded9bb-26b1-48e7-9da3-6c6181c7748d" xlink:to="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bd159c6-57df-400f-8c65-24c3b2280e23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bd159c6-57df-400f-8c65-24c3b2280e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3b3b47e9-167b-49ab-b288-295d82317641" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bd159c6-57df-400f-8c65-24c3b2280e23" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3b3b47e9-167b-49ab-b288-295d82317641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7d88ddc8-f4c8-41af-b65f-77424b135130" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3b3b47e9-167b-49ab-b288-295d82317641" xlink:to="loc_us-gaap_SeniorNotesMember_7d88ddc8-f4c8-41af-b65f-77424b135130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bc259ddc-190f-453a-9bda-7d43e98c12cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:to="loc_us-gaap_DebtInstrumentAxis_bc259ddc-190f-453a-9bda-7d43e98c12cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bc259ddc-190f-453a-9bda-7d43e98c12cd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A235SeniorUnsecuredNotesDueFebruary2020Member_956d846d-83ee-440f-86e3-8ebd3f148ae1" xlink:href="gild-20200930.xsd#gild_A235SeniorUnsecuredNotesDueFebruary2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A235SeniorUnsecuredNotesDueFebruary2020Member_956d846d-83ee-440f-86e3-8ebd3f148ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A255SeniorUnsecuredNotesDueSeptember2020Member_837141ed-bd1c-4343-9803-a9bc2fe5d62a" xlink:href="gild-20200930.xsd#gild_A255SeniorUnsecuredNotesDueSeptember2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A255SeniorUnsecuredNotesDueSeptember2020Member_837141ed-bd1c-4343-9803-a9bc2fe5d62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A450SeniorUnsecuredNotesDueApril2021Member_df836dd8-97d3-4225-88e3-0487770330dd" xlink:href="gild-20200930.xsd#gild_A450SeniorUnsecuredNotesDueApril2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A450SeniorUnsecuredNotesDueApril2021Member_df836dd8-97d3-4225-88e3-0487770330dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_a70d2254-b509-41c4-871d-2788f6953035" xlink:href="gild-20200930.xsd#gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_a70d2254-b509-41c4-871d-2788f6953035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A440SeniorUnsecuredNotesDueDecember2021Member_ed6a1ba0-f337-4b2a-ad7c-618c9ffde015" xlink:href="gild-20200930.xsd#gild_A440SeniorUnsecuredNotesDueDecember2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A440SeniorUnsecuredNotesDueDecember2021Member_ed6a1ba0-f337-4b2a-ad7c-618c9ffde015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A195SeniorUnsecuredNotesDueMarch2022Member_3f3ab69d-a2bf-410f-930f-46e7d469daac" xlink:href="gild-20200930.xsd#gild_A195SeniorUnsecuredNotesDueMarch2022Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A195SeniorUnsecuredNotesDueMarch2022Member_3f3ab69d-a2bf-410f-930f-46e7d469daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A325SeniorUnsecuredNotesDueSeptember2022Member_c551c945-c094-4535-88c7-40f96014d9c4" xlink:href="gild-20200930.xsd#gild_A325SeniorUnsecuredNotesDueSeptember2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A325SeniorUnsecuredNotesDueSeptember2022Member_c551c945-c094-4535-88c7-40f96014d9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A250SeniorUnsecuredNotesDueSeptember2023Member_ef05c0aa-d502-4b14-87a4-75ce20d40eb6" xlink:href="gild-20200930.xsd#gild_A250SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A250SeniorUnsecuredNotesDueSeptember2023Member_ef05c0aa-d502-4b14-87a4-75ce20d40eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_a6710a53-5d81-47e9-bf87-45c491f213c1" xlink:href="gild-20200930.xsd#gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_a6710a53-5d81-47e9-bf87-45c491f213c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_f6339a9c-5047-419d-96fc-578cf58f051c" xlink:href="gild-20200930.xsd#gild_A075SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_f6339a9c-5047-419d-96fc-578cf58f051c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A370SeniorUnsecuredNotesDueApril2024Member_478cb758-f024-4c3a-8ee3-041481e23c46" xlink:href="gild-20200930.xsd#gild_A370SeniorUnsecuredNotesDueApril2024Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A370SeniorUnsecuredNotesDueApril2024Member_478cb758-f024-4c3a-8ee3-041481e23c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A350SeniorUnsecuredNotesDueFebruary2025Member_51c0fee7-74a0-4ba2-9fc1-16cda7691cc7" xlink:href="gild-20200930.xsd#gild_A350SeniorUnsecuredNotesDueFebruary2025Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A350SeniorUnsecuredNotesDueFebruary2025Member_51c0fee7-74a0-4ba2-9fc1-16cda7691cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A365SeniorUnsecuredNotesDueMarch2026Member_3985fa4f-12af-4608-a9dd-2d4d00cc8308" xlink:href="gild-20200930.xsd#gild_A365SeniorUnsecuredNotesDueMarch2026Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A365SeniorUnsecuredNotesDueMarch2026Member_3985fa4f-12af-4608-a9dd-2d4d00cc8308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A295SeniorUnsecuredNotesDueMarch2027Member_ba789b56-d82e-4428-b929-ecf68e19b4f9" xlink:href="gild-20200930.xsd#gild_A295SeniorUnsecuredNotesDueMarch2027Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A295SeniorUnsecuredNotesDueMarch2027Member_ba789b56-d82e-4428-b929-ecf68e19b4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_e6eb0e1b-a7cd-4175-ab2e-74b2bdb3546d" xlink:href="gild-20200930.xsd#gild_A120SeniorUnsecuredNotesDueOctober2027Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_e6eb0e1b-a7cd-4175-ab2e-74b2bdb3546d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_06af5cb4-3064-42a3-a115-8617a07c17d9" xlink:href="gild-20200930.xsd#gild_A165SeniorUnsecuredNotesDueOctober2030Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_06af5cb4-3064-42a3-a115-8617a07c17d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A460SeniorUnsecuredNotesDueSeptember2035Member_b2bbf53e-03dc-47a0-ac7f-3016da1c67eb" xlink:href="gild-20200930.xsd#gild_A460SeniorUnsecuredNotesDueSeptember2035Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A460SeniorUnsecuredNotesDueSeptember2035Member_b2bbf53e-03dc-47a0-ac7f-3016da1c67eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A400SeniorUnsecuredNotesDueSeptember2036Member_9ea86750-971e-4f82-b3c8-7884600e8e5e" xlink:href="gild-20200930.xsd#gild_A400SeniorUnsecuredNotesDueSeptember2036Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A400SeniorUnsecuredNotesDueSeptember2036Member_9ea86750-971e-4f82-b3c8-7884600e8e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_cdc9ed91-4842-4ea0-bd7f-5dc33b2fe116" xlink:href="gild-20200930.xsd#gild_A260SeniorUnsecuredNotesDueOctober2040Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_cdc9ed91-4842-4ea0-bd7f-5dc33b2fe116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A565SeniorUnsecuredNotesDueDecember2041Member_d8317b0b-443b-4337-846c-18a78583cd15" xlink:href="gild-20200930.xsd#gild_A565SeniorUnsecuredNotesDueDecember2041Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A565SeniorUnsecuredNotesDueDecember2041Member_d8317b0b-443b-4337-846c-18a78583cd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A480SeniorUnsecuredNotesDueApril2044Member_bb0c97b7-7d7c-4eb6-bb5f-af5bdef4f8d6" xlink:href="gild-20200930.xsd#gild_A480SeniorUnsecuredNotesDueApril2044Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A480SeniorUnsecuredNotesDueApril2044Member_bb0c97b7-7d7c-4eb6-bb5f-af5bdef4f8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A450SeniorUnsecuredNotesDueFebruary2045Member_ef0195ec-9a82-4fc3-8832-728202fae552" xlink:href="gild-20200930.xsd#gild_A450SeniorUnsecuredNotesDueFebruary2045Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A450SeniorUnsecuredNotesDueFebruary2045Member_ef0195ec-9a82-4fc3-8832-728202fae552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A475SeniorUnsecuredNotesDueMarch2046Member_360afd0b-e3c8-4f13-8cab-6127c28d0790" xlink:href="gild-20200930.xsd#gild_A475SeniorUnsecuredNotesDueMarch2046Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A475SeniorUnsecuredNotesDueMarch2046Member_360afd0b-e3c8-4f13-8cab-6127c28d0790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A415SeniorUnsecuredNotesDueMarch2047Member_6c39d623-4ea8-42f7-99df-e04ce5fdca96" xlink:href="gild-20200930.xsd#gild_A415SeniorUnsecuredNotesDueMarch2047Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A415SeniorUnsecuredNotesDueMarch2047Member_6c39d623-4ea8-42f7-99df-e04ce5fdca96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_17d4ac33-5593-4182-9245-ab0f71d163fb" xlink:href="gild-20200930.xsd#gild_A280SeniorUnsecuredNotesDueOctober2050Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c172d12-3ef0-4f1b-8a2f-9fe69d1fb90d" xlink:to="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_17d4ac33-5593-4182-9245-ab0f71d163fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f7a5abca-4aae-400a-a323-0acb8a57d1be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:to="loc_us-gaap_VariableRateAxis_f7a5abca-4aae-400a-a323-0acb8a57d1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9ec32d63-c95c-4742-98f0-848f4c6c7e80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f7a5abca-4aae-400a-a323-0acb8a57d1be" xlink:to="loc_us-gaap_VariableRateDomain_9ec32d63-c95c-4742-98f0-848f4c6c7e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd086723-4e71-4438-9509-e31aae165299" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9ec32d63-c95c-4742-98f0-848f4c6c7e80" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd086723-4e71-4438-9509-e31aae165299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f16aa89-5bf2-4e83-be34-c9e637a94b7b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49b74b4f-ae0d-4c2a-a227-dc1205a1cc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49b74b4f-ae0d-4c2a-a227-dc1205a1cc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_830bd5e3-6d80-4e63-bd21-aebc4189077f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_830bd5e3-6d80-4e63-bd21-aebc4189077f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5d0403a3-fc30-4399-a034-26be7dab51d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_LongTermDebt_5d0403a3-fc30-4399-a034-26be7dab51d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_62a627c9-8fc2-4698-a6ee-29e892298f73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_62a627c9-8fc2-4698-a6ee-29e892298f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_59ed4074-1ffa-49ab-84c2-83a4eab99971" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_LongTermDebtCurrent_59ed4074-1ffa-49ab-84c2-83a4eab99971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a798c005-aadd-4b18-9602-9a9307575a47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_982da0ab-384a-4def-ac25-315e7aca64dd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a798c005-aadd-4b18-9602-9a9307575a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#DebtandCreditFacilitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_546e24ca-690f-4862-93cc-137debbe48f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_546e24ca-690f-4862-93cc-137debbe48f5" xlink:to="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_989159ce-4aec-4a22-858f-726ba0eeac75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_989159ce-4aec-4a22-858f-726ba0eeac75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_989159ce-4aec-4a22-858f-726ba0eeac75" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_39c632d4-e94f-4910-bdd0-6db62e6d13ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:to="loc_us-gaap_SeniorNotesMember_39c632d4-e94f-4910-bdd0-6db62e6d13ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_722b4425-e3a3-4056-a424-bc257ad6fa54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ad34bb8-5058-4c43-89d6-df4a8d22f459" xlink:to="loc_us-gaap_MediumTermNotesMember_722b4425-e3a3-4056-a424-bc257ad6fa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2a5d62ee-bf88-4307-83ab-e60baaaf9838" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_CreditFacilityAxis_2a5d62ee-bf88-4307-83ab-e60baaaf9838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d599758a-8469-4344-80b5-b5aec6a09421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2a5d62ee-bf88-4307-83ab-e60baaaf9838" xlink:to="loc_us-gaap_CreditFacilityDomain_d599758a-8469-4344-80b5-b5aec6a09421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17e13074-229c-4f9c-a67c-4c6badf2a7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d599758a-8469-4344-80b5-b5aec6a09421" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17e13074-229c-4f9c-a67c-4c6badf2a7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2e19c5e0-6313-40d3-81d4-b216ba3bfecc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_DebtInstrumentAxis_2e19c5e0-6313-40d3-81d4-b216ba3bfecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2e19c5e0-6313-40d3-81d4-b216ba3bfecc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedSeptember2020Member_69ff6686-d401-496d-9caf-ec1fcc94ac79" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedSeptember2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_SeniorUnsecuredNoteIssuedSeptember2020Member_69ff6686-d401-496d-9caf-ec1fcc94ac79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_61a4577f-8839-4270-8412-f96bb5df5e74" xlink:href="gild-20200930.xsd#gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member_61a4577f-8839-4270-8412-f96bb5df5e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_03fdac44-e899-4893-8dc6-82aecece4e12" xlink:href="gild-20200930.xsd#gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member_03fdac44-e899-4893-8dc6-82aecece4e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_84386571-bf40-4a9a-b671-7102765457f0" xlink:href="gild-20200930.xsd#gild_A075SeniorUnsecuredNotesDueSeptember2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A075SeniorUnsecuredNotesDueSeptember2023Member_84386571-bf40-4a9a-b671-7102765457f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_85cf70af-ee96-4a2d-bd77-e06c4450ffa9" xlink:href="gild-20200930.xsd#gild_A120SeniorUnsecuredNotesDueOctober2027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A120SeniorUnsecuredNotesDueOctober2027Member_85cf70af-ee96-4a2d-bd77-e06c4450ffa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_0c4acd89-0806-4c84-ae83-980703eba46d" xlink:href="gild-20200930.xsd#gild_A165SeniorUnsecuredNotesDueOctober2030Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A165SeniorUnsecuredNotesDueOctober2030Member_0c4acd89-0806-4c84-ae83-980703eba46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_8cda564b-5110-442d-89b2-c233c8c53d60" xlink:href="gild-20200930.xsd#gild_A260SeniorUnsecuredNotesDueOctober2040Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A260SeniorUnsecuredNotesDueOctober2040Member_8cda564b-5110-442d-89b2-c233c8c53d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_30ce8572-da83-46c0-85a6-746987b0a8b0" xlink:href="gild-20200930.xsd#gild_A280SeniorUnsecuredNotesDueOctober2050Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_A280SeniorUnsecuredNotesDueOctober2050Member_30ce8572-da83-46c0-85a6-746987b0a8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member_fc930d09-b5cb-4044-9c8e-8fa7c6038620" xlink:href="gild-20200930.xsd#gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member_fc930d09-b5cb-4044-9c8e-8fa7c6038620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedNovember2014Member_f3f74d6e-e62c-4373-9f48-1c56d48b61ed" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedNovember2014Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_SeniorUnsecuredNoteIssuedNovember2014Member_f3f74d6e-e62c-4373-9f48-1c56d48b61ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_SeniorUnsecuredNoteIssuedSeptember2015Member_9239da4f-d094-4505-83af-338fdc94d1d0" xlink:href="gild-20200930.xsd#gild_SeniorUnsecuredNoteIssuedSeptember2015Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_SeniorUnsecuredNoteIssuedSeptember2015Member_9239da4f-d094-4505-83af-338fdc94d1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_b44c0d23-9209-4b58-b66f-80abc49d3131" xlink:href="gild-20200930.xsd#gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember_b44c0d23-9209-4b58-b66f-80abc49d3131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CreditFacilityDueMay2021Member_07fd7e4b-66f7-4324-9816-bab9bf2b4b4c" xlink:href="gild-20200930.xsd#gild_CreditFacilityDueMay2021Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_CreditFacilityDueMay2021Member_07fd7e4b-66f7-4324-9816-bab9bf2b4b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_CreditFacilityDueJune2025Member_ec2c00ef-8267-4985-be25-87f53d78c07d" xlink:href="gild-20200930.xsd#gild_CreditFacilityDueJune2025Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ee94bcc-9b1f-4b10-9252-a39b64463fbd" xlink:to="loc_gild_CreditFacilityDueJune2025Member_ec2c00ef-8267-4985-be25-87f53d78c07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e4bf8dd2-12c0-4b14-864d-422418e521ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_VariableRateAxis_e4bf8dd2-12c0-4b14-864d-422418e521ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7fa1cd2a-3921-4885-bbac-8cf260b5e4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e4bf8dd2-12c0-4b14-864d-422418e521ce" xlink:to="loc_us-gaap_VariableRateDomain_7fa1cd2a-3921-4885-bbac-8cf260b5e4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_55753d9d-a5e8-46de-92f0-b4df3de26563" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7fa1cd2a-3921-4885-bbac-8cf260b5e4e6" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_55753d9d-a5e8-46de-92f0-b4df3de26563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a08c0da-ecc7-4a8d-8126-7955a669f650" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_srt_RangeAxis_7a08c0da-ecc7-4a8d-8126-7955a669f650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7a08c0da-ecc7-4a8d-8126-7955a669f650" xlink:to="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5e07ccc5-c9fc-465f-9084-3a0168fde498" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:to="loc_srt_MinimumMember_5e07ccc5-c9fc-465f-9084-3a0168fde498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b8af2ac3-0f61-4bbc-8e31-045ed5a88fe2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e55a22d6-7185-4c9a-9874-3910915c644d" xlink:to="loc_srt_MaximumMember_b8af2ac3-0f61-4bbc-8e31-045ed5a88fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_195e2bf8-4908-41fc-aec1-b5f279c8fa46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_94b57c09-1b9d-4f0b-b3dd-20e318ea12d1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_195e2bf8-4908-41fc-aec1-b5f279c8fa46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_86160105-e586-4515-8909-765169357d76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_195e2bf8-4908-41fc-aec1-b5f279c8fa46" xlink:to="loc_us-gaap_SubsequentEventMember_86160105-e586-4515-8909-765169357d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e615ac83-4378-46a7-bf89-35a684ca8e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e615ac83-4378-46a7-bf89-35a684ca8e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dd531fa-d1e2-46e2-9c63-677955d12306" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e615ac83-4378-46a7-bf89-35a684ca8e6b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dd531fa-d1e2-46e2-9c63-677955d12306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_ImmunomedicsIncMember_327442df-adbf-498f-a4ea-1cbf428dc1c6" xlink:href="gild-20200930.xsd#gild_ImmunomedicsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dd531fa-d1e2-46e2-9c63-677955d12306" xlink:to="loc_gild_ImmunomedicsIncMember_327442df-adbf-498f-a4ea-1cbf428dc1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246d2fc0-3a18-4a7a-9ff6-efe76056a81e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7182a4a3-22f6-4fad-ba8d-de7b0335df12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7182a4a3-22f6-4fad-ba8d-de7b0335df12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3e5465b3-e051-45fc-81c6-a160045d41c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3e5465b3-e051-45fc-81c6-a160045d41c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_7f11b24c-cb47-471f-8bf5-453eaf1ef125" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_7f11b24c-cb47-471f-8bf5-453eaf1ef125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments_d373e6ec-d051-4844-8ba1-a4c35fa3e7a2" xlink:href="gild-20200930.xsd#gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments_d373e6ec-d051-4844-8ba1-a4c35fa3e7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity_06b7f260-2cd9-4483-a7d9-06bf38a73346" xlink:href="gild-20200930.xsd#gild_DebtInstrumentCallFeaturePeriodBeforeMaturity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity_06b7f260-2cd9-4483-a7d9-06bf38a73346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt_4d14e918-0547-4a1f-b50f-7d2f97e2265b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_RepaymentsOfUnsecuredDebt_4d14e918-0547-4a1f-b50f-7d2f97e2265b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_024425c9-9506-4290-98b3-da906393d057" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_DebtInstrumentTerm_024425c9-9506-4290-98b3-da906393d057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91a11503-1f7e-467c-be6d-e403ab8ed028" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91a11503-1f7e-467c-be6d-e403ab8ed028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a45cc26a-50e3-4e54-90a2-3d3675e51505" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_LongTermDebt_a45cc26a-50e3-4e54-90a2-3d3675e51505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_3fd43e42-1ea1-4d7a-a5f2-acb86e74177c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d29febe5-14ba-4594-93c7-e21d041be154" xlink:to="loc_us-gaap_LineOfCredit_3fd43e42-1ea1-4d7a-a5f2-acb86e74177c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="gild-20200930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ee65e0e-bf18-4aec-b28c-6487d3263bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_07a45a5c-6a3b-4e13-8813-3e87782ffcf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ee65e0e-bf18-4aec-b28c-6487d3263bb4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_07a45a5c-6a3b-4e13-8813-3e87782ffcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6aea91d2-2849-40f2-ad79-442869e04c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6aea91d2-2849-40f2-ad79-442869e04c0a" xlink:to="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9e5b4aa6-1eb4-4f06-b158-c17250b17709" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:to="loc_srt_LitigationCaseAxis_9e5b4aa6-1eb4-4f06-b158-c17250b17709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9e5b4aa6-1eb4-4f06-b158-c17250b17709" xlink:to="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_IndenixMember_699100d4-8d4c-4b01-936e-cf3e883a66c6" xlink:href="gild-20200930.xsd#gild_IndenixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:to="loc_gild_IndenixMember_699100d4-8d4c-4b01-936e-cf3e883a66c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JunoMember_ad2f9e04-94c9-47aa-89bd-0ed3e44948eb" xlink:href="gild-20200930.xsd#gild_JunoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_db783d46-3a7e-454e-96a6-10fecb5c4970" xlink:to="loc_gild_JunoMember_ad2f9e04-94c9-47aa-89bd-0ed3e44948eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89654bb6-b552-4fa0-bce0-fc09ad716713" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:to="loc_srt_RangeAxis_89654bb6-b552-4fa0-bce0-fc09ad716713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_89654bb6-b552-4fa0-bce0-fc09ad716713" xlink:to="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c1a40eb8-8fde-4d71-ad70-6f307654dd8d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:to="loc_srt_MinimumMember_c1a40eb8-8fde-4d71-ad70-6f307654dd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0f3da065-a3e0-4735-b865-e70e0f5b4e35" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_af046836-84e7-4d13-9108-3dd554d1c1d5" xlink:to="loc_srt_MaximumMember_0f3da065-a3e0-4735-b865-e70e0f5b4e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4cf1713a-df49-4020-91f3-60d97f05b5af" xlink:to="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_582db721-b52a-4321-9b54-85e2eeb3f9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_582db721-b52a-4321-9b54-85e2eeb3f9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyMotionInvalidatedForPastDamagesValue_b3137f02-ce14-48c3-9706-541c6ddc8156" xlink:href="gild-20200930.xsd#gild_LossContingencyMotionInvalidatedForPastDamagesValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyMotionInvalidatedForPastDamagesValue_b3137f02-ce14-48c3-9706-541c6ddc8156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentRoyaltyRateFromOctober2017_f22debd9-8e99-48b5-ae43-ab39b1df7a6c" xlink:href="gild-20200930.xsd#gild_JudgmentRoyaltyRateFromOctober2017"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_JudgmentRoyaltyRateFromOctober2017_f22debd9-8e99-48b5-ae43-ab39b1df7a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentEnhancedDamagesonPastSales_af2b09e4-67b2-43a4-93f0-01eb1a368b2d" xlink:href="gild-20200930.xsd#gild_JudgmentEnhancedDamagesonPastSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_JudgmentEnhancedDamagesonPastSales_af2b09e4-67b2-43a4-93f0-01eb1a368b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_JudgmentRoyaltyRateOnFutureSales_20d41f77-b8f9-46a6-966e-fec5939b260d" xlink:href="gild-20200930.xsd#gild_JudgmentRoyaltyRateOnFutureSales"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_JudgmentRoyaltyRateOnFutureSales_20d41f77-b8f9-46a6-966e-fec5939b260d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_1173b043-4b16-4ad9-9d5b-2d56e5d42353" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_1173b043-4b16-4ad9-9d5b-2d56e5d42353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLossPastSales_9ca3a570-6769-4c52-a904-57004a2281db" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLossPastSales"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyEstimateofPossibleLossPastSales_9ca3a570-6769-4c52-a904-57004a2281db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages_15d6c53d-7cdc-4ba9-b811-f896d58a456a" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages_15d6c53d-7cdc-4ba9-b811-f896d58a456a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest_5b968b5f-6fb8-45a6-bc42-736afd96f069" xlink:href="gild-20200930.xsd#gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest_5b968b5f-6fb8-45a6-bc42-736afd96f069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_63898735-195e-4342-a59f-78b7a18a41e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_bbad5ee3-aeac-49a8-bb6c-f73359d1b5a9" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_63898735-195e-4342-a59f-78b7a18a41e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquity" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a29f0b7e-f9ef-4269-9658-c7537f01716d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_352f3598-afb0-4fa9-ba8b-30f0150b887c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a29f0b7e-f9ef-4269-9658-c7537f01716d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_352f3598-afb0-4fa9-ba8b-30f0150b887c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4a3b9d98-3909-4c10-906b-16530f1be943" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e844787f-7db3-4ff7-bbd4-30e73401b7b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4a3b9d98-3909-4c10-906b-16530f1be943" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e844787f-7db3-4ff7-bbd4-30e73401b7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8b30b1c9-d8c7-4bfa-a9f0-828b1136d3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8b30b1c9-d8c7-4bfa-a9f0-828b1136d3f4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8e89c19f-aed5-4f47-85bc-124169cc918d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8e89c19f-aed5-4f47-85bc-124169cc918d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8e89c19f-aed5-4f47-85bc-124169cc918d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A2016StockRepurchaseProgramMember_82bc9dcd-080f-4b9f-bf1c-650766eef5b9" xlink:href="gild-20200930.xsd#gild_A2016StockRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:to="loc_gild_A2016StockRepurchaseProgramMember_82bc9dcd-080f-4b9f-bf1c-650766eef5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gild_A2020StockRepurchaseProgramMember_03c53527-8e4d-46b8-a187-a362f8269176" xlink:href="gild-20200930.xsd#gild_A2020StockRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6c0cfde1-d060-4d66-8e49-f2d3d8f476fc" xlink:to="loc_gild_A2020StockRepurchaseProgramMember_03c53527-8e4d-46b8-a187-a362f8269176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fdc59149-676f-4569-b02f-9699600a541c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ec830ffa-e6fa-4f8b-bc7f-6c441235cdd2" xlink:to="loc_us-gaap_ClassOfStockDomain_fdc59149-676f-4569-b02f-9699600a541c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_794747b6-98ee-4511-954d-ed70cfe851b7" xlink:to="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_6ce1f154-7866-4d3d-95a8-0c86f41627d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_6ce1f154-7866-4d3d-95a8-0c86f41627d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20212901-6c57-46c3-b036-afbe20ff17d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20212901-6c57-46c3-b036-afbe20ff17d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e26ee781-61e8-4665-9c31-25b288620987" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e26ee781-61e8-4665-9c31-25b288620987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f58f146f-443d-43bb-a856-61267e739b20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a436aa56-2e70-4a3f-baaf-0ff5aeadfd9c" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f58f146f-443d-43bb-a856-61267e739b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_19432cdf-606a-472c-b913-13ede7c78da1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d81e4e04-2062-4a7f-b926-d8aacdfabb57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_19432cdf-606a-472c-b913-13ede7c78da1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d81e4e04-2062-4a7f-b926-d8aacdfabb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3e38f25c-b9c1-42ee-9283-438101aae168" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d81e4e04-2062-4a7f-b926-d8aacdfabb57" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3e38f25c-b9c1-42ee-9283-438101aae168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3e38f25c-b9c1-42ee-9283-438101aae168" xlink:to="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6763d9c5-5788-43a4-92c6-b2c7be06a6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6763d9c5-5788-43a4-92c6-b2c7be06a6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0b94b215-2ad6-4738-803a-d48b8695cb5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0b94b215-2ad6-4738-803a-d48b8695cb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c598aaab-6678-4d6a-bdcf-338298373d30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c598aaab-6678-4d6a-bdcf-338298373d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4092607-59d7-4d43-9988-32adafcdf764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c6e41a51-06c5-4c32-8402-f8b21dfd99c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a4092607-59d7-4d43-9988-32adafcdf764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_07cbcc26-ad44-44cd-9045-107bdf080fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d81e4e04-2062-4a7f-b926-d8aacdfabb57" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_07cbcc26-ad44-44cd-9045-107bdf080fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_07cbcc26-ad44-44cd-9045-107bdf080fc9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_76bc11e6-508c-4638-b22d-20ff66e88e95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_StockholdersEquity_76bc11e6-508c-4638-b22d-20ff66e88e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_47b4904c-978b-4839-963e-92e65de8dd8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_47b4904c-978b-4839-963e-92e65de8dd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_db823ff6-74f3-44ed-9c60-8ed48029cfbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_db823ff6-74f3-44ed-9c60-8ed48029cfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3af184bd-75c4-4014-9c95-bddc3634b7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3af184bd-75c4-4014-9c95-bddc3634b7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3e2d3bb6-80be-4da0-84f4-7210c8999bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d3e4e155-df35-46ab-8e86-8f18c0cefd3f" xlink:to="loc_us-gaap_StockholdersEquity_3e2d3bb6-80be-4da0-84f4-7210c8999bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholders"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c3d0cf79-fdad-45dd-8a16-2805fd225ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3ac62061-fe3f-48dd-8702-7bf260a3a5f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c3d0cf79-fdad-45dd-8a16-2805fd225ce3" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3ac62061-fe3f-48dd-8702-7bf260a3a5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8a0fbaaf-3958-4ecf-9b97-005d10bcef69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_aaabd03b-0486-46d8-b0fa-e1cab954f63f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a0fbaaf-3958-4ecf-9b97-005d10bcef69" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_aaabd03b-0486-46d8-b0fa-e1cab954f63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gild_AdditionalInformationAbstract_39909bf6-4e3e-4755-af7d-9bb210a5d0d7" xlink:href="gild-20200930.xsd#gild_AdditionalInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_49141679-3f81-4ea6-be4c-558a77b80e64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gild_AdditionalInformationAbstract_39909bf6-4e3e-4755-af7d-9bb210a5d0d7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_49141679-3f81-4ea6-be4c-558a77b80e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3012263f-bb7a-4485-95c4-91aca4eb5c92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8c5a5775-0ae9-4838-8ea8-135841b09fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3012263f-bb7a-4485-95c4-91aca4eb5c92" xlink:to="loc_us-gaap_NetIncomeLoss_8c5a5775-0ae9-4838-8ea8-135841b09fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4949ef04-a75f-4f16-899c-1b492cd5d612" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3012263f-bb7a-4485-95c4-91aca4eb5c92" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4949ef04-a75f-4f16-899c-1b492cd5d612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_add82b02-7b09-4fe4-bc3e-9101c7e31bce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3012263f-bb7a-4485-95c4-91aca4eb5c92" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_add82b02-7b09-4fe4-bc3e-9101c7e31bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_311e1e81-d709-469c-b5d3-102adc32bf2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3012263f-bb7a-4485-95c4-91aca4eb5c92" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_311e1e81-d709-469c-b5d3-102adc32bf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5ad68f0a-5076-4b19-a854-930ec1ae1dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3012263f-bb7a-4485-95c4-91aca4eb5c92" xlink:to="loc_us-gaap_EarningsPerShareBasic_5ad68f0a-5076-4b19-a854-930ec1ae1dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_96dc3e0d-3701-4922-b802-812e0e1d7af2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3012263f-bb7a-4485-95c4-91aca4eb5c92" xlink:to="loc_us-gaap_EarningsPerShareDiluted_96dc3e0d-3701-4922-b802-812e0e1d7af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxes" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_91f6c036-9edd-4af5-b051-f6edc6cfe0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8701141c-7fdc-44ec-9c4a-f4249db9f513" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_91f6c036-9edd-4af5-b051-f6edc6cfe0b1" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8701141c-7fdc-44ec-9c4a-f4249db9f513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f4efa85a-ed50-472d-b7d9-6aae9fe1faca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8d2efff4-a169-4b4e-af9c-9a57098738e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f4efa85a-ed50-472d-b7d9-6aae9fe1faca" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8d2efff4-a169-4b4e-af9c-9a57098738e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2e78a574-9f19-4d76-a6a2-4e10c0d82886" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b69d4304-5bf7-4042-a2e2-2917f732df12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2e78a574-9f19-4d76-a6a2-4e10c0d82886" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b69d4304-5bf7-4042-a2e2-2917f732df12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d082d048-3ce2-4ed0-924a-7f481e5eb3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2e78a574-9f19-4d76-a6a2-4e10c0d82886" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d082d048-3ce2-4ed0-924a-7f481e5eb3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_817f68c6-9bdf-460c-822c-708542cede35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2e78a574-9f19-4d76-a6a2-4e10c0d82886" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_817f68c6-9bdf-460c-822c-708542cede35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="gild-20200930.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7891cb43-ae54-4a47-b063-716940788847" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_14a64750-2d2b-4640-937c-2f98eba204b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7891cb43-ae54-4a47-b063-716940788847" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_14a64750-2d2b-4640-937c-2f98eba204b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_93e5f171-3ee7-4e98-9b13-757c276ed91e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7891cb43-ae54-4a47-b063-716940788847" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_93e5f171-3ee7-4e98-9b13-757c276ed91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_687c2b3f-c5f5-4e2f-8995-a4341c80aab6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7891cb43-ae54-4a47-b063-716940788847" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_687c2b3f-c5f5-4e2f-8995-a4341c80aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_fbd7d072-e85f-4b9e-a249-4cb726f98384" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7891cb43-ae54-4a47-b063-716940788847" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_fbd7d072-e85f-4b9e-a249-4cb726f98384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>gild-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:gild="http://www.gilead.com/20200930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="gild-20200930.xsd" xlink:type="simple"/>
    <context id="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icc039174bd574d08b570f9adbabafac8_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i8428dd318d974b2db41a333de386ece2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9ff69c4fb8e64039b4ddd0748345671c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic38a8d4d52c34caa8db328baf10699aa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i83a2687827294d87a300d031d1858df3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia542ffe4c807464b9cb360eb9f6c08b4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib4ab6f6260e54f569438ef8ea0ff6cd6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i96064d1c8c184d5ab1297ec54cb44590_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaf6dd01e1e2047839e25939a3ae0a70b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifaad7749126c4b9a9ca4c44b1cff7a4f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icb6e106923dd4893989458d5e54fa96b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ideb48a35fba64fd59df61666f92213c4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9e65980547d349c5a71d09c2359de137_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i535a6da229a34ac799fa2c08e368ed62_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie2e051c6d4e941d495baf35b525c1fcd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if6832292dc744de38ecb457d6fa63dc1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6b2c16973a1646478086092143c77e53_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if40d55dade8445298ddf59323f025103_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic93b18523ecf4d8cad1a70d4ca601e65_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i28490f5280b24530b512cc82d79acf78_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id288e44f34634d5c93fb6b663e378514_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2c997087db1f4d44953e502e4e51d968_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic20a282f852c4c7dbb87cc18035c48ad_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i89e1b216261147f0aa8922793f836cec_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i92194d01f9f6426db2f230db32348009_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7e35c67616af43299f00f59e19a5a18d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie738a97278064bb387639c4cf08d5982_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i697547cbd3024af6ab47310c99aecd30_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6761db60bfad4d1a83000fe1aa00c987_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i060edfd2f245412088dbd1d22a228e8c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1359c5ce919042c9b30bbb420ab9f586_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i3d7a75396cae46eaa5a500fd466bed84_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i286718c980e742f3ad7ff5fa3cb8d52e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i204f0504916b49cda213142878d3d673_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib63cbbf9eb664b268663f0c27aa85f33_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i510270b913b147c08dd65ad6c95c2caa_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i86be1800e75d42dcba0a3eb9a98551a3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic72dfa28da994e0a853f4aad7f2a6e63_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8ae5dc2210454fa58a3557195e59fdba_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0ed0ecdfb5ae4e86a678c62132da6ab3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i79bf3801a1984d3280d2a88a5644d5f3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifc1677cc7c59497aa73455736d88394f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i156fd24197fc427e8672e730ff2e10b0_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id7ee747ba17a4a47a3ef814fd196e4fc_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ic0d3e46703834e0098456a41f5ef8be5_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iecaaaabb21fa447299f1e341b4985cce_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7ea68edf9adb482a984d6a2f46ed8c18_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i95de9d6ff3964391ab5aa52b050944f9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i1572613d4ff74b2786f78674a86e1d1d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic66670c48dad4abbaf4a7e4afd0bfce3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id8d14e1d51864d97b88c87da0f398d28_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic339b862d834437592eff9f1aeb8752a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib374a36c14ac45c0817de5c423a7dc5c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9e8b0210f3494723826b5d6eaf202e5f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icbf61511cccd4d31be2efc81754d695f_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i042635c737c840d7a0b0cc891e439e49_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5c95cf4710d74cd08f24a559657ba257_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i110b9cc08563489b822c59613b540894_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i405be8dac8594d43b53d27d487d15bf5_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ic65b5d2d76914339a0bfc5c853141a8b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic7a5f8acf2f948e68c92502a66bd5414_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c2c92fef300487ab03f8620479ac358_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib1411829f6bb4060867b0218c7ad64ff_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6bde0012620b4b358093fc1ee9a71f5b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifaf48f8bb6d943c7b3230cf9b8f49d16_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iecd2a02077434613a5f82bf83e672d63_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i772bad7600f04babbcf984bea94a0f49_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i67a923c7fdeb42a1881b0f06f38a17b4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0a2dea3e60a54f91bbd1ff13643e9957_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i94bc6499871f430b883a5c26a9224567_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1a11bdc34a1243b683eb633df7c23e11_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea294903d17f4240a785bf9497f358ee_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id9e4bc40c0fc45b9ad367dc82a8b46e4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8ac6788431d54ecea456ad29ab15114b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i96beb5e6c9d64cd88a2b544fa0558012_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if9d662f4b0514c71b93ab738ec761143_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i37bf74c0f355430b8a23cd0b26f52891_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i316ef52a4bd846c592de38f7af36ea13_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3d1ea3f49aa84699a8330b8beaf83836_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id2c5c00fd5c74399b684e5b33b4ab1a6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6bcba0865c9745c28ae1be5e32d30858_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id2b5cdefab314e10af27865b284a261b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i020fa5bbe23148259e98dce5d3e6db76_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia983ed5089b04e17ba4a1f33f9b9848e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3c69000ef95548fabbdc3b282e51e2e7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d4d5d7839e94505b43297794bc17592_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic966bee37fa6405b83576f4f740b30df_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45de8b04cd5245018515cdea5655f777_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2910166058884915a9bb2ea6a203d1a6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i855d34f7c7914eabb6d8012d1730432f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ied0a00ea00d246fcb752c2b14624ed71_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7c8efb370883401b83e55838b7fbc9d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i76aeab63735947a3abc22f62baacab4e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2166e16f87b04a429939389261643a67_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifac735e4f674431abdbc98a0e04572c0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c3f8e5e8d70429facde72a5fc634bb8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3a121061085a43ea9ef1c9a36676b466_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie478e9e1575e48d9a95499553e51f752_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6e5ccce04a2f4a5db1b5196399fa7842_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5d3683aaebc3492eb3e2b434a9a15ec2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i92538fca9ff2482dbc32c61c001b3ea3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie4e3405a679d4587b527f12c3cd7f625_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5b5fd963d3fe41aaaa285ed9bc365e62_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3144e9c3e72a42adade54c619991a43f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia145801994314a5d8116188b3b69b3ef_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ied1a75b107a64c93a3d3f333c07064aa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i10a2b8e40abd48c9b7742b2cf6099560_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic8b41aff3e0f4e9cb626769cea608d12_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibd67b9aae7cb40cfbf1e3c78614f30ae_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2743ffe9c1a24dd78139e89db866b972_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia1ea9576cd9946a4891493d9dd47e7b3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i39a4fed8fd1443d5bedb3020421da791_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie08938975b3748498c8cc0261e8b436c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie14202ab77ae4a9686d66114ad05a515_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7bc975ef1eb341ceadf0507525e9651c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5bc2b300cda84f6baa63c7b71950cdd1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5a5b342cbe6442e48842c846ee6caf71_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0319161df99e404986d1aa33de8ba71e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3c0926b30f1a498c81b6140b57053153_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2823fce1a4cf405a8b27b56aac04a3aa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e1c05c57e8343419f9bfde5e1395322_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iedc4539dbd004ec38a3c5475cd403514_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7b237de69f3e4923ac93d5745b8e90d2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if71725c2f0354f888e38d6f4ed36cfea_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i644c9ff59ab54478a13d8d84ac3ba4fb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if9982b46a2fb427caa4de7e6521eb30c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icdf79e96886d4938b1b1a211272ce1a7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2cbd8e9ef0a944d486a151c6936fb75a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i12ca1f1a0e024c22a8de469e578ba9fc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6086aba1234445049abb9c8cdd8e9f1c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaab34afd10054eefb1e8edd6dd4b0519_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie47edc1cfc9f4eb0a97fb226a0a5a37d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i60af3f7f93b047d8ace0daf527ff4265_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i92ecb2b4824649fc9f38af061f3b4ef7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i14ff3a03a206465aaa2896ba1ba6e120_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iee22b1cffb1043bfbc54e365d26d4af5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6d1453646ea740d890d612ac6873f4aa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5dda27b4a5904907ad5d4a661c2c5d3a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7bb31aa2cd1546fcbb6fc72d3d42b118_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3dd3136d6efa4348a1c8cd540f898277_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i35fb08a6be124efc91105a96329d32e9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b87c9b49b5b4c0ebe6fef12c1b938ed_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3221247bffcd4c4f96e064e12dc3ba2a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i27dc9139c37245a49548419d47d24b75_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if979cf6c414f426db10c23f8e83a02ec_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib1770394dbe848a9a641f08327a05206_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i71a54848fe844a30bbbac60e370dcda0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2ddf43c851594f2a8bf0c1f63f0ebf86_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4459d3bbac2644ae99e4b532e143767b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib58865b745844ff890bb5f1166984a27_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib09eff6286d14ec48d858094f19da7cd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4adf09430df24472bbed2f462ed4b1b9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8287111b10174ec98d26d3aa97917df0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4f5c18c207ee433db038e9927f2ec41c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6fdc0c20d21e46e39f5a774886ca08fa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7b2274275fb74059946345b7e79e2776_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i023e3c59b73b4c7f8d3da3030435d0c1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib73a8929861940e2a2c89e5e42452c04_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iec2a016a7766464484ecbb334372727c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5582c730584d4002b1814d828c048d1f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1dc774a64fa54549b0e01a1765162583_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i86d4379fd8b24c718b703229ff1bdb41_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1df27de735a2435fb01a652087a96fcd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8dc70b538fbd4236be65e5c74b37b74c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieae2a10921654f3e990c42a09a686fff_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5627a8aa26e48b8a494fc4c472f2e5e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib0448ba338934e15a3d8c6bb32a0c7ec_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifdce8cc1010a433d867e9991049ce48c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i12865b7767774a1c981d8f35ee6a2976_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i96870ee369b3451bb3e3ad1e5c6f0632_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8638be037d2a44e8a36d55221e058f60_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i42f1e832a84c4cb48a7cb31c748947ca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3ead7edc72f24ce5915cebe08299ca44_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7f7dc5506b3a434a8de2b4b60fdbdcf5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7dd8bed6771947af86f38ea8c65de78f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6b267b50c2af4842a3de6c83f9b6ab45_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e0d8f0313da4158a72192a2602a6ee4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icacd2391f4764a14ab37c6a4543fc4fa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6d18645d77f44dfe871bdfeab7f7edbf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieebbbb7c948845dca583fe54913d5e89_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaec3ebe00aaa45b2bed5ac91c8cccaaa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e56d52f566e45598878238694ba623c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i26b2c25650b44b69acccebcc55606d1f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea9e3da549e244cfb2c9f5158ec401fd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i084c745c22464ce3a8fb3c8cebf5ed60_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i03d68e9a626743bda07e2eefb20fce19_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i07cc2d2384f34425b810bae675903dc8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6e964e7db79a4ccd99b0c7be936bf507_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7d58a4e6c2d84e70bc347ef87d4a87f7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i046a86b5fdab4ff1b14916d76f73e510_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id3e70ff742c140d496526d7b1527c3ce_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffb9eb566b2941829c54cd50ea568c38_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5b5a4371abc747f3a1a8c3bd6ed8c486_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3084899d86f64538b7a6f2a33bbec0c8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i600ed37165bd4db9ae547ea571cb7978_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i101ecfcaae0e4864b20047dbd8a3e1fd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i684803a0664e4bfcb6efc1517674d221_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icff41edc76614451b4b1bd6a03d7ae63_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i005d53c4c52c4720aeb394e3fbb50e7d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90b6f6af4c6542d191026032ce0f1df6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i98bb9c7cfee24ac286f7fff99b0c0715_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i57f1ffa20dec429da02ec0b008e998ef_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icb3caa46f38f41edbc114ca92e65b04d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i84113ab047d242869074a29c0fe984ff_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibebac49aadb9416897c8ab8c4cce79d7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i420f5df1a84346a6ac938d443c5e8a4c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic76dfe31026e42c694ebb48c2f5b658a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b8628d1ff0448278a92b391d45f5eae_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i47125f71c9b44d7194c89e9640d482f3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i39cdba108be14c79af8376028b06b4cf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3eabf5693f71408c90d3d4cc46f5eb22_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i398d207fdaaa461195fbeae21a779dd8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i03d38dfb8dc048e08df6eb090d1f549c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6ad8ec3782bd4ea2a07fef27fa912cf0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i135bbf9df1b6455c9fa3dafbd8eb2d1c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c82e95c68504866bf36dd9d81d52cf9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibe3be05bfa934699977eb8087f45d14f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i417780d1b25c4ca8b079ea42b721fc54_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i56ba2a1561ad4430842ec1db3b8257ed_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id254ad4a4ea547639bf93c052e3be138_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i720551245e854687876b7379d1f78d8e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ife74578569994b51ae64ef03ce69c1ca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i766eabb290f046f2b9e62b6e3784b275_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2a0e17ea897448e5912132a36ff6b28c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie9c060397c8742309b60bf12b6512021_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2e84a4da6fad46a791ebe608e6ee198e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7ae5847663714779b1bf9154604a6df1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id0803d3be2d04db0a4c0867464be9229_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9c5b8dca94e743a398f30129643066bd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c39bb504ba14d2986890843ad30a9ef_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i09fd9a81e73348fa825cda04d1f6cb1e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6d9ccdd2e0584f9095a5e2c1d8e8c353_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idcae3cba7d164d41a999db4406d7e5b6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6d19a5c115024a04beaf946d538fddb3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9cc2465f59b5458abb466db3d7f8da8a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4558c2340efd4a3b900cf6ee1d86b0d2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idbc17d0d001d43998d445fb4be3e013c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3a0767d0f4ae47b39b6fd2f49267f647_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id85ae5108e3144a5a16efecd6144cfbb_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib43accb591714a6287366d5532b6fd0f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1a8489222bf149abb359b6eea6f8bc61_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia2645cba50844271a731aae129127e28_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e766da00a6e45ac94d46524fc6f1728_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i871689c0193846e98c4fedd49ddf8879_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia934aa3ae79b4bd5a663f8ac317ecba2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5abcb64ac3454f9b8c7088b53bbf545a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6bd381436407454e84dd9a12523cff3d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iad03c82878af430ca095a94ae4b7784a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb823a15d78b42bdbb60a26249e4c280_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i075da22059a446ea9056836364417160_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ife78a8506d7c4d589c917a4f5d611434_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib9bb7b9b91b746c9a6316ed3fbdf29ee_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6b50ecf683a64f88a5112a6814698895_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i10f2796e131745b49722c54e29dd1a14_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i540c328c3fd14b1bab1625ac3b70947b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4147a1bf6ed04df392a5e94f4d66f8ee_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3b3c544ea4624677af1db8cc46d8ba43_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if5390c9235c84fc5a5e7cfe2a469da26_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i83641512c7304560a36b1a26f5a833c6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3d94b806ce2c4380a472c5ded0a0d478_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8447af5ba87c40c0b94c057ccb036d8d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsAtriplaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib6fc0306b3664070b9024e4164bc3d18_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie8053154621043638573e26bca07c8e2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iab0b80da40d144dfb51e5296d491561d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c7bdbf4839341078ab571b1ade61e83_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id44c5b80cc3c4605ab9a62fddf9b0edd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9255844714024bfaa7176a097341eaf1_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id46c95e16d09481db3bbf57af272cc8f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idcf44eb315184b4daea10d586af9bb99_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsBiktarvyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7ba3f34d91ba4467a1b960bb57ff4f77_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icee191d2a7da42e5b2888a7142bc28e5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i97761b52dc964ca1b75b02bb63e6f7e5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia53b54d337a5449196f847ce9e41479f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i750af09cffdf45b2aaa3f24e2a2098d3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7e68305b0ec249bea1c290a603e685b2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3a4a6615211c46d2927e8dca0a2062b9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1bee71fa9ee64eeba4daeabec5940ac3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsCompleraEvipleraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i56bf813b0d4440c08a3e4699f552745b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i231be2fba64f4bf896c38f1aa81104f8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i43c573558c37477bacbe4f59e9970f84_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9c61cbc63afb40c48e57d8fdca17c0a1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifee265db13f644ecbcffa4b46083b9c2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id9e932ecab3d42f0bd2a802ca26cd95a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i58ed61a0e5644751a963832357838e7a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0740e92dc52c4649a9234a51ea22bc60_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsDescovyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6ecb7cae048e406eb9a99e8d678c765b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie0dfbec2369f4a4d84782aa2a96b2dd6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i29f0cb97877c451f8d0410a288a7c508_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i742e3ac34dc14d3ca51197c0177e3a0e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7412e3583c694088b81933255ffe9b92_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i384483b6f05f451d8e772b8b5eebf9d2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9705c0a59c384067b58147f9968d335f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9bde46834ced4ac9aca77149c77ff785_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsGenvoyaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i467448f2935c4949adb25f0dc29fd71d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i34c9b9f109374b3a9fd9b41bac8d04f6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9f4205c2046c4142803828d004750696_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a68dbfe80e344da8c9c590f8e88b515_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d9f10d767e14ff0996e4f9207bf98b8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib8126adf8f45426599f7339d161fd9c6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib3631587c26c450cae9fea5710c15b8f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia34b59098d814cb0a08a98e99e0c60a9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsOdefseyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i290b413904764919839f932725c8daaf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i851f06a9af1042fcb2a409bbe3756a72_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i783ec34abc8144819c7e7d092ae11132_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic755c8fddb3d4084bf2b80625b08ea26_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i805a20329e504fa2a33c2687c7ea5ea9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i01577dfbd4f147ec828c3cc0fb9ebf13_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i52d0a27e691146369f40b9b33565966a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i95eadaf94faf41fba9c79f5cb150e93d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsStribildMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icc833249283042d5b7c62e05feb45290_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i16e84af25770413aa8f9456d8ddc2e52_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ied066108123545128f8dcb45a48c3bed_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9c7cd5d5e7a442f48cb8b9feb0094fe1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffbc1fa1c55740df98bd6134594b7219_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i03d87e9eb0a54aa08eedd0dd9ea5c4e3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icfb35282d4ad48f783dd0c11877ba0ec_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i81dc6799abca4db8ab88cae7fa763d01_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HIVProductsTruvadaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i727f0920e4f64f1880a2ebe8c13e3bcb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id5fe7357a4c84db8bc7fca6f59f5bd47_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2bc28b56f8d48139043a74668f46dd4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibe112c628c62494ab437ea9eeaebc991_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i852a43ddcd8046829ad1899671088c66_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8a35be3874ab4149bb860d0946e69a81_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4b92f07f2e0a47c3a983d243a98baf35_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibc785f3b9046480faf38fea90b8c3023_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsOtherHIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4aebf9bb5c2346d6a0b7ca54d4d4eabc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9292897cc8904a42948da3e2971f4571_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e9ec444a5cd49f1bfcd9dd0820a2023_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaf9bc6d09aec41d184db3a49214b840f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i902da8b28069408a8c42b356a90a4950_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ida2f089d53c447b199f1aa839ca1668e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia189ef02a42c4b41a97661844b973b00_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i75e30ef252704139a8c49152c92d6fe5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:ProductsRevenueShareSymtuzaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibfb2e5ffe6574e3bb9835ef3ad021eba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10f7621603774791b39109ff98d0b462_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie6876a3bead0430cab7025f3a176623c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1216dcb7f79948829a9e8c0013253508_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i38621f45cc7c42abb0b3b65928e20ac1_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i42a4279f407d406cb284cc2edc96ad1a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i82688362eef04085b653508050f8f422_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia1d0a82cc5d540e987b6673d38b892bd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsAmBisomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia14da41d357c4519ad6e0f90343d204c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic97ad43f65774b7094b3a379df786172_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea3bf3186cb94890a8c57a6616584439_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia45b3f782eb04b7e861b03896b46c351_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i03eef6be4f4649c3a18607489e2d41fc_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i82b54e6960b4405f8590d818220a3f95_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibd48fdbbda9146a484254f1e767cc90c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i883550dc5b2e40a5bbb96599635c444b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsLedipasvirSofosbuvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9bf480b492bf4fe09ebf0fc197965303_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib9bb91712e39437b936294b2735c13d6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e5b7f7113df4f099c265bb2954a56eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ida3484e902294670acc409da1ba4e0d4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2641a1a842544e209516e50ec96c27b0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2e6404156b2847f181b5d1bd7b274323_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i770bcef54ce64fe388b602f9e6584063_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1dac5ce142294efdb06ad2c8c9ec3cea_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsLetairisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7bc1d1479cd648439d07c37d2ab148bb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i64b4d4435c8a4f83a0f27f31211068c5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i85e0424cfa2f4e97b30415fd7e13e4f2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1a3c4e259bef48d08c592ec5a9e88090_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i79fdd8a2b3e147d395c164637e7427f9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic0fee0ad1ea8468fa383b85fe7b7143b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i03d935f01a0e4ce7af8e635a7a172ab9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic4eec3ec224342aba0682ca3a09c4082_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsRanexaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie28996bf75474bb6b566e27bdb76a76d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i168a1ac690494b26a0ffda594222e1bf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4480c0b7198d4340abbdea40d9168391_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i255cdd4a6e2745f6b4c4695c024a26b5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i813e081e9063466a97d1059c75816be2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6244d0354fb04ecd8098b5e3bac74231_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3b1edb8c2b0045c7973d66c486950a77_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if758b0a643444e158af4faf00dabffcb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsSofosbuvirVelpatasvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7e47efb0a051404592f124c05e259845_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i43df52b49eec4fd985700ab74700f187_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i12ecda589633462d9718e5074b78e1f6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if14a0f64631c43c587d9d721103ee2c3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i174b7d15e02f410b8f1d31ccdc7a13ff_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i844571eb2df140729ef8179477274f42_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i28663efe02324a84b779525d9431c777_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i15345e0a267842739752f2512f08855f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:COVID19ProductsVekluryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i12734f9dde1a41feb3c30e72d478860c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic60ae20d01ab4ca884b6a676ad457b13_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f201861e937474292f64e97131f815c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i41acb1f4c6d84c1c8cbda1fd11bba630_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea2acca92b854994b32a72c07a2aed73_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib95cfac35a9a4dfaa8213afe8cf1742a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ide92661b1b6740029933d532260622e8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia5d9b5844fdb44dca1c2ccd68053d3ab_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVemlidyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4924f62835d947d593de516d3eb5bd4b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8b19822d0cfa438e89b18807a9cf9e85_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie6bbfe6897734d888e60bf1689e0476a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic7c3fa3e98e64124ab3a4e81c8b27cfb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffcf254dcfa549e8af3b55df2a518bb5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibaef6b26552d46d1a943326e4f631348_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia091375d714a4af68c9a4c3286c57151_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i469fb002cdb84ed4a5287f8c3a0c82f0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsVireadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie801464f2af24b6db9580bcc799e8ed0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie9e28ff274164fa5873e4f98ae0032eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i25a8067a5b7a4233a4795cf8b3a1e2de_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i640acf012c444e8896d04840405bc26d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6189e39123304106b05d084b2f10f2eb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i369c0f4c20b2434ab53ae12dfd9718fe_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0609460d710a44d795a4a5b9718c88ca_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id2525996f7074ffe8fed7cbd90a965d4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:HCVProductsVoseviMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i46b971cbacba4ffcbe41b30a57c4ada5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6cf5589198704a3a9eaf1b0b016c3346_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia8a49d3ca5034dc399ac09438153fe99_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i074bdcf660fb4535964c4423fbe341ef_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1c1ec0d72918417a956f0174b7d3c346_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1824caa947414b7096f32b2b67d14786_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4a83c69b2be54c018955d99da45844b7_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icbe54791ae9241c4aa29ddeb88cf9d1e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsYescartaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i251385f2e42b4b1aa5d365acc3ea9c9c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b331bf063c54bfabd806c7596fc3c27_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia8ef2dad4ad2412486b5ea11f53023fa_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic98a59cc78974919ba762eeec3eb216d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i997559821d1a4a16a73dd88830cf5174_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i72ec3d326d4242959cc35197614e8409_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2af4b394c8b54e37830a1db47238b3ce_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2247de6dfc784a9b868f0819caf83870_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsZydeligMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3d6b25963e724b4e9173371c02a0efb8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3d2cfbbe26ee4febb9b48574fd162233_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8060638d08784ee0a62d3f6ca7218aa3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i63441ce40ba84fa7ba414d3c9f749407_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id7e8741122cb4adb92eba65068bc4aa2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie92e99fb19404d699c9090195126fcbe_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i985de888cc224fff89bc3914c4f615ce_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6064ee7dedd34944b949c382cdd8cdbb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:OtherProductsOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibc19fdfb19b8400abf3317f7988947dd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id0c2677c28fa40e08640a377bf09b729_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iad7b65bb41c9454391dd5c4c5f30cdd3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i87253831ae434b6c84a09a210ade93fd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if70a1a73cd2a4d09bbcea125f90ccdb6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7aaac2bc6875471f9ceeb394f6c3798e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1822fe145b174f858d3559312d4b8f07_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e63b6b02edb4668bfc3e4cf5963b880_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id3b020739eb14d59b3f71d4b1dbff8fa_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5c3814004476430eb98633e8d57f0ec4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i581d05693e9a4a06b56980cfd2f297a6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ida77997dde894ccf8cb1e4b0f492b8a3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gild:RoyaltyContractAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia74680bc621445ff90e26deda6b247a0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib5c7d640e5a74988b2acbeca36e215a4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icf9ba585026444bda0371b5c9792d66c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9f7edbbe0058498ba07f1c694f172ae5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6ae67afc268c481189809b0cb77b19b0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3d15d27b4f1147e9a39d0edfa87476a6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">gild:OtherInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib51bea2a549043ccb4d2d8b9b4e6f2fd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6d4f1c22279841b1bc41d5c7af3e12f3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifdf756e786804feaac25586f0993f6ad_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie0344ff608be498d82fb0639f25f1fbb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:AmerisourcebergenCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id5e4c86e2a164127b1e60622b100f769_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3351e615eb324ecfbe90c19cb5ed63af_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6cabee79f5b442639e665379940075f6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2d001f2fdfb4dd69dbbf58a803cf0b1_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:CardinalHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifd52bba8c8b746ceb4390db580f35332_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3a8e91519874ec798163966b238f366_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i493449153f79453f9dfe0eacaa0db3b2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id668da46343f4db6a7137fe89d885862_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gild:MckessonCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic6441f2721574eb2b066460bd0098a33_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifea4251592be4a09bb586ecf7b0877b6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i70cc122877ef421aa55fd71bb8bc36aa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i92e9a07c98224bbaaaf8f40807d0e83c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i016620e60b0e45a2b86d94e4bedcd1d4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9b0f034dcaa0404585e485dfbb6d10e3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i65f5244a5e8f4ed5b372521b97d023cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id4ed4d70910c4494a6240e2ac85171eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4cda5ed87da74c01ab8c6f23f4b7f768_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i62c6e23a89e1448f9ed6fbf3ca90c206_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifd5b88ed58b34df29d8e5cad8f3c7ef6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibffb351639be43d6ba1030c106ff8eb8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i74c7b09230e8405fb21eb18f3e0dfae7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb611e0fbed54ad5968a92550e95897b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i75300f98c39f4d63a888fcd33da6f547_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifae90ac2d91e4170b23f8a6a66efc12f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b24cc4056cf47e784957e18bd3d8fef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i08217eba7b4040989c8927514a8e4667_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic06f0fae2eba4968aaef1e5ccbb6b62c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i899ff3da4637496c978fdba31ede1851_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0f7cfa70f7d44abeb0a42230869dd083_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id93f2ac2c6184cdc88f83b027e6b6987_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0205ea3174f84373ad0b7317fb14ee43_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2175ecdb247344f380a11e6cc2fff2c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff8d2177f2e648dbbf9fb7e466067dd7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic455f28a60e74c3fb60fa85587a50d84_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic3eca0222a334fe6a0daa4b5b8dab50f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1c28da23233147d9b46404d8348cc986_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iacec8636d81c4ccca6752cd4f9295732_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib2a82defc66745f690df80e8668e890c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2762aff7213c485a9bd438bb60c288d0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i05ed3d6b01754487a4a76050317ca559_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ddeab33a06c4acf87407a2dd4a0fa57_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ieb532ca82c864b69bcefe78f95dbff76_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iba47020efd0947a3a230d76409764d71_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if8e91ec83eb244499df3127b2b341240_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i45b5ab6cbfea4b5ba7e0e248c8955c25_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iffbc3256a0924126aa99e6bbeadc7d47_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i346980582de5432fab397590fe91e43e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4cc2a2681941419293fadf9296a83636_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i98a2dbe200754e44ba989b4ac9964ff1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib6341635988148b8ae35b14f5506e068_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia390b9822bae42bb96393b307440c66b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5c74ca81b25645129c007d405131d946_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8446aa5e56ad47e4866b4ffd7bc9103d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i256bfd9c10a3491e8671599c334071c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ebfc4a0cc6a403fb9a858f1755f42fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb62bb7ec71e4bdab398215247c43327_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80339bdd09004325869ace1cd2d34105_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ieef34b5a375d4d90a234962b99965328_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i06f736d48d424b4bb10af44ec2c200c5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i80ed5764050847e49062635ab01cae21_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i77e8c6f47d2041209000d04abb655b79_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib6533f6ca1a8499c9911c6c29ec5e81d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i92ae46288d7648bc98a7b52b5e2a2e94_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic990aad2d80c4f41a16acb8758ad9e39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:EquityinvestmentinGalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7457789a3f89476fa8de57c200293d14_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie7fb86f9d78a402a80e9cf34ac4e8cd6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i49cf4dabb9324f5d8ca59ddfb2c21457_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9f94575eafb6420daedc818f3fbaaf52_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if96baf7453ec488d8b4ee4a49d5a698d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1e53a276f8f04098947f2d530352c0c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2514dcd1744c42d99689f65cf992ea80_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7ebf1e84f3954ab8a1cc2392c6e28569_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8598034c1a26461fb3d885c48a66e8ac_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3836c33667544e528fc4feb3ed36fc42_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic5a034e702f740f381d179248d096442_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idf34775baa8f4d23afc2547f765fed5d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie22107d806154b21b150e48b8ced2120_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i332100bf65a74c73b78f88558ca64905_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc3a038de51d492da6acb057be109969_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifca554c2c1754c65b519605f1694f915_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i16bea56fb72747d698df8fbf549baa95_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5f9c716a8e98448eb4565f3e04a28ebf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2836e0ba225f4e40aaa8bf556a63e011_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if4fd4965df6c4aba98b90509f6af2d11_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3680162306264834bb21711e1ff3044a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3ecb4569c8314f7c8e009e95c3628aa7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i343a612674094b2083c8d08bac298824_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if86851181e3a487098e2236460b2dada_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:DeferredCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb6d3cfa89a44fc4b021c0457c085a5f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id3fcb255d1824b2288a9ce395b9da146_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i15165eda3c9345ff8f6ae2cebaafe873_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1832e7b713ea47d0a15518b89e0f27bb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie9bf9c41df7549ccae89be301ed3f03b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia379b9e5e4e84e8b9e9aa4b43ba92bdf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ife8fdfe82c0246158810b46b13c00e97_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1ef925d0d174ed992b1c8c45928db38_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:ForeignCurrencyDerivativeContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5bcbde7b6799451db4c9c818cfeead67_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i93eadd341c934b73a3e6940d3f6413a4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic41b4012b457481dbffd93eb9153e360_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idb5e4a50b9284e4d9af880ee03a84122_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia76f2122a7b7462cb1fc9f410f396ff4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9219113fc2d041d29935ac7469176613_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if4a61c55dc4b4663867980b24fdcb0a1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7d1fdb77ea804ee193031561a281a198_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i79bd59bb3d5a446c898736046871d68f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i202d8dd34b4048a6a70528355ccc07d7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1aad028e1dd94922b809346982b70e6f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i63529910aec24b4797650b819a035d38_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id95a598ab9ac4ba38343c2442e163984_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0cf8f6a568ff4422830e566cac20c2b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i973aae8a8cc74f1285d8fcfa96228c98_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6f86e6b410fe461e99132bb73eb20f07_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">gild:OtherEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3f57c5401fe14752b2128178cf57b7b8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib076e25c99fb466c9bc9ec757f4c69ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1fd39ebfac5e489099472ca928286c5d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i152b037ec98d48b8b0f21c10881726a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iab61524bb61c418da02f67470629315a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i90378da552dd4d3397c49bfd840fcf32_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ed486534dc045088bf927345ba227e0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i280f5420541248679b56a8d625ccd64a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i915f187c67784380afcab80212da1735_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i44901ae9d576485b846e66590a5145bb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if908b69b55404379949b8cb6f1d24c00_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i97f03d9c1ed5426d9d26ec720a56d292_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1d2d59bc54514c03bb9fe2216e669758_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gild:ResidentialMortgageAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e30f2b68c584a1cae64f4692423ac60_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if077c28b2a3549009e4351063889daee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifdb967509b8d4595b980817e4efe72c4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0649099fa908450db840cbbb3e57fe0b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie2ac5e322d254b9da70701bbc22881e2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesNoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9901b9b6eb08420fbd35a1817088ca98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">gild:MarketableSecuritiesNoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i885c8e3d7c564884960c80c8d85d08fd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0a333aeeecec4ed9b2e05cc1f18eca61_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8dd9abcdf6fa4e63ac008c910c2064e7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifcad679966294ff2a2a4a7fce703e297_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if94c93bbf7284ee089c617ef366c010b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3441f3a2b4f440a8bc916049c259e00f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i727aeb50823e469a9b8a9e02739b65d8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i36e630b95ff54a039e3b28faf946f40d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i69bdaf8a67d84555bf6582631022fc61_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i778d229a5af747b7afc0e73451dbaca6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i41cf8059cc904b458c6aeb8f0e345448_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia63da40b12964679bd495e281370437e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie3bada8f952b40819bd558e693f22b13_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i48fffe834ce34e46a02a3296f02cfe58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i093f149708bc438285250a031a978d87_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0fca64d1acd048958ee9a481adb0d0ab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i25b6a29b0c8f4d5fae00186fc6544d94_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic81637a074d1401ba756b4140e12c426_I20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="gild:AssetAcquisitionAxis">gild:FortySevenIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-07</instant>
        </period>
    </context>
    <context id="i71639a47b1bd4ad797ffe29d99a1a286_D20200407-20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="gild:AssetAcquisitionAxis">gild:FortySevenIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-07</startDate>
            <endDate>2020-04-07</endDate>
        </period>
    </context>
    <context id="i17d546d74ae148b5a021eb383025f81b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="gild:AssetAcquisitionAxis">gild:FortySevenIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icd56ba38aa8046bba054f36afeef99eb_D20200924-20200924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gild:ImmunomedicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-24</startDate>
            <endDate>2020-09-24</endDate>
        </period>
    </context>
    <context id="ia0f837e863ae43748f6f3d4be7b759a9_I20200924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gild:ImmunomedicsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-24</instant>
        </period>
    </context>
    <context id="ib8a8484ba93b4e959a292d7acd17712e_D20201023-20201023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-23</startDate>
            <endDate>2020-10-23</endDate>
        </period>
    </context>
    <context id="i10ded791c9da4652a9c01c141f86a369_I20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-29</instant>
        </period>
    </context>
    <context id="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-13</startDate>
            <endDate>2020-07-13</endDate>
        </period>
    </context>
    <context id="i578e5f2171814bedb8947beb0fec392b_I20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-13</instant>
        </period>
    </context>
    <context id="i052a9ab163094c12a8e0e749e1a27ad0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iae7c61328cd345d19182e7d8c3116c73_I20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-13</instant>
        </period>
    </context>
    <context id="i3562638e6f29454e9b2073af015cfd17_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia3d27c4b18e74db390be0856717db477_I20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-13</instant>
        </period>
    </context>
    <context id="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:ArcusBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:CommonStockPurchaseAgreementAndInvestorRightsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-13</startDate>
            <endDate>2020-07-13</endDate>
        </period>
    </context>
    <context id="i17375473d31a4fa98457488c706cd582_I20200619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-19</instant>
        </period>
    </context>
    <context id="i211cbe851f934c1b9e00538e84f893fc_D20200713-20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:PionyrMergerAndOptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-13</startDate>
            <endDate>2020-07-13</endDate>
        </period>
    </context>
    <context id="ied8aaf6ee07c4c68b0c9d4a257521bf3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:PionyrMergerAndOptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i665e017e6d564f3f848b9735e5795f2f_I20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:PionyrMergerAndOptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-13</instant>
        </period>
    </context>
    <context id="i2823e599701c40b09d1834198af15d61_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:ResearchAndDevelopmentServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5669c974fb37460591c74bfced921611_I20200713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:PionyrImmunotherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:ResearchAndDevelopmentServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-13</instant>
        </period>
    </context>
    <context id="ia7c901a1a55647e6ba26816eb4351009_I20200717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-17</instant>
        </period>
    </context>
    <context id="ib29eaffb63144ef9be056132abb82695_D20200825-20200825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:TizonaMergerAndOptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-25</startDate>
            <endDate>2020-08-25</endDate>
        </period>
    </context>
    <context id="iabe5bc9211f04bfa9c594ba7cff3169b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:TizonaMergerAndOptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i23962171ea454e2fa69a3ea748b90d4c_I20200825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:TizonaMergerAndOptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-25</instant>
        </period>
    </context>
    <context id="if8210403301349c7b8277961e43603dc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TizonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:DevelopmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TangoTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-17</startDate>
            <endDate>2020-08-17</endDate>
        </period>
    </context>
    <context id="if6a49596afb64be2a40ce0133770c139_I20200817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">gild:TangoTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-17</instant>
        </period>
    </context>
    <context id="i6d1c0da9b7b548618507b7b986013f51_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:TangoTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i291a141ad60a40e18d8e16c054569bd6_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:JounceTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:LicenseRegistrationRightsAndStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ibb7dec07426445a0b61fd7ee1c436ae5_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">gild:JounceTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:LicenseRegistrationRightsAndStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ic2051ed6e5a04c058e858df3aa244c5b_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:JounceTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:LicenseRegistrationRightsAndStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i9f8f334438e149d4bb54e84038e20f1c_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i22eab18f188d4327810ed03862e4e414_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic68ebf48645046309e24289804996aac_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gild:GalapagosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if0c15f0a4bf24e5faedca42d6ccbed3f_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:GadetaBVCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i55b9f2307b7d494fb84ae4a2f95e61ff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:GadetaBVCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1624c0037f5a41c4bfefb2aab54ddab5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib97742c494394b88bc0725331e447507_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iad7fd7f958c54653849a9d5ba294d69c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i26766cda4c294fe982cb31efc05bed10_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gild:OtherCollaborationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iecca81affd53498284282e31cecf32f7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:IntangibleAssetSofosbuvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3a84de8a34fb438289702707097480b8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:IntangibleAssetSofosbuvirMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e0778e433874a438dd80bee8239dfb2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:AxicabtageneciloleucelDLBCLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6f2eac9102cf4e899ccdac8659d5f711_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gild:AxicabtageneciloleucelDLBCLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1024af71b9a45278ffccef5760b5fe2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id8e66ce2fe3440d99f60869474e8fd99_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0440dbc560c34febb8b14b9e45c4454d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i957437a2c5fb481fbc92c780ca815df7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3160daa24dd5457a91283b0e02bb2b28_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A235SeniorUnsecuredNotesDueFebruary2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8b3518888b6449e28a4dd8a1ebb01448_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A235SeniorUnsecuredNotesDueFebruary2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1c5233e0d1e34dc1b9b616c2b9958ae9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A255SeniorUnsecuredNotesDueSeptember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i323f9eee9390464fb82fbcab9d0a9a54_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A255SeniorUnsecuredNotesDueSeptember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7bd2f1324bbe4577aaaa0b02e886a09d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueApril2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i04f678f93d81402b94b3fe583ae53808_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueApril2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i076a134b65754ba59bc1587c4dba35f0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i78b6a868c97f4d47b86b691b5a97102c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iff5c939d7a664dbcaa1fe8a25b93b1e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5cfd9d16d0134db083a80208f18fb127_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A440SeniorUnsecuredNotesDueDecember2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9b49b10ace4044ddb35f895db112ee9b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A440SeniorUnsecuredNotesDueDecember2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f3d085128dc47ddbc2b7e8c7b158013_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A195SeniorUnsecuredNotesDueMarch2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i943f74870a1242a68086cfeba9802e0e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A195SeniorUnsecuredNotesDueMarch2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7115ef027e1437da78e8c0e4770de11_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A325SeniorUnsecuredNotesDueSeptember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3a4445c6b7b641c6ac7e8571db780c2e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A325SeniorUnsecuredNotesDueSeptember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice6ce99e645641b1b447d7873df500b8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A250SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i034bc53776884c94ae8a3268988a8403_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A250SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa3287ce6d5c46038d6d90283ff80eeb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i024047c0ec56431f91c17a86fae8c5fc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icb855db743fc4e4d8bfeb913a9465b4b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A075SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1740f93795744755a3ee51a0609192ff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A075SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53f786cdbfbe4e19a3f79eb22d33def6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A370SeniorUnsecuredNotesDueApril2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i830b9fd58a46421ca2f14073652a8b07_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A370SeniorUnsecuredNotesDueApril2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i69184deceb83472e87a54770bd526907_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A350SeniorUnsecuredNotesDueFebruary2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib08649fd40b64b78a3ac992ce45ffe51_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A350SeniorUnsecuredNotesDueFebruary2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3db367e747ab469885d1e740050763a3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A365SeniorUnsecuredNotesDueMarch2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9037d73ce3734b9781f89c898abc8331_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A365SeniorUnsecuredNotesDueMarch2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i819d350aa46949b1927defb662d03b4a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A295SeniorUnsecuredNotesDueMarch2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9543cb5e44cf49dc9f987a6ce144eb4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A295SeniorUnsecuredNotesDueMarch2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i66e503faf08b4182b4ae149c600e7779_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A120SeniorUnsecuredNotesDueOctober2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i56a72c53bb76412d862e75ceca21ea29_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A120SeniorUnsecuredNotesDueOctober2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0f72724ee7414879a83048bd3532f197_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A165SeniorUnsecuredNotesDueOctober2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if172b80ce0344955a3bae899f1aef873_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A165SeniorUnsecuredNotesDueOctober2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i27ddc1e9a89a48ae9793e4c7f3c3ee5e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A460SeniorUnsecuredNotesDueSeptember2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1dc4618a73204298852a45480a01610f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A460SeniorUnsecuredNotesDueSeptember2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie746e67ba8d64af0b6434070b1135780_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A400SeniorUnsecuredNotesDueSeptember2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i917d5ae043a6482ea2fe51d188f57fdd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A400SeniorUnsecuredNotesDueSeptember2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6f741e6d070e4fe882119870d1184cef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A260SeniorUnsecuredNotesDueOctober2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie29e93986f134ebcadfa3bf09afe5797_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A260SeniorUnsecuredNotesDueOctober2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idfec6ce2d495407e91872cb50eb1d277_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A565SeniorUnsecuredNotesDueDecember2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie65e28716f114e31bb0b12b21ca5d7b3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A565SeniorUnsecuredNotesDueDecember2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i916f791cc0b141c9acf5ce3bcf4af863_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A480SeniorUnsecuredNotesDueApril2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i516c59fe4fdb420fa10752e3f879ee6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A480SeniorUnsecuredNotesDueApril2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icd8ad038d121413794732443f43b0dd4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueFebruary2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id493a8861f6f49eebbc2bfe998aabff2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A450SeniorUnsecuredNotesDueFebruary2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i924d914a188c41fabc11cc7f15cdc373_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A475SeniorUnsecuredNotesDueMarch2046Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5f55700d855e42528ccc24cdf5849a69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A475SeniorUnsecuredNotesDueMarch2046Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i04dd812e93aa44c9a770b8e0110ad89d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A415SeniorUnsecuredNotesDueMarch2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iffee9b8a237845ffb486442200c4c758_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A415SeniorUnsecuredNotesDueMarch2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A280SeniorUnsecuredNotesDueOctober2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic09bf1bed99a4abc8990ec17f2674ada_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A280SeniorUnsecuredNotesDueOctober2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i732e6064e491434f97f7abba277ffc08_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7ff2cdfdf7c743e5a3c192c472818845_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6942d430090747b99d43a27db7846096_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A075SeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5d133b8c794a496097f8802c3cee3c74_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A120SeniorUnsecuredNotesDueOctober2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia93111f675b84d0185cffe796ba9ad0f_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A165SeniorUnsecuredNotesDueOctober2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0af1b61d1bd24f02bcf41645b802cfef_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A260SeniorUnsecuredNotesDueOctober2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib35e51d4a6e5413d804346c20c4d645d_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A280SeniorUnsecuredNotesDueOctober2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie2873f7c29354cc8a00cc6b3eadad4b9_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i332b81acd0e34cb68ce82c944141e308_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie5f98f733a534405a4a7aceadcbae8db_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifebe1e104a53429d9f4985f21acfcf6f_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedSeptember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c112e7007ab4912b6828d7439e90eed_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedNovember2014Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="if350b42852dd44f48da9f53e1b8ff9e9_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:SeniorUnsecuredNoteIssuedSeptember2015Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id43f9dfea2c7418cb87a1a84ccc9a37e_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i66ad83bd55674a5489ec01dc33324735_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i05c93da51a924b19ae6284b9a552e965_I20201023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:ThreeYearSeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-23</instant>
        </period>
    </context>
    <context id="i1bfe479f1cd340f3a96f534ba41654ad_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:CreditFacilityDueMay2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i345776f175ba45628e7886736d46d225_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gild:CreditFacilityDueJune2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifda8f675af864a82a9abe9b9a27454d7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3c8da64f2584082a30059c2ef0db569_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iadae1c7466ea41e990dd30ccf69b5887_D20161201-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:IndenixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="ib20b3c03bc154daba1331e8af30fdb76_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:IndenixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i375f4aa83089473d80f0894376a87131_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3b9e6e8a3097447b8a5306434ceee570_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i81637e03a86945a093db345c6214f5d9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie7181038d12c4972b2d35c23670305e2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i61fb468d46454c35be375b3bf645c786_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gild:JunoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i83dbde55d11d4cca843046da3156ede0_I20160128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-28</instant>
        </period>
    </context>
    <context id="i8e803091b7ae47a28cf31980b4e75241_I20200129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2020StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-29</instant>
        </period>
    </context>
    <context id="i2f8986f71eb946ce91a3ac37191c811a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c72d335e955423da6fa2cc5ce0ca6a9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f6d71b9595c455b91d1695466faaa46_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9c5133b40b7348ee9a886cf367a8c92a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">gild:A2016StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i126913deb985494cbae4e16c0eefaaa0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i31e50be0c1b8444dac6878e054031f95_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i92120c1df08941c0baa875930620ab7b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3c2d992fc41144e698540022573aae90_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaa15a6a2044f4dffbdd84d9bd4107466_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i87bf3701a61048ce98060b964e89b9d6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic3ea6d768f5a439a8c7671f8e1b2734e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i931ba07aa5b84693bb30002c9e25ba8f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibc9ff79601b7441a89cc4803200d5db3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie21170d6027749b8ac405fbc5d0c14f3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i032461dad5024966ae092159c3844bbf_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5caf79123df745c29fab67273cf54adf_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i646702f3b9c14ffda1e398222e462a80_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i27914e2a7fbd4b0dbcc730cd7b58c33c_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ia16228b8cf344fd0b17a751f84856174_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>gild:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="position">
        <measure>gild:position</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="agreement">
        <measure>gild:agreement</measure>
    </unit>
    <unit id="program">
        <measure>gild:program</measure>
    </unit>
    <unit id="plaintiff">
        <measure>gild:plaintiff</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV80LTEtMS0xLTA_ec9db607-71a4-4138-aa66-985c69d835c2">0000882095</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV81LTEtMS0xLTA_e70d779a-2282-4416-b9bb-239a0f41570c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV85LTEtMS0xLTA_769e61cf-1c17-42c3-b1c5-999e66b2ee21">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV8xMC0xLTEtMS0w_247b3962-0099-46a3-803f-dfaabd59cb85">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180L2ZyYWc6MzU0ZjQ5MDUyNzI2NDRmOTgwODg1MzMwNDZhNzUxMjIvdGFibGU6YTJmMDliYWQzMWI1NDA0Yzk5NmEwNWQwMzM1Yjk1NjkvdGFibGVyYW5nZTphMmYwOWJhZDMxYjU0MDRjOTk2YTA1ZDAzMzViOTU2OV8xMy0xLTEtMS0w_a6b5fa77-9972-46ad-994c-60a2715567db">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV84OQ_97285032-48b3-4745-a951-b611c009a14d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6MGJlZTdlODNmMWNmNGU4NDhkMTUwM2UzNTBiOGJjNjgvdGFibGVyYW5nZTowYmVlN2U4M2YxY2Y0ZTg0OGQxNTAzZTM1MGI4YmM2OF8wLTAtMS0xLTA_0f453487-1599-4987-bd51-8e909531cab2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8xMTA_034e27d6-752a-4e19-869d-4e5b4ab397a5">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6N2UxY2YxNmEzNWJkNGRjMzk0NzEyNDBiYjc1M2M1OWUvdGFibGVyYW5nZTo3ZTFjZjE2YTM1YmQ0ZGMzOTQ3MTI0MGJiNzUzYzU5ZV8wLTAtMS0xLTA_40bc0dd6-f9aa-4ed3-bbcc-a5590368dd19">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8xOTg_35b2b8f4-6e18-4fe6-bf9d-0cc51bd984d2">0-19731</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMDY_1aa4a7db-d17e-4069-9ca6-4f1b4e7dc69c">GILEAD SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6MTUwN2JmODA0MjYwNGVmZGFjZThiZTk4MzM3OGJiMzUvdGFibGVyYW5nZToxNTA3YmY4MDQyNjA0ZWZkYWNlOGJlOTgzMzc4YmIzNV8wLTAtMS0xLTA_3f62fc65-9ef8-4843-b2ea-788bf95021c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6MTUwN2JmODA0MjYwNGVmZGFjZThiZTk4MzM3OGJiMzUvdGFibGVyYW5nZToxNTA3YmY4MDQyNjA0ZWZkYWNlOGJlOTgzMzc4YmIzNV8wLTEtMS0xLTA_29284353-c690-444a-826c-f68fbefde984">94-3047598</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yNzI_9b1589dd-9b71-4e45-b471-49dd308ee457">333 Lakeside Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yNzY_3f357da2-3d51-476c-a085-36e1a11d3e1e">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yODA_db5f1d98-ec21-473f-ae65-d5366dd02249">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yODM_6845189f-1ebb-4916-a3d1-5c1919a92c8a">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8zMzk_1a29947b-2352-4d05-ab15-6428fd117460">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8zNDI_c9ebdc4d-fe1e-43ed-9547-d7902f856b99">574-3000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6YmM3MDQ1ODQ2Zjk5NGEzNjlkOGIzYTVmZTAwYWUzMWYvdGFibGVyYW5nZTpiYzcwNDU4NDZmOTk0YTM2OWQ4YjNhNWZlMDBhZTMxZl8xLTAtMS0xLTA_cbfa6402-425a-4e6a-9ce8-e896beae3c0b">Common Stock, par value, $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6YmM3MDQ1ODQ2Zjk5NGEzNjlkOGIzYTVmZTAwYWUzMWYvdGFibGVyYW5nZTpiYzcwNDU4NDZmOTk0YTM2OWQ4YjNhNWZlMDBhZTMxZl8xLTItMS0xLTA_36eadad2-aacb-4b19-a5d0-cf7d498b4ab3">GILD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGFibGU6YmM3MDQ1ODQ2Zjk5NGEzNjlkOGIzYTVmZTAwYWUzMWYvdGFibGVyYW5nZTpiYzcwNDU4NDZmOTk0YTM2OWQ4YjNhNWZlMDBhZTMxZl8xLTQtMS0xLTA_e5cc5408-9c40-4ecb-ae0f-85cbad01858a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV84MTI_0395088d-0b1f-4461-89be-0a7751821348">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8xMTMx_24f03407-1a95-45a0-96c1-7c43596ced0a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTEx_6a0bb4bf-be0a-45b6-8b58-c6e1b85e160c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTEy_fc0a141c-4a84-46d2-afef-164ac00beaab">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTA5_3b7457ef-ab31-45aa-abe9-4758485636e3">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTEw_427affc5-df53-4fb7-8429-8f3a7000f790">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="icc039174bd574d08b570f9adbabafac8_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xL2ZyYWc6OWI1NjM3MDdkMmMxNDJhOGI2MjNjY2M1NDA0ZmE4MWEvdGV4dHJlZ2lvbjo5YjU2MzcwN2QyYzE0MmE4YjYyM2NjYzU0MDRmYTgxYV8yMTA0_f2d627ff-51ca-4612-be55-de0171eb3db5"
      unitRef="shares">1253528149</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMy0xLTEtMS0w_cf3038fe-66fc-4ab2-84e1-be918cab3e14"
      unitRef="usd">12886000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMy0zLTEtMS0w_97278762-b9a4-45f5-a0d5-f7eb6b5984b0"
      unitRef="usd">11631000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNC0xLTEtMS0w_c410f611-ba73-487f-8cf8-727fe154da86"
      unitRef="usd">11089000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNC0zLTEtMS0w_eb102ee9-f9fa-404a-b152-280441291e66"
      unitRef="usd">12721000000</us-gaap:MarketableSecuritiesCurrent>
    <gild:AllowanceforAccountsReceivableandChargebacks
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0wLTEtMS0wL3RleHRyZWdpb246NTQxYWE4YjNjN2FhNDFmMTk0NDU4MTk4MjYwMGE1Y2NfNDc_eea7ea22-2a85-4898-b545-e026e4eb06fe"
      unitRef="usd">714000000</gild:AllowanceforAccountsReceivableandChargebacks>
    <gild:AllowanceforAccountsReceivableandChargebacks
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0wLTEtMS0wL3RleHRyZWdpb246NTQxYWE4YjNjN2FhNDFmMTk0NDU4MTk4MjYwMGE1Y2NfNTQ_2fdfc3f7-8572-454e-ac96-265aa7fbc965"
      unitRef="usd">758000000</gild:AllowanceforAccountsReceivableandChargebacks>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0xLTEtMS0w_70a6d1bb-4065-436a-ada7-88ad32f827ef"
      unitRef="usd">3913000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNS0zLTEtMS0w_856b9892-7a48-4544-b7f3-c69a634043db"
      unitRef="usd">3582000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNi0xLTEtMS0w_b3c0c200-aa69-4ad7-b5e0-d2f5ca8f66ef"
      unitRef="usd">1008000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNi0zLTEtMS0w_40b354c7-c91e-410b-af7b-50ea9d59be66"
      unitRef="usd">922000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNy0xLTEtMS0w_46e49806-1989-42ac-a049-0368827b70f0"
      unitRef="usd">2030000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfNy0zLTEtMS0w_4a8de30b-3432-4822-8573-28c5a1cfec82"
      unitRef="usd">1440000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOC0xLTEtMS0w_836e8251-28ad-424e-b72e-4bb723e463b6"
      unitRef="usd">30926000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOC0zLTEtMS0w_473df3a4-421b-4934-af0e-24f4441f4eba"
      unitRef="usd">30296000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOS0xLTEtMS0w_0194ed65-11e8-4d99-bf90-dfb77a2e992a"
      unitRef="usd">4810000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfOS0zLTEtMS0w_2d9d947e-f1b4-4320-ac7b-cf4fdc37dbcb"
      unitRef="usd">4502000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTAtMS0xLTEtMA_7c94a7c8-fdd4-49c8-bbe1-2d0c54897dad"
      unitRef="usd">2074000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTAtMy0xLTEtMA_d5238a0a-dda6-48c2-ae3d-c314454649d2"
      unitRef="usd">1488000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTEtMS0xLTEtMA_8dd4112f-2000-4fb5-b2a0-121ab7c3f714"
      unitRef="usd">12939000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTEtMy0xLTEtMA_876ef9df-5d49-4664-b8d7-3850216496c4"
      unitRef="usd">13786000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTItMS0xLTEtMA_12c00dc5-3c92-4ce8-85fc-d39ffcf3553e"
      unitRef="usd">4117000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTItMy0xLTEtMA_1671b4fc-f5c2-4752-92e1-d3ad6a489bbf"
      unitRef="usd">4117000000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTMtMS0xLTEtMA_003dd1c6-1199-419f-adc5-8c03ce2a8776"
      unitRef="usd">6012000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTMtMy0xLTEtMA_0fe195dd-ee68-4ea4-b37a-798ed0ccc9ba"
      unitRef="usd">7438000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTQtMS0xLTEtMA_ac1d493b-b0e0-4452-b105-2a87110ebb6b"
      unitRef="usd">60878000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTQtMy0xLTEtMA_53b3b915-73e8-4aae-8d93-b6d31859fb93"
      unitRef="usd">61627000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTctMS0xLTEtMA_1e4652e7-1285-45fd-847c-94bd689e47d1"
      unitRef="usd">527000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTctMy0xLTEtMA_725aac1c-eff7-4287-91ec-0d4283dd4e5c"
      unitRef="usd">713000000</us-gaap:AccountsPayableCurrent>
    <gild:Accruedgovernmentandotherrebates
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTgtMS0xLTEtMA_ed6d3c4d-0d0c-4d88-b526-ae2d6d6956a5"
      unitRef="usd">3343000000</gild:Accruedgovernmentandotherrebates>
    <gild:Accruedgovernmentandotherrebates
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTgtMy0xLTEtMA_b60aadb4-d9f9-404c-8543-47b571ca3981"
      unitRef="usd">3473000000</gild:Accruedgovernmentandotherrebates>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTktMS0xLTEtMA_3aebf34d-bb28-4153-b30d-1a7d288c4fb4"
      unitRef="usd">4141000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMTktMy0xLTEtMA_09767e70-3188-40db-a078-e6343aac3c2f"
      unitRef="usd">3074000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjAtMS0xLTEtMA_b7f212a6-9be6-4fe9-bf9c-231dcac8214a"
      unitRef="usd">1498000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjAtMy0xLTEtMA_5b6355bc-6306-44ca-9e1d-7f62d556a4d3"
      unitRef="usd">2499000000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjEtMS0xLTEtMA_b98f70b9-ba21-4aaa-a5ce-6f5b378b0074"
      unitRef="usd">9509000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjEtMy0xLTEtMA_9ff7ab75-dd34-45ca-bd8b-5e3ca215b598"
      unitRef="usd">9759000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjItMS0xLTEtMA_63d58040-7f52-4b4c-bf24-2df82482afb3"
      unitRef="usd">27792000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjItMy0xLTEtMA_78518c58-e5e6-4924-af91-ea536a548190"
      unitRef="usd">22094000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjMtMS0xLTEtMA_bcb9af8c-a473-42e4-a457-4276aaa643b4"
      unitRef="usd">5020000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjMtMy0xLTEtMA_e2d318ad-a0a7-44f9-9035-00cfee634dc9"
      unitRef="usd">6115000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjQtMS0xLTEtMA_6a7e83ee-5467-43c8-a698-9a73df684167"
      unitRef="usd">1086000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjQtMy0xLTEtMA_d9ab2c33-506e-4477-9129-806531aa93b5"
      unitRef="usd">1009000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjUtMS0xLTEtMA_7018c63c-7020-4917-b66e-668754132872"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjUtMy0xLTEtMA_aa6e420c-f049-4b4f-a0f7-4e95dacb0336"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzMx_97967f8a-4ed6-4ccb-bc5d-a1f1850f92d2"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzMx_e26d60b0-f4ad-4d6e-b001-623d10e6e6b9"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzQ1_081fccc4-99be-4a6e-b3ae-a651b67af7d3"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzQ1_9c41e649-b054-4637-b5f5-a1be817982d8"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzY3_2961b04a-3672-4f26-a957-657b9230ab1f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmEyYzQ1MTBjNDk5MTQ0ZDJhZDBiOWEzMjRhNjVmNGE2XzY3_b621f9a1-bdb7-4af9-b6e2-9f472833a441"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMS0xLTEtMA_4cd89ffd-f3d7-457b-b4bd-e1b2513c8473"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjctMy0xLTEtMA_98fe60a3-9b57-4b87-90af-2f7883d16138"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzI5_3731d142-fd57-4ab6-b0bf-aea3528e8242"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzI5_d210dfbd-d937-4381-91bb-cdd061db1d0c"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzQz_9e5ff5f3-614b-47a7-a26d-bdb6abe74744"
      unitRef="shares">5600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzQz_a4ffc6c8-6826-4b0e-b4bb-403ed4fec781"
      unitRef="shares">5600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzY1_a14c586c-4f5e-4651-94ac-00780bbbe62d"
      unitRef="shares">1253000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzY1_d06a2547-6052-476b-af5a-4ee4f8ce44e4"
      unitRef="shares">1253000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzcy_21c0fea7-2265-4ac8-92c3-a39464f69b6b"
      unitRef="shares">1266000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjEwYzM5MTJkZjE0MzQxNDQ4ZGNjNDM4NzcwMDgxMTMzXzcy_f271e29d-5d91-46ed-9870-7e80de76e8ce"
      unitRef="shares">1266000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMS0xLTEtMA_9ff96449-2bf3-4082-8746-fe7139266986"
      unitRef="usd">1000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjgtMy0xLTEtMA_8b3e8918-0738-445e-b222-9e57306807fe"
      unitRef="usd">1000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjktMS0xLTEtMA_295dbf4e-fb0d-4ec0-8937-19d336883c42"
      unitRef="usd">3712000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMjktMy0xLTEtMA_dc70f31d-0a9d-46b4-92e6-3c0dbf9305ff"
      unitRef="usd">3051000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzAtMS0xLTEtMA_85d4c6e2-1dd4-4b7a-a424-6cdd9eb187a2"
      unitRef="usd">23000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzAtMy0xLTEtMA_6ca144d5-de64-4d6c-83a9-b2fd9c40358a"
      unitRef="usd">85000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzEtMS0xLTEtMA_d0eed13c-bce3-4b5e-87a9-0269c3e3373c"
      unitRef="usd">13709000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzEtMy0xLTEtMA_bb9cc643-fcef-4f0c-9533-d8fb780b8213"
      unitRef="usd">19388000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzItMS0xLTEtMA_87e6477b-e714-482b-b2b5-eb6eb8c9a4f4"
      unitRef="usd">17445000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzItMy0xLTEtMA_b776b656-fba3-4e43-8bb1-852a23b4179f"
      unitRef="usd">22525000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzMtMS0xLTEtMA_f0e27a11-6b24-46fd-9da1-c9bf40ea34a1"
      unitRef="usd">26000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzMtMy0xLTEtMA_ad811f0c-b342-46dc-8f8a-c22b20e648e1"
      unitRef="usd">125000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzQtMS0xLTEtMA_1d8f011c-4188-40dd-bb14-b9d969fd9590"
      unitRef="usd">17471000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzQtMy0xLTEtMA_ceba2c44-8f83-4a7e-8cb5-6464ea017dd7"
      unitRef="usd">22650000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzUtMS0xLTEtMA_b8e55e09-494f-409d-9f50-7953595ecdc8"
      unitRef="usd">60878000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xNi9mcmFnOjQzNWIwNDNmYjQwMjRhMjk4NDBmMTIxNTdjYzc0ZjQzL3RhYmxlOjM4ZmQwN2RkNTRhZDRkMTc4ZDAyMzZmNGQ4ZDA0ZTllL3RhYmxlcmFuZ2U6MzhmZDA3ZGQ1NGFkNGQxNzhkMDIzNmY0ZDhkMDRlOWVfMzUtMy0xLTEtMA_69c7446a-79a5-43c8-8fe2-fa5f88d974f8"
      unitRef="usd">61627000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="ic38a8d4d52c34caa8db328baf10699aa_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC0yLTEtMS0w_6e6df5d8-ffea-4b6a-84f2-88cb87c88d81"
      unitRef="usd">6493000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83a2687827294d87a300d031d1858df3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC00LTEtMS0w_0a960f55-5504-48cb-a57f-b2c902d4faf4"
      unitRef="usd">5516000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia542ffe4c807464b9cb360eb9f6c08b4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC02LTEtMS0w_d7e64a90-71fe-4a71-ba53-051b25dd0f51"
      unitRef="usd">17027000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4ab6f6260e54f569438ef8ea0ff6cd6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNC04LTEtMS0w_13a1e097-704f-410a-893d-35767edcce13"
      unitRef="usd">16323000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i96064d1c8c184d5ab1297ec54cb44590_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS0yLTEtMS0w_b80b001f-c7d6-4e38-b59a-3e7209cee112"
      unitRef="usd">84000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf6dd01e1e2047839e25939a3ae0a70b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS00LTEtMS0w_616ed25d-6f9d-4b0a-8098-60d82089ccb3"
      unitRef="usd">88000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifaad7749126c4b9a9ca4c44b1cff7a4f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS02LTEtMS0w_04cab02d-cdf0-47fa-a56b-9a92e04846b5"
      unitRef="usd">241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb6e106923dd4893989458d5e54fa96b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNS04LTEtMS0w_8a8770e8-d6bf-477c-9d20-2f337a4fd083"
      unitRef="usd">247000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi0yLTEtMS0w_3b66e14b-53fe-472f-8a26-12346a57d6a1"
      unitRef="usd">6577000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi00LTEtMS0w_aa48d1d2-43d3-43b0-8fd2-9fe2f8951552"
      unitRef="usd">5604000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi02LTEtMS0w_c95d40e2-dc5a-4922-a044-bd8bb6db32e0"
      unitRef="usd">17268000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfNi04LTEtMS0w_ad0823b9-66d1-4aaf-a064-10f821da6979"
      unitRef="usd">16570000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC0yLTEtMS0w_30f8b9c8-1699-42e1-99f9-76239c946633"
      unitRef="usd">1141000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC00LTEtMS0w_c90f5c9d-cc83-460c-9bb4-47297c5b0c85"
      unitRef="usd">1035000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC02LTEtMS0w_7b18fb1e-c24a-4ccd-a749-603141a5805e"
      unitRef="usd">3174000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOC04LTEtMS0w_ff8bc89f-dae3-4dd8-84cd-2ffdf894a475"
      unitRef="usd">2992000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS0yLTEtMS0w_5dada9e2-0c96-4d68-b7f9-a135514fa11c"
      unitRef="usd">1158000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS00LTEtMS0w_07a26715-5b96-4335-b7d5-a907bcd30bba"
      unitRef="usd">1030000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS02LTEtMS0w_88f35076-f942-43dc-9e12-f17cf6fdabbc"
      unitRef="usd">3461000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfOS04LTEtMS0w_4c6fbc69-d166-4334-bac2-e51f4f93326f"
      unitRef="usd">2956000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtMi0xLTEtMA_b8d65786-0326-4879-a165-a6dc9acb1ed0"
      unitRef="usd">1171000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtNC0xLTEtMA_88efd6cc-8cb6-425a-8470-6181572cdcd6"
      unitRef="usd">3960000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtNi0xLTEtMA_b32fc3e8-d755-456b-af41-8236595ea73c"
      unitRef="usd">5792000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTAtOC0xLTEtMA_c804a500-6661-4356-9099-3ab1016f0c81"
      unitRef="usd">4251000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtMi0xLTEtMA_8be50941-4367-4b55-8402-d8328968e34d"
      unitRef="usd">1106000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtNC0xLTEtMA_d03e75c3-34dd-4b8b-b865-bbb35b37b114"
      unitRef="usd">1052000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtNi0xLTEtMA_714bb384-9b01-4846-b42b-81f5f0ef872f"
      unitRef="usd">3421000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTEtOC0xLTEtMA_061256ad-bc50-4663-b478-751cb4ecea12"
      unitRef="usd">3177000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItMi0xLTEtMA_11652ef3-3a04-4d19-808e-8e18e4691683"
      unitRef="usd">4576000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItNC0xLTEtMA_5225d5c7-fcac-4627-826b-fa130ece56c3"
      unitRef="usd">7077000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItNi0xLTEtMA_ee163517-01f4-4696-bc05-8cd99ce30a46"
      unitRef="usd">15848000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTItOC0xLTEtMA_786b66f6-8a57-46ae-8789-45d9cfc3e55b"
      unitRef="usd">13376000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtMi0xLTEtMA_66c8be95-f251-4660-ae34-7f7150ad5159"
      unitRef="usd">2001000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtNC0xLTEtMA_e7ee308b-14ae-4713-809f-e2447f602f46"
      unitRef="usd">-1473000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtNi0xLTEtMA_ced91fc8-db3d-4ede-b2e3-4c37aa0017ac"
      unitRef="usd">1420000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTMtOC0xLTEtMA_2757bac8-ac18-4921-b3a7-61a1d8db6a47"
      unitRef="usd">3194000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtMi0xLTEtMA_512a2c84-d52c-4d47-a2fe-509756fe9b18"
      unitRef="usd">236000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtNC0xLTEtMA_13ab5e0f-b93f-48ee-852a-8105d589b6e4"
      unitRef="usd">250000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtNi0xLTEtMA_b968850a-5a19-40dd-a7ed-b752baaac052"
      unitRef="usd">717000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTQtOC0xLTEtMA_dd7caa5f-d105-446f-a65f-b745210ca24a"
      unitRef="usd">752000000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtMi0xLTEtMA_cfb5e650-d33a-4697-a4ea-e91648b2cec3"
      unitRef="usd">-940000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtNC0xLTEtMA_36895465-a48e-43a6-8f69-d815f7e39943"
      unitRef="usd">222000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtNi0xLTEtMA_f7f9d441-e2a0-43ba-90d5-bc81b09bed0f"
      unitRef="usd">-848000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTUtOC0xLTEtMA_6f5fb7cd-c72a-4ff4-a32c-60ed86dd7dc6"
      unitRef="usd">817000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtMi0xLTEtMA_9742a7e4-140b-416e-a118-16631ee731bc"
      unitRef="usd">825000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtMi0xLTEtMA_b3f64fc1-fbb2-49b0-95d9-7549807af89c"
      unitRef="usd">825000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNC0xLTEtMA_1ba1953b-aaff-4d24-8527-3f9e84027b35"
      unitRef="usd">-1501000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNC0xLTEtMA_a031a6ca-aa2b-452c-befc-bcd0160841a2"
      unitRef="usd">-1501000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNi0xLTEtMA_0b03bae9-1848-49be-a617-4053a01ee632"
      unitRef="usd">-145000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtNi0xLTEtMA_4ac698fd-868e-4df6-9489-a7c61046caf3"
      unitRef="usd">-145000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtOC0xLTEtMA_18763f2a-5869-4244-90b5-87294d8830f5"
      unitRef="usd">3259000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTYtOC0xLTEtMA_fdb3fd5d-e46c-4cfd-8ac4-41ca0dd9a05a"
      unitRef="usd">3259000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctMi0xLTEtMA_cfb44b27-6daf-4df4-8d37-7106b8d9fe62"
      unitRef="usd">472000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctNC0xLTEtMA_a1d14eed-d1c4-44fd-9143-f8a1c8033bc4"
      unitRef="usd">-333000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctNi0xLTEtMA_59cde5c8-9ce9-4adb-9d44-3fd1ddd2c0d6"
      unitRef="usd">1310000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTctOC0xLTEtMA_251a80f4-aba4-4073-839b-4facf066efe6"
      unitRef="usd">584000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtMi0xLTEtMA_41f485d2-cf8d-406e-84dd-e00e14d068b5"
      unitRef="usd">353000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtNC0xLTEtMA_04e47547-dbd8-4cc9-a103-e3c5b752dd50"
      unitRef="usd">-1168000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtNi0xLTEtMA_8829470c-f607-40ba-bc55-dcbd287f0173"
      unitRef="usd">-1455000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTgtOC0xLTEtMA_c50877f0-a325-40b3-97be-bd11b0a2e6af"
      unitRef="usd">2675000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktMi0xLTEtMA_5d877606-6827-4036-8c81-75c1df28c1b9"
      unitRef="usd">-7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktNC0xLTEtMA_91bc9d3c-7037-41a1-8715-4a85cd8f458a"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktNi0xLTEtMA_b2fc6651-065f-4544-8b4b-84b94e106421"
      unitRef="usd">-27000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMTktOC0xLTEtMA_93a06059-a9c5-4f00-a9f7-5dd032494fb7"
      unitRef="usd">-15000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtMi0xLTEtMA_35172059-0623-4939-a2ab-2632005c8bb4"
      unitRef="usd">360000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtNC0xLTEtMA_b825f899-78bc-4a82-b89c-3f4464b98d9d"
      unitRef="usd">-1165000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtNi0xLTEtMA_4dd5b14c-c310-4e84-a116-e6392ecf99d0"
      unitRef="usd">-1428000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjAtOC0xLTEtMA_62df4d19-ea2c-4228-ba74-5245f457d6f3"
      unitRef="usd">2690000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtMi0xLTEtMA_fe324573-1663-48c1-a7c1-717efedb6f15"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtNC0xLTEtMA_9cb4a5ed-8e68-45f7-bb7d-7395eacd649e"
      unitRef="usdPerShare">-0.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtNi0xLTEtMA_43b6c3d9-202b-4afc-9154-a8add711692b"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjEtOC0xLTEtMA_6bad210f-e526-4d86-9189-525d142e876a"
      unitRef="usdPerShare">2.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItMi0xLTEtMA_817ef201-2673-4330-8458-bbc9c0459c51"
      unitRef="shares">1255000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItNC0xLTEtMA_afe4a809-7062-40b2-8276-3de0b4606282"
      unitRef="shares">1267000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItNi0xLTEtMA_db995722-d092-45d1-9c01-cbf97969c5d3"
      unitRef="shares">1257000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjItOC0xLTEtMA_c2716530-624d-4015-a2a8-d87a9bde5a94"
      unitRef="shares">1271000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtMi0xLTEtMA_d586c26d-20dc-4f6b-8b01-4e24eec59f66"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtNC0xLTEtMA_38044d96-ccbc-4ec2-8a92-f681f5981a36"
      unitRef="usdPerShare">-0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtNi0xLTEtMA_69f8cefb-0962-47c3-a1af-11617c333981"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjMtOC0xLTEtMA_886b01a4-0200-4bec-bf1b-f9799b41c169"
      unitRef="usdPerShare">2.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtMi0xLTEtMA_82e80403-44c9-4d71-b8f0-99bb9ccab110"
      unitRef="shares">1261000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtNC0xLTEtMA_1ae144cc-b97a-438c-bf7d-4b4f9eea85b4"
      unitRef="shares">1267000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtNi0xLTEtMA_fed1a5e0-06a6-4506-b4ac-55b253d80fa9"
      unitRef="shares">1257000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18xOS9mcmFnOjBlYTA3YTlkYzk5YjRlZWVhMTNkMWVmNzhlYTY1ODhlL3RhYmxlOjc0YjBlZDliMThlZDQzMTU5NGRkYzFjMmJlM2Y0NjFmL3RhYmxlcmFuZ2U6NzRiMGVkOWIxOGVkNDMxNTk0ZGRjMWMyYmUzZjQ2MWZfMjQtOC0xLTEtMA_ac290765-8f6c-4639-a0bd-12dd0f3f60fe"
      unitRef="shares">1278000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy0yLTEtMS0w_41f485d2-cf8d-406e-84dd-e00e14d068b5"
      unitRef="usd">353000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy00LTEtMS0w_04e47547-dbd8-4cc9-a103-e3c5b752dd50"
      unitRef="usd">-1168000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy02LTEtMS0w_d6b6bee0-2a63-4e8b-b47a-0378eaf1efcf"
      unitRef="usd">-1455000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMy04LTEtMS0w_d4977638-245d-4a89-bcd4-6fe98f1045f7"
      unitRef="usd">2675000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS0yLTEtMS0w_8a75c10b-6ef8-4dad-a3a4-aeeeac78def2"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS00LTEtMS0w_30f83682-efc0-4c4d-816f-73a25e6c1d81"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS02LTEtMS0w_b666e213-fe07-425a-93ec-925db0f67b1e"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNS04LTEtMS0w_204b1757-a43d-4ed4-bc15-97d45de39038"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy0yLTEtMS0w_64a7bdd8-cb88-4c6e-9228-464fc7414f4b"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy00LTEtMS0w_5a1890bc-146b-4aae-9752-37126d1a10fb"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy02LTEtMS0w_4ea6359c-f74f-4271-a218-2b4d98137e82"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfNy04LTEtMS0w_d16650fa-cd46-400d-b85a-b1806b93d1ab"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC0yLTEtMS0w_7988b93d-b5d3-40e7-9de0-20d0170cd6cc"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC00LTEtMS0w_952cdc56-2d41-4589-ae7e-2a91fb133ef4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC02LTEtMS0w_9cfa77bf-0880-4d42-bb9f-77d826c94684"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOC04LTEtMS0w_4838c9a8-ccc9-44cc-9bfb-eb3c3b0bd0a7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS0yLTEtMS0w_8f0d56ad-d072-4f85-ac3f-7c4957f6eb1f"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS00LTEtMS0w_06485557-96ba-4b6e-b1cf-edc8926bd159"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS02LTEtMS0w_e98c2863-1092-454b-ac75-55b1be10c463"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfOS04LTEtMS0w_c6692efa-3ecb-4167-8e71-d32b701657ce"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtMi0xLTEtMA_65b67633-a6cd-49f5-861b-72c7a8d6492c"
      unitRef="usd">-46000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtNC0xLTEtMA_481f9afd-2bf9-4bc9-9f25-10c3b13f8c9a"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtNi0xLTEtMA_eb481646-c01e-40e7-84f8-324c7ffa18d6"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTEtOC0xLTEtMA_6f1dfb1d-24d4-4370-bcd6-e1d1ee790e31"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItMi0xLTEtMA_9657c61e-4452-48ca-add7-d1aae634632c"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItNC0xLTEtMA_df3523f9-0171-43ce-84c5-246cb4095095"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItNi0xLTEtMA_986b026a-2ba0-4e99-bef1-2524ee6564f2"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTItOC0xLTEtMA_e193e788-7806-4049-a2cc-d24085c4af22"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtMi0xLTEtMA_b7f5fa07-7fc4-427b-b805-35d4f7d065e5"
      unitRef="usd">-57000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtNC0xLTEtMA_760b036e-c630-4118-b2e0-f55ec4191ee6"
      unitRef="usd">38000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtNi0xLTEtMA_ee3ca100-d3a1-477a-b367-6d2765efcb21"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTMtOC0xLTEtMA_a2bfcf95-177b-41bd-834d-e71975f4a752"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtMi0xLTEtMA_604ee536-0e0f-49d2-b4ce-4f05e69a07eb"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtNC0xLTEtMA_0b73b89d-c6ea-47e8-937b-8947beaaaf8f"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtNi0xLTEtMA_0f44ebbd-2bd0-4b4a-930f-f146428bca68"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTQtOC0xLTEtMA_29e3161b-7613-480c-a08f-58af25ba71ee"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtMi0xLTEtMA_08ce28ec-d81c-452c-b119-da30a9d1402f"
      unitRef="usd">306000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtNC0xLTEtMA_1c7bbbcb-9446-4ca9-b5d2-cf8191e8a5ef"
      unitRef="usd">-1153000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtNi0xLTEtMA_09b58e28-9111-4e90-8d3c-909a6deb0b81"
      unitRef="usd">-1517000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTUtOC0xLTEtMA_ae3ca9bd-ada0-4259-9bb0-fbed18ef9f10"
      unitRef="usd">2712000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtMi0xLTEtMA_e80267f2-db0c-4393-8275-76a55ff72d34"
      unitRef="usd">-7000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtNC0xLTEtMA_cef9cd9c-37bc-49a4-b51c-dbd662f7d6b9"
      unitRef="usd">-3000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtNi0xLTEtMA_00d4679f-e3d7-4c90-a348-c6662adbdc73"
      unitRef="usd">-27000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTYtOC0xLTEtMA_cb4ab964-1814-4406-ba6a-4fc6d2a1ff71"
      unitRef="usd">-15000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctMi0xLTEtMA_ee049e22-0d4b-455e-8455-a2e656d76d93"
      unitRef="usd">313000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctNC0xLTEtMA_21588b65-4d89-4609-a754-846cac0632be"
      unitRef="usd">-1150000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctNi0xLTEtMA_393461e8-0955-428d-996e-9c9b4120666e"
      unitRef="usd">-1490000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yMi9mcmFnOmQ2OThiMWVhNmE3NDQzN2E4ZmUxNjRkNWViYjdlNmY3L3RhYmxlOmIzMDViMjNiNGY1NDQ1ZTU5OWQxMDZmMjg1MWNmNDU3L3RhYmxlcmFuZ2U6YjMwNWIyM2I0ZjU0NDVlNTk5ZDEwNmYyODUxY2Y0NTdfMTctOC0xLTEtMA_058bd25a-9bd7-438f-a8e5-f0aa3d70079f"
      unitRef="usd">2727000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ideb48a35fba64fd59df61666f92213c4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0yLTEtMS0w_f2a7b13c-e60d-4de5-870e-b024d271d06b"
      unitRef="shares">1254000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ideb48a35fba64fd59df61666f92213c4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC00LTEtMS0w_f97d2a68-a1bf-4f13-986a-144ec624794d"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e65980547d349c5a71d09c2359de137_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC02LTEtMS0w_e7e4ec34-5273-4573-9ada-cc080a6e0b65"
      unitRef="usd">3511000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i535a6da229a34ac799fa2c08e368ed62_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC04LTEtMS0w_456509a9-62a0-44a6-a73e-2d1450271427"
      unitRef="usd">70000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2e051c6d4e941d495baf35b525c1fcd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0xMC0xLTEtMA_f580ad0f-82d9-433e-b1fd-861377054b86"
      unitRef="usd">14445000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6832292dc744de38ecb457d6fa63dc1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0xMi0xLTEtMA_d7c873b1-199b-42cb-8ddd-b40d06b5040b"
      unitRef="usd">115000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b2c16973a1646478086092143c77e53_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNC0xNC0xLTEtMA_eb719dc7-02ca-4fc8-9e4f-3068753a3806"
      unitRef="usd">18142000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="if40d55dade8445298ddf59323f025103_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNS0xMi0xLTEtMA_7bbf9225-ce03-4786-82fd-d2b4d68e942a"
      unitRef="usd">-82000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNS0xNC0xLTEtMA_825c8bda-6dc7-409a-86ff-98c00baa9876"
      unitRef="usd">-82000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:ProfitLoss
      contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNi0xMC0xLTEtMA_f226e882-02fe-4483-b533-0f86e1bb7d37"
      unitRef="usd">360000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if40d55dade8445298ddf59323f025103_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNi0xMi0xLTEtMA_4261bdec-3e3b-412b-bbfe-c11aeaa5a24b"
      unitRef="usd">-7000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNi0xNC0xLTEtMA_b1aac66c-2d16-4fbb-868f-4472fdc0a475"
      unitRef="usd">353000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy02LTEtMS0w_f30c2a87-8d2f-49d0-9e18-14d4ea3b1e04"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic93b18523ecf4d8cad1a70d4ca601e65_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy04LTEtMS0w_d9694870-831d-43f1-8c39-fae9dda2300c"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy0xMC0xLTEtMA_d2b0e617-c770-44c2-9fab-66ee26ca5e50"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfNy0xNC0xLTEtMA_49ef633c-5c66-4ddf-9744-75680648a718"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i28490f5280b24530b512cc82d79acf78_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0yLTEtMS02NDA2_5cd1c2b6-786d-4494-8de1-ec30ca4c4379"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC02LTEtMS02NDA2_5d8e5f1a-df4d-407b-9481-69dfeff496d8"
      unitRef="usd">34000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0xNC0xLTEtNjQwNg_d564e36d-d2b9-4687-9b94-e32730c4306c"
      unitRef="usd">34000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i28490f5280b24530b512cc82d79acf78_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0yLTEtMS0w_8a7c2db2-ef3e-4d97-90bf-e4cec1510920"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC02LTEtMS0w_608eaf4a-e334-4ce4-abb3-463403b95919"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOC0xNC0xLTEtMA_49a266a4-f43a-4dd5-9c7e-6e52ef8bc4c1"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOS02LTEtMS0w_048c9883-dd88-45aa-8084-cd87ede69b1f"
      unitRef="usd">173000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfOS0xNC0xLTEtMA_76a740b0-66f0-453a-b584-0e2f9c8d83b7"
      unitRef="usd">173000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i28490f5280b24530b512cc82d79acf78_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtMi0xLTEtMA_e0d27a4c-f632-47dc-bf44-739f7d2b0c84"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4c49ad58509d4c5fb2c0b6912e9f7adc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtNi0xLTEtMA_974e14b5-e4f9-427f-b0b6-2ca3578823a7"
      unitRef="usd">9000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtMTAtMS0xLTA_bfbdc870-42bc-4d5d-b086-02245bf2dd0f"
      unitRef="usd">229000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTAtMTQtMS0xLTA_d76b7615-63f2-4cbc-a0e6-019125492539"
      unitRef="usd">238000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmFiZWY0MTgxZmYwYjQ1OGNhZTliNjdmNTVmYWM0YjZlXzI0_47ff7b2b-8488-44ce-b65c-7f840b190630"
      unitRef="usdPerShare">0.68</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="iae4bbbe6f9f7484898d385f1b6413b13_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTEtMTAtMS0xLTA_dafe3397-a3a3-4867-b953-925c074dee73"
      unitRef="usd">866000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTEtMTQtMS0xLTA_8f801ee9-150a-4c3e-930f-6ba487720be2"
      unitRef="usd">866000000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id288e44f34634d5c93fb6b663e378514_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMi0xLTEtMA_1d97ba06-1b2e-478c-9571-055f1ee7c9c7"
      unitRef="shares">1253000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id288e44f34634d5c93fb6b663e378514_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItNC0xLTEtMA_7738ff23-1072-4aae-beec-ba789bee772b"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c997087db1f4d44953e502e4e51d968_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItNi0xLTEtMA_fe298efa-261a-4581-a13d-903a770af91d"
      unitRef="usd">3712000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic20a282f852c4c7dbb87cc18035c48ad_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItOC0xLTEtMA_ce59b526-7334-4101-aadc-3456c9916a04"
      unitRef="usd">23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89e1b216261147f0aa8922793f836cec_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMTAtMS0xLTA_bb88ec79-4bc3-4f15-80ae-b9673d251089"
      unitRef="usd">13709000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92194d01f9f6426db2f230db32348009_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMTItMS0xLTA_fb6052a5-3af2-49a6-890d-30440bed9329"
      unitRef="usd">26000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmMzMmFmNGU3YTFhMjQ1YjM4NjI3ZjcxYWNmNjk5NzViL3RhYmxlcmFuZ2U6YzMyYWY0ZTdhMWEyNDViMzg2MjdmNzFhY2Y2OTk3NWJfMTItMTQtMS0xLTA_9904aff0-4e5a-4201-a35f-6fc26331daf3"
      unitRef="usd">17471000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7e35c67616af43299f00f59e19a5a18d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0yLTEtMS0w_7340b4f8-ecb6-4581-bb69-28ff18159940"
      unitRef="shares">1266000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e35c67616af43299f00f59e19a5a18d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC00LTEtMS0w_cdfec8b6-a7c5-447c-9c39-83b040a3be36"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie738a97278064bb387639c4cf08d5982_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC02LTEtMS0w_8487741b-a6aa-4e46-90a1-0c0efa5698ba"
      unitRef="usd">3051000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i697547cbd3024af6ab47310c99aecd30_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC04LTEtMS0w_a01fabaa-131a-424d-bcc1-5f2c8aca5ddf"
      unitRef="usd">85000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6761db60bfad4d1a83000fe1aa00c987_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0xMC0xLTEtMA_ada0a1ad-1d6c-4e4e-8d5f-4a9f1b73f04a"
      unitRef="usd">19388000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i060edfd2f245412088dbd1d22a228e8c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0xMi0xLTEtMA_fc6c6fc6-a2ec-4d4d-a67d-7e7dd2a6ada4"
      unitRef="usd">125000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNC0xNC0xLTEtMA_01ddbf44-b5eb-4970-9b60-92a0a334f9cb"
      unitRef="usd">22650000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i1359c5ce919042c9b30bbb420ab9f586_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNS0xMC0xLTEtMA_c96a6244-5b57-4b26-8ba5-ee0a00b96779"
      unitRef="usd">-7000000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i3d7a75396cae46eaa5a500fd466bed84_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNS0xNC0xLTEtMA_4990616f-bd0c-4002-b845-d8d4a0e61486"
      unitRef="usd">-7000000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i286718c980e742f3ad7ff5fa3cb8d52e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNi0xMi0xLTEtMA_fb20bbfc-8f62-441d-a1aa-a5c60e92b6a2"
      unitRef="usd">-72000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNi0xNC0xLTEtMA_e12b445c-2eac-413e-b45b-25579214f114"
      unitRef="usd">-72000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:ProfitLoss
      contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNy0xMC0xLTEtMA_f359619a-a16f-4310-90e6-fb483b7b83b5"
      unitRef="usd">-1428000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i286718c980e742f3ad7ff5fa3cb8d52e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNy0xMi0xLTEtMA_22488609-e078-485b-a472-446560329f7c"
      unitRef="usd">-27000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfNy0xNC0xLTEtMA_eedcb353-ef52-4a6f-a087-a5a0f718cc86"
      unitRef="usd">-1455000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC02LTEtMS0w_23f43c92-f6f1-4f75-a7df-a2490fd82703"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC04LTEtMS0w_3e0a955c-0ef1-4949-ad42-23e6de364927"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC0xMC0xLTEtMA_1d846e2f-dd05-4fbd-8918-6262d7ae8b55"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOC0xNC0xLTEtMA_13acd8b3-7d67-472d-9486-a8a94aa0de50"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOS0yLTEtMS0w_96fc6d42-6d25-4505-a7b7-450accb9fc17"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOS02LTEtMS0w_f74e3ad5-274e-44c9-8fd0-dd81f4fb6366"
      unitRef="usd">100000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfOS0xNC0xLTEtMA_0cfc090a-b83e-4332-8ea1-b08ce1ac4ce6"
      unitRef="usd">100000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTAtMi0xLTEtMA_07dd0866-4029-40a3-9172-7fe6acc14890"
      unitRef="shares">10000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTAtNi0xLTEtMA_b3149711-8d1e-4b2d-b5ec-237d1ae0afe5"
      unitRef="usd">148000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTAtMTQtMS0xLTA_6cfd2e80-55a2-4aea-a931-7b0ec5bee189"
      unitRef="usd">148000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTEtNi0xLTEtMA_18010eba-99e0-47f4-9183-bd747a7e9582"
      unitRef="usd">482000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTEtMTQtMS0xLTA_341a6a1c-91b3-4cec-a79a-9c4ee4cf3e90"
      unitRef="usd">482000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iaccb5d808e4f47fb80f35f0250ed382a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItMi0xLTEtMA_7de95830-331f-4369-b1d9-37afe3cfe442"
      unitRef="shares">25000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib838fa5566d74e9598a90f0f603cb68e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItNi0xLTEtMA_3c4418e8-67a7-4823-a7e4-97eeb9529c28"
      unitRef="usd">70000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItMTAtMS0xLTA_9a91b743-39cb-40fc-ac18-76abf9d3e4c2"
      unitRef="usd">1644000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTItMTQtMS0xLTA_a43b0c55-b48e-4760-acd6-5d035ef3eb69"
      unitRef="usd">1714000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjM5Y2RlNWJjNDBkMjRhMDg4MjYzMTk0ZmI1ZDJhMjIzXzI0_a9288b6a-a1cf-41e1-b26f-b830f7a04a7e"
      unitRef="usdPerShare">2.04</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i204f0504916b49cda213142878d3d673_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTMtMTAtMS0xLTA_561ce167-f2f0-4024-aefa-655d6d762a04"
      unitRef="usd">2599000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTMtMTQtMS0xLTA_ca897cf3-513f-45ef-894c-35256c004de7"
      unitRef="usd">2599000000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id288e44f34634d5c93fb6b663e378514_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMi0xLTEtMA_0751f2f7-eee3-4b99-b523-331831f0f026"
      unitRef="shares">1253000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id288e44f34634d5c93fb6b663e378514_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtNC0xLTEtMA_5e3d22e4-2c87-4b2b-85cf-b3ca28d716ed"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c997087db1f4d44953e502e4e51d968_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtNi0xLTEtMA_41865193-18fd-4011-aefd-261489ee2084"
      unitRef="usd">3712000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic20a282f852c4c7dbb87cc18035c48ad_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtOC0xLTEtMA_27f02500-a170-424e-9cd7-8442a4fcb41b"
      unitRef="usd">23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89e1b216261147f0aa8922793f836cec_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMTAtMS0xLTA_2cb5e0cb-51e7-49c7-b8d2-8e8130f8e0f0"
      unitRef="usd">13709000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92194d01f9f6426db2f230db32348009_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMTItMS0xLTA_ddeddf9e-c560-47f5-beb8-80d0bc3a98cf"
      unitRef="usd">26000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjk0OTM5YWNhNTY1MTQ5MjJiOTVhZDBjYzIxMWMzMjYwL3RhYmxlcmFuZ2U6OTQ5MzlhY2E1NjUxNDkyMmI5NWFkMGNjMjExYzMyNjBfMTQtMTQtMS0xLTA_113603a4-7192-4b31-befb-2b67011b5098"
      unitRef="usd">17471000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib63cbbf9eb664b268663f0c27aa85f33_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0yLTEtMS0w_0caebacd-3ae6-423a-a66e-6ce261de5c53"
      unitRef="shares">1267000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib63cbbf9eb664b268663f0c27aa85f33_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC00LTEtMS0w_6bd41fc3-5c79-4fca-8987-8c8fb5548855"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i510270b913b147c08dd65ad6c95c2caa_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC02LTEtMS0w_d80da830-7253-46e9-8f5e-9532e985fa93"
      unitRef="usd">2684000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86be1800e75d42dcba0a3eb9a98551a3_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC04LTEtMS0w_cf31b5fd-42b5-4f26-876a-5c85b701e547"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic72dfa28da994e0a853f4aad7f2a6e63_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0xMC0xLTEtMA_54a3beec-c1eb-415d-aff4-970fada69559"
      unitRef="usd">19829000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ae5dc2210454fa58a3557195e59fdba_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0xMi0xLTEtMA_71d07368-0d6c-4c8e-bc2e-91853815fbcb"
      unitRef="usd">135000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ed0ecdfb5ae4e86a678c62132da6ab3_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNC0xNC0xLTEtMA_0130ebf6-2d9c-4516-9926-573d6411bc5d"
      unitRef="usd">22751000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNS0xMC0xLTEtMA_e460ae51-6367-483d-8e23-9bb49acf6dde"
      unitRef="usd">-1165000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i79bf3801a1984d3280d2a88a5644d5f3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNS0xMi0xLTEtMA_6530d65d-0b0b-4ae0-ba79-752c307ce874"
      unitRef="usd">-3000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNS0xNC0xLTEtMA_c5921b4b-ad3e-4d1d-8b15-bc08420bbb86"
      unitRef="usd">-1168000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifc1677cc7c59497aa73455736d88394f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNi04LTEtMS0w_70abe768-c856-4292-a2ac-f70d6332daf3"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNi0xNC0xLTEtMA_56c1e62e-7ef2-4865-8fff-0673f075ebda"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0yLTEtMS0xMjg2_9aabec1b-766a-4f9b-b694-b0bd56b82cdb"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy02LTEtMS0xMjg2_f6b0334c-df50-4af9-b081-4ef962c36c7c"
      unitRef="usd">27000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0xNC0xLTEtMTI4Ng_de8a5392-e2b1-46b2-a8e9-1c23de77c69c"
      unitRef="usd">27000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0yLTEtMS0w_74e371b8-69ff-476b-b231-5599eea7ba79"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy02LTEtMS0w_5b746e1b-0b1f-47f0-869f-68e1f164b77b"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfNy0xNC0xLTEtMA_9dae47a2-3879-416f-b191-ccc2fa6af51b"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOC02LTEtMS0w_da504005-1338-43f6-b7a8-2da01ab0429f"
      unitRef="usd">160000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOC0xNC0xLTEtMA_90d8f1aa-534c-42ee-9e46-b9bb6279237d"
      unitRef="usd">160000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i1748686714964d3ca2273820c5d7ce71_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS0yLTEtMS0w_7dcb9384-63fc-43ba-8276-f59316f82131"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i71d071b210df40e2a6dd4af16ed49070_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS02LTEtMS0w_45b18235-f610-4a26-821d-7b736ce34814"
      unitRef="usd">11000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS0xMC0xLTEtMA_37a4d529-7fd0-4083-ac26-a841a0aaeefa"
      unitRef="usd">241000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfOS0xNC0xLTEtMA_10589a38-893c-45ff-848c-0f29c5b94a5b"
      unitRef="usd">252000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOmU0NWY4NDNmNmE0YzQxYzc5ZDljNjliYTNmY2Q0NzY0XzI0_f7cf66ae-379f-404c-878b-bbbdf27b3195"
      unitRef="usdPerShare">0.63</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i0dfb4067d7ed4efda5a71b457addfa11_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTAtMTAtMS0xLTA_f05075ee-cf1b-48c8-907f-1a0f586d794d"
      unitRef="usd">807000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTAtMTQtMS0xLTA_86f323a9-0f22-4e41-935c-92214673aede"
      unitRef="usd">807000000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMi0xLTEtMA_bd6f8bce-d352-43af-99b5-16797ec8598d"
      unitRef="shares">1266000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtNC0xLTEtMA_9e07ea85-7044-4dca-86a9-d4780f591eb3"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7ee747ba17a4a47a3ef814fd196e4fc_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtNi0xLTEtMA_8fb24c20-3dbe-4423-9af3-6e03a7058bc0"
      unitRef="usd">2870000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0d3e46703834e0098456a41f5ef8be5_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtOC0xLTEtMA_bd7bfbe0-3661-49c1-a5a5-7149e784918f"
      unitRef="usd">117000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iecaaaabb21fa447299f1e341b4985cce_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMTAtMS0xLTA_a84e3b4b-a33b-4a04-a982-aee010db2c6b"
      unitRef="usd">17616000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ea68edf9adb482a984d6a2f46ed8c18_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMTItMS0xLTA_0a4aa86e-74cf-49d5-9661-be127b774fde"
      unitRef="usd">132000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95de9d6ff3964391ab5aa52b050944f9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOjA3YWRiZjIxMjkzZTQ4NjJiZjIzNzYzNWViNThlNGE5L3RhYmxlcmFuZ2U6MDdhZGJmMjEyOTNlNDg2MmJmMjM3NjM1ZWI1OGU0YTlfMTEtMTQtMS0xLTA_11916152-1793-442c-ae81-967c372280d7"
      unitRef="usd">20736000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1572613d4ff74b2786f78674a86e1d1d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0yLTEtMS0w_fa435f0d-d443-47f4-8d8c-2a540cd4847a"
      unitRef="shares">1282000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1572613d4ff74b2786f78674a86e1d1d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC00LTEtMS0w_ecbb2164-d532-4ada-ab38-1ef13efce8a5"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic66670c48dad4abbaf4a7e4afd0bfce3_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC02LTEtMS0w_8494755d-79f0-4b7c-856e-48a8e0e3a246"
      unitRef="usd">2282000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8d14e1d51864d97b88c87da0f398d28_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC04LTEtMS0w_d48943c0-e35b-4d69-8e29-c46054651dc2"
      unitRef="usd">80000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic339b862d834437592eff9f1aeb8752a_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0xMC0xLTEtMA_d7153ac9-4b0f-4e88-b5ea-93ac6ec2d5ed"
      unitRef="usd">19024000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib374a36c14ac45c0817de5c423a7dc5c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0xMi0xLTEtMA_a2b63018-77e9-4abf-9ea3-f52ef3aca35c"
      unitRef="usd">147000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e8b0210f3494723826b5d6eaf202e5f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNC0xNC0xLTEtMA_24c94557-026b-4df9-99fb-cf3eaf4d6856"
      unitRef="usd">21534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="icbf61511cccd4d31be2efc81754d695f_I20190101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNS0xMC0xLTEtMA_98c0f9c1-9755-4552-9db2-03015786d458"
      unitRef="usd">8000000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i042635c737c840d7a0b0cc891e439e49_I20190101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNS0xNC0xLTEtMA_7984dd6e-6756-489c-9e5a-7df1022883e3"
      unitRef="usd">8000000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:ProfitLoss
      contextRef="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNi0xMC0xLTEtMA_b251bade-4abd-48b8-854f-4474f832830b"
      unitRef="usd">2690000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5c95cf4710d74cd08f24a559657ba257_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNi0xMi0xLTEtMA_ff87fc44-491b-4e80-b23e-cf54ef731601"
      unitRef="usd">-15000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNi0xNC0xLTEtMA_7b3f3127-3cbd-4b39-9293-6eb586550f7d"
      unitRef="usd">2675000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNy04LTEtMS0w_7ce1f6a0-c47c-4a00-8f45-d05ee58e2fb1"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfNy0xNC0xLTEtMA_3df9b99b-8bd7-4eb4-845d-1d1c7a61b303"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOC0yLTEtMS0w_4f782ec5-8a07-4681-b6ff-83287973e29d"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOC02LTEtMS0w_48ac2639-89a1-47f5-b4b7-7ea5182e7661"
      unitRef="usd">90000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOC0xNC0xLTEtMA_df701541-fed1-4672-a44d-864fcc6e8fa1"
      unitRef="usd">90000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOS0yLTEtMS0w_bac94b18-0df9-49b6-94e7-3c600242a201"
      unitRef="shares">8000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOS02LTEtMS0w_712b5c1c-7d9a-4088-8ca1-f56c3536a10f"
      unitRef="usd">92000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfOS0xNC0xLTEtMA_a423dbd6-3a4b-4996-a233-688e4b330a10"
      unitRef="usd">92000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTAtNi0xLTEtMA_e43efb2a-0478-4cb0-a33c-96b2c2eca9a2"
      unitRef="usd">479000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTAtMTQtMS0xLTA_70ef217f-f0fc-4979-89a1-d74b8cc97709"
      unitRef="usd">479000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id9bc6c39da024cd990f1e7f27f85e3e5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtMi0xLTEtMA_fbfe9d96-231a-43ad-87d8-bb368ebc36ce"
      unitRef="shares">26000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i110b9cc08563489b822c59613b540894_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtNi0xLTEtMA_e154c8e8-87b7-4dfd-b636-a237d5a73ece"
      unitRef="usd">73000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtMTAtMS0xLTA_e0ec3e34-4193-40bb-b2b4-5f6b7b168b84"
      unitRef="usd">1675000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTEtMTQtMS0xLTA_66f53d17-c02b-42b6-b381-5a93434e30f6"
      unitRef="usd">1748000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmMxNmU3YzA2MTBjNzRhNzQ5YTBlYjA2Zjk4MzI3MjVlXzI0_77f33284-e1a3-40a9-81ba-fade490d08d9"
      unitRef="usdPerShare">1.89</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i8989b510a0644298bacf33d2a58b508b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTItMTAtMS0xLTA_780645ba-d077-4b37-89f1-3d3c5d9305ea"
      unitRef="usd">2431000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTItMTQtMS0xLTA_2d3cc34a-a489-4992-9106-632c4e899b17"
      unitRef="usd">2431000000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMi0xLTEtMA_6a0203aa-2994-46a1-9aab-6138e65d1cbf"
      unitRef="shares">1266000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i156fd24197fc427e8672e730ff2e10b0_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtNC0xLTEtMA_d73646d2-6425-4d9f-b32e-de1a406708af"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7ee747ba17a4a47a3ef814fd196e4fc_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtNi0xLTEtMA_4f70b9d6-ed06-4368-9f28-93453b18dd98"
      unitRef="usd">2870000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0d3e46703834e0098456a41f5ef8be5_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtOC0xLTEtMA_53da46f4-8e2c-49b9-b5fc-f6ba20d0b2f0"
      unitRef="usd">117000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iecaaaabb21fa447299f1e341b4985cce_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMTAtMS0xLTA_fb0f5d82-9835-4a82-a85f-569b75daae46"
      unitRef="usd">17616000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ea68edf9adb482a984d6a2f46ed8c18_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMTItMS0xLTA_6c851c31-1b36-4b4b-b094-4f5a295ec451"
      unitRef="usd">132000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95de9d6ff3964391ab5aa52b050944f9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yNS9mcmFnOjUzZjdlODcxODgyNTQzYjk5NTg3YTRlZWQ3YThlYmY4L3RhYmxlOmRkN2RhMjQ1ZmJlYTRkMDQ4Y2NjMTM2MzMzNWNkN2VhL3RhYmxlcmFuZ2U6ZGQ3ZGEyNDVmYmVhNGQwNDhjY2MxMzYzMzM1Y2Q3ZWFfMTMtMTQtMS0xLTA_c02889e0-87c4-47f2-afd5-89398db73923"
      unitRef="usd">20736000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNC0yLTEtMS0w_8829470c-f607-40ba-bc55-dcbd287f0173"
      unitRef="usd">-1455000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNC00LTEtMS0w_c50877f0-a325-40b3-97be-bd11b0a2e6af"
      unitRef="usd">2675000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNi0yLTEtMS0w_64ac9a5e-ff20-4154-83b2-939d2173a7c9"
      unitRef="usd">209000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNi00LTEtMS0w_411d29a8-8140-4abe-b458-19246e16cc8c"
      unitRef="usd">186000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNy0yLTEtMS0w_a9a69600-a6c1-48b1-b912-87054d2b11ab"
      unitRef="usd">844000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNy00LTEtMS0w_67caf5f7-df25-4715-9cfb-1b90854dc69d"
      unitRef="usd">868000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOC0yLTEtMS0w_ea2e5e88-7a6d-41a5-ae50-b70f0f855ec0"
      unitRef="usd">482000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOC00LTEtMS0w_85a3fe17-f144-4ec4-af7a-ba8873830326"
      unitRef="usd">479000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOS0yLTEtMS0w_3e29f232-421c-4cfe-ba3d-209d2a0c882e"
      unitRef="usd">5792000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfOS00LTEtMS0w_dda6d751-889f-4731-ae7f-0ede34c4fa64"
      unitRef="usd">4251000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTAtMi0xLTEtMA_f10fb602-e14c-46f6-a1a5-ffb268369feb"
      unitRef="usd">-12000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTAtNC0xLTEtMA_a9e4a1aa-af89-47c3-b087-adb607d46203"
      unitRef="usd">-796000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTEtMi0xLTEtMA_63f76db4-613c-4db5-9bee-2b288b6e834f"
      unitRef="usd">-1046000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTEtNC0xLTEtMA_1890ffba-ce16-44b8-a47c-0b4b8fe4340b"
      unitRef="usd">312000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTItMi0xLTEtMA_562202a0-24f7-4114-bb47-8d74f073854c"
      unitRef="usd">-210000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTItNC0xLTEtMA_6b842449-1f40-4335-b76c-080e9a71fe36"
      unitRef="usd">-199000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTQtMi0xLTEtMA_1fb6cfde-02a1-4731-9f4d-de1d3d114c60"
      unitRef="usd">334000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTQtNC0xLTEtMA_190300a7-ce96-4246-a38b-9ccfdec65cf6"
      unitRef="usd">-33000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTUtMi0xLTEtMA_1d127dae-ca03-412e-855c-3be35ece496e"
      unitRef="usd">48000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTUtNC0xLTEtMA_e691247b-b0be-4141-9535-2126c425a453"
      unitRef="usd">35000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTYtMi0xLTEtMA_8d7996a8-02f0-4c71-b724-fde6cc0c3c45"
      unitRef="usd">-22000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTYtNC0xLTEtMA_71ce0017-12bf-4b7c-bad5-14a51fe095df"
      unitRef="usd">225000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTctMi0xLTEtMA_a5ef6b64-ef5f-4f7c-bfe6-f1190358b3c2"
      unitRef="usd">-134000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTctNC0xLTEtMA_da09216c-67bf-423e-82aa-93f792c08ce1"
      unitRef="usd">-142000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTgtMi0xLTEtMA_00834d82-0b39-487d-b03c-f6a1506b3ce7"
      unitRef="usd">-428000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTgtNC0xLTEtMA_ed9fd5f5-b198-494f-9e36-bb0ca2892f50"
      unitRef="usd">107000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTktMi0xLTEtMA_72368956-ca2b-4f5b-ac5c-5fda3880c59c"
      unitRef="usd">58000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMTktNC0xLTEtMA_7195537d-c876-4a8a-99d8-adfe22887cd1"
      unitRef="usd">-724000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjAtMi0xLTEtMA_c5a0e310-3928-4d6b-83d8-98c0b75693b6"
      unitRef="usd">6252000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjAtNC0xLTEtMA_c761a37d-af9f-4f58-8b93-22a546380919"
      unitRef="usd">6564000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjItMi0xLTEtMA_bb3ca915-e442-4e8e-af44-522e537609c1"
      unitRef="usd">19809000000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjItNC0xLTEtMA_5571b06d-dda9-4ffa-89e8-76404831fa91"
      unitRef="usd">24057000000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjMtMi0xLTEtMA_a9854e0e-6407-4e92-b6ea-5078a029a999"
      unitRef="usd">12367000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjMtNC0xLTEtMA_8ac6e812-549f-4bc5-9b50-788f74be1d7f"
      unitRef="usd">4522000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjQtMi0xLTEtMA_07861082-84a0-4079-a4b9-e0dbe996ed3b"
      unitRef="usd">8528000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjQtNC0xLTEtMA_e04a59bc-53d5-4e16-89f1-4d58cd7d7fad"
      unitRef="usd">17639000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjUtMi0xLTEtMA_30db6f9b-901a-4425-aba0-d3dee27ea616"
      unitRef="usd">5804000000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjUtNC0xLTEtMA_2db7e955-6b67-4aa6-97ee-35c33aa340ab"
      unitRef="usd">4251000000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjYtMi0xLTEtMA_0c2c3d33-450e-4f22-a8e2-9b68f551ec1a"
      unitRef="usd">388000000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjYtNC0xLTEtMA_81c05a0e-dc32-43be-bc03-382b37f362a5"
      unitRef="usd">1251000000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjctMi0xLTEtMA_036a7820-4d6c-418c-b0fb-78877a751764"
      unitRef="usd">469000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjctNC0xLTEtMA_d9094595-47ed-4963-a115-baa9a61d6daf"
      unitRef="usd">622000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjgtMi0xLTEtMA_e058e28d-844c-47d0-8e9b-844821f91df4"
      unitRef="usd">63000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjgtNC0xLTEtMA_ab5caa94-f489-4af2-8841-3716a168adc0"
      unitRef="usd">228000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjktMi0xLTEtMA_e8d3ee15-86ff-4398-b340-076d96dfc016"
      unitRef="usd">-5638000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMjktNC0xLTEtMA_55d76d1f-f933-45cc-8b6c-25341987d2a5"
      unitRef="usd">-8248000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtMi0xLTEtNjQ0Ng_2839f120-66fb-4850-b091-44e2ddd3c487"
      unitRef="usd">7189000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtNC0xLTEtNjQ0Ng_e3e8e80a-f10c-4830-a1a4-c371ecd64e15"
      unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtMi0xLTEtMA_18894bdd-30c8-4f4f-87d3-1ad5efad92ca"
      unitRef="usd">248000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzEtNC0xLTEtMA_1ef943ec-c572-4ee6-bf79-edcf93c72df6"
      unitRef="usd">182000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzItMi0xLTEtMA_2a6814d3-bcba-4a08-9b26-926327312182"
      unitRef="usd">1583000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzItNC0xLTEtMA_b12b14e1-e94b-4c62-a608-313dc763e0dc"
      unitRef="usd">1644000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:RepaymentsOfDebt
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzMtMi0xLTEtMA_d61266ad-eb0f-4e50-8c3b-ae7f85529066"
      unitRef="usd">2500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzMtNC0xLTEtMA_bfeef7e8-61f1-4ed7-b1b8-8b755b003a94"
      unitRef="usd">2750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzQtMi0xLTEtMA_b44b86c9-88d8-4462-ae6e-cf4c2bf51ff0"
      unitRef="usd">2591000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzQtNC0xLTEtMA_0d43264d-97fa-4cff-87c7-2181cd6237e4"
      unitRef="usd">2421000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzUtMi0xLTEtMA_8d62e467-da72-4230-943c-6a7c08e2b28a"
      unitRef="usd">-124000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzUtNC0xLTEtMA_83d34476-3e33-4ffc-b4d0-d1032682f587"
      unitRef="usd">-105000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzYtMi0xLTEtMA_f438d7f1-4d02-4e4a-894c-a7b0047746ba"
      unitRef="usd">639000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzYtNC0xLTEtMA_998b368b-b06f-4467-8202-9bea091f83e5"
      unitRef="usd">-6738000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzctMi0xLTEtMA_ada2adfd-c223-4282-8059-3421048c0b64"
      unitRef="usd">2000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzctNC0xLTEtMA_fd5242d0-dfb8-4e57-8fce-4f9ce719a39e"
      unitRef="usd">-44000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzgtMi0xLTEtMA_788c5693-90cd-46ac-a2d1-07981fa1340c"
      unitRef="usd">1255000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzgtNC0xLTEtMA_4236dea7-e950-4830-9ee7-c5f9590e82b8"
      unitRef="usd">-8466000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzktMi0xLTEtMA_66d7288c-4dac-4f51-b5d3-c20e5da879ba"
      unitRef="usd">11631000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9e8b0210f3494723826b5d6eaf202e5f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfMzktNC0xLTEtMA_676989ad-6ee1-416e-8ab4-3a076c9db2f2"
      unitRef="usd">17940000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNDAtMi0xLTEtMA_03716fca-6263-4768-925f-41ee621f8c52"
      unitRef="usd">12886000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i95de9d6ff3964391ab5aa52b050944f9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18yOC9mcmFnOmM3MTc3MzVlNjAzOTRiMWFhZTNiOGE1ZDY0NzYyY2Y2L3RhYmxlOjI5NzNiZjdiMmM1NzQ1ZjZiNDUwODExMGExZWVhNTRmL3RhYmxlcmFuZ2U6Mjk3M2JmN2IyYzU3NDVmNmI0NTA4MTEwYTFlZWE1NGZfNDAtNC0xLTEtMA_9b88893e-3f31-43f2-a19c-74b2e88791b4"
      unitRef="usd">9474000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzYwNQ_8c15160f-3317-479a-bc5f-04d4d6790cee">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES &lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. The financial statements include all adjustments consisting of normal recurring adjustments that the management of Gilead Sciences, Inc. (&#x201c;Gilead&#x201d;, &#x201c;we&#x201d;, &#x201c;our&#x201d; or &#x201c;us&#x201d;) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements include the accounts of Gilead, our wholly-owned subsidiaries and certain variable interest entities for which we are the primary beneficiary. All intercompany transactions have been eliminated. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess whether we are the primary beneficiary of a variable interest entity (&#x201c;VIE&#x201d;) at the inception of the arrangement and at each reporting date. This assessment is based on our power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements and related Notes to Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December&#160;31, 2019, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one operating segment, which focuses on the discovery, development and commercialization of innovative medicines in areas of unmet medical need. Our Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision-maker, manages and allocates resources to the operations of our company on an entity-wide basis. Managing and allocating resources on an entity-wide basis enables our CEO to assess the overall level of resources available and how to best deploy these resources across functions and research and development (&#x201c;R&amp;amp;D&#x201d;) projects based on unmet medical need and, as necessary, reallocate resources among our internal R&amp;amp;D portfolio and external opportunities to best support the long-term growth of our business. See Note 2. Revenues for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Accounting Policies, Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of these Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. On an ongoing basis, we evaluate our significant accounting policies and estimates. We base our estimates on historical experience and on various market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent coronavirus disease (&#x201c;COVID-19&#x201d;) could have on our significant accounting estimates. Actual results could differ materially from these estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain amounts for the three and nine months ended September 30, 2019 were reclassified to conform to the current period presentation. Beginning in the second quarter of 2020, acquired in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) expenses are reported separately from Research and development expenses on our Condensed Consolidated Statements of Operations. Acquired IPR&amp;amp;D expenses reflect IPR&amp;amp;D impairments as well as the initial costs of externally developed IPR&amp;amp;D projects, acquired directly in a transaction other than a business combination, that do not have an alternative future use, including upfront payments related to various collaborations and the initial costs of rights to IPR&amp;amp;D projects. Our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019, has been conformed to separately present acquired IPR&amp;amp;D expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to credit risk from our portfolio of cash equivalents and marketable securities. Under our investment policy, we limit amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. We are not exposed to any significant concentrations of credit risk from our investment portfolio. The goals of our investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and a competitive after-tax rate of return. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also subject to credit risk from our accounts receivable related to our product sales. Trade accounts receivable are recorded net of allowances for wholesaler chargebacks related to government and other programs, cash discounts for prompt payment and credit losses. Estimates of our allowance for credit losses consider a number of factors including existing contractual payment terms, individual customer circumstances, historical payment patterns of our customers, a review of the local economic environment and its potential impact on expected future customer payment patterns and government funding and reimbursement practices. The majority of our trade accounts receivable arises from product sales in the United States, Europe and Japan. Our allowance for credit losses was $47 million as of September&#160;30, 2020 and January 1, 2020. There were no material write-offs charged against the allowance for the three and nine months ended September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016,&#160;the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update No. 2016-13 &#x201c;Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments&#x201d; and has since modified the standard with several ASUs (collectively, &#x201c;Topic 326&#x201d;).&#160;Topic 326 requires measurement and recognition of expected credit losses for financial assets. On January 1, 2020, we adopted this standard using a modified retrospective approach.&#160;The adoption did not have a material impact on our Condensed Consolidated Financial Statements. In connection with the adoption of Topic 326, we made an accounting policy election to not measure an allowance for credit losses for accrued interest receivable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018,&#160;the FASB issued Accounting Standards Update No. 2018-18 &#x201c;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#x201d; (&#x201c;ASU 2018-18&#x201d;).&#160;ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606, &#x201c;Revenue from Contracts with Customers&#x201d; when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as customer revenue if the counterparty is not a customer for that transaction. On January 1, 2020, we adopted this standard and applied it retrospectively to January 1, 2018 when we initially adopted Topic 606. The adoption did not have an impact on our Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU5Mw_7b485bf8-4aee-4220-8de2-a346eb1981f4">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. The financial statements include all adjustments consisting of normal recurring adjustments that the management of Gilead Sciences, Inc. (&#x201c;Gilead&#x201d;, &#x201c;we&#x201d;, &#x201c;our&#x201d; or &#x201c;us&#x201d;) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements include the accounts of Gilead, our wholly-owned subsidiaries and certain variable interest entities for which we are the primary beneficiary. All intercompany transactions have been eliminated. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess whether we are the primary beneficiary of a variable interest entity (&#x201c;VIE&#x201d;) at the inception of the arrangement and at each reporting date. This assessment is based on our power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;The accompanying Condensed Consolidated Financial Statements and related Notes to Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December&#160;31, 2019, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU3NQ_072f5def-73b2-4974-ac05-8762b2468dd2">Segment Information We have one operating segment, which focuses on the discovery, development and commercialization of innovative medicines in areas of unmet medical need. Our Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision-maker, manages and allocates resources to the operations of our company on an entity-wide basis. Managing and allocating resources on an entity-wide basis enables our CEO to assess the overall level of resources available and how to best deploy these resources across functions and research and development (&#x201c;R&amp;amp;D&#x201d;) projects based on unmet medical need and, as necessary, reallocate resources among our internal R&amp;amp;D portfolio and external opportunities to best support the long-term growth of our business.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfMTgwNQ_dd6b9846-2c6b-42ca-95cc-44694273e3ef"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:UseOfEstimates
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU3Mw_b94f2fa0-9bb0-4271-8fa7-ef37963b8283">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Accounting Policies, Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of these Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. On an ongoing basis, we evaluate our significant accounting policies and estimates. We base our estimates on historical experience and on various market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent coronavirus disease (&#x201c;COVID-19&#x201d;) could have on our significant accounting estimates. Actual results could differ materially from these estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU4MA_2465c7ff-cf25-4284-9099-c2cad35c93d3">ReclassificationCertain amounts for the three and nine months ended September 30, 2019 were reclassified to conform to the current period presentation. Beginning in the second quarter of 2020, acquired in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) expenses are reported separately from Research and development expenses on our Condensed Consolidated Statements of Operations. Acquired IPR&amp;amp;D expenses reflect IPR&amp;amp;D impairments as well as the initial costs of externally developed IPR&amp;amp;D projects, acquired directly in a transaction other than a business combination, that do not have an alternative future use, including upfront payments related to various collaborations and the initial costs of rights to IPR&amp;amp;D projects. Our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019, has been conformed to separately present acquired IPR&amp;amp;D expenses.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzU2MA_b3eaa43f-b460-435d-8681-1996585f098e">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to credit risk from our portfolio of cash equivalents and marketable securities. Under our investment policy, we limit amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. We are not exposed to any significant concentrations of credit risk from our investment portfolio. The goals of our investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and a competitive after-tax rate of return. &lt;/span&gt;&lt;/div&gt;We are also subject to credit risk from our accounts receivable related to our product sales. Trade accounts receivable are recorded net of allowances for wholesaler chargebacks related to government and other programs, cash discounts for prompt payment and credit losses. Estimates of our allowance for credit losses consider a number of factors including existing contractual payment terms, individual customer circumstances, historical payment patterns of our customers, a review of the local economic environment and its potential impact on expected future customer payment patterns and government funding and reimbursement practices.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i405be8dac8594d43b53d27d487d15bf5_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjA1Mw_1dd9ca40-7230-467b-81b9-e4db0c3f8f22"
      unitRef="usd">47000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjA1Mw_e6f8e6a3-b9c4-4fd1-9915-d11bc7af7d56"
      unitRef="usd">47000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjExMQ_43c2ab1a-3065-44b7-94b1-06f7af2d6e70"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNjExMQ_8705b6fc-0e31-407c-9a78-f378aadf2f18"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNC9mcmFnOjU0NmM0NTg1ZGUyMzQzMWI5OGMxNmNiZWU2MGRmMGQ2L3RleHRyZWdpb246NTQ2YzQ1ODVkZTIzNDMxYjk4YzE2Y2JlZTYwZGYwZDZfNzYwMw_72b15f93-bcbe-4c3e-9cc9-fbeff385534a">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016,&#160;the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update No. 2016-13 &#x201c;Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments&#x201d; and has since modified the standard with several ASUs (collectively, &#x201c;Topic 326&#x201d;).&#160;Topic 326 requires measurement and recognition of expected credit losses for financial assets. On January 1, 2020, we adopted this standard using a modified retrospective approach.&#160;The adoption did not have a material impact on our Condensed Consolidated Financial Statements. In connection with the adoption of Topic 326, we made an accounting policy election to not measure an allowance for credit losses for accrued interest receivable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018,&#160;the FASB issued Accounting Standards Update No. 2018-18 &#x201c;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#x201d; (&#x201c;ASU 2018-18&#x201d;).&#160;ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606, &#x201c;Revenue from Contracts with Customers&#x201d; when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as customer revenue if the counterparty is not a customer for that transaction. On January 1, 2020, we adopted this standard and applied it retrospectively to January 1, 2018 when we initially adopted Topic 606. The adoption did not have an impact on our Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNzE0NjgyNTU4MzM0NA_1ded7b40-3b60-48e6-a150-dc93c64838e9">REVENUES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates our product sales by product and geographic region and disaggregates our royalty, contract and other revenues by geographic region (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:9.5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Atripla&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Biktarvy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Complera/Eviplera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Descovy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Genvoya&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Odefsey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stribild&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Truvada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other HIV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue share &#x2013; Symtuza&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AmBisome&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ledipasvir/Sofosbuvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Letairis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ranexa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sofosbuvir/Velpatasvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Veklury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vemlidy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Viread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vosevi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Yescarta&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Zydelig&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalty, contract and other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9.5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Atripla&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Biktarvy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Complera/Eviplera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Descovy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Genvoya&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Odefsey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stribild&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Truvada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other HIV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue share &#x2013; Symtuza&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AmBisome&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ledipasvir/Sofosbuvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Letairis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ranexa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sofosbuvir/Velpatasvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Veklury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vemlidy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Viread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vosevi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Yescarta&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Zydelig&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalty, contract and other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:96.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;________________________________&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Includes Emtriva and Tybost.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Represents our revenue from cobicistat (C), emtricitabine (FTC) and tenofovir alafenamide (TAF) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland UC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts consist of sales of Harvoni and the authorized generic version of Harvoni sold by our separate subsidiary, Asegua Therapeutics LLC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by our separate subsidiary, Asegua Therapeutics LLC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Includes Cayston, Hepsera, Sovaldi and Tecartus. Europe product sales included unfavorable adjustments recorded in 2019 for statutory rebates related to sales of Sovaldi made in prior years.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenues from Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AmerisourceBergen Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardinal Health, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenues Recognized from Performance Obligations Satisfied in Prior Periods &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from performance obligations satisfied in prior years related to royalties for licenses of our intellectual property were &lt;/span&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$206 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$618 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the three and nine months ended September 30, 2020, respectively, and $201 million and $527 million for the three and nine months ended September 30, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable consideration is included in the net sales price only to the extent a significant reversal in the amount of cumulative revenue recognized is not probable of occurring when the uncertainty associated with the variable consideration is subsequently resolved. Estimates are assessed each period and updated to reflect current information. Changes in estimates for variable consideration related to sales made in prior years resulted in a $13 million and $94 million increase in revenues for the three and nine months ended September 30, 2020, respectively, and a $9 million and $309 million increase in revenues for the three and nine months ended September 30, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract assets, which consist of unbilled amounts primarily from arrangements where the licensing of intellectual property is the only or predominant performance obligation, totaled $186 million and $144 million as of September&#160;30, 2020 and December&#160;31, 2019, respectively. Contract liabilities, which generally result from receipt of advance payment before our performance under the contract, were $103&#160;million and $45&#160;million as of September&#160;30, 2020 and December&#160;31, 2019. During the three and nine months ended September 30, 2020 and 2019, revenue recognized that was included in the contract liability balance as of the beginning of the respective years was not material. Revenue expected to be recognized in the future from contract liabilities as the related performance obligations are satisfied is not expected to be material in any one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTI1NQ_67f5c559-178c-453a-88be-5126b8793efc">&lt;div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates our product sales by product and geographic region and disaggregates our royalty, contract and other revenues by geographic region (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:9.5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Atripla&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Biktarvy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Complera/Eviplera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Descovy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Genvoya&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Odefsey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stribild&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Truvada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other HIV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue share &#x2013; Symtuza&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AmBisome&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ledipasvir/Sofosbuvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Letairis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ranexa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sofosbuvir/Velpatasvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Veklury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vemlidy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Viread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vosevi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Yescarta&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Zydelig&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalty, contract and other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9.5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Atripla&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Biktarvy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Complera/Eviplera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Descovy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Genvoya&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Odefsey&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stribild&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Truvada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other HIV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue share &#x2013; Symtuza&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AmBisome&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ledipasvir/Sofosbuvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Letairis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ranexa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sofosbuvir/Velpatasvir&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Veklury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vemlidy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Viread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vosevi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Yescarta&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Zydelig&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalty, contract and other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:96.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;________________________________&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Includes Emtriva and Tybost.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Represents our revenue from cobicistat (C), emtricitabine (FTC) and tenofovir alafenamide (TAF) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland UC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts consist of sales of Harvoni and the authorized generic version of Harvoni sold by our separate subsidiary, Asegua Therapeutics LLC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by our separate subsidiary, Asegua Therapeutics LLC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Includes Cayston, Hepsera, Sovaldi and Tecartus. Europe product sales included unfavorable adjustments recorded in 2019 for statutory rebates related to sales of Sovaldi made in prior years.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic65b5d2d76914339a0bfc5c853141a8b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0yLTEtMS0w_cc3131a3-a1e6-4bcd-b922-7fa2c5762881"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7a5f8acf2f948e68c92502a66bd5414_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy00LTEtMS0w_5a63b103-931a-497f-a37f-b7ce908d2b82"
      unitRef="usd">5000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c2c92fef300487ab03f8620479ac358_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy02LTEtMS0w_d210bbe2-ca14-4f91-99b1-414d23bbdd9d"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1411829f6bb4060867b0218c7ad64ff_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy04LTEtMS0w_0eef24be-4101-49fa-9517-8ec2fb5dc634"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bde0012620b4b358093fc1ee9a71f5b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xMC0xLTEtMA_13e8da8d-6aaf-43b6-9639-a9ed3c6a0719"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifaf48f8bb6d943c7b3230cf9b8f49d16_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xMi0xLTEtMA_79509e4b-0380-4a5d-917c-b7747b8551a9"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecd2a02077434613a5f82bf83e672d63_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xNC0xLTEtMA_20c4ad11-cae6-4e75-866a-de0552e757af"
      unitRef="usd">7000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i772bad7600f04babbcf984bea94a0f49_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMy0xNi0xLTEtMA_a080a99d-e393-4e3c-b756-84a58eba4ce3"
      unitRef="usd">149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67a923c7fdeb42a1881b0f06f38a17b4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0yLTEtMS0w_c3b93319-ca5a-4eae-9d4d-8f97d05820b5"
      unitRef="usd">1584000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a2dea3e60a54f91bbd1ff13643e9957_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC00LTEtMS0w_e4c937a8-917a-432e-b9e5-f0b7d83be8fe"
      unitRef="usd">194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94bc6499871f430b883a5c26a9224567_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC02LTEtMS0w_c6695f41-3bda-4d06-92d7-ddf4dbb45e61"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a11bdc34a1243b683eb633df7c23e11_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC04LTEtMS0w_60460f6f-113f-4d34-b19f-523fce16444c"
      unitRef="usd">1891000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea294903d17f4240a785bf9497f358ee_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xMC0xLTEtMA_b9b6d707-0b30-4095-b30e-7b78b7cf520d"
      unitRef="usd">1106000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9e4bc40c0fc45b9ad367dc82a8b46e4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xMi0xLTEtMA_2051627a-2702-42b7-ba00-fab4590ea6d0"
      unitRef="usd">108000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ac6788431d54ecea456ad29ab15114b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xNC0xLTEtMA_5ae752e8-e0a1-4a3e-8564-c4aea9dd970c"
      unitRef="usd">45000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96beb5e6c9d64cd88a2b544fa0558012_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNC0xNi0xLTEtMA_86abd518-c5c2-4270-afc3-2a2b7276513c"
      unitRef="usd">1259000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9d662f4b0514c71b93ab738ec761143_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0yLTEtMS0w_ddfb706a-b165-444b-8166-efd7b5f2d763"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37bf74c0f355430b8a23cd0b26f52891_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS00LTEtMS0w_8883796e-2fdf-4220-8992-fed3a10a2301"
      unitRef="usd">35000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i316ef52a4bd846c592de38f7af36ea13_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS02LTEtMS0w_3e0c02b1-ca08-4681-9edb-458038f4e9dd"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d1ea3f49aa84699a8330b8beaf83836_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS04LTEtMS0w_2264a89a-fb52-4092-b65f-fabcf111deac"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2c5c00fd5c74399b684e5b33b4ab1a6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xMC0xLTEtMA_be06d017-3377-4e48-8e98-44510a79243e"
      unitRef="usd">40000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bcba0865c9745c28ae1be5e32d30858_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xMi0xLTEtMA_849fb611-5bba-4a50-a595-59a3855d396c"
      unitRef="usd">45000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2b5cdefab314e10af27865b284a261b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xNC0xLTEtMA_dbb80261-e268-4d57-8e14-e07cf618ed79"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i020fa5bbe23148259e98dce5d3e6db76_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNS0xNi0xLTEtMA_bf12b193-d837-4c02-98c5-833953673a7b"
      unitRef="usd">93000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia983ed5089b04e17ba4a1f33f9b9848e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0yLTEtMS0w_e3d5c129-4a10-4c10-939d-fd0fbd3db2d2"
      unitRef="usd">424000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c69000ef95548fabbdc3b282e51e2e7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi00LTEtMS0w_018a72a8-072a-4bee-9a20-ee6a8c1ca67a"
      unitRef="usd">49000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d4d5d7839e94505b43297794bc17592_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi02LTEtMS0w_384fd4d4-d35f-4275-b253-50dc883b6ece"
      unitRef="usd">35000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic966bee37fa6405b83576f4f740b30df_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi04LTEtMS0w_662c732c-b687-4751-9d20-5adb101d7cd4"
      unitRef="usd">508000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45de8b04cd5245018515cdea5655f777_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xMC0xLTEtMA_9b7bcc81-f508-4e90-a726-540da98633e9"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2910166058884915a9bb2ea6a203d1a6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xMi0xLTEtMA_87616e3a-c4b6-40bc-a663-d62b44d842d0"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i855d34f7c7914eabb6d8012d1730432f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xNC0xLTEtMA_89ecd151-c3bd-4cbb-a15d-6ab3b44f7944"
      unitRef="usd">44000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied0a00ea00d246fcb752c2b14624ed71_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNi0xNi0xLTEtMA_567b0fab-02c5-454f-9c14-0c62a8865e16"
      unitRef="usd">363000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c8efb370883401b83e55838b7fbc9d5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0yLTEtMS0w_8417ea68-59ae-4898-8984-55b2e45449df"
      unitRef="usd">669000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76aeab63735947a3abc22f62baacab4e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy00LTEtMS0w_c81f6992-7537-4822-a2e2-a43b2d90e017"
      unitRef="usd">116000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2166e16f87b04a429939389261643a67_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy02LTEtMS0w_3792eaaf-4c19-4a3a-bed7-ecdc253df62b"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifac735e4f674431abdbc98a0e04572c0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy04LTEtMS0w_81582e46-d3f4-4320-b325-a845036cbc70"
      unitRef="usd">846000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c3f8e5e8d70429facde72a5fc634bb8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xMC0xLTEtMA_90b9645a-7392-4ccd-920e-f2bcfe39886f"
      unitRef="usd">761000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a121061085a43ea9ef1c9a36676b466_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xMi0xLTEtMA_9544f1f7-4637-46d1-8f43-23ee0b778fb9"
      unitRef="usd">152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie478e9e1575e48d9a95499553e51f752_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xNC0xLTEtMA_9787dc94-cb33-44fe-8f36-21d7cf0f9984"
      unitRef="usd">65000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e5ccce04a2f4a5db1b5196399fa7842_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfNy0xNi0xLTEtMA_2b70a406-4f04-457c-87f4-3b180a9aa63f"
      unitRef="usd">978000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d3683aaebc3492eb3e2b434a9a15ec2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0yLTEtMS0w_d0f1668f-67a2-4429-904f-4c210a14e87d"
      unitRef="usd">309000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92538fca9ff2482dbc32c61c001b3ea3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC00LTEtMS0w_58109f47-ae6e-4778-b561-3ae6ae8db67b"
      unitRef="usd">116000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4e3405a679d4587b527f12c3cd7f625_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC02LTEtMS0w_01799bcf-2ccc-496c-afee-59c8fcb23750"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b5fd963d3fe41aaaa285ed9bc365e62_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC04LTEtMS0w_55f2d959-9d77-461c-be4f-a2c058870d7f"
      unitRef="usd">437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3144e9c3e72a42adade54c619991a43f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xMC0xLTEtMA_5e688fcf-ce7c-4848-ae57-9f3d99db5f9d"
      unitRef="usd">317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia145801994314a5d8116188b3b69b3ef_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xMi0xLTEtMA_c66e3f85-e107-4a7c-b82a-b3b69c05d546"
      unitRef="usd">111000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied1a75b107a64c93a3d3f333c07064aa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xNC0xLTEtMA_1d3b725a-93a8-42c6-9b39-2b6e604fc37a"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10a2b8e40abd48c9b7742b2cf6099560_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOC0xNi0xLTEtMA_7bb37a23-cfc4-4e2e-9cb7-059ab0412684"
      unitRef="usd">436000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8b41aff3e0f4e9cb626769cea608d12_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0yLTEtMS0w_583397bf-0856-48d1-9a17-2a962a7da7c0"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd67b9aae7cb40cfbf1e3c78614f30ae_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS00LTEtMS0w_97ffcf9f-b7ca-48b4-9db4-20d5b66a5013"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2743ffe9c1a24dd78139e89db866b972_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS02LTEtMS0w_35ccbe3d-d004-4584-a1b0-a05fd9d65d16"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1ea9576cd9946a4891493d9dd47e7b3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS04LTEtMS0w_72de9676-2eaf-44df-938d-3e7cf0245809"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39a4fed8fd1443d5bedb3020421da791_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xMC0xLTEtMA_0ddc3d3a-ee1d-481b-95dc-3b20bb5a3e35"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie08938975b3748498c8cc0261e8b436c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xMi0xLTEtMA_17c29ec8-ec64-4c4b-bbb6-4833b11c35e8"
      unitRef="usd">18000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie14202ab77ae4a9686d66114ad05a515_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xNC0xLTEtMA_6bf113e2-761c-46c2-9024-8eaa44f6c796"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bc975ef1eb341ceadf0507525e9651c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfOS0xNi0xLTEtMA_b4a5f876-403c-47c2-b8bd-c67a13763b0c"
      unitRef="usd">94000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bc2b300cda84f6baa63c7b71950cdd1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMi0xLTEtMA_92dbdda2-9eaf-4cf4-af01-ef5858d002e4"
      unitRef="usd">492000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a5b342cbe6442e48842c846ee6caf71_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtNC0xLTEtMA_a638e2b3-ab97-40ee-b068-8d3fdf8a5403"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0319161df99e404986d1aa33de8ba71e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtNi0xLTEtMA_6d52d45a-2f77-4e56-a515-6b96d3eddb62"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c0926b30f1a498c81b6140b57053153_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtOC0xLTEtMA_804e4fad-a90e-434f-9e7b-f9678c0c7862"
      unitRef="usd">509000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2823fce1a4cf405a8b27b56aac04a3aa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTAtMS0xLTA_c982e014-2eb2-4429-9439-209bdff1dbe2"
      unitRef="usd">688000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e1c05c57e8343419f9bfde5e1395322_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTItMS0xLTA_c3ee4ccd-50e1-484d-bda9-4ae7edb81a38"
      unitRef="usd">14000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedc4539dbd004ec38a3c5475cd403514_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTQtMS0xLTA_51afc96e-2cae-4f03-8c65-956a6c1d86ae"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b237de69f3e4923ac93d5745b8e90d2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTAtMTYtMS0xLTA_e63fcf36-3be1-4586-be18-4bee7f197a18"
      unitRef="usd">721000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if71725c2f0354f888e38d6f4ed36cfea_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMi0xLTEtMA_51ff5a5a-316f-42e2-a341-943aecd742d1"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i644c9ff59ab54478a13d8d84ac3ba4fb_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtNC0xLTEtMA_564116dd-04a2-4091-b7f9-e3f1f871cee7"
      unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9982b46a2fb427caa4de7e6521eb30c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtNi0xLTEtMA_5d1a5298-913c-4157-87d5-2f7ca0309605"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdf79e96886d4938b1b1a211272ce1a7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtOC0xLTEtMA_08536139-7b7d-4e28-88a7-da04bbf39656"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cbd8e9ef0a944d486a151c6936fb75a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTAtMS0xLTA_ef17b94b-d5b6-4b99-aa8f-b098402eb1e7"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12ca1f1a0e024c22a8de469e578ba9fc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTItMS0xLTA_7221c574-5604-4fa4-b9b6-e862a39a9625"
      unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6086aba1234445049abb9c8cdd8e9f1c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTQtMS0xLTA_c1b6d941-706e-411c-ab51-915bb1fea203"
      unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaab34afd10054eefb1e8edd6dd4b0519_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTEtMTYtMS0xLTA_e0a23ccb-acf7-446c-9526-5465a109971e"
      unitRef="usd">5000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie47edc1cfc9f4eb0a97fb226a0a5a37d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMi0xLTEtMA_de105068-c594-45fe-bebb-59daabcd0277"
      unitRef="usd">82000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60af3f7f93b047d8ace0daf527ff4265_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItNC0xLTEtMA_35a867a4-42b8-4ad7-be40-bb7dadb1b4e2"
      unitRef="usd">34000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92ecb2b4824649fc9f38af061f3b4ef7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItNi0xLTEtMA_294107e9-677c-4176-b0a3-1b3534603eb4"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14ff3a03a206465aaa2896ba1ba6e120_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItOC0xLTEtMA_d15ee309-1f00-4d4f-a96c-92c898dbbec2"
      unitRef="usd">118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee22b1cffb1043bfbc54e365d26d4af5_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTAtMS0xLTA_554280e8-d370-4fa6-b3f1-4fc31f97b084"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d1453646ea740d890d612ac6873f4aa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTItMS0xLTA_e43d9429-bf5d-4a46-abad-c1ffe4d1131a"
      unitRef="usd">36000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5dda27b4a5904907ad5d4a661c2c5d3a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTQtMS0xLTA_d4ba46d5-2a91-4d31-8ca7-99678508df84"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bb31aa2cd1546fcbb6fc72d3d42b118_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTItMTYtMS0xLTA_8df59af7-5def-486c-a077-320d7313f2b4"
      unitRef="usd">104000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3dd3136d6efa4348a1c8cd540f898277_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMi0xLTEtMA_2328976e-67db-4be4-8cda-e719b4d08af1"
      unitRef="usd">18000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35fb08a6be124efc91105a96329d32e9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtNC0xLTEtMA_07f94680-600a-4b0d-84c0-31be6d99c1c9"
      unitRef="usd">58000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b87c9b49b5b4c0ebe6fef12c1b938ed_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtNi0xLTEtMA_724b1c82-49f6-433a-948a-2995365f72d4"
      unitRef="usd">35000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3221247bffcd4c4f96e064e12dc3ba2a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtOC0xLTEtMA_4dc1acde-8a30-4906-90f1-0e6365ba106e"
      unitRef="usd">111000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27dc9139c37245a49548419d47d24b75_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTAtMS0xLTA_b5bb2919-a9c1-4b19-8d47-fa5bfe318b37"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if979cf6c414f426db10c23f8e83a02ec_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTItMS0xLTA_06ca236a-7f95-4641-a5e7-75803ebe332a"
      unitRef="usd">57000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1770394dbe848a9a641f08327a05206_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTQtMS0xLTA_add12094-54ff-46ef-9586-e370dc403ffe"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71a54848fe844a30bbbac60e370dcda0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTMtMTYtMS0xLTA_e88f863f-9d2a-457b-a1ef-eaadfd9f0ab7"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ddf43c851594f2a8bf0c1f63f0ebf86_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMi0xLTEtMA_ad84a47c-9827-4bd0-9028-c15bc5b73339"
      unitRef="usd">36000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4459d3bbac2644ae99e4b532e143767b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtNC0xLTEtMA_6bce94ca-8655-4825-a952-790fe25929dd"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib58865b745844ff890bb5f1166984a27_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtNi0xLTEtMA_cb6aefc0-4651-4ae4-b6b1-426a5e777e4b"
      unitRef="usd">37000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib09eff6286d14ec48d858094f19da7cd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtOC0xLTEtMA_f0e18908-9581-409c-a2dc-da9e3b9f2e56"
      unitRef="usd">84000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4adf09430df24472bbed2f462ed4b1b9_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTAtMS0xLTA_0c5961f8-bf54-47b3-aecf-4c59c4860052"
      unitRef="usd">54000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8287111b10174ec98d26d3aa97917df0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTItMS0xLTA_b46e518d-0f2f-4d80-8a00-81b9144c9dfe"
      unitRef="usd">14000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f5c18c207ee433db038e9927f2ec41c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTQtMS0xLTA_4e7481c8-5c2b-4a5f-b07b-6b555e6158f3"
      unitRef="usd">56000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fdc0c20d21e46e39f5a774886ca08fa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTQtMTYtMS0xLTA_67e1785e-f3cb-4827-affa-f89d20a572a9"
      unitRef="usd">124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b2274275fb74059946345b7e79e2776_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMi0xLTEtMA_5c9f18bb-b30d-4df7-a410-0fae2d0d5118"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i023e3c59b73b4c7f8d3da3030435d0c1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtNC0xLTEtMA_fe378ebc-8d97-4c92-be99-fe3366d68852"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib73a8929861940e2a2c89e5e42452c04_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtNi0xLTEtMA_a5d8a558-4c94-4ea5-96f8-354e6fea5797"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec2a016a7766464484ecbb334372727c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtOC0xLTEtMA_a5de0eb5-dfb6-4a49-9ff1-857fe9c75348"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5582c730584d4002b1814d828c048d1f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTAtMS0xLTA_ceff7f05-ace9-471d-88a9-c832ebfc5c94"
      unitRef="usd">121000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dc774a64fa54549b0e01a1765162583_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTItMS0xLTA_380b43ca-b2af-4f5b-9c40-0badcd542b8d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86d4379fd8b24c718b703229ff1bdb41_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTQtMS0xLTA_3e2fef15-0b7b-4128-b8af-2dca996d63b3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1df27de735a2435fb01a652087a96fcd_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTUtMTYtMS0xLTA_ef76829a-0b93-4780-bd78-d03c74f3cb0b"
      unitRef="usd">121000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8dc70b538fbd4236be65e5c74b37b74c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMi0xLTEtMA_5d53db5e-999a-4513-bc3d-15acd1ff274d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieae2a10921654f3e990c42a09a686fff_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtNC0xLTEtMA_ecfa2aaf-0376-4e62-b2dc-8773e402865c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5627a8aa26e48b8a494fc4c472f2e5e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtNi0xLTEtMA_060033c2-02f5-4ac9-89e8-d54f5479b6cb"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0448ba338934e15a3d8c6bb32a0c7ec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtOC0xLTEtMA_14473936-f048-4f3e-a139-337222002971"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdce8cc1010a433d867e9991049ce48c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTAtMS0xLTA_c6068fb8-446f-4a68-8e16-4b9159288257"
      unitRef="usd">31000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12865b7767774a1c981d8f35ee6a2976_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTItMS0xLTA_ac0a6a76-fd72-4c12-9baf-d39736b32380"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96870ee369b3451bb3e3ad1e5c6f0632_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTQtMS0xLTA_96800f0c-1380-42fe-b8d1-7366d70af5cd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8638be037d2a44e8a36d55221e058f60_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTYtMTYtMS0xLTA_0576f350-f008-4af8-893a-787f8681a78b"
      unitRef="usd">31000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42f1e832a84c4cb48a7cb31c748947ca_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMi0xLTEtMA_48cac303-dae1-4c56-87f5-e8ad9935bfa8"
      unitRef="usd">170000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ead7edc72f24ce5915cebe08299ca44_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctNC0xLTEtMA_ddbb60a3-c165-4fa4-a154-3f1f42978c71"
      unitRef="usd">74000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f7dc5506b3a434a8de2b4b60fdbdcf5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctNi0xLTEtMA_5e7ec18d-5912-4643-a085-2877c720969b"
      unitRef="usd">86000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dd8bed6771947af86f38ea8c65de78f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctOC0xLTEtMA_0da560f4-e125-4207-9f66-df8fd089e3fd"
      unitRef="usd">330000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b267b50c2af4842a3de6c83f9b6ab45_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTAtMS0xLTA_ce4f1710-9688-4647-bfc6-ce501f0a6e3f"
      unitRef="usd">282000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e0d8f0313da4158a72192a2602a6ee4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTItMS0xLTA_d4e3deb3-8239-4b2a-b981-1d0ee88ece0d"
      unitRef="usd">118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icacd2391f4764a14ab37c6a4543fc4fa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTQtMS0xLTA_e73bdaa5-445d-43e5-ae4f-4641c7a8a027"
      unitRef="usd">116000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d18645d77f44dfe871bdfeab7f7edbf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTctMTYtMS0xLTA_7b221869-76f3-4327-b740-8d3053bc62d9"
      unitRef="usd">516000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieebbbb7c948845dca583fe54913d5e89_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMi0xLTEtMTQ4Mg_369b6f58-1a3b-4fb7-823e-e83a3f37e32e"
      unitRef="usd">785000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaec3ebe00aaa45b2bed5ac91c8cccaaa_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNC0xLTEtMTQ4Ng_0c06bf02-abd1-4941-99db-8a28b0f3c78d"
      unitRef="usd">60000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e56d52f566e45598878238694ba623c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNi0xLTEtMTQ5MA_2e9165e5-f6c7-4f50-a3a4-463dbf69df61"
      unitRef="usd">28000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26b2c25650b44b69acccebcc55606d1f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtOC0xLTEtMTQ5NA_3b16afcc-532d-428b-a32b-0ad53cf80b73"
      unitRef="usd">873000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea9e3da549e244cfb2c9f5158ec401fd_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTAtMS0xLTE0OTc_bbe5931f-7e3b-46de-bce5-ed80976f045a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i084c745c22464ce3a8fb3c8cebf5ed60_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTItMS0xLTE1MDE_4e3730f5-b966-4602-ad41-974afa0ddff8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03d68e9a626743bda07e2eefb20fce19_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTQtMS0xLTE1MDU_45d87dac-20a2-4e3f-a7f2-0586812dfb7e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07cc2d2384f34425b810bae675903dc8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTYtMS0xLTE1MDk_52b0baa1-ed90-40fa-95d8-66dc05df26d8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e964e7db79a4ccd99b0c7be936bf507_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMi0xLTEtMA_40ee710f-eaef-4be8-be4a-3280cf937de2"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d58a4e6c2d84e70bc347ef87d4a87f7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNC0xLTEtMA_d91f2619-1f20-49b8-981a-c5ef2791e5f8"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i046a86b5fdab4ff1b14916d76f73e510_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtNi0xLTEtMA_e571faf7-8750-4962-8d0d-b65ed316c18a"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3e70ff742c140d496526d7b1527c3ce_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtOC0xLTEtMA_98dc63fc-98be-42cf-acfa-9db1b3386192"
      unitRef="usd">177000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffb9eb566b2941829c54cd50ea568c38_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTAtMS0xLTA_14696b93-8e8f-4726-a5ca-01821813828d"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b5a4371abc747f3a1a8c3bd6ed8c486_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTItMS0xLTA_dd04d0fe-401a-4f83-8cdb-d54870d1e9a2"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3084899d86f64538b7a6f2a33bbec0c8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTQtMS0xLTA_1ce0ac49-3be4-4f24-a783-307a9b58c9d2"
      unitRef="usd">50000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i600ed37165bd4db9ae547ea571cb7978_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTgtMTYtMS0xLTA_a31b47ca-737e-42d2-bf94-563964789b9e"
      unitRef="usd">134000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i101ecfcaae0e4864b20047dbd8a3e1fd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMi0xLTEtMA_a0679ed2-151d-4861-b1fc-07d156d9ca9b"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i684803a0664e4bfcb6efc1517674d221_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktNC0xLTEtMA_7df62dfe-fb68-4e8e-8131-269a5fde4c5f"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icff41edc76614451b4b1bd6a03d7ae63_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktNi0xLTEtMA_a00c29a1-415c-47ce-8f9c-ab9dfa0bca83"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i005d53c4c52c4720aeb394e3fbb50e7d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktOC0xLTEtMA_7a4fef71-7a37-41bf-a214-12b79e753524"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90b6f6af4c6542d191026032ce0f1df6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTAtMS0xLTA_5f0ff6a0-b489-4b93-bbe6-cc6d74087302"
      unitRef="usd">7000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98bb9c7cfee24ac286f7fff99b0c0715_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTItMS0xLTA_137476b8-19c4-4657-89bd-3880511b25e9"
      unitRef="usd">15000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57f1ffa20dec429da02ec0b008e998ef_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTQtMS0xLTA_285e6dd9-10a9-4ab7-a536-e443445950cc"
      unitRef="usd">35000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb3caa46f38f41edbc114ca92e65b04d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMTktMTYtMS0xLTA_0c189f2b-9c58-4d00-be06-2bb602f4bde9"
      unitRef="usd">57000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84113ab047d242869074a29c0fe984ff_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMi0xLTEtMA_afa11c39-f899-4288-82be-1dddad8ed4e7"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibebac49aadb9416897c8ab8c4cce79d7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtNC0xLTEtMA_c0a77f88-65e2-4615-abb8-c3250a03a1d6"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i420f5df1a84346a6ac938d443c5e8a4c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtNi0xLTEtMA_51465670-6e67-47a6-982c-d552e16f3f29"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic76dfe31026e42c694ebb48c2f5b658a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtOC0xLTEtMA_a3642f38-0e33-4651-adb8-b8788b030f9a"
      unitRef="usd">45000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b8628d1ff0448278a92b391d45f5eae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTAtMS0xLTA_803aac99-3bc7-46a1-b9b2-66950170cc5f"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47125f71c9b44d7194c89e9640d482f3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTItMS0xLTA_f5738e3a-8a26-488e-96b7-af667ba2c4c4"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39cdba108be14c79af8376028b06b4cf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTQtMS0xLTA_4f6ff0a2-0a2e-4366-b81a-b5def235daef"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3eabf5693f71408c90d3d4cc46f5eb22_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjAtMTYtMS0xLTA_e054ebdd-aa3f-469a-8dfa-3afc352f1c6f"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i398d207fdaaa461195fbeae21a779dd8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMi0xLTEtMA_1e530295-1c84-487f-b2af-03a04f225297"
      unitRef="usd">85000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03d38dfb8dc048e08df6eb090d1f549c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtNC0xLTEtMA_1249f0f6-8354-43c1-a462-2e0c748cf343"
      unitRef="usd">51000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ad8ec3782bd4ea2a07fef27fa912cf0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtNi0xLTEtMA_0de7a3b6-9169-46dc-9cce-701f4eb39d7a"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i135bbf9df1b6455c9fa3dafbd8eb2d1c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtOC0xLTEtMA_45cb872b-ff33-458f-aa3c-be00717dde23"
      unitRef="usd">138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c82e95c68504866bf36dd9d81d52cf9_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTAtMS0xLTA_76f052ee-90af-4e1e-a769-266d489054b0"
      unitRef="usd">86000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe3be05bfa934699977eb8087f45d14f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTItMS0xLTA_3c1137ee-8ff4-49ab-a666-75f00098f877"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i417780d1b25c4ca8b079ea42b721fc54_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTQtMS0xLTA_2399f056-c808-4ddb-a372-940d54d9c5a6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56ba2a1561ad4430842ec1db3b8257ed_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjEtMTYtMS0xLTA_d6f32925-26ca-487d-a45c-98ca722b5692"
      unitRef="usd">118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id254ad4a4ea547639bf93c052e3be138_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMi0xLTEtMA_5c266d9c-9ae7-4d19-a115-dc6a4dded28a"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i720551245e854687876b7379d1f78d8e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItNC0xLTEtMA_d829c1a9-522e-41a0-bb9c-f60780312f61"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife74578569994b51ae64ef03ce69c1ca_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItNi0xLTEtMA_9caf44b0-8552-4eac-bad1-25ab9c44fba0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766eabb290f046f2b9e62b6e3784b275_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItOC0xLTEtMA_a847d800-6a31-4cd5-b115-dada05657ab4"
      unitRef="usd">17000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a0e17ea897448e5912132a36ff6b28c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTAtMS0xLTA_dfc46a61-6511-4cd9-9a87-59780e49d135"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9c060397c8742309b60bf12b6512021_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTItMS0xLTA_f637116b-88c8-4d71-b6aa-ebf428c69e35"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e84a4da6fad46a791ebe608e6ee198e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTQtMS0xLTA_9ecc6bc9-58a5-4083-bc6a-f123c0d8301b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ae5847663714779b1bf9154604a6df1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjItMTYtMS0xLTA_c3f7e04d-76f8-4433-865e-f5f0623d472b"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0803d3be2d04db0a4c0867464be9229_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMi0xLTEtMA_e26d4b9b-74cf-4494-a536-3e83141c0d47"
      unitRef="usd">39000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c5b8dca94e743a398f30129643066bd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtNC0xLTEtMA_c6728077-1aff-4f52-b2d4-4af64b004ef5"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c39bb504ba14d2986890843ad30a9ef_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtNi0xLTEtMA_152c489b-db30-42a3-b567-c936f5dd5347"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09fd9a81e73348fa825cda04d1f6cb1e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtOC0xLTEtMA_40af96bc-fc83-4fe6-a091-7bc42a50cb44"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d9ccdd2e0584f9095a5e2c1d8e8c353_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTAtMS0xLTA_fe067d30-2b08-4cfd-b280-758b5929f061"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcae3cba7d164d41a999db4406d7e5b6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTItMS0xLTA_afdd0085-a655-4cd5-8ecc-7495420304af"
      unitRef="usd">-21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d19a5c115024a04beaf946d538fddb3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTQtMS0xLTA_edf6a713-208d-4cf1-9106-89a8668dafeb"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9cc2465f59b5458abb466db3d7f8da8a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjMtMTYtMS0xLTA_0ad729b5-dba0-4f9e-9506-a25a2fac284f"
      unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4558c2340efd4a3b900cf6ee1d86b0d2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMi0xLTEtMA_bedf6ac9-fd3e-447b-9edc-a8dc80d54e5a"
      unitRef="usd">5076000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbc17d0d001d43998d445fb4be3e013c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtNC0xLTEtMA_35a43b59-587d-4dcc-86f0-1af8153e66dd"
      unitRef="usd">877000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a0767d0f4ae47b39b6fd2f49267f647_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtNi0xLTEtMA_5c05318f-fd8f-49ae-bd24-9220fea75b70"
      unitRef="usd">540000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic38a8d4d52c34caa8db328baf10699aa_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtOC0xLTEtMA_963509e0-1b42-4998-8d34-552fb3f62057"
      unitRef="usd">6493000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id85ae5108e3144a5a16efecd6144cfbb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTAtMS0xLTA_7572b904-899a-4066-8cd7-d097840cc950"
      unitRef="usd">4199000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib43accb591714a6287366d5532b6fd0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTItMS0xLTA_ad8a77b4-7c91-4102-ba9a-dd3b8a52c182"
      unitRef="usd">804000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a8489222bf149abb359b6eea6f8bc61_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTQtMS0xLTA_12bc6103-43f7-4095-b7c6-c9f5c49048df"
      unitRef="usd">513000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83a2687827294d87a300d031d1858df3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjQtMTYtMS0xLTA_bcb862e2-0a90-4833-8cb2-97d87ef3850d"
      unitRef="usd">5516000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ia2645cba50844271a731aae129127e28_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMi0xLTEtMA_360e7c8c-b29c-4d09-8858-e89432b9767e"
      unitRef="usd">24000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e766da00a6e45ac94d46524fc6f1728_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtNC0xLTEtMA_6d3ae96e-9db8-4aac-aacc-ced3912db54b"
      unitRef="usd">60000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i871689c0193846e98c4fedd49ddf8879_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtNi0xLTEtMA_f6ce2b67-28d8-47d3-863f-586d8a3b1536"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i96064d1c8c184d5ab1297ec54cb44590_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtOC0xLTEtMA_e3636578-7e75-41d5-8d21-396e759d8062"
      unitRef="usd">84000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia934aa3ae79b4bd5a663f8ac317ecba2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTAtMS0xLTA_3fd54a6f-1d23-4080-a3e3-7a2f837e7afb"
      unitRef="usd">20000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5abcb64ac3454f9b8c7088b53bbf545a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTItMS0xLTA_e8dfe3e3-b167-498d-aa3a-ea1b51017798"
      unitRef="usd">67000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6bd381436407454e84dd9a12523cff3d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTQtMS0xLTA_048a83d6-069b-4cba-9bc3-ebea3e355e26"
      unitRef="usd">1000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf6dd01e1e2047839e25939a3ae0a70b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjUtMTYtMS0xLTA_be1b9fac-bc42-456c-baf4-ac78513a02e4"
      unitRef="usd">88000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad03c82878af430ca095a94ae4b7784a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMi0xLTEtMA_71a20102-de60-4ed9-b669-07fbdb38968f"
      unitRef="usd">5100000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb823a15d78b42bdbb60a26249e4c280_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtNC0xLTEtMA_1078f513-2a80-4eb8-a135-a4a875201f84"
      unitRef="usd">937000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i075da22059a446ea9056836364417160_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtNi0xLTEtMA_638d756e-1655-4443-ab4d-8438ba80fe58"
      unitRef="usd">540000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtOC0xLTEtMA_af104fbd-ce08-4619-adba-1c882a99546a"
      unitRef="usd">6577000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ife78a8506d7c4d589c917a4f5d611434_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTAtMS0xLTA_acdbae21-23dc-4885-8ee4-437d3cfd4901"
      unitRef="usd">4219000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib9bb7b9b91b746c9a6316ed3fbdf29ee_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTItMS0xLTA_1648b45b-6b2c-4c55-805b-3cec681bc270"
      unitRef="usd">871000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b50ecf683a64f88a5112a6814698895_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTQtMS0xLTA_fbfa3494-5087-4489-9496-8cd510751f3a"
      unitRef="usd">514000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOjQ0N2M4NzMwMWVkNTRkYzk5OGVkNGM4OGFhYzVlNGViL3RhYmxlcmFuZ2U6NDQ3Yzg3MzAxZWQ1NGRjOTk4ZWQ0Yzg4YWFjNWU0ZWJfMjYtMTYtMS0xLTA_c3c9485d-01d9-4c83-aea4-b645a18c6922"
      unitRef="usd">5604000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10f2796e131745b49722c54e29dd1a14_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0yLTEtMS0w_d78f22ce-41c4-4029-94cb-c2287586f047"
      unitRef="usd">275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i540c328c3fd14b1bab1625ac3b70947b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy00LTEtMS0w_3c06ab2c-c961-4d1d-8c59-2234b443553d"
      unitRef="usd">17000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4147a1bf6ed04df392a5e94f4d66f8ee_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy02LTEtMS0w_d5cf18c3-383b-411f-80ad-66f65d59fb96"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b3c544ea4624677af1db8cc46d8ba43_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy04LTEtMS0w_34c0182b-56e1-4c24-b5a2-9c149bfb9822"
      unitRef="usd">311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5390c9235c84fc5a5e7cfe2a469da26_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xMC0xLTEtMA_0cca9334-7b90-4040-94f4-a762dcf41926"
      unitRef="usd">387000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83641512c7304560a36b1a26f5a833c6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xMi0xLTEtMA_1b2e7992-3fef-40e9-a397-d77e247d5e03"
      unitRef="usd">52000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d94b806ce2c4380a472c5ded0a0d478_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xNC0xLTEtMA_69e7a19a-aa7d-4412-b001-23658b779292"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8447af5ba87c40c0b94c057ccb036d8d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMy0xNi0xLTEtMA_0f3bce20-7dca-4864-854c-0063440eb811"
      unitRef="usd">472000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6fc0306b3664070b9024e4164bc3d18_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0yLTEtMS0w_0c4e9c8f-8c19-49b1-b1b0-88e084085b4a"
      unitRef="usd">4346000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8053154621043638573e26bca07c8e2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC00LTEtMS0w_0b605782-b3b4-4836-b9d0-f02a1975c6c9"
      unitRef="usd">528000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab0b80da40d144dfb51e5296d491561d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC02LTEtMS0w_5e838b3c-bf3b-42cc-aeb9-4d4ff1d996c1"
      unitRef="usd">314000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c7bdbf4839341078ab571b1ade61e83_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC04LTEtMS0w_af29e8f3-c261-4e4b-a120-a2718c254a47"
      unitRef="usd">5188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id44c5b80cc3c4605ab9a62fddf9b0edd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xMC0xLTEtMA_36ace52a-4308-4c98-8645-dd8bef05090f"
      unitRef="usd">2868000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9255844714024bfaa7176a097341eaf1_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xMi0xLTEtMA_3c38e1d7-3b51-4db0-a8ee-47a6fba9e848"
      unitRef="usd">229000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id46c95e16d09481db3bbf57af272cc8f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xNC0xLTEtMA_59ecac00-49cf-48c8-af7d-4ee4d095a4ee"
      unitRef="usd">71000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcf44eb315184b4daea10d586af9bb99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNC0xNi0xLTEtMA_a866de4b-6cda-4b4d-9482-f1e41462bc64"
      unitRef="usd">3168000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ba3f34d91ba4467a1b960bb57ff4f77_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0yLTEtMS0w_a2bedceb-82ff-43b7-a631-03c7a0da135c"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icee191d2a7da42e5b2888a7142bc28e5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS00LTEtMS0w_b0355ab9-0416-4f82-9475-9a305946e08e"
      unitRef="usd">124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97761b52dc964ca1b75b02bb63e6f7e5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS02LTEtMS0w_74a8bc5e-9859-4bd8-b19e-5bff9998c5d8"
      unitRef="usd">17000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia53b54d337a5449196f847ce9e41479f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS04LTEtMS0w_1ca3dc9d-003f-46a6-99a1-6e71a8275884"
      unitRef="usd">218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i750af09cffdf45b2aaa3f24e2a2098d3_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xMC0xLTEtMA_a4075f60-101b-40b4-ac7c-df00e56d028f"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e68305b0ec249bea1c290a603e685b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xMi0xLTEtMA_9aa177d7-1223-4fe8-a7f2-3c83fcf31719"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a4a6615211c46d2927e8dca0a2062b9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xNC0xLTEtMA_96494025-95fe-47e3-a57b-eeb0b031c2f1"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bee71fa9ee64eeba4daeabec5940ac3_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNS0xNi0xLTEtMA_80b6dd1b-c2dd-4939-b5ce-a541b27ebf7f"
      unitRef="usd">331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56bf813b0d4440c08a3e4699f552745b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0yLTEtMS0w_978c44b3-d717-482e-9895-7d2256ee3090"
      unitRef="usd">1124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i231be2fba64f4bf896c38f1aa81104f8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi00LTEtMS0w_418dadc8-f9d3-4306-ac13-ef67750cbe5e"
      unitRef="usd">156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43c573558c37477bacbe4f59e9970f84_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi02LTEtMS0w_27a7ea02-7fa6-4b76-be5a-874a9b8db749"
      unitRef="usd">103000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c61cbc63afb40c48e57d8fdca17c0a1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi04LTEtMS0w_b16e8231-7336-4777-a174-603da772578b"
      unitRef="usd">1383000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifee265db13f644ecbcffa4b46083b9c2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xMC0xLTEtMA_f12f8888-9112-444e-bba0-e71822aace3a"
      unitRef="usd">735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9e932ecab3d42f0bd2a802ca26cd95a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xMi0xLTEtMA_15ee0e6b-3683-46b8-b065-7a1aa0b4d04d"
      unitRef="usd">200000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58ed61a0e5644751a963832357838e7a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xNC0xLTEtMA_82aba944-e5a7-4698-be18-3a39d0be9713"
      unitRef="usd">128000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0740e92dc52c4649a9234a51ea22bc60_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNi0xNi0xLTEtMA_7c080644-fa7e-4a80-99d1-c52648d1a6e7"
      unitRef="usd">1063000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ecb7cae048e406eb9a99e8d678c765b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0yLTEtMS0w_69cda323-f7b1-4bba-8ab1-163abe074ff6"
      unitRef="usd">1927000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0dfbec2369f4a4d84782aa2a96b2dd6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy00LTEtMS0w_f2ce63bc-125d-489b-89a9-c34804d5a260"
      unitRef="usd">376000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29f0cb97877c451f8d0410a288a7c508_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy02LTEtMS0w_0a622eb7-463e-4a39-aff4-76c2bfd2e3ea"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i742e3ac34dc14d3ca51197c0177e3a0e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy04LTEtMS0w_89f97b93-ae00-460d-b15b-7686118f776d"
      unitRef="usd">2486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7412e3583c694088b81933255ffe9b92_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xMC0xLTEtMA_97f5202a-ee09-449f-a61f-47f8e624cf74"
      unitRef="usd">2222000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i384483b6f05f451d8e772b8b5eebf9d2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xMi0xLTEtMA_4db329b0-a01f-40b5-bbbf-4486bc7927c7"
      unitRef="usd">522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9705c0a59c384067b58147f9968d335f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xNC0xLTEtMA_afbe0fbd-4c1c-4b33-9b41-343c3e6e0263"
      unitRef="usd">229000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bde46834ced4ac9aca77149c77ff785_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfNy0xNi0xLTEtMA_261bffe2-498d-43e4-b82e-3f71d0341781"
      unitRef="usd">2973000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i467448f2935c4949adb25f0dc29fd71d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0yLTEtMS0w_df434a73-e30a-4daf-8936-a8ac28e5100a"
      unitRef="usd">851000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34c9b9f109374b3a9fd9b41bac8d04f6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC00LTEtMS0w_37ddfc9a-10db-485b-a4fb-477e537daec6"
      unitRef="usd">341000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f4205c2046c4142803828d004750696_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC02LTEtMS0w_e09735d5-be9d-444c-9343-0ae1675de0ec"
      unitRef="usd">36000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a68dbfe80e344da8c9c590f8e88b515_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC04LTEtMS0w_e30b1582-50a5-470c-b3b2-e2088e2bffe1"
      unitRef="usd">1228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d9f10d767e14ff0996e4f9207bf98b8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xMC0xLTEtMA_d33f1014-c172-4d96-a49b-b4949b96c4e3"
      unitRef="usd">865000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8126adf8f45426599f7339d161fd9c6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xMi0xLTEtMA_76c8bea1-3d9b-4ee7-afe6-632a7c07fa41"
      unitRef="usd">328000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3631587c26c450cae9fea5710c15b8f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xNC0xLTEtMA_b9f499c4-d949-4635-90ab-3732a888f69f"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia34b59098d814cb0a08a98e99e0c60a9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOC0xNi0xLTEtMA_7934b712-0a01-4241-b3ed-b8a852e8178a"
      unitRef="usd">1220000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i290b413904764919839f932725c8daaf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0yLTEtMS0w_d2f4b288-4e88-473b-a5be-45230b60db2f"
      unitRef="usd">100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i851f06a9af1042fcb2a409bbe3756a72_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS00LTEtMS0w_4a6b0c7e-8fb1-4954-886e-8cb986dd9164"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i783ec34abc8144819c7e7d092ae11132_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS02LTEtMS0w_a8bf47db-8d7e-4b7f-9dda-091be2e136df"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic755c8fddb3d4084bf2b80625b08ea26_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS04LTEtMS0w_c20e5046-90c0-49e3-9e6f-5cdca597353f"
      unitRef="usd">154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i805a20329e504fa2a33c2687c7ea5ea9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xMC0xLTEtMA_bee521bc-263d-42b1-8a73-115b388cd924"
      unitRef="usd">208000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01577dfbd4f147ec828c3cc0fb9ebf13_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xMi0xLTEtMA_80683970-0e1b-432a-88bb-d6165255f070"
      unitRef="usd">60000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52d0a27e691146369f40b9b33565966a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xNC0xLTEtMA_a3a18057-2fbd-447b-a601-7b6905349e8f"
      unitRef="usd">30000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95eadaf94faf41fba9c79f5cb150e93d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfOS0xNi0xLTEtMA_af745a19-7e28-4cc6-8b85-b99b05d785be"
      unitRef="usd">298000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc833249283042d5b7c62e05feb45290_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMi0xLTEtMA_66fb378a-99fe-4f9b-b74c-9ed7be021744"
      unitRef="usd">1245000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16e84af25770413aa8f9456d8ddc2e52_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtNC0xLTEtMA_e0527f74-ae3c-4f6b-96a4-11fdb7ba07f8"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied066108123545128f8dcb45a48c3bed_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtNi0xLTEtMA_e9293858-b48e-42f3-add3-3bce2eec2e4c"
      unitRef="usd">37000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c7cd5d5e7a442f48cb8b9feb0094fe1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtOC0xLTEtMA_8703befd-0e8e-4638-9cbb-b35f95875ce9"
      unitRef="usd">1302000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffbc1fa1c55740df98bd6134594b7219_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTAtMS0xLTA_7e438bca-cc69-4a11-babc-5cdb2fc5382d"
      unitRef="usd">1896000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03d87e9eb0a54aa08eedd0dd9ea5c4e3_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTItMS0xLTA_a1275fa1-3674-4f9c-9627-c7d4f29d6717"
      unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfb35282d4ad48f783dd0c11877ba0ec_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTQtMS0xLTA_a7be886c-85ee-41cb-bcb8-8996dc87d6ad"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81dc6799abca4db8ab88cae7fa763d01_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTAtMTYtMS0xLTA_04652120-52c5-4794-a30f-625f36c83f27"
      unitRef="usd">2045000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i727f0920e4f64f1880a2ebe8c13e3bcb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMi0xLTEtMA_bd968cd6-5d04-4bc3-bdc4-af64ab7c5ddc"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5fe7357a4c84db8bc7fca6f59f5bd47_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtNC0xLTEtMA_9d302a97-6f2f-4d3e-ad59-3cb460822d41"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2bc28b56f8d48139043a74668f46dd4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtNi0xLTEtMA_fa4bad18-390c-4a44-9b68-9ab4e6294a68"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe112c628c62494ab437ea9eeaebc991_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtOC0xLTEtMA_ea1cd606-5a6a-400d-961b-4d046837fd78"
      unitRef="usd">49000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i852a43ddcd8046829ad1899671088c66_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTAtMS0xLTA_3456d1e2-ff94-4957-ae80-762f6e87eb35"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a35be3874ab4149bb860d0946e69a81_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTItMS0xLTA_874fb0ae-8467-46e2-a125-e46339015837"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b92f07f2e0a47c3a983d243a98baf35_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTQtMS0xLTA_c50614f6-2e99-44b0-b49e-7f7551819544"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc785f3b9046480faf38fea90b8c3023_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTEtMTYtMS0xLTA_c9a42a91-122c-4421-9698-987bad20673f"
      unitRef="usd">37000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aebf9bb5c2346d6a0b7ca54d4d4eabc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMi0xLTEtMA_8a64018c-dedf-4fc7-9aae-b40fb8595c24"
      unitRef="usd">244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9292897cc8904a42948da3e2971f4571_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItNC0xLTEtMA_8fb5d969-5de9-4bee-8b07-0c3770299ef1"
      unitRef="usd">112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e9ec444a5cd49f1bfcd9dd0820a2023_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItNi0xLTEtMA_8663ea6b-954a-42b9-b243-480f4f081fc4"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf9bc6d09aec41d184db3a49214b840f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItOC0xLTEtMA_a7c17fea-922a-4d64-ab52-ce0b283cb4b7"
      unitRef="usd">362000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i902da8b28069408a8c42b356a90a4950_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTAtMS0xLTA_dad715b4-9132-4795-aa14-2b7ac8f01411"
      unitRef="usd">165000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida2f089d53c447b199f1aa839ca1668e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTItMS0xLTA_0ece6f38-d479-4a90-b46d-927cb58edfda"
      unitRef="usd">89000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia189ef02a42c4b41a97661844b973b00_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTQtMS0xLTA_b9514d34-1009-4c14-ae6a-e8aef003bcec"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75e30ef252704139a8c49152c92d6fe5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTItMTYtMS0xLTA_b23a2966-9730-4d13-ab83-9381ec7c4cc0"
      unitRef="usd">254000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfb2e5ffe6574e3bb9835ef3ad021eba_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMi0xLTEtMA_aae15535-5e29-45de-bb7c-c39d12e57aaa"
      unitRef="usd">46000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10f7621603774791b39109ff98d0b462_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtNC0xLTEtMA_0219a5ad-21c2-4de0-9be4-ee5424df265b"
      unitRef="usd">166000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6876a3bead0430cab7025f3a176623c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtNi0xLTEtMA_23bf896d-9b44-4ca0-93a2-bb1b8851127f"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1216dcb7f79948829a9e8c0013253508_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtOC0xLTEtMA_ae2cc0a2-7459-473c-85c7-2ce627da847d"
      unitRef="usd">325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38621f45cc7c42abb0b3b65928e20ac1_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTAtMS0xLTA_c2454c9e-9abe-4b1f-b11f-499fe7d386e8"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42a4279f407d406cb284cc2edc96ad1a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTItMS0xLTA_de962d96-dd7f-42c8-84d5-97de185fcd85"
      unitRef="usd">174000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82688362eef04085b653508050f8f422_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTQtMS0xLTA_02f99ef2-2264-4a63-95ab-fd08ac3ac4c3"
      unitRef="usd">96000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1d0a82cc5d540e987b6673d38b892bd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTMtMTYtMS0xLTA_376060f0-ff81-48c4-bb5b-c7a8cde98b2a"
      unitRef="usd">297000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia14da41d357c4519ad6e0f90343d204c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMi0xLTEtMA_5d034298-c23a-4978-8433-9df619bf975d"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic97ad43f65774b7094b3a379df786172_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtNC0xLTEtMA_5a24d976-d9b5-4215-a9c3-46a766f22772"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea3bf3186cb94890a8c57a6616584439_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtNi0xLTEtMA_1bf335bd-f2a2-4d33-a50c-d12ea635d101"
      unitRef="usd">124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia45b3f782eb04b7e861b03896b46c351_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtOC0xLTEtMA_ed856631-36f9-4a13-885f-abe5e395496a"
      unitRef="usd">263000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03eef6be4f4649c3a18607489e2d41fc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTAtMS0xLTA_2b2e7231-fcdb-42e5-9254-a7c052629118"
      unitRef="usd">257000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82b54e6960b4405f8590d818220a3f95_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTItMS0xLTA_5976e243-b361-4dfb-b4b1-1ba12b43a577"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd48fdbbda9146a484254f1e767cc90c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTQtMS0xLTA_89b691b5-a4cc-4ee8-b68b-84edf1ea7287"
      unitRef="usd">222000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i883550dc5b2e40a5bbb96599635c444b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTQtMTYtMS0xLTA_88615243-a59e-4d3e-a8fc-e193ba80e9b6"
      unitRef="usd">542000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bf480b492bf4fe09ebf0fc197965303_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMi0xLTEtMA_0c7a6c92-70bc-4f30-b853-c5572933a0b5"
      unitRef="usd">241000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9bb91712e39437b936294b2735c13d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtNC0xLTEtMA_e71a4b4e-d925-463d-8195-69755f519b56"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e5b7f7113df4f099c265bb2954a56eb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtNi0xLTEtMA_8c4d7807-fe07-4e19-ad38-7f7974a0e67c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida3484e902294670acc409da1ba4e0d4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtOC0xLTEtMA_9c237e08-a59c-427d-8710-38b874cdae7f"
      unitRef="usd">241000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2641a1a842544e209516e50ec96c27b0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTAtMS0xLTA_4d6b4ee7-088c-42c7-aaa9-95ff2fc93fec"
      unitRef="usd">522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e6404156b2847f181b5d1bd7b274323_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTAtMS0xLTA_d48d4b25-da98-4b8f-95c7-72f68e7d9138"
      unitRef="usd">522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i770bcef54ce64fe388b602f9e6584063_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTItMS0xLTA_3f06a69d-ed2f-4883-a14a-be4b96ea789c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dac5ce142294efdb06ad2c8c9ec3cea_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTQtMS0xLTA_acc2b82d-e5cd-43be-8ae2-40fc906d6cda"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2641a1a842544e209516e50ec96c27b0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTYtMS0xLTA_4d6b4ee7-088c-42c7-aaa9-95ff2fc93fec"
      unitRef="usd">522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e6404156b2847f181b5d1bd7b274323_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTUtMTYtMS0xLTA_d48d4b25-da98-4b8f-95c7-72f68e7d9138"
      unitRef="usd">522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bc1d1479cd648439d07c37d2ab148bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMi0xLTEtMA_39d416f6-5374-4957-80f9-2a4a3c657e82"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64b4d4435c8a4f83a0f27f31211068c5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtNC0xLTEtMA_39f08de2-2411-4ea3-8c60-d664e04859c6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85e0424cfa2f4e97b30415fd7e13e4f2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtNi0xLTEtMA_77a3ff52-68d5-48d7-8754-38cb74dad3f4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a3c4e259bef48d08c592ec5a9e88090_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtOC0xLTEtMA_3875eadf-7018-4690-8909-ec47e765d757"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79fdd8a2b3e147d395c164637e7427f9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTAtMS0xLTA_56d37787-4e27-41de-9f92-4ea0091a2ceb"
      unitRef="usd">205000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0fee0ad1ea8468fa383b85fe7b7143b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTItMS0xLTA_53c4c8e5-e602-4dee-90a1-58e87321b203"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03d935f01a0e4ce7af8e635a7a172ab9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTQtMS0xLTA_ff782473-8f4f-4d0c-90f0-9a66bcc729a1"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4eec3ec224342aba0682ca3a09c4082_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTYtMTYtMS0xLTA_f7625ce2-dbd1-4597-a02d-3725c4d3baea"
      unitRef="usd">205000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie28996bf75474bb6b566e27bdb76a76d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMi0xLTEtMA_d3a7912f-25dc-477e-a4b1-328d52813855"
      unitRef="usd">646000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i168a1ac690494b26a0ffda594222e1bf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctNC0xLTEtMA_7104a493-12f7-4548-b4bd-aead59c4454e"
      unitRef="usd">253000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4480c0b7198d4340abbdea40d9168391_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctNi0xLTEtMA_bfe1ea89-2214-4442-89c5-361564467b4c"
      unitRef="usd">330000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i255cdd4a6e2745f6b4c4695c024a26b5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctOC0xLTEtMA_4edf42e1-6ed7-4fd0-95b2-4a6e21737524"
      unitRef="usd">1229000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i813e081e9063466a97d1059c75816be2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTAtMS0xLTA_7fc5efac-be92-4f46-833e-ad7eb908a0d6"
      unitRef="usd">731000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6244d0354fb04ecd8098b5e3bac74231_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTItMS0xLTA_cf62d66b-8e57-4a1e-bba8-97472e5a6860"
      unitRef="usd">428000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b1edb8c2b0045c7973d66c486950a77_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTQtMS0xLTA_45409e05-91bb-471a-89cb-8f60e50bff36"
      unitRef="usd">341000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if758b0a643444e158af4faf00dabffcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTctMTYtMS0xLTA_6aaf973b-c899-4f98-8434-2eaef911eaa6"
      unitRef="usd">1500000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e47efb0a051404592f124c05e259845_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMi0xLTEtMTUxNA_5d023f41-0df3-4c02-997e-411348366343"
      unitRef="usd">785000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43df52b49eec4fd985700ab74700f187_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNC0xLTEtMTUxOA_e92b5f25-ab30-493f-a5e7-d413ea67652f"
      unitRef="usd">60000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12ecda589633462d9718e5074b78e1f6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNi0xLTEtMTUyMg_a43ea6aa-be28-4993-9a52-65b127464a21"
      unitRef="usd">28000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if14a0f64631c43c587d9d721103ee2c3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtOC0xLTEtMTUyNw_4b3b0076-45e2-4797-ba51-86d235c434b8"
      unitRef="usd">873000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i174b7d15e02f410b8f1d31ccdc7a13ff_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTAtMS0xLTE1MzA_01cda4a4-7962-4397-91fa-539cbf84d972"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i844571eb2df140729ef8179477274f42_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTItMS0xLTE1MzQ_e2e63ef0-0925-4feb-bb6f-4d956d0e97f0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28663efe02324a84b779525d9431c777_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTQtMS0xLTE1Mzg_5e0cfca7-e01e-4d37-8f4f-80fbe1c7cce8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15345e0a267842739752f2512f08855f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTYtMS0xLTE1NDI_2fb31a49-ad4a-4335-9430-5b0fce8cfbda"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12734f9dde1a41feb3c30e72d478860c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMi0xLTEtMA_9eb111a4-2ae9-4ef3-a865-cc805bc6b531"
      unitRef="usd">248000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic60ae20d01ab4ca884b6a676ad457b13_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNC0xLTEtMA_080aee2d-1049-4c40-92a2-43b90409e9ef"
      unitRef="usd">22000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f201861e937474292f64e97131f815c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtNi0xLTEtMA_7a70880f-5377-4636-bc25-bc801e14db45"
      unitRef="usd">194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41acb1f4c6d84c1c8cbda1fd11bba630_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtOC0xLTEtMA_021fcea3-8dc8-490f-93ec-f5b64f4154f3"
      unitRef="usd">464000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea2acca92b854994b32a72c07a2aed73_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTAtMS0xLTA_2f647c23-9208-4c41-9e45-e899ed1a23c8"
      unitRef="usd">214000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib95cfac35a9a4dfaa8213afe8cf1742a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTItMS0xLTA_0deec2ef-ce4f-4a61-9925-df4781e45731"
      unitRef="usd">15000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide92661b1b6740029933d532260622e8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTQtMS0xLTA_892175d4-5a1f-4ac7-9201-74b7f92e9ed2"
      unitRef="usd">122000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5d9b5844fdb44dca1c2ccd68053d3ab_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTgtMTYtMS0xLTA_64321be7-f226-4127-9dc7-d57d8acb346d"
      unitRef="usd">351000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4924f62835d947d593de516d3eb5bd4b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMi0xLTEtMA_b18c597f-7a03-49b0-84d2-8f0f17737cab"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b19822d0cfa438e89b18807a9cf9e85_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktNC0xLTEtMA_25e2f2bd-4786-4e62-9dab-b3a8492ef73a"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6bbfe6897734d888e60bf1689e0476a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktNi0xLTEtMA_518db2ac-d518-4134-800d-d411eec4954c"
      unitRef="usd">100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7c3fa3e98e64124ab3a4e81c8b27cfb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktOC0xLTEtMA_1ada29da-d688-4daa-a09a-04d8ee3e357d"
      unitRef="usd">137000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffcf254dcfa549e8af3b55df2a518bb5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTAtMS0xLTA_0ca2d531-b70e-4234-995b-acbe49d2985c"
      unitRef="usd">28000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibaef6b26552d46d1a943326e4f631348_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTItMS0xLTA_fcc3327f-81db-4c25-80fd-d9a6b911659a"
      unitRef="usd">57000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia091375d714a4af68c9a4c3286c57151_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTQtMS0xLTA_42a65600-c914-4073-9f3b-45577176469a"
      unitRef="usd">119000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i469fb002cdb84ed4a5287f8c3a0c82f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMTktMTYtMS0xLTA_4b16eca6-f0f2-4af3-8f52-ae081a6ed1f3"
      unitRef="usd">204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie801464f2af24b6db9580bcc799e8ed0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMi0xLTEtMA_9cb7d776-7596-4564-9271-364033a0bba3"
      unitRef="usd">93000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9e28ff274164fa5873e4f98ae0032eb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtNC0xLTEtMA_32a400c4-84a1-4bce-b05b-ed27c6ea4272"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25a8067a5b7a4233a4795cf8b3a1e2de_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtNi0xLTEtMA_93c5e933-7b60-4d7d-bd42-3e46ed428877"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i640acf012c444e8896d04840405bc26d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtOC0xLTEtMA_fab68834-9e7b-402f-a696-dec9aa9a5a30"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6189e39123304106b05d084b2f10f2eb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTAtMS0xLTA_6e11d85b-43ff-4fb6-9c90-c71bd8ba7074"
      unitRef="usd">140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i369c0f4c20b2434ab53ae12dfd9718fe_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTItMS0xLTA_edbde77a-a975-4e5b-81c1-fba64e88ff11"
      unitRef="usd">43000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0609460d710a44d795a4a5b9718c88ca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTQtMS0xLTA_bf663492-4719-40ca-afaa-56d73acfa84b"
      unitRef="usd">18000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2525996f7074ffe8fed7cbd90a965d4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjAtMTYtMS0xLTA_e769d1c5-dbeb-46ab-a39a-5fb15fa133a0"
      unitRef="usd">201000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46b971cbacba4ffcbe41b30a57c4ada5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMi0xLTEtMA_e96f3282-0f66-4cd1-bd76-6c8fa2fa8307"
      unitRef="usd">283000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cf5589198704a3a9eaf1b0b016c3346_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtNC0xLTEtMA_6b539b97-c22b-4e12-9d50-d50839b4712a"
      unitRef="usd">144000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8a49d3ca5034dc399ac09438153fe99_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtNi0xLTEtMA_86872d9d-1a2f-4b73-ac8f-8098b992233c"
      unitRef="usd">7000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i074bdcf660fb4535964c4423fbe341ef_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtOC0xLTEtMA_bc3934ec-980c-4008-aa5d-843d568d05ba"
      unitRef="usd">434000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c1ec0d72918417a956f0174b7d3c346_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTAtMS0xLTA_84240f6c-82e6-429b-83b2-fd2225b96ce8"
      unitRef="usd">275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1824caa947414b7096f32b2b67d14786_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTItMS0xLTA_0124f270-966c-4b47-b0a9-bdad4536c946"
      unitRef="usd">59000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a83c69b2be54c018955d99da45844b7_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTQtMS0xLTA_2cd433c5-5d7f-4ee5-a838-89bfeba6a9fd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbe54791ae9241c4aa29ddeb88cf9d1e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjEtMTYtMS0xLTA_8c3f20f2-2e31-4fbd-a046-629436a215df"
      unitRef="usd">334000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i251385f2e42b4b1aa5d365acc3ea9c9c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMi0xLTEtMA_1eefaaa4-8c66-4341-9cd6-88ebc6b03212"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b331bf063c54bfabd806c7596fc3c27_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItNC0xLTEtMA_649a7788-c34d-48aa-8714-8e20122395de"
      unitRef="usd">30000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8ef2dad4ad2412486b5ea11f53023fa_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItNi0xLTEtMA_2f39b011-5e64-481b-9f0a-092a0dc1f95e"
      unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic98a59cc78974919ba762eeec3eb216d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItOC0xLTEtMA_2d574580-d943-4b00-ac3b-e93315c83ce8"
      unitRef="usd">55000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i997559821d1a4a16a73dd88830cf5174_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTAtMS0xLTA_e2d5f0a1-2528-4513-8465-0a9dd2f1c9e4"
      unitRef="usd">36000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72ec3d326d4242959cc35197614e8409_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTItMS0xLTA_97e59b1c-ae87-4cb5-94d0-983600433c33"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2af4b394c8b54e37830a1db47238b3ce_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTQtMS0xLTA_005c1402-19a3-47f8-a515-79c992da08d1"
      unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2247de6dfc784a9b868f0819caf83870_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjItMTYtMS0xLTA_61b73c9a-fae6-4825-af4d-512cda70e56f"
      unitRef="usd">79000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d6b25963e724b4e9173371c02a0efb8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMi0xLTEtMA_8ed9f0c0-310e-41e0-a8a6-40b109dc399a"
      unitRef="usd">124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d2cfbbe26ee4febb9b48574fd162233_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtNC0xLTEtMA_bf82c950-b659-4fbf-8c29-29129eba72e5"
      unitRef="usd">54000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8060638d08784ee0a62d3f6ca7218aa3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtNi0xLTEtMA_15af2e94-c693-4b46-82e0-573e7dd75dd7"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63441ce40ba84fa7ba414d3c9f749407_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtOC0xLTEtMA_1f8939de-dde5-4759-b790-604a73181cc5"
      unitRef="usd">184000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7e8741122cb4adb92eba65068bc4aa2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTAtMS0xLTA_9c83ec10-ad85-4211-ad23-8ca4eab6d44a"
      unitRef="usd">119000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie92e99fb19404d699c9090195126fcbe_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTItMS0xLTA_10539d7f-37f9-4a5b-80ab-85001c2768a0"
      unitRef="usd">96000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i985de888cc224fff89bc3914c4f615ce_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTQtMS0xLTA_10c8def6-2e55-4c6d-90f4-ed079b06466a"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6064ee7dedd34944b949c382cdd8cdbb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjMtMTYtMS0xLTA_19345913-55a4-4202-82b4-7028a66a0fe3"
      unitRef="usd">227000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc19fdfb19b8400abf3317f7988947dd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMi0xLTEtMA_c17a9f24-a7a6-4f56-9d25-1728891d6e7a"
      unitRef="usd">12835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0c2677c28fa40e08640a377bf09b729_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtNC0xLTEtMA_fd7b4c68-13ff-45c6-8ea9-77128d1e6958"
      unitRef="usd">2528000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad7b65bb41c9454391dd5c4c5f30cdd3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtNi0xLTEtMA_f9092df1-7d0a-4f43-882d-e82ca1076c0a"
      unitRef="usd">1664000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia542ffe4c807464b9cb360eb9f6c08b4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtOC0xLTEtMA_3250a92f-6353-4fc4-b7c2-91a0ceab8e8f"
      unitRef="usd">17027000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87253831ae434b6c84a09a210ade93fd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTAtMS0xLTA_85178e7b-93a4-409a-866d-efae242cfb38"
      unitRef="usd">12049000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if70a1a73cd2a4d09bbcea125f90ccdb6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTItMS0xLTA_2591f618-8cff-4fc6-86a2-19ecf2e77755"
      unitRef="usd">2727000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7aaac2bc6875471f9ceeb394f6c3798e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTQtMS0xLTA_d7709e46-d82c-4155-83bb-f79edc69bb6f"
      unitRef="usd">1547000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4ab6f6260e54f569438ef8ea0ff6cd6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjQtMTYtMS0xLTA_e19933b8-31ac-4710-ace6-4107167b22f8"
      unitRef="usd">16323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i1822fe145b174f858d3559312d4b8f07_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMi0xLTEtMA_c30c27a5-a2d5-4e6c-8171-59c7069ea9c2"
      unitRef="usd">55000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e63b6b02edb4668bfc3e4cf5963b880_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtNC0xLTEtMA_3890c1a3-4c7e-4ec9-98a2-93f6ce62342b"
      unitRef="usd">170000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id3b020739eb14d59b3f71d4b1dbff8fa_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtNi0xLTEtMA_d6528aa2-26e9-4270-8771-6457ec053a4c"
      unitRef="usd">16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifaad7749126c4b9a9ca4c44b1cff7a4f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtOC0xLTEtMA_943e6a8f-82ef-4520-adf8-12f7746c920e"
      unitRef="usd">241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c3814004476430eb98633e8d57f0ec4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTAtMS0xLTA_c0a30d73-0f15-4585-ba43-d81663a55c1d"
      unitRef="usd">61000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i581d05693e9a4a06b56980cfd2f297a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTItMS0xLTA_2ebee9ab-0527-42e0-9842-fe2f045044c6"
      unitRef="usd">181000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida77997dde894ccf8cb1e4b0f492b8a3_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTQtMS0xLTA_9a2c3ed5-3836-4236-b244-82dc73589913"
      unitRef="usd">5000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb6e106923dd4893989458d5e54fa96b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjUtMTYtMS0xLTA_ed723cb0-9978-4f57-8538-734a9e685d13"
      unitRef="usd">247000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia74680bc621445ff90e26deda6b247a0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMi0xLTEtMA_2b3d6a4a-ecba-4f4f-b278-80a7caef53ce"
      unitRef="usd">12890000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib5c7d640e5a74988b2acbeca36e215a4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtNC0xLTEtMA_f9149608-130e-4b23-8dce-4eeb3b6af322"
      unitRef="usd">2698000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf9ba585026444bda0371b5c9792d66c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtNi0xLTEtMA_c991f986-f6c0-41ad-bed7-5a38c06e0eab"
      unitRef="usd">1680000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtOC0xLTEtMA_02a4d319-5388-412a-9e2d-a42e727e3448"
      unitRef="usd">17268000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f7edbbe0058498ba07f1c694f172ae5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTAtMS0xLTA_417f6f18-bb1d-4bbd-93d9-8003a73c1e28"
      unitRef="usd">12110000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ae67afc268c481189809b0cb77b19b0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTItMS0xLTA_32e7d593-a204-488e-989e-b79ac35426a7"
      unitRef="usd">2908000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3d15d27b4f1147e9a39d0edfa87476a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTQtMS0xLTA_f624efdf-6331-4259-a371-6351b06936a5"
      unitRef="usd">1552000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmVmZDA4MzhkYTVlMTRiYTI4NGViODg4MThjYzkzOGU4L3RhYmxlcmFuZ2U6ZWZkMDgzOGRhNWUxNGJhMjg0ZWI4ODgxOGNjOTM4ZThfMjYtMTYtMS0xLTA_e0ef9620-c040-487e-bd8e-5eb3c92df675"
      unitRef="usd">16570000000</us-gaap:Revenues>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTI0OA_658a9d08-008d-4f14-9d07-63f4cfae1969">&lt;div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AmerisourceBergen Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardinal Health, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib51bea2a549043ccb4d2d8b9b4e6f2fd_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy0yLTEtMS0w_cff9618a-a014-4662-96f2-afe3e202c858"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6d4f1c22279841b1bc41d5c7af3e12f3_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy00LTEtMS0w_7bf7ef64-c906-4d6a-801f-c7e521ebad03"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifdf756e786804feaac25586f0993f6ad_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy02LTEtMS0w_bb2b5d98-935b-470f-9118-d7f6170a44ec"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie0344ff608be498d82fb0639f25f1fbb_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfMy04LTEtMS0w_1cd6519c-9bdf-4d0f-8891-be296003bbc0"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id5e4c86e2a164127b1e60622b100f769_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC0yLTEtMS0w_32dd2612-4d53-4948-986d-5ef1c4140711"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3351e615eb324ecfbe90c19cb5ed63af_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC00LTEtMS0w_15fa8c62-f755-4a88-b17c-8a1c63b7ca5d"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6cabee79f5b442639e665379940075f6_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC02LTEtMS0w_81502c34-2d15-4229-a381-1a60c5365d58"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if2d001f2fdfb4dd69dbbf58a803cf0b1_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNC04LTEtMS0w_b73fabf8-ad54-4691-9a44-6ea42a08cd32"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifd52bba8c8b746ceb4390db580f35332_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS0yLTEtMS0w_f8393fef-a54e-49d0-9629-928aa47129dc"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib3a8e91519874ec798163966b238f366_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS00LTEtMS0w_ffdc854a-9b7a-481d-87e1-d5066b317a15"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i493449153f79453f9dfe0eacaa0db3b2_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS02LTEtMS0w_640c2db3-f3be-4efc-bf96-bb3e8575cc16"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id668da46343f4db6a7137fe89d885862_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RhYmxlOmI5YTY1MjY0YzcxYjRlYjA5ZTYzOTA2ZDgxODY5YWU0L3RhYmxlcmFuZ2U6YjlhNjUyNjRjNzFiNGViMDllNjM5MDZkODE4NjlhZTRfNS04LTEtMS0w_f0c41565-92f7-4e46-91c2-23a1423df1a8"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjUw_a0b9d552-a2f4-4b1c-9438-956bd7350179"
      unitRef="usd">206000000</gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods>
    <gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjU3_b5e51674-b557-4b04-b934-1d2cec199ee7"
      unitRef="usd">618000000</gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods>
    <gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjkw_c08980ea-ebbe-47d9-9f44-ed9c1a1636fe"
      unitRef="usd">201000000</gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods>
    <gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfNjk3_478b9f6d-9728-4c2d-934e-8d698038233b"
      unitRef="usd">527000000</gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODI1_898b6731-44d6-49e4-93a5-1df4bb33c1a5"
      unitRef="usd">13000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODMy_30ba220a-54b2-48ad-a6ae-d1869975fa07"
      unitRef="usd">94000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODg4_7a342115-2f3d-4389-bae4-89deaecf4737"
      unitRef="usd">9000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfODk1_c6dd233c-6fca-4e4f-a52c-320963f4ccbf"
      unitRef="usd">309000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTE1Mg_5799806a-1fa2-4e73-bcad-e35fab2f5ee3"
      unitRef="usd">186000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTE1OQ_bfd74ac0-ff2c-4c44-96e8-595d36bce616"
      unitRef="usd">144000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTA5OTUxMTYzMjM1MQ_1e42d762-d762-473b-b1c4-fec9edaade50"
      unitRef="usd">103000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN18zNy9mcmFnOmNhZTViMjFkYjZiZDQ3MjBhYjQzNjlhYTk0NTYxZjM2L3RleHRyZWdpb246Y2FlNWIyMWRiNmJkNDcyMGFiNDM2OWFhOTQ1NjFmMzZfMTA5OTUxMTYzMjM1OA_8abbe923-5112-4647-985e-b0be9cac7264"
      unitRef="usd">45000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg3NQ_6591e167-fd29-4579-8800-6b23c1ece789">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of financial and non-financial assets and liabilities using the fair value hierarchy, which establishes three levels of inputs that may be used to measure fair value, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Level 1 inputs include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Level 2 inputs include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For our marketable securities, we review trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Level 3 inputs include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Our Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments consist primarily of cash and cash equivalents, marketable debt securities, accounts receivable, foreign currency exchange contracts, equity securities, accounts payable and short-term and long-term debt. Cash and cash equivalents, marketable debt securities, certain equity securities and foreign currency exchange contracts are reported at their respective fair values in our Condensed Consolidated Balance Sheets. Equity securities without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. Short-term and long-term debt are reported at their amortized costs in our Condensed Consolidated Balance Sheets. The remaining financial instruments are reported in our Condensed Consolidated Balance Sheets at amounts that approximate current fair values. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage and asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment in Galapagos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other publicly traded equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency derivative contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of equity securities resulted in net unrealized losses of $964 million and $1,046 million for the three and nine months ended September 30, 2020, respectively, and net unrealized gains of $58 million and $312 million for the three and nine months ended September 30, 2019, respectively, which were included in Other income (expense), net on our Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of our equity securities in our Condensed Consolidated Balance Sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:9.5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our available-for-sale debt securities are classified as cash equivalents, short-term marketable securities and long-term marketable securities in our Condensed Consolidated Balance Sheets. See Note 4. Available-For-Sale Debt Securities for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6. Acquisitions, Collaborations and Other Arrangements for additional information on our equity investment in Galapagos NV (&#x201c;Galapagos&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2 Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair values of Level 2 instruments by taking into consideration valuations obtained from third-party pricing services. The pricing services utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate the fair value. These inputs include reported trades of and broker/dealer quotes on the same or similar securities, issuer credit spreads, benchmark securities, prepayment/default projections based on historical data and other observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of our foreign currency derivative contracts have maturities within an 18-month time horizon and all are with counterparties that have a minimum credit rating of A- or equivalent by S&amp;amp;P Global Ratings, Moody&#x2019;s Investors Service, Inc. or Fitch Ratings, Inc. We estimate the fair values of these contracts by taking into consideration the valuations obtained from a third-party valuation service that utilizes an income-based industry standard valuation model for which all significant inputs are observable, either directly or indirectly. These inputs include foreign currency exchange rates, London Interbank Offered Rates and swap rates. These inputs, where applicable, are observable at commonly quoted intervals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total estimated fair values of our aggregate short-term and long-term debt, determined using Level 2 inputs based on their quoted market values, were approximately $33.3 billion and $27.3 billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively, and the carrying values were $29.3 billion and $24.6 billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg2Mw_698db302-766a-4c9c-b93b-47d6e832c9fd">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of financial and non-financial assets and liabilities using the fair value hierarchy, which establishes three levels of inputs that may be used to measure fair value, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Level 1 inputs include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Level 2 inputs include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For our marketable securities, we review trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Level 3 inputs include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Our Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. &lt;/span&gt;&lt;/div&gt;Our financial instruments consist primarily of cash and cash equivalents, marketable debt securities, accounts receivable, foreign currency exchange contracts, equity securities, accounts payable and short-term and long-term debt. Cash and cash equivalents, marketable debt securities, certain equity securities and foreign currency exchange contracts are reported at their respective fair values in our Condensed Consolidated Balance Sheets. Equity securities without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. Short-term and long-term debt are reported at their amortized costs in our Condensed Consolidated Balance Sheets. The remaining financial instruments are reported in our Condensed Consolidated Balance Sheets at amounts that approximate current fair values.</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg4MA_2b4fe557-3fdc-4ea2-a64a-7a3e01c49989">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage and asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment in Galapagos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other publicly traded equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency derivative contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic6441f2721574eb2b066460bd0098a33_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xLTEtMS0w_a2814abf-b7bb-4b18-830e-a7bed58047c4"
      unitRef="usd">2238000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifea4251592be4a09bb586ecf7b0877b6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0zLTEtMS0w_be26339f-1968-429c-adfb-47bf6b39c70b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i70cc122877ef421aa55fd71bb8bc36aa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC01LTEtMS0w_daf82902-83e8-426e-b5da-ee1e2524b91f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i92e9a07c98224bbaaaf8f40807d0e83c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC03LTEtMS0w_e5a4fec3-ca82-4f10-b2e0-32065ecbf5a9"
      unitRef="usd">2238000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i016620e60b0e45a2b86d94e4bedcd1d4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC05LTEtMS0w_281e1b61-99a3-430c-845e-4b909aab1077"
      unitRef="usd">2433000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b0f034dcaa0404585e485dfbb6d10e3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xMS0xLTEtMA_0906dc17-0990-49aa-bde7-d58db5f26626"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i65f5244a5e8f4ed5b372521b97d023cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xMy0xLTEtMA_1757ef5b-82c4-4ed1-9f37-0283586d54a6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id4ed4d70910c4494a6240e2ac85171eb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNC0xNS0xLTEtMA_b195ed81-dd16-41f3-aaf9-5f53ac905afa"
      unitRef="usd">2433000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4cda5ed87da74c01ab8c6f23f4b7f768_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xLTEtMS0w_d0b33c74-7af0-413e-83b0-f965c03e6831"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i62c6e23a89e1448f9ed6fbf3ca90c206_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0zLTEtMS0w_f4209c7b-5ffa-429b-b11e-e1d63fe59114"
      unitRef="usd">2136000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd5b88ed58b34df29d8e5cad8f3c7ef6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS01LTEtMS0w_402c4fff-a346-4559-9bd0-93e7cdd4019b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibffb351639be43d6ba1030c106ff8eb8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS03LTEtMS0w_66087a72-4e32-4cf6-9598-33c6e02133dc"
      unitRef="usd">2136000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i74c7b09230e8405fb21eb18f3e0dfae7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS05LTEtMS0w_eda564f2-ff0f-4f86-92c8-8fa13f451d08"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifb611e0fbed54ad5968a92550e95897b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xMS0xLTEtMA_d42e0ebc-e10f-467e-8f5e-bd678f384a0b"
      unitRef="usd">3517000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75300f98c39f4d63a888fcd33da6f547_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xMy0xLTEtMA_893aa2d9-3c46-42eb-bb39-a31b1f54e68b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifae90ac2d91e4170b23f8a6a66efc12f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNS0xNS0xLTEtMA_071b40ce-a739-4b18-a7e2-2080141908e2"
      unitRef="usd">3517000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b24cc4056cf47e784957e18bd3d8fef_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xLTEtMS0w_f04ce90e-649b-45e8-9e6a-816859ac5b57"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i08217eba7b4040989c8927514a8e4667_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0zLTEtMS0w_d811ea8f-98ae-498c-b8c5-273c8af7230b"
      unitRef="usd">71000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic06f0fae2eba4968aaef1e5ccbb6b62c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi01LTEtMS0w_02fb8312-12e6-4693-a780-12ae6ea82ae4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i899ff3da4637496c978fdba31ede1851_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi03LTEtMS0w_dbaf7ba5-a275-43f3-9d53-619dcedd1428"
      unitRef="usd">71000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0f7cfa70f7d44abeb0a42230869dd083_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi05LTEtMS0w_6dc71d86-b1f8-4abe-b618-73cab829683c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id93f2ac2c6184cdc88f83b027e6b6987_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xMS0xLTEtMA_124960ff-4992-459b-acf5-34733020a606"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0205ea3174f84373ad0b7317fb14ee43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xMy0xLTEtMA_4ac717f2-70b3-46aa-847a-79a745443917"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2175ecdb247344f380a11e6cc2fff2c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNi0xNS0xLTEtMA_33296d2f-f7d7-41b3-bb00-5e13ad34b49d"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iff8d2177f2e648dbbf9fb7e466067dd7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xLTEtMS0w_8274e599-bf05-432c-9e04-daca74af3594"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic455f28a60e74c3fb60fa85587a50d84_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0zLTEtMS0w_2b00fcfd-0e0f-4207-968e-f6df8d67d006"
      unitRef="usd">220000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic3eca0222a334fe6a0daa4b5b8dab50f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy01LTEtMS0w_c2bdb6fe-ae3d-43e6-b936-8399ce018e87"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1c28da23233147d9b46404d8348cc986_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy03LTEtMS0w_f93e8359-7e95-4726-a4f7-c5258ee29736"
      unitRef="usd">220000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iacec8636d81c4ccca6752cd4f9295732_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy05LTEtMS0w_f5fd0e2d-ce13-4296-8d64-b6aab30abe78"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib2a82defc66745f690df80e8668e890c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xMS0xLTEtMA_9905858a-4ffc-4a21-b815-55d277595f89"
      unitRef="usd">174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2762aff7213c485a9bd438bb60c288d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xMy0xLTEtMA_0c621a0c-b843-4740-b9cf-d4b2129e9126"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05ed3d6b01754487a4a76050317ca559_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfNy0xNS0xLTEtMA_f833090d-4600-4d37-a93a-e375e52362b2"
      unitRef="usd">174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ddeab33a06c4acf87407a2dd4a0fa57_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xLTEtMS0w_848b0428-1439-4466-b3d8-8491c85e8344"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb532ca82c864b69bcefe78f95dbff76_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0zLTEtMS0w_135a6914-5475-43c6-a48a-7eff1351c494"
      unitRef="usd">7525000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iba47020efd0947a3a230d76409764d71_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC01LTEtMS0w_609e6e91-57a9-489a-8e07-338f2a753034"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if8e91ec83eb244499df3127b2b341240_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC03LTEtMS0w_a0a713fd-53ed-4125-a4c1-1f4b42732526"
      unitRef="usd">7525000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i45b5ab6cbfea4b5ba7e0e248c8955c25_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC05LTEtMS0w_bdc197be-11c0-4f55-905f-86be68facd8c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iffbc3256a0924126aa99e6bbeadc7d47_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xMS0xLTEtMA_bd5c17be-e4f7-4d6f-ab4b-d2953d7bfd6f"
      unitRef="usd">9204000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i346980582de5432fab397590fe91e43e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xMy0xLTEtMA_4be9c909-eea4-42dc-a104-c00a13cf824a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4cc2a2681941419293fadf9296a83636_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOC0xNS0xLTEtMA_7039eef1-37ca-495a-a0ce-0daa354b2f6c"
      unitRef="usd">9204000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i98a2dbe200754e44ba989b4ac9964ff1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xLTEtMS0w_9aa23c06-d0d4-4bab-a3d4-855cf14ef418"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6341635988148b8ae35b14f5506e068_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0zLTEtMS0w_68916f76-775f-4e6b-9b45-bc96adae2d30"
      unitRef="usd">1209000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia390b9822bae42bb96393b307440c66b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS01LTEtMS0w_2f6d2a38-898a-46f6-801d-06394112772a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5c74ca81b25645129c007d405131d946_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS03LTEtMS0w_643e8bb1-0d34-4883-b9f2-c01771af2f54"
      unitRef="usd">1209000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8446aa5e56ad47e4866b4ffd7bc9103d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS05LTEtMS0w_4f778f06-be12-4835-849a-bcfe45787867"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i256bfd9c10a3491e8671599c334071c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xMS0xLTEtMA_6c5eaa17-ac1c-4978-9dea-b4b085d320da"
      unitRef="usd">91000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ebfc4a0cc6a403fb9a858f1755f42fe_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xMy0xLTEtMA_107b9660-0cc0-4b06-a11c-b502a2724113"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb62bb7ec71e4bdab398215247c43327_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfOS0xNS0xLTEtMA_ff48bae8-e122-4d85-bbe9-562e3964b903"
      unitRef="usd">91000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i80339bdd09004325869ace1cd2d34105_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMS0xLTEtMA_4d8aaa8e-b4cd-44b8-897b-1dcac9ffcb81"
      unitRef="usd">2361000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ieef34b5a375d4d90a234962b99965328_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMy0xLTEtMA_4fd1359f-da3a-4149-9342-90dd3a87f630"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i06f736d48d424b4bb10af44ec2c200c5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtNS0xLTEtMA_1a8b5d7d-c595-4c3c-9ba9-500392154091"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i80ed5764050847e49062635ab01cae21_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtNy0xLTEtMA_4bb02c68-8c0e-4327-b748-08fdc6bdccde"
      unitRef="usd">2361000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i77e8c6f47d2041209000d04abb655b79_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtOS0xLTEtMA_68135894-a9e6-46da-becb-97fbc3fe747b"
      unitRef="usd">3477000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib6533f6ca1a8499c9911c6c29ec5e81d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMTEtMS0xLTA_674bcbdf-e05b-4fe5-a80b-433e7a346e9c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i92ae46288d7648bc98a7b52b5e2a2e94_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMTMtMS0xLTA_f48b0dcf-b5b9-42c9-9ade-d58a270b6682"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic990aad2d80c4f41a16acb8758ad9e39_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTEtMTUtMS0xLTA_e5d60757-75f8-439a-a23c-adfdb906cf00"
      unitRef="usd">3477000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7457789a3f89476fa8de57c200293d14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMS0xLTEtMA_fbe145b5-6413-41b4-9842-2ade070b944d"
      unitRef="usd">11430000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie7fb86f9d78a402a80e9cf34ac4e8cd6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMy0xLTEtMA_b1d60d0e-feda-415d-9f5b-4760aa7872c0"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i49cf4dabb9324f5d8ca59ddfb2c21457_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItNS0xLTEtMA_acd4c1ff-13ef-4b17-8948-fc1213908eec"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9f94575eafb6420daedc818f3fbaaf52_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItNy0xLTEtMA_f415b752-942f-4228-90fe-5f09d59ad727"
      unitRef="usd">11430000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if96baf7453ec488d8b4ee4a49d5a698d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItOS0xLTEtMA_e31a0ce4-84a2-4a5f-9ff3-eed36d081496"
      unitRef="usd">7069000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1e53a276f8f04098947f2d530352c0c1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMTEtMS0xLTA_e146ed1a-f937-4519-a9c4-a95eb2a453c2"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2514dcd1744c42d99689f65cf992ea80_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMTMtMS0xLTA_29d6d6cd-77b2-4af0-a3e2-a1109107b19b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7ebf1e84f3954ab8a1cc2392c6e28569_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTItMTUtMS0xLTA_8ee099b4-98b0-4b8d-9bac-7c22e4ba103f"
      unitRef="usd">7069000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8598034c1a26461fb3d885c48a66e8ac_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMS0xLTEtMA_1e4ee118-2d43-4929-add8-959f5920d377"
      unitRef="usd">619000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3836c33667544e528fc4feb3ed36fc42_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMy0xLTEtMA_db857bfb-510f-40d1-82f7-36e7c8a9ff7e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic5a034e702f740f381d179248d096442_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtNS0xLTEtMA_dbba2dbd-5612-4ba0-8f65-9484dc00ec6d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="idf34775baa8f4d23afc2547f765fed5d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtNy0xLTEtMA_3a513762-68ea-49ee-9690-17e064a18292"
      unitRef="usd">619000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie22107d806154b21b150e48b8ced2120_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtOS0xLTEtMA_fb680474-3d50-4f45-ba45-93b9155aa1c4"
      unitRef="usd">322000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i332100bf65a74c73b78f88558ca64905_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMTEtMS0xLTA_9cf4f544-ac7b-4267-b8be-77114a70a6bf"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifc3a038de51d492da6acb057be109969_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMTMtMS0xLTA_7db7e4d9-7f40-4781-8038-8501ffd10859"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifca554c2c1754c65b519605f1694f915_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTMtMTUtMS0xLTA_892c7d69-e4b7-4dd9-ac16-a5a6bb14fcbb"
      unitRef="usd">322000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i16bea56fb72747d698df8fbf549baa95_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMS0xLTEtMA_e4b1b04b-b486-410d-a1fa-a4ac0ded602a"
      unitRef="usd">200000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5f9c716a8e98448eb4565f3e04a28ebf_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMy0xLTEtMA_3700bb0c-35ef-4ca9-b6e3-0622e0a1f73e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2836e0ba225f4e40aaa8bf556a63e011_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtNS0xLTEtMA_63b1ac89-0277-4241-b347-584f7d7cad95"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if4fd4965df6c4aba98b90509f6af2d11_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtNy0xLTEtMA_1a1c3504-0758-4861-9ea2-fe04b192d59b"
      unitRef="usd">200000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3680162306264834bb21711e1ff3044a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtOS0xLTEtMA_8e622be0-2c24-4395-90c1-8d42b9468ab8"
      unitRef="usd">171000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3ecb4569c8314f7c8e009e95c3628aa7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMTEtMS0xLTA_cd123e89-0853-46d2-bd4c-36f43b685d0b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i343a612674094b2083c8d08bac298824_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMTMtMS0xLTA_0efca191-def6-4356-a4ca-080dd6b44a92"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if86851181e3a487098e2236460b2dada_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTQtMTUtMS0xLTA_1d33b869-303a-4e6e-9a61-c9a42adc0df9"
      unitRef="usd">171000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ifb6d3cfa89a44fc4b021c0457c085a5f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMS0xLTEtMA_2eabcc4a-4691-474a-a2a7-47acf7382a06"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="id3fcb255d1824b2288a9ce395b9da146_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMy0xLTEtMA_3a5e4916-0bed-4902-b8c7-554d3e189bfb"
      unitRef="usd">6000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i15165eda3c9345ff8f6ae2cebaafe873_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtNS0xLTEtMA_e3d7fd1a-8678-49e8-b414-a09a632bc1b9"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i1832e7b713ea47d0a15518b89e0f27bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtNy0xLTEtMA_dd508fd6-f374-4e4d-b72b-5f56f4501835"
      unitRef="usd">6000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie9bf9c41df7549ccae89be301ed3f03b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtOS0xLTEtMA_b35ad794-8cb8-4d84-a411-dffb5c2db411"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia379b9e5e4e84e8b9e9aa4b43ba92bdf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMTEtMS0xLTA_b0dab716-35a6-4b2d-ba73-31a01206cd2f"
      unitRef="usd">37000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ife8fdfe82c0246158810b46b13c00e97_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMTMtMS0xLTA_c3c09a15-ab36-4778-a944-ef7317646347"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie1ef925d0d174ed992b1c8c45928db38_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTUtMTUtMS0xLTA_765b430c-b387-4263-9c78-5c6e7240a08e"
      unitRef="usd">37000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5bcbde7b6799451db4c9c818cfeead67_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMS0xLTEtMA_b78a80f0-0232-4e79-87e1-49dbd51bccfd"
      unitRef="usd">16848000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i93eadd341c934b73a3e6940d3f6413a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMy0xLTEtMA_3a346aec-9995-4b88-90a6-3c85ffe51a47"
      unitRef="usd">11167000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic41b4012b457481dbffd93eb9153e360_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtNS0xLTEtMA_4744a7e8-6920-434b-8213-a5b124d87e08"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idb5e4a50b9284e4d9af880ee03a84122_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtNy0xLTEtMA_99dc0543-4884-4129-9477-17a421e5263c"
      unitRef="usd">28015000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia76f2122a7b7462cb1fc9f410f396ff4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtOS0xLTEtMA_4bc85cf0-1d85-4914-8809-02f647e97135"
      unitRef="usd">13472000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9219113fc2d041d29935ac7469176613_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMTEtMS0xLTA_e7da08c8-d00b-48db-bbd9-162e58f73dd1"
      unitRef="usd">14104000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if4a61c55dc4b4663867980b24fdcb0a1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMTMtMS0xLTA_961923d7-7784-4119-a75e-6f7b98f6c19f"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7d1fdb77ea804ee193031561a281a198_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTYtMTUtMS0xLTA_bd676286-8f00-4eb5-b2c7-5b8b049a26e1"
      unitRef="usd">27576000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i16bea56fb72747d698df8fbf549baa95_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMS0xLTEtMA_c09cdcd7-4441-4502-b89c-da64a5b59ee0"
      unitRef="usd">200000000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i5f9c716a8e98448eb4565f3e04a28ebf_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMy0xLTEtMA_1cba6716-7f15-4401-bb0d-6788c2c5b7b5"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i2836e0ba225f4e40aaa8bf556a63e011_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtNS0xLTEtMA_da3ace92-c47f-408b-b828-640a816936e7"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="if4fd4965df6c4aba98b90509f6af2d11_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtNy0xLTEtMA_9372dae2-ec2f-4d1f-b692-4107f7783282"
      unitRef="usd">200000000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i3680162306264834bb21711e1ff3044a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtOS0xLTEtMA_afc5978c-94f4-47dd-a594-b1f330763432"
      unitRef="usd">171000000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i3ecb4569c8314f7c8e009e95c3628aa7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMTEtMS0xLTA_af160dc3-b750-4ba8-8ca5-c745da15edc2"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i343a612674094b2083c8d08bac298824_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMTMtMS0xLTA_0d91b29b-fe40-4394-b0a9-9d0f9a7f1868"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="if86851181e3a487098e2236460b2dada_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTgtMTUtMS0xLTA_4717e295-0f74-4df6-ac56-1c2413496e53"
      unitRef="usd">171000000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ifb6d3cfa89a44fc4b021c0457c085a5f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMS0xLTEtMA_606b571d-01e3-41d1-b26c-ebd51c6afc5f"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id3fcb255d1824b2288a9ce395b9da146_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMy0xLTEtMA_62d41f89-49ce-4b33-992b-07a039ac16bc"
      unitRef="usd">50000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i15165eda3c9345ff8f6ae2cebaafe873_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktNS0xLTEtMA_e4ba8555-ac84-4649-bf5a-314a29459f76"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1832e7b713ea47d0a15518b89e0f27bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktNy0xLTEtMA_b80f2ebe-d3f0-4896-9f16-0a9c1286bafe"
      unitRef="usd">50000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ie9bf9c41df7549ccae89be301ed3f03b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktOS0xLTEtMA_fe73ec48-3b01-414b-87aa-4c72fd096065"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ia379b9e5e4e84e8b9e9aa4b43ba92bdf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMTEtMS0xLTA_463f234b-346e-4e91-861d-89634d2043fa"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ife8fdfe82c0246158810b46b13c00e97_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMTMtMS0xLTA_3ddd6cda-1bd7-42df-b066-f318e7996fe6"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ie1ef925d0d174ed992b1c8c45928db38_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMTktMTUtMS0xLTA_ae88486c-3af0-4e90-9a1b-dc2950fb1e4a"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5bcbde7b6799451db4c9c818cfeead67_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMS0xLTEtMA_ff6f0678-edec-4373-8012-388fe6281c56"
      unitRef="usd">200000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i93eadd341c934b73a3e6940d3f6413a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMy0xLTEtMA_0ceae389-8969-4e39-87f7-3aaa22a80d11"
      unitRef="usd">50000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic41b4012b457481dbffd93eb9153e360_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtNS0xLTEtMA_5d21c509-53db-46fa-8950-1b062eb9b237"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idb5e4a50b9284e4d9af880ee03a84122_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtNy0xLTEtMA_1d13b8da-104f-4252-8688-eb977f58c9fc"
      unitRef="usd">250000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia76f2122a7b7462cb1fc9f410f396ff4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtOS0xLTEtMA_5fc59343-3e3f-40c6-b196-684c71b11a90"
      unitRef="usd">171000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9219113fc2d041d29935ac7469176613_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMTEtMS0xLTA_baa3f167-c9ce-4b4e-9f3b-70480f1d3e86"
      unitRef="usd">8000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if4a61c55dc4b4663867980b24fdcb0a1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMTMtMS0xLTA_9d2188fa-7888-4b3f-a8bb-49d188300a48"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7d1fdb77ea804ee193031561a281a198_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjcyMWE5YjIwZWEwMjQzNDZiMzAxOGE3NzJhOWRmMDZlL3RhYmxlcmFuZ2U6NzIxYTliMjBlYTAyNDM0NmIzMDE4YTc3MmE5ZGYwNmVfMjAtMTUtMS0xLTA_e3f09abb-3a4a-4faf-86d9-464f76e73d00"
      unitRef="usd">179000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjYzMA_71485cbe-8571-4494-a636-8b30da770190"
      unitRef="usd">964000000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjY2MA_19cad957-873d-4aa6-99a3-a6afdabd6748"
      unitRef="usd">1046000000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjcxNw_002113e4-1d5b-4375-b56d-40952f180205"
      unitRef="usd">58000000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfMjcyNA_a27e0b55-d4ba-495d-93b8-261a9020d193"
      unitRef="usd">312000000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDg4NA_bfa6a8cf-0f90-4a12-bad0-1dca2c84ca66">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of our equity securities in our Condensed Consolidated Balance Sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:9.5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i79bd59bb3d5a446c898736046871d68f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMS0xLTEtMS0w_295f0b5b-1676-4b03-87ff-936c19cf899b"
      unitRef="usd">11430000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i202d8dd34b4048a6a70528355ccc07d7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMS0zLTEtMS0w_06806a5f-aeff-4a77-94aa-8fc61fc150f3"
      unitRef="usd">7069000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1aad028e1dd94922b809346982b70e6f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMi0xLTEtMS0w_fb400701-9aca-46dc-8ed1-439260741a42"
      unitRef="usd">986000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i63529910aec24b4797650b819a035d38_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMi0zLTEtMS0w_79b4c0ec-7713-4af4-a16a-2d97c5515556"
      unitRef="usd">319000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id95a598ab9ac4ba38343c2442e163984_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMy0xLTEtMS0w_d84c504f-0638-4788-ae2a-0ed03b5250ab"
      unitRef="usd">2194000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0cf8f6a568ff4422830e566cac20c2b1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfMy0zLTEtMS0w_bf0cef09-3ba0-4045-a13f-f8e11602a016"
      unitRef="usd">3651000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i973aae8a8cc74f1285d8fcfa96228c98_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfNC0xLTEtMS0w_bbdc236e-7293-421c-8f35-0572c73111ab"
      unitRef="usd">14610000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6f86e6b410fe461e99132bb73eb20f07_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RhYmxlOjI3M2RhNWJmMTRiNjRiZWVhNGMxYmE5NTA3NDdkYjRkL3RhYmxlcmFuZ2U6MjczZGE1YmYxNGI2NGJlZWE0YzFiYTk1MDc0N2RiNGRfNC0zLTEtMS0w_d8d716a3-2746-40ab-ba56-bad5f1bbe927"
      unitRef="usd">11039000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LongTermDebtFairValue
      contextRef="i3f57c5401fe14752b2128178cf57b7b8_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDc0NA_b23981cd-608b-454a-8fd0-0d8043598873"
      unitRef="usd">33300000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ib076e25c99fb466c9bc9ec757f4c69ba_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDc1MQ_18ac93f8-1d51-4e0e-8946-fbf28a3f8bce"
      unitRef="usd">27300000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1fd39ebfac5e489099472ca928286c5d_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDgxNA_3ef93fdd-dbad-470d-a194-823cd946d2c7"
      unitRef="usd">29300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i152b037ec98d48b8b0f21c10881726a8_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180MC9mcmFnOmFlY2M3NjA3NTFkZTQ4NThiNmNiYmQxMzFkZTNmMWVhL3RleHRyZWdpb246YWVjYzc2MDc1MWRlNDg1OGI2Y2JiZDEzMWRlM2YxZWFfNDgyMQ_eca48778-7b9b-490a-be2b-f129a3c488e0"
      unitRef="usd">24600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMwNA_496d41bc-f5f7-4185-b091-fe93d137eff6">AVAILABLE-FOR-SALE DEBT SECURITIES&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage and asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest receivable excluded from both the fair value and amortized cost basis of the available-for-sale debt securities was $49 million and $37 million as of September&#160;30, 2020 and December&#160;31, 2019, respectively, and is recorded in Prepaid and other current assets on our Condensed Consolidated Balance Sheets. There were no write-offs of accrued interest receivable during the three and nine months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&#160;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities in an unrealized loss position (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#acacac;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We held a total of 208 positions which were in an unrealized loss position as of September&#160;30, 2020. The unrealized losses are largely due to changes in interest rates. Aggregated gross unrealized losses on available-for-sale corporate debt securities were not material, and accordingly, no impairments were recognized for the three and nine months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMyMg_ef10da42-4595-423c-ab4e-04409facd78b">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage and asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iab61524bb61c418da02f67470629315a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0yLTEtMS0w_88d7838d-0824-4c24-a528-d9b91c92b4e1"
      unitRef="usd">2225000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iab61524bb61c418da02f67470629315a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi00LTEtMS0w_0e0ed200-a983-410e-9c1a-16a2a58a1534"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iab61524bb61c418da02f67470629315a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi02LTEtMS0w_4e52606e-4fce-4852-9c1c-90b25d6d499e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iab61524bb61c418da02f67470629315a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi04LTEtMS0w_9dcff39f-f7e0-431a-bd28-a2e98f9e3701"
      unitRef="usd">2238000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xMC0xLTEtMA_d19c2252-0c22-4174-a247-51f6ab9dbca9"
      unitRef="usd">2433000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xMi0xLTEtMA_cfc0910f-2d99-453e-aea7-66371b83f533"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xNC0xLTEtMA_c5d6a038-7700-4ab9-bb76-d6b70124d04e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i90378da552dd4d3397c49bfd840fcf32_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMi0xNi0xLTEtMA_8bbb86a0-bc7f-447d-a0ee-2133ec92997b"
      unitRef="usd">2433000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0ed486534dc045088bf927345ba227e0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0yLTEtMS0w_532daedd-4e43-4773-99a6-42bcd3e69214"
      unitRef="usd">2136000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0ed486534dc045088bf927345ba227e0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy00LTEtMS0w_8da112e2-d9b7-4500-ba6a-c1713c093d51"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0ed486534dc045088bf927345ba227e0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy02LTEtMS0w_19c7a933-81a7-44bf-a6ea-5c1ee30de8c0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ed486534dc045088bf927345ba227e0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy04LTEtMS0w_0240821c-a487-47a6-8819-eba224d3844a"
      unitRef="usd">2136000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i280f5420541248679b56a8d625ccd64a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xMC0xLTEtMA_4f4d10de-cef7-4536-bb7a-f323093218ac"
      unitRef="usd">3517000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i280f5420541248679b56a8d625ccd64a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xMi0xLTEtMA_a251f64a-d168-4694-b510-f125cfef9f0c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i280f5420541248679b56a8d625ccd64a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xNC0xLTEtMA_5ec195ee-e4cd-4784-96a3-f46c2d8c324e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i280f5420541248679b56a8d625ccd64a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfMy0xNi0xLTEtMA_6e2c5f4d-3767-4368-a434-fb38e3855e9f"
      unitRef="usd">3517000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i915f187c67784380afcab80212da1735_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0yLTEtMS0w_e778f6fa-d8f4-42fe-a6ec-ef5e48aa6556"
      unitRef="usd">71000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i915f187c67784380afcab80212da1735_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC00LTEtMS0w_12c2caa8-27bc-43fb-8adb-873924c79382"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i915f187c67784380afcab80212da1735_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC02LTEtMS0w_0536b894-0c54-4518-aa42-337cf61b869f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i915f187c67784380afcab80212da1735_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC04LTEtMS0w_ec883757-6877-4ee7-a4c7-04865a43990b"
      unitRef="usd">71000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xMC0xLTEtMA_4fe1e556-ecee-40b3-b1e4-0f4e5463f3f1"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xMi0xLTEtMA_764e6e41-3687-43dc-b890-d22f9034ff3b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xNC0xLTEtMA_c28efff7-0658-45d0-be5e-6a22e766677c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8e5d7a0ad7844a59b40332fc20d71cbc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNC0xNi0xLTEtMA_41141639-4c30-452f-bbf9-fe0985261249"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i44901ae9d576485b846e66590a5145bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0yLTEtMS0w_5c46e247-cbb0-4c80-92cb-62c22d9ed581"
      unitRef="usd">220000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i44901ae9d576485b846e66590a5145bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS00LTEtMS0w_ad748d90-a462-4d99-930e-ee1d52142403"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i44901ae9d576485b846e66590a5145bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS02LTEtMS0w_1f37e273-82a3-4533-8325-cbd65c9423c4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i44901ae9d576485b846e66590a5145bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS04LTEtMS0w_8937ec2e-371f-4f0a-985a-3d4e52c1ee8b"
      unitRef="usd">220000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xMC0xLTEtMA_2eef2858-29bc-42b8-83d1-4773863f5076"
      unitRef="usd">174000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xMi0xLTEtMA_36f60bb3-ad2b-49ab-96a3-30693684f7c3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xNC0xLTEtMA_fd94099e-ced2-4e29-b37b-19a820c5771c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if908b69b55404379949b8cb6f1d24c00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNS0xNi0xLTEtMA_27f8af8f-d932-410a-ae2b-3aee21ad91a3"
      unitRef="usd">174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0yLTEtMS0w_ec0ecac0-3fe5-4f3f-ae02-c00dfb91a134"
      unitRef="usd">7506000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi00LTEtMS0w_36382d98-4f6d-44bd-bc5d-9d3fce58b3ab"
      unitRef="usd">20000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi02LTEtMS0w_f044e870-6533-411f-8db9-4b3871c06738"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi04LTEtMS0w_48f84d24-a133-4a66-9ac7-0a9c3e6b0062"
      unitRef="usd">7525000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xMC0xLTEtMA_8302f62a-75d6-43b4-b5ec-966a9ed7e1ff"
      unitRef="usd">9203000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xMi0xLTEtMA_909e5270-e3a8-43f7-9e16-fc19f5549f41"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xNC0xLTEtMA_465a45cf-1bc4-417d-bfc8-ab2c34f35f8e"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNi0xNi0xLTEtMA_30ef7278-68a6-40e3-bdc0-9561f2018f6e"
      unitRef="usd">9204000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0yLTEtMS0w_8a683228-247a-4666-a6bb-3db18640c912"
      unitRef="usd">1207000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy00LTEtMS0w_3f62e0cc-6e9b-4667-a279-7c827a988531"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy02LTEtMS0w_82cf4b64-6079-4391-8c44-834f04d43e4e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb3300ee2f174ff5ba1aaf1c27c45eed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy04LTEtMS0w_67e33824-316c-465b-8c13-60da74576d94"
      unitRef="usd">1209000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xMC0xLTEtMA_6e860b27-3919-4a52-86a6-7cf1d4d86b62"
      unitRef="usd">91000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xMi0xLTEtMA_3d552b8e-d115-42ff-ae80-04cde15ccf5f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xNC0xLTEtMA_27d5eb54-6d0d-403e-9dcc-346e6385c38a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d2d59bc54514c03bb9fe2216e669758_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfNy0xNi0xLTEtMA_25c11a38-2881-405e-a319-9c011cd55f59"
      unitRef="usd">91000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0yLTEtMS0w_9c94422d-1115-45fa-a907-ab116e334f38"
      unitRef="usd">13365000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC00LTEtMS0w_903eb647-92e5-4aef-a5c7-e0f1bf911ed9"
      unitRef="usd">35000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC02LTEtMS0w_11747adb-c484-4b16-918b-1ef021f8283d"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC04LTEtMS0w_0cf8ab3f-2a78-49a8-a1b4-750ac5fef770"
      unitRef="usd">13399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xMC0xLTEtMA_4eccedbc-fd17-4eca-9ce9-1f627214a134"
      unitRef="usd">16499000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xMi0xLTEtMA_87909408-34a2-4513-a5c1-9f8668acdc46"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xNC0xLTEtMA_8459623e-b445-4074-ac8f-1711e7c31de2"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjlmNjk2MzVmMDZmZTRlZWY5MWIwY2VlZTc0MzZkOTQ3L3RhYmxlcmFuZ2U6OWY2OTYzNWYwNmZlNGVlZjkxYjBjZWVlNzQzNmQ5NDdfOC0xNi0xLTEtMA_8291ff7b-cf90-4af7-8b79-31289fb24a7e"
      unitRef="usd">16500000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMyMA_86f73fa5-e727-4c01-a2b6-fd860a847bf8">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8e30f2b68c584a1cae64f4692423ac60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMS0yLTEtMS0w_10018885-c3a0-452c-b82c-b14f3a6f5747"
      unitRef="usd">236000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if077c28b2a3549009e4351063889daee_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMS00LTEtMS0w_6cabf54f-2acb-4a84-8a52-cec36280919a"
      unitRef="usd">2291000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifdb967509b8d4595b980817e4efe72c4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMi0yLTEtMS0w_05d5e5ae-8285-43cb-9c0a-ff06c15e47d3"
      unitRef="usd">11089000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0649099fa908450db840cbbb3e57fe0b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMi00LTEtMS0w_8cdbee75-efe2-4c6a-98b4-c617682fbd1f"
      unitRef="usd">12721000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie2ac5e322d254b9da70701bbc22881e2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMy0yLTEtMS0w_4af95004-cb9d-495b-af91-c8eebf4c9c18"
      unitRef="usd">2074000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9901b9b6eb08420fbd35a1817088ca98_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfMy00LTEtMS0w_891130f2-a8f4-4fbc-947a-e2316801a541"
      unitRef="usd">1488000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfNC0yLTEtMS0w_447f3b8b-570e-45e5-b85c-4dc331c03d0b"
      unitRef="usd">13399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjhkZmFiYzczMjEyOTRmMjBhYTg0M2IzZGRlNTZmMTJhL3RhYmxlcmFuZ2U6OGRmYWJjNzMyMTI5NGYyMGFhODQzYjNkZGU1NmYxMmFfNC00LTEtMS0w_7f145d1c-94f8-4259-aa9e-f6a080586fbd"
      unitRef="usd">16500000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InterestReceivableCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzUx_b9885200-aa38-4e85-84c9-172257c4eebf"
      unitRef="usd">49000000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzU4_7492ad6e-6389-4235-a8cb-309804849ea3"
      unitRef="usd">37000000</us-gaap:InterestReceivableCurrent>
    <gild:Writeoffsinaccruedinterestreceivable
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzg0ODI5MDcwMDEyOQ_1612028f-d412-4632-be60-207b06b1428b"
      unitRef="usd">0</gild:Writeoffsinaccruedinterestreceivable>
    <gild:Writeoffsinaccruedinterestreceivable
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMzg0ODI5MDcwMDEyOQ_56832d7e-d4f4-4a2c-9214-98591439b909"
      unitRef="usd">0</gild:Writeoffsinaccruedinterestreceivable>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTMxMg_b8de82e6-67d4-4f6c-b0ad-92e29a86ff6d">&lt;div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&#160;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMi0yLTEtMS0w_e3cf649b-d968-417e-a888-3dcecc2f9273"
      unitRef="usd">11292000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMi00LTEtMS0w_1e69a2c5-a8c3-4b42-8797-4becd2811cc3"
      unitRef="usd">11325000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMy0yLTEtMS0w_6c7f7895-357f-4a00-bc52-e540625fb6ea"
      unitRef="usd">1991000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfMy00LTEtMS0w_8e1200e4-87d9-44e7-97ee-669223988924"
      unitRef="usd">1992000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNC0yLTEtMS0w_15212464-4cb8-4a99-b4fe-c4cef905916e"
      unitRef="usd">82000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNC00LTEtMS0w_f347d5e4-5855-481c-b6b8-85584945df4f"
      unitRef="usd">82000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNS0yLTEtMS0w_a9539405-9540-492c-b41f-11c09e64861d"
      unitRef="usd">13365000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOjc3NmIwMTVhNGE1OTQyYzk5M2ZmZTFkMWIzMDZhZjA3L3RhYmxlcmFuZ2U6Nzc2YjAxNWE0YTU5NDJjOTkzZmZlMWQxYjMwNmFmMDdfNS00LTEtMS0w_dce8b61e-6e2d-42dd-bac4-8378f8ec2b2a"
      unitRef="usd">13399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTI5Nw_5b0f1947-cccd-4bda-8ea8-3fc079383898">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities in an unrealized loss position (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#acacac;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy0yLTEtMS0w_2da1dae7-68b0-4698-b544-2af90300aa6e"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy00LTEtMS0w_f5233c90-3711-4e56-8ddb-ff104ce475fd"
      unitRef="usd">1042000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy02LTEtMS0w_706589e5-f5e1-4fa6-beb9-0178057ade65"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy04LTEtMS0w_4ad53fec-618b-47b1-8049-e9717b92db5d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy0xMC0xLTEtMA_213be6f6-7308-4278-b84a-9808708fd808"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i97f03d9c1ed5426d9d26ec720a56d292_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfMy0xMi0xLTEtMA_5272ef2a-76a8-4071-8b26-11f56f5ca854"
      unitRef="usd">1042000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS0yLTEtMS0w_cba2469c-faa8-4f38-a132-27ead3a80498"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS00LTEtMS0w_3e5a9946-0d86-4ee0-8b9d-bbdf46a82f00"
      unitRef="usd">1866000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS02LTEtMS0w_307be479-ae6a-4e43-aeda-bef798625b03"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS04LTEtMS0w_02d08960-3138-45e0-a94b-ce0ecbe94e64"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS0xMC0xLTEtMA_74354299-83dc-42c7-8f23-5fb52655f4df"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i58bb04e1da2e4c1c8823f8cd6b2aea63_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RhYmxlOmE2NWNhYzA3OGMzYjRkYjY5ZjNkZDNhZGUzNTg1MWJhL3RhYmxlcmFuZ2U6YTY1Y2FjMDc4YzNiNGRiNjlmM2RkM2FkZTM1ODUxYmFfNS0xMi0xLTEtMA_89399969-ac86-4b17-a95c-a56590dc8ca2"
      unitRef="usd">1870000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfOTM4_98104235-6333-4a1d-9505-8793e70502ef"
      unitRef="position">208</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTI0Mw_7e16d16e-df51-4d21-aed6-b93671a000b8"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180My9mcmFnOmFmNGYxYWNiYTRiZTQ5YmY5Yjk4YTM1NDQ4NTQ3MmFlL3RleHRyZWdpb246YWY0ZjFhY2JhNGJlNDliZjliOThhMzU0NDg1NDcyYWVfMTI0Mw_ebcccf3c-c918-4cf8-95b8-073c40ff70f5"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM2OA_73f18a8d-cf04-4d7b-976f-a46965e9183d">DERIVATIVE FINANCIAL INSTRUMENTS&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operations in foreign countries expose us to market risk associated with foreign currency exchange rate fluctuations between the U.S. dollar and various foreign currencies, primarily the Euro. To manage this risk, we may hedge a portion of our foreign currency exposures related to outstanding monetary assets and liabilities as well as forecasted product sales using foreign currency exchange forward or option contracts. In general, the market risk related to these contracts is offset by corresponding gains and losses on the hedged transactions. The credit risk associated with these contracts is driven by changes in interest and currency exchange rates and, as a result, varies over time. By working only with major banks and closely monitoring current market conditions, we seek to limit the risk that counterparties to these contracts may be unable to perform. We also seek to limit our risk of loss by entering into contracts that permit net settlement at maturity. Therefore, our overall risk of loss in the event of a counterparty default is limited to the amount of any unrealized gains on outstanding contracts (i.e., those contracts that have a positive fair value) at the date of default. We do not enter into derivative contracts for trading purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hedge our exposure to foreign currency exchange rate fluctuations for certain monetary assets and liabilities that are denominated in a non-functional currency. The derivative instruments we use to hedge this exposure are not designated as hedges and, as a result, changes in their fair value are recorded in Other income (expense), net on our Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hedge our exposure to foreign currency exchange rate fluctuations for forecasted product sales that are denominated in a non-functional currency. The derivative instruments we use to hedge this exposure are designated as cash flow hedges and have maturities of 18 months or less. Upon executing a hedging contract and quarterly thereafter, we assess hedge effectiveness using regression analysis. The unrealized gains or losses in Accumulated other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;AOCI&#x201d;) are reclassified into product sales when the respective hedged transactions affect earnings. The majority of gains and losses related to the hedged forecasted transactions reported in AOCI as of September&#160;30, 2020 are expected to be reclassified to product sales within 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flow effects of our derivative contracts for the nine months ended September 30, 2020 and 2019 were included within Net cash provided by operating activities on our Condensed Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had notional amounts on foreign currency exchange contracts outstanding of $2.8 billion and $2.9 billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While all our derivative contracts allow us the right to offset assets and liabilities, we have presented amounts on a gross basis. The following table summarizes the classification and fair values of derivative instruments in our Condensed Consolidated Balance Sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of our foreign currency exchange contracts on our Condensed Consolidated Financial Statements (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) recognized in AOCI &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains reclassified from AOCI into product sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) recognized in Other income (expense), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may discontinue cash flow hedges and, as a result, record related amounts in Other income (expense), net on our Condensed Consolidated Statements of Operations. There were no discontinuances of cash flow hedges for the three and nine months ended September 30, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020 and December&#160;31, 2019, we only held foreign currency exchange contracts. The following table summarizes the potential effect of offsetting our foreign currency exchange contracts on our Condensed Consolidated Balance Sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross Amounts Not Offset &lt;br/&gt;on our Condensed &lt;br/&gt;Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt; of Recognized &lt;br/&gt;Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt; Offset on our &lt;br/&gt;Condensed &lt;br/&gt;Consolidated &lt;br/&gt;Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Amounts of Assets/Liabilities Presented&lt;br/&gt; on our Condensed Consolidated&lt;br/&gt;Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Derivative &lt;br/&gt;Financial &lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Cash Collateral &lt;br/&gt;Received/&lt;br/&gt;Pledged&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;br/&gt; (Legal Offset)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeRemainingMaturity1
      contextRef="i885c8e3d7c564884960c80c8d85d08fd_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMTg3Ng_c8818cd3-4dbb-4a11-a209-a75d493b97a2">P18M</us-gaap:DerivativeRemainingMaturity1>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
      contextRef="i885c8e3d7c564884960c80c8d85d08fd_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMjM0MQ_8943b0b5-626f-4fe1-990e-fb3ba39e3230">P12M</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMjU2NQ_b1b753e9-201c-404d-ade7-f5d59d02c8e3"
      unitRef="usd">2800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMTcwNDI0MzAyMzM5MzE_8d562474-17e4-4893-8adf-1079dc4802f4"
      unitRef="usd">2900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM0MA_81f71090-ae5e-4aef-8678-acbf9d275758">The following table summarizes the classification and fair values of derivative instruments in our Condensed Consolidated Balance Sheets (in millions):&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid and other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i0a333aeeecec4ed9b2e05cc1f18eca61_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNC00LTEtMS0w_7c69303b-e4f5-4850-b1ee-d440a45b6f12"
      unitRef="usd">4000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i8dd9abcdf6fa4e63ac008c910c2064e7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNC04LTEtMS0w_ef7b4d2d-09cc-434c-9a0f-e36442eba4a0"
      unitRef="usd">45000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="ifcad679966294ff2a2a4a7fce703e297_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNS00LTEtMS0w_13f65908-ac3d-44e6-af2f-da430b100070"
      unitRef="usd">2000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="if94c93bbf7284ee089c617ef366c010b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNS04LTEtMS0w_46856dad-a582-4962-8fe5-0797e9876e6b"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i3441f3a2b4f440a8bc916049c259e00f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNi00LTEtMS0w_11763140-1559-4391-bc5a-785eee54ddce"
      unitRef="usd">6000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i3441f3a2b4f440a8bc916049c259e00f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfNi04LTEtMS0w_fc92f9dd-4a2a-4f3a-baa1-02e8f3d5591e"
      unitRef="usd">50000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i727aeb50823e469a9b8a9e02739b65d8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOC00LTEtMS0w_5d47f63f-0aa2-4250-9ab4-caa57d7adecd"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i36e630b95ff54a039e3b28faf946f40d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOC04LTEtMS0w_d757988f-c8f8-4f54-8413-1c95498caa94"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i69bdaf8a67d84555bf6582631022fc61_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOS00LTEtMS0w_a298aeb7-9a17-4f5d-8a01-7eb4c3b60240"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i69bdaf8a67d84555bf6582631022fc61_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfOS04LTEtMS0w_552f063a-b24c-4e91-8ded-125bbe0286e0"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfMTAtNC0xLTEtMA_37545e4f-f812-4f74-be6a-bb7300c422f4"
      unitRef="usd">6000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjI2ZTI3ODRhYmNkMzQ3MjI4YmU3MmI3ZTJlZjc0YjFmL3RhYmxlcmFuZ2U6MjZlMjc4NGFiY2QzNDcyMjhiZTcyYjdlMmVmNzRiMWZfMTAtOC0xLTEtMA_a22df877-8817-4f43-957a-d5e52dd1c813"
      unitRef="usd">50000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i778d229a5af747b7afc0e73451dbaca6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNC00LTEtMS0w_09bc61cd-f450-4fab-a35c-4e7d1b186222"
      unitRef="usd">36000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i41cf8059cc904b458c6aeb8f0e345448_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNC04LTEtMS0w_ae260316-bb7e-41ed-a516-18a2c75457ba"
      unitRef="usd">6000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="ia63da40b12964679bd495e281370437e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNS00LTEtMS0w_790dcd0a-e65f-4bd5-8340-ebef5343c0d9"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="ie3bada8f952b40819bd558e693f22b13_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNS04LTEtMS0w_e0808ff4-6ac5-45a7-81ca-b4866bd5d938"
      unitRef="usd">2000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i48fffe834ce34e46a02a3296f02cfe58_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNi00LTEtMS0w_4a3f6e6d-9ce6-4fb9-9f49-d60d556de0c6"
      unitRef="usd">36000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i48fffe834ce34e46a02a3296f02cfe58_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfNi04LTEtMS0w_915cefaa-4a0d-455e-aa2c-b686ddf250a3"
      unitRef="usd">8000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i093f149708bc438285250a031a978d87_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOC00LTEtMS0w_aefbf0ea-7a57-4e16-b5c9-89b539a8aab7"
      unitRef="usd">1000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i0fca64d1acd048958ee9a481adb0d0ab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOC04LTEtMS0w_8a1be679-1615-49bf-8cac-f483cf4e2257"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i25b6a29b0c8f4d5fae00186fc6544d94_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOS00LTEtMS0w_26b5670a-d610-4de1-b842-73ce2f768203"
      unitRef="usd">1000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i25b6a29b0c8f4d5fae00186fc6544d94_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfOS04LTEtMS0w_6cb05199-b5c1-4413-a4cf-4b65390878a5"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfMTAtNC0xLTEtMA_6485b1f9-16f5-4a34-8a18-1b7c247d24b1"
      unitRef="usd">37000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjVmYmZjZTJkYWU0MDQzNGM5NDY5NDhiZjBmNzUzMjUxL3RhYmxlcmFuZ2U6NWZiZmNlMmRhZTQwNDM0Yzk0Njk0OGJmMGY3NTMyNTFfMTAtOC0xLTEtMA_2342dd0b-474d-42c2-82a8-876d633e404a"
      unitRef="usd">8000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM3MA_b84110f5-9686-49aa-b9b9-90e4c0fb7f51">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of our foreign currency exchange contracts on our Condensed Consolidated Financial Statements (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) recognized in AOCI &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains reclassified from AOCI into product sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) recognized in Other income (expense), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC0yLTEtMS0w_a12c2399-704f-4b45-8162-f5c4629858f9"
      unitRef="usd">-52000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC00LTEtMS0w_7931b53e-0dd5-427f-952c-b1429654f279"
      unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC02LTEtMS0w_1f9dfb15-d501-439a-9376-3fc403035032"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNC04LTEtMS0w_6255adab-aa94-4be2-87f6-43504bfd2754"
      unitRef="usd">98000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS0yLTEtMS0w_582602db-34cb-4b1f-b6ed-fc1fd2d8529d"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS00LTEtMS0w_0c3ae987-def5-4b92-8a69-c421c18fc14d"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS02LTEtMS0w_bfb272be-0ae4-4510-8461-3cc15d2a1362"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNS04LTEtMS0w_28213f2a-e9a2-4f20-bcba-2361ecb83189"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy0yLTEtMS0w_af9b465c-8570-48b5-b350-6b1331ac09f6"
      unitRef="usd">-13000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy00LTEtMS0w_4059eca0-d74f-4b94-8bb3-5189a175f477"
      unitRef="usd">40000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy02LTEtMS0w_804548e4-955d-4213-9c68-9d8948a3fc55"
      unitRef="usd">-10000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOjAzNjQ2M2NiOTk0OTRlZTQ5ZTQ4YjQxOTg3MTc4ZWQ4L3RhYmxlcmFuZ2U6MDM2NDYzY2I5OTQ5NGVlNDllNDhiNDE5ODcxNzhlZDhfNy04LTEtMS0w_5ed5c413-580b-4966-80e6-40252b085aaa"
      unitRef="usd">29000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_078103af-6d5b-4dd0-b7a0-24aadc4cbd1f"
      unitRef="usd">0</us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet>
    <us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_843ecc1d-4114-40ec-8a1f-059cee53a150"
      unitRef="usd">0</us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet>
    <us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_a4b80256-16f7-4a91-9ca8-10e6a567d89f"
      unitRef="usd">0</us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet>
    <us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzA3Nw_f6d01f90-070f-4d19-a081-a84df18e28b1"
      unitRef="usd">0</us-gaap:GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RleHRyZWdpb246OTVlNTg0MzdiMDA3NGQ4YWJkNjIzNzRhYTc1ODg2MjVfMzM1Mw_5a59ff7b-8db9-451b-ae6a-3c2dd96f210f">The following table summarizes the potential effect of offsetting our foreign currency exchange contracts on our Condensed Consolidated Balance Sheets (in millions):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross Amounts Not Offset &lt;br/&gt;on our Condensed &lt;br/&gt;Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt; of Recognized &lt;br/&gt;Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt; Offset on our &lt;br/&gt;Condensed &lt;br/&gt;Consolidated &lt;br/&gt;Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Amounts of Assets/Liabilities Presented&lt;br/&gt; on our Condensed Consolidated&lt;br/&gt;Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Derivative &lt;br/&gt;Financial &lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Cash Collateral &lt;br/&gt;Received/&lt;br/&gt;Pledged&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;br/&gt; (Legal Offset)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC0yLTEtMS0w_5a0f855b-dd6a-41a9-8ca7-6c81f0b0f528"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC00LTEtMS0w_b8aa8868-3e6d-4fc1-9f7f-0f272a39e27b"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC02LTEtMS0w_79299a51-7288-4a24-9015-108edc63a33f"
      unitRef="usd">6000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC04LTEtMS0w_8a6235b4-1c53-4659-bfec-3e10003c87c6"
      unitRef="usd">6000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC0xMC0xLTEtMA_3f5c3339-6356-42b5-bc96-4d06e2b25d72"
      unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNC0xMi0xLTEtMA_e77b30c9-0bdb-4db3-aebf-695aabdd67a3"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS0yLTEtMS0w_85fa617c-e8fc-4e63-8575-93b3aff8a5a7"
      unitRef="usd">50000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS00LTEtMS0w_93aee8fd-c146-45c8-8b81-df961d4bc53e"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS02LTEtMS0w_633e75cf-b7ce-4056-b8b1-2b5046d372e7"
      unitRef="usd">50000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS04LTEtMS0w_7ef5467d-7199-499e-9d76-d43971dcf698"
      unitRef="usd">6000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS0xMC0xLTEtMA_1d910126-4f99-4bc8-943f-6bdaa828e613"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNS0xMi0xLTEtMA_5be00b6c-dcc4-4387-97d4-ec532f49ada0"
      unitRef="usd">44000000</us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy0yLTEtMS0w_95caf579-28e3-4e50-86e4-74cee17d5227"
      unitRef="usd">37000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy00LTEtMS0w_a719c55f-1387-4efa-aab5-ed6351b0381d"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy02LTEtMS0w_a3cd7de1-fd76-4671-9dbb-b6472595b75c"
      unitRef="usd">37000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy04LTEtMS0w_a4ffddd8-4547-49df-ac55-6f98a87ebb35"
      unitRef="usd">6000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy0xMC0xLTEtMA_ca661bee-f0af-4f6f-9615-dfbd5e77b802"
      unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfNy0xMi0xLTEtMA_ba20bb6b-b87f-4543-ab0a-9ba66a68bbdf"
      unitRef="usd">31000000</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC0yLTEtMS0w_0b0db519-7983-4244-bcd9-b91905924e10"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC00LTEtMS0w_01c1b9df-9052-4a24-b8ae-a1f86d796987"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC02LTEtMS0w_bf77cfe7-97b2-4a65-b8e0-8fa0b44dd572"
      unitRef="usd">8000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC04LTEtMS0w_3aadf4dc-754d-435d-a7cd-466bf32d2b0a"
      unitRef="usd">7000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC0xMC0xLTEtMA_05e64b52-bfa8-4726-bc93-f8c045e52436"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180Ni9mcmFnOjk1ZTU4NDM3YjAwNzRkOGFiZDYyMzc0YWE3NTg4NjI1L3RhYmxlOmNlNjZiMGYwYWZiODQ1OGQ4ZmQ3MjZkOTdlN2U5NjI0L3RhYmxlcmFuZ2U6Y2U2NmIwZjBhZmI4NDU4ZDhmZDcyNmQ5N2U3ZTk2MjRfOC0xMi0xLTEtMA_8dc5ec4f-62de-42ca-958d-b256c452a288"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <gild:AcquisitionCollaborationsandOtherArrangementsTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfOTQwMA_4f3b13a7-ad31-4a96-bed9-1ed2d909385a">ACQUISITIONS, COLLABORATIONS AND OTHER ARRANGEMENTS&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We continue to pursue acquisitions, licensing and strategic collaborations and other similar arrangements including equity investments with third parties for the development and commercialization of certain products and product candidates. These arrangements may include non-refundable upfront payments, expense reimbursements or payments by us for options to acquire certain rights, contingent obligations by us for potential development and regulatory milestone payments and/or sales-based milestone payments, royalty payments, revenue or profit-sharing arrangements and cost-sharing arrangements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:150%"&gt;Forty Seven, Inc. (&#x201c;Forty Seven&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On&#160;April 7, 2020, we acquired all of the then issued and outstanding common stock of Forty Seven, a clinical-stage immuno-oncology company focused on developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches, for a price of $95.50 per share in cash, for total consideration of $4.7 billion, net of acquired cash. As a result, Forty Seven became our wholly-owned subsidiary. Forty Seven&#x2019;s lead program, magrolimab, is an investigational monoclonal antibody in clinical development for the treatment of myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma and solid tumors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the transaction as an asset acquisition since the lead asset, magrolimab, represented substantially all the fair value of the gross assets acquired. At the acquisition date, we recorded a $4.5 billion charge representing an acquired IPR&amp;amp;D asset with no alternative future use in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. In connection with this acquisition, we recorded $202 million of assets acquired primarily consisting of deferred tax assets. Liabilities assumed were not material. During the three months ended June 30, 2020, we also recorded share-based compensation expense of $144 million related to the cash settlement of unvested Forty Seven employee stock awards attributable to post-acquisition services, which was primarily recorded in Research and development expenses on our Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:150%"&gt;Immunomedics, Inc. (&#x201c;Immunomedics&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On September 13, 2020, we entered into an agreement and plan of merger (&#x201c;Agreement and Plan of Merger&#x201d;) to acquire Immunomedics, a company focused on the development of antibody-drug conjugate (&#x201c;ADC&#x201d;) technology. Immunomedics researches and develops biopharmaceutical products, particularly antibody-based products for patients with solid tumors and blood cancers, and manufactures and markets Trodelvy. Trodelvy, a Trop-2-directed ADC, developed by Immunomedics is the first ADC that the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) approved for the treatment of adult patients with metastatic triple-negative breast cancer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 24, 2020, under the terms of the Agreement and Plan of Merger, we commenced a tender offer (&#x201c;Offer&#x201d;) to acquire all of the outstanding shares of common stock of Immunomedics for approximately $21 billion (at a price of $88.00 per share), net in cash, without interest and subject to any withholding of taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In an event subsequent to September 30, 2020, on October 23, 2020, we completed the Offer for all outstanding shares of common stock of Immunomedics and accepted all shares validly tendered and not withdrawn as of the expiration time of the Offer. Following the Offer, we also acquired all remaining shares not tendered at Offer pursuant to the merger contemplated by the Agreement and Plan of Merger. As a result, the acquisition was completed and Immunomedics became a wholly owned subsidiary of Gilead. The financial results of Immunomedics will be included in our consolidated financial results for the year ending December 31, 2020 from the date of completion of the acquisition. We financed the acquisition with the majority of the proceeds from the September 2020 senior unsecured notes offering, an additional $1.0 billion borrowing under a new senior unsecured term loan facility and the balance with cash on hand. See Note 9. Debt and Credit Facilities for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our acquisition of Immunomedics will be accounted for as a business combination using the acquisition method of accounting in the fourth quarter of 2020. Given the recent timing of the transaction close, we are in the process of estimating fair values of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the assets acquired and liabilities assumed in the business combination.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result, we are currently unable to provide preliminary allocation of purchase consideration based on the acquisition date fair values of the assets acquired and liabilities assumed as well as other related information, but we will disclose such information in our Annual Report on Form 10-K for the year ending December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Collaborations and Other Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arcus Biosciences, Inc. (&#x201c;Arcus&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 29, 2020, we acquired 2.2&#160;million shares of the common stock of Arcus, a publicly traded oncology-focused biopharmaceutical company, for approximately $61 million in a secondary equity offering. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separately, on&#160;May 27, 2020, we entered into a transaction with Arcus, which included entry into an option, license and collaboration agreement (the &#x201c;Collaboration Agreement&#x201d;) and a common stock purchase agreement and an investor rights agreement (together, the &#x201c;Stock Purchase Agreements&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon closing of the Collaboration Agreement and Stock Purchase Agreements, on July 13, 2020, we made an upfront payment of $175 million and acquired approximately 6&#160;million additional shares of Arcus&#x2019; common stock for $200 million in accordance with the terms of the Collaboration Agreement and the Stock Purchase Agreements. Of the total $391 million initial cash payments made under the agreements and direct transactional costs, we recorded $135 million as an equity investment, which was calculated based on Arcus&#x2019; closing stock price of $22.67 on the closing date of the transaction. As a result, combined with our existing share holdings, we own 8.2&#160;million shares of Arcus, representing approximately 13% of the issued and outstanding voting stock of Arcus immediately following the closing of the transaction. We recorded our equity investments in Arcus in Other long-term assets on our Condensed Consolidated Balance Sheets as the investments are subject to contractual lock-up provisions for a period up to 2 years from the closing date of the agreements, subject to certain conditions. We account for our equity investment in Arcus at fair value with changes in fair value recognized in Other income (expense), net for each reporting period. The remaining $256 million was attributed to the acquired license and option rights of $175 million representing IPR&amp;amp;D assets with no alternative future use, $65 million of an issuance premium for the equity purchase and $16 million of direct transactional costs. These amounts were expensed as Acquired in-process research and development expenses during the three months ended September 30, 2020 on our Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gilead has the right to opt-in to all current and future investigational product candidates that emerge from Arcus&#x2019; research portfolio for the ten years following the closing of the transaction. Upon our exercise of an option for a program, unless Arcus opts out according to the terms of the Collaboration Agreement, the companies will co-develop and share global development costs and co-commercialize and share profits in the U.S. We will obtain exclusive rights to commercialize any optioned programs outside of the U.S., subject to any rights of Arcus&#x2019; existing partners, for which we will pay to Arcus tiered royalties ranging from the high teens to the low twenties on net sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Collaboration Agreement, subject to certain limited exceptions, we are required to provide $100&#160;million to Arcus on the second anniversary of the agreement and may pay an additional $100 million at our option on each of the fourth, sixth, and eighth anniversaries of the agreement, unless terminated early, as ongoing research and development support to extend our collaboration term to up to 10-years. Accordingly, during the three months ended September 30, 2020, we recorded a $100 million charge representing the contractually committed payment in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Collaboration Agreement, we will potentially provide up to $1.2 billion in opt-in and milestone payments with respect to current clinical product candidates, if and when such payments are triggered under the Collaboration Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Stock Purchase Agreements, we have the right to purchase additional shares of Arcus from Arcus over the next five years, up to a maximum of 35% of the outstanding voting stock. We are subject to a three-year standstill restricting our ability to acquire voting stock of Arcus exceeding more than 35% of the then issued and outstanding voting stock of Arcus, subject to certain exceptions. Additionally, we agreed not to dispose of any equity securities of Arcus prior to the second anniversary of the closing of the Stock Purchase Agreements without the prior consent of Arcus, subject to certain exceptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pionyr Immunotherapeutics, Inc. (&#x201c;Pionyr&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2020, we entered into a transaction with Pionyr, a privately held company pursuing novel biology in the field of immuno-oncology, which included entry into two separate merger agreements, one contemplating the initial acquisition of 49.9% equity interest in Pionyr, and the other providing us the exclusive option, subject to certain terms and conditions, to acquire the remaining outstanding capital stock of Pionyr (together, the &#x201c;Pionyr Merger and Option Agreements&#x201d;) and a research and development service agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 13, 2020, we closed the transaction with Pionyr and paid $269 million in cash and accrued an additional $6 million payable, subject to certain customary adjustments, to Pionyr&#x2019;s shareholders in accordance with the terms of the Pionyr Merger and Option Agreements. We account for our investment in Pionyr using the equity method of accounting because our equity interest provides us with the ability to exercise significance influence over Pionyr. Our investment in Pionyr, consisting of the transaction price noted above and transaction costs, exceeded our pro-rata portion of Pionyr's net assets at transaction closing. We determined that the resulting basis difference primarily relates to Pionyr&#x2019;s IPR&amp;amp;D which has no alternative future use and that Pionyr is not a business as defined in ASC 805, &#x201c;Business Combinations.&#x201d; As a result, we immediately recorded a charge for this basis difference of $215 million in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our exclusive option to acquire the remaining outstanding capital stock of Pionyr is approximately $70 million based on a probability weighted option pricing model and recorded in Other long-term assets on our Condensed Consolidated Balance Sheet. From the first anniversary of the closing date, we may choose to exercise our exclusive option to purchase the remaining equity interest from Pionyr&#x2019;s current shareholders for a $315 million option exercise fee and up to $1.2 billion in potential future milestone payments upon achievement of certain development and regulatory milestones, in each case subject to certain negotiated adjustments. Such option to purchase will expire following the earliest occurrence of specified events, including the delivery of data following completion of certain Phase 1b trials by Pionyr. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the research and development service agreement, we made an initial cash funding of $80 million and recorded a charge in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020. We will provide additional payments of up to $115 million to Pionyr upon achievement of certain development milestones. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tizona Therapeutics, Inc. (&#x201c;Tizona&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 17, 2020, we entered into a transaction with Tizona, a privately held company developing cancer immunotherapies, which included entry into two separate merger agreements, one contemplating the initial acquisition of a 49.9% equity interest in Tizona, and the other providing us the exclusive option, subject to certain terms and conditions, to acquire the remaining outstanding capital stock of Tizona (together, the &#x201c;Tizona Merger and Option Agreements&#x201d;) and a development agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 25, 2020, we closed the transaction with Tizona and paid $302 million in cash to Tizona&#x2019;s shareholders in accordance with the terms of the Tizona Merger and Option Agreements. We account for our investment in Tizona using the equity method of accounting because our equity interest provides us with the ability to exercise significance influence over Tizona. Our investment in Tizona, consisting of the transaction price noted above and transaction costs, exceeded our pro-rata portion of Tizona&#x2019;s net assets at transaction closing. We determined that the resulting basis difference primarily relates to Tizona&#x2019;s IPR&amp;amp;D with no alternative future use and that Tizona is not a business as defined in ASC 805, &#x201c;Business Combinations.&#x201d; As a result, during the three months ended September 30, 2020, we immediately recorded this basis difference of $272 million in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our exclusive option to acquire Tizona is approximately $41 million based on a probability weighted option pricing model and recorded in Other long-term assets on our Condensed Consolidated Balance Sheet. From the first anniversary of the closing date, we may choose to exercise our exclusive option to purchase the remaining equity interest from Tizona&#x2019;s current shareholders for up to $1.3 billion, including an option fee and potential future milestone payments upon achievement of certain development and regulatory milestones, in each case subject to certain negotiated adjustments. Such option to purchase will expire following the earliest occurrence of specified events, including the delivery of data following completion of certain Phase 1b trials by Tizona. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the development agreement, we committed to provide funding to Tizona of $115 million, which was recorded in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tango Therapeutics, Inc. (&#x201c;Tango&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 17, 2020, we entered into a transaction with Tango, a privately held company pursuing innovative targeted immune evasion therapies for patients with cancer through its proprietary, CRISPR-enabled functional genomics target discovery platform, which included entry into an amended and restated research collaboration and license agreement and a stock purchase agreement (together, the &#x201c;Collaboration and Stock Purchase Agreements&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon entering into this transaction, we made an upfront payment of $125 million and a $20 million equity investment in Tango, representing approximately 7% of the issued and outstanding voting stock of Tango immediately following the transaction, in accordance with the terms of the Collaboration and Stock Purchase Agreements. During the three months ended September 30, 2020, we recorded the $125 million upfront expense in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. Our equity investment in Tango is recorded at cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of Tango.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Collaboration and Stock Purchase Agreements, Gilead has the right to option up to 15 programs over the seven-year collaboration for up to $410 million per program in opt-in, extension and milestone payments. The parties will equally split profits and losses, as well as development costs in the U.S., for the products that Tango opts to co-develop and co-promote. We will provide Tango milestone payments and royalties on sales outside of the U.S. For products that Tango does not opt to co-develop and co-promote, we will pay Tango up to low double digit tiered royalties on net sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jounce Therapeutics, Inc. (&#x201c;Jounce&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 1, 2020, we entered into a transaction with Jounce, a publicly traded company developing novel cancer immunotherapies, which included entry into license, registration rights and stock purchase agreements (together, &#x201c;License and Stock Purchase Agreement&#x201d;). In an event subsequent to September 30, 2020, in October 2020, we closed this transaction and made a total payment of $120 million in accordance with the terms of the License and Stock Purchase Agreement and recorded $56 million as an equity investment, representing approximately 14% of the issued and outstanding voting stock of Jounce immediately following the transaction, which was calculated based on Jounce&#x2019;s closing stock price of $10.06 on the closing date of the transaction. In addition, we will provide up to $685 million in future potential clinical, regulatory and commercial milestone payments upon achievement of certain milestones, and pay Jounce royalties ranging from high single digit to mid-teens based upon worldwide sales, subject to certain adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Galapagos &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, we closed an option, license and collaboration agreement (the &#x201c;Collaboration Agreement&#x201d;) and a subscription agreement (the &#x201c;Subscription Agreement&#x201d;), each with Galapagos, pursuant to which the parties entered into a global collaboration that covers Galapagos&#x2019; current and future product portfolio (other than filgotinib). Upon closing, we paid $5.1&#160;billion for the license and option rights and 6.8&#160;million new ordinary shares of Galapagos at a subscription price of &#x20ac;140.59 per share. As a result, combined with our then existing share holdings, we owned 13.6&#160;million ordinary shares of Galapagos, representing approximately 22% of the issued and outstanding voting securities of Galapagos at the closing of the Collaboration Agreement and Subscription Agreement. The parties also amended certain terms relating to the development and commercialization of filgotinib pursuant to the license and collaboration agreement previously entered into between Gilead and Galapagos in 2015.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected the fair value option to account for our equity investment in Galapagos whereby the investment is marked to market through earnings in each reporting period based on the market price of Galapagos shares. We believe the fair value option best reflects the underlying economics of the investment. The $1.1&#160;billion equity investment, which included an issuance discount of $63 million calculated based on Galapagos&#x2019; closing stock price on the date of closing of the Subscription Agreement and the subscription price of &#x20ac;140.59 per share, and our existing equity investment in Galapagos was recorded in Other long-term assets on our Condensed Consolidated Balance Sheets as our equity investment in Galapagos is subject to contractual lock-up provisions for a period up to 5 years from the closing date of the Subscription Agreement. The remaining $3.9&#160;billion of the payment was recorded in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2020, as the initial contractual lock-up provision for certain Galapagos shares will expire in August 2021, the corresponding equity investment balance of $505 million was reclassified to Prepaid and other current assets from Other long-term assets on our Condensed Consolidated Balance Sheets. During the three months ended September 30, 2020, we recorded a pre-tax unrealized loss of $923&#160;million related to our investment in Galapagos in Other income (expense), net on our Condensed Consolidated Statement of Operations due to a decline in Galapagos&#x2019; stock price. See Note 3. Fair Value Measurements for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gadeta B.V. (&#x201c;Gadeta&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2018, we entered into a collaboration arrangement with Gadeta and made a purchase of equity in Gadeta from Gadeta&#x2019;s shareholders. We determined that Gadeta was a VIE, and we were its primary beneficiary because we had the power to direct the activities of Gadeta that most significantly impact its economic performance. Upon the initial consolidation of Gadeta, we recorded $82 million to Noncontrolling interest, primarily reflecting acquired intangible assets related to IPR&amp;amp;D on our Condensed Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2020, we effectively terminated the agreement with Gadeta. Upon the effective termination, we ceased to have a controlling interest and deconsolidated this VIE by removing the related net assets and noncontrolling interest of $82 million from our Condensed Consolidated Balance Sheets. The net loss from the deconsolidation was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September 30, 2020 and 2019, we entered into several collaborative, equity investments and licensing arrangements as well as other similar arrangements that we do not consider to be individually material. We recorded upfront collaboration expenses related to these arrangements of $7 million and $129 million for the three and nine months ended September 30, 2020, respectively, and $40 million and $331 million for the three and nine months ended September 30, 2019, respectively, within Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. Cash payments made related to our equity investments for the three and nine months ended September 30, 2020 were $36 million and $61 million, respectively, and totaled $15 million and $119 million for the three and nine months ended September 30, 2019, respectively, which were primarily recorded within Prepaid and other current assets and Other long-term assets on our Condensed Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the financial terms of these arrangements, we may be required to make payments upon achievement of developmental, regulatory and commercial milestones, which could be significant. Future milestone payments, if any, will be reflected in our Condensed Consolidated Statements of Operations when the corresponding events become probable. In addition, we may be required to pay significant royalties on future sales if products related to these arrangements are commercialized. The payment of these amounts, however, is contingent upon the occurrence of various future events, which have a high degree of uncertainty of occurrence.&lt;/span&gt;&lt;/div&gt;</gild:AcquisitionCollaborationsandOtherArrangementsTextBlock>
    <us-gaap:SharePrice
      contextRef="ic81637a074d1401ba756b4140e12c426_I20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0Mjc4Mw_082f4689-e6e1-4455-ba41-4eda37a424aa"
      unitRef="usdPerShare">95.50</us-gaap:SharePrice>
    <gild:AssetAcquisitionCashOutflowNetOfCashAcquired
      contextRef="ic81637a074d1401ba756b4140e12c426_I20200407"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MjgzMw_52318e23-1b83-4981-a97f-8738e5f89475"
      unitRef="usd">4700000000</gild:AssetAcquisitionCashOutflowNetOfCashAcquired>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i71639a47b1bd4ad797ffe29d99a1a286_D20200407-20200407"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MzM0Mw_47df4ca3-b288-4e65-8fe1-db3048a875fa"
      unitRef="usd">4500000000</us-gaap:ResearchAndDevelopmentInProcess>
    <gild:AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash
      contextRef="i71639a47b1bd4ad797ffe29d99a1a286_D20200407-20200407"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MzQ5MA_e7437848-71a9-4421-84c3-e46271ad4e15"
      unitRef="usd">202000000</gild:AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash>
    <us-gaap:ShareBasedCompensation
      contextRef="i17d546d74ae148b5a021eb383025f81b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc0MzY5NQ_906c6c6b-3a6d-4b01-abfd-f984cabf3dea"
      unitRef="usd">144000000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icd56ba38aa8046bba054f36afeef99eb_D20200924-20200924"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMTY0OTI2NzUyODc1Mg_26763a1b-2c36-40f8-b3ae-c06f25a965d2"
      unitRef="usd">21000000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ia0f837e863ae43748f6f3d4be7b759a9_I20200924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzI5Mw_255b2bf0-e42c-42bb-9b2f-3a5da8f942c0"
      unitRef="usdPerShare">88.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ib8a8484ba93b4e959a292d7acd17712e_D20201023-20201023"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMTY0OTI2NzUyMjAwMQ_777c18cd-441a-4997-82a7-971028c90c86"
      unitRef="usd">1000000000.0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="i10ded791c9da4652a9c01c141f86a369_I20200529"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjEzNA_d09a516f-59b9-44d4-ab7a-63be9afee11a"
      unitRef="shares">2200000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent
      contextRef="i10ded791c9da4652a9c01c141f86a369_I20200529"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjI1NA_2c03aa8a-8092-4313-b056-11596da653bf"
      unitRef="usd">61000000</us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjY5Ng_61f4a2c2-62cd-401f-b6ff-cd32da309d0e"
      unitRef="usd">175000000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <gild:InvestmentOwnedBalanceAdditionalShares
      contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjcyNg_6f267e01-38f3-41f1-a49e-208077d56ab5"
      unitRef="shares">6000000</gild:InvestmentOwnedBalanceAdditionalShares>
    <us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent
      contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjc3NA_727b5fd1-970f-46a2-b727-1c9e964fa5bc"
      unitRef="usd">200000000</us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent>
    <gild:TotalUpfrontPaymentsMade
      contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQwMg_37f01e53-48ab-4218-b597-ee4aa2d6a74f"
      unitRef="usd">391000000</gild:TotalUpfrontPaymentsMade>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i052a9ab163094c12a8e0e749e1a27ad0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQyMA_337cd120-ce26-4d09-a5a9-e230f76a6e12"
      unitRef="usd">135000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:SharePrice
      contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQzMg_175853da-9aff-4c9f-b221-4ea94dfb8c60"
      unitRef="eurPerShare">22.67</us-gaap:SharePrice>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ0Ng_2bd89057-b8da-490f-878f-27ed36e2a54b"
      unitRef="shares">8200000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="iae7c61328cd345d19182e7d8c3116c73_I20200713"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMjkwNg_1a627b68-8e3f-4612-82ea-fb3fe62fb4b9"
      unitRef="number">0.13</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ2NA_ef0c14cc-43de-4c57-9829-a979d5a58e16"
      unitRef="usd">256000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ4Mg_fc816af0-adbc-4cc9-b1ca-43f92e23da71"
      unitRef="usd">175000000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <gild:IssuanceDiscountPremium
      contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzQ5OQ_9e0eab99-0acd-4800-9f46-8c34948f5f0c"
      unitRef="usd">-65000000</gild:IssuanceDiscountPremium>
    <gild:PaymentsForDirectTransactionalExpense
      contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc3ODA3OA_2a15f5b5-e10b-4b2e-a1c9-80991f384546"
      unitRef="usd">16000000</gild:PaymentsForDirectTransactionalExpense>
    <gild:EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary
      contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjU5NzA2OTg0NDg1OQ_489f4a65-0b4d-49be-8351-6cbe431d5567"
      unitRef="usd">100000000</gild:EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary>
    <gild:EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries
      contextRef="i578e5f2171814bedb8947beb0fec392b_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzUzNQ_0c117b5a-9031-4a69-b835-a1bb79b79f74"
      unitRef="usd">100000000</gild:EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries>
    <gild:CollaborativeArrangementTerm
      contextRef="ia3743834a80e45e696d0218209dc20c5_D20200713-20200713"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfOTQwNA_896188c4-99a6-4a12-bed2-0e9416896cb0">P10Y</gild:CollaborativeArrangementTerm>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i3562638e6f29454e9b2073af015cfd17_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzU1NA_7f022ddd-b8b4-484c-be6b-55e233906cee"
      unitRef="usd">100000000</us-gaap:ResearchAndDevelopmentInProcess>
    <gild:EquitySecuritiesFVNIFutureMaximumMilestonePayments
      contextRef="ia3d27c4b18e74db390be0856717db477_I20200713"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDE0Mg_e673c9af-890b-4fae-a88a-9d27614dc679"
      unitRef="usd">1200000000</gild:EquitySecuritiesFVNIFutureMaximumMilestonePayments>
    <gild:EquitySecuritiesFVNIPurchasePeriod
      contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDQxNQ_6319738f-0906-44c1-b352-c48c0504ef1f">P5Y</gild:EquitySecuritiesFVNIPurchasePeriod>
    <gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased
      contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDQzOA_f5a19cf7-44e0-414a-bd55-8942ba66cdcc"
      unitRef="number">0.35</gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased>
    <gild:EquitySecuritiesFVNIRestrictionPeriod
      contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfOTM5OA_7fb55139-89f4-4a29-860c-6f26989f123f">P3Y</gild:EquitySecuritiesFVNIRestrictionPeriod>
    <gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased
      contextRef="i8c8c0fde4b4c45b0bd94dcf32861763c_D20200713-20200713"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDU5MA_f5a19cf7-44e0-414a-bd55-8942ba66cdcc"
      unitRef="number">0.35</gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased>
    <gild:NumberOfAgreements
      contextRef="i17375473d31a4fa98457488c706cd582_I20200619"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTA4Mw_a585ac1d-453d-439e-97f6-f02900dc9ee2"
      unitRef="agreement">2</gild:NumberOfAgreements>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i17375473d31a4fa98457488c706cd582_I20200619"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTE1OQ_297ba64b-afa8-4e9c-87f8-7967bf59b8db"
      unitRef="number">0.499</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i211cbe851f934c1b9e00538e84f893fc_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTUzNQ_66534bd6-80ed-4ec6-a224-094f17b42a75"
      unitRef="usd">269000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <gild:InvestmentOwnedBalanceAdditionalPayable
      contextRef="i211cbe851f934c1b9e00538e84f893fc_D20200713-20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzU2Nw_5ff922ce-3d57-4623-b4a6-5721eee644f4"
      unitRef="usd">6000000</gild:InvestmentOwnedBalanceAdditionalPayable>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ied8aaf6ee07c4c68b0c9d4a257521bf3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzU4Ng_7ad49937-45da-49bd-8b8c-4d581dd2ca27"
      unitRef="usd">215000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i665e017e6d564f3f848b9735e5795f2f_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzYwMw_e3b5477c-b9ca-480a-a3c2-2a0de96acfd2"
      unitRef="usd">70000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <gild:EquityMethodInvestmentOptionExerciseFee
      contextRef="i665e017e6d564f3f848b9735e5795f2f_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTkzNA_42766079-ea2b-43bd-8eff-9b726afda318"
      unitRef="usd">315000000</gild:EquityMethodInvestmentOptionExerciseFee>
    <gild:PotentialFutureMaximumMilestonePayments
      contextRef="i665e017e6d564f3f848b9735e5795f2f_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNTk2Nw_5f6348cf-81ce-4b35-95b3-66949abb5b31"
      unitRef="usd">1200000000</gild:PotentialFutureMaximumMilestonePayments>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i2823e599701c40b09d1834198af15d61_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjQwNw_98768072-53c4-4a0b-989a-92f4376d9352"
      unitRef="usd">80000000</us-gaap:ResearchAndDevelopmentInProcess>
    <gild:ResearchAndDevelopmentFutureMaximumPayments
      contextRef="i5669c974fb37460591c74bfced921611_I20200713"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjQ1Ng_bf81814b-cfa9-4870-a0d4-28b1acaf712c"
      unitRef="usd">115000000</gild:ResearchAndDevelopmentFutureMaximumPayments>
    <gild:NumberOfAgreements
      contextRef="ia7c901a1a55647e6ba26816eb4351009_I20200717"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjc2MA_4c3f00eb-49ef-4c80-8d1d-2a89a8ac8b53"
      unitRef="agreement">2</gild:NumberOfAgreements>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia7c901a1a55647e6ba26816eb4351009_I20200717"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjgzOA_ba2679ac-cbad-4640-b4a8-00f2ba370093"
      unitRef="number">0.499</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ib29eaffb63144ef9be056132abb82695_D20200825-20200825"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNzMyMQ_e7c0abbd-8bf5-4d26-aa84-d3434ac0a8d1"
      unitRef="usd">302000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="iabe5bc9211f04bfa9c594ba7cff3169b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzYyMQ_60a1f887-d26f-4553-9aa0-48d0b3d39a93"
      unitRef="usd">272000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i23962171ea454e2fa69a3ea748b90d4c_I20200825"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzYzOQ_40e44310-0edb-4a35-a3a7-d7e104b455e2"
      unitRef="usd">41000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <gild:EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments
      contextRef="i23962171ea454e2fa69a3ea748b90d4c_I20200825"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNzcyNA_190fd565-00c1-4d62-a0a7-7995ec664c4b"
      unitRef="usd">1300000000</gild:EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="if8210403301349c7b8277961e43603dc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzY1OA_ad4177cc-cc9d-4804-b2a9-af1a43d4c09a"
      unitRef="usd">115000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzczMQ_7dc1184a-ce8b-4a61-b6b3-dfc9623d0e35"
      unitRef="usd">125000000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <gild:CashPaymentsMadeRelatedToEquityInvestments
      contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzc0OQ_a1ac24b4-e379-4f4d-9141-52e6ba6e6e6a"
      unitRef="usd">20000000</gild:CashPaymentsMadeRelatedToEquityInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="if6a49596afb64be2a40ce0133770c139_I20200817"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU5NDIxMw_9e28e51c-594b-477e-a90c-f1f34b427f04"
      unitRef="number">0.07</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i6d1c0da9b7b548618507b7b986013f51_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc4MDYxMg_e7186c25-2761-4fa8-a84d-993a99e9ffba"
      unitRef="usd">125000000</us-gaap:ResearchAndDevelopmentInProcess>
    <gild:NumberOfPrograms
      contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjU5NzA2OTgyOTU4Nw_d094f6cc-a762-4941-9d34-441d5ec65807"
      unitRef="program">15</gild:NumberOfPrograms>
    <gild:CollaborativeArrangementTerm
      contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNjU5NzA2OTg0NDg5OA_47df5d8d-b6c5-4694-8303-d540c01e15a7">P7Y</gild:CollaborativeArrangementTerm>
    <gild:EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments
      contextRef="i0af6f7ffa5324bc587f68b3e299213a0_D20200817-20200817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzc4Mw_ddfbd56a-852a-4f33-9ba9-867b8d5e9b0a"
      unitRef="usd">410000000</gild:EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments>
    <gild:TotalUpfrontPaymentsMade
      contextRef="i291a141ad60a40e18d8e16c054569bd6_D20201001-20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM4MjM5OQ_1f1f4e00-8500-4aec-b313-e998ea8c7c99"
      unitRef="usd">120000000</gild:TotalUpfrontPaymentsMade>
    <gild:CashPaymentsMadeRelatedToEquityInvestments
      contextRef="i291a141ad60a40e18d8e16c054569bd6_D20201001-20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM4MjY0Mg_99ac7857-0915-44c2-bbfc-cb6ca14fdb29"
      unitRef="usd">56000000</gild:CashPaymentsMadeRelatedToEquityInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ibb7dec07426445a0b61fd7ee1c436ae5_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU5NDIxOQ_3f85749a-9d79-4245-bc97-869ac62d6956"
      unitRef="number">0.14</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:SharePrice
      contextRef="ic2051ed6e5a04c058e858df3aa244c5b_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM4MjYyOA_ceed35fd-b39c-42d7-aefb-b03df85cf743"
      unitRef="eurPerShare">10.06</us-gaap:SharePrice>
    <gild:ResearchAndDevelopmentFutureMaximumPayments
      contextRef="ic2051ed6e5a04c058e858df3aa244c5b_I20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzgzOA_24bc46df-c3c2-4a8b-85bd-d79e615f06fa"
      unitRef="usd">685000000</gild:ResearchAndDevelopmentFutureMaximumPayments>
    <gild:PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing
      contextRef="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzg1Nw_716cc30e-7c73-4f81-a04e-e34344c4d596"
      unitRef="usd">5100000000</gild:PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing>
    <gild:InvestmentOwnedBalanceAdditionalShares
      contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzg3Ng_9e97e370-e9c2-4b64-82c3-1722cae4ef98"
      unitRef="shares">6800000</gild:InvestmentOwnedBalanceAdditionalShares>
    <us-gaap:SharePrice
      contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzg4OQ_8daa2a27-569c-41b1-974a-18868f9b7aa8"
      unitRef="eurPerShare">140.59</us-gaap:SharePrice>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzkwNg_12484348-4214-4f91-a66d-de92f1391e37"
      unitRef="shares">13600000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzkxNQ_12074afd-8010-4d9e-8259-fd95e92864cf"
      unitRef="number">0.22</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2MzkzMA_37b55609-878a-4db8-99c8-b86eb81f347c"
      unitRef="usd">1100000000</us-gaap:EquityMethodInvestments>
    <gild:IssuanceDiscountPremium
      contextRef="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzk0Nw_7a0d2720-ea12-48a1-8496-c515deb71e52"
      unitRef="usd">63000000</gild:IssuanceDiscountPremium>
    <us-gaap:SharePrice
      contextRef="i9f8f334438e149d4bb54e84038e20f1c_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzk2NQ_8daa2a27-569c-41b1-974a-18868f9b7aa8"
      unitRef="eurPerShare">140.59</us-gaap:SharePrice>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i62b8bc9468db4b989188f5c19d373e62_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDM5ODA0NjU2Mzk4MA_30093069-8ead-4e23-954f-e8ca2ee45fea"
      unitRef="usd">3900000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i22eab18f188d4327810ed03862e4e414_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc1MTI0Ng_e3d78231-3530-4d4e-9556-c640c291c4a8"
      unitRef="usd">505000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="ic68ebf48645046309e24289804996aac_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc1MDI1OQ_758328f0-9162-482c-9335-47b36d24c942"
      unitRef="usd">923000000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:NoncontrollingInterestInVariableInterestEntity
      contextRef="if0c15f0a4bf24e5faedca42d6ccbed3f_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc3NjM5OA_14e0f8a1-aa3d-4901-8f02-a69dc77bd4ee"
      unitRef="usd">82000000</us-gaap:NoncontrollingInterestInVariableInterestEntity>
    <us-gaap:NoncontrollingInterestInVariableInterestEntity
      contextRef="i55b9f2307b7d494fb84ae4a2f95e61ff_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc4MDU4MA_4c5ead7b-f848-42ea-8b0e-e8cd91c97305"
      unitRef="usd">82000000</us-gaap:NoncontrollingInterestInVariableInterestEntity>
    <gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements
      contextRef="i1624c0037f5a41c4bfefb2aab54ddab5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODQ3Mw_ba9731c9-0b14-450c-987e-67b0a5b8ab49"
      unitRef="usd">7000000</gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements>
    <gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements
      contextRef="ib97742c494394b88bc0725331e447507_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODQ4MA_73b06ce4-3f1d-4491-bae7-816ea6be5a67"
      unitRef="usd">129000000</gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements>
    <gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements
      contextRef="iad7fd7f958c54653849a9d5ba294d69c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODUxMw_4f58d224-2992-4d21-b6c4-60cb037d7b28"
      unitRef="usd">40000000</gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements>
    <gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements
      contextRef="i26766cda4c294fe982cb31efc05bed10_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODUyMA_f29a0e83-a54c-4667-9263-3dbe0b6a8e9d"
      unitRef="usd">331000000</gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements>
    <gild:CashPaymentsMadeRelatedToEquityInvestments
      contextRef="i1624c0037f5a41c4bfefb2aab54ddab5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM3ODA0NQ_fbee12f2-9e7d-469c-ab9b-13d5ddef1ed1"
      unitRef="usd">36000000</gild:CashPaymentsMadeRelatedToEquityInvestments>
    <gild:CashPaymentsMadeRelatedToEquityInvestments
      contextRef="ib97742c494394b88bc0725331e447507_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfNDk0NzgwMjM3ODA1Mw_fd9dbdb1-2b99-4012-9450-50f7635b57d8"
      unitRef="usd">61000000</gild:CashPaymentsMadeRelatedToEquityInvestments>
    <gild:CashPaymentsMadeRelatedToEquityInvestments
      contextRef="iad7fd7f958c54653849a9d5ba294d69c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfMzg0ODI5MDc1MjYwMA_c7eb332b-e648-49d5-95a4-2b3dd5fe8dc5"
      unitRef="usd">15000000</gild:CashPaymentsMadeRelatedToEquityInvestments>
    <gild:CashPaymentsMadeRelatedToEquityInvestments
      contextRef="i26766cda4c294fe982cb31efc05bed10_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN180OS9mcmFnOmVlYmVlNjQ4M2EzOTQyNGQ4ZGRlMGIxNWQ3NDNkYjdhL3RleHRyZWdpb246ZWViZWU2NDgzYTM5NDI0ZDhkZGUwYjE1ZDc0M2RiN2FfODY3Mg_f2aa9f5f-528e-4ae9-8ead-b77ba7198a84"
      unitRef="usd">119000000</gild:CashPaymentsMadeRelatedToEquityInvestments>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RleHRyZWdpb246YTVmNWRkYTUzOTJhNDg2NGI2YWNiN2E3N2M2OTJjNzdfMTg1_e97664d5-eb59-43a3-bded-4d2dc2caa1cd">OTHER FINANCIAL INFORMATION&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our Inventories (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:96.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;________________________________&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts primarily consist of raw materials.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Accrued Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of Other accrued liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RleHRyZWdpb246YTVmNWRkYTUzOTJhNDg2NGI2YWNiN2E3N2M2OTJjNzdfMTc2_e41efe52-a1f9-462d-98c9-6912a80e81e8">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our Inventories (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:96.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;________________________________&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amounts primarily consist of raw materials.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMS0yLTEtMS0w_4c060190-1b31-4345-8623-d05c4e85af40"
      unitRef="usd">1061000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMS00LTEtMS0w_19552bb8-3363-4ef6-9448-9847a9aaf8a9"
      unitRef="usd">1348000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMi0yLTEtMS0w_9a4597f6-439d-48c0-9fbb-d2f2e5a2b663"
      unitRef="usd">182000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMi00LTEtMS0w_733cf98d-1fbd-4a2f-9123-dfc16b3b6a19"
      unitRef="usd">170000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMy0yLTEtMS0w_71dc9056-9d1d-4a52-8f08-ecd192a58c7a"
      unitRef="usd">710000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfMy00LTEtMS0w_0d27770b-b0b9-4cd1-9147-5ab4b84a9f3d"
      unitRef="usd">549000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <gild:InventoryNetAndInventoryNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNC0yLTEtMS0w_fcd4423f-be81-44af-aa7c-5ab548db065e"
      unitRef="usd">1953000000</gild:InventoryNetAndInventoryNoncurrent>
    <gild:InventoryNetAndInventoryNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNC00LTEtMS0w_bd26d1fb-ae12-442d-b005-9490784b2013"
      unitRef="usd">2067000000</gild:InventoryNetAndInventoryNoncurrent>
    <us-gaap:InventoryNet
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNy0yLTEtMS0w_b3c0c200-aa69-4ad7-b5e0-d2f5ca8f66ef"
      unitRef="usd">1008000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfNy00LTEtMS0w_40b354c7-c91e-410b-af7b-50ea9d59be66"
      unitRef="usd">922000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOC0yLTEtMS0w_8530a2a1-789e-4af6-8acb-d09a8cc23131"
      unitRef="usd">945000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOC00LTEtMS0w_6d4c1300-3209-428e-acc9-73a0dcb2c6d4"
      unitRef="usd">1145000000</us-gaap:InventoryNoncurrent>
    <gild:InventoryNetAndInventoryNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOS0yLTEtMS0w_51119b6e-8349-467f-8339-e5c54795c628"
      unitRef="usd">1953000000</gild:InventoryNetAndInventoryNoncurrent>
    <gild:InventoryNetAndInventoryNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjE3ZGYzYzZlMGQyOTQ2Nzk4MWQ4OWMzMzE1OGIwMjI3L3RhYmxlcmFuZ2U6MTdkZjNjNmUwZDI5NDY3OTgxZDg5YzMzMTU4YjAyMjdfOS00LTEtMS0w_9a3ffe29-8d0b-4872-8de2-3c0ac81c3273"
      unitRef="usd">2067000000</gild:InventoryNetAndInventoryNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RleHRyZWdpb246YTVmNWRkYTUzOTJhNDg2NGI2YWNiN2E3N2M2OTJjNzdfMTg0_b84ea6ab-8e81-47e2-bacf-45a24a0fb690">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of Other accrued liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMS0yLTEtMS0w_86bc3798-05b3-45f8-862b-e5e254a046b2"
      unitRef="usd">648000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMS00LTEtMS0w_d18df827-9b95-401c-bc07-64afdf76b623"
      unitRef="usd">599000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMi0yLTEtMS0w_f3bf55de-793d-4ee5-96d5-64a263284f65"
      unitRef="usd">943000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMi00LTEtMS0w_f9aadaae-855b-4e74-b1b0-691fae2b4f6d"
      unitRef="usd">287000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMy0yLTEtMS0w_d47d06d8-c689-4acf-80c5-11acc8817a65"
      unitRef="usd">2550000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfMy00LTEtMS0w_51152680-e011-4a59-9443-4fad03191349"
      unitRef="usd">2188000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfNC0yLTEtMS0w_3904a82c-f681-4bd1-8e22-183477f42b7e"
      unitRef="usd">4141000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181Mi9mcmFnOmE1ZjVkZGE1MzkyYTQ4NjRiNmFjYjdhNzdjNjkyYzc3L3RhYmxlOjNlOWU5ZDczMmM4ZTQ4OTFiNDVlMTQzYmQzYTQ0YWFiL3RhYmxlcmFuZ2U6M2U5ZTlkNzMyYzhlNDg5MWI0NWUxNDNiZDNhNDRhYWJfNC00LTEtMS0w_75d6d5d7-f19d-4cc5-af56-0ec367e0c1f9"
      unitRef="usd">3074000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDMy_0c6a6397-5a20-4132-b7f1-ade47182bb39">INTANGIBLE ASSETS&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our intangible assets, net (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&#160;&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&#160;&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finite-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset - sofosbuvir&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset - axicabtagene ciloleucel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived assets - IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate amortization expense related to finite-lived intangible assets was $281 million and $844 million for the three and nine months ended September 30, 2020, respectively, $281 million and $868 million for the three and nine months ended September 30, 2019, respectively, and was primarily included in Cost of goods sold on our Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;span style="color:#b6b6b6;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of September&#160;30, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDQ1_e62c6336-4315-4928-b182-9da00928ba7f">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our intangible assets, net (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&#160;&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&#160;&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finite-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset - sofosbuvir&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset - axicabtagene ciloleucel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived assets - IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDY0_b7c770b9-b173-4e0f-b0b1-dd598ff1df63">&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our intangible assets, net (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&#160;&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&#160;&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finite-lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset - sofosbuvir&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible asset - axicabtagene ciloleucel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived assets - IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iecca81affd53498284282e31cecf32f7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0yLTEtMS0w_43e6ab37-9745-4f8f-87a9-5691e583938b"
      unitRef="usd">10720000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iecca81affd53498284282e31cecf32f7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy00LTEtMS0w_254c8f5d-bdd6-420c-b40c-ef8a0804c98f"
      unitRef="usd">4777000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="iecca81affd53498284282e31cecf32f7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy02LTEtMS0w_c371d6d3-91a5-40a3-a569-342c742866cf"
      unitRef="usd">0</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iecca81affd53498284282e31cecf32f7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy04LTEtMS0w_8397f30a-9169-4f94-8602-e56ad320bc7d"
      unitRef="usd">5943000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3a84de8a34fb438289702707097480b8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xMC0xLTEtMA_2f70d2d2-3bcc-4ce2-a064-d8feeebbf1cc"
      unitRef="usd">10720000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3a84de8a34fb438289702707097480b8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xMi0xLTEtMA_057acb39-94ce-4765-9cf1-210eb6ba3a41"
      unitRef="usd">4253000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i3a84de8a34fb438289702707097480b8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xNC0xLTEtMA_6751ab12-ae4d-4436-9a4a-4dd116e3fe24"
      unitRef="usd">0</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3a84de8a34fb438289702707097480b8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfMy0xNi0xLTEtMA_11e5d17b-ac34-4aec-a0cd-30fea33f2d89"
      unitRef="usd">6467000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0yLTEtMS0w_449f4675-3804-4316-8ce3-94f635ed4986"
      unitRef="usd">6200000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC00LTEtMS0w_27193d44-3baa-4a4a-8bac-85c113736fef"
      unitRef="usd">1019000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC02LTEtMS0w_9a704326-f462-4799-a1c5-5217ce3e3c5c"
      unitRef="usd">0</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7e0778e433874a438dd80bee8239dfb2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC04LTEtMS0w_18362524-d63f-4377-aa56-d81a14a01cc4"
      unitRef="usd">5181000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xMC0xLTEtMA_3a6b9eeb-ddca-4e8c-a969-f02cc09c1e94"
      unitRef="usd">6200000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xMi0xLTEtMA_e9a2b24b-4837-49f1-9093-76e1f46e29ef"
      unitRef="usd">761000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xNC0xLTEtMA_ae9e3103-d9d4-4b1e-b23c-cc18321a3297"
      unitRef="usd">0</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6f2eac9102cf4e899ccdac8659d5f711_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNC0xNi0xLTEtMA_d60b0d95-b213-4e4a-93b9-1da85200b08c"
      unitRef="usd">5439000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0yLTEtMS0w_b0e0a9c5-c0f0-4a87-9bbd-a0037196b6ae"
      unitRef="usd">1203000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS00LTEtMS0w_7bd4877b-f088-4c06-a60a-8a6bba082e46"
      unitRef="usd">516000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS02LTEtMS0w_a86996b8-d81d-4e62-91f9-43d7762062a7"
      unitRef="usd">-2000000</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic1024af71b9a45278ffccef5760b5fe2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS04LTEtMS0w_5d44df43-3823-4e4b-94b7-c113c1c31c4d"
      unitRef="usd">685000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xMC0xLTEtMA_d6d150ff-6bc3-4285-99b5-6091176370a2"
      unitRef="usd">1098000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xMi0xLTEtMA_478debd0-2068-462c-82fb-1a5ebacbe536"
      unitRef="usd">454000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xNC0xLTEtMA_c88b4856-7662-4c4d-a105-6cdcb71d39fa"
      unitRef="usd">-6000000</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id8e66ce2fe3440d99f60869474e8fd99_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNS0xNi0xLTEtMA_37f9cefb-c2d4-4b66-a765-837c2fce445e"
      unitRef="usd">638000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0yLTEtMS0w_374015ce-c7ba-44d5-a715-a5585c110439"
      unitRef="usd">18123000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi00LTEtMS0w_ebe4ce67-0dc8-4cb0-89fe-7d0806dde205"
      unitRef="usd">6312000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi02LTEtMS0w_c220d986-5984-4ffc-8fc4-850578ded980"
      unitRef="usd">-2000000</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi04LTEtMS0w_94830913-3674-49cd-abae-3d215b66e41c"
      unitRef="usd">11809000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xMC0xLTEtMA_ec7a5e4b-6f1c-4496-92e7-a284e7379808"
      unitRef="usd">18018000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xMi0xLTEtMA_87006bd0-560b-49f7-940b-d449a0d4288a"
      unitRef="usd">5468000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xNC0xLTEtMA_41284a66-7f6c-4470-b99f-8f9af5aeb139"
      unitRef="usd">-6000000</gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNi0xNi0xLTEtMA_6911abeb-372b-4076-b3ec-c08b025a215c"
      unitRef="usd">12544000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0440dbc560c34febb8b14b9e45c4454d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0yLTEtMS0w_3b6eec7f-274d-4e5a-a7ef-e2944830fdd0"
      unitRef="usd">1130000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <gild:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i0440dbc560c34febb8b14b9e45c4454d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy02LTEtMS0w_af972984-4d76-45b8-bf02-3239b6e14664"
      unitRef="usd">0</gild:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <gild:TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0440dbc560c34febb8b14b9e45c4454d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy04LTEtMS0w_9f694a59-b98f-4551-a79f-7dbe665f6aa1"
      unitRef="usd">1130000000</gild:TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i957437a2c5fb481fbc92c780ca815df7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0xMC0xLTEtMA_9d381afa-9d14-4061-8130-f99c03d3c431"
      unitRef="usd">1247000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <gild:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i957437a2c5fb481fbc92c780ca815df7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0xNC0xLTEtMA_0989a680-0e4b-428d-8b8d-303abbdcb75e"
      unitRef="usd">-5000000</gild:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <gild:TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i957437a2c5fb481fbc92c780ca815df7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfNy0xNi0xLTEtMA_e9f38c86-4838-4394-957b-8110fe27f49f"
      unitRef="usd">1242000000</gild:TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0yLTEtMS0w_3d6259d1-b114-4bbd-9ca3-a2d49ffaa975"
      unitRef="usd">19253000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC00LTEtMS0w_2ff10bb0-7ab3-450a-b2e0-6085570aa7bc"
      unitRef="usd">6312000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC02LTEtMS0w_f09cb295-800c-4700-9c93-9db8bd8beb5f"
      unitRef="usd">-2000000</gild:FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC04LTEtMS0w_b8cbac6e-4718-486e-9928-cc42309b8693"
      unitRef="usd">12939000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xMC0xLTEtMA_fa582978-0d8f-41b0-80e0-760007425141"
      unitRef="usd">19265000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xMi0xLTEtMA_3763e302-7847-40d2-85a9-9938512e0acc"
      unitRef="usd">5468000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <gild:FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xNC0xLTEtMA_f6a9ec67-ba9d-41ec-b938-203f33e5b992"
      unitRef="usd">-11000000</gild:FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOjY5OTg3ZDhmZmJlMTQ2ZDU5NDg0ZjM1Zjg3M2FlODE0L3RhYmxlcmFuZ2U6Njk5ODdkOGZmYmUxNDZkNTk0ODRmMzVmODczYWU4MTRfOC0xNi0xLTEtMA_2c765257-86b1-4a67-85e4-4e909e169e22"
      unitRef="usd">13786000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMTY1_9e31f617-fef1-4409-92b2-7c5b00911e58"
      unitRef="usd">281000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMTcy_0f8b01a1-5196-407e-afbe-055f83394d51"
      unitRef="usd">844000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMjAx_a1b621bf-38ce-4575-9c7b-0b9f210e454b"
      unitRef="usd">281000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfMjA4_b1aa57d3-5d84-4575-8c93-485b62ca698c"
      unitRef="usd">868000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RleHRyZWdpb246ZWZkNTcyY2YwMDUyNDI3MGI0NzAwMzczY2E2Y2MwZWVfNDQ2_75f4a6da-e9d7-4724-acb1-7594192fee58">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of September&#160;30, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfMS0yLTEtMS0w_d1e3f68a-d879-4adf-a909-2eeba853f872"
      unitRef="usd">284000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfMi0yLTEtMS0w_b077b9ed-462d-4ad9-b7e1-687c012d1652"
      unitRef="usd">1137000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfMy0yLTEtMS0w_3a3793db-12b6-49a3-a4c7-28c23c6d40bb"
      unitRef="usd">1137000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNC0yLTEtMS0w_1f9be901-dba9-457d-a576-c6b3cce183f2"
      unitRef="usd">1137000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNS0yLTEtMS0w_d5c995cc-d73c-4c0e-b8d6-2b67649ce943"
      unitRef="usd">1137000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNi0yLTEtMS0w_75cb9aeb-b7ef-4eaf-97ac-5c8ce5041683"
      unitRef="usd">6977000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181NS9mcmFnOmVmZDU3MmNmMDA1MjQyNzBiNDcwMDM3M2NhNmNjMGVlL3RhYmxlOmUxMzMyZmNmMzE0OTRlY2VhY2ZhY2Y1MDU2MWJjMDg2L3RhYmxlcmFuZ2U6ZTEzMzJmY2YzMTQ5NGVjZWFjZmFjZjUwNTYxYmMwODZfNy0yLTEtMS0w_42c27dd5-080e-4f7b-b8b3-0f57fd29beb0"
      unitRef="usd">11809000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgyMzU1Ng_18d5168c-080f-4031-a7ce-35ebae8e01d2">DEBT AND CREDIT FACILITIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Unsecured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our borrowings under our senior unsecured notes (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2011&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-month LIBOR + 0.15%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2011&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-month LIBOR + 0.52%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2011&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt 2px 42pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Unsecured Notes Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we issued $7.25 billion aggregate principal amount of senior unsecured notes consisting of (i) $500 million principal amount of floating rate notes due September 2021 and $500 million principal amount of floating rate notes due September 2023 (together, the &#x201c;Floating Rate Notes&#x201d;); and (ii) $2.0 billion principal amount of 0.75% senior notes due September 2023, $750 million principal amount of 1.20% senior notes due October 2027, $1.0 billion principal amount of 1.65% senior notes due October 2030, $1.0 billion principal amount of 2.60% senior notes due October 2040 and $1.5 billion principal amount of 2.80% senior notes due October 2050 (together, the &#x201c;Fixed Rate Notes&#x201d; and, together the Floating Rate Notes, the &#x201c;2020 Senior Notes&#x201d;), the terms of which are summarized in the table above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Fixed Rate Notes may be redeemed at our option at a redemption price equal to the greater of (i) 100% of the principal amount of the Fixed Rate Notes to be redeemed and (ii) the sum, as determined by an independent investment banker, of the present values of the remaining scheduled payments of principal and interest on the Fixed Rate Notes to be redeemed (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semiannual basis at the treasury rate, plus 10 basis points in the case of the 2023 fixed rate notes, 12.5 basis points in the case of the 2027 fixed rates notes, 15 basis points in the case of the 2030 fixed rate notes, 20 basis points in the case of the 2040 fixed notes and 25 basis points in the case of the 2050 fixed rate notes, plus any accrued and unpaid interest on the Fixed Rate Notes to be redeemed to, but excluding, the date of redemption. The Fixed Rate Notes also have a call feature, exercisable at our option, to redeem the notes at par in whole, or in part, on dates ranging from two months to two years prior to maturity. In each case, accrued and unpaid interest is also required to be redeemed to the date of redemption. The September 2023 floating rate notes also have a call feature, exercisable at our option, to redeem the notes at par, in whole, or in part, approximately two years prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of the occurrence of a change in control and a downgrade in the rating of the 2020 Senior Notes below investment grade by Moody&#x2019;s Investors Service, Inc. and S&amp;amp;P Global Ratings, the holders may require us to purchase all or a portion of their notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest to the date of repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are required to comply with certain covenants under our note indentures governing our senior unsecured notes. As of September&#160;30, 2020, we were in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Unsecured Notes Repayments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, we repaid $500 million of our senior unsecured notes upon maturity. In September 2020, we repaid $2.0 billion of our senior unsecured notes upon maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Term Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we entered into a commitment letter with a group of institutional lenders to provide for a three-year senior unsecured term loan facility (the &#x201c;Term Loan Facility&#x201d;) in an aggregate principal amount of $1.0 billion. As of September&#160;30, 2020, there were no borrowings outstanding. In an event subsequent to September&#160;30, 2020, on October 23, 2020, we entered into a term loan credit agreement under the Term Loan Facility and borrowed an aggregate principal amount of $1.0&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan Facility contains customary representations, warranties, affirmative and negative covenants and events of default. The Term Loan Facility bears interest at 3-month LIBOR plus the Applicable Percentage as defined in the Term Loan Facility credit agreement. We may terminate or reduce the amount borrowed under the Term Loan Facility in whole or in part at any time without premium or penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revolving Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, we terminated our $2.5 billion revolving credit facility maturing in May 2021 (the &#x201c;2016 Revolving Credit Facility&#x201d;) and entered into a new $2.5 billion revolving credit facility maturing in June 2025 (the &#x201c;2020 Revolving Credit Facility&#x201d;), which has terms substantially similar to the 2016 Revolving Credit Facility. The 2020 Revolving Credit Facility can be used for working capital requirements and for general corporate purposes, including, without limitation, acquisitions. As of September&#160;30, 2020 and December&#160;31, 2019, there were no amounts outstanding under these revolving credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Revolving Credit Facility contains customary representations, warranties, affirmative and negative covenants and events of default. At September&#160;30, 2020, we were in compliance with all covenants. Loans under the 2020 Revolving Credit Facility bear interest at either (i) the Eurodollar Rate plus the Applicable Percentage, or (ii) the Base Rate plus the Applicable Percentage, each as defined in the 2020 Revolving Credit Facility agreement. We may terminate or reduce the commitments, and may prepay any loans under the new credit facility in whole or in part at any time without premium or penalty.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTU1NA_e2c30e99-7fac-4797-9b75-64599467623e">&lt;div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our borrowings under our senior unsecured notes (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2011&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-month LIBOR + 0.15%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2011&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-month LIBOR + 0.52%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.70%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2011&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt 2px 42pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3160daa24dd5457a91283b0e02bb2b28_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMi00LTEtMS0w_52feec6a-e274-483a-a39d-3a0ef1f679dc"
      unitRef="number">0.0235</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3160daa24dd5457a91283b0e02bb2b28_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMi02LTEtMS0w_bd2bbe95-868b-44c4-acf3-682f81b14c81"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8b3518888b6449e28a4dd8a1ebb01448_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMi04LTEtMS0w_93ddbeb1-58a9-4908-8b95-fcc8d8bce5cd"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1c5233e0d1e34dc1b9b616c2b9958ae9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMy00LTEtMS0w_15372c45-765c-430c-9753-280ff80209cd"
      unitRef="number">0.0255</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1c5233e0d1e34dc1b9b616c2b9958ae9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMy02LTEtMS0w_ef985bcb-b4aa-4101-9211-1285ffecb744"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i323f9eee9390464fb82fbcab9d0a9a54_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMy04LTEtMS0w_f503291f-55ec-4e08-93fc-d83a170301c3"
      unitRef="usd">1999000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7bd2f1324bbe4577aaaa0b02e886a09d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNC00LTEtMS0w_8e8ea4fe-f5a5-44f6-8a40-769af82726c2"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7bd2f1324bbe4577aaaa0b02e886a09d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNC02LTEtMS0w_62744910-2377-481a-9a3e-74da76bfea23"
      unitRef="usd">999000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i04f678f93d81402b94b3fe583ae53808_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNC04LTEtMS0w_9e518046-f27f-43c3-ab05-ba40c202efd0"
      unitRef="usd">998000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i076a134b65754ba59bc1587c4dba35f0_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS00LTEtMS04MjAyL3RleHRyZWdpb246NTliY2UxMjQ2YTgzNGMzNWE2YTYwODNkNWRlNzMyMzlfMTA5OTUxMTYyNzgwNg_5f9ffec1-5400-45bc-9152-f36547c88c70"
      unitRef="number">0.0015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermDebt
      contextRef="i78b6a868c97f4d47b86b691b5a97102c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS02LTEtMS0zMjMz_5d02325c-2313-4f48-8ef4-af17e9aacccd"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iff5c939d7a664dbcaa1fe8a25b93b1e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS04LTEtMS0zMjMz_9f1a47a0-b684-443f-ac72-9840a1887f4f"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5cfd9d16d0134db083a80208f18fb127_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS00LTEtMS0w_c0e1aa6d-44dc-400c-9ed8-44cba294050e"
      unitRef="number">0.0440</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5cfd9d16d0134db083a80208f18fb127_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS02LTEtMS0w_161fd37a-241f-4891-b684-da4712d52f32"
      unitRef="usd">1249000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9b49b10ace4044ddb35f895db112ee9b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNS04LTEtMS0w_20e4a2cf-adb0-4025-8e4b-d6c0815e16fb"
      unitRef="usd">1248000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8f3d085128dc47ddbc2b7e8c7b158013_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNi00LTEtMS0w_78de0def-263a-4ab6-b74a-e7cc349acf93"
      unitRef="number">0.0195</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i8f3d085128dc47ddbc2b7e8c7b158013_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNi02LTEtMS0w_946fe99f-163a-4315-a46a-af007e7817a4"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i943f74870a1242a68086cfeba9802e0e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNi04LTEtMS0w_7907651f-02a8-40d7-a505-c6185a10a306"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib7115ef027e1437da78e8c0e4770de11_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNy00LTEtMS0w_d37f5fa9-7f0d-4d0c-9492-7e4d2e8656d4"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib7115ef027e1437da78e8c0e4770de11_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNy02LTEtMS0w_6ef4d8b8-ab92-4155-adb0-adb52d96362f"
      unitRef="usd">998000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3a4445c6b7b641c6ac7e8571db780c2e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfNy04LTEtMS0w_ea59b451-03c1-4d21-9787-ac28c1c3caef"
      unitRef="usd">998000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ice6ce99e645641b1b447d7873df500b8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOC00LTEtMS0w_72ca6269-d4d6-4353-a0b4-523b2c9734dc"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ice6ce99e645641b1b447d7873df500b8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOC02LTEtMS0w_04fce8b6-51a3-4964-9d3e-ceff3efac558"
      unitRef="usd">747000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i034bc53776884c94ae8a3268988a8403_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOC04LTEtMS0w_d2a52f27-4847-4c56-b61d-91066e3c647d"
      unitRef="usd">747000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifa3287ce6d5c46038d6d90283ff80eeb_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNC0xLTEtODIwNC90ZXh0cmVnaW9uOjA0ZGQ4NjAxMDEyODQ3NzU5MGQyZTg5NDY1MjJjNzQ3XzEwOTk1MTE2Mjc4MDY_da6a5064-8a70-4150-a9ef-11bb32c34c0c"
      unitRef="number">0.0052</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermDebt
      contextRef="i024047c0ec56431f91c17a86fae8c5fc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNi0xLTEtMzIzNg_1deca093-b6b3-4b0c-9332-6a3391c425ed"
      unitRef="usd">496000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icb855db743fc4e4d8bfeb913a9465b4b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtOC0xLTEtMzIzNg_16ea1c16-2e83-4460-9e63-b720bac9de09"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNC0xLTEtODE4OQ_5a811fd2-7583-44a8-8f69-9837ac44cd08"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNi0xLTEtMzIzNg_1465689f-8701-4009-ad4d-ed2a4d1152b4"
      unitRef="usd">1992000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1740f93795744755a3ee51a0609192ff_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtOC0xLTEtMzIzNg_ab89615d-abee-405e-bbe4-f4e1cf589ddb"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i53f786cdbfbe4e19a3f79eb22d33def6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOS00LTEtMS0w_a5179945-58ef-42c1-9a54-13fe1fc5f1e4"
      unitRef="number">0.0370</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i53f786cdbfbe4e19a3f79eb22d33def6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOS02LTEtMS0w_5044f8cb-d2b3-4c0b-8cb7-36d169f9c49e"
      unitRef="usd">1746000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i830b9fd58a46421ca2f14073652a8b07_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfOS04LTEtMS0w_0e2b0687-62ab-4308-9747-b27fc80f74e1"
      unitRef="usd">1745000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69184deceb83472e87a54770bd526907_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNC0xLTEtMA_da253860-867c-4160-8cd8-42132675ed3b"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i69184deceb83472e87a54770bd526907_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtNi0xLTEtMA_cc893293-1719-46ff-ad75-1e70efc4fbb3"
      unitRef="usd">1746000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib08649fd40b64b78a3ac992ce45ffe51_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTAtOC0xLTEtMA_0e04f0a8-60ce-408d-9774-256a09070c34"
      unitRef="usd">1746000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3db367e747ab469885d1e740050763a3_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNC0xLTEtMA_e5fbb185-080c-4d13-9521-0fd82e56c73d"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3db367e747ab469885d1e740050763a3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtNi0xLTEtMA_6bdee1fd-7851-473e-93f6-6dbcd410ed3d"
      unitRef="usd">2736000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9037d73ce3734b9781f89c898abc8331_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTEtOC0xLTEtMA_54185139-ece6-4f21-96cf-ce97701f0606"
      unitRef="usd">2734000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i819d350aa46949b1927defb662d03b4a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTItNC0xLTEtMA_7ead8c60-ebfd-4335-86d7-d33827227435"
      unitRef="number">0.0295</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i819d350aa46949b1927defb662d03b4a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTItNi0xLTEtMA_f9c901ff-6679-4ee6-ae11-8d96bfa6c491"
      unitRef="usd">1246000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9543cb5e44cf49dc9f987a6ce144eb4d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTItOC0xLTEtMA_6bee6f89-3f1f-45bf-ae5b-87ff770be426"
      unitRef="usd">1245000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNC0xLTEtODE5Mw_ce54adb2-3941-4e1d-8bc5-773a4e854359"
      unitRef="number">0.0120</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNi0xLTEtMzIzOQ_bcc78140-5d45-4cf3-8057-0b3055d862d0"
      unitRef="usd">745000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i56a72c53bb76412d862e75ceca21ea29_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtOC0xLTEtMzIzOQ_67413b31-49f8-4fba-a2ca-b5de03ce4913"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f72724ee7414879a83048bd3532f197_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNC0xLTEtODE5Mw_cce3054b-7eee-42a7-9df6-b047c8354230"
      unitRef="number">0.0165</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0f72724ee7414879a83048bd3532f197_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNi0xLTEtMzIzOQ_8fbaddb6-d770-4672-bf47-61612ec47545"
      unitRef="usd">992000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if172b80ce0344955a3bae899f1aef873_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctOC0xLTEtMzIzOQ_0cfde10e-1146-4987-95b9-72d5b5421e9b"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i27ddc1e9a89a48ae9793e4c7f3c3ee5e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTMtNC0xLTEtMA_49e361ab-037b-4de7-8918-0b57043209cf"
      unitRef="number">0.0460</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i27ddc1e9a89a48ae9793e4c7f3c3ee5e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTMtNi0xLTEtMA_b4b14a32-89bd-4dd6-b2b2-b44c70196ce1"
      unitRef="usd">991000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1dc4618a73204298852a45480a01610f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTMtOC0xLTEtMA_cdcbe2ff-e8b9-4452-ace4-3ae74018e181"
      unitRef="usd">991000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie746e67ba8d64af0b6434070b1135780_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTQtNC0xLTEtMA_3d3d20be-a3d0-4999-9e32-979b1ad015e7"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie746e67ba8d64af0b6434070b1135780_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTQtNi0xLTEtMA_37f2426d-0ed7-4ed8-9219-36e0eb26bc14"
      unitRef="usd">741000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i917d5ae043a6482ea2fe51d188f57fdd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTQtOC0xLTEtMA_5d140f5a-5358-497a-bc9c-4507571808b6"
      unitRef="usd">741000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtNC0xLTEtODE5NQ_917b7168-7b6e-432c-a55d-4a1b62d9b808"
      unitRef="number">0.0260</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtNi0xLTEtMzI0Mg_21721800-fd89-4ec5-a9c8-364186ee411a"
      unitRef="usd">986000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie29e93986f134ebcadfa3bf09afe5797_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtOC0xLTEtMzI0OQ_493cdc59-03b4-4ef5-b87e-1ebed34cbaa0"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idfec6ce2d495407e91872cb50eb1d277_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTUtNC0xLTEtMA_27eab932-f4f3-4d94-b4cd-c102dfb6ee0d"
      unitRef="number">0.0565</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="idfec6ce2d495407e91872cb50eb1d277_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTUtNi0xLTEtMA_4039b493-7021-4c64-b365-e2fab14ee53b"
      unitRef="usd">996000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie65e28716f114e31bb0b12b21ca5d7b3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTUtOC0xLTEtMA_0bbbc5a6-de49-45ec-bd95-e0e1ba0cbd46"
      unitRef="usd">995000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i916f791cc0b141c9acf5ce3bcf4af863_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNC0xLTEtMA_7de655f7-5712-4ac7-9917-dd6b651d034b"
      unitRef="number">0.0480</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i916f791cc0b141c9acf5ce3bcf4af863_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtNi0xLTEtMA_8d83be07-0300-4d01-8394-432c76a93630"
      unitRef="usd">1735000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i516c59fe4fdb420fa10752e3f879ee6a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTYtOC0xLTEtMA_02035841-9ccb-4ea7-9232-4b64cc342553"
      unitRef="usd">1734000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd8ad038d121413794732443f43b0dd4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNC0xLTEtMA_5c94afec-a38b-402b-ac3f-2d8f3257eb28"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icd8ad038d121413794732443f43b0dd4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctNi0xLTEtMA_f0bf25a5-56dc-42c7-8263-ae8a97b2f2a1"
      unitRef="usd">1732000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id493a8861f6f49eebbc2bfe998aabff2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTctOC0xLTEtMA_542d8a85-ebd2-4af7-8008-5741689507e4"
      unitRef="usd">1731000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i924d914a188c41fabc11cc7f15cdc373_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTgtNC0xLTEtMA_dccd4ef2-56c4-4589-bff3-e0bcde22c2ea"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i924d914a188c41fabc11cc7f15cdc373_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTgtNi0xLTEtMA_4c240fa6-b3e9-4c74-9b48-67d9f269586b"
      unitRef="usd">2218000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5f55700d855e42528ccc24cdf5849a69_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTgtOC0xLTEtMA_81ae9972-e66c-4589-9f9c-7ce49683b62d"
      unitRef="usd">2217000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i04dd812e93aa44c9a770b8e0110ad89d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTktNC0xLTEtMA_26352176-d61f-47d0-ab13-925e2d733d6a"
      unitRef="number">0.0415</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i04dd812e93aa44c9a770b8e0110ad89d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTktNi0xLTEtMA_079aa6e1-3ab2-4af3-871a-dd4fa807314a"
      unitRef="usd">1726000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iffee9b8a237845ffb486442200c4c758_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMTktOC0xLTEtMA_0e89e5e6-2013-46cd-a858-d48145175e25"
      unitRef="usd">1725000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjYtNC0xLTEtODE5Nw_f0be2aea-9855-488d-b92d-a22036139aca"
      unitRef="number">0.0280</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjYtNi0xLTEtMzI0NQ_602b3702-31dd-4451-8b4d-a07a21346b64"
      unitRef="usd">1475000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic09bf1bed99a4abc8990ec17f2674ada_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjYtOC0xLTEtMzI0NQ_5eaf6556-5053-4517-8700-3dfaa9bfe543"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtNi0xLTEtMA_48a3ac8d-225b-460b-9261-ef2c2a1cf165"
      unitRef="usd">29290000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjAtOC0xLTEtMA_03064761-7448-4e0e-bc57-2e73e122887f"
      unitRef="usd">24593000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjEtNi0xLTEtMA_ab98df47-1874-4a01-b3ba-1455d5dcb88d"
      unitRef="usd">1498000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjEtOC0xLTEtMA_2a5d9287-f1ec-4fd8-a392-a4141a133351"
      unitRef="usd">2499000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjItNi0xLTEtMA_c0e893a1-e887-44d6-9781-b81c7f76ee0d"
      unitRef="usd">27792000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9ff69c4fb8e64039b4ddd0748345671c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RhYmxlOjAyNzFlMWY1ODg5YzRhZDliYzY2ZTQ3MjdlMWNmY2M4L3RhYmxlcmFuZ2U6MDI3MWUxZjU4ODljNGFkOWJjNjZlNDcyN2UxY2ZjYzhfMjItOC0xLTEtMA_5129342b-22c0-4153-a012-0f7328a2e17e"
      unitRef="usd">22094000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i732e6064e491434f97f7abba277ffc08_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2Mjk3NQ_7cdca5c9-af46-40f9-9503-fefd1f0feb8b"
      unitRef="usd">7250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i78b6a868c97f4d47b86b691b5a97102c_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2Mjk1OQ_46cffe76-01b5-44a4-91b4-b9187cbe1581"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i024047c0ec56431f91c17a86fae8c5fc_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2Mjk5OA_f1ff7704-3de2-4138-8817-69e81d18fb1e"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzAxMw_97a9a7e7-2d9c-42b0-9e26-0fe048b193ba"
      unitRef="usd">2000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i16b3ca29d5874d9f8e4b7ec0405fbd81_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgwMg_f29cbf55-d326-48c8-91e9-ed4e6fc9faa1"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzAyOA_5ce8e87a-3c1b-40af-9045-e753ef5a1ad1"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i66e503faf08b4182b4ae149c600e7779_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgxMA_c6c7cfdb-3adf-437a-90c1-bfe519ad8eb2"
      unitRef="number">0.0120</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0f72724ee7414879a83048bd3532f197_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzA0Mw_e390cc1c-c37c-4d52-a66c-f5e447feb91e"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f72724ee7414879a83048bd3532f197_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgxOA_903ba683-01eb-46f3-bfff-3436044373c8"
      unitRef="number">0.0165</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzA1OA_f6a1152f-0b50-40ea-bfe7-f9aa678c985d"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f741e6d070e4fe882119870d1184cef_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgyNg_09d5fbbc-74fe-4005-b26f-d04f6ab95a52"
      unitRef="number">0.0260</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2MzA3Mw_cae1cb2d-29c7-4164-93bd-e4f2e2bfed6b"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibcafd6d3d3a9427f8d2b547f31db3df7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDgzNA_721c02a4-009b-4de2-b62b-1031c2e8be6b"
      unitRef="number">0.0280</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i7ff2cdfdf7c743e5a3c192c472818845_D20200901-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIxMw_4c06cc80-09ac-4cff-b738-dde25ab3ebe8"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments
      contextRef="i6942d430090747b99d43a27db7846096_D20200901-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUwOA_3bbb961d-7aea-4f25-803a-cb00933007a3"
      unitRef="number">0.0010</gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments>
    <gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments
      contextRef="i5d133b8c794a496097f8802c3cee3c74_D20200901-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUxNw_230ffee9-ad60-4054-8871-fb9217c4a7c4"
      unitRef="number">0.00125</gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments>
    <gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments
      contextRef="ia93111f675b84d0185cffe796ba9ad0f_D20200901-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUyNg_05f09f7e-ae7f-4f3a-ab1f-2dc03779cd5b"
      unitRef="number">0.0015</gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments>
    <gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments
      contextRef="i0af1b61d1bd24f02bcf41645b802cfef_D20200901-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDUzMw_eda5a18a-b738-4f40-9c4e-cb3e10cdc5e6"
      unitRef="number">0.0020</gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments>
    <gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments
      contextRef="ib35e51d4a6e5413d804346c20c4d645d_D20200901-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDU0MA_41467b7f-cb54-414b-8aa3-360487e19b97"
      unitRef="number">0.0025</gild:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments>
    <gild:DebtInstrumentCallFeaturePeriodBeforeMaturity
      contextRef="ie2873f7c29354cc8a00cc6b3eadad4b9_D20200901-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDU2Mg_52c0e139-9b38-4fd0-8286-14f6fac932d4">P2M</gild:DebtInstrumentCallFeaturePeriodBeforeMaturity>
    <gild:DebtInstrumentCallFeaturePeriodBeforeMaturity
      contextRef="i332b81acd0e34cb68ce82c944141e308_D20200901-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxNDU4MA_a9ad9214-7190-436f-9392-61bdff6f05cf">P2Y</gild:DebtInstrumentCallFeaturePeriodBeforeMaturity>
    <gild:DebtInstrumentCallFeaturePeriodBeforeMaturity
      contextRef="ie5f98f733a534405a4a7aceadcbae8db_D20200901-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgyMzcyMQ_49dcacca-8c9f-4ff8-943e-1fa90c1052bc">P2Y</gild:DebtInstrumentCallFeaturePeriodBeforeMaturity>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ifebe1e104a53429d9f4985f21acfcf6f_D20200901-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIxOQ_205977b8-ac7e-49cf-af3c-3bd56d0e3d44"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="i8c112e7007ab4912b6828d7439e90eed_D20200201-20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTYx_52979457-1bdc-430f-9ba4-49b35a9ae4d7"
      unitRef="usd">500000000</us-gaap:RepaymentsOfUnsecuredDebt>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="if350b42852dd44f48da9f53e1b8ff9e9_D20200901-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTY0OTI2NzQ5NDg2Ng_514a5a7f-ae78-421b-aed0-4be2b4de7709"
      unitRef="usd">2000000000.0</us-gaap:RepaymentsOfUnsecuredDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="id43f9dfea2c7418cb87a1a84ccc9a37e_D20200901-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNjU5NzA2OTgxOTc0OA_d012b62c-b1b9-4835-8367-4baa4be71e36">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i66ad83bd55674a5489ec01dc33324735_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfMTA5OTUxMTY2NDg0OQ_108deeab-6083-4941-b01f-d4120365552c"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="i66ad83bd55674a5489ec01dc33324735_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIyOA_045d589a-9664-404f-a1d1-485f3035dfc6"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i05c93da51a924b19ae6284b9a552e965_I20201023"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNzE0NjgyNTYyNzIzMw_f08ca5b2-3454-493c-87a7-d217833ad8e7"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1bfe479f1cd340f3a96f534ba41654ad_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNDE2_7db32e1c-fcfd-483b-9804-36da1409d4e4"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i345776f175ba45628e7886736d46d225_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfNTI4_e748075d-7cee-40d8-9f8a-cc7e3a75b928"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ifda8f675af864a82a9abe9b9a27454d7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfODg1_3a735a28-7912-4742-b17e-f55c9cd9cf4e"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ic3c8da64f2584082a30059c2ef0db569_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN181OC9mcmFnOjc1OWIyYzY4NDljMTQ1YWZhYjUwMDgwYTFjNTBhNjQ4L3RleHRyZWdpb246NzU5YjJjNjg0OWMxNDVhZmFiNTAwODBhMWM1MGE2NDhfODg1_3accfb16-0080-4ab9-a8e0-038e18b1b111"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfMjQxODM_9a2b541e-cb57-4c8b-acbf-8154e7d57f0d">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a party to various legal actions. The most significant of these are described below. We recognize accruals for such actions to the extent that we conclude that a loss is both probable and reasonably estimable. We accrue for the best estimate of a loss within a range; however, if no estimate in the range is better than any other, then we accrue the minimum amount in the range. If we determine that a material loss is reasonably possible and the loss or range of loss can be estimated, we disclose the possible loss. Unless otherwise noted, it is not possible to determine the outcome of these matters or the outcome (including in excess of any accrual) is not expected to be material, and we cannot reasonably estimate the maximum potential exposure or the range of possible loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have any material accruals for the matters described below in our Condensed Consolidated Balance Sheets as of September&#160;30, 2020 and December&#160;31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation Related to Sofosbuvir&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, we acquired Pharmasset, Inc. Through the acquisition, we acquired sofosbuvir, a nucleotide analog that acts to inhibit the replication of the hepatitis C virus (&#x201c;HCV&#x201d;). In 2013, we received approval from FDA for sofosbuvir, now known commercially as Sovaldi. Sofosbuvir is also included in all of our marketed HCV products. We have received a number of litigation claims regarding sofosbuvir. While we have carefully considered these claims both prior to and following the acquisition and believe they are without merit, we cannot predict the ultimate outcome of such claims or range of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are aware of patents and patent applications owned by third parties that have been or may in the future be alleged by such parties to cover the use of our HCV products. If third parties obtain valid and enforceable patents, and successfully prove infringement of those patents by our HCV products, we could be required to pay significant monetary damages. We cannot predict the ultimate outcome of intellectual property claims related to our HCV products. We have spent, and will continue to spend, significant resources defending against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Litigation with Idenix Pharmaceuticals, Inc. (&#x201c;Idenix&#x201d;), Universita Degli Studi di Cagliari (&#x201c;UDSG&#x201d;), Centre National de la Recherche Scientifique and L&#x2019;Universit&#xe9; Montpellier II&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2013, Idenix, UDSG, Centre National de la Recherche Scientifique and L&#x2019;Universit&#xe9; Montpellier II sued us in the U.S. District Court for the District of Delaware alleging that the commercialization of sofosbuvir infringes U.S. Patent No. 7,608,600 (the &#x201c;&#x2019;600 patent&#x201d;). We prevailed at all phases of litigation concerning the &#x2019;600 patent, and in 2018, the U.S. Supreme Court denied Idenix&#x2019;s petition for certiorari. Also in 2013, Idenix and UDSG sued us in the U.S. District Court for the District of Massachusetts alleging that the commercialization of sofosbuvir infringes U.S. Patent Nos. 6,914,054 (the &#x201c;&#x2019;054 patent&#x201d;) and 7,608,597 (the &#x201c;&#x2019;597 patent&#x201d;). In 2014, the court transferred the Massachusetts litigation to the U.S. District Court for the District of Delaware.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to trial in 2016, Idenix committed to give us a covenant not to sue with respect to any claims arising out of the &#x2019;054 patent related to sofosbuvir and withdrew that patent from the trial. A jury trial was held in 2016 on the &#x2019;597 patent, and the jury found that we willfully infringed the asserted claims of the &#x2019;597 patent and awarded Idenix $2.54 billion in past damages. In 2018, the judge invalidated Idenix&#x2019;s &#x2019;597 patent and vacated the jury&#x2019;s award of $2.54 billion in past damages. Idenix appealed this decision to the U.S. Court of Appeals for the Federal Circuit (&#x201c;CAFC&#x201d;), and in October 2019, the CAFC issued an opinion affirming the trial court&#x2019;s decision that the &#x2019;597 patent is invalid. In April 2020, the CAFC denied Idenix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s petition for rehearing en banc. Idenix has sought review by the U.S. Supreme Court. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Litigation with the University of Minnesota&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The University of Minnesota (the &#x201c;University&#x201d;) has obtained U.S. Patent No. 8,815,830 (the &#x201c;&#x2019;830 patent&#x201d;), which purports to broadly cover nucleosides with antiviral and anticancer activity.&#160;In 2016, the University filed a lawsuit against us in the U.S. District Court for the District of Minnesota, alleging that the commercialization of sofosbuvir-containing products infringes the &#x2019;830 patent.&#160;We believe the &#x2019;830 patent is invalid and will not be infringed by the continued commercialization of sofosbuvir. In 2017, the court granted our motion to transfer the case to California. We have also filed petitions for inter partes review with the U.S. Patent and Trademark Office Patent Trial and Appeal Board (&#x201c;PTAB&#x201d;) alleging that all asserted claims are invalid for anticipation and obviousness, and the PTAB instituted one of these petitions. In 2018, the U.S. District Court for the Northern District of California stayed the litigation until after the PTAB concludes the inter partes review that it has initiated, which we expect will occur by 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation Related to Axicabtagene Ciloleucel&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We own patents and patent applications that protect our axicabtagene ciloleucel chimeric DNA segments. Third parties may have, or may obtain rights to, patents that could allegedly be used to prevent or attempt to prevent us from commercializing axicabtagene ciloleucel or to require us to obtain a license in order to commercialize axicabtagene ciloleucel. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, Juno Therapeutics, Inc. and Sloan Kettering Cancer Center (collectively, &#x201c;Juno&#x201d;) filed a lawsuit against us in the U.S. District Court for the Central District of California, alleging that the commercialization of axicabtagene ciloleucel, sold commercially as Yescarta, infringes on U.S. Patent No. 7,446,190 (the &#x201c;&#x2019;190 patent&#x201d;). A jury trial was held on the &#x2019;190 patent, and in December 2019, the jury found that the asserted claims of the &#x2019;190 patent were valid, and that we willfully infringed the asserted claims of the &#x2019;190 patent. The jury also awarded Juno damages in amounts of $585 million in an up-front payment and a 27.6% running royalty from October 2017 through the date of the jury&#x2019;s verdict. The parties filed post-trial motions in the first quarter of 2020, and the trial judge entered a judgment in April 2020. The trial judge affirmed the jury&#x2019;s verdict, enhanced the past damages by 50% and maintained the royalties on future Yescarta sales at 27.6%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In assessing whether we should accrue a liability for this litigation in our consolidated financial statements, we considered various factors, including the legal and factual circumstances of the case, the jury&#x2019;s verdict, the district court&#x2019;s pre- and post-trial orders, the current status of the proceedings, applicable law, the views of legal counsel and the likelihood that the judgment will be upheld on appeal. As a result of this review, we have determined, in accordance with applicable accounting standards, that it is not probable that we will incur a material loss as a result of this litigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the judgment is reversed on appeal, the loss is expected to be zero. If the judgment is upheld in its entirety on appeal, we estimate a loss through the third quarter of 2020 to be approximately $1.3&#160;billion, which consists of (i) approximately $811 million, which represents damages on Yescarta revenues through December 12, 2019, and prejudgment interest thereon, (ii) approximately $389 million, which represents a 50% enhancement of past damages and (iii) approximately $128 million for royalties and prejudgment interest on Yescarta revenues from December 13, 2019 to September&#160;30, 2020. Although we cannot predict with certainty the ultimate outcome of this litigation on appeal, we believe the jury&#x2019;s verdict and the judgment to be in error. In April 2020, we filed an appeal seeking to reverse the judgment or obtain a new trial due to errors made by the trial judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation Related to Bictegravir&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2018, ViiV Healthcare Company (&#x201c;ViiV&#x201d;) filed a lawsuit against us in the U.S. District Court of Delaware, alleging that the commercialization of bictegravir, sold commercially in combination with tenofovir alafenamide and emtricitabine as Biktarvy, infringes ViiV&#x2019;s U.S. Patent No. 8,129,385 (the &#x201c;&#x2019;385 patent&#x201d;) covering ViiV&#x2019;s dolutegravir. Bictegravir is structurally different from dolutegravir, and we believe that bictegravir does not infringe the sole asserted claim of the &#x2019;385 patent. The court has set a trial date of March 2021 for this lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2018, ViiV also filed a lawsuit against us in the Federal Court of Canada, alleging that our activities relating to our bictegravir compound have infringed ViiV&#x2019;s Canadian Patent No. 2,606,282 (the &#x201c;&#x2019;282 patent&#x201d;), which was issued to Shionogi &amp;amp; Co. Ltd. and ViiV. The &#x2019;282 patent is the compound patent covering ViiV&#x2019;s dolutegravir. We believe that bictegravir does not infringe the claims of the &#x2019;282 patent. In January 2020, the court held a summary trial to assess ViiV&#x2019;s infringement allegations. In April 2020, the court determined that bictegravir does not infringe the claims of the &#x2019;282 patent and dismissed the case. ViiV has appealed this decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November and December 2019, ViiV filed lawsuits in France, Germany, Ireland and the UK asserting the relevant national designations of European Patent No. 3 045 206 (&#x201c;EP &#x2019;206&#x201d;); in Australia asserting Australian Patent No. 2006239177; in Japan asserting Japanese Patent No. 4295353; and in Korea asserting Korean Patent Nos. 1848819 and 1363875. These patents all relate to molecules which ViiV claims would act as integrase inhibitors. We believe that bictegravir does not infringe the claims of any of ViiV&#x2019;s patents. In 2019, we filed an opposition in the European Patent Office (&#x201c;EPO&#x201d;) requesting revocation of EP &#x2019;206. The EPO hearing is scheduled for 2021. In all jurisdictions, to the extent that the claims of ViiV&#x2019;s patents are interpreted to cover bictegravir, we believe that those claims are invalid. We cannot predict the ultimate outcome of intellectual property claims related to bictegravir. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation Relating to Pre-Exposure Prophylaxis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, we filed petitions requesting inter partes review of U.S. Patent Nos. 9,044,509, 9,579,333, 9,937,191 and 10,335,423 (collectively, &#x201c;HHS Patents&#x201d;) by PTAB. The HHS Patents are assigned to the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) and purport to claim a process of protecting a primate host from infection by an immunodeficiency retrovirus by administering a combination of emtricitabine and tenofovir or TDF prior to exposure of the host to the immunodeficiency retrovirus, a process commonly known as pre-exposure prophylaxis (&#x201c;PrEP&#x201d;). In November 2019, the U.S. Department of Justice filed a lawsuit against us in the U.S. District Court of Delaware, alleging that the sale of Truvada and Descovy for use as PrEP infringes the HHS Patents. In February 2020, PTAB declined to institute our petitions for inter partes review of the HHS Patents. In April 2020, we filed a breach of contract lawsuit against the U.S. federal government in the Court of Federal Claims, alleging violations of four material transfer agreements (&#x201c;MTAs&#x201d;) related to the research underlying the HHS Patents and a clinical trial agreement (&#x201c;CTA&#x201d;) by the U.S. Centers for Disease Control and Prevention related to PrEP research. Although we cannot predict with certainty the ultimate outcome of these litigation matters, we believe that the U.S. federal government breached the MTAs and CTA, that Truvada and Descovy do not infringe the HHS Patents and that the HHS Patents are invalid over prior art descriptions of Truvada&#x2019;s use for PrEP and post-exposure prophylaxis as well because physicians and patients were using the claimed methods years before HHS filed the applications for the patents. A trial date for the lawsuit in the District Court of Delaware has been set for May 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation with Generic Manufacturers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the approval process for some of our products, FDA granted us a New Chemical Entity (&#x201c;NCE&#x201d;) exclusivity period during which other manufacturers&#x2019; applications for approval of generic versions of our product will not be approved. Generic manufacturers may challenge the patents protecting products that have been granted NCE exclusivity one year prior to the end of the NCE exclusivity period. Generic manufacturers have sought and may continue to seek FDA approval for a similar or identical drug through an abbreviated new drug application (&#x201c;ANDA&#x201d;), the application form typically used by manufacturers seeking approval of a generic drug. The sale of generic versions of our products earlier than their patent expiration would have a significant negative effect on our revenues and results of operations. To seek approval for a generic version of a product having NCE status, a generic company may submit its ANDA to FDA four years after the branded product&#x2019;s approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Starting in December 2019, we received letters from Lupin Ltd., Apotex Inc., Shilpa Medicare Ltd., Sunshine Lake Pharma Co. Ltd., Laurus Labs, Natco Pharma Ltd., Macleods Pharma Ltd., Hetero Labs Ltd. and Cipla Ltd. (collectively, &#x201c;generic manufacturers&#x201d;) indicating that they have submitted ANDAs to FDA requesting permission to market and manufacture generic versions of certain of our tenofovir alafenamide (&#x201c;TAF&#x201d;)-containing products. Between them, these generic manufacturers seek to market generic versions of Odefsey, Descovy and Vemlidy. Some generic manufacturers have challenged the validity of four patents listed on the Orange Book and associated with TAF, while others have challenged the validity of two of our Orange Book-listed patents associated with TAF. We filed lawsuits against the generic manufacturers, and we intend to enforce and defend our intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;European Patent Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2015, several parties filed oppositions in the EPO requesting revocation of one of our granted European patents covering sofosbuvir that expires in 2028. In 2016, the EPO upheld the validity of certain claims of our sofosbuvir patent. We have appealed this decision, seeking to restore all of the original claims, and several of the original opposing parties have also appealed, requesting full revocation. The appeal hearing is scheduled for July 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, several parties filed oppositions in the EPO requesting revocation of our granted European patent relating to sofosbuvir that expires in 2024. The EPO conducted an oral hearing for this opposition in 2018 and upheld the claims. Two of the original opposing parties have appealed, requesting full revocation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, several parties filed oppositions in the EPO requesting revocation of our granted European patent covering TAF that expires in 2026. In 2017, the EPO upheld the validity of the claims of our TAF patent. Three parties have appealed this decision. The appeal hearing is scheduled for March 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, several parties filed oppositions in the EPO requesting revocation of our granted European patent relating to TAF hemifumarate that expires in 2032. In 2019, the EPO upheld the validity of the claims of our TAF hemifumarate patent. Three parties have appealed this decision. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, three parties filed oppositions in the EPO requesting revocation of our granted European patent covering cobicistat that expires in 2027. In 2017, the EPO upheld the validity of the claims of our cobicistat patent. Two parties have appealed this decision. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The appeal process may take several years for all EPO opposition proceedings. While we are confident in the strength of our patents, we cannot predict the ultimate outcome of these oppositions. If we are unsuccessful in defending these oppositions, some or all of our patent claims may be narrowed or revoked and the patent protection for sofosbuvir, TAF, TAF hemifumarate and cobicistat in the European Union could be substantially shortened or eliminated entirely. If our patents are revoked, and no other European patents are granted covering these compounds, our exclusivity may be based entirely on regulatory exclusivity granted by the European Medicines Agency. If we lose patent protection for any of these compounds, our revenues and results of operations could be negatively impacted for the years including and succeeding the year in which such exclusivity is lost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Investigations and Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2011, we received a subpoena from the U.S. Attorney&#x2019;s Office for the Northern District of California requesting documents related to the manufacture, quality and distribution practices of Complera, Atripla, Truvada, Viread, Emtriva, Hepsera and Letairis. We cooperated with the government&#x2019;s inquiry. In 2014, the U.S. Department of Justice informed us that it had declined to intervene in a False Claims Act lawsuit filed by two former employees. In 2019, the District Court granted the Department of Justice&#x2019;s motion to dismiss plaintiffs&#x2019; federal claims. In April 2020, plaintiffs refiled their California False Claims Act and California retaliation claims in the Superior Court of California, County of San Mateo. In July 2020, the California Attorney General declined to intervene in the case, and the state court complaint was unsealed. In September 2020, we filed a demurrer requesting that the Superior Court dismiss plaintiffs&#x2019; claims, and we expect the court to rule on our demurrer before the end of the year. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit and we intend to vigorously defend against it.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, we received a subpoena from the U.S. Attorney&#x2019;s Office for the District of Massachusetts requesting documents related to our support of 501(c)(3) organizations that provide financial assistance to patients and documents concerning our provision of financial assistance to patients for our HCV products. In 2020, the matter was resolved through settlement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, we received a subpoena from the U.S. Attorney&#x2019;s Office for the District of Massachusetts requesting documents related to our copay coupon program and Medicaid price reporting methodology. We cooperated with this inquiry, and in July 2020, the government notified us that it was closed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, we received a voluntary request for information from the U.S. Attorney&#x2019;s Office for the Eastern District of Pennsylvania requesting information related to our reimbursement support offerings, clinical education programs and interactions with specialty pharmacies for Sovaldi and Harvoni. In 2018, we received another voluntary request for information related to our speaker programs and advisory boards for our HCV and hepatitis B virus (&#x201c;HBV&#x201d;) products. We cooperated with these voluntary requests. In October 2019, the government informed us that, following an investigation, it declined to intervene in two False Claims Act lawsuits against us relating to HCV reimbursement support and clinical education programs and hepatitis B speaker programs and advisory boards, respectively. Notwithstanding the government&#x2019;s declination, two plaintiffs have continued to pursue the lawsuit relating to HBV speaker programs and advisory boards and served us with the Second Amended Complaint in November 2019. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit and we intend to vigorously defend against it.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, we received a subpoena from the California Department of Insurance and the Alameda County District Attorney&#x2019;s Office requesting documents related to our marketing activities, reimbursement support offerings, clinical education programs and interactions with specialty pharmacies for Harvoni and Sovaldi.&#160;In August 2020, we were informed that the government had closed this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, we also received a subpoena from the U.S. Attorney&#x2019;s Office for the Southern District of New York requesting documents related to our promotional speaker programs for HIV. We are cooperating with this inquiry.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, Health Choice Advocates, LLC (&#x201c;Health Choice Advocates&#x201d;) filed a qui tam lawsuit against us under seal in New Jersey state court alleging violations of the New Jersey False Claims Act through our clinical education programs for Sovaldi and Harvoni and our HCV and HIV patient access programs. In July 2020, the New Jersey Attorney General&#x2019;s Office declined to intervene in the lawsuit and the complaint was unsealed. In May 2020, Health Choice Advocates filed a qui tam lawsuit under seal against us in Texas state court making similar allegations. In October 2020, the Texas Attorney General&#x2019;s Office declined to intervene in the lawsuit and the complaint was unsealed. Health Choice Advocates previously filed a lawsuit making similar allegations in federal court in the Eastern District of Texas in June 2017 and the court entered an order dismissing that matter without prejudice in July 2018. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have been named as a defendant in two class action lawsuits and various product liability lawsuits related to Viread, Truvada, Atripla, Complera and Stribild.&#160;Plaintiffs allege that Viread, Truvada, Atripla, Complera and/or Stribild caused them to experience kidney, bone and/or tooth injuries. The lawsuits, which are pending in state or federal court in California, Delaware, Florida, New Jersey and Missouri, involve more than 19,000 plaintiffs.&#160;Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. We intend to vigorously defend ourselves in these actions. While we believe these cases are without merit, we cannot predict the ultimate outcome. If plaintiffs are successful in their claims, we could be required to pay significant monetary damages.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Antitrust and Consumer Protection&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We (along with Japan Tobacco Inc. (&#x201c;Japan Tobacco&#x201d;), Bristol-Myers Squibb Company and Johnson &amp;amp; Johnson, Inc.) have been named as defendants in class action lawsuits filed in 2019 and 2020 related to various drugs used to treat HIV, including drugs used in combination antiretroviral therapy.&#160;Japan Tobacco was dismissed from the lawsuit after a favorable court ruling on the defendants&#x2019; motion to dismiss. Plaintiffs allege that we (and the other remaining defendants) engaged in various conduct to restrain competition in violation of federal and state antitrust laws and state consumer protection laws.&#160;The lawsuits, which have been or may be consolidated, are all pending in the U.S. District Court for the Northern District of California. The lawsuits seek to bring claims on behalf of two nationwide classes - one of direct purchasers consisting largely of wholesales, and another of end-payor purchasers, including health insurers and individual patients.&#160;Plaintiffs seek damages, permanent injunctive relief and other relief.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we along with generic manufacturers Cipla Ltd. and Cipla USA Inc. (&#x201c;Cipla&#x201d;) were named as defendants in a class action lawsuit filed by Jacksonville Police Officers and Fire Fighters Health Insurance Trust (&#x201c;Jacksonville Trust&#x201d;) on behalf of end-payor purchasers. Jacksonville Trust claims that the 2014 settlement agreement between us and Cipla, which settled a patent dispute relating to patents covering our Emtriva, Truvada, and Atripla products and permitted generic entry prior to patent expiry, violates certain federal and state antitrust and consumer protection laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While we believe these cases are without merit, we cannot predict the ultimate outcome.&#160;If plaintiffs are successful in their claims, we could be required to pay significant monetary damages or could be subject to permanent injunctive relief awarded in favor of plaintiffs.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a party to various legal actions that arose in the ordinary course of our business. We do not believe that these other legal actions will have a material adverse impact on our consolidated business, financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="iadae1c7466ea41e990dd30ccf69b5887_D20161201-20161231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfMzQ3Mg_e7644ee9-18ad-421c-a692-84f3880b161c"
      unitRef="usd">2540000000</us-gaap:LossContingencyDamagesAwardedValue>
    <gild:LossContingencyMotionInvalidatedForPastDamagesValue
      contextRef="ib20b3c03bc154daba1331e8af30fdb76_D20180101-20181231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfMzU3Ng_a857cc5d-8495-454f-bbe6-da9af41d413d"
      unitRef="usd">2540000000</gild:LossContingencyMotionInvalidatedForPastDamagesValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i375f4aa83089473d80f0894376a87131_D20191201-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjA1Mg_854ecec1-d518-4eaf-9483-6e06d5b6c90f"
      unitRef="usd">585000000</us-gaap:LossContingencyDamagesAwardedValue>
    <gild:JudgmentRoyaltyRateFromOctober2017
      contextRef="i375f4aa83089473d80f0894376a87131_D20191201-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjA4NA_9eb72da1-3e27-4866-8410-dbc866d156d7"
      unitRef="number">0.276</gild:JudgmentRoyaltyRateFromOctober2017>
    <gild:JudgmentEnhancedDamagesonPastSales
      contextRef="i3b9e6e8a3097447b8a5306434ceee570_I20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjM1Ng_41e3b9ae-9e14-4814-a02d-36e4301c9024"
      unitRef="number">0.50</gild:JudgmentEnhancedDamagesonPastSales>
    <gild:JudgmentRoyaltyRateOnFutureSales
      contextRef="i3b9e6e8a3097447b8a5306434ceee570_I20200430"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjQxNg_0eef38f4-fad8-4410-82da-05f0ad65dc54"
      unitRef="number">0.276</gild:JudgmentRoyaltyRateOnFutureSales>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i81637e03a86945a093db345c6214f5d9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzA4NA_4e8f87be-5408-414c-94b4-b5630d819e70"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ie7181038d12c4972b2d35c23670305e2_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzIxNQ_b3ab7248-5bf2-44e1-b03f-a44cf43daf89"
      unitRef="usd">1300000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <gild:LossContingencyEstimateofPossibleLossPastSales
      contextRef="i61fb468d46454c35be375b3bf645c786_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzI1NQ_b2a59f27-d5ac-4647-8b07-33f9829c921b"
      unitRef="usd">811000000</gild:LossContingencyEstimateofPossibleLossPastSales>
    <gild:LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages
      contextRef="i61fb468d46454c35be375b3bf645c786_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzM4NQ_b304b1d6-fb6d-44fc-8610-9b7b07dbf69c"
      unitRef="usd">389000000</gild:LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages>
    <gild:JudgmentEnhancedDamagesonPastSales
      contextRef="i3b9e6e8a3097447b8a5306434ceee570_I20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzQwOA_41e3b9ae-9e14-4814-a02d-36e4301c9024"
      unitRef="number">0.50</gild:JudgmentEnhancedDamagesonPastSales>
    <gild:LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest
      contextRef="i61fb468d46454c35be375b3bf645c786_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNjA0NzMxNDAwMDM3NA_4591b38a-60db-49cb-b775-6a4cb1570679"
      unitRef="usd">128000000</gild:LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182MS9mcmFnOmNmZmY5NTVmNzM4YTQ1OTY5ZDc0YjczZGUzYmFlYzQwL3RleHRyZWdpb246Y2ZmZjk1NWY3MzhhNDU5NjlkNzRiNzNkZTNiYWVjNDBfNzE0NjgyNTY1NjMwMw_95d7bd1a-1c52-4a6c-a3f4-0c6967f9b830"
      unitRef="plaintiff">19000</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMTYxMA_cf2e5c06-9555-462e-95a5-e1039e52f8e6">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2016, our Board of Directors authorized a $12.0 billion stock repurchase program (&#x201c;2016 Program&#x201d;) under which repurchases may be made in the open market or in privately negotiated transactions. We started repurchases under the 2016 Program in April 2016. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2020, our Board of Directors authorized a new $5.0 billion&#160;stock repurchase program (&#x201c;2020 Program&#x201d;), which will commence upon the completion of the&#160;2016 Program. Purchases under the 2020 Program may be made in the open market or in privately negotiated transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September 30, 2020, we repurchased and retired 3 million and 22 million shares of our common stock for $201 million and $1.6 billion, respectively, through open market transactions under the 2016 Program. During the three and nine months ended September 30, 2019, we repurchased and retired 3 million and 25 million shares of our common stock for $223 million and $1.6 billion, respectively, through open market transactions under the 2016 Program. As of September&#160;30, 2020, the remaining authorized repurchase amount under both programs was $6.8 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in AOCI by component, net of tax (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications to net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications to net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts reclassified to net income for gains and losses on cash flow hedges are recorded as part of Product sales on our Condensed Consolidated Statements of Operations. See Note 5. Derivative Financial Instruments for additional information. The amounts reclassified to net income for gains and losses on available-for-sale debt securities are recorded as part of Other income (expense), net on our Condensed Consolidated Statements of Operations. Gross realized gains and losses on available-for-sale debt securities were not material for the nine months ended September 30, 2020 and 2019. The income tax impact allocated to each component of other comprehensive income (loss) was not material for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i83dbde55d11d4cca843046da3156ede0_I20160128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMTA0_231358a0-74bb-4ad3-b78e-cce9bcac326c"
      unitRef="usd">12000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i8e803091b7ae47a28cf31980b4e75241_I20200129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzU3_3d4f2519-396d-4b18-883d-c9d830f1828c"
      unitRef="usd">5000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i2f8986f71eb946ce91a3ac37191c811a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMjkzNA_9a67c86b-8280-4846-9743-d44575d13ca1"
      unitRef="shares">3000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i2c72d335e955423da6fa2cc5ce0ca6a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMjk2NA_b150f0d9-f86e-4309-ba11-e1a1fee86362"
      unitRef="shares">22000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2f8986f71eb946ce91a3ac37191c811a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMjk5Ng_1539574e-f091-46e2-9679-e0fd92cb8093"
      unitRef="usd">201000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2c72d335e955423da6fa2cc5ce0ca6a9_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMzAyNg_93ff5987-bfa3-4fb9-9083-5fd6c20b235a"
      unitRef="usd">1600000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i5f6d71b9595c455b91d1695466faaa46_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODg1MA_776608a0-9822-4c36-ba07-b0615394c87d"
      unitRef="shares">3000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i9c5133b40b7348ee9a886cf367a8c92a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODg5NQ_25fe3418-b7f8-4abe-bfd2-2996ab045a57"
      unitRef="shares">25000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5f6d71b9595c455b91d1695466faaa46_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODk0Mw_8a7929de-caac-4309-8248-a027f755ecc6"
      unitRef="usd">223000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9c5133b40b7348ee9a886cf367a8c92a_D20190101-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMzg0ODI5MDY5ODk5Mw_d9c8c895-2c8f-4f6e-836c-83b07369c78e"
      unitRef="usd">1600000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i8428dd318d974b2db41a333de386ece2_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfNDM5ODA0NjUxMzA1OA_5cd1dc66-f951-4f0f-a31d-e5a1f551fc0f"
      unitRef="usd">6800000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RleHRyZWdpb246ODJmNDRmODhkYThhNGE1Yjg0MGEwYjhkNGEzZTlkZGRfMTYwNw_cf96bd2c-9561-4ad5-a1da-d35ce56ff05a">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in AOCI by component, net of tax (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications to net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications to net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i126913deb985494cbae4e16c0eefaaa0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS0yLTEtMS0w_aa26253b-f5c8-4132-8696-7cff55b2132f"
      unitRef="usd">53000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i31e50be0c1b8444dac6878e054031f95_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS00LTEtMS0w_b2fc035b-0c0d-4884-9c85-90477fe8167a"
      unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i92120c1df08941c0baa875930620ab7b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS02LTEtMS0w_4459620b-f413-45ed-815a-ab73fa261662"
      unitRef="usd">31000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i697547cbd3024af6ab47310c99aecd30_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMS04LTEtMS0w_764ba89c-52fa-4682-bbe9-da3c68f08183"
      unitRef="usd">85000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi0yLTEtMS0w_46115c3f-b617-4eb9-b240-e2cae4490940"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3c2d992fc41144e698540022573aae90_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi00LTEtMS0w_3ed5d647-e708-4c22-abc3-1ef7e055cf43"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi02LTEtMS0w_6f06a302-8a6d-4a62-946e-90d9f16f49cc"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMi04LTEtMS0w_b0f4f02b-6915-4965-b176-a6fba3811fc5"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy0yLTEtMS0w_760b3898-818d-4926-a249-243e7f43efc6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3c2d992fc41144e698540022573aae90_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy00LTEtMS0w_2e7c9bef-6b26-4cc5-9abd-4e1e270117b8"
      unitRef="usd">17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy02LTEtMS0w_eeb46c1e-e88a-4ee7-ab71-7b506e82f746"
      unitRef="usd">50000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfMy04LTEtMS0w_afe3c3cc-5302-4390-a010-623981e00b99"
      unitRef="usd">67000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f712d24dc464a64b80b5718374a3efa_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC0yLTEtMS0w_8c90c302-003c-40eb-a421-7396bed55a27"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c2d992fc41144e698540022573aae90_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC00LTEtMS0w_d8b1e6bd-286e-40a9-b5a6-c424c031c319"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i183a2cd9e02a4c92a679210db987678d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC02LTEtMS0w_8860e8bb-ee09-406b-8997-62809723c05d"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaa9f4594621e4deebed30c8d75426a16_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNC04LTEtMS0w_cb14cf32-3128-4afd-90fd-57bcc706f120"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="iaa15a6a2044f4dffbdd84d9bd4107466_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS0yLTEtMS0w_ab0daffa-12cb-4138-9add-e576003b2781"
      unitRef="usd">41000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87bf3701a61048ce98060b964e89b9d6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS00LTEtMS0w_3a3362bf-2dd8-4aa9-91c1-7d85f470f4e9"
      unitRef="usd">26000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic3ea6d768f5a439a8c7671f8e1b2734e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS02LTEtMS0w_d7405359-39e7-4ef8-af7b-72d8f31343af"
      unitRef="usd">-44000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic20a282f852c4c7dbb87cc18035c48ad_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjhiOGE5Njc1ZWQ0ZDRjZmNiZDVlYWQ1NjU1YmI0NWIxL3RhYmxlcmFuZ2U6OGI4YTk2NzVlZDRkNGNmY2JkNWVhZDU2NTViYjQ1YjFfNS04LTEtMS0w_248606de-08ab-455d-8d6e-e0c5de2d461b"
      unitRef="usd">23000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i931ba07aa5b84693bb30002c9e25ba8f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS0yLTEtMS0w_2a699d06-af39-4b1b-85e1-bbdef5ced9de"
      unitRef="usd">47000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc9ff79601b7441a89cc4803200d5db3_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS00LTEtMS0w_8261bfb8-9ac5-4c7c-8b47-66c2f09407e1"
      unitRef="usd">-52000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie21170d6027749b8ac405fbc5d0c14f3_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS02LTEtMS0w_948df819-e857-4798-956e-0e9166952ff9"
      unitRef="usd">85000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id8d14e1d51864d97b88c87da0f398d28_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMS04LTEtMS0w_4aef999d-0a1c-4366-b82a-8385910e7fd8"
      unitRef="usd">80000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i032461dad5024966ae092159c3844bbf_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi0yLTEtMS0w_73e48e2f-ed85-4a24-b66a-2b7d75e64cf9"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi00LTEtMS0w_4afb5eaa-b62f-4e91-afce-85844811a0c5"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5caf79123df745c29fab67273cf54adf_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi02LTEtMS0w_cdea34bd-592d-4ba3-8c9d-0ec92aa5d2c8"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMi04LTEtMS0w_01f30488-32dc-468c-a2e7-4bbb5ab95d41"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i032461dad5024966ae092159c3844bbf_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy0yLTEtMS0w_7f5925f7-c9a8-4da2-8193-e17a5a80e3f3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy00LTEtMS0w_855faf74-99f7-4f16-ac9a-e1bffc7b85a4"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5caf79123df745c29fab67273cf54adf_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy02LTEtMS0w_8d672b6b-0e18-4956-b1a7-2caf25eeda61"
      unitRef="usd">96000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfMy04LTEtMS0w_879bcbd4-866a-4ebf-ac92-c706477094ff"
      unitRef="usd">96000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i032461dad5024966ae092159c3844bbf_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC0yLTEtMS0w_a6372ce3-8c07-4ca6-b134-989a7c14d856"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i84a901b965964f39a4772c43e2b6dbd4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC00LTEtMS0w_5d19a2a7-d452-4626-b16f-305c7e271b6a"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5caf79123df745c29fab67273cf54adf_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC02LTEtMS0w_95a29b94-d2e8-4efb-bb12-63dc8b0e903b"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9113e4b3def4ebe821ad9a5ba9dd637_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNC04LTEtMS0w_6d06ca8f-b809-4873-88b1-d1a08a95d152"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i646702f3b9c14ffda1e398222e462a80_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS0yLTEtMS0w_3661f18e-2227-41d0-b288-3ce1357664f0"
      unitRef="usd">28000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i27914e2a7fbd4b0dbcc730cd7b58c33c_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS00LTEtMS0w_06ea2540-9f41-45b1-a930-91f7e3644fb7"
      unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia16228b8cf344fd0b17a751f84856174_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS02LTEtMS0w_d310db2f-28ce-4a68-b15c-1e6c93a71469"
      unitRef="usd">88000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0d3e46703834e0098456a41f5ef8be5_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182NC9mcmFnOjgyZjQ0Zjg4ZGE4YTRhNWI4NDBhMGI4ZDRhM2U5ZGRkL3RhYmxlOjE1NTZlYjlmYWQ0MDRjYjhhZmZiMGNjNTQ5ODQzMGZjL3RhYmxlcmFuZ2U6MTU1NmViOWZhZDQwNGNiOGFmZmIwY2M1NDk4NDMwZmNfNS04LTEtMS0w_70b2f150-a498-41c7-8788-f82b98c98629"
      unitRef="usd">117000000</us-gaap:StockholdersEquity>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTA1OQ_6e1ed379-356f-4cd2-acdc-30abfa8c2d1f">NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO GILEAD COMMON STOCKHOLDERS&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share attributable to Gilead common stockholders is calculated based on the weighted average number of shares of our common stock outstanding during the period. Diluted net income (loss) per share attributable to Gilead common stockholders is calculated based on the weighted average number of shares of our common stock and other dilutive securities outstanding during the period. The potentially dilutive shares of our common stock resulting from the assumed exercise of outstanding stock options and equivalents were determined under the treasury stock metho&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential shares of common stock excluded from the computation of diluted net income (loss) per share attributable to Gilead common stockholders because their effect would have been antidilutive were 13 million and 38 million for the three and nine months ended September 30, 2020, respectively, and 40 million and 14 million, for the three and nine months ended September 30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the calculation of basic and diluted net income (loss) per share attributable to Gilead common stockholders (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to Gilead&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share attributable to Gilead common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share attributable to Gilead common stockholders - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE3MA_b24e8dc5-aa3a-483a-8147-09b0050b07f8"
      unitRef="shares">13000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE3NA_551770e0-252a-4831-b02f-4124d537fcb5"
      unitRef="shares">38000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE3OA_153bf480-ee3e-4b05-84f9-2b722fdefbac"
      unitRef="shares">40000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTY0OTI2NzQ0MzE4Mg_221e17d5-a67d-4cf7-a116-95db52ac416a"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RleHRyZWdpb246YTY2MjhjNjBlMDVkNGY3NTk0ZTU1ZTRiNGMyYTE2MDBfMTA2Nw_ebbdeb6b-fc30-4f7c-8cf3-17d0a55b79f2">&lt;div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the calculation of basic and diluted net income (loss) per share attributable to Gilead common stockholders (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to Gilead&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share attributable to Gilead common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share attributable to Gilead common stockholders - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy0yLTEtMS0w_35172059-0623-4939-a2ab-2632005c8bb4"
      unitRef="usd">360000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy00LTEtMS0w_b825f899-78bc-4a82-b89c-3f4464b98d9d"
      unitRef="usd">-1165000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy02LTEtMS0w_6500a031-b81e-4f80-bb64-23b105f26df9"
      unitRef="usd">-1428000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfMy04LTEtMS0w_7795d942-fd0c-473a-b45c-6a949ce99ce6"
      unitRef="usd">2690000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC0yLTEtMS0w_52f495ba-4ba7-496a-baee-5a5e772277c6"
      unitRef="shares">1255000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC00LTEtMS0w_5b9c0625-0f25-4fab-a21f-3ebb4a84b582"
      unitRef="shares">1267000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC02LTEtMS0w_eecf04e5-e225-4177-af46-2140f3356814"
      unitRef="shares">1257000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNC04LTEtMS0w_9a572ba2-9d10-4a2b-8be7-cb3daab3a267"
      unitRef="shares">1271000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS0yLTEtMS0w_c316eb8a-c8bb-4446-8073-bf418cae7f04"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS00LTEtMS0w_dcaaaa79-1536-4aa5-bb33-01595673c51d"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS02LTEtMS0w_f9dac7d6-48fc-434e-ba0d-ff2b413f1822"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNS04LTEtMS0w_5e47a675-4c1b-4583-89f5-4a0665b2f836"
      unitRef="shares">7000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi0yLTEtMS0w_455a2ddc-4c6c-49d8-b208-2a0f6bca5d02"
      unitRef="shares">1261000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi00LTEtMS0w_647686b9-d5b9-469b-9cc4-91b0e9e4f4f7"
      unitRef="shares">1267000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi02LTEtMS0w_2f31f061-4b2d-441f-b835-c051458d2b86"
      unitRef="shares">1257000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfNi04LTEtMS0w_017ea0e0-d07e-4442-9ae5-6f9c648d7019"
      unitRef="shares">1278000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC0yLTEtMS0w_fe324573-1663-48c1-a7c1-717efedb6f15"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC00LTEtMS0w_9cb4a5ed-8e68-45f7-bb7d-7395eacd649e"
      unitRef="usdPerShare">-0.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC02LTEtMS0w_43b6c3d9-202b-4afc-9154-a8add711692b"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOC04LTEtMS0w_6bad210f-e526-4d86-9189-525d142e876a"
      unitRef="usdPerShare">2.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS0yLTEtMS0w_d586c26d-20dc-4f6b-8b01-4e24eec59f66"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS00LTEtMS0w_38044d96-ccbc-4ec2-8a92-f681f5981a36"
      unitRef="usdPerShare">-0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS02LTEtMS0w_69f8cefb-0962-47c3-a1af-11617c333981"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN182Ny9mcmFnOmE2NjI4YzYwZTA1ZDRmNzU5NGU1NWU0YjRjMmExNjAwL3RhYmxlOmMwMmU1OWFmNmY5YTQ3YzJiMGZlZDNhNDVlOWNlNGQ2L3RhYmxlcmFuZ2U6YzAyZTU5YWY2ZjlhNDdjMmIwZmVkM2E0NWU5Y2U0ZDZfOS04LTEtMS0w_886b01a4-0200-4bec-bf1b-f9799b41c169"
      unitRef="usdPerShare">2.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMjA1OA_7a5a2a34-c693-485e-81b8-307fdb456af2">INCOME TAXES &lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our income tax expense (benefit) (in millions, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate of 57.2% for the three months ended September 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to $511 million of certain acquired IPR&amp;amp;D charges and $923 million of unfavorable changes in the fair value of our equity investments in Galapagos that are non-deductible for income tax purposes. The three months ended September 30, 2020 also included a $91 million net discrete tax benefit related to a settlement with a taxing authority. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate of (903.4)% for the nine months ended September 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to a non-deductible $4.5 billion IPR&amp;amp;D charge recorded in connection with our acquisition of Forty Seven, in addition to the above mentioned amounts for the three months ended September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate of 22.2% for the three months ended September 30, 2019 differed from the U.S. federal statutory rate of 21% primarily due to the Global Intangible Low-Taxed Income (&#x201c;GILTI&#x201d;) tax, state taxes and our portion of the non-deductible branded prescription drug (&#x201c;BPD&#x201d;) fee, partially offset by research tax credits and earnings from non-U.S. subsidiaries that operate in jurisdictions with lower tax rates than the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate of 17.9% for the nine months ended September 30, 2019 differed from the U.S. federal statutory rate of 21% primarily due to a $119 million tax benefit related to settlements with taxing authorities, research tax credits and earnings from non-U.S. subsidiaries that operate in jurisdictions with lower tax rates than the United States, partially offset by the GILTI tax, state taxes and our portion of the non-deductible BPD fee.&lt;/span&gt;&lt;/div&gt;We are currently under examination by the U.S. Internal Revenue Service for the tax years from 2013 to 2015 and by various state and foreign jurisdictions. There are differing interpretations of tax laws and regulations, and as a result, significant disputes may arise with these tax authorities involving issues of the timing and amount of deductions and allocations of income among various tax jurisdictions. We regularly evaluate our exposures associated with our tax filing positions to determine our assessment of unrecognized tax benefits in accordance with the income tax guidance which clarifies the accounting for uncertainty in income taxes.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMjA2OQ_de794d49-ef66-464b-bbf8-27472137ad06">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our income tax expense (benefit) (in millions, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy0yLTEtMS0w_9742a7e4-140b-416e-a118-16631ee731bc"
      unitRef="usd">825000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy0yLTEtMS0w_b3f64fc1-fbb2-49b0-95d9-7549807af89c"
      unitRef="usd">825000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy00LTEtMS0w_1ba1953b-aaff-4d24-8527-3f9e84027b35"
      unitRef="usd">-1501000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy00LTEtMS0w_a031a6ca-aa2b-452c-befc-bcd0160841a2"
      unitRef="usd">-1501000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy02LTEtMS0w_0b03bae9-1848-49be-a617-4053a01ee632"
      unitRef="usd">-145000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy02LTEtMS0w_4ac698fd-868e-4df6-9489-a7c61046caf3"
      unitRef="usd">-145000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy04LTEtMS0w_18763f2a-5869-4244-90b5-87294d8830f5"
      unitRef="usd">3259000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfMy04LTEtMS0w_fdb3fd5d-e46c-4cfd-8ac4-41ca0dd9a05a"
      unitRef="usd">3259000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC0yLTEtMS0w_cfb44b27-6daf-4df4-8d37-7106b8d9fe62"
      unitRef="usd">472000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC00LTEtMS0w_a1d14eed-d1c4-44fd-9143-f8a1c8033bc4"
      unitRef="usd">-333000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC02LTEtMS0w_59cde5c8-9ce9-4adb-9d44-3fd1ddd2c0d6"
      unitRef="usd">1310000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNC04LTEtMS0w_251a80f4-aba4-4073-839b-4facf066efe6"
      unitRef="usd">584000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS0yLTEtMS0w_456a2914-203f-46c9-af97-50452c7cb019"
      unitRef="number">0.572</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS00LTEtMS0w_467e631d-e61d-4b07-ab35-b9e672961e1c"
      unitRef="number">0.222</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS02LTEtMS0w_ad72b523-59da-4a7f-88a9-baac9c96c3e2"
      unitRef="number">-9.034</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RhYmxlOmUzNDc0YWIzZmQ3ZDRmYjU4OTA0ZmFiMTc5MWE1OWRmL3RhYmxlcmFuZ2U6ZTM0NzRhYjNmZDdkNGZiNTg5MDRmYWIxNzkxYTU5ZGZfNS04LTEtMS0w_e46d1faf-e919-4b79-937c-5eb81e1998f3"
      unitRef="number">0.179</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTQ3_456a2914-203f-46c9-af97-50452c7cb019"
      unitRef="number">0.572</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTA5OTUxMTYzMTU3Mg_1a68006b-f871-426d-8b73-99fb72d51c53"
      unitRef="usd">511000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="ic68ebf48645046309e24289804996aac_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTA5OTUxMTYzMTQyMQ_758328f0-9162-482c-9335-47b36d24c942"
      unitRef="usd">923000000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMTA5OTUxMTYzMTQwNQ_c6ec6b7d-a92a-4df4-90e1-6671576d7c36"
      unitRef="usd">-91000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfNjU5NzA2OTc3MDgyMQ_a3d063f4-5690-4518-950a-bcb5126b67b4"
      unitRef="number">-9.034</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="i268c8b20aecd4e98828852a2e0529281_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfMjY5_b13325fa-5538-414f-988b-cc414aa9c507"
      unitRef="usd">4500000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfNDY0_467e631d-e61d-4b07-ab35-b9e672961e1c"
      unitRef="number">0.222</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfODU0_e46d1faf-e919-4b79-937c-5eb81e1998f3"
      unitRef="number">0.179</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="ieb1b7681b6304608b53a84321025bd99_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhNWQwOTg5MTUwNjQyYzU5OThkMmEzNDVhZDQ2ZDM3L3NlYzo5YTVkMDk4OTE1MDY0MmM1OTk4ZDJhMzQ1YWQ0NmQzN183MC9mcmFnOmVhMWQ0YzFjZTNlYTQwZmI4MDVmYzg4M2Y0MzE4OWRmL3RleHRyZWdpb246ZWExZDRjMWNlM2VhNDBmYjgwNWZjODgzZjQzMTg5ZGZfOTM5_ba8f4643-c9e0-4a31-b337-9b9f2d4c6722"
      unitRef="usd">-119000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575232358712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">333 Lakeside Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value, $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GILEAD SCIENCES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-19731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,253,528,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3047598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GILD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">574-3000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238756088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,886<span></span>
</td>
<td class="nump">$ 11,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">11,089<span></span>
</td>
<td class="nump">12,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $714 and $758, respectively</a></td>
<td class="nump">3,913<span></span>
</td>
<td class="nump">3,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">2,030<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">30,926<span></span>
</td>
<td class="nump">30,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,810<span></span>
</td>
<td class="nump">4,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term marketable securities</a></td>
<td class="nump">2,074<span></span>
</td>
<td class="nump">1,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">12,939<span></span>
</td>
<td class="nump">13,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,117<span></span>
</td>
<td class="nump">4,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">6,012<span></span>
</td>
<td class="nump">7,438<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">60,878<span></span>
</td>
<td class="nump">61,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">527<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_Accruedgovernmentandotherrebates', window );">Accrued government and other rebates</a></td>
<td class="nump">3,343<span></span>
</td>
<td class="nump">3,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,141<span></span>
</td>
<td class="nump">3,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,498<span></span>
</td>
<td class="nump">2,499<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">9,509<span></span>
</td>
<td class="nump">9,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">27,792<span></span>
</td>
<td class="nump">22,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Long-term income taxes payable</a></td>
<td class="nump">5,020<span></span>
</td>
<td class="nump">6,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term obligations</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 5,600 shares authorized; 1,253 and 1,266 shares issued and outstanding, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">3,712<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">13,709<span></span>
</td>
<td class="nump">19,388<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Gilead stockholders&#8217; equity</a></td>
<td class="nump">17,445<span></span>
</td>
<td class="nump">22,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">17,471<span></span>
</td>
<td class="nump">22,650<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 60,878<span></span>
</td>
<td class="nump">$ 61,627<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_Accruedgovernmentandotherrebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued government and other rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_Accruedgovernmentandotherrebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239537240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AllowanceforAccountsReceivableandChargebacks', window );">Allowance for accounts receivable</a></td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">5,600,000,000<span></span>
</td>
<td class="nump">5,600,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">1,253,000,000<span></span>
</td>
<td class="nump">1,266,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">1,253,000,000<span></span>
</td>
<td class="nump">1,266,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AllowanceforAccountsReceivableandChargebacks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for accounts receivable and other receivables not elsewhere defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AllowanceforAccountsReceivableandChargebacks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239051432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 6,577<span></span>
</td>
<td class="nump">$ 5,604<span></span>
</td>
<td class="nump">$ 17,268<span></span>
</td>
<td class="nump">$ 16,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">1,035<span></span>
</td>
<td class="nump">3,174<span></span>
</td>
<td class="nump">2,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expenses</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
<td class="nump">3,461<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">3,960<span></span>
</td>
<td class="nump">5,792<span></span>
</td>
<td class="nump">4,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">3,421<span></span>
</td>
<td class="nump">3,177<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">4,576<span></span>
</td>
<td class="nump">7,077<span></span>
</td>
<td class="nump">15,848<span></span>
</td>
<td class="nump">13,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">2,001<span></span>
</td>
<td class="num">(1,473)<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
<td class="nump">3,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(236)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
<td class="num">(717)<span></span>
</td>
<td class="num">(752)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(940)<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="num">(848)<span></span>
</td>
<td class="nump">817<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">825<span></span>
</td>
<td class="num">(1,501)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="nump">3,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">472<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">353<span></span>
</td>
<td class="num">(1,168)<span></span>
</td>
<td class="num">(1,455)<span></span>
</td>
<td class="nump">2,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Gilead</a></td>
<td class="nump">$ 360<span></span>
</td>
<td class="num">$ (1,165)<span></span>
</td>
<td class="num">$ (1,428)<span></span>
</td>
<td class="nump">$ 2,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share attributable to Gilead common stockholders - basic (usd per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in per share calculation - basic (in shares)</a></td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share attributable to Gilead common stockholders - diluted (usd per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 2.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in per share calculation - diluted (in shares)</a></td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 6,493<span></span>
</td>
<td class="nump">$ 5,516<span></span>
</td>
<td class="nump">$ 17,027<span></span>
</td>
<td class="nump">$ 16,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember', window );">Royalty, contract and other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575232385640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 353<span></span>
</td>
<td class="num">$ (1,168)<span></span>
</td>
<td class="num">$ (1,455)<span></span>
</td>
<td class="nump">$ 2,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net foreign currency translation gain (loss), net of tax</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Available-for-sale debt securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Unrealized gain (loss), net of tax</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassifications to net income (loss), net of tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Cash flow hedges:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss), net of tax</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassifications to net income (loss), net of tax</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change</a></td>
<td class="num">(57)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">306<span></span>
</td>
<td class="num">(1,153)<span></span>
</td>
<td class="num">(1,517)<span></span>
</td>
<td class="nump">2,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive (loss) attributable to noncontrolling interest</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to Gilead</a></td>
<td class="nump">$ 313<span></span>
</td>
<td class="num">$ (1,150)<span></span>
</td>
<td class="num">$ (1,490)<span></span>
</td>
<td class="nump">$ 2,727<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale classification and out of the held-to-maturity classification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575319431160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock&#160;</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,282,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 21,534<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2,282<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 19,024<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">2,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,690<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuances under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuances under employee stock purchase plan</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances under equity incentive plans</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of common stock</a></td>
<td class="num">(1,748)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,675)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(2,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,266,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="nump">20,736<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">17,616<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,267,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2019</a></td>
<td class="nump">22,751<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,684<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">19,829<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(1,168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,165)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuances under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuances under employee stock purchase plan</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances under equity incentive plans</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of common stock</a></td>
<td class="num">(252)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,266,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="nump">$ 20,736<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">17,616<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">1,266,000,000<span></span>
</td>
<td class="nump">1,266,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 22,650<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">19,388<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interest (Note 6)</a></td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(1,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,428)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuances under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuances under employee stock purchase plan</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances under equity incentive plans</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of common stock</a></td>
<td class="num">(1,714)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">$ (2,599)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,599)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="nump">1,253,000,000<span></span>
</td>
<td class="nump">1,253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 17,471<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,712<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">13,709<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,254,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="nump">18,142<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,511<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">14,445<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interest (Note 6)</a></td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuances under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuances under employee stock purchase plan</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances under equity incentive plans</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of common stock</a></td>
<td class="num">(238)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">$ (866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="nump">1,253,000,000<span></span>
</td>
<td class="nump">1,253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 17,471<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 3,712<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 13,709<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575351559544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common stock, dividends declared (usd per share)</a></td>
<td class="nump">$ 0.68<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 2.04<span></span>
</td>
<td class="nump">$ 1.89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239451368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (1,455)<span></span>
</td>
<td class="nump">$ 2,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">844<span></span>
</td>
<td class="nump">868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">482<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="nump">5,792<span></span>
</td>
<td class="nump">4,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(796)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Net unrealized (gain) loss from equity securities</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="num">(312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(334)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(225)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(134)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(428)<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities and other</a></td>
<td class="nump">58<span></span>
</td>
<td class="num">(724)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">6,252<span></span>
</td>
<td class="nump">6,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Purchases of marketable debt securities</a></td>
<td class="num">(19,809)<span></span>
</td>
<td class="num">(24,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sales of marketable debt securities</a></td>
<td class="nump">12,367<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable debt securities</a></td>
<td class="nump">8,528<span></span>
</td>
<td class="nump">17,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Acquisitions, including in-process research and development, net of cash acquired</a></td>
<td class="num">(5,804)<span></span>
</td>
<td class="num">(4,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Purchases of equity securities</a></td>
<td class="num">(388)<span></span>
</td>
<td class="num">(1,251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(469)<span></span>
</td>
<td class="num">(622)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(5,638)<span></span>
</td>
<td class="num">(8,248)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt financing, net of issuance costs</a></td>
<td class="nump">7,189<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuances of common stock</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="num">(1,583)<span></span>
</td>
<td class="num">(1,644)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt and other obligations</a></td>
<td class="num">(2,500)<span></span>
</td>
<td class="num">(2,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of dividends</a></td>
<td class="num">(2,591)<span></span>
</td>
<td class="num">(2,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">639<span></span>
</td>
<td class="num">(6,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">1,255<span></span>
</td>
<td class="num">(8,466)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">11,631<span></span>
</td>
<td class="nump">17,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 12,886<span></span>
</td>
<td class="nump">$ 9,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229843016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. The financial statements include all adjustments consisting of normal recurring adjustments that the management of Gilead Sciences, Inc. (&#8220;Gilead&#8221;, &#8220;we&#8221;, &#8220;our&#8221; or &#8220;us&#8221;) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of Gilead, our wholly-owned subsidiaries and certain variable interest entities for which we are the primary beneficiary. All intercompany transactions have been eliminated. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess whether we are the primary beneficiary of a variable interest entity (&#8220;VIE&#8221;) at the inception of the arrangement and at each reporting date. This assessment is based on our power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements and related Notes to Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December&#160;31, 2019, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one operating segment, which focuses on the discovery, development and commercialization of innovative medicines in areas of unmet medical need. Our Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision-maker, manages and allocates resources to the operations of our company on an entity-wide basis. Managing and allocating resources on an entity-wide basis enables our CEO to assess the overall level of resources available and how to best deploy these resources across functions and research and development (&#8220;R&amp;D&#8221;) projects based on unmet medical need and, as necessary, reallocate resources among our internal R&amp;D portfolio and external opportunities to best support the long-term growth of our business. See Note 2. Revenues for additional information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies, Estimates and Judgments</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. On an ongoing basis, we evaluate our significant accounting policies and estimates. We base our estimates on historical experience and on various market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent coronavirus disease (&#8220;COVID-19&#8221;) could have on our significant accounting estimates. Actual results could differ materially from these estimates under different assumptions or conditions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain amounts for the three and nine months ended September 30, 2019 were reclassified to conform to the current period presentation. Beginning in the second quarter of 2020, acquired in-process research and development (&#8220;IPR&amp;D&#8221;) expenses are reported separately from Research and development expenses on our Condensed Consolidated Statements of Operations. Acquired IPR&amp;D expenses reflect IPR&amp;D impairments as well as the initial costs of externally developed IPR&amp;D projects, acquired directly in a transaction other than a business combination, that do not have an alternative future use, including upfront payments related to various collaborations and the initial costs of rights to IPR&amp;D projects. Our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019, has been conformed to separately present acquired IPR&amp;D expenses. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to credit risk from our portfolio of cash equivalents and marketable securities. Under our investment policy, we limit amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. We are not exposed to any significant concentrations of credit risk from our investment portfolio. The goals of our investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and a competitive after-tax rate of return. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to credit risk from our accounts receivable related to our product sales. Trade accounts receivable are recorded net of allowances for wholesaler chargebacks related to government and other programs, cash discounts for prompt payment and credit losses. Estimates of our allowance for credit losses consider a number of factors including existing contractual payment terms, individual customer circumstances, historical payment patterns of our customers, a review of the local economic environment and its potential impact on expected future customer payment patterns and government funding and reimbursement practices. The majority of our trade accounts receivable arises from product sales in the United States, Europe and Japan. Our allowance for credit losses was $47 million as of September&#160;30, 2020 and January 1, 2020. There were no material write-offs charged against the allowance for the three and nine months ended September 30, 2020. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016,&#160;the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2016-13 &#8220;Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments&#8221; and has since modified the standard with several ASUs (collectively, &#8220;Topic 326&#8221;).&#160;Topic 326 requires measurement and recognition of expected credit losses for financial assets. On January 1, 2020, we adopted this standard using a modified retrospective approach.&#160;The adoption did not have a material impact on our Condensed Consolidated Financial Statements. In connection with the adoption of Topic 326, we made an accounting policy election to not measure an allowance for credit losses for accrued interest receivable. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018,&#160;the FASB issued Accounting Standards Update No. 2018-18 &#8220;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#8221; (&#8220;ASU 2018-18&#8221;).&#160;ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606, &#8220;Revenue from Contracts with Customers&#8221; when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as customer revenue if the counterparty is not a customer for that transaction. On January 1, 2020, we adopted this standard and applied it retrospectively to January 1, 2018 when we initially adopted Topic 606. The adoption did not have an impact on our Condensed Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231378440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text">REVENUES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates our product sales by product and geographic region and disaggregates our royalty, contract and other revenues by geographic region (in millions):</span></div><div style="margin-bottom:8pt;margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Atripla</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biktarvy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complera/Eviplera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Descovy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genvoya</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Odefsey</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stribild</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Truvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other HIV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue share &#8211; Symtuza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmBisome</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ledipasvir/Sofosbuvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letairis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ranexa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sofosbuvir/Velpatasvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vemlidy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viread</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vosevi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yescarta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydelig</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,219&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Atripla</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biktarvy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complera/Eviplera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Descovy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genvoya</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Odefsey</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stribild</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Truvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other HIV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue share &#8211; Symtuza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmBisome</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ledipasvir/Sofosbuvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letairis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ranexa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sofosbuvir/Velpatasvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vemlidy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viread</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vosevi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yescarta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydelig</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,908&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.408%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Emtriva and Tybost.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents our revenue from cobicistat (C), emtricitabine (FTC) and tenofovir alafenamide (TAF) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland UC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Harvoni and the authorized generic version of Harvoni sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Cayston, Hepsera, Sovaldi and Tecartus. Europe product sales included unfavorable adjustments recorded in 2019 for statutory rebates related to sales of Sovaldi made in prior years.</span></div></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues from Major Customers</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmerisourceBergen Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues Recognized from Performance Obligations Satisfied in Prior Periods </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from performance obligations satisfied in prior years related to royalties for licenses of our intellectual property were </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$206 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$618 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the three and nine months ended September 30, 2020, respectively, and $201 million and $527 million for the three and nine months ended September 30, 2019, respectively. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable consideration is included in the net sales price only to the extent a significant reversal in the amount of cumulative revenue recognized is not probable of occurring when the uncertainty associated with the variable consideration is subsequently resolved. Estimates are assessed each period and updated to reflect current information. Changes in estimates for variable consideration related to sales made in prior years resulted in a $13 million and $94 million increase in revenues for the three and nine months ended September 30, 2020, respectively, and a $9 million and $309 million increase in revenues for the three and nine months ended September 30, 2019, respectively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets, which consist of unbilled amounts primarily from arrangements where the licensing of intellectual property is the only or predominant performance obligation, totaled $186 million and $144 million as of September&#160;30, 2020 and December&#160;31, 2019, respectively. Contract liabilities, which generally result from receipt of advance payment before our performance under the contract, were $103&#160;million and $45&#160;million as of September&#160;30, 2020 and December&#160;31, 2019. During the three and nine months ended September 30, 2020 and 2019, revenue recognized that was included in the contract liability balance as of the beginning of the respective years was not material. Revenue expected to be recognized in the future from contract liabilities as the related performance obligations are satisfied is not expected to be material in any one year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575351277464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of financial and non-financial assets and liabilities using the fair value hierarchy, which establishes three levels of inputs that may be used to measure fair value, as follows:</span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 1 inputs include quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 2 inputs include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For our marketable securities, we review trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and </span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 3 inputs include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Our Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments consist primarily of cash and cash equivalents, marketable debt securities, accounts receivable, foreign currency exchange contracts, equity securities, accounts payable and short-term and long-term debt. Cash and cash equivalents, marketable debt securities, certain equity securities and foreign currency exchange contracts are reported at their respective fair values in our Condensed Consolidated Balance Sheets. Equity securities without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. Short-term and long-term debt are reported at their amortized costs in our Condensed Consolidated Balance Sheets. The remaining financial instruments are reported in our Condensed Consolidated Balance Sheets at amounts that approximate current fair values. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.660%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment in Galapagos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other publicly traded equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency derivative contracts </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency derivative contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of equity securities resulted in net unrealized losses of $964 million and $1,046 million for the three and nine months ended September 30, 2020, respectively, and net unrealized gains of $58 million and $312 million for the three and nine months ended September 30, 2019, respectively, which were included in Other income (expense), net on our Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of our equity securities in our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:11pt;margin-top:9.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,039&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our available-for-sale debt securities are classified as cash equivalents, short-term marketable securities and long-term marketable securities in our Condensed Consolidated Balance Sheets. See Note 4. Available-For-Sale Debt Securities for additional information. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6. Acquisitions, Collaborations and Other Arrangements for additional information on our equity investment in Galapagos NV (&#8220;Galapagos&#8221;).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 Inputs</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair values of Level 2 instruments by taking into consideration valuations obtained from third-party pricing services. The pricing services utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate the fair value. These inputs include reported trades of and broker/dealer quotes on the same or similar securities, issuer credit spreads, benchmark securities, prepayment/default projections based on historical data and other observable inputs.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our foreign currency derivative contracts have maturities within an 18-month time horizon and all are with counterparties that have a minimum credit rating of A- or equivalent by S&amp;P Global Ratings, Moody&#8217;s Investors Service, Inc. or Fitch Ratings, Inc. We estimate the fair values of these contracts by taking into consideration the valuations obtained from a third-party valuation service that utilizes an income-based industry standard valuation model for which all significant inputs are observable, either directly or indirectly. These inputs include foreign currency exchange rates, London Interbank Offered Rates and swap rates. These inputs, where applicable, are observable at commonly quoted intervals.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total estimated fair values of our aggregate short-term and long-term debt, determined using Level 2 inputs based on their quoted market values, were approximately $33.3 billion and $27.3 billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively, and the carrying values were $29.3 billion and $24.6 billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575232601320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale Debt Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Available-for-Sale Debt Securities</a></td>
<td class="text">AVAILABLE-FOR-SALE DEBT SECURITIES<div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage and asset-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest receivable excluded from both the fair value and amortized cost basis of the available-for-sale debt securities was $49 million and $37 million as of September&#160;30, 2020 and December&#160;31, 2019, respectively, and is recorded in Prepaid and other current assets on our Condensed Consolidated Balance Sheets. There were no write-offs of accrued interest receivable during the three and nine months ended September 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in millions): </span></div><div style="margin-bottom:6pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within one year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#acacac;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held a total of 208 positions which were in an unrealized loss position as of September&#160;30, 2020. The unrealized losses are largely due to changes in interest rates. Aggregated gross unrealized losses on available-for-sale corporate debt securities were not material, and accordingly, no impairments were recognized for the three and nine months ended September 30, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231435096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">DERIVATIVE FINANCIAL INSTRUMENTS<div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in foreign countries expose us to market risk associated with foreign currency exchange rate fluctuations between the U.S. dollar and various foreign currencies, primarily the Euro. To manage this risk, we may hedge a portion of our foreign currency exposures related to outstanding monetary assets and liabilities as well as forecasted product sales using foreign currency exchange forward or option contracts. In general, the market risk related to these contracts is offset by corresponding gains and losses on the hedged transactions. The credit risk associated with these contracts is driven by changes in interest and currency exchange rates and, as a result, varies over time. By working only with major banks and closely monitoring current market conditions, we seek to limit the risk that counterparties to these contracts may be unable to perform. We also seek to limit our risk of loss by entering into contracts that permit net settlement at maturity. Therefore, our overall risk of loss in the event of a counterparty default is limited to the amount of any unrealized gains on outstanding contracts (i.e., those contracts that have a positive fair value) at the date of default. We do not enter into derivative contracts for trading purposes. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge our exposure to foreign currency exchange rate fluctuations for certain monetary assets and liabilities that are denominated in a non-functional currency. The derivative instruments we use to hedge this exposure are not designated as hedges and, as a result, changes in their fair value are recorded in Other income (expense), net on our Condensed Consolidated Statements of Operations. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge our exposure to foreign currency exchange rate fluctuations for forecasted product sales that are denominated in a non-functional currency. The derivative instruments we use to hedge this exposure are designated as cash flow hedges and have maturities of 18 months or less. Upon executing a hedging contract and quarterly thereafter, we assess hedge effectiveness using regression analysis. The unrealized gains or losses in Accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;AOCI&#8221;) are reclassified into product sales when the respective hedged transactions affect earnings. The majority of gains and losses related to the hedged forecasted transactions reported in AOCI as of September&#160;30, 2020 are expected to be reclassified to product sales within 12 months.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flow effects of our derivative contracts for the nine months ended September 30, 2020 and 2019 were included within Net cash provided by operating activities on our Condensed Consolidated Statements of Cash Flows.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had notional amounts on foreign currency exchange contracts outstanding of $2.8 billion and $2.9 billion as of September&#160;30, 2020 and December&#160;31, 2019, respectively. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While all our derivative contracts allow us the right to offset assets and liabilities, we have presented amounts on a gross basis. The following table summarizes the classification and fair values of derivative instruments in our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:33.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;accrued&#160;liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.338%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;accrued&#160;liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of our foreign currency exchange contracts on our Condensed Consolidated Financial Statements (in millions): </span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) recognized in AOCI </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains reclassified from AOCI into product sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) recognized in Other income (expense), net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may discontinue cash flow hedges and, as a result, record related amounts in Other income (expense), net on our Condensed Consolidated Statements of Operations. There were no discontinuances of cash flow hedges for the three and nine months ended September 30, 2020 and 2019. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and December&#160;31, 2019, we only held foreign currency exchange contracts. The following table summarizes the potential effect of offsetting our foreign currency exchange contracts on our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.899%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts Not Offset <br/>on our Condensed <br/>Consolidated Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts<br/> of Recognized <br/>Assets/Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts<br/> Offset on our <br/>Condensed <br/>Consolidated <br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amounts of Assets/Liabilities Presented<br/> on our Condensed Consolidated<br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Derivative <br/>Financial <br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash Collateral <br/>Received/<br/>Pledged</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net Amount<br/> (Legal Offset)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">As of September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">As of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231342072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Collaborations and Other Arrangements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract', window );"><strong>Acquisitions, Collaborations and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock', window );">Acquisitions, Collaborations and Other Arrangements</a></td>
<td class="text">ACQUISITIONS, COLLABORATIONS AND OTHER ARRANGEMENTS<div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to pursue acquisitions, licensing and strategic collaborations and other similar arrangements including equity investments with third parties for the development and commercialization of certain products and product candidates. These arrangements may include non-refundable upfront payments, expense reimbursements or payments by us for options to acquire certain rights, contingent obligations by us for potential development and regulatory milestone payments and/or sales-based milestone payments, royalty payments, revenue or profit-sharing arrangements and cost-sharing arrangements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:150%">Forty Seven, Inc. (&#8220;Forty Seven&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On&#160;April 7, 2020, we acquired all of the then issued and outstanding common stock of Forty Seven, a clinical-stage immuno-oncology company focused on developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches, for a price of $95.50 per share in cash, for total consideration of $4.7 billion, net of acquired cash. As a result, Forty Seven became our wholly-owned subsidiary. Forty Seven&#8217;s lead program, magrolimab, is an investigational monoclonal antibody in clinical development for the treatment of myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma and solid tumors. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the transaction as an asset acquisition since the lead asset, magrolimab, represented substantially all the fair value of the gross assets acquired. At the acquisition date, we recorded a $4.5 billion charge representing an acquired IPR&amp;D asset with no alternative future use in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. In connection with this acquisition, we recorded $202 million of assets acquired primarily consisting of deferred tax assets. Liabilities assumed were not material. During the three months ended June 30, 2020, we also recorded share-based compensation expense of $144 million related to the cash settlement of unvested Forty Seven employee stock awards attributable to post-acquisition services, which was primarily recorded in Research and development expenses on our Condensed Consolidated Statements of Operations. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:150%">Immunomedics, Inc. (&#8220;Immunomedics&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 13, 2020, we entered into an agreement and plan of merger (&#8220;Agreement and Plan of Merger&#8221;) to acquire Immunomedics, a company focused on the development of antibody-drug conjugate (&#8220;ADC&#8221;) technology. Immunomedics researches and develops biopharmaceutical products, particularly antibody-based products for patients with solid tumors and blood cancers, and manufactures and markets Trodelvy. Trodelvy, a Trop-2-directed ADC, developed by Immunomedics is the first ADC that the U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved for the treatment of adult patients with metastatic triple-negative breast cancer.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 24, 2020, under the terms of the Agreement and Plan of Merger, we commenced a tender offer (&#8220;Offer&#8221;) to acquire all of the outstanding shares of common stock of Immunomedics for approximately $21 billion (at a price of $88.00 per share), net in cash, without interest and subject to any withholding of taxes. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an event subsequent to September 30, 2020, on October 23, 2020, we completed the Offer for all outstanding shares of common stock of Immunomedics and accepted all shares validly tendered and not withdrawn as of the expiration time of the Offer. Following the Offer, we also acquired all remaining shares not tendered at Offer pursuant to the merger contemplated by the Agreement and Plan of Merger. As a result, the acquisition was completed and Immunomedics became a wholly owned subsidiary of Gilead. The financial results of Immunomedics will be included in our consolidated financial results for the year ending December 31, 2020 from the date of completion of the acquisition. We financed the acquisition with the majority of the proceeds from the September 2020 senior unsecured notes offering, an additional $1.0 billion borrowing under a new senior unsecured term loan facility and the balance with cash on hand. See Note 9. Debt and Credit Facilities for additional information.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our acquisition of Immunomedics will be accounted for as a business combination using the acquisition method of accounting in the fourth quarter of 2020. Given the recent timing of the transaction close, we are in the process of estimating fair values of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assets acquired and liabilities assumed in the business combination.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we are currently unable to provide preliminary allocation of purchase consideration based on the acquisition date fair values of the assets acquired and liabilities assumed as well as other related information, but we will disclose such information in our Annual Report on Form 10-K for the year ending December 31, 2020. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaborations and Other Arrangements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arcus Biosciences, Inc. (&#8220;Arcus&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 29, 2020, we acquired 2.2&#160;million shares of the common stock of Arcus, a publicly traded oncology-focused biopharmaceutical company, for approximately $61 million in a secondary equity offering. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, on&#160;May 27, 2020, we entered into a transaction with Arcus, which included entry into an option, license and collaboration agreement (the &#8220;Collaboration Agreement&#8221;) and a common stock purchase agreement and an investor rights agreement (together, the &#8220;Stock Purchase Agreements&#8221;). </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Collaboration Agreement and Stock Purchase Agreements, on July 13, 2020, we made an upfront payment of $175 million and acquired approximately 6&#160;million additional shares of Arcus&#8217; common stock for $200 million in accordance with the terms of the Collaboration Agreement and the Stock Purchase Agreements. Of the total $391 million initial cash payments made under the agreements and direct transactional costs, we recorded $135 million as an equity investment, which was calculated based on Arcus&#8217; closing stock price of $22.67 on the closing date of the transaction. As a result, combined with our existing share holdings, we own 8.2&#160;million shares of Arcus, representing approximately 13% of the issued and outstanding voting stock of Arcus immediately following the closing of the transaction. We recorded our equity investments in Arcus in Other long-term assets on our Condensed Consolidated Balance Sheets as the investments are subject to contractual lock-up provisions for a period up to 2 years from the closing date of the agreements, subject to certain conditions. We account for our equity investment in Arcus at fair value with changes in fair value recognized in Other income (expense), net for each reporting period. The remaining $256 million was attributed to the acquired license and option rights of $175 million representing IPR&amp;D assets with no alternative future use, $65 million of an issuance premium for the equity purchase and $16 million of direct transactional costs. These amounts were expensed as Acquired in-process research and development expenses during the three months ended September 30, 2020 on our Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gilead has the right to opt-in to all current and future investigational product candidates that emerge from Arcus&#8217; research portfolio for the ten years following the closing of the transaction. Upon our exercise of an option for a program, unless Arcus opts out according to the terms of the Collaboration Agreement, the companies will co-develop and share global development costs and co-commercialize and share profits in the U.S. We will obtain exclusive rights to commercialize any optioned programs outside of the U.S., subject to any rights of Arcus&#8217; existing partners, for which we will pay to Arcus tiered royalties ranging from the high teens to the low twenties on net sales. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Collaboration Agreement, subject to certain limited exceptions, we are required to provide $100&#160;million to Arcus on the second anniversary of the agreement and may pay an additional $100 million at our option on each of the fourth, sixth, and eighth anniversaries of the agreement, unless terminated early, as ongoing research and development support to extend our collaboration term to up to 10-years. Accordingly, during the three months ended September 30, 2020, we recorded a $100 million charge representing the contractually committed payment in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Collaboration Agreement, we will potentially provide up to $1.2 billion in opt-in and milestone payments with respect to current clinical product candidates, if and when such payments are triggered under the Collaboration Agreement. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stock Purchase Agreements, we have the right to purchase additional shares of Arcus from Arcus over the next five years, up to a maximum of 35% of the outstanding voting stock. We are subject to a three-year standstill restricting our ability to acquire voting stock of Arcus exceeding more than 35% of the then issued and outstanding voting stock of Arcus, subject to certain exceptions. Additionally, we agreed not to dispose of any equity securities of Arcus prior to the second anniversary of the closing of the Stock Purchase Agreements without the prior consent of Arcus, subject to certain exceptions. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pionyr Immunotherapeutics, Inc. (&#8220;Pionyr&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2020, we entered into a transaction with Pionyr, a privately held company pursuing novel biology in the field of immuno-oncology, which included entry into two separate merger agreements, one contemplating the initial acquisition of 49.9% equity interest in Pionyr, and the other providing us the exclusive option, subject to certain terms and conditions, to acquire the remaining outstanding capital stock of Pionyr (together, the &#8220;Pionyr Merger and Option Agreements&#8221;) and a research and development service agreement. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2020, we closed the transaction with Pionyr and paid $269 million in cash and accrued an additional $6 million payable, subject to certain customary adjustments, to Pionyr&#8217;s shareholders in accordance with the terms of the Pionyr Merger and Option Agreements. We account for our investment in Pionyr using the equity method of accounting because our equity interest provides us with the ability to exercise significance influence over Pionyr. Our investment in Pionyr, consisting of the transaction price noted above and transaction costs, exceeded our pro-rata portion of Pionyr's net assets at transaction closing. We determined that the resulting basis difference primarily relates to Pionyr&#8217;s IPR&amp;D which has no alternative future use and that Pionyr is not a business as defined in ASC 805, &#8220;Business Combinations.&#8221; As a result, we immediately recorded a charge for this basis difference of $215 million in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our exclusive option to acquire the remaining outstanding capital stock of Pionyr is approximately $70 million based on a probability weighted option pricing model and recorded in Other long-term assets on our Condensed Consolidated Balance Sheet. From the first anniversary of the closing date, we may choose to exercise our exclusive option to purchase the remaining equity interest from Pionyr&#8217;s current shareholders for a $315 million option exercise fee and up to $1.2 billion in potential future milestone payments upon achievement of certain development and regulatory milestones, in each case subject to certain negotiated adjustments. Such option to purchase will expire following the earliest occurrence of specified events, including the delivery of data following completion of certain Phase 1b trials by Pionyr. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the research and development service agreement, we made an initial cash funding of $80 million and recorded a charge in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020. We will provide additional payments of up to $115 million to Pionyr upon achievement of certain development milestones. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tizona Therapeutics, Inc. (&#8220;Tizona&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2020, we entered into a transaction with Tizona, a privately held company developing cancer immunotherapies, which included entry into two separate merger agreements, one contemplating the initial acquisition of a 49.9% equity interest in Tizona, and the other providing us the exclusive option, subject to certain terms and conditions, to acquire the remaining outstanding capital stock of Tizona (together, the &#8220;Tizona Merger and Option Agreements&#8221;) and a development agreement. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2020, we closed the transaction with Tizona and paid $302 million in cash to Tizona&#8217;s shareholders in accordance with the terms of the Tizona Merger and Option Agreements. We account for our investment in Tizona using the equity method of accounting because our equity interest provides us with the ability to exercise significance influence over Tizona. Our investment in Tizona, consisting of the transaction price noted above and transaction costs, exceeded our pro-rata portion of Tizona&#8217;s net assets at transaction closing. We determined that the resulting basis difference primarily relates to Tizona&#8217;s IPR&amp;D with no alternative future use and that Tizona is not a business as defined in ASC 805, &#8220;Business Combinations.&#8221; As a result, during the three months ended September 30, 2020, we immediately recorded this basis difference of $272 million in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our exclusive option to acquire Tizona is approximately $41 million based on a probability weighted option pricing model and recorded in Other long-term assets on our Condensed Consolidated Balance Sheet. From the first anniversary of the closing date, we may choose to exercise our exclusive option to purchase the remaining equity interest from Tizona&#8217;s current shareholders for up to $1.3 billion, including an option fee and potential future milestone payments upon achievement of certain development and regulatory milestones, in each case subject to certain negotiated adjustments. Such option to purchase will expire following the earliest occurrence of specified events, including the delivery of data following completion of certain Phase 1b trials by Tizona. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the development agreement, we committed to provide funding to Tizona of $115 million, which was recorded in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations during the three months ended September 30, 2020.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tango Therapeutics, Inc. (&#8220;Tango&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2020, we entered into a transaction with Tango, a privately held company pursuing innovative targeted immune evasion therapies for patients with cancer through its proprietary, CRISPR-enabled functional genomics target discovery platform, which included entry into an amended and restated research collaboration and license agreement and a stock purchase agreement (together, the &#8220;Collaboration and Stock Purchase Agreements&#8221;). </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon entering into this transaction, we made an upfront payment of $125 million and a $20 million equity investment in Tango, representing approximately 7% of the issued and outstanding voting stock of Tango immediately following the transaction, in accordance with the terms of the Collaboration and Stock Purchase Agreements. During the three months ended September 30, 2020, we recorded the $125 million upfront expense in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. Our equity investment in Tango is recorded at cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of Tango.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Collaboration and Stock Purchase Agreements, Gilead has the right to option up to 15 programs over the seven-year collaboration for up to $410 million per program in opt-in, extension and milestone payments. The parties will equally split profits and losses, as well as development costs in the U.S., for the products that Tango opts to co-develop and co-promote. We will provide Tango milestone payments and royalties on sales outside of the U.S. For products that Tango does not opt to co-develop and co-promote, we will pay Tango up to low double digit tiered royalties on net sales. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jounce Therapeutics, Inc. (&#8220;Jounce&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2020, we entered into a transaction with Jounce, a publicly traded company developing novel cancer immunotherapies, which included entry into license, registration rights and stock purchase agreements (together, &#8220;License and Stock Purchase Agreement&#8221;). In an event subsequent to September 30, 2020, in October 2020, we closed this transaction and made a total payment of $120 million in accordance with the terms of the License and Stock Purchase Agreement and recorded $56 million as an equity investment, representing approximately 14% of the issued and outstanding voting stock of Jounce immediately following the transaction, which was calculated based on Jounce&#8217;s closing stock price of $10.06 on the closing date of the transaction. In addition, we will provide up to $685 million in future potential clinical, regulatory and commercial milestone payments upon achievement of certain milestones, and pay Jounce royalties ranging from high single digit to mid-teens based upon worldwide sales, subject to certain adjustments. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Galapagos </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we closed an option, license and collaboration agreement (the &#8220;Collaboration Agreement&#8221;) and a subscription agreement (the &#8220;Subscription Agreement&#8221;), each with Galapagos, pursuant to which the parties entered into a global collaboration that covers Galapagos&#8217; current and future product portfolio (other than filgotinib). Upon closing, we paid $5.1&#160;billion for the license and option rights and 6.8&#160;million new ordinary shares of Galapagos at a subscription price of &#8364;140.59 per share. As a result, combined with our then existing share holdings, we owned 13.6&#160;million ordinary shares of Galapagos, representing approximately 22% of the issued and outstanding voting securities of Galapagos at the closing of the Collaboration Agreement and Subscription Agreement. The parties also amended certain terms relating to the development and commercialization of filgotinib pursuant to the license and collaboration agreement previously entered into between Gilead and Galapagos in 2015.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected the fair value option to account for our equity investment in Galapagos whereby the investment is marked to market through earnings in each reporting period based on the market price of Galapagos shares. We believe the fair value option best reflects the underlying economics of the investment. The $1.1&#160;billion equity investment, which included an issuance discount of $63 million calculated based on Galapagos&#8217; closing stock price on the date of closing of the Subscription Agreement and the subscription price of &#8364;140.59 per share, and our existing equity investment in Galapagos was recorded in Other long-term assets on our Condensed Consolidated Balance Sheets as our equity investment in Galapagos is subject to contractual lock-up provisions for a period up to 5 years from the closing date of the Subscription Agreement. The remaining $3.9&#160;billion of the payment was recorded in Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, as the initial contractual lock-up provision for certain Galapagos shares will expire in August 2021, the corresponding equity investment balance of $505 million was reclassified to Prepaid and other current assets from Other long-term assets on our Condensed Consolidated Balance Sheets. During the three months ended September 30, 2020, we recorded a pre-tax unrealized loss of $923&#160;million related to our investment in Galapagos in Other income (expense), net on our Condensed Consolidated Statement of Operations due to a decline in Galapagos&#8217; stock price. See Note 3. Fair Value Measurements for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gadeta B.V. (&#8220;Gadeta&#8221;)</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2018, we entered into a collaboration arrangement with Gadeta and made a purchase of equity in Gadeta from Gadeta&#8217;s shareholders. We determined that Gadeta was a VIE, and we were its primary beneficiary because we had the power to direct the activities of Gadeta that most significantly impact its economic performance. Upon the initial consolidation of Gadeta, we recorded $82 million to Noncontrolling interest, primarily reflecting acquired intangible assets related to IPR&amp;D on our Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, we effectively terminated the agreement with Gadeta. Upon the effective termination, we ceased to have a controlling interest and deconsolidated this VIE by removing the related net assets and noncontrolling interest of $82 million from our Condensed Consolidated Balance Sheets. The net loss from the deconsolidation was not material.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2020 and 2019, we entered into several collaborative, equity investments and licensing arrangements as well as other similar arrangements that we do not consider to be individually material. We recorded upfront collaboration expenses related to these arrangements of $7 million and $129 million for the three and nine months ended September 30, 2020, respectively, and $40 million and $331 million for the three and nine months ended September 30, 2019, respectively, within Acquired in-process research and development expenses on our Condensed Consolidated Statements of Operations. Cash payments made related to our equity investments for the three and nine months ended September 30, 2020 were $36 million and $61 million, respectively, and totaled $15 million and $119 million for the three and nine months ended September 30, 2019, respectively, which were primarily recorded within Prepaid and other current assets and Other long-term assets on our Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the financial terms of these arrangements, we may be required to make payments upon achievement of developmental, regulatory and commercial milestones, which could be significant. Future milestone payments, if any, will be reflected in our Condensed Consolidated Statements of Operations when the corresponding events become probable. In addition, we may be required to pay significant royalties on future sales if products related to these arrangements are commercialized. The payment of these amounts, however, is contingent upon the occurrence of various future events, which have a high degree of uncertainty of occurrence.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AcquisitionCollaborationsandOtherArrangementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition, Collaboratiions and Other Arrangements [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AcquisitionCollaborationsandOtherArrangementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Collaborations and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229882216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Financial Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_OtherFinancialInformationAbstract', window );"><strong>Other Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Other Financial Information</a></td>
<td class="text">OTHER FINANCIAL INFORMATION<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our Inventories (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:0.1%"/><td style="width:2.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.344%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts primarily consist of raw materials.</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Accrued Liabilities </span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of Other accrued liabilities (in millions):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,074&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_OtherFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Financial Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_OtherFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231313864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">INTANGIBLE ASSETS<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our intangible assets, net (in millions): </span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finite-lived assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - sofosbuvir</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - axicabtagene ciloleucel</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,312)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,809&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,468)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived assets - IPR&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,312)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,468)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate amortization expense related to finite-lived intangible assets was $281 million and $844 million for the three and nine months ended September 30, 2020, respectively, $281 million and $868 million for the three and nine months ended September 30, 2019, respectively, and was primarily included in Cost of goods sold on our Condensed Consolidated Statements of Operations.</span><span style="color:#b6b6b6;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of September&#160;30, 2020 (in millions):</span></div><div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:86.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,809&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229820232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Credit Facilities</a></td>
<td class="text">DEBT AND CREDIT FACILITIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Unsecured Notes</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our borrowings under our senior unsecured notes (in millions):</span></div><div style="margin-bottom:11pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.55%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-month LIBOR + 0.15%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-month LIBOR + 0.52%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.70%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.60%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2041</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2045</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2046</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2047</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,290&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,593&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt 2px 42pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes Offering</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we issued $7.25 billion aggregate principal amount of senior unsecured notes consisting of (i) $500 million principal amount of floating rate notes due September 2021 and $500 million principal amount of floating rate notes due September 2023 (together, the &#8220;Floating Rate Notes&#8221;); and (ii) $2.0 billion principal amount of 0.75% senior notes due September 2023, $750 million principal amount of 1.20% senior notes due October 2027, $1.0 billion principal amount of 1.65% senior notes due October 2030, $1.0 billion principal amount of 2.60% senior notes due October 2040 and $1.5 billion principal amount of 2.80% senior notes due October 2050 (together, the &#8220;Fixed Rate Notes&#8221; and, together the Floating Rate Notes, the &#8220;2020 Senior Notes&#8221;), the terms of which are summarized in the table above. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed Rate Notes may be redeemed at our option at a redemption price equal to the greater of (i) 100% of the principal amount of the Fixed Rate Notes to be redeemed and (ii) the sum, as determined by an independent investment banker, of the present values of the remaining scheduled payments of principal and interest on the Fixed Rate Notes to be redeemed (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semiannual basis at the treasury rate, plus 10 basis points in the case of the 2023 fixed rate notes, 12.5 basis points in the case of the 2027 fixed rates notes, 15 basis points in the case of the 2030 fixed rate notes, 20 basis points in the case of the 2040 fixed notes and 25 basis points in the case of the 2050 fixed rate notes, plus any accrued and unpaid interest on the Fixed Rate Notes to be redeemed to, but excluding, the date of redemption. The Fixed Rate Notes also have a call feature, exercisable at our option, to redeem the notes at par in whole, or in part, on dates ranging from two months to two years prior to maturity. In each case, accrued and unpaid interest is also required to be redeemed to the date of redemption. The September 2023 floating rate notes also have a call feature, exercisable at our option, to redeem the notes at par, in whole, or in part, approximately two years prior to maturity.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of the occurrence of a change in control and a downgrade in the rating of the 2020 Senior Notes below investment grade by Moody&#8217;s Investors Service, Inc. and S&amp;P Global Ratings, the holders may require us to purchase all or a portion of their notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest to the date of repurchase.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to comply with certain covenants under our note indentures governing our senior unsecured notes. As of September&#160;30, 2020, we were in compliance with all covenants.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes Repayments</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, we repaid $500 million of our senior unsecured notes upon maturity. In September 2020, we repaid $2.0 billion of our senior unsecured notes upon maturity.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Facility</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a commitment letter with a group of institutional lenders to provide for a three-year senior unsecured term loan facility (the &#8220;Term Loan Facility&#8221;) in an aggregate principal amount of $1.0 billion. As of September&#160;30, 2020, there were no borrowings outstanding. In an event subsequent to September&#160;30, 2020, on October 23, 2020, we entered into a term loan credit agreement under the Term Loan Facility and borrowed an aggregate principal amount of $1.0&#160;billion.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan Facility contains customary representations, warranties, affirmative and negative covenants and events of default. The Term Loan Facility bears interest at 3-month LIBOR plus the Applicable Percentage as defined in the Term Loan Facility credit agreement. We may terminate or reduce the amount borrowed under the Term Loan Facility in whole or in part at any time without premium or penalty.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving Credit Facilities</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we terminated our $2.5 billion revolving credit facility maturing in May 2021 (the &#8220;2016 Revolving Credit Facility&#8221;) and entered into a new $2.5 billion revolving credit facility maturing in June 2025 (the &#8220;2020 Revolving Credit Facility&#8221;), which has terms substantially similar to the 2016 Revolving Credit Facility. The 2020 Revolving Credit Facility can be used for working capital requirements and for general corporate purposes, including, without limitation, acquisitions. As of September&#160;30, 2020 and December&#160;31, 2019, there were no amounts outstanding under these revolving credit facilities.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Revolving Credit Facility contains customary representations, warranties, affirmative and negative covenants and events of default. At September&#160;30, 2020, we were in compliance with all covenants. Loans under the 2020 Revolving Credit Facility bear interest at either (i) the Eurodollar Rate plus the Applicable Percentage, or (ii) the Base Rate plus the Applicable Percentage, each as defined in the 2020 Revolving Credit Facility agreement. We may terminate or reduce the commitments, and may prepay any loans under the new credit facility in whole or in part at any time without premium or penalty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231418776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to various legal actions. The most significant of these are described below. We recognize accruals for such actions to the extent that we conclude that a loss is both probable and reasonably estimable. We accrue for the best estimate of a loss within a range; however, if no estimate in the range is better than any other, then we accrue the minimum amount in the range. If we determine that a material loss is reasonably possible and the loss or range of loss can be estimated, we disclose the possible loss. Unless otherwise noted, it is not possible to determine the outcome of these matters or the outcome (including in excess of any accrual) is not expected to be material, and we cannot reasonably estimate the maximum potential exposure or the range of possible loss.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any material accruals for the matters described below in our Condensed Consolidated Balance Sheets as of September&#160;30, 2020 and December&#160;31, 2019. </span></div><div style="margin-bottom:5pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Related to Sofosbuvir</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, we acquired Pharmasset, Inc. Through the acquisition, we acquired sofosbuvir, a nucleotide analog that acts to inhibit the replication of the hepatitis C virus (&#8220;HCV&#8221;). In 2013, we received approval from FDA for sofosbuvir, now known commercially as Sovaldi. Sofosbuvir is also included in all of our marketed HCV products. We have received a number of litigation claims regarding sofosbuvir. While we have carefully considered these claims both prior to and following the acquisition and believe they are without merit, we cannot predict the ultimate outcome of such claims or range of loss.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are aware of patents and patent applications owned by third parties that have been or may in the future be alleged by such parties to cover the use of our HCV products. If third parties obtain valid and enforceable patents, and successfully prove infringement of those patents by our HCV products, we could be required to pay significant monetary damages. We cannot predict the ultimate outcome of intellectual property claims related to our HCV products. We have spent, and will continue to spend, significant resources defending against these claims.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Litigation with Idenix Pharmaceuticals, Inc. (&#8220;Idenix&#8221;), Universita Degli Studi di Cagliari (&#8220;UDSG&#8221;), Centre National de la Recherche Scientifique and L&#8217;Universit&#233; Montpellier II</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2013, Idenix, UDSG, Centre National de la Recherche Scientifique and L&#8217;Universit&#233; Montpellier II sued us in the U.S. District Court for the District of Delaware alleging that the commercialization of sofosbuvir infringes U.S. Patent No. 7,608,600 (the &#8220;&#8217;600 patent&#8221;). We prevailed at all phases of litigation concerning the &#8217;600 patent, and in 2018, the U.S. Supreme Court denied Idenix&#8217;s petition for certiorari. Also in 2013, Idenix and UDSG sued us in the U.S. District Court for the District of Massachusetts alleging that the commercialization of sofosbuvir infringes U.S. Patent Nos. 6,914,054 (the &#8220;&#8217;054 patent&#8221;) and 7,608,597 (the &#8220;&#8217;597 patent&#8221;). In 2014, the court transferred the Massachusetts litigation to the U.S. District Court for the District of Delaware.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to trial in 2016, Idenix committed to give us a covenant not to sue with respect to any claims arising out of the &#8217;054 patent related to sofosbuvir and withdrew that patent from the trial. A jury trial was held in 2016 on the &#8217;597 patent, and the jury found that we willfully infringed the asserted claims of the &#8217;597 patent and awarded Idenix $2.54 billion in past damages. In 2018, the judge invalidated Idenix&#8217;s &#8217;597 patent and vacated the jury&#8217;s award of $2.54 billion in past damages. Idenix appealed this decision to the U.S. Court of Appeals for the Federal Circuit (&#8220;CAFC&#8221;), and in October 2019, the CAFC issued an opinion affirming the trial court&#8217;s decision that the &#8217;597 patent is invalid. In April 2020, the CAFC denied Idenix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s petition for rehearing en banc. Idenix has sought review by the U.S. Supreme Court. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Litigation with the University of Minnesota</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The University of Minnesota (the &#8220;University&#8221;) has obtained U.S. Patent No. 8,815,830 (the &#8220;&#8217;830 patent&#8221;), which purports to broadly cover nucleosides with antiviral and anticancer activity.&#160;In 2016, the University filed a lawsuit against us in the U.S. District Court for the District of Minnesota, alleging that the commercialization of sofosbuvir-containing products infringes the &#8217;830 patent.&#160;We believe the &#8217;830 patent is invalid and will not be infringed by the continued commercialization of sofosbuvir. In 2017, the court granted our motion to transfer the case to California. We have also filed petitions for inter partes review with the U.S. Patent and Trademark Office Patent Trial and Appeal Board (&#8220;PTAB&#8221;) alleging that all asserted claims are invalid for anticipation and obviousness, and the PTAB instituted one of these petitions. In 2018, the U.S. District Court for the Northern District of California stayed the litigation until after the PTAB concludes the inter partes review that it has initiated, which we expect will occur by 2021.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Related to Axicabtagene Ciloleucel</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own patents and patent applications that protect our axicabtagene ciloleucel chimeric DNA segments. Third parties may have, or may obtain rights to, patents that could allegedly be used to prevent or attempt to prevent us from commercializing axicabtagene ciloleucel or to require us to obtain a license in order to commercialize axicabtagene ciloleucel. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno Therapeutics, Inc. and Sloan Kettering Cancer Center (collectively, &#8220;Juno&#8221;) filed a lawsuit against us in the U.S. District Court for the Central District of California, alleging that the commercialization of axicabtagene ciloleucel, sold commercially as Yescarta, infringes on U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 patent&#8221;). A jury trial was held on the &#8217;190 patent, and in December 2019, the jury found that the asserted claims of the &#8217;190 patent were valid, and that we willfully infringed the asserted claims of the &#8217;190 patent. The jury also awarded Juno damages in amounts of $585 million in an up-front payment and a 27.6% running royalty from October 2017 through the date of the jury&#8217;s verdict. The parties filed post-trial motions in the first quarter of 2020, and the trial judge entered a judgment in April 2020. The trial judge affirmed the jury&#8217;s verdict, enhanced the past damages by 50% and maintained the royalties on future Yescarta sales at 27.6%.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing whether we should accrue a liability for this litigation in our consolidated financial statements, we considered various factors, including the legal and factual circumstances of the case, the jury&#8217;s verdict, the district court&#8217;s pre- and post-trial orders, the current status of the proceedings, applicable law, the views of legal counsel and the likelihood that the judgment will be upheld on appeal. As a result of this review, we have determined, in accordance with applicable accounting standards, that it is not probable that we will incur a material loss as a result of this litigation. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the judgment is reversed on appeal, the loss is expected to be zero. If the judgment is upheld in its entirety on appeal, we estimate a loss through the third quarter of 2020 to be approximately $1.3&#160;billion, which consists of (i) approximately $811 million, which represents damages on Yescarta revenues through December 12, 2019, and prejudgment interest thereon, (ii) approximately $389 million, which represents a 50% enhancement of past damages and (iii) approximately $128 million for royalties and prejudgment interest on Yescarta revenues from December 13, 2019 to September&#160;30, 2020. Although we cannot predict with certainty the ultimate outcome of this litigation on appeal, we believe the jury&#8217;s verdict and the judgment to be in error. In April 2020, we filed an appeal seeking to reverse the judgment or obtain a new trial due to errors made by the trial judge.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Related to Bictegravir</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, ViiV Healthcare Company (&#8220;ViiV&#8221;) filed a lawsuit against us in the U.S. District Court of Delaware, alleging that the commercialization of bictegravir, sold commercially in combination with tenofovir alafenamide and emtricitabine as Biktarvy, infringes ViiV&#8217;s U.S. Patent No. 8,129,385 (the &#8220;&#8217;385 patent&#8221;) covering ViiV&#8217;s dolutegravir. Bictegravir is structurally different from dolutegravir, and we believe that bictegravir does not infringe the sole asserted claim of the &#8217;385 patent. The court has set a trial date of March 2021 for this lawsuit.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, ViiV also filed a lawsuit against us in the Federal Court of Canada, alleging that our activities relating to our bictegravir compound have infringed ViiV&#8217;s Canadian Patent No. 2,606,282 (the &#8220;&#8217;282 patent&#8221;), which was issued to Shionogi &amp; Co. Ltd. and ViiV. The &#8217;282 patent is the compound patent covering ViiV&#8217;s dolutegravir. We believe that bictegravir does not infringe the claims of the &#8217;282 patent. In January 2020, the court held a summary trial to assess ViiV&#8217;s infringement allegations. In April 2020, the court determined that bictegravir does not infringe the claims of the &#8217;282 patent and dismissed the case. ViiV has appealed this decision.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November and December 2019, ViiV filed lawsuits in France, Germany, Ireland and the UK asserting the relevant national designations of European Patent No. 3 045 206 (&#8220;EP &#8217;206&#8221;); in Australia asserting Australian Patent No. 2006239177; in Japan asserting Japanese Patent No. 4295353; and in Korea asserting Korean Patent Nos. 1848819 and 1363875. These patents all relate to molecules which ViiV claims would act as integrase inhibitors. We believe that bictegravir does not infringe the claims of any of ViiV&#8217;s patents. In 2019, we filed an opposition in the European Patent Office (&#8220;EPO&#8221;) requesting revocation of EP &#8217;206. The EPO hearing is scheduled for 2021. In all jurisdictions, to the extent that the claims of ViiV&#8217;s patents are interpreted to cover bictegravir, we believe that those claims are invalid. We cannot predict the ultimate outcome of intellectual property claims related to bictegravir. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Relating to Pre-Exposure Prophylaxis</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we filed petitions requesting inter partes review of U.S. Patent Nos. 9,044,509, 9,579,333, 9,937,191 and 10,335,423 (collectively, &#8220;HHS Patents&#8221;) by PTAB. The HHS Patents are assigned to the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) and purport to claim a process of protecting a primate host from infection by an immunodeficiency retrovirus by administering a combination of emtricitabine and tenofovir or TDF prior to exposure of the host to the immunodeficiency retrovirus, a process commonly known as pre-exposure prophylaxis (&#8220;PrEP&#8221;). In November 2019, the U.S. Department of Justice filed a lawsuit against us in the U.S. District Court of Delaware, alleging that the sale of Truvada and Descovy for use as PrEP infringes the HHS Patents. In February 2020, PTAB declined to institute our petitions for inter partes review of the HHS Patents. In April 2020, we filed a breach of contract lawsuit against the U.S. federal government in the Court of Federal Claims, alleging violations of four material transfer agreements (&#8220;MTAs&#8221;) related to the research underlying the HHS Patents and a clinical trial agreement (&#8220;CTA&#8221;) by the U.S. Centers for Disease Control and Prevention related to PrEP research. Although we cannot predict with certainty the ultimate outcome of these litigation matters, we believe that the U.S. federal government breached the MTAs and CTA, that Truvada and Descovy do not infringe the HHS Patents and that the HHS Patents are invalid over prior art descriptions of Truvada&#8217;s use for PrEP and post-exposure prophylaxis as well because physicians and patients were using the claimed methods years before HHS filed the applications for the patents. A trial date for the lawsuit in the District Court of Delaware has been set for May 2023.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation with Generic Manufacturers</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the approval process for some of our products, FDA granted us a New Chemical Entity (&#8220;NCE&#8221;) exclusivity period during which other manufacturers&#8217; applications for approval of generic versions of our product will not be approved. Generic manufacturers may challenge the patents protecting products that have been granted NCE exclusivity one year prior to the end of the NCE exclusivity period. Generic manufacturers have sought and may continue to seek FDA approval for a similar or identical drug through an abbreviated new drug application (&#8220;ANDA&#8221;), the application form typically used by manufacturers seeking approval of a generic drug. The sale of generic versions of our products earlier than their patent expiration would have a significant negative effect on our revenues and results of operations. To seek approval for a generic version of a product having NCE status, a generic company may submit its ANDA to FDA four years after the branded product&#8217;s approval.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting in December 2019, we received letters from Lupin Ltd., Apotex Inc., Shilpa Medicare Ltd., Sunshine Lake Pharma Co. Ltd., Laurus Labs, Natco Pharma Ltd., Macleods Pharma Ltd., Hetero Labs Ltd. and Cipla Ltd. (collectively, &#8220;generic manufacturers&#8221;) indicating that they have submitted ANDAs to FDA requesting permission to market and manufacture generic versions of certain of our tenofovir alafenamide (&#8220;TAF&#8221;)-containing products. Between them, these generic manufacturers seek to market generic versions of Odefsey, Descovy and Vemlidy. Some generic manufacturers have challenged the validity of four patents listed on the Orange Book and associated with TAF, while others have challenged the validity of two of our Orange Book-listed patents associated with TAF. We filed lawsuits against the generic manufacturers, and we intend to enforce and defend our intellectual property.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Patent Claims</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, several parties filed oppositions in the EPO requesting revocation of one of our granted European patents covering sofosbuvir that expires in 2028. In 2016, the EPO upheld the validity of certain claims of our sofosbuvir patent. We have appealed this decision, seeking to restore all of the original claims, and several of the original opposing parties have also appealed, requesting full revocation. The appeal hearing is scheduled for July 2021.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, several parties filed oppositions in the EPO requesting revocation of our granted European patent relating to sofosbuvir that expires in 2024. The EPO conducted an oral hearing for this opposition in 2018 and upheld the claims. Two of the original opposing parties have appealed, requesting full revocation. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, several parties filed oppositions in the EPO requesting revocation of our granted European patent covering TAF that expires in 2026. In 2017, the EPO upheld the validity of the claims of our TAF patent. Three parties have appealed this decision. The appeal hearing is scheduled for March 2021.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, several parties filed oppositions in the EPO requesting revocation of our granted European patent relating to TAF hemifumarate that expires in 2032. In 2019, the EPO upheld the validity of the claims of our TAF hemifumarate patent. Three parties have appealed this decision. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, three parties filed oppositions in the EPO requesting revocation of our granted European patent covering cobicistat that expires in 2027. In 2017, the EPO upheld the validity of the claims of our cobicistat patent. Two parties have appealed this decision. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The appeal process may take several years for all EPO opposition proceedings. While we are confident in the strength of our patents, we cannot predict the ultimate outcome of these oppositions. If we are unsuccessful in defending these oppositions, some or all of our patent claims may be narrowed or revoked and the patent protection for sofosbuvir, TAF, TAF hemifumarate and cobicistat in the European Union could be substantially shortened or eliminated entirely. If our patents are revoked, and no other European patents are granted covering these compounds, our exclusivity may be based entirely on regulatory exclusivity granted by the European Medicines Agency. If we lose patent protection for any of these compounds, our revenues and results of operations could be negatively impacted for the years including and succeeding the year in which such exclusivity is lost.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Investigations and Related Litigation</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2011, we received a subpoena from the U.S. Attorney&#8217;s Office for the Northern District of California requesting documents related to the manufacture, quality and distribution practices of Complera, Atripla, Truvada, Viread, Emtriva, Hepsera and Letairis. We cooperated with the government&#8217;s inquiry. In 2014, the U.S. Department of Justice informed us that it had declined to intervene in a False Claims Act lawsuit filed by two former employees. In 2019, the District Court granted the Department of Justice&#8217;s motion to dismiss plaintiffs&#8217; federal claims. In April 2020, plaintiffs refiled their California False Claims Act and California retaliation claims in the Superior Court of California, County of San Mateo. In July 2020, the California Attorney General declined to intervene in the case, and the state court complaint was unsealed. In September 2020, we filed a demurrer requesting that the Superior Court dismiss plaintiffs&#8217; claims, and we expect the court to rule on our demurrer before the end of the year. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit and we intend to vigorously defend against it.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, we received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts requesting documents related to our support of 501(c)(3) organizations that provide financial assistance to patients and documents concerning our provision of financial assistance to patients for our HCV products. In 2020, the matter was resolved through settlement. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts requesting documents related to our copay coupon program and Medicaid price reporting methodology. We cooperated with this inquiry, and in July 2020, the government notified us that it was closed.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we received a voluntary request for information from the U.S. Attorney&#8217;s Office for the Eastern District of Pennsylvania requesting information related to our reimbursement support offerings, clinical education programs and interactions with specialty pharmacies for Sovaldi and Harvoni. In 2018, we received another voluntary request for information related to our speaker programs and advisory boards for our HCV and hepatitis B virus (&#8220;HBV&#8221;) products. We cooperated with these voluntary requests. In October 2019, the government informed us that, following an investigation, it declined to intervene in two False Claims Act lawsuits against us relating to HCV reimbursement support and clinical education programs and hepatitis B speaker programs and advisory boards, respectively. Notwithstanding the government&#8217;s declination, two plaintiffs have continued to pursue the lawsuit relating to HBV speaker programs and advisory boards and served us with the Second Amended Complaint in November 2019. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit and we intend to vigorously defend against it.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we received a subpoena from the California Department of Insurance and the Alameda County District Attorney&#8217;s Office requesting documents related to our marketing activities, reimbursement support offerings, clinical education programs and interactions with specialty pharmacies for Harvoni and Sovaldi.&#160;In August 2020, we were informed that the government had closed this matter.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we also received a subpoena from the U.S. Attorney&#8217;s Office for the Southern District of New York requesting documents related to our promotional speaker programs for HIV. We are cooperating with this inquiry.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, Health Choice Advocates, LLC (&#8220;Health Choice Advocates&#8221;) filed a qui tam lawsuit against us under seal in New Jersey state court alleging violations of the New Jersey False Claims Act through our clinical education programs for Sovaldi and Harvoni and our HCV and HIV patient access programs. In July 2020, the New Jersey Attorney General&#8217;s Office declined to intervene in the lawsuit and the complaint was unsealed. In May 2020, Health Choice Advocates filed a qui tam lawsuit under seal against us in Texas state court making similar allegations. In October 2020, the Texas Attorney General&#8217;s Office declined to intervene in the lawsuit and the complaint was unsealed. Health Choice Advocates previously filed a lawsuit making similar allegations in federal court in the Eastern District of Texas in June 2017 and the court entered an order dismissing that matter without prejudice in July 2018. Although we cannot predict the ultimate outcome of this lawsuit, we believe the action is without merit.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been named as a defendant in two class action lawsuits and various product liability lawsuits related to Viread, Truvada, Atripla, Complera and Stribild.&#160;Plaintiffs allege that Viread, Truvada, Atripla, Complera and/or Stribild caused them to experience kidney, bone and/or tooth injuries. The lawsuits, which are pending in state or federal court in California, Delaware, Florida, New Jersey and Missouri, involve more than 19,000 plaintiffs.&#160;Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. We intend to vigorously defend ourselves in these actions. While we believe these cases are without merit, we cannot predict the ultimate outcome. If plaintiffs are successful in their claims, we could be required to pay significant monetary damages.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Antitrust and Consumer Protection</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We (along with Japan Tobacco Inc. (&#8220;Japan Tobacco&#8221;), Bristol-Myers Squibb Company and Johnson &amp; Johnson, Inc.) have been named as defendants in class action lawsuits filed in 2019 and 2020 related to various drugs used to treat HIV, including drugs used in combination antiretroviral therapy.&#160;Japan Tobacco was dismissed from the lawsuit after a favorable court ruling on the defendants&#8217; motion to dismiss. Plaintiffs allege that we (and the other remaining defendants) engaged in various conduct to restrain competition in violation of federal and state antitrust laws and state consumer protection laws.&#160;The lawsuits, which have been or may be consolidated, are all pending in the U.S. District Court for the Northern District of California. The lawsuits seek to bring claims on behalf of two nationwide classes - one of direct purchasers consisting largely of wholesales, and another of end-payor purchasers, including health insurers and individual patients.&#160;Plaintiffs seek damages, permanent injunctive relief and other relief.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we along with generic manufacturers Cipla Ltd. and Cipla USA Inc. (&#8220;Cipla&#8221;) were named as defendants in a class action lawsuit filed by Jacksonville Police Officers and Fire Fighters Health Insurance Trust (&#8220;Jacksonville Trust&#8221;) on behalf of end-payor purchasers. Jacksonville Trust claims that the 2014 settlement agreement between us and Cipla, which settled a patent dispute relating to patents covering our Emtriva, Truvada, and Atripla products and permitted generic entry prior to patent expiry, violates certain federal and state antitrust and consumer protection laws.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe these cases are without merit, we cannot predict the ultimate outcome.&#160;If plaintiffs are successful in their claims, we could be required to pay significant monetary damages or could be subject to permanent injunctive relief awarded in favor of plaintiffs.&#160;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to various legal actions that arose in the ordinary course of our business. We do not believe that these other legal actions will have a material adverse impact on our consolidated business, financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575320395752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2016, our Board of Directors authorized a $12.0 billion stock repurchase program (&#8220;2016 Program&#8221;) under which repurchases may be made in the open market or in privately negotiated transactions. We started repurchases under the 2016 Program in April 2016. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, our Board of Directors authorized a new $5.0 billion&#160;stock repurchase program (&#8220;2020 Program&#8221;), which will commence upon the completion of the&#160;2016 Program. Purchases under the 2020 Program may be made in the open market or in privately negotiated transactions.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2020, we repurchased and retired 3 million and 22 million shares of our common stock for $201 million and $1.6 billion, respectively, through open market transactions under the 2016 Program. During the three and nine months ended September 30, 2019, we repurchased and retired 3 million and 25 million shares of our common stock for $223 million and $1.6 billion, respectively, through open market transactions under the 2016 Program. As of September&#160;30, 2020, the remaining authorized repurchase amount under both programs was $6.8 billion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in AOCI by component, net of tax (in millions):</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:11pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts reclassified to net income for gains and losses on cash flow hedges are recorded as part of Product sales on our Condensed Consolidated Statements of Operations. See Note 5. Derivative Financial Instruments for additional information. The amounts reclassified to net income for gains and losses on available-for-sale debt securities are recorded as part of Other income (expense), net on our Condensed Consolidated Statements of Operations. Gross realized gains and losses on available-for-sale debt securities were not material for the nine months ended September 30, 2020 and 2019. The income tax impact allocated to each component of other comprehensive income (loss) was not material for the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229901144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share Attributable to Gilead Common Stockholders</a></td>
<td class="text">NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO GILEAD COMMON STOCKHOLDERS<div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share attributable to Gilead common stockholders is calculated based on the weighted average number of shares of our common stock outstanding during the period. Diluted net income (loss) per share attributable to Gilead common stockholders is calculated based on the weighted average number of shares of our common stock and other dilutive securities outstanding during the period. The potentially dilutive shares of our common stock resulting from the assumed exercise of outstanding stock options and equivalents were determined under the treasury stock metho</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential shares of common stock excluded from the computation of diluted net income (loss) per share attributable to Gilead common stockholders because their effect would have been antidilutive were 13 million and 38 million for the three and nine months ended September 30, 2020, respectively, and 40 million and 14 million, for the three and nine months ended September 30, 2019, respectively.</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the calculation of basic and diluted net income (loss) per share attributable to Gilead common stockholders (in millions, except per share amounts):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575332200040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES <div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our income tax expense (benefit) (in millions, except percentages):</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.822%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,501)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of 57.2% for the three months ended September 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to $511 million of certain acquired IPR&amp;D charges and $923 million of unfavorable changes in the fair value of our equity investments in Galapagos that are non-deductible for income tax purposes. The three months ended September 30, 2020 also included a $91 million net discrete tax benefit related to a settlement with a taxing authority. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of (903.4)% for the nine months ended September 30, 2020 differed from the U.S. federal statutory rate of 21%, primarily due to a non-deductible $4.5 billion IPR&amp;D charge recorded in connection with our acquisition of Forty Seven, in addition to the above mentioned amounts for the three months ended September 30, 2020. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of 22.2% for the three months ended September 30, 2019 differed from the U.S. federal statutory rate of 21% primarily due to the Global Intangible Low-Taxed Income (&#8220;GILTI&#8221;) tax, state taxes and our portion of the non-deductible branded prescription drug (&#8220;BPD&#8221;) fee, partially offset by research tax credits and earnings from non-U.S. subsidiaries that operate in jurisdictions with lower tax rates than the United States.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate of 17.9% for the nine months ended September 30, 2019 differed from the U.S. federal statutory rate of 21% primarily due to a $119 million tax benefit related to settlements with taxing authorities, research tax credits and earnings from non-U.S. subsidiaries that operate in jurisdictions with lower tax rates than the United States, partially offset by the GILTI tax, state taxes and our portion of the non-deductible BPD fee.</span></div>We are currently under examination by the U.S. Internal Revenue Service for the tax years from 2013 to 2015 and by various state and foreign jurisdictions. There are differing interpretations of tax laws and regulations, and as a result, significant disputes may arise with these tax authorities involving issues of the timing and amount of deductions and allocations of income among various tax jurisdictions. We regularly evaluate our exposures associated with our tax filing positions to determine our assessment of unrecognized tax benefits in accordance with the income tax guidance which clarifies the accounting for uncertainty in income taxes.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238373688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. The financial statements include all adjustments consisting of normal recurring adjustments that the management of Gilead Sciences, Inc. (&#8220;Gilead&#8221;, &#8220;we&#8221;, &#8220;our&#8221; or &#8220;us&#8221;) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period.</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of Gilead, our wholly-owned subsidiaries and certain variable interest entities for which we are the primary beneficiary. All intercompany transactions have been eliminated. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interest in our Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess whether we are the primary beneficiary of a variable interest entity (&#8220;VIE&#8221;) at the inception of the arrangement and at each reporting date. This assessment is based on our power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and our obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. </span></div>The accompanying Condensed Consolidated Financial Statements and related Notes to Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December&#160;31, 2019, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information We have one operating segment, which focuses on the discovery, development and commercialization of innovative medicines in areas of unmet medical need. Our Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision-maker, manages and allocates resources to the operations of our company on an entity-wide basis. Managing and allocating resources on an entity-wide basis enables our CEO to assess the overall level of resources available and how to best deploy these resources across functions and research and development (&#8220;R&amp;D&#8221;) projects based on unmet medical need and, as necessary, reallocate resources among our internal R&amp;D portfolio and external opportunities to best support the long-term growth of our business.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Significant Accounting Policies, Estimates and Judgments</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies, Estimates and Judgments</span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. On an ongoing basis, we evaluate our significant accounting policies and estimates. We base our estimates on historical experience and on various market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent coronavirus disease (&#8220;COVID-19&#8221;) could have on our significant accounting estimates. Actual results could differ materially from these estimates under different assumptions or conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">ReclassificationCertain amounts for the three and nine months ended September 30, 2019 were reclassified to conform to the current period presentation. Beginning in the second quarter of 2020, acquired in-process research and development (&#8220;IPR&amp;D&#8221;) expenses are reported separately from Research and development expenses on our Condensed Consolidated Statements of Operations. Acquired IPR&amp;D expenses reflect IPR&amp;D impairments as well as the initial costs of externally developed IPR&amp;D projects, acquired directly in a transaction other than a business combination, that do not have an alternative future use, including upfront payments related to various collaborations and the initial costs of rights to IPR&amp;D projects. Our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019, has been conformed to separately present acquired IPR&amp;D expenses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Risk</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to credit risk from our portfolio of cash equivalents and marketable securities. Under our investment policy, we limit amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. We are not exposed to any significant concentrations of credit risk from our investment portfolio. The goals of our investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and a competitive after-tax rate of return. </span></div>We are also subject to credit risk from our accounts receivable related to our product sales. Trade accounts receivable are recorded net of allowances for wholesaler chargebacks related to government and other programs, cash discounts for prompt payment and credit losses. Estimates of our allowance for credit losses consider a number of factors including existing contractual payment terms, individual customer circumstances, historical payment patterns of our customers, a review of the local economic environment and its potential impact on expected future customer payment patterns and government funding and reimbursement practices.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016,&#160;the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2016-13 &#8220;Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments&#8221; and has since modified the standard with several ASUs (collectively, &#8220;Topic 326&#8221;).&#160;Topic 326 requires measurement and recognition of expected credit losses for financial assets. On January 1, 2020, we adopted this standard using a modified retrospective approach.&#160;The adoption did not have a material impact on our Condensed Consolidated Financial Statements. In connection with the adoption of Topic 326, we made an accounting policy election to not measure an allowance for credit losses for accrued interest receivable. </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018,&#160;the FASB issued Accounting Standards Update No. 2018-18 &#8220;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#8221; (&#8220;ASU 2018-18&#8221;).&#160;ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606, &#8220;Revenue from Contracts with Customers&#8221; when the counterparty is a customer. In addition, the update precludes an entity from presenting consideration from a transaction in a collaborative arrangement as customer revenue if the counterparty is not a customer for that transaction. On January 1, 2020, we adopted this standard and applied it retrospectively to January 1, 2018 when we initially adopted Topic 606. The adoption did not have an impact on our Condensed Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of financial and non-financial assets and liabilities using the fair value hierarchy, which establishes three levels of inputs that may be used to measure fair value, as follows:</span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 1 inputs include quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 2 inputs include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For our marketable securities, we review trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and </span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Level 3 inputs include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Our Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. </span></div>Our financial instruments consist primarily of cash and cash equivalents, marketable debt securities, accounts receivable, foreign currency exchange contracts, equity securities, accounts payable and short-term and long-term debt. Cash and cash equivalents, marketable debt securities, certain equity securities and foreign currency exchange contracts are reported at their respective fair values in our Condensed Consolidated Balance Sheets. Equity securities without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. Short-term and long-term debt are reported at their amortized costs in our Condensed Consolidated Balance Sheets. The remaining financial instruments are reported in our Condensed Consolidated Balance Sheets at amounts that approximate current fair values.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231333400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenues</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates our product sales by product and geographic region and disaggregates our royalty, contract and other revenues by geographic region (in millions):</span></div><div style="margin-bottom:8pt;margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Atripla</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biktarvy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complera/Eviplera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Descovy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genvoya</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Odefsey</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stribild</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Truvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other HIV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue share &#8211; Symtuza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmBisome</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ledipasvir/Sofosbuvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letairis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ranexa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sofosbuvir/Velpatasvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vemlidy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viread</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vosevi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yescarta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydelig</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,219&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Locations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Atripla</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Biktarvy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complera/Eviplera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Descovy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genvoya</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Odefsey</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stribild</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Truvada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other HIV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue share &#8211; Symtuza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmBisome</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ledipasvir/Sofosbuvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letairis</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ranexa</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sofosbuvir/Velpatasvir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Veklury</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vemlidy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viread</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vosevi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yescarta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zydelig</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty, contract and other revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,908&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.408%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Emtriva and Tybost.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents our revenue from cobicistat (C), emtricitabine (FTC) and tenofovir alafenamide (TAF) in Symtuza (darunavir/C/FTC/TAF), a fixed dose combination product commercialized by Janssen Sciences Ireland UC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Harvoni and the authorized generic version of Harvoni sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by our separate subsidiary, Asegua Therapeutics LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes Cayston, Hepsera, Sovaldi and Tecartus. Europe product sales included unfavorable adjustments recorded in 2019 for statutory rebates related to sales of Sovaldi made in prior years.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Revenues from Major Customers</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmerisourceBergen Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229858168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of assets and liabilities measured at fair value</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.660%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment in Galapagos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other publicly traded equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 15.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency derivative contracts </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency derivative contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Summary of classification of equity securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of our equity securities in our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:11pt;margin-top:9.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,039&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238818792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale Debt Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Reconciliation of Available-for-Sale Debt Securities from Cost Basis to Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage and asset-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Classification of Available-for-Sale Debt Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of Available-for-Sale Debt Securities by Contractual Maturity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in millions): </span></div><div style="margin-bottom:6pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized&#160;Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within one year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Summary of Available-for-Sale Debt Securities in a Continuous Loss Position</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in millions):</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#acacac;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118942371&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239752040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Summary of classification and fair value of derivative instruments</a></td>
<td class="text">The following table summarizes the classification and fair values of derivative instruments in our Condensed Consolidated Balance Sheets (in millions):<div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:33.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;accrued&#160;liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.338%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;accrued&#160;liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other&#160;current&#160;assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of effect of foreign currency exchange contracts</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of our foreign currency exchange contracts on our Condensed Consolidated Financial Statements (in millions): </span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) recognized in AOCI </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains reclassified from AOCI into product sales</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) recognized in Other income (expense), net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Summary of potential effect of offsetting derivatives</a></td>
<td class="text">The following table summarizes the potential effect of offsetting our foreign currency exchange contracts on our Condensed Consolidated Balance Sheets (in millions):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.899%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts Not Offset <br/>on our Condensed <br/>Consolidated Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts<br/> of Recognized <br/>Assets/Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Gross Amounts<br/> Offset on our <br/>Condensed <br/>Consolidated <br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amounts of Assets/Liabilities Presented<br/> on our Condensed Consolidated<br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Derivative <br/>Financial <br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash Collateral <br/>Received/<br/>Pledged</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net Amount<br/> (Legal Offset)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">As of September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%;text-decoration:underline">As of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229788728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_OtherFinancialInformationAbstract', window );"><strong>Other Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our Inventories (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:0.1%"/><td style="width:2.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.344%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">________________________________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amounts primarily consist of raw materials.</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of Other accrued liabilities (in millions):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,074&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_OtherFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Financial Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_OtherFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239834296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our intangible assets, net (in millions): </span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finite-lived assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - sofosbuvir</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - axicabtagene ciloleucel</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,312)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,809&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,468)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived assets - IPR&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,312)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,468)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our intangible assets, net (in millions): </span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross&#160;<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finite-lived assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - sofosbuvir</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset - axicabtagene ciloleucel</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finite-lived assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,312)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,809&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,468)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived assets - IPR&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,312)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,468)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Future Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of September&#160;30, 2020 (in millions):</span></div><div style="margin-bottom:5pt;margin-top:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:86.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,809&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231362024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Debt Carrying Amount</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our borrowings under our senior unsecured notes (in millions):</span></div><div style="margin-bottom:11pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.55%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-month LIBOR + 0.15%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-month LIBOR + 0.52%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.70%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.60%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2041</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2045</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2046</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2047</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2050</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,290&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,593&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt 2px 42pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231384600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of Changes in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in AOCI by component, net of tax (in millions):</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:11pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications to net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231166520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of the Calculation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the calculation of basic and diluted net income (loss) per share attributable to Gilead common stockholders (in millions, except per share amounts):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Gilead common stockholders - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231219928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of the Provision for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our income tax expense (benefit) (in millions, except percentages):</span></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.822%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,501)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231977032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies Additional Details (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">$ 47,000,000<span></span>
</td>
<td class="nump">$ 47,000,000<span></span>
</td>
<td class="nump">$ 47,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs charged against allowance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575226178232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Disaggregation of Revenues (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 6,577<span></span>
</td>
<td class="nump">$ 5,604<span></span>
</td>
<td class="nump">$ 17,268<span></span>
</td>
<td class="nump">$ 16,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">5,100<span></span>
</td>
<td class="nump">4,219<span></span>
</td>
<td class="nump">12,890<span></span>
</td>
<td class="nump">12,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">937<span></span>
</td>
<td class="nump">871<span></span>
</td>
<td class="nump">2,698<span></span>
</td>
<td class="nump">2,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=gild_OtherInternationalMember', window );">Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">514<span></span>
</td>
<td class="nump">1,680<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsAtriplaMember', window );">Atripla</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsAtriplaMember', window );">Atripla | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsAtriplaMember', window );">Atripla | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsAtriplaMember', window );">Atripla | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsBiktarvyMember', window );">Biktarvy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">1,891<span></span>
</td>
<td class="nump">1,259<span></span>
</td>
<td class="nump">5,188<span></span>
</td>
<td class="nump">3,168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsBiktarvyMember', window );">Biktarvy | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">4,346<span></span>
</td>
<td class="nump">2,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsBiktarvyMember', window );">Biktarvy | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">528<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsBiktarvyMember', window );">Biktarvy | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsCompleraEvipleraMember', window );">Complera/Eviplera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsCompleraEvipleraMember', window );">Complera/Eviplera | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsCompleraEvipleraMember', window );">Complera/Eviplera | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsCompleraEvipleraMember', window );">Complera/Eviplera | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsDescovyMember', window );">Descovy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">1,383<span></span>
</td>
<td class="nump">1,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsDescovyMember', window );">Descovy | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">424<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsDescovyMember', window );">Descovy | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsDescovyMember', window );">Descovy | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsGenvoyaMember', window );">Genvoya</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">846<span></span>
</td>
<td class="nump">978<span></span>
</td>
<td class="nump">2,486<span></span>
</td>
<td class="nump">2,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsGenvoyaMember', window );">Genvoya | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">761<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
<td class="nump">2,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsGenvoyaMember', window );">Genvoya | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">376<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsGenvoyaMember', window );">Genvoya | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsOdefseyMember', window );">Odefsey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">437<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsOdefseyMember', window );">Odefsey | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsOdefseyMember', window );">Odefsey | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsOdefseyMember', window );">Odefsey | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsStribildMember', window );">Stribild</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsStribildMember', window );">Stribild | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsStribildMember', window );">Stribild | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsStribildMember', window );">Stribild | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsTruvadaMember', window );">Truvada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsTruvadaMember', window );">Truvada | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="nump">1,245<span></span>
</td>
<td class="nump">1,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsTruvadaMember', window );">Truvada | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HIVProductsTruvadaMember', window );">Truvada | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsOtherHIVMember', window );">Other HIV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsOtherHIVMember', window );">Other HIV | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsOtherHIVMember', window );">Other HIV | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsOtherHIVMember', window );">Other HIV | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsRevenueShareSymtuzaMember', window );">Revenue share - Symtuza</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsRevenueShareSymtuzaMember', window );">Revenue share - Symtuza | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsRevenueShareSymtuzaMember', window );">Revenue share - Symtuza | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_ProductsRevenueShareSymtuzaMember', window );">Revenue share - Symtuza | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsAmBisomeMember', window );">AmBisome</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsAmBisomeMember', window );">AmBisome | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsAmBisomeMember', window );">AmBisome | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsAmBisomeMember', window );">AmBisome | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsLedipasvirSofosbuvirMember', window );">Ledipasvir/Sofosbuvir</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsLedipasvirSofosbuvirMember', window );">Ledipasvir/Sofosbuvir | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsLedipasvirSofosbuvirMember', window );">Ledipasvir/Sofosbuvir | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsLedipasvirSofosbuvirMember', window );">Ledipasvir/Sofosbuvir | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsLetairisMember', window );">Letairis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsLetairisMember', window );">Letairis | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsLetairisMember', window );">Letairis | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsLetairisMember', window );">Letairis | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsRanexaMember', window );">Ranexa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsRanexaMember', window );">Ranexa | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsRanexaMember', window );">Ranexa | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsRanexaMember', window );">Ranexa | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsSofosbuvirVelpatasvirMember', window );">Sofosbuvir/Velpatasvir</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsSofosbuvirVelpatasvirMember', window );">Sofosbuvir/Velpatasvir | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="nump">731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsSofosbuvirVelpatasvirMember', window );">Sofosbuvir/Velpatasvir | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsSofosbuvirVelpatasvirMember', window );">Sofosbuvir/Velpatasvir | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_COVID19ProductsVekluryMember', window );">Veklury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">873<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">873<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_COVID19ProductsVekluryMember', window );">Veklury | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">785<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">785<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_COVID19ProductsVekluryMember', window );">Veklury | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_COVID19ProductsVekluryMember', window );">Veklury | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVemlidyMember', window );">Vemlidy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVemlidyMember', window );">Vemlidy | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVemlidyMember', window );">Vemlidy | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVemlidyMember', window );">Vemlidy | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVireadMember', window );">Viread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVireadMember', window );">Viread | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVireadMember', window );">Viread | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsVireadMember', window );">Viread | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsVoseviMember', window );">Vosevi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsVoseviMember', window );">Vosevi | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsVoseviMember', window );">Vosevi | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_HCVProductsVoseviMember', window );">Vosevi | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsYescartaMember', window );">Yescarta</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsYescartaMember', window );">Yescarta | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsYescartaMember', window );">Yescarta | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsYescartaMember', window );">Yescarta | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsZydeligMember', window );">Zydelig</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsZydeligMember', window );">Zydelig | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsZydeligMember', window );">Zydelig | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsZydeligMember', window );">Zydelig | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsOtherMember', window );">Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsOtherMember', window );">Other | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">20<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_OtherProductsOtherMember', window );">Other | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">6,493<span></span>
</td>
<td class="nump">5,516<span></span>
</td>
<td class="nump">17,027<span></span>
</td>
<td class="nump">16,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">6,493<span></span>
</td>
<td class="nump">5,516<span></span>
</td>
<td class="nump">17,027<span></span>
</td>
<td class="nump">16,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product sales | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">5,076<span></span>
</td>
<td class="nump">4,199<span></span>
</td>
<td class="nump">12,835<span></span>
</td>
<td class="nump">12,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product sales | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">877<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">2,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product sales | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenues</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">1,664<span></span>
</td>
<td class="nump">1,547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember', window );">Royalty, contract and other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember', window );">Royalty, contract and other revenues | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember', window );">Royalty, contract and other revenues | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember', window );">Royalty, contract and other revenues | Other International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=gild_OtherInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=gild_OtherInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsAtriplaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsAtriplaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsBiktarvyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsBiktarvyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsCompleraEvipleraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsCompleraEvipleraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsDescovyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsDescovyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsGenvoyaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsGenvoyaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsOdefseyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsOdefseyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsStribildMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsStribildMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HIVProductsTruvadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HIVProductsTruvadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_ProductsOtherHIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_ProductsOtherHIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_ProductsRevenueShareSymtuzaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_ProductsRevenueShareSymtuzaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsAmBisomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsAmBisomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HCVProductsLedipasvirSofosbuvirMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HCVProductsLedipasvirSofosbuvirMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsLetairisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsLetairisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsRanexaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsRanexaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HCVProductsSofosbuvirVelpatasvirMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HCVProductsSofosbuvirVelpatasvirMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_COVID19ProductsVekluryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_COVID19ProductsVekluryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsVemlidyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsVemlidyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsVireadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsVireadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_HCVProductsVoseviMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_HCVProductsVoseviMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsYescartaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsYescartaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsZydeligMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsZydeligMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_OtherProductsOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_OtherProductsOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gild_RoyaltyContractAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238926904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Revenues from Major Customers (Details) - Revenue Benchmark - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=gild_AmerisourcebergenCorpMember', window );">AmerisourceBergen Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=gild_CardinalHealthIncMember', window );">Cardinal Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=gild_MckessonCorpMember', window );">McKesson Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=gild_AmerisourcebergenCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=gild_AmerisourcebergenCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=gild_CardinalHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=gild_CardinalHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=gild_MckessonCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=gild_MckessonCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575240356920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods', window );">Revenues recognized from performance obligations satisfied in prior periods</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
<td class="nump">$ 618<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with customer, performance obligation satisfied in previous period</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues recognized from performance obligations satisfied in previous periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575232810936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements Summary of Assets and Liabilities Measured at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">$ 13,399<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">28,015<span></span>
</td>
<td class="nump">27,576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2,238<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | U.S. government agencies securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Non-U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">7,525<span></span>
</td>
<td class="nump">9,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Residential mortgage and asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Equity investment in Galapagos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">2,361<span></span>
</td>
<td class="nump">3,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">11,430<span></span>
</td>
<td class="nump">7,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Other publicly traded equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">619<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Deferred compensation plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Deferred compensation plan</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Foreign currency derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">16,848<span></span>
</td>
<td class="nump">13,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2,238<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | U.S. government agencies securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Non-U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Residential mortgage and asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Equity investment in Galapagos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">2,361<span></span>
</td>
<td class="nump">3,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">11,430<span></span>
</td>
<td class="nump">7,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Other publicly traded equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">619<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Deferred compensation plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Deferred compensation plan</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 1 | Foreign currency derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">11,167<span></span>
</td>
<td class="nump">14,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | U.S. government agencies securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Non-U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">7,525<span></span>
</td>
<td class="nump">9,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Residential mortgage and asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Equity investment in Galapagos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Other publicly traded equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Deferred compensation plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Deferred compensation plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Foreign currency derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | U.S. government agencies securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Non-U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Residential mortgage and asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Equity investment in Galapagos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Other publicly traded equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Deferred compensation plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Deferred compensation plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 3 | Foreign currency derivative contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency derivative contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=gild_ResidentialMortgageAndAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=gild_ResidentialMortgageAndAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=gild_EquityinvestmentinGalapagosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=gild_EquityinvestmentinGalapagosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=gild_DeferredCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=gild_DeferredCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=gild_ForeignCurrencyDerivativeContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=gild_ForeignCurrencyDerivativeContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575233122568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Net unrealized loss on investment of equity securities</a></td>
<td class="nump">$ 964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Net unrealized gain on investment of equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Short-term and long-term debt</a></td>
<td class="nump">29,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Market value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Short-term and long-term debt</a></td>
<td class="nump">33,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Short-term and long-term debt</a></td>
<td class="nump">$ 29,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239286344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements Summary of Classification of Equity Securities (Details) - Other Equity Securities - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 14,610<span></span>
</td>
<td class="nump">$ 11,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=gild_OtherEquitySecuritiesMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">11,430<span></span>
</td>
<td class="nump">7,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=gild_OtherEquitySecuritiesMember', window );">Prepaid and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">986<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=gild_OtherEquitySecuritiesMember', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">$ 2,194<span></span>
</td>
<td class="nump">$ 3,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=gild_OtherEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=gild_OtherEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575235488216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities at Estimated Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">$ 13,365<span></span>
</td>
<td class="nump">$ 16,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value&#160;</a></td>
<td class="nump">13,399<span></span>
</td>
<td class="nump">16,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">2,225<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value&#160;</a></td>
<td class="nump">2,238<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value&#160;</a></td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agencies securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value&#160;</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Non-U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value&#160;</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">7,506<span></span>
</td>
<td class="nump">9,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value&#160;</a></td>
<td class="nump">7,525<span></span>
</td>
<td class="nump">9,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gild_ResidentialMortgageAndAssetBackedSecuritiesMember', window );">Residential mortgage and asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">1,207<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value&#160;</a></td>
<td class="nump">$ 1,209<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gild_ResidentialMortgageAndAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gild_ResidentialMortgageAndAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239621304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale Debt Securities - Summary of the Balance Sheet Classification of Available-for-Sale Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">$ 13,399<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=gild_MarketableSecuritiesCurrentMember', window );">Short-term marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">11,089<span></span>
</td>
<td class="nump">12,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=gild_MarketableSecuritiesNoncurrentMember', window );">Long-term marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">$ 2,074<span></span>
</td>
<td class="nump">$ 1,488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=gild_MarketableSecuritiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=gild_MarketableSecuritiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=gild_MarketableSecuritiesNoncurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=gild_MarketableSecuritiesNoncurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238670296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale Debt Securities - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Accrued interest receivable</a></td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_Writeoffsinaccruedinterestreceivable', window );">Write-offs of accrued interest receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions held in an unrealized loss position | position</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale', window );">Impairment recognized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_Writeoffsinaccruedinterestreceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off in accrued interest receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_Writeoffsinaccruedinterestreceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575240353896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities by Contractual Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized&#160;Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Within one year</a></td>
<td class="nump">$ 11,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">After one year through five years</a></td>
<td class="nump">1,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">After five years</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">13,365<span></span>
</td>
<td class="nump">$ 16,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Within one year</a></td>
<td class="nump">11,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">After one year through five years</a></td>
<td class="nump">1,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">After five years</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 13,399<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239919368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities in a Continuous Unrealized Loss Position (Details) - Corporate debt securities - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-Sale Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, gross unrealized losses</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, fair value</a></td>
<td class="nump">1,042<span></span>
</td>
<td class="nump">1,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or greater, gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or greater, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total gross unrealized losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total estimated fair value</a></td>
<td class="nump">$ 1,042<span></span>
</td>
<td class="nump">$ 1,870<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118942371&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118942371&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118942371&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239115864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 2,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet', window );">Discontinuances of cash flow hedges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeRemainingMaturity1', window );">Maturities of derivative instruments</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1', window );">Time estimate for gains (losses) to be reclassified from AOCI to product sales</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period for the anticipated transfer of gain (loss), net, from accumulated other comprehensive income into earnings, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeRemainingMaturity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeRemainingMaturity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gain (loss) reclassified into earnings when foreign currency cash flow hedge is discontinued because it is probable that the original forecasted transactions will not occur by the end of the original period or an additional two month time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238855640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Summary of Classification and Fair Value of Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liability, fair value</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative asset, fair value</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liability, fair value</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Prepaid and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative asset, fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other&#160;accrued&#160;liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liability, fair value</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative asset, fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other&#160;long-term&#160;obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liability, fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative asset, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liability, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Prepaid and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative asset, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other&#160;accrued&#160;liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liability, fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and elected not to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and elected not to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229606088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Summary of Effect of Foreign Currency Exchange Contracts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gains (losses) recognized in AOCI</a></td>
<td class="num">$ (52)<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gains (losses) reclassified from AOCI into product sales</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gains (losses) recognized in Other income (expense), net</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239083368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Summary of Potential Effect of Offsetting Derivatives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Derivative assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amounts of Recognized Assets/Liabilities</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Gross Amounts Offset on our Condensed Consolidated Balance Sheets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Amounts of Assets/Liabilities Presented on our Condensed Consolidated Balance Sheets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Derivative Financial Instruments</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Cash Collateral Received/ Pledged</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection', window );">Net Amount (Legal Offset)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amounts of Recognized Assets/Liabilities</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossAsset', window );">Gross Amounts Offset on our Condensed Consolidated Balance Sheets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Amounts of Assets/Liabilities Presented on our Condensed Consolidated Balance Sheets</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Derivative Financial Instruments</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Cash Collateral Received/ Pledged</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection', window );">Net Amount (Legal Offset)</a></td>
<td class="num">$ (44)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226003-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralObligationToReturnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41678-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralObligationToReturnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralRightToReclaimCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41678-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralRightToReclaimCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueGrossAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226003-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueGrossAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, deduction of liabilities not subject to a master netting arrangement and elected not to be offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against the right to receive collateral.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575221969384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Collaborations and Other Arrangements (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 24, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 25, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 17, 2020 </div>
<div>USD ($) </div>
<div>program</div>
</th>
<th class="th">
<div>Jul. 13, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 07, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 17, 2020 </div>
<div>agreement</div>
</th>
<th class="th">
<div>Jul. 13, 2020 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>agreement</div>
</th>
<th class="th">
<div>May 29, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,960<span></span>
</td>
<td class="nump">$ 5,792<span></span>
</td>
<td class="nump">$ 4,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Payments to acquire in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,804<span></span>
</td>
<td class="nump">4,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Net unrealized loss on investment of equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_ArcusBiosciencesIncMember', window );">Arcus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Equity securities owned (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent', window );">Equity securities in offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_PionyrImmunotherapeuticsIncMember', window );">Pionyr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_NumberOfAgreements', window );">Number of agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_TizonaTherapeuticsIncMember', window );">Tizona</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_NumberOfAgreements', window );">Number of agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember', window );">the &#8220;Collaboration Agreement" and the &#8220;Stock Purchase Agreements&#8221; | Arcus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember', window );">the &#8220;Collaboration Agreement" and the &#8220;Stock Purchase Agreements&#8221; | Arcus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (usd per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Equity securities owned (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent', window );">Equity securities in offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Payments to acquire in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_TotalUpfrontPaymentsMade', window );">Total upfront payments made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_InvestmentOwnedBalanceAdditionalShares', window );">Additional equity securities owned (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_IssuanceDiscountPremium', window );">Issuance discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_PaymentsForDirectTransactionalExpense', window );">Payments for direct transactional costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary', window );">Additional option fee on second anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries', window );">Additional option fee on 4th, 6th, and 8th anniversaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_CollaborativeArrangementTerm', window );">Collaborative term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementMember', window );">the &#8220;Collaboration Agreement" | Arcus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments', window );">Future maximum milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember', window );">the &#8220;Stock Purchase Agreements&#8221; | Arcus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquitySecuritiesFVNIPurchasePeriod', window );">Purchase period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased', window );">Maximum percentage of outstanding stock allowed to be purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquitySecuritiesFVNIRestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_PionyrMergerAndOptionAgreementsMember', window );">the "Pionyr Merger and Option Agreements" | Pionyr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_InvestmentOwnedBalanceAdditionalPayable', window );">Additional payable accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Estimated fair value to acquire equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquityMethodInvestmentOptionExerciseFee', window );">Option exercise fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_PotentialFutureMaximumMilestonePayments', window );">Potential future maximum milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_ResearchAndDevelopmentServiceAgreementMember', window );">Research and Development Service Agreement | Pionyr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_ResearchAndDevelopmentFutureMaximumPayments', window );">Potential maximum future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_TizonaMergerAndOptionAgreementsMember', window );">the "Tizona Merger and Option Agreements" | Tizona</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Estimated fair value to acquire equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments', window );">Option fee and potential future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_DevelopmentAgreementMember', window );">Development Agreement | Tizona</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember', window );">the &#8220;Collaboration and Stock Purchase Agreements&#8221; | Tango</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember', window );">the &#8220;Collaboration and Stock Purchase Agreements&#8221; | Tango</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Payments to acquire in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_CollaborativeArrangementTerm', window );">Collaborative term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments', window );">Opt-in, extension and milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_NumberOfPrograms', window );">Number of programs | program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_CashPaymentsMadeRelatedToEquityInvestments', window );">Cash payments made related to equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember', window );">the "Collaboration Agreement" and "Subscription Agreement" | Galapagos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (usd per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 140.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Equity securities owned (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_InvestmentOwnedBalanceAdditionalShares', window );">Additional equity securities owned (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_IssuanceDiscountPremium', window );">Issuance discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing', window );">License and option rights paid upon closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Net unrealized loss on investment of equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_GadetaBVCollaborationArrangementMember', window );">Gadeta Collaboration Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInVariableInterestEntity', window );">Noncontrolling interest in VIE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gild_OtherCollaborationArrangementsMember', window );">Other Arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements', window );">Upfront collaboration expenses related to other collaborative arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_CashPaymentsMadeRelatedToEquityInvestments', window );">Cash payments made related to equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | the "License and Stock Purchase Agreement" | Jounce</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | the "License and Stock Purchase Agreement" | Jounce</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (usd per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_TotalUpfrontPaymentsMade', window );">Total upfront payments made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_ResearchAndDevelopmentFutureMaximumPayments', window );">Potential maximum future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_CashPaymentsMadeRelatedToEquityInvestments', window );">Cash payments made related to equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Three-Year Senior Term Loan Facility | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Borrowing from senior unsecured term loan facility</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gild_ImmunomedicsIncMember', window );">Immunomedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Acquisition consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Acquisition share price (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AssetAcquisitionAxis=gild_FortySevenIncMember', window );">Forty Seven</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems', window );"><strong>Acquisition, Collaborations and Other Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AssetAcquisitionCashOutflowNetOfCashAcquired', window );">Total consideration, net of acquired cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash', window );">Assets acquired, net of cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AcquisitionCollaborationsAndOtherArrangementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition, Collaborations and Other Arrangements [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AcquisitionCollaborationsAndOtherArrangementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AssetAcquisitionCashOutflowNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition Cash Outflow Net Of Cash Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AssetAcquisitionCashOutflowNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Net of Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_CashPaymentsMadeRelatedToEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Payments Made Related to Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_CashPaymentsMadeRelatedToEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_CollaborativeArrangementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_CollaborativeArrangementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquityMethodInvestmentOptionExerciseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Option Exercise Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquityMethodInvestmentOptionExerciseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Option Fee And Potential Future Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Additional Option Fee on Fourth, Sixth, and Eighth Anniversaries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Additional Option Fee on Second Anniversary</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Future Maximum Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Percentage Of Outstanding Stock Allowed To Be Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Option Opt-in, Extension and Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquitySecuritiesFVNIPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Purchase Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquitySecuritiesFVNIPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_EquitySecuritiesFVNIRestrictionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Restriction Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_EquitySecuritiesFVNIRestrictionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_InvestmentOwnedBalanceAdditionalPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Balance, Additional Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_InvestmentOwnedBalanceAdditionalPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_InvestmentOwnedBalanceAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Balance, Additional Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_InvestmentOwnedBalanceAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_IssuanceDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance Discount (Premium)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_IssuanceDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_NumberOfAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_NumberOfAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_NumberOfPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Programs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_NumberOfPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment for license and option rights for equity investments upon closing of collaboration agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_PaymentsForDirectTransactionalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Direct Transactional Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_PaymentsForDirectTransactionalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_PotentialFutureMaximumMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Future Maximum Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_PotentialFutureMaximumMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_ResearchAndDevelopmentFutureMaximumPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Future Maximum Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_ResearchAndDevelopmentFutureMaximumPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_TotalUpfrontPaymentsMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Upfront Payments Made</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_TotalUpfrontPaymentsMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront Collaboration Expenses Related to Other Collaborative Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity securities categorized neither as held-to-maturity nor trading which are intended be sold more than one year from the balance sheet date or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117311354&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611322-123010<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-12C.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611225-123010<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611133-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_ArcusBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_ArcusBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_PionyrImmunotherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_PionyrImmunotherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_TizonaTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_TizonaTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=gild_ArcusBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=gild_ArcusBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_PionyrMergerAndOptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_PionyrMergerAndOptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_ResearchAndDevelopmentServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_ResearchAndDevelopmentServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_TizonaMergerAndOptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_TizonaMergerAndOptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_DevelopmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_DevelopmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=gild_TangoTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=gild_TangoTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_TangoTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_TangoTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_GalapagosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_GalapagosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_GadetaBVCollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_GadetaBVCollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_OtherCollaborationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_OtherCollaborationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=gild_JounceTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=gild_JounceTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_JounceTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gild_JounceTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=gild_ImmunomedicsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=gild_ImmunomedicsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AssetAcquisitionAxis=gild_FortySevenIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AssetAcquisitionAxis=gild_FortySevenIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229696632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Financial Information Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_OtherFinancialInformationAbstract', window );"><strong>Other Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 1,061<span></span>
</td>
<td class="nump">$ 1,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_InventoryNetAndInventoryNoncurrent', window );">Total</a></td>
<td class="nump">1,953<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">$ 945<span></span>
</td>
<td class="nump">$ 1,145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_InventoryNetAndInventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory Net And Inventory Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_InventoryNetAndInventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_OtherFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Financial Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_OtherFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229681080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Financial Information Other Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_OtherFinancialInformationAbstract', window );"><strong>Other Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation and employee benefits</a></td>
<td class="nump">$ 648<span></span>
</td>
<td class="nump">$ 599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">2,550<span></span>
</td>
<td class="nump">2,188<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 4,141<span></span>
</td>
<td class="nump">$ 3,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_OtherFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Financial Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_OtherFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575232364984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Summary of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, finite-lived assets</a></td>
<td class="nump">$ 18,123<span></span>
</td>
<td class="nump">$ 18,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, finite-lived assets</a></td>
<td class="num">(6,312)<span></span>
</td>
<td class="num">(5,468)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss', window );">Foreign Currency Translation Adjustment, finite-lived assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, finite-lived assets</a></td>
<td class="nump">11,809<span></span>
</td>
<td class="nump">12,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross&#160; Carrying Amount</a></td>
<td class="nump">19,253<span></span>
</td>
<td class="nump">19,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6,312)<span></span>
</td>
<td class="num">(5,468)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss', window );">Foreign Currency Translation Adjustment</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">12,939<span></span>
</td>
<td class="nump">13,786<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">Indefinite-lived assets - IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount, indefinite-lived assets</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="nump">1,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss', window );">Foreign Currency Translation Adjustment, indefinite-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Carrying Amount, indefinite-lived assets</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gild_IntangibleAssetSofosbuvirMember', window );">Intangible asset - sofosbuvir</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, finite-lived assets</a></td>
<td class="nump">10,720<span></span>
</td>
<td class="nump">10,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, finite-lived assets</a></td>
<td class="num">(4,777)<span></span>
</td>
<td class="num">(4,253)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss', window );">Foreign Currency Translation Adjustment, finite-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, finite-lived assets</a></td>
<td class="nump">5,943<span></span>
</td>
<td class="nump">6,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4,777)<span></span>
</td>
<td class="num">(4,253)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gild_AxicabtageneciloleucelDLBCLMember', window );">Intangible asset - axicabtagene ciloleucel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, finite-lived assets</a></td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, finite-lived assets</a></td>
<td class="num">(1,019)<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss', window );">Foreign Currency Translation Adjustment, finite-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, finite-lived assets</a></td>
<td class="nump">5,181<span></span>
</td>
<td class="nump">5,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,019)<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, finite-lived assets</a></td>
<td class="nump">1,203<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, finite-lived assets</a></td>
<td class="num">(516)<span></span>
</td>
<td class="num">(454)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss', window );">Foreign Currency Translation Adjustment, finite-lived assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, finite-lived assets</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (516)<span></span>
</td>
<td class="num">$ (454)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived And Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total carrying amount of assets (excluding financial assets) that lack physical substance, excluding goodwill, having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gild_IntangibleAssetSofosbuvirMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gild_IntangibleAssetSofosbuvirMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gild_AxicabtageneciloleucelDLBCLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gild_AxicabtageneciloleucelDLBCLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231360904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Aggregate amortization expense related to finite-lived intangible assets</a></td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 844<span></span>
</td>
<td class="nump">$ 868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231142680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Schedule of Estimated Future Amortization Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2020 (remaining three months)</a></td>
<td class="nump">$ 284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2021</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2022</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2024</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, finite-lived assets</a></td>
<td class="nump">$ 11,809<span></span>
</td>
<td class="nump">$ 12,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575231564968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities - Summary of Debt Carrying Amount (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt, net</a></td>
<td class="nump">$ 29,290<span></span>
</td>
<td class="nump">$ 24,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion</a></td>
<td class="nump">1,498<span></span>
</td>
<td class="nump">2,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net</a></td>
<td class="nump">$ 27,792<span></span>
</td>
<td class="nump">22,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.35% Senior Unsecured Notes Due February 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.55% Senior Unsecured Notes Due September 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50% Senior Unsecured Notes Due April 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 999<span></span>
</td>
<td class="nump">998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.15% LIBOR Senior Unsecured Notes Due September 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.15% LIBOR Senior Unsecured Notes Due September 2021 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.40% Senior Unsecured Notes Due December 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,249<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.95% Senior Unsecured Notes Due March 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% Senior Unsecured Notes Due September 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 998<span></span>
</td>
<td class="nump">998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.50% Senior Unsecured Notes Due September 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 747<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.52% LIBOR Senior Unsecured Notes Due September 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.52% LIBOR Senior Unsecured Notes Due September 2023 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.75% Senior Unsecured Notes Due September 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,992<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.70% Senior Unsecured Notes Due April 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,746<span></span>
</td>
<td class="nump">1,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.50% Senior Unsecured Notes Due February 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,746<span></span>
</td>
<td class="nump">1,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.65% Senior Unsecured Notes Due March 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,736<span></span>
</td>
<td class="nump">2,734<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.95% Senior Unsecured Notes Due March 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,246<span></span>
</td>
<td class="nump">1,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.20% Senior Unsecured Notes Due October 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 745<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.65% Senior Unsecured Notes Due October 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 992<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.60% Senior Unsecured Notes Due September 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="nump">991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.00% Senior Unsecured Notes Due September 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 741<span></span>
</td>
<td class="nump">741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.60% Senior Unsecured Notes Due October 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 986<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.65% Senior Unsecured Notes Due December 204</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">5.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.80% Senior Unsecured Notes Due April 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,735<span></span>
</td>
<td class="nump">1,734<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50% Senior Unsecured Notes Due February 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,732<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% Senior Unsecured Notes Due March 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,218<span></span>
</td>
<td class="nump">2,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.15% Senior Unsecured Notes Due March 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,726<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.80% Senior Unsecured Notes Due October 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,475<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A235SeniorUnsecuredNotesDueFebruary2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A235SeniorUnsecuredNotesDueFebruary2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A255SeniorUnsecuredNotesDueSeptember2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A255SeniorUnsecuredNotesDueSeptember2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A450SeniorUnsecuredNotesDueApril2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A450SeniorUnsecuredNotesDueApril2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A440SeniorUnsecuredNotesDueDecember2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A440SeniorUnsecuredNotesDueDecember2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A195SeniorUnsecuredNotesDueMarch2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A195SeniorUnsecuredNotesDueMarch2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A325SeniorUnsecuredNotesDueSeptember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A325SeniorUnsecuredNotesDueSeptember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A250SeniorUnsecuredNotesDueSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A250SeniorUnsecuredNotesDueSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A075SeniorUnsecuredNotesDueSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A075SeniorUnsecuredNotesDueSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A370SeniorUnsecuredNotesDueApril2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A370SeniorUnsecuredNotesDueApril2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A350SeniorUnsecuredNotesDueFebruary2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A350SeniorUnsecuredNotesDueFebruary2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A365SeniorUnsecuredNotesDueMarch2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A365SeniorUnsecuredNotesDueMarch2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A295SeniorUnsecuredNotesDueMarch2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A295SeniorUnsecuredNotesDueMarch2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A120SeniorUnsecuredNotesDueOctober2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A120SeniorUnsecuredNotesDueOctober2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A165SeniorUnsecuredNotesDueOctober2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A165SeniorUnsecuredNotesDueOctober2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A460SeniorUnsecuredNotesDueSeptember2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A460SeniorUnsecuredNotesDueSeptember2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A400SeniorUnsecuredNotesDueSeptember2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A400SeniorUnsecuredNotesDueSeptember2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A260SeniorUnsecuredNotesDueOctober2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A260SeniorUnsecuredNotesDueOctober2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A565SeniorUnsecuredNotesDueDecember2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A565SeniorUnsecuredNotesDueDecember2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A480SeniorUnsecuredNotesDueApril2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A480SeniorUnsecuredNotesDueApril2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A450SeniorUnsecuredNotesDueFebruary2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A450SeniorUnsecuredNotesDueFebruary2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A475SeniorUnsecuredNotesDueMarch2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A475SeniorUnsecuredNotesDueMarch2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A415SeniorUnsecuredNotesDueMarch2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A415SeniorUnsecuredNotesDueMarch2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A280SeniorUnsecuredNotesDueOctober2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A280SeniorUnsecuredNotesDueOctober2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575313949304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Oct. 23, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amounts outstanding under revolving credit facilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | the "2016 Revolving Credit Facility"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | the "2020 Revolving Credit Facility"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | the "2020 Senior Notes"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 7,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption percentage</a></td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.15% LIBOR Senior Unsecured Notes Due September 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">499,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.52% LIBOR Senior Unsecured Notes Due September 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity', window );">Call feature, period prior to maturity</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.75% Senior Unsecured Notes Due September 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">$ 1,992,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 0.75% Senior Unsecured Notes Due September 2023 | Treasury Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments', window );">Basis spread on variable rate to discount remaining payments</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.20% Senior Unsecured Notes Due October 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">$ 745,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.20% Senior Unsecured Notes Due October 2027 | Treasury Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments', window );">Basis spread on variable rate to discount remaining payments</a></td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.65% Senior Unsecured Notes Due October 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">$ 992,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.65% Senior Unsecured Notes Due October 2030 | Treasury Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments', window );">Basis spread on variable rate to discount remaining payments</a></td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.60% Senior Unsecured Notes Due October 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">$ 986,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.60% Senior Unsecured Notes Due October 2040 | Treasury Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments', window );">Basis spread on variable rate to discount remaining payments</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.80% Senior Unsecured Notes Due October 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">$ 1,475,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.80% Senior Unsecured Notes Due October 2050 | Treasury Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments', window );">Basis spread on variable rate to discount remaining payments</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | the "2020 Fixed Rate Notes"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | the "2020 Fixed Rate Notes" | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity', window );">Call feature, period prior to maturity</a></td>
<td class="text">2 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | the "2020 Fixed Rate Notes" | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity', window );">Call feature, period prior to maturity</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | the "2014 Senior Notes"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Repayments of senior unsecured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | the "2015 Senior Notes"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Repayments of senior unsecured notes</a></td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Three-Year Senior Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Contractual term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding borrowings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Three-Year Senior Term Loan Facility | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_DebtInstrumentCallFeaturePeriodBeforeMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Call Feature, Period Before Maturity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_DebtInstrumentCallFeaturePeriodBeforeMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Price, Basis Spread On Variable Rate To Discount Remaining Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_CreditFacilityDueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_CreditFacilityDueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_CreditFacilityDueJune2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_CreditFacilityDueJune2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_SeniorUnsecuredNoteIssuedSeptember2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_SeniorUnsecuredNoteIssuedSeptember2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A075SeniorUnsecuredNotesDueSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A075SeniorUnsecuredNotesDueSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A120SeniorUnsecuredNotesDueOctober2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A120SeniorUnsecuredNotesDueOctober2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A165SeniorUnsecuredNotesDueOctober2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A165SeniorUnsecuredNotesDueOctober2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A260SeniorUnsecuredNotesDueOctober2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A260SeniorUnsecuredNotesDueOctober2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_A280SeniorUnsecuredNotesDueOctober2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_A280SeniorUnsecuredNotesDueOctober2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_SeniorUnsecuredNoteIssuedNovember2014Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_SeniorUnsecuredNoteIssuedNovember2014Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_SeniorUnsecuredNoteIssuedSeptember2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_SeniorUnsecuredNoteIssuedSeptember2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575235982856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs involved | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=gild_IndenixMember', window );">Indenix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,540,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_LossContingencyMotionInvalidatedForPastDamagesValue', window );">Past damages vacated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,540,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=gild_JunoMember', window );">Juno</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded</a></td>
<td class="nump">$ 585,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_JudgmentRoyaltyRateFromOctober2017', window );">Running royalty rate from October 2017</a></td>
<td class="nump">27.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_JudgmentEnhancedDamagesonPastSales', window );">Enhancement rate on past damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_JudgmentRoyaltyRateOnFutureSales', window );">Running royalty rate on future sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_LossContingencyEstimateofPossibleLossPastSales', window );">Estimate of possible loss representing past sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 811,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages', window );">Estimate of possible loss representing enhancement of past damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest', window );">Estimate of possible loss representing royalties and prejudgment interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=gild_JunoMember', window );">Juno | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=gild_JunoMember', window );">Juno | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_JudgmentEnhancedDamagesonPastSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Judgment: Enhanced Damages on Past Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_JudgmentEnhancedDamagesonPastSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_JudgmentRoyaltyRateFromOctober2017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Judgment: Royalty Rate from October 2017</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_JudgmentRoyaltyRateFromOctober2017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_JudgmentRoyaltyRateOnFutureSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Judgment: Royalty Rate on Future Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_JudgmentRoyaltyRateOnFutureSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Estimate of Possible Loss (50% Enhancement of Past Damages)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_LossContingencyEstimateofPossibleLossPastSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Estimate of Possible Loss (Past Sales)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_LossContingencyEstimateofPossibleLossPastSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Estimate of Possible Loss (Royalties and Prejudgment Interest)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_LossContingencyMotionInvalidatedForPastDamagesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Motion Invalidated For Past Damages, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_LossContingencyMotionInvalidatedForPastDamagesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118943654&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=gild_IndenixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=gild_IndenixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=gild_JunoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=gild_JunoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239775224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jan. 29, 2020</div></th>
<th class="th"><div>Jan. 28, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount under stock repurchase programs</a></td>
<td class="nump">$ 6,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=gild_A2016StockRepurchaseProgramMember', window );">2016 Stock Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized amount under stock repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Value of shares repurchased and retired</a></td>
<td class="nump">$ 201,000,000<span></span>
</td>
<td class="nump">$ 223,000,000<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=gild_A2020StockRepurchaseProgramMember', window );">2020 Stock Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized amount under stock repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=gild_A2016StockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=gild_A2016StockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=gild_A2020StockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=gild_A2020StockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575232756360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="num">$ (47)<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">17,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Net unrealized gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications to net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Net unrealized gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications to net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Net unrealized gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications to net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(44)<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Net unrealized gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications to net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575229955768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_gild_AdditionalInformationAbstract', window );"><strong>Additional Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from earnings per share computation (in shares)</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gild_AdditionalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gild_AdditionalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gild_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239169192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Schedule of the Calculation of Basic and Diluted EPS (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Gilead</a></td>
<td class="nump">$ 360<span></span>
</td>
<td class="num">$ (1,165)<span></span>
</td>
<td class="num">$ (1,428)<span></span>
</td>
<td class="nump">$ 2,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in per share calculation - basic (in shares)</a></td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and equivalents (in shares)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in per share calculation - diluted (in shares)</a></td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to Gilead common stockholders - basic (usd per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to Gilead common stockholders - diluted (usd per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="nump">$ 2.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1500-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238457416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of the Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">$ 825<span></span>
</td>
<td class="num">$ (1,501)<span></span>
</td>
<td class="num">$ (145)<span></span>
</td>
<td class="nump">$ 3,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 472<span></span>
</td>
<td class="num">$ (333)<span></span>
</td>
<td class="nump">$ 1,310<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">57.20%<span></span>
</td>
<td class="nump">22.20%<span></span>
</td>
<td class="num">(903.40%)<span></span>
</td>
<td class="nump">17.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575238983528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">57.20%<span></span>
</td>
<td class="nump">22.20%<span></span>
</td>
<td class="num">(903.40%)<span></span>
</td>
<td class="nump">17.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Non-deductible IPR&amp;D charges</a></td>
<td class="nump">$ 511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Net unrealized loss on investment of equity securities</a></td>
<td class="nump">964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Tax benefit related to settlements with taxing authorities</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28511-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28446-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140575239076136">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative Effect of New Accounting Principle in Period of Adoption</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
<td class="nump">$ 8,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member] | Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative Effect of New Accounting Principle in Period of Adoption</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
<td class="nump">8,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative Effect of New Accounting Principle in Period of Adoption</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
<td class="num">(7,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13 [Member] | Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative Effect of New Accounting Principle in Period of Adoption</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
<td class="num">$ (7,000,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M(%.R./,K;I1(\F.SM5!*1/FESYG'I1X [S="J-.-_D!Y\CK]#U!+ P04
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M5NCJPS42AYA3@;(2?<[R7/]X@SZ<W\ZG4G50-S--FL[<UYTA/9UQT6=6RH-
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M5AD" 589@G5996XEE+]BZQC.*=0[]M9XE]A!V/94#AK-)W::8?I0BUA)C_F
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M]8"R ?A\):79&Y:@_9FE?P!02P,$%     @ A)EC4?T%@@G\!@  NQT  !@
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MC,&/^P_@[*]S\!=@+?C"FD:MAKB<2 5&NYQ4^Q??[EZ, B^>@B^\E2L!/BH
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MXRE*/LK(6XH#:^C!F?H-H8J17 0W8DWX0O!(-?VY++@I!?WKV:M2E D/X%C
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MWD1]JE/GN=B&"L[_<U6H4L\8U-MVAS%_ZSM*H$?/<81D92ANZ .*8>Y8 $P
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M@LMHW"Y19N<DQ,T]3P]HQ)#YF8ZBF<Z>Y!!TZJ.4J@LZMRG" AG82W!ZMBG
M,(S^$?MPNLW>SRH>E%5-T<]&^5 WQP"-$D_4#T*.>AJPI.;1K'];XE];U7PH
MD#6Y$/I+^3Q.$?]\>B$508 X[=[?+Q4>?R=?'RRIO7=2$#NN ]9'E$-2)YT&
MN*EFZJ)D>C8&X2:RK>NX^C-RY'2$2#H^#=>18!2,PX'G-1A.N9&1/TW_7)PU
M)J2BQ^WI"#J]Q-YAPU:QN7_/K]65M\#G>_3D8M3K%#&('B>WI,4KTN)V39R
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MI0WX/C>XH/J%&+0_R;_X/U!+ P04    " "$F6-1-+$,>'8%  "=#@  &0
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MNCBV71XKZ./TE*[C2/05X*\X4.B--I@ZDV^BP>[;&7L"9A(\@-J#_V8IW+^
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MJ52O"?Z*<U/0&2&F<]D^YI?.@@*&P.>N9@IC:I(G)2SS**9-Y@0A?%).!+2
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MKS<2?CE&NY8//#42M=G( I@1?0/3H#3@W+69Z_:X6<J:N!]3C5G1#/\Z%K'
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M0-!*@8/VLT7F U<!:$[#<COPHUF'/ 4&DY "6V'=(_)N>:XM^#Z:C$^\GD(
M7[,8L?V1H)?K[1'1)(G"P$!@PQ$';8AWN)B9+'!#O'Y"(##L$GX=PSJ5> 5K
M$5> C-2,Q>49C*=;\1V/XV+]:'VZXFPD4>PUL"JFTB[VIJ =0;J8=8#)$9,"
M4V:Z8DWJ&J<R\:A@O)?@(2A2HG'P(<V^>0[2 CO[K0/?2+:5B#X&,40HA4^
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M=#H<!*#; MT.K&I\45PK2R76=RMZTU [ UK?*&4/ Q>@?R5G7P%02P,$%
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M!KNS01(\/8FC(7PQ:[J(@,XCZ/2#I N=L M)VB>>/TP)6C\F'O&3*(5;:9B
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M<DT+'BHK0.=+*<WNPSK8KXR3?P%02P,$%     @ A)EC4:B4O/H9"@  T1X
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M,[QK[D*EPX@R<H V53AMZAH>PIE6_UADY%Q:R.>)?.;()9/$Y%/&29?8_^L
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MY)'<!N9^:<V2_^3&Q""87/"/,,20<WH WT\!P]TO-('_&RS?_1M02P,$%
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M+MUHVY*%.L"E :,-RV+**L2%LC\+1N2XC)MPQ45A,?^O](DY2#)7$%NF5,M
M8T0Z#+<6Q\4M;5L:S QG0CS7(-YW2.-4VBS26LG4P3%-Q9N(XQ.JB&LL[5X\
M5X'.;<'5CC%^+_@C$^18DVX*88P&%14R0BGHZ"N':^@^T85ZK@!2-(D$HGV_
MHUSC>< 1GR)14 %YH4C3.27(E7Q:'7]L5E<8L8)TDR>N -=KNESHWBE$# EE
MD^:1;AJBO ^P$QVTJ78+X:XA"DJ[M^_2M5I&(%&(;I*J#D):%D>TQ1&HM!ET
M.V17WQHV.3FZ&TT\-YQ=QS_P$71VW<8/.0G.#YV4>V@M!5WC;G>Y:)5W.?^;
M4N."7^WX*O@K5P^LOP].PPG/=NITPVX"(E]'2F5!&^[S!7&VBNM7#4RM](.1
M0^FOH^VB46M-7XEXA_HG:'=]^IX$C:![^KEL=<*>;86-[KE?UGL-A:T.I.E%
M0CV2OU2!#!KAZ:G]=L]<VWW/@K)RV;U6[4=;1XX>Q"[\_%,O#,)?]_^S?\MD
METC+(GC%I?=&;'XHP3O)G\!OAN<V<'[S/"PCV PZ+H#-(/PX=SM=QQWZ\-;-
MWZH]OU)4&_?(I/)O-V'Y$MN/[M^QH_+Y]K*\? 3?,;7AE#&!:S+UFV>G'JCR
M85EVC,S=8VXE#3T-73,A5:CL II?2RJ95<<ZV+_NA_\ 4$L#!!0    ( (29
M8U'P2R'(S00  *<,   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;,U7
M:V_;-A3]*X27%@G@VI9D+TF;!$B:K O01U"GVX!A'RCIRN8JD2I)Q<E^_<ZE
M9,7ITC8IAF%?S.>YCW,?H@]6QGYT2R(OKJM2N\/!TOOZ^7CLLB55THU,31HG
MA;&5]%C:Q=C5EF0>0%4YCB>3'\>55'IP=!#V+NS1@6E\J31=6.&:JI+VYH1*
MLSH<1(/UQGNU6'K>&!\=U')!<_(?Z@N+U;B7DJN*M%-&"TO%X> X>GXRY?OA
MPB^*5FYC+MB3U)B/O#C/#P<3-HA*RCQ+D!BNZ"65)0N"&9\ZF8->)0,WYVOI
M/P7?X4LJ';TTY:\J]\O#P=Y Y%3(IO3OS>IGZOR9L;S,E"[\BE5[-TD&(FN<
M-U4'A@65TNTHKSL>-@![DR\ X@X0![M;1<'*4^GET8$U*V'Y-J3Q)+@:T#!.
M:0[*W%N<*N#\T;G.3$7B4EZ3.QA[2.3]<=:A3UIT_ 7TOGACM%\Z<:9SRN_B
MQ["D-R=>FW,2?U7@G.J12"9#$4_BR5?D);U[29"7?-,]<:I<5AK76!*_'Z?.
M6R3$'U]1,>U53(.*Z7<R^ WTVY?OWIR)R^/?SN;B<DFB,"4*1>F%\#(MJ:L6
M]1<Y81HK5*O-PR&Z1F4Z$MLI:2J4WQ';2B-'RA+I[H8XSZCVHB:;D?:H,+?S
M'"HLT9VHB;<PZ>X.HN"I2LF&4-Q=<6#P$^UOS#H*MD&OVQ$IH5?0AJ4P?4OL
MQ3/\;D?#V23:";/IC,=D&,]Z"?>[M26FNS%#DB3A531,H@G&V=Y4G!4%A<(.
M6"L]B=GN*!9/1!R'87M_DHRF.YA%NZ-]#._ (O6H#3X#V!0!_P1QL,(C'CX0
M5K7TT#WT!!IR!8D69X4U5<!]&,U'HJ"<K"R%\](WWMB;7DD</1F*VBJ.;7DC
M\@::C-B:1=$Z@GPK(^O16-&[/C6*Q9]?O'\JJ_K%J<B6TB*D0NI<;.W'R2:L
MT86\,C;D#^YIO@<I;%8AE157LFR"%9Q1!-'^!N=7Y#S:K0]W7\E2HBL;!Y3T
M0B*@VNAG<+\!<2R8"=I@KVYL;1RY4<CBA[$F2V=81MGP!0D_;KW7^"#E*%E+
MOE70I0.^!"4XS)DN*1QY7Q);C;[IE]C!52X>V?BEL7!L].V =RER&W/-%?$?
MA5Q^SNO6=#03:<?"Y_&&]YFQ;!%BE!FMNX];<)ZC&3+%*=]E KY<B.V<KD@/
M&2+SO#V#9C99I@:<,'_8Y!A4IN$,>%3V/X!B+L9'U12ZRO<0_$]^&?>J-"D0
MY^B">A%(?FU6S[ACYWWO>OK#7AQ/7KPZ?WUY'N;1BQUV81@4K?L85QO37(/7
MCN*0,'=#F%H9G,(S"0FLZG UM\VB5W-R<=HK*8B0%Q("90F[35$@JT4*O\B1
MM-DR,(E"0.A:"["+%%VXEAE6'IAQ3>I4KN ^=66+MUL@!Y'_L['*Y2JDBVOS
M!=\9\+T.4X"T3>*#5EQA<W;</2"ZW%D?4SW_6G#1,B((6_>,+[2)VR;1.?Y9
MCP!=P_\)V?<G0LAA3LSO34BD&Z?9Z+[GSGCC\5@1>@P_D1V:"QI!^X[L=_M7
M^''[^+R]WC[AWZ!%*3A<4@'H9+0[&PC;/HO;A3=U>(JFQN-A&Z9+_),@RQ=P
M7ACCUPM6T/\W.?H;4$L#!!0    ( (298U&NY),J>@X  )@H   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;+5:6W,3.1;^*ZIL[114.<Z% 0(!JI(,
M[&9J&"@R, ];^R!WR[:@N]4C==MX?_U^YQQ)W4X<,^SE 6)W2T?G^IV+_&+M
M_)>P-*937^NJ"2\/EEW7/C\Z"L72U#I,76L:O)D[7^L.7_WB*+3>Z)(WU=71
MZ?'QDZ-:V^;@U0M^]MZ_>N'ZKK*->>]5Z.M:^\VEJ=SZY<')07KPP2Z6'3TX
M>O6BU0MS8[J/[7N/;T>92FEKTP3K&N7-_.7!Q<GSRY-CVL K/EFS#J//BD29
M.?>%OER7+P^.B2-3F:(C$AI_5N;*5!51 A]_1*('^4S:./Z<J+]AX2',3 =S
MY:K?;=DM7QZ<':C2S'5?=1_<^N\F"O28Z!6N"OR_6LO:QT\/5-&'SM5Q,SBH
M;2-_]=>HB-&&L^-[-IS&#:?,MQS$7/ZD._WJA7=KY6DUJ-$'%I5W@SG;D%5N
M.H^W%ONZ5S=B#>7FZL8N&CNWA6XZ=5$4KF\ZVRS4>U?9PIJ@'J1/#U\<=3B:
M"!P5\9A+.>;TGF.>J;>NZ99!O6Y*4V[O/P++F>_3Q/?EZ5Z"-Z:=JD?'$W5Z
M?'J\A]ZCK(='3._1/?1V"?R/BUGH//SFGWL.^#$?\",?\.,]!USJ8 .I^;TW
MP32=)J?<I<B]9"A(GX=6%^;E04N$_,H<[*:M?EL:.'WAZE8W&Q*L;W1?VLZ4
MZLK!#$V03P'REIH>O[&-;@JK*W4#&@;!UP6UU"NC9L8T"@>VVF.=;9BP+[':
MP&&[I?HXO9FJA6F,UU6UH=>F)9)ZT&OK+8BW%30+- &1SGA;JWD^U#:",F!^
MRMP/K\+ #XA4?0G1JDKI\C-"1)X7D,0&/@F::(A2!=PH>N_IV7AIM]0=_C,(
MI ;00P]IS]]L!5Q3-S ^Y H3==T44_7@A[^<G9X>G\M;_G)R/E'QZ=K<?N)Z
M'Q\I2!D?]B$^>PA55M:LH 2H4C4&!P4*0%*)5G-MO6K'5@1?Q&D+7;DRI'>F
M9 T%LT.-6 %(BO1=E\^PL(MM2@0X 2$13BO-UQ8@"6L1$W3:O(=RYS84(+<Q
MVI,DS&"S 7[/@OFC)YVELX6YZ5V/^QX_2W;M(I&>'F:K3!3TJM9+!^\Z=.L&
M5(@16UH(1LIL2E48WR$/J14>Z5D5=6-"IW" [6QTO/72%DNU-JP@UBUD(!/,
MX+[ /U#<3-5%5<G^*(X"$C1!<RX9!P6L"5C6;!'D"7;#+&@^=[T$(W0F6"=E
MTM'0NB/5=$XA)M@K&W5R?/S79',#6JZV!3P1.^'*B#A8D_0.IHQZ4+D0'BK=
M==[.^HY%!K'&X773>:B*;)"5 ,V0#N^QR<@2./X=3*I%5-@:A@+=Z(8%N>;"
MW&:2I"*[^+"T[7"H-V02P8S00^]9);,-[\<J<C[RR%N, VMHX53]#E.%0"J"
M&K''?\-XQ)J^SPLV.: _7;_.01GQ (H%;(W"3GM8/2($N1C6&0TI@(3.,]:0
M]LCS <#")*_%-ZH52N5$Z:U;@VTHL;2P8Q>='%*++N)IX$BPJ79@-PSYF"(7
M7A@W1L9/GIZ'0?VP#*,G(3)Q2J>Z6647 B,X6L^"\S-%3D-'2J1[JEKH+=@R
MEIV:] @OF'M7;W.%F*Q*B-*1(AGF9V;,97(2;)BJ/2GS<4Z9C_>FS!NS8&5>
M#WEA5\+\;B+D4!S KL$_\718,LC*202(N4/Y18IJ6*@2:.A6QF\F*/I6J&;;
M[!0(QAIQ 978?V70MDWC5H*TM0'H@JW B1.U,QN\;VJ$,K]#?#6& .0=Q>?2
MFKEZ_169BW>_FT.[<)[DME>OWR6WG<#EF+F"]PRBE*:P5#<?UOJ+\9.8YP0E
M83B'%(!O" IX"9)#,IP;HAX,D@<E\*/ZN8D!=(@*U9![6\3F6Z+,^74@35\'
MVO=LQ1.*SB"8]/H=>ZA$.;.RXDH"R A=QUP5">J5MA5'-IVYA$]AZXP"O#1M
MY1A6@AEO*#Q\'DFMB>A-^RB/:@\[TY>Q19.>/_R@Z_:<_OV48:+U[C/"=Q3<
M=ZU(!-DP.;=/<%C2^IBMVE&MTL=2J,'^T9F* &8.>';,H?D:E[B67O2- $>2
M//3\F%57@>PA5M=J@8!#;19M.>L#.6&8[@G-)SDTG^R/JOV]PD2]1B56LY<1
M]S_W)<=6V!6__Y^3N!B1BG5<2,$QOJ<H\<A^0.R@>M8UA9,R6P=^S@<R1NKY
M/.&[Y ARB#H7,^3A'9BND)ILQ38D[UB9IH_TJ!9K@DE.6C%O!#[ [=Y3.GS'
M 04C.U($!Q,7"&:EJYY<C(P]AN5Q#9YZ&SXJ"<(IEER:MP[R06O(:YWS[-S$
MF>?26!*,%%H.FD$"_F*Z0TKD=*:\YD0- < 6\1#0][<2?JRHM4F5L#@QQ4AP
MC D(JM)(>BJL+_H:U;\4Y+%@X*(5VDQ [251":Y0B0<[D;2#;?3,]6*5 BF=
M:U/2EAD9A;D>V27:,Q;1-/&@ EJWU )!($Z/(F0,Z.G8%7VJ6:@*I(I!:F0^
MI&_%XSCKSFD^H:A+D8HZ9ZF)U$L1X7.>YS:GS#B=/"0B>*X2=/)!*M>PR4.U
M*^MA+/B2(5/G?/+NT_5/AR?/,LA)FH\)<I\SC?SGHNCZ4>LA)$J+8"!C4)?
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M?7P@LZ/TI7,M__1LYCH4"/QQ:5 )>UJ ]W,'3XU?Z(#\8\17_P902P,$%
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MSE1_/-"(;[P&>8MUVF %KV -X;.H]$K!1570XGG\ 'EUY((MN=/@(. M79]
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M8D%3%I4UH/M<2G-4;(!N;B_^ E!+ P04    " "$F6-14?Z#.J<"   \!P
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M_^<ARJI\&59Y2U2T2I564\O$?D5EQ;4ZWZ^HM(5 Y-Y3"%2X;Q<!R%3N+05
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MA7< R+6K6@0J/4O-2,;\(CF_%\;^]M/'T*4[RM0E-BY(!NWH?.MB/T9P;HA
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MT,1%,:,>F#:,.3Y-D7*D2,SQ_7C6_1Y\YR:2A%2E=DA$J)"J"S@DE78L%$$
M8Y04 I!:/@(PG/G>UXA,(T5"C2\<]:A;(D!(56HW1"0,J;J &U)I=T)3!<P0
M316P.1158.V(GRHA]Y&$XX&J>,6JY"[-J5T0D3*DZ@(N2*5-"4U6%#/J@6G#
M&.<TA;Y'(HX'IDZL5R);2'5J^T-D#JF^@/U1:SM"T1;'C'I@VC#&.4VA^I'
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MC$"D O((Q9E/$663PTB8\H6F'O7KJ)MA8D^#95O!2%_!?FP!BT&1!9:%**Z
M[:%F\P#D,Z=8=C>,1"@/3,5+EVQDR(EM#98M!2,]!?MQ!<P(Q17(S;@[&B"0
MVML9@7S+3UGV.XS$)0]DG5BZ9)]#3NQQL.PS&&DTV(\Y$%=1314!R%W3/T(@
MO:,<1)$G/L@B*LF1J.3'^;)[GH2NG,@BLDGM;8@0(D=Z#/:BR8"=/E0K60!2
M^_XAD.H+W"(49[YG+R,;RD;\C2U-/4J72!RR2>UGB#PB1_H,]F,+K.A0M0N
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M9$4UB$0;P1]JCT(NXHV<.M[((M[(%X@W,@HN9F[?XR&"Y:3V"$4P6E\391E
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MM),HP#PB%*?H"G JDQ-T3<->!^]9S7OVGG4_KV7.WZCNW3SNL*WNW;CVNA_
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MV0&DT\ &G?XNGD3A +=%2(N!*2T&2(O!S-)LH*&V* FZI3^=F0SW>KZD N3
MP H'ALB!(<^!O0L-Q]"=QJB7[D*DN] &W>TOG7G%YA!I+#2EL1!I+#Q'#A^J
M!*4I-NNL>HO-(1)9:".'1RRF5Y1#<K9DFH^'2$_A.?+Q4,VTE5N",SEU%IDM
MM)&+=VZ(V07C$%DR-,VZ0V2VD,^Z9P*B9M4*()S)Z=$DLF9D(^M&0&97A",D
MS<@TS8Z0\R(^S9Z'1:1FT5TL6)-39Y%4(QM9-F&H&27?"/DR,DV>(^2[B(_Y
M9L*@!G,*#)S)J;/DN-YBO&>WHALAD4:F(6*$Y!?Q(>),=-3 4$&',SEU%MDU
MLG&TC^C,+MG&R*&QZ2E^C.07\Q'CU"I&K#F95TNV&JO^DFV,[!K;.+]'+";5
M96/DS=CT?#Y&UHOY*''R_JMG[KJZK,:LORX;(Z_&-H[F$0#SXFN,-!J;GL''
MI%N)#QLGHZ*>K*O%5XU1;_$U1C*-;9R^(R2S*JPQTF5L>KR>(,\E?*PX%85D
M3.*M,>I-O!.DT82/(<?VMR'5)3S53:NP)FITJ%FYYDBG=^5(AHG=(-*TC)H@
MM2:F 66"Q)><J8B8#,>4K,FIOTB&"4^&8Z]'9,1D()&>O0$JZRD;P)F<^DL:
M1.W1HL?M$#)?8LI\*3)?.K.VF&K8"R"*.SNJ,PN@KR\E19I+K=!<BC27\C37
MOU"5K)3BN\:FI_B>(IVE]NC,FU=!39'!4E,&2Y'!TG.DQ.DP?;$FI\XB?:7V
M4F)O5NTT1>9+33/?%%DI/4?FFVI.CM5N7(U5?S=N2CK;[>6_GG$%%5S:RV[<
MS.Z2;G;W+.WLKIKIJGVW&B.F\=8E_>RNO838,^JO=4GWNFO<ONZ2_G7W+ WL
MKJ:#76FRU5GU=MF"2SK877MYLC>SL@HN:4]WC?O37=*@[IZE0]W5M*BK';4Z
ML_Z66GD;$;<MAH1VZZS@DOYTUS2.!"KX@7.TJ!]F'6B?U9GU]<_"B;+(WC&V
M9U)S!:H= M/C;* 2'^#CS*FUC<-\7"3&VW1<)0P\("&:BL:DJBM071"8GF(#
ME>P 'V-.1V#X")NWZ;A*"'= $C05 ?.R*U#Y#YB>90.5YX#='O+#?#PLHT^R
M@:A_8$#^,Q666:57(.H>\$Q/LH%(<,"SVS)^F(]%@K7IN$K8U.-#SI%U"2 *
M'!B0X$PKP!YFX]?.V70<):SHV8TU30NP0*0[X!G'G417 T/"FKDUR,/$7#.K
MSJ:OFQ6(O 8&]#6C+TU"D0,R&X-]4'E0J:KIC'K*:D#4-F!%;K.[3'U61DWX
MT%A  T1! P,2FMY:)6A4,,JNLC8=GZA2W [Q$0T+^#SQ,<L<P7&L3<<GPG$#
M8IA)%\_,AR@0O0OXQK1&-"G@GR6=]H</5GB;CL.$T@:4+U/1F/.L!,*& ^*6
M,4]+(#0UH&R9^[P$-1%6P&!M.@X3CK.B<.G<&O/KLT3% L8R%B Z%A@0LLP%
M9D3:S-IT'*8/WK"7-OM&M5FBA8' .(4F0A484*K,Q61$(LW:=!PF5!O82Z3]
MN759HI6!P#AU)@H7",[1"'Z8E8=C? )-%#0P(*&9"H?-BBP1U4!H'$8250R$
MYV@1/\S*HL3:=!PFS#N@O9F*TOQJ+!'70&AZ- XA?>*07;'U83X>C=$'XT#4
M-S @OYF*QK1J+%'60&AZ+@Y$#P.A737U83X>@=']X$#D-C"@MYF*@(5J+-'7
M0&1\*DZD,1#9;0\_S,?"PMIT7"6\.B"]F0K+O&HL4== 9'P.3M0Q$-EM%#_,
MQR,Q/ELGXAN(^"!S;%$BHL]7XUEO8C4V&A%ALC8=1PDK1G8C3.-J+)'=0&0<
M;1)=# P)8V97(:,1 2=K<^HS$<[ @')F[)5)]#,P(*"9OPW[B2-N&UB;G<\+
M\K#D]E'5DBCN\W7M%.).CG'?M)*.:O?PY]V;IMQLGY]\4S9-N=J^?!#R.ZEJ
M#>3?[\JR.;QI'\E\? ;WU?\!4$L#!!0    ( (298U$%!ZZX;0,  "D,   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;,U7RV[;.!3]%4+HH@7:2*(>
MB0+;0&S':(!D$,1H9S'H@K:N;2(4Z9*4W13S\4-2LF+'BL9]++JQ1.J><\]]
MB+KN;85\5"L C;X5C*N^M])Z?>G[:KZ"@J@SL09NGBR$+(@V2[GTU5H"R1VH
M8#X.@M0O".7>H.?V[N6@)TK-*(=[B519%$0^#8&);=\+O=W& UVNM-WP![TU
M6<(4]*?UO30KOV'):0%<4<&1A$7?NPHO)R&V &?QF<)6[=TC&\I,B$>[N,G[
M7F 5 8.YMA3$7#8P L8LD]'QM2;U&I\6N'^_8Y^XX$TP,Z)@)-C?-->KOG?A
MH1P6I&3Z06P_0AU08OGF@BGWB[:U;>"A>:FT*&JP45!07EW)MSH1>P##TP[
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MQ^J)'W^GQ8;ZF;\ECV7^%QP+;."!Y5XJGA3&FD'"TM-_\JT(Q)D!#%L,4&&
MNAK@P@#G&STQR[?U0!29C@4_ I&AM;?L0QZ;W%KOAJ79,<Z5T+\R;:>F[P^$
MQ601TYY.B=Z<Q!0\T(4"<[K<"Z88E: 'YJ<S!GP-.N") K])Q72(Z0I\)$R
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MX8JJ![[Y#(V?H>%+.)7V&VWJV+'GH*22BA<-6"LH"*N?^*6IPP[ GYP ^ W
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MP"<K(7.J<2O7KBHET*45Y=P-/"]T<\H*)Q[;>W,9CT6E.2M@+HFJ\IS*/[?
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MDK*>8?5&B]*.@870.%3L,L.Q#](8X/.5$/IU8R9+^T<B_@M02P,$%     @
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M /@^%'@AS0?F-EQ\_0Q_ U!+ P04    " "$F6-1#P:/>%4-   ;40  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6S%7&USVS82_BL87>\FG4DD@N]L
M',\XL94HC1W7=G)S<W,?: JR..&+2E)VW.F/OP5%"J"(%]I1JWY(+1M8+'87
MSSY8 #IZR(MOY9*0"GU/DZQ\,UI6U>J7R:2,EB0-RW&^(AG\99$7:5C!Q^)N
M4JX*$L[K3FDR,0W#G:1AG(V.C^K?71;'1_FZ2N*,7!:H7*=I6#R^)4G^\&:$
M1^TOKN*[945_,3D^6H5WY)I47U:7!7R:;*7,XY1D99QGJ""+-Z,3_,M7C /:
MHV[R-28/)?<SHG.YS?-O],-L_F9D4)5(0J**R@CA?_?D'4D2*@H4^;V1.MH.
M2COR/[?2I_7L83:W84G>Y<F_XWFU?#/R1VA.%N$ZJ:[RAP^DF9%#Y45Y4M;_
MHH>FK3%"T;JL\K3I#!JD<;;Y?_B]L037P<22#F;3P=SI8,DZ6$T':^@(=M/!
MWNW@2SHX30=GMX,GZ> V'=RA<_":#M[0.?A-!W^H2D'3(1@Z C9:SQF#NVR=
M/=C;N'4WWO6WO$OK<#S8X[AU.>[YW)9U:9V.>UZW9%U:M^-=O\M':1V/>YZ7
MCM*Z'O=\[\JZM,['@[UOMMXW>]Z7S<5LO6\.7^O;Q5Y[?[*!E1J33L,J/#XJ
M\@=4T/8@C_Y0 UO='Z HSB@(7U<%_#6&?M7Q2?3[.BYCBH?E2P1(EH2W>1'6
MGU&8S='G:DD*=%(4879' 'VK$KTX)548)^7/Z"<T0>4R+$B)X@Q]R>(*A+!?
MG,=)LA'\$__Q:%*!YG3\2=1H^7:CI2G1\G-4C9%IO42F81I?KD_1BY]^%DAY
MIY9R358@Q>Y(83,0R#M5RSM9WX$\1Z?5V0 IV.M(617Y71&F F%3M;"/ZP2$
M=0TEG=Y[C6*K8HP,;[BY/@QPHH5UYIH-,-=&"@YT,_PX(" L0Z?1KSJ;9T.D
M?!JLRW9> BGG>YG1Q5YT^?P$?__K'[[EVJ]5X7,Y)+2;< SO"E*CD4#.;T]8
M(@/4NAK@?1SHU;I6RSD/'Y$9#%NX-VI1IR3J+1&!E"]/6&@#[/1U@-D;<;Y0
MJ0FDKFW^,K?YRZS%6OK\-31]_?<3R$"SBJ3E_Q0:6%L-K%H#6Z5!0>:0X5X!
M;D>D+&%W4I*PB):U"G-R#WN=%1T<D>^P>RK%6+49QJV'H7NG^V.,/7PTN>=!
MI-_("ERCV^B\W\CQ K/;Z*+?R#8=-ES'%O;6%K;2%M=5'GU[1?=$<Q3E*9UK
M[8MVWB) VTAT>#W\75T%;;Q K*JS5=51JGH9/F["H<IA(UB[D'(4G0=%,W!Z
MVCF^8>],H=](;FYW.P=7/8>"K,)X7NN8UX$>K8N"QEE8EJ021IG;T\,TK-T
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M(O#:VW:4G?N9TECG'B49:L2=I>DZRU/P0:0T//^ZLGG_> ##=UY3#JC];+0
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M01O WQ<YY-;F _V&K>WW(1[_'U!+ P04    " "$F6-1R1.Z.J("  !W!P
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MG9%5IF[X^A>Z#2@N_:4\D]5?L-YBPQY(5U+Q?&NL&>2LV/PG]]M$- Q@U&&
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M&P=/E]C;GV 2?FHGS)6;@1WU$,7MFG*BDMB=FV'-=+A73;EH#I]5/@Y4=_G
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M$%S[)67"2V)G>U!)+->&,P$/BNAU65+U<PQ<;H9>S]L9'EE>&&OPD[BB.2S
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M=3O_-[:_,PGM5^B.JA43FG!(41><]S%M54[V<F/DV@W'A30X:MTRPX\A*&N
M[U,IS=O&SMOZ\SKY"U!+ P04    " "$F6-14T0#&:((   E/0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970U-2YX;6RUFVUOX[@1Q[\*85R!.V#/YJ,D+I(
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M=JI+FFY3 E)3VX+HUV%)R@*O)!VB&]8YND4X@]!:A*TAPLG_09!TZL",M)=
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M_BM6-&FMM#6) ^$B0&J!;IU6"8':/4Q[<(DA5AT[M9W2[M?/=M*00DC1JO(
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M%#?^EVRZV"@@16.L$AT8,Q!,MD_ZU/5A!X \^P%Q!XA? M(#@*0#)&]52#M
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M#8#O!\[5ZT [J/^M+/\&4$L#!!0    ( (298U'^UYQ[ZP(  .<(   9
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;*56VX[:,!#]%2OJ2JS4)7=85H"T
M7*KNPTIHZ;8/51],F!!KDYC:YM*_[]@)*9=LBMH7L)USSLR93#+I[[AXDPF
M(OLLS>7 2I1:/]BVC!+(J&SS->1X)>8BHPJW8F7+M0"Z-*0LM3W'Z=@99;DU
M[)NSF1CV^4:E+(>9('*3953\&D'*=P/+M0X'+VR5*'U@#_MKNH(YJ-?U3.#.
MKE26+(-<,IX3 ?' >G0?IAV--X"O#';R:$VTDP7G;WKSM!Q8CDX(4HB45J#X
MMX4QI*D6PC1^EII6%5(3C]<']4_&.WI94 ECGGYC2Y4,K'N++"&FFU2]\-UG
M*/V$6B_BJ32_9%=B'8M$&ZEX5I(Q@XSEQ3_=EW4X(J!./<$K"=XY(7B'X)<$
M_]H(04D(KHT0E@1CW2Z\F\)-J*+#ON [(C0:U?3"5-^PL5XLUWTR5P*O,N2I
MX5,>\0S(%[H'2>[(O&@7PF.B$B SP;?,M 1V)#G!MB:@*$OE+;)>YQ/2^G!+
M/A"6DV>6ILB0?5MA?CJ*'96YC(I<O'=R\<DSSU4BR31?PK*&/VGF]QKX-M:E
M*HYW*,[(:Q2<P[I-?.<C\1S/J<EG?#7=[=79^;_HTW^.?E(,O^H4W^CY?^T4
M,F$R2KG<""#?'Q=2"7S<?S2$"*H0@0D1-(=HH3;VU0*PZ0!;RAPJW75U/55(
M=HRD?BMNA_=>V+>WQ_?I$G/GAHY[BIK4H8(SJ>DER/?"7@4Z\1U6OL-K?*-%
M GN< !)KL( <8J9NZRR'%SD$7>_,\B7FSO?],\>7(-=WG3/'EZ#P/J@WW*D,
M=QH-3^,8S(0PG@554&>S62/LMCWGINZI;.9YWCN\23.OU7/\=N#<U-V1:3/5
M[;9[YR&+NME';^X,Q,J,3$DBOLE5\6A6I]54?C3#Z.Q\Y#Z,W9KS"4[Q8NC^
MD2\^ 9ZI6+%<DA1B#.6TNWB?13%6BXWB:S,W%ESA%#++!+]$0&@ 7H\Y5X>-
M#E!]VPQ_ U!+ P04    " "$F6-1@$,&ORD#   ="0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6RE5DUOVS@0_2L#H2T2H+4^+-OKU#:0Q%YL#BF"
MI-T>BAYH:601I4B7I.)T?_T.)45U'%D-VHM$4O/FS1L..9KME/YF<D0+#X60
M9N[EUF[/?-\D.1;,#-06)7W)E"Z8I:G>^&:KD:45J!!^% 1COV!<>HM9M7:C
M%S-56L$EWF@P95$P_>,"A=K-O=![7+CEF]RZ!7\QV[(-WJ']M+W1-/-;+RDO
M4!JN)&C,YMYY>+::./O*X%^..[,W!J=DK=0W-[E*YU[@ D*!B74>&+WN\1*%
M<(XHC.^-3Z^E=,#]\:/WOROMI&7-#%XJ\9FG-I][?WF08L9*86_5[A]L](R<
MOT0)4SUA5]M.(@^2TEA5-&"*H."R?K.')@][ /+3#8@:0'0(B(\ A@U@^%*&
MN '$+V48-8!*NE]KKQ*W9)8M9EKM0#MK\N8&5?8K-.6+2U<G=U;35TXXN[B2
MB2H0/K('-/ .SM.4NPUD JYD785N.T^6:!D7YI1,/MTMX>35*;P"+N&:"T$&
M9N9;"L:Y]).&^*(FCHX0#^%:29L;6,D4TP[\LA\_[<'[E(0V$]%C)BZB7H=W
MN!W ,'@+41 %'?%<OA@>3KOD_!G[ZK?9GR1CV);%L/(W_&59P)*;1"A3:H0O
MYVMC-9WMKST4<4L15Q3Q$8I5EF%U2X E%LTL=A51OX_19! %K[LVJQ\714=P
MRW[<R308#N+@]6G7#O5#P\E@>DCY)&^C-F^C7D<?E'Q'%5]2[M8"X>KF]@TK
MMN^7D.1,;[#S*-8>QY5'USGN%Z,PG/GW^\J?V\2C(&B-GL0Z;F,=]\=*C:Z4
MU+\$_P]3H#(R0-<)E_=H+'4;"RH#_%YR^P,,)J6FRZ=;0<TSVHMN.HX/%(R?
M*0B#>-RM8-(JF/0J<"=@C1(S;JDM"JK2%*RB8*T5Z!08NK!M[FJ8RPVPTN;J
MN(K)LPBG!]NP>FX2NA/]1(._=]\72)ON&JV!1)72UF>\76U[^7G5P@[6+\*S
MR[!C?4F]OV[5/]W7/P[75&-<&A"8$54PF-"6Z+H9UQ.KME6W62M+O:L:YO3_
M@MH9T/=,*?LX<03M']'B?U!+ P04    " "$F6-1O\*_)84"  "D"0  &0
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MH*EG8.*EG$K[C[:U;]3W4%I)Q8L&K#,H"*N?^+'IPPY@&!T A T@_ O0[1T
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ A)EC4>+R/?3W!   T"H   \
M  !X;"]W;W)K8F]O:RYX;6S%FMMRVS800'\%HY<F,U4E\>;$8WE&M>-6,[EX
M+->O&9B$)#0@X *@'.?KNZ0L>QG+.WW9ZDDD>#M<"CB+)4_NG?]VZ]PW\;TV
M-DP'ZQCOCD>C4*Y5+<-O[DY9V+)TOI815OUJ%.Z\DE58*Q5K,TK&XV)42VT'
MIR>[<UWZ$5YQ4951.PN-;<.-5O?A>7N[*C8ZZ%MM='R8#KIEHP:BUE;7^H>J
MIH/Q0(2UN__3>?W#V2C-HO3.F.E@LMUPHWS4Y8OF10MY+6]#UQ+E[94$D.F@
M&,,)E]J'V.W1G5\"XT;!SMNU)KH+;:+RYS*J/[QK[K1=M:>!NQBAV^CBL/O=
M!O'8_Y<PNN52E^K<E4VM;-S&T2O3 MJPUG=A(*RLU72PVT5(6XD/-D*0Q-QN
M3P7[MG<*EYY7V[N.@(MBZ(\U;/#SJ@/G@SQSME(VJ$K 4G!&5\!1B=^ED;94
M D$F!&1R0,BO"8),"<CT()"+%@<.19 9 9D=$+(7R9R S \)F2+(@H LV"&?
MT5YR(L@C O+HD)',$.0[ O(=+^2BJ6OI'X1;BH5>60V'21@U9V7I&A@U$>1[
M O(]+^25VBC;J(!'[3$U;(]Y>2ZD]N)&FD:)3TJ&QK=C3.SAD59AULIL([61
M<,TA'#Y<2*/$N;J-8J'*QNN(,2FO3)C%<JZ\WL@V?Q 7VH),M#3@Z!!]=R3&
MI,PR85;+K/RG@8MV[;]"5S806N>W^T%V@3$IMTR8Y?(EKI7O!7)OLD.99<*L
MECGDH';57E3,0E#]#D/99,*LDZYWM(GBF5>5CN)"EFU:K?LC#J62";M+ZEK'
M;I39@D(^#ZFU@F?=AZ14,N%V273EM[4SE?+A%_$!NDU\P&R402;,"OD,YYW;
MTM5*O/GH0G@K+J&[+-;2PY\QXL$FH<R2,)OE$?%:?N\]UH322<*L$S)%Z*6M
M"3E-8=;)+DD0;ZY;]X6W&(P22,(LD%>RA1TGQJ0$DC +A,P:^H^9DDC"+!$R
M:^AC4DI)F)5"Z+A]\!B3\DK"[)472M[;>RBI),Q2>=W-'2K&I/R2,/MEG_OV
MQ3*E[)(RVX648+^40PDG918.EN#>&%*:29DU0]L0UT=2LA[&+)TG&P[%N0YR
MM?)JM1U] /P*5TA22CHILW00YM/BTKM:?))_.X\KH"DEG919.@AS5E7=7!"/
MZ1B3DD[*+)W7,HW'_RS&I*23,DOG-<S'T&),RCPILWG(:/9'2\H\*;-YZ+P-
M#T@9Y9Z,V3TT)JZ&9I1[LD/6SK[F&).R4,9L(1JSP)B4A3+NVAF)>80QR?<R
MS!:BYQ2]+D19*#OHU*?7A2@+9>S5- JSUX4H"V7,%J(Q>UV(LE#&;"&R_-RS
M4$99*&.V$#7?G=L-?K=)62AGMA"%"=LP)F6AG'T&]/.T?"C0Q -C4A;*F2VT
M#Q/EQQB3LE#.;*&]T83S5@VTN"7&I"R4LUOHU4I'^_0Q)OE] +N%",Q9A3$I
M"^7LGP@0;TS$$&-2%LJ9+;2W;O3<BS F9:'\ *]VT)B$,2D+Y8=\R]/_>(6R
M4''0.AQ.Y K*0L7_68?K"0@L*BXQ)F6A@MU"/<R?"S08D[)0P6RAOVP)5UZU
M'V.J2LRCJEO:E3;5,!EW+QV?,"D+%9V%1MW.X?2D4DMM5?49+A&@O92FO/2B
M_=E^WY'E[6O796/,&;1]L1^=K'8?9.X^)CW]%U!+ P04    " "$F6-1TDF\
M;1$"   7)@  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=D[;MM
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M              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ A)EC49U@@"D_!0  A14  !@              ("!# @  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (298U&:WMC>408  'D9   8
M              " @8$-  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    " "$F6-1H%W^0/L"  "D"0  &               @($(%   >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ A)EC4;XI&G]%!@
M8AL  !@              ("!.1<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+ 0(4 Q0    ( (298U&MVNQJE 0  +(2   8              " @;0=
M  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "$F6-11$'J
M4-D(  ":-   &               @(%^(@  >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&UL4$L! A0#%     @ A)EC49%V_'F) @  V 8  !@
M ("!C2L  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( (29
M8U']!8()_ 8  +L=   8              " @4PN  !X;"]W;W)K<VAE971S
M+W-H965T."YX;6Q02P$"% ,4    " "$F6-1G%5QMO4-  !T)   &
M        @(%^-0  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%
M  @ A)EC4;-"_?DW"P  TAL  !D              ("!J4,  'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "$F6-1R$&MHN\*  ">'P
M&0              @($73P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+
M 0(4 Q0    ( (298U$TL0QX=@4  )T.   9              " @3U:  !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ A)EC46F;!)>_
M"   IAL  !D              ("!ZE\  'AL+W=O<FMS:&5E=',O<VAE970Q
M,RYX;6Q02P$"% ,4    " "$F6-1]MJVAA0:  !O8   &0
M@('@:   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( (29
M8U&+XA!:/0,  #$'   9              " @2N#  !X;"]W;W)K<VAE971S
M+W-H965T,34N>&UL4$L! A0#%     @ A)EC46% (;QV!   /@H  !D
M         ("!GX8  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M    " "$F6-1J)2\^AD*  #1'@  &0              @(%,BP  >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( (298U' B<7GZ!\  (]E
M   9              " @9R5  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
M4$L! A0#%     @ A)EC43>0(^F]!0  ]@\  !D              ("!N[4
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "$F6-1#F&/
M\5P$  #I"P  &0              @(&ONP  >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;%!+ 0(4 Q0    ( (298U'P2R'(S00  *<,   9
M  " @4+   !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @
MA)EC4:[DDRIZ#@  F"@  !D              ("!1L4  'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6Q02P$"% ,4    " "$F6-1M(=EB+X(  ![%   &0
M            @('WTP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4
M Q0    ( (298U'2E[J&PP0  *X,   9              " @>S<  !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ A)EC4?0CN_6\!
M"PX  !D              ("!YN$  'AL+W=O<FMS:&5E=',O<VAE970R-2YX
M;6Q02P$"% ,4    " "$F6-14;)5',4$  #W#P  &0              @('9
MY@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( (298U$!
M"LP&.@,  (T'   9              " @=7K  !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL4$L! A0#%     @ A)EC4:G%X)0L!   7 T  !D
M     ("!1N\  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (298U%1_H,ZIP(  #P'   9              "
M@?(! 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ A)EC
M41!D6,SY%   ^*X  !D              ("!T 0! 'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6Q02P$"% ,4    " "$F6-1DP<_+/$"  !E"P  &0
M        @($ &@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0
M   ( (298U%FV?SF%@,  .4)   9              " @2@= 0!X;"]W;W)K
M<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ A)EC4:3@H+ ;"P  CUL
M !D              ("!=2 ! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q0
M2P$"% ,4    " "$F6-1!0>NN&T#   I#   &0              @(''*P$
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( (298U&AD31-
M] (  )8)   9              " @6LO 0!X;"]W;W)K<VAE971S+W-H965T
M,SDN>&UL4$L! A0#%     @ A)EC42Y=P$?]!   ]AH  !D
M ("!EC(! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " "$
MF6-1&G!LI[L"  !""0  &0              @('*-P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( (298U%7F^UHV@(  #8(   9
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M970T-BYX;6Q02P$"% ,4    " "$F6-1E".\\R8#   ."0  &0
M    @($=2P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (
M (298U&(TI-G9@,   D-   9              " @7I. 0!X;"]W;W)K<VAE
M971S+W-H965T-#@N>&UL4$L! A0#%     @ A)EC40\&CWA5#0  &U$  !D
M             ("!%U(! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"
M% ,4    " "$F6-1R1.Z.J("  !W!P  &0              @(&C7P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( (298U%,>@VG@0(
M &X&   9              " @7QB 0!X;"]W;W)K<VAE971S+W-H965T-3$N
M>&UL4$L! A0#%     @ A)EC42AI N$A!0  UAL  !D              ("!
M-&4! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " "$F6-1
MO^T; IT"  #I!@  &0              @(&,:@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;%!+ 0(4 Q0    ( (298U'EA61/N0(  &H'   9
M      " @6!M 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%
M  @ A)EC45-$ QFB"   )3T  !D              ("!4' ! 'AL+W=O<FMS
M:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " "$F6-1BJ_XS\H'   ],0
M&0              @($I>0$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+
M 0(4 Q0    ( (298U$A5!:.%@0  #H0   9              " @2J! 0!X
M;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ A)EC46MF\O-G
M P  1@P  !D              ("!=X4! 'AL+W=O<FMS:&5E=',O<VAE970U
M."YX;6Q02P$"% ,4    " "$F6-1P*ZX:VT%  "D&@  &0
M@($5B0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( (29
M8U&"<0ASL (  !$'   9              " @;F. 0!X;"]W;W)K<VAE971S
M+W-H965T-C N>&UL4$L! A0#%     @ A)EC4;Y7^C>_ P  N0P  !D
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M<R\N<F5L<U!+ 0(4 Q0    ( (298U'B\CWT]P0  - J   /
M  "  4"B 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "$F6-1TDF\;1$"
M   7)@  &@              @ %DIP$ >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " "$F6-1P(AM=.D!  !^)0  $P
M@ &MJ0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     2 !( *\3  #'JP$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>769</ContextCount>
  <ElementCount>396</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>146</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - Available-for-Sale Debt Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AvailableforSaleDebtSecurities</Role>
      <ShortName>Available-for-Sale Debt Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121105 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127106 - Disclosure - Acquisitions, Collaborations and Other Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements</Role>
      <ShortName>Acquisitions, Collaborations and Other Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2129107 - Disclosure - Other Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/OtherFinancialInformation</Role>
      <ShortName>Other Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2133108 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2138109 - Disclosure - Debt and Credit Facilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DebtandCreditFacilities</Role>
      <ShortName>Debt and Credit Facilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2142110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2144111 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.gilead.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/RevenuesTables</Role>
      <ShortName>Revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/Revenues</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/FairValueMeasurements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Available-for-Sale Debt Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables</Role>
      <ShortName>Available-for-Sale Debt Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/AvailableforSaleDebtSecurities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2330305 - Disclosure - Other Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/OtherFinancialInformationTables</Role>
      <ShortName>Other Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/OtherFinancialInformation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2334306 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/IntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2339307 - Disclosure - Debt and Credit Facilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DebtandCreditFacilitiesTables</Role>
      <ShortName>Debt and Credit Facilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/DebtandCreditFacilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2345308 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/StockholdersEquity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2349309 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2353310 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gilead.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Summary of Significant Accounting Policies Additional Details (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies Additional Details (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Revenues - Disaggregation of Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails</Role>
      <ShortName>Revenues - Disaggregation of Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenues - Revenues from Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails</Role>
      <ShortName>Revenues - Revenues from Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Revenues - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/RevenuesAdditionalInformationDetails</Role>
      <ShortName>Revenues - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Fair Value Measurements Summary of Assets and Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails</Role>
      <ShortName>Fair Value Measurements Summary of Assets and Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Fair Value Measurements Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Fair Value Measurements Summary of Classification of Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails</Role>
      <ShortName>Fair Value Measurements Summary of Classification of Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities at Estimated Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails</Role>
      <ShortName>Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities at Estimated Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Available-for-Sale Debt Securities - Summary of the Balance Sheet Classification of Available-for-Sale Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails</Role>
      <ShortName>Available-for-Sale Debt Securities - Summary of the Balance Sheet Classification of Available-for-Sale Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Available-for-Sale Debt Securities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails</Role>
      <ShortName>Available-for-Sale Debt Securities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities in a Continuous Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails</Role>
      <ShortName>Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities in a Continuous Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Derivative Financial Instruments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails</Role>
      <ShortName>Derivative Financial Instruments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Derivative Financial Instruments - Summary of Classification and Fair Value of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments - Summary of Classification and Fair Value of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - Derivative Financial Instruments - Summary of Effect of Foreign Currency Exchange Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails</Role>
      <ShortName>Derivative Financial Instruments - Summary of Effect of Foreign Currency Exchange Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - Derivative Financial Instruments - Summary of Potential Effect of Offsetting Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails</Role>
      <ShortName>Derivative Financial Instruments - Summary of Potential Effect of Offsetting Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2428417 - Disclosure - Acquisitions, Collaborations and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails</Role>
      <ShortName>Acquisitions, Collaborations and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Other Financial Information Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails</Role>
      <ShortName>Other Financial Information Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - Other Financial Information Other Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails</Role>
      <ShortName>Other Financial Information Other Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Summary of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Intangible Assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Intangible Assets - Schedule of Estimated Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Schedule of Estimated Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - Debt and Credit Facilities - Summary of Debt Carrying Amount (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails</Role>
      <ShortName>Debt and Credit Facilities - Summary of Debt Carrying Amount (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2441424 - Disclosure - Debt and Credit Facilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails</Role>
      <ShortName>Debt and Credit Facilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - Stockholders' Equity - Summary of Changes in Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Changes in Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Schedule of the Calculation of Basic and Diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Schedule of the Calculation of Basic and Diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2454430 - Disclosure - Income Taxes - Summary of the Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Summary of the Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="gild-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - gild-20200930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - gild-20200930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="gild-20200930.htm">gild-20200930.htm</File>
    <File>gild-20200930.xsd</File>
    <File>gild-20200930_cal.xml</File>
    <File>gild-20200930_def.xml</File>
    <File>gild-20200930_lab.xml</File>
    <File>gild-20200930_pre.xml</File>
    <File>gildq32020ex311.htm</File>
    <File>gildq32020ex312.htm</File>
    <File>gildq32020ex32.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>81
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "gild-20200930.htm": {
   "axisCustom": 1,
   "axisStandard": 28,
   "contextCount": 769,
   "dts": {
    "calculationLink": {
     "local": [
      "gild-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "gild-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "gild-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gild-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gild-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "gild-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 598,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 5
   },
   "keyCustom": 43,
   "keyStandard": 353,
   "memberCustom": 92,
   "memberStandard": 45,
   "nsprefix": "gild",
   "nsuri": "http://www.gilead.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityInteractiveDataCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.gilead.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityInteractiveDataCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Revenues",
     "role": "http://www.gilead.com/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Fair Value Measurements",
     "role": "http://www.gilead.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - Available-for-Sale Debt Securities",
     "role": "http://www.gilead.com/role/AvailableforSaleDebtSecurities",
     "shortName": "Available-for-Sale Debt Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121105 - Disclosure - Derivative Financial Instruments",
     "role": "http://www.gilead.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "gild:AcquisitionCollaborationsandOtherArrangementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127106 - Disclosure - Acquisitions, Collaborations and Other Arrangements",
     "role": "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements",
     "shortName": "Acquisitions, Collaborations and Other Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "gild:AcquisitionCollaborationsandOtherArrangementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129107 - Disclosure - Other Financial Information",
     "role": "http://www.gilead.com/role/OtherFinancialInformation",
     "shortName": "Other Financial Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133108 - Disclosure - Intangible Assets",
     "role": "http://www.gilead.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138109 - Disclosure - Debt and Credit Facilities",
     "role": "http://www.gilead.com/role/DebtandCreditFacilities",
     "shortName": "Debt and Credit Facilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.gilead.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144111 - Disclosure - Stockholders' Equity",
     "role": "http://www.gilead.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders",
     "role": "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders",
     "shortName": "Net Income (Loss) Per Share Attributable to Gilead Common Stockholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - Income Taxes",
     "role": "http://www.gilead.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenues (Tables)",
     "role": "http://www.gilead.com/role/RevenuesTables",
     "shortName": "Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.gilead.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Available-for-Sale Debt Securities (Tables)",
     "role": "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables",
     "shortName": "Available-for-Sale Debt Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Derivative Financial Instruments (Tables)",
     "role": "http://www.gilead.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330305 - Disclosure - Other Financial Information (Tables)",
     "role": "http://www.gilead.com/role/OtherFinancialInformationTables",
     "shortName": "Other Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334306 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.gilead.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339307 - Disclosure - Debt and Credit Facilities (Tables)",
     "role": "http://www.gilead.com/role/DebtandCreditFacilitiesTables",
     "shortName": "Debt and Credit Facilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "gild:AllowanceforAccountsReceivableandChargebacks",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "gild:AllowanceforAccountsReceivableandChargebacks",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345308 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.gilead.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349309 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders (Tables)",
     "role": "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables",
     "shortName": "Net Income (Loss) Per Share Attributable to Gilead Common Stockholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353310 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.gilead.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Summary of Significant Accounting Policies Additional Details (Details)",
     "role": "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails",
     "shortName": "Summary of Significant Accounting Policies Additional Details (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenues - Disaggregation of Revenues (Details)",
     "role": "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails",
     "shortName": "Revenues - Disaggregation of Revenues (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "iad03c82878af430ca095a94ae4b7784a_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "ib51bea2a549043ccb4d2d8b9b4e6f2fd_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenues - Revenues from Major Customers (Details)",
     "role": "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails",
     "shortName": "Revenues - Revenues from Major Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "ib51bea2a549043ccb4d2d8b9b4e6f2fd_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Revenues - Additional Information (Details)",
     "role": "http://www.gilead.com/role/RevenuesAdditionalInformationDetails",
     "shortName": "Revenues - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Fair Value Measurements Summary of Assets and Liabilities Measured at Fair Value (Details)",
     "role": "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
     "shortName": "Fair Value Measurements Summary of Assets and Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "idb5e4a50b9284e4d9af880ee03a84122_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Fair Value Measurements Additional Information (Details)",
     "role": "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "ia47f0a6fbe014c478d009387fe36168c_D20190701-20190930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i973aae8a8cc74f1285d8fcfa96228c98_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Fair Value Measurements Summary of Classification of Equity Securities (Details)",
     "role": "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails",
     "shortName": "Fair Value Measurements Summary of Classification of Equity Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i973aae8a8cc74f1285d8fcfa96228c98_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities at Estimated Fair Value (Details)",
     "role": "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
     "shortName": "Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities at Estimated Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Available-for-Sale Debt Securities - Summary of the Balance Sheet Classification of Available-for-Sale Debt Securities (Details)",
     "role": "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails",
     "shortName": "Available-for-Sale Debt Securities - Summary of the Balance Sheet Classification of Available-for-Sale Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8e30f2b68c584a1cae64f4692423ac60_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Available-for-Sale Debt Securities - Additional Information (Details)",
     "role": "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails",
     "shortName": "Available-for-Sale Debt Securities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i9ff69c4fb8e64039b4ddd0748345671c_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InterestReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i97f03d9c1ed5426d9d26ec720a56d292_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities in a Continuous Unrealized Loss Position (Details)",
     "role": "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails",
     "shortName": "Available-for-Sale Debt Securities - Summary of Available-for-Sale Debt Securities in a Continuous Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i97f03d9c1ed5426d9d26ec720a56d292_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Derivative Financial Instruments - Additional Information (Details)",
     "role": "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails",
     "shortName": "Derivative Financial Instruments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i9ff69c4fb8e64039b4ddd0748345671c_I20191231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Derivative Financial Instruments - Summary of Classification and Fair Value of Derivative Instruments (Details)",
     "role": "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails",
     "shortName": "Derivative Financial Instruments - Summary of Classification and Fair Value of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - Derivative Financial Instruments - Summary of Effect of Foreign Currency Exchange Contracts (Details)",
     "role": "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails",
     "shortName": "Derivative Financial Instruments - Summary of Effect of Foreign Currency Exchange Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - Derivative Financial Instruments - Summary of Potential Effect of Offsetting Derivatives (Details)",
     "role": "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails",
     "shortName": "Derivative Financial Instruments - Summary of Potential Effect of Offsetting Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428417 - Disclosure - Acquisitions, Collaborations and Other Arrangements (Details)",
     "role": "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
     "shortName": "Acquisitions, Collaborations and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i10ded791c9da4652a9c01c141f86a369_I20200529",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Other Financial Information Inventories (Details)",
     "role": "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails",
     "shortName": "Other Financial Information Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - Other Financial Information Other Accrued Liabilities (Details)",
     "role": "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails",
     "shortName": "Other Financial Information Other Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)",
     "role": "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
     "shortName": "Intangible Assets - Summary of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Intangible Assets - Additional Information (Details)",
     "role": "http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails",
     "shortName": "Intangible Assets - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Intangible Assets - Schedule of Estimated Future Amortization Expense (Details)",
     "role": "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails",
     "shortName": "Intangible Assets - Schedule of Estimated Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - Debt and Credit Facilities - Summary of Debt Carrying Amount (Details)",
     "role": "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails",
     "shortName": "Debt and Credit Facilities - Summary of Debt Carrying Amount (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LineOfCredit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "ic3c8da64f2584082a30059c2ef0db569_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441424 - Disclosure - Debt and Credit Facilities - Additional Information (Details)",
     "role": "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
     "shortName": "Debt and Credit Facilities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LineOfCredit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "ic3c8da64f2584082a30059c2ef0db569_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNumberOfPlaintiffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plaintiff",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNumberOfPlaintiffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plaintiff",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i8428dd318d974b2db41a333de386ece2_I20200930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "role": "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i83dbde55d11d4cca843046da3156ede0_I20160128",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i9ff69c4fb8e64039b4ddd0748345671c_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - Stockholders' Equity - Summary of Changes in Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Stockholders' Equity - Summary of Changes in Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i126913deb985494cbae4e16c0eefaaa0_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i1572613d4ff74b2786f78674a86e1d1d_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i1572613d4ff74b2786f78674a86e1d1d_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Additional Information (Details)",
     "role": "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails",
     "shortName": "Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Schedule of the Calculation of Basic and Diluted EPS (Details)",
     "role": "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails",
     "shortName": "Net Income (Loss) Per Share Attributable to Gilead Common Stockholders - Schedule of the Calculation of Basic and Diluted EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - Income Taxes - Summary of the Provision for Income Taxes (Details)",
     "role": "http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Summary of the Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "role": "http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical",
     "shortName": "Consolidated Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i5d99cbd2cf514ba994d16296651f280c_D20200701-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.gilead.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i268c8b20aecd4e98828852a2e0529281_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gild-20200930.htm",
      "contextRef": "i042635c737c840d7a0b0cc891e439e49_I20190101",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - gild-20200930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - gild-20200930.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 146,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "gild_A015LIBORSeniorUnsecuredNotesDueSeptember2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.15% LIBOR Senior Unsecured Notes Due September 2021",
        "label": "0.15% LIBOR Senior Unsecured Notes Due September 2021 [Member]",
        "terseLabel": "0.15% LIBOR Senior Unsecured Notes Due September 2021"
       }
      }
     },
     "localname": "A015LIBORSeniorUnsecuredNotesDueSeptember2021Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A052LIBORSeniorUnsecuredNotesDueSeptember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.52% LIBOR Senior Unsecured Notes Due September 2023",
        "label": "0.52% LIBOR Senior Unsecured Notes Due September 2023 [Member]",
        "terseLabel": "0.52% LIBOR Senior Unsecured Notes Due September 2023"
       }
      }
     },
     "localname": "A052LIBORSeniorUnsecuredNotesDueSeptember2023Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A075SeniorUnsecuredNotesDueSeptember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.75% Senior Unsecured Notes Due in September 2023 [Member]",
        "label": "0.75% Senior Unsecured Notes Due September 2023 [Member]",
        "terseLabel": "0.75% Senior Unsecured Notes Due September 2023"
       }
      }
     },
     "localname": "A075SeniorUnsecuredNotesDueSeptember2023Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A120SeniorUnsecuredNotesDueOctober2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.20% Senior Unsecured Notes Due October 2027",
        "label": "1.20% Senior Unsecured Notes Due October 2027 [Member]",
        "terseLabel": "1.20% Senior Unsecured Notes Due October 2027"
       }
      }
     },
     "localname": "A120SeniorUnsecuredNotesDueOctober2027Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A165SeniorUnsecuredNotesDueOctober2030Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.65% Senior Unsecured Notes Due October 2030",
        "label": "1.65% Senior Unsecured Notes Due October 2030 [Member]",
        "terseLabel": "1.65% Senior Unsecured Notes Due October 2030"
       }
      }
     },
     "localname": "A165SeniorUnsecuredNotesDueOctober2030Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A195SeniorUnsecuredNotesDueMarch2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.95% Senior Unsecured Notes Due March 2022 [Member]",
        "label": "1.95% Senior Unsecured Notes Due March 2022 [Member]",
        "terseLabel": "1.95% Senior Unsecured Notes Due March 2022"
       }
      }
     },
     "localname": "A195SeniorUnsecuredNotesDueMarch2022Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A2016StockRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2016 Stock Repurchase Program [Member]",
        "label": "2016 Stock Repurchase Program [Member]",
        "terseLabel": "2016 Stock Repurchase Program"
       }
      }
     },
     "localname": "A2016StockRepurchaseProgramMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A2020StockRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2020 Stock Repurchase Program [Member]",
        "label": "2020 Stock Repurchase Program [Member]",
        "terseLabel": "2020 Stock Repurchase Program"
       }
      }
     },
     "localname": "A2020StockRepurchaseProgramMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A235SeniorUnsecuredNotesDueFebruary2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.35% Senior Unsecured Notes Due February 2020",
        "label": "2.35% Senior Unsecured Notes Due February 2020 [Member]",
        "terseLabel": "2.35% Senior Unsecured Notes Due February 2020"
       }
      }
     },
     "localname": "A235SeniorUnsecuredNotesDueFebruary2020Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A250SeniorUnsecuredNotesDueSeptember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.50% Senior Unsecured Notes Due September 2023",
        "label": "2.50% Senior Unsecured Notes Due September 2023 [Member]",
        "terseLabel": "2.50% Senior Unsecured Notes Due September 2023"
       }
      }
     },
     "localname": "A250SeniorUnsecuredNotesDueSeptember2023Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A255SeniorUnsecuredNotesDueSeptember2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.55% Senior Unsecured Notes Due September 2020",
        "label": "2.55% Senior Unsecured Notes Due September 2020 [Member]",
        "terseLabel": "2.55% Senior Unsecured Notes Due September 2020"
       }
      }
     },
     "localname": "A255SeniorUnsecuredNotesDueSeptember2020Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A260SeniorUnsecuredNotesDueOctober2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.60% Senior Unsecured Notes Due October 2040",
        "label": "2.60% Senior Unsecured Notes Due October 2040 [Member]",
        "terseLabel": "2.60% Senior Unsecured Notes Due October 2040"
       }
      }
     },
     "localname": "A260SeniorUnsecuredNotesDueOctober2040Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A280SeniorUnsecuredNotesDueOctober2050Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.80% Senior Unsecured Notes Due October 2050",
        "label": "2.80% Senior Unsecured Notes Due October 2050 [Member]",
        "terseLabel": "2.80% Senior Unsecured Notes Due October 2050"
       }
      }
     },
     "localname": "A280SeniorUnsecuredNotesDueOctober2050Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A295SeniorUnsecuredNotesDueMarch2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.95% Senior Unsecured Notes Due March 2027 [Member]",
        "label": "2.95% Senior Unsecured Notes Due March 2027 [Member]",
        "terseLabel": "2.95% Senior Unsecured Notes Due March 2027"
       }
      }
     },
     "localname": "A295SeniorUnsecuredNotesDueMarch2027Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A325SeniorUnsecuredNotesDueSeptember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.25% Senior Unsecured Notes Due September 2022",
        "label": "3.25% Senior Unsecured Notes Due September 2022 [Member]",
        "terseLabel": "3.25% Senior Unsecured Notes Due September 2022"
       }
      }
     },
     "localname": "A325SeniorUnsecuredNotesDueSeptember2022Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A350SeniorUnsecuredNotesDueFebruary2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.50% Senior Unsecured Notes Due February 2025 [Member]",
        "label": "3.50% Senior Unsecured Notes Due February 2025 [Member]",
        "terseLabel": "3.50% Senior Unsecured Notes Due February 2025"
       }
      }
     },
     "localname": "A350SeniorUnsecuredNotesDueFebruary2025Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A365SeniorUnsecuredNotesDueMarch2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.65% Senior Unsecured Notes Due March 2026",
        "label": "3.65% Senior Unsecured Notes Due March 2026 [Member]",
        "terseLabel": "3.65% Senior Unsecured Notes Due March 2026"
       }
      }
     },
     "localname": "A365SeniorUnsecuredNotesDueMarch2026Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A370SeniorUnsecuredNotesDueApril2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.70% Senior Unsecured Notes Due April 2024 [Member]",
        "label": "3.70% Senior Unsecured Notes Due April 2024 [Member]",
        "terseLabel": "3.70% Senior Unsecured Notes Due April 2024"
       }
      }
     },
     "localname": "A370SeniorUnsecuredNotesDueApril2024Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A400SeniorUnsecuredNotesDueSeptember2036Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.00% Senior Unsecured Notes Due September 2036",
        "label": "4.00% Senior Unsecured Notes Due September 2036 [Member]",
        "terseLabel": "4.00% Senior Unsecured Notes Due September 2036"
       }
      }
     },
     "localname": "A400SeniorUnsecuredNotesDueSeptember2036Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A415SeniorUnsecuredNotesDueMarch2047Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.15% Senior Unsecured Notes Due March 2047 [Member]",
        "label": "4.15% Senior Unsecured Notes Due March 2047 [Member]",
        "terseLabel": "4.15% Senior Unsecured Notes Due March 2047"
       }
      }
     },
     "localname": "A415SeniorUnsecuredNotesDueMarch2047Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A440SeniorUnsecuredNotesDueDecember2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.40% Senior Unsecured Notes Due December 2021",
        "label": "4.40% Senior Unsecured Notes Due December 2021 [Member]",
        "terseLabel": "4.40% Senior Unsecured Notes Due December 2021"
       }
      }
     },
     "localname": "A440SeniorUnsecuredNotesDueDecember2021Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A450SeniorUnsecuredNotesDueApril2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.50% Senior Unsecured Notes Due April 2021 [Member]",
        "label": "4.50% Senior Unsecured Notes Due April 2021 [Member]",
        "terseLabel": "4.50% Senior Unsecured Notes Due April 2021"
       }
      }
     },
     "localname": "A450SeniorUnsecuredNotesDueApril2021Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A450SeniorUnsecuredNotesDueFebruary2045Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.50% Senior Unsecured Notes Due February 2045 [Member]",
        "label": "4.50% Senior Unsecured Notes Due February 2045 [Member]",
        "terseLabel": "4.50% Senior Unsecured Notes Due February 2045"
       }
      }
     },
     "localname": "A450SeniorUnsecuredNotesDueFebruary2045Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A460SeniorUnsecuredNotesDueSeptember2035Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.60% Senior Unsecured Notes Due September 2035",
        "label": "4.60% Senior Unsecured Notes Due September 2035 [Member]",
        "terseLabel": "4.60% Senior Unsecured Notes Due September 2035"
       }
      }
     },
     "localname": "A460SeniorUnsecuredNotesDueSeptember2035Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A475SeniorUnsecuredNotesDueMarch2046Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.75% Senior Unsecured Notes Due March 2046 [Member]",
        "label": "4.75% Senior Unsecured Notes Due March 2046 [Member]",
        "terseLabel": "4.75% Senior Unsecured Notes Due March 2046"
       }
      }
     },
     "localname": "A475SeniorUnsecuredNotesDueMarch2046Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A480SeniorUnsecuredNotesDueApril2044Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.80% Senior Unsecured Notes Due April 2044 [Member]",
        "label": "4.80% Senior Unsecured Notes Due April 2044 [Member]",
        "terseLabel": "4.80% Senior Unsecured Notes Due April 2044"
       }
      }
     },
     "localname": "A480SeniorUnsecuredNotesDueApril2044Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_A565SeniorUnsecuredNotesDueDecember2041Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.65% Senior Unsecured Notes Due December 2041 [Member]",
        "label": "5.65% Senior Unsecured Notes Due December 2041 [Member]",
        "terseLabel": "5.65% Senior Unsecured Notes Due December 204"
       }
      }
     },
     "localname": "A565SeniorUnsecuredNotesDueDecember2041Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_Accruedgovernmentandotherrebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued government and other rebates",
        "label": "Accrued government and other rebates",
        "terseLabel": "Accrued government and other rebates"
       }
      }
     },
     "localname": "Accruedgovernmentandotherrebates",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_AcquisitionCollaborationsAndOtherArrangementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acquisition, Collaborations and Other Arrangements [Line Items]",
        "label": "Acquisition, Collaborations and Other Arrangements [Line Items]",
        "terseLabel": "Acquisition, Collaborations and Other Arrangements [Line Items]"
       }
      }
     },
     "localname": "AcquisitionCollaborationsAndOtherArrangementsLineItems",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gild_AcquisitionCollaborationsAndOtherArrangementsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acquisition, Collaborations and Other Arrangements [Table]",
        "label": "Acquisition, Collaborations and Other Arrangements [Table]",
        "terseLabel": "Acquisition, Collaborations and Other Arrangements [Table]"
       }
      }
     },
     "localname": "AcquisitionCollaborationsAndOtherArrangementsTable",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gild_AcquisitionCollaborationsandOtherArrangementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acquisition, Collaboratiions and Other Arrangements [Text Block]",
        "label": "Acquisition, Collaborations and Other Arrangements [Text Block]",
        "terseLabel": "Acquisitions, Collaborations and Other Arrangements"
       }
      }
     },
     "localname": "AcquisitionCollaborationsandOtherArrangementsTextBlock",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "gild_AcquisitionsCollaborationsAndOtherArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acquisitions, Collaborations and Other Arrangements [Abstract]",
        "label": "Acquisitions, Collaborations and Other Arrangements [Abstract]",
        "terseLabel": "Acquisition, Collaborations and Other Arrangements [Abstract]"
       }
      }
     },
     "localname": "AcquisitionsCollaborationsAndOtherArrangementsAbstract",
     "nsuri": "http://www.gilead.com/20200930",
     "xbrltype": "stringItemType"
    },
    "gild_AdditionalInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional Information [Abstract]",
        "label": "Additional Information [Abstract]",
        "terseLabel": "Additional Information [Abstract]"
       }
      }
     },
     "localname": "AdditionalInformationAbstract",
     "nsuri": "http://www.gilead.com/20200930",
     "xbrltype": "stringItemType"
    },
    "gild_AllowanceforAccountsReceivableandChargebacks": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance for accounts receivable and other receivables not elsewhere defined in the taxonomy.",
        "label": "Allowance for Accounts Receivable and Chargebacks",
        "terseLabel": "Allowance for accounts receivable"
       }
      }
     },
     "localname": "AllowanceforAccountsReceivableandChargebacks",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amended and Restated Research Collaboration and License Agreement and Stock Purchase Agreement",
        "label": "Amended and Restated Research Collaboration and License Agreement and Stock Purchase Agreement [Member]",
        "terseLabel": "the \u201cCollaboration and Stock Purchase Agreements\u201d"
       }
      }
     },
     "localname": "AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_AmerisourcebergenCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "AmerisourceBergen Corp [Member]",
        "label": "AmerisourceBergen Corp [Member]",
        "terseLabel": "AmerisourceBergen Corporation"
       }
      }
     },
     "localname": "AmerisourcebergenCorpMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_ArcusBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arcus Biosciences, Inc.",
        "label": "Arcus Biosciences, Inc. [Member]",
        "terseLabel": "Arcus"
       }
      }
     },
     "localname": "ArcusBiosciencesIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_AssetAcquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gild_AssetAcquisitionCashOutflowNetOfCashAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Acquisition Cash Outflow Net Of Cash Acquired",
        "label": "Asset Acquisition Cash Outflow Net Of Cash Acquired",
        "terseLabel": "Total consideration, net of acquired cash"
       }
      }
     },
     "localname": "AssetAcquisitionCashOutflowNetOfCashAcquired",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_AssetAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Acquisition, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Net of Cash",
        "label": "Asset Acquisition, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Net of Cash",
        "terseLabel": "Assets acquired, net of cash"
       }
      }
     },
     "localname": "AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsNetOfCash",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_AxicabtageneciloleucelDLBCLMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "axicabtagene ciloleucel (DLBCL) [Member]",
        "label": "axicabtagene ciloleucel (DLBCL) [Member]",
        "terseLabel": "Intangible asset - axicabtagene ciloleucel"
       }
      }
     },
     "localname": "AxicabtageneciloleucelDLBCLMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_COVID19ProductsVekluryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "COVID-19 Products, Veklury",
        "label": "COVID-19 Products, Veklury [Member]",
        "terseLabel": "Veklury"
       }
      }
     },
     "localname": "COVID19ProductsVekluryMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_CardinalHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardinal Health Inc [Member]",
        "label": "Cardinal Health Inc [Member]",
        "terseLabel": "Cardinal Health, Inc."
       }
      }
     },
     "localname": "CardinalHealthIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_CashPaymentsMadeRelatedToEquityInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Payments Made Related to Equity Investments",
        "label": "Cash Payments Made Related to Equity Investments",
        "terseLabel": "Cash payments made related to equity investments"
       }
      }
     },
     "localname": "CashPaymentsMadeRelatedToEquityInvestments",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_CollaborativeArrangementTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, Term",
        "label": "Collaborative Arrangement, Term",
        "terseLabel": "Collaborative term"
       }
      }
     },
     "localname": "CollaborativeArrangementTerm",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gild_CommonStockPurchaseAgreementAndInvestorRightsAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock Purchase Agreement and Investor Rights Agreement",
        "label": "Common Stock Purchase Agreement and Investor Rights Agreement [Member]",
        "terseLabel": "the \u201cStock Purchase Agreements\u201d"
       }
      }
     },
     "localname": "CommonStockPurchaseAgreementAndInvestorRightsAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_CreditFacilityDueJune2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Facility Due June 2025",
        "label": "Credit Facility Due June 2025 [Member]",
        "terseLabel": "the \"2020 Revolving Credit Facility\""
       }
      }
     },
     "localname": "CreditFacilityDueJune2025Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_CreditFacilityDueMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Facility Due May 2021 [Member]",
        "label": "Credit Facility Due May 2021 [Member]",
        "terseLabel": "the \"2016 Revolving Credit Facility\""
       }
      }
     },
     "localname": "CreditFacilityDueMay2021Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_DebtInstrumentCallFeaturePeriodBeforeMaturity": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Call Feature, Period Before Maturity",
        "label": "Debt Instrument, Call Feature, Period Before Maturity",
        "terseLabel": "Call feature, period prior to maturity"
       }
      }
     },
     "localname": "DebtInstrumentCallFeaturePeriodBeforeMaturity",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gild_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Redemption Price, Basis Spread On Variable Rate To Discount Remaining Payments",
        "label": "Debt Instrument, Redemption Price, Basis Spread On Variable Rate To Discount Remaining Payments",
        "terseLabel": "Basis spread on variable rate to discount remaining payments"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPriceBasisSpreadOnVariableRateToDiscountRemainingPayments",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gild_DeferredCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Compensation Plan [Member]",
        "label": "Deferred Compensation Plan [Member]",
        "terseLabel": "Deferred compensation plan"
       }
      }
     },
     "localname": "DeferredCompensationPlanMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_DevelopmentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Development Agreement",
        "label": "Development Agreement [Member]",
        "terseLabel": "Development Agreement"
       }
      }
     },
     "localname": "DevelopmentAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_EquityMethodInvestmentOptionExerciseFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Option Exercise Fee",
        "label": "Equity Method Investment, Option Exercise Fee",
        "terseLabel": "Option exercise fee"
       }
      }
     },
     "localname": "EquityMethodInvestmentOptionExerciseFee",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Option Fee And Potential Future Milestone Payments",
        "label": "Equity Method Investment, Option Fee And Potential Future Milestone Payments",
        "terseLabel": "Option fee and potential future milestone payments"
       }
      }
     },
     "localname": "EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Additional Option Fee on Fourth, Sixth, and Eighth Anniversaries",
        "label": "Equity Securities, FV-NI, Additional Option Fee on Fourth, Sixth, and Eighth Anniversaries",
        "terseLabel": "Additional option fee on 4th, 6th, and 8th anniversaries"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Additional Option Fee on Second Anniversary",
        "label": "Equity Securities, FV-NI, Additional Option Fee on Second Anniversary",
        "terseLabel": "Additional option fee on second anniversary"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_EquitySecuritiesFVNIFutureMaximumMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Future Maximum Milestone Payments",
        "label": "Equity Securities, FV-NI, Future Maximum Milestone Payments",
        "terseLabel": "Future maximum milestone payments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIFutureMaximumMilestonePayments",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Maximum Percentage Of Outstanding Stock Allowed To Be Purchased",
        "label": "Equity Securities, FV-NI, Maximum Percentage Of Outstanding Stock Allowed To Be Purchased",
        "terseLabel": "Maximum percentage of outstanding stock allowed to be purchased"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gild_EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Option Opt-in, Extension and Milestone Payments",
        "label": "Equity Securities, FV-NI, Option Opt-in, Extension and Milestone Payments",
        "terseLabel": "Opt-in, extension and milestone payments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_EquitySecuritiesFVNIPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Purchase Period",
        "label": "Equity Securities, FV-NI, Purchase Period",
        "terseLabel": "Purchase period"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIPurchasePeriod",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gild_EquitySecuritiesFVNIRestrictionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Restriction Period",
        "label": "Equity Securities, FV-NI, Restriction Period",
        "terseLabel": "Restriction period"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIRestrictionPeriod",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gild_EquityinvestmentinGalapagosMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity investment in Galapagos [Member]",
        "label": "Equity investment in Galapagos [Member]",
        "terseLabel": "Equity investment in Galapagos"
       }
      }
     },
     "localname": "EquityinvestmentinGalapagosMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite-Lived And Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)",
        "label": "Finite-Lived And Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)",
        "totalLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)",
        "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)",
        "terseLabel": "Foreign Currency Translation Adjustment, finite-lived assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fixed Rate Senior Unsecured Note Issued September 2020",
        "label": "Fixed Rate Senior Unsecured Note Issued September 2020 [Member]",
        "terseLabel": "the \"2020 Fixed Rate Notes\""
       }
      }
     },
     "localname": "FixedRateSeniorUnsecuredNoteIssuedSeptember2020Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_ForeignCurrencyDerivativeContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign Currency Derivative Contracts [Member]",
        "label": "Foreign Currency Derivative Contracts [Member]",
        "terseLabel": "Foreign currency derivative contracts"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeContractsMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_FortySevenIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forty Seven, Inc. [Member]",
        "label": "Forty Seven, Inc. [Member]",
        "terseLabel": "Forty Seven"
       }
      }
     },
     "localname": "FortySevenIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_GadetaBVCollaborationArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gadeta B.V. Collaboration Arrangement",
        "label": "Gadeta B.V. Collaboration Arrangement [Member]",
        "terseLabel": "Gadeta Collaboration Arrangement"
       }
      }
     },
     "localname": "GadetaBVCollaborationArrangementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_GalapagosMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Galapagos [Member]",
        "label": "Galapagos [Member]",
        "terseLabel": "Galapagos"
       }
      }
     },
     "localname": "GalapagosMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HCVProductsLedipasvirSofosbuvirMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HCV Products, Ledipasvir/Sofosbuvir",
        "label": "HCV Products, Ledipasvir/Sofosbuvir [Member]",
        "terseLabel": "Ledipasvir/Sofosbuvir"
       }
      }
     },
     "localname": "HCVProductsLedipasvirSofosbuvirMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HCVProductsSofosbuvirVelpatasvirMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HCV Products, Sofosbuvir/Velpatasvir",
        "label": "HCV Products, Sofosbuvir/Velpatasvir [Member]",
        "terseLabel": "Sofosbuvir/Velpatasvir"
       }
      }
     },
     "localname": "HCVProductsSofosbuvirVelpatasvirMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HCVProductsVoseviMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HCV Products, Vosevi [Member]",
        "label": "HCV Products, Vosevi [Member]",
        "terseLabel": "Vosevi"
       }
      }
     },
     "localname": "HCVProductsVoseviMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsAtriplaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Atripla [Member]",
        "label": "HIV Products, Atripla [Member]",
        "terseLabel": "Atripla"
       }
      }
     },
     "localname": "HIVProductsAtriplaMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsBiktarvyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Biktarvy [Member]",
        "label": "HIV Products, Biktarvy [Member]",
        "terseLabel": "Biktarvy"
       }
      }
     },
     "localname": "HIVProductsBiktarvyMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsCompleraEvipleraMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Complera/Eviplera [Member]",
        "label": "HIV Products, Complera/Eviplera [Member]",
        "terseLabel": "Complera/Eviplera"
       }
      }
     },
     "localname": "HIVProductsCompleraEvipleraMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsDescovyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Descovy [Member]",
        "label": "HIV Products, Descovy [Member]",
        "terseLabel": "Descovy"
       }
      }
     },
     "localname": "HIVProductsDescovyMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsGenvoyaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Genvoya [Member]",
        "label": "HIV Products, Genvoya [Member]",
        "terseLabel": "Genvoya"
       }
      }
     },
     "localname": "HIVProductsGenvoyaMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsOdefseyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Odefsey [Member]",
        "label": "HIV Products, Odefsey [Member]",
        "terseLabel": "Odefsey"
       }
      }
     },
     "localname": "HIVProductsOdefseyMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsStribildMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Stribild [Member]",
        "label": "HIV Products, Stribild [Member]",
        "terseLabel": "Stribild"
       }
      }
     },
     "localname": "HIVProductsStribildMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_HIVProductsTruvadaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIV Products, Truvada [Member]",
        "label": "HIV Products, Truvada [Member]",
        "terseLabel": "Truvada"
       }
      }
     },
     "localname": "HIVProductsTruvadaMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_ImmunomedicsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Immunomedics, Inc. (\u201cImmunomedics\u201d), a leading company in antibody-drug conjugate (\u201cADC\u201d) technology",
        "label": "Immunomedics, Inc. [Member]",
        "terseLabel": "Immunomedics"
       }
      }
     },
     "localname": "ImmunomedicsIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)",
        "label": "Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss), Cumulative Gain (Loss)",
        "terseLabel": "Foreign Currency Translation Adjustment, indefinite-lived assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_IndenixMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indenix [Member]",
        "label": "Indenix [Member]",
        "terseLabel": "Indenix"
       }
      }
     },
     "localname": "IndenixMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_IntangibleAssetSofosbuvirMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sofosbuvir [Member]",
        "label": "Intangible Asset - Sofosbuvir [Member]",
        "terseLabel": "Intangible asset - sofosbuvir"
       }
      }
     },
     "localname": "IntangibleAssetSofosbuvirMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_InventoryNetAndInventoryNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inventory Net And Inventory Noncurrent",
        "label": "Inventory Net And Inventory Noncurrent",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNetAndInventoryNoncurrent",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_InvestmentOwnedBalanceAdditionalPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment Owned, Balance, Additional Payable",
        "label": "Investment Owned, Balance, Additional Payable",
        "terseLabel": "Additional payable accrued"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceAdditionalPayable",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_InvestmentOwnedBalanceAdditionalShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment Owned, Balance, Additional Shares",
        "label": "Investment Owned, Balance, Additional Shares",
        "terseLabel": "Additional equity securities owned (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceAdditionalShares",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gild_IssuanceDiscountPremium": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Issuance Discount (Premium)",
        "label": "Issuance Discount (Premium)",
        "terseLabel": "Issuance discount (premium)"
       }
      }
     },
     "localname": "IssuanceDiscountPremium",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_JounceTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Jounce Therapeutics, Inc.",
        "label": "Jounce Therapeutics, Inc. [Member]",
        "terseLabel": "Jounce"
       }
      }
     },
     "localname": "JounceTherapeuticsIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_JudgmentEnhancedDamagesonPastSales": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Judgment: Enhanced Damages on Past Sales",
        "label": "Judgment: Enhanced Damages on Past Sales",
        "terseLabel": "Enhancement rate on past damages"
       }
      }
     },
     "localname": "JudgmentEnhancedDamagesonPastSales",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gild_JudgmentRoyaltyRateFromOctober2017": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Judgment: Royalty Rate from October 2017",
        "label": "Judgment: Royalty Rate from October 2017",
        "terseLabel": "Running royalty rate from October 2017"
       }
      }
     },
     "localname": "JudgmentRoyaltyRateFromOctober2017",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gild_JudgmentRoyaltyRateOnFutureSales": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Judgment: Royalty Rate on Future Sales",
        "label": "Judgment: Royalty Rate on Future Sales",
        "terseLabel": "Running royalty rate on future sales"
       }
      }
     },
     "localname": "JudgmentRoyaltyRateOnFutureSales",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gild_JunoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Juno [Member]",
        "label": "Juno [Member]",
        "terseLabel": "Juno"
       }
      }
     },
     "localname": "JunoMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_LicenseRegistrationRightsAndStockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "License, Registration Rights and Stock Purchase Agreement",
        "label": "License, Registration Rights and Stock Purchase Agreement [Member]",
        "terseLabel": "the \"License and Stock Purchase Agreement\""
       }
      }
     },
     "localname": "LicenseRegistrationRightsAndStockPurchaseAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Estimate of Possible Loss (50% Enhancement of Past Damages)",
        "label": "Loss Contingency, Estimate of Possible Loss (50% Enhancement of Past Damages)",
        "terseLabel": "Estimate of possible loss representing enhancement of past damages"
       }
      }
     },
     "localname": "LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_LossContingencyEstimateofPossibleLossPastSales": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Estimate of Possible Loss (Past Sales)",
        "label": "Loss Contingency, Estimate of Possible Loss (Past Sales)",
        "terseLabel": "Estimate of possible loss representing past sales"
       }
      }
     },
     "localname": "LossContingencyEstimateofPossibleLossPastSales",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Estimate of Possible Loss (Royalties and Prejudgment Interest)",
        "label": "Loss Contingency, Estimate of Possible Loss (Royalties and Prejudgment Interest)",
        "terseLabel": "Estimate of possible loss representing royalties and prejudgment interest"
       }
      }
     },
     "localname": "LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_LossContingencyMotionInvalidatedForPastDamagesValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Motion Invalidated For Past Damages, Value",
        "label": "Loss Contingency, Motion Invalidated For Past Damages, Value",
        "terseLabel": "Past damages vacated"
       }
      }
     },
     "localname": "LossContingencyMotionInvalidatedForPastDamagesValue",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_MarketableSecuritiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Marketable Securities, Current [Member]",
        "label": "Marketable Securities, Current [Member]",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrentMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_MarketableSecuritiesNoncurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Marketable Securities, Noncurrent [Member]",
        "label": "Marketable Securities, Noncurrent [Member]",
        "terseLabel": "Long-term marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrentMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_MckessonCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "McKesson Corp [Member]",
        "label": "McKesson Corp [Member]",
        "terseLabel": "McKesson Corporation"
       }
      }
     },
     "localname": "MckessonCorpMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_NumberOfAgreements": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Agreements",
        "label": "Number of Agreements",
        "terseLabel": "Number of agreements"
       }
      }
     },
     "localname": "NumberOfAgreements",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "gild_NumberOfPrograms": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Programs",
        "label": "Number of Programs",
        "terseLabel": "Number of programs"
       }
      }
     },
     "localname": "NumberOfPrograms",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "gild_OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An option, license and collaboration agreement (the \u201cCollaboration Agreement\u201d) and a common stock purchase agreement and an investor rights agreement (together, the \u201cStock Purchase Agreements\u201d).",
        "label": "Option, License and Collaboration Agreement and Common Stock Purchase Agreement and Investor Rights Agreement [Member]",
        "terseLabel": "the \u201cCollaboration Agreement\" and the \u201cStock Purchase Agreements\u201d"
       }
      }
     },
     "localname": "OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An option, license and collaboration Agreement (the \u201cCollaboration Agreement\u201d) and a Subscription Agreement (the \u201cSubscription Agreement\u201d)",
        "label": "Option License and Collaboration Agreement and Subscription Agreement [Member]",
        "terseLabel": "the \"Collaboration Agreement\" and \"Subscription Agreement\""
       }
      }
     },
     "localname": "OptionLicenseAndCollaborationAgreementAndSubscriptionAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OptionLicenseAndCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Option, License and Collaboration Agreement",
        "label": "Option, License and Collaboration Agreement [Member]",
        "terseLabel": "the \u201cCollaboration Agreement\""
       }
      }
     },
     "localname": "OptionLicenseAndCollaborationAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherCollaborationArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Collaboration Arrangements [Member]",
        "label": "Other Collaboration Arrangements [Member]",
        "terseLabel": "Other Arrangements"
       }
      }
     },
     "localname": "OtherCollaborationArrangementsMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Equity Securities [Member]",
        "label": "Other Equity Securities [Member]",
        "terseLabel": "Other Equity Securities"
       }
      }
     },
     "localname": "OtherEquitySecuritiesMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Financial Information",
        "label": "Other Financial Information [Abstract]",
        "terseLabel": "Other Financial Information [Abstract]"
       }
      }
     },
     "localname": "OtherFinancialInformationAbstract",
     "nsuri": "http://www.gilead.com/20200930",
     "xbrltype": "stringItemType"
    },
    "gild_OtherInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other International [Member]",
        "label": "Other International [Member]",
        "terseLabel": "Other International"
       }
      }
     },
     "localname": "OtherInternationalMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsAmBisomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, AmBisome [Member]",
        "label": "Other Products, AmBisome [Member]",
        "terseLabel": "AmBisome"
       }
      }
     },
     "localname": "OtherProductsAmBisomeMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsLetairisMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, Letairis [Member]",
        "label": "Other Products, Letairis [Member]",
        "terseLabel": "Letairis"
       }
      }
     },
     "localname": "OtherProductsLetairisMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, Other [Member]",
        "label": "Other Products, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductsOtherMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsRanexaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, Ranexa [Member]",
        "label": "Other Products, Ranexa [Member]",
        "terseLabel": "Ranexa"
       }
      }
     },
     "localname": "OtherProductsRanexaMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsVemlidyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, Vemlidy [Member]",
        "label": "Other Products, Vemlidy [Member]",
        "terseLabel": "Vemlidy"
       }
      }
     },
     "localname": "OtherProductsVemlidyMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsVireadMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, Viread [Member]",
        "label": "Other Products, Viread [Member]",
        "terseLabel": "Viread"
       }
      }
     },
     "localname": "OtherProductsVireadMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsYescartaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, Yescarta [Member]",
        "label": "Other Products, Yescarta [Member]",
        "terseLabel": "Yescarta"
       }
      }
     },
     "localname": "OtherProductsYescartaMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_OtherProductsZydeligMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Products, Zydelig [Member]",
        "label": "Other Products, Zydelig [Member]",
        "terseLabel": "Zydelig"
       }
      }
     },
     "localname": "OtherProductsZydeligMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payment for license and option rights for equity investments upon closing of collaboration agreement",
        "label": "Payment for License and Option Rights for Equity Investments Upon Closing",
        "terseLabel": "License and option rights paid upon closing"
       }
      }
     },
     "localname": "PaymentForLicenseAndOptionRightsForEquityInvestmentsUponClosing",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_PaymentsForDirectTransactionalExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments for Direct Transactional Expense",
        "label": "Payments for Direct Transactional Expense",
        "terseLabel": "Payments for direct transactional costs"
       }
      }
     },
     "localname": "PaymentsForDirectTransactionalExpense",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_PionyrImmunotherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pionyr Immunotherapeutics, Inc.",
        "label": "Pionyr Immunotherapeutics, Inc. [Member]",
        "terseLabel": "Pionyr"
       }
      }
     },
     "localname": "PionyrImmunotherapeuticsIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_PionyrMergerAndOptionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pionyr Merger and Option Agreements",
        "label": "Pionyr Merger and Option Agreements [Member]",
        "terseLabel": "the \"Pionyr Merger and Option Agreements\""
       }
      }
     },
     "localname": "PionyrMergerAndOptionAgreementsMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_PotentialFutureMaximumMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Potential Future Maximum Milestone Payments",
        "label": "Potential Future Maximum Milestone Payments",
        "terseLabel": "Potential future maximum milestone payments"
       }
      }
     },
     "localname": "PotentialFutureMaximumMilestonePayments",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_ProductsOtherHIVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Products, Other HIV [Member]",
        "label": "Products, Other HIV [Member]",
        "terseLabel": "Other HIV"
       }
      }
     },
     "localname": "ProductsOtherHIVMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_ProductsRevenueShareSymtuzaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Products, Revenue Share-Symtuza [Member]",
        "label": "Products, Revenue Share-Symtuza [Member]",
        "terseLabel": "Revenue share - Symtuza"
       }
      }
     },
     "localname": "ProductsRevenueShareSymtuzaMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_ResearchAndDevelopmentFutureMaximumPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Future Maximum Payments",
        "label": "Research And Development Future Maximum Payments",
        "terseLabel": "Potential maximum future milestone payments"
       }
      }
     },
     "localname": "ResearchAndDevelopmentFutureMaximumPayments",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_ResearchAndDevelopmentServiceAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Service Agreement",
        "label": "Research And Development Service Agreement [Member]",
        "terseLabel": "Research and Development Service Agreement"
       }
      }
     },
     "localname": "ResearchAndDevelopmentServiceAgreementMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_ResidentialMortgageAndAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Residential Mortgage And Asset-Backed Securities [Member]",
        "label": "Residential Mortgage And Asset-Backed Securities [Member]",
        "terseLabel": "Residential mortgage and asset-backed securities",
        "verboseLabel": "Residential mortgage and asset-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageAndAssetBackedSecuritiesMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenues recognized from performance obligations satisfied in previous periods",
        "label": "Revenues recognized from performance obligations satisfied in previous periods",
        "terseLabel": "Revenues recognized from performance obligations satisfied in prior periods"
       }
      }
     },
     "localname": "Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/RevenuesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_RoyaltyContractAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Royalty, Contract, And Other [Member]",
        "label": "Royalty, Contract, And Other [Member]",
        "terseLabel": "Royalty, contract and other revenues"
       }
      }
     },
     "localname": "RoyaltyContractAndOtherMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_SeniorUnsecuredNoteIssuedNovember2014Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Unsecured Note Issued November 2014",
        "label": "Senior Unsecured Note Issued November 2014 [Member]",
        "terseLabel": "the \"2014 Senior Notes\""
       }
      }
     },
     "localname": "SeniorUnsecuredNoteIssuedNovember2014Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_SeniorUnsecuredNoteIssuedSeptember2015Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Unsecured Note Issued September 2015",
        "label": "Senior Unsecured Note Issued September 2015 [Member]",
        "terseLabel": "the \"2015 Senior Notes\""
       }
      }
     },
     "localname": "SeniorUnsecuredNoteIssuedSeptember2015Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_SeniorUnsecuredNoteIssuedSeptember2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Unsecured Note Issued September 2020",
        "label": "Senior Unsecured Note Issued September 2020 [Member]",
        "terseLabel": "the \"2020 Senior Notes\""
       }
      }
     },
     "localname": "SeniorUnsecuredNoteIssuedSeptember2020Member",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_TangoTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tango Therapeutics, Inc.",
        "label": "Tango Therapeutics, Inc. [Member]",
        "terseLabel": "Tango"
       }
      }
     },
     "localname": "TangoTherapeuticsIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_ThreeYearSeniorUnsecuredTermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Three Year Senior Unsecured Term Loan Facility",
        "label": "Three Year Senior Unsecured Term Loan Facility [Member]",
        "terseLabel": "Three-Year Senior Term Loan Facility"
       }
      }
     },
     "localname": "ThreeYearSeniorUnsecuredTermLoanFacilityMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_TizonaMergerAndOptionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tizona Merger and Option Agreements",
        "label": "Tizona Merger and Option Agreements [Member]",
        "terseLabel": "the \"Tizona Merger and Option Agreements\""
       }
      }
     },
     "localname": "TizonaMergerAndOptionAgreementsMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_TizonaTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tizona Therapeutics, Inc.",
        "label": "Tizona Therapeutics, Inc. [Member]",
        "terseLabel": "Tizona"
       }
      }
     },
     "localname": "TizonaTherapeuticsIncMember",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gild_TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total carrying amount of assets (excluding financial assets) that lack physical substance, excluding goodwill, having a projected indefinite period of benefit.",
        "label": "Total Indefinite Lived Intangible Assets Excluding Goodwill",
        "totalLabel": "Net Carrying Amount, indefinite-lived assets"
       }
      }
     },
     "localname": "TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_TotalUpfrontPaymentsMade": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Upfront Payments Made",
        "label": "Total Upfront Payments Made",
        "terseLabel": "Total upfront payments made"
       }
      }
     },
     "localname": "TotalUpfrontPaymentsMade",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upfront Collaboration Expenses Related to Other Collaborative Arrangements",
        "label": "Upfront Collaboration Expenses Related to Other Collaborative Arrangements",
        "terseLabel": "Upfront collaboration expenses related to other collaborative arrangements"
       }
      }
     },
     "localname": "UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gild_Writeoffsinaccruedinterestreceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Write-off in accrued interest receivable",
        "label": "Write-offs in accrued interest receivable",
        "terseLabel": "Write-offs of accrued interest receivable"
       }
      }
     },
     "localname": "Writeoffsinaccruedinterestreceivable",
     "nsuri": "http://www.gilead.com/20200930",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r158",
      "r266",
      "r270",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r156",
      "r266",
      "r268",
      "r406",
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r157",
      "r266",
      "r269",
      "r408",
      "r418",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r2",
      "r21",
      "r159",
      "r160",
      "r267"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances of $714 and $758, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r15",
      "r373",
      "r397"
     ],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r17",
      "r373",
      "r397"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Long-term income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r66",
      "r73",
      "r76",
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Unrealized Gains and Losses on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r73",
      "r76"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized Gains and Losses on Available-for-Sale Debt Securities, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r70",
      "r73",
      "r76",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r65",
      "r73",
      "r76",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Other Financial Information"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r111",
      "r222"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by new accounting pronouncement.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r275",
      "r276",
      "r279",
      "r280"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r161",
      "r191",
      "r193",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "terseLabel": "Write-offs charged against allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r111",
      "r215",
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Aggregate amortization expense related to finite-lived intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from earnings per share computation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborations and Other Arrangements [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r152",
      "r371",
      "r396"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r53"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r169"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r166",
      "r200"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r173"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r170",
      "r173",
      "r385"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r174"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Allocated and Single Maturity Date, Maturity, after 10 Years, Amortized Cost",
        "terseLabel": "After five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r170",
      "r174",
      "r386"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value",
        "terseLabel": "After five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized\u00a0Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r172"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r170",
      "r172",
      "r384"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r163",
      "r167",
      "r200"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesEquitySecuritiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity securities categorized neither as held-to-maturity nor trading which are intended be sold more than one year from the balance sheet date or operating cycle, if longer.",
        "label": "Available-for-sale Securities, Equity Securities, Noncurrent",
        "terseLabel": "Equity securities in offering"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesEquitySecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails",
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r316",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails",
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r291",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Acquisition share price (usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r293",
      "r294",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Acquisition consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r108",
      "r113",
      "r114"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r108",
      "r354"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit",
        "verboseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r231",
      "r379",
      "r403"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r230",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Common stock, dividends declared (usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/ConsolidatedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.001 per share; 5,600 shares authorized; 1,253 and 1,266 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r79",
      "r81",
      "r82"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to Gilead"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r79",
      "r81",
      "r300",
      "r301",
      "r309"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive (loss) attributable to noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r79",
      "r81",
      "r299",
      "r309"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r352",
      "r353"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r143",
      "r144",
      "r352",
      "r353",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r143",
      "r144",
      "r352",
      "r353",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r139",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r143",
      "r144",
      "r352",
      "r353"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of revenues"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r352",
      "r353"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r261",
      "r263",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r261",
      "r262",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Contract with customer, performance obligation satisfied in previous period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r272",
      "r274",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities",
        "verboseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Cumulative Effect of New Accounting Principle in Period of Adoption",
        "terseLabel": "Cumulative effect from the adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt and Credit Facilities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r15",
      "r16",
      "r372",
      "r374",
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r246",
      "r374",
      "r394"
     ],
     "calculation": {
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Short-term and long-term debt",
        "totalLabel": "Total debt, net"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails",
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r358",
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt instrument, redemption percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r44",
      "r118",
      "r253",
      "r256",
      "r257",
      "r258",
      "r357",
      "r358",
      "r360",
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Contractual term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r181",
      "r205",
      "r208"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 Months or greater, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r181",
      "r205"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "12 Months or greater, gross unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r181",
      "r205",
      "r208"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less than 12 months, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r181",
      "r205"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Less than 12 months, gross unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Summary of Classification of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r177",
      "r201",
      "r208"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Total estimated fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r178",
      "r202"
     ],
     "calculation": {
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total gross unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r176",
      "r204",
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of Available-for-Sale Debt Securities in a Continuous Loss Position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r179",
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions held in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r111",
      "r116",
      "r286",
      "r288"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r111",
      "r228"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and elected not to be offset.",
        "label": "Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement",
        "terseLabel": "Derivative asset, fair value"
       }
      }
     },
     "localname": "DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueGrossLiability": {
     "auth_ref": [
      "r55",
      "r63",
      "r319"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Asset, Fair Value, Gross Liability",
        "negatedTerseLabel": "Gross Amounts Offset on our Condensed Consolidated Balance Sheets"
       }
      }
     },
     "localname": "DerivativeAssetFairValueGrossLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": {
     "auth_ref": [
      "r59",
      "r61"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.",
        "label": "Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election",
        "totalLabel": "Net Amount (Legal Offset)"
       }
      }
     },
     "localname": "DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r57",
      "r61"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.",
        "label": "Derivative Asset, Not Offset, Policy Election Deduction",
        "negatedTerseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r56",
      "r60",
      "r349"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "totalLabel": "Amounts of Assets/Liabilities Presented on our Condensed Consolidated Balance Sheets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Asset [Abstract]",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeCollateralObligationToReturnCash": {
     "auth_ref": [
      "r58",
      "r61",
      "r329"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.",
        "label": "Derivative, Collateral, Obligation to Return Cash",
        "negatedTerseLabel": "Cash Collateral Received/ Pledged"
       }
      }
     },
     "localname": "DerivativeCollateralObligationToReturnCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCollateralRightToReclaimCash": {
     "auth_ref": [
      "r58",
      "r61",
      "r329"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.",
        "label": "Derivative, Collateral, Right to Reclaim Cash",
        "terseLabel": "Cash Collateral Received/ Pledged"
       }
      }
     },
     "localname": "DerivativeCollateralRightToReclaimCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r54",
      "r62",
      "r319",
      "r367"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Gross Amounts of Recognized Assets/Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r54",
      "r62",
      "r319",
      "r367"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedTerseLabel": "Gross Amounts of Recognized Assets/Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Estimated period for the anticipated transfer of gain (loss), net, from accumulated other comprehensive income into earnings, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimate of Time to Transfer",
        "terseLabel": "Time estimate for gains (losses) to be reclassified from AOCI to product sales"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r324",
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gains (losses) recognized in Other income (expense), net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r56",
      "r60",
      "r349"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "negatedTotalLabel": "Amounts of Assets/Liabilities Presented on our Condensed Consolidated Balance Sheets"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Liability [Abstract]",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueGrossAsset": {
     "auth_ref": [
      "r55",
      "r63",
      "r319"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Liability, Fair Value, Gross Asset",
        "terseLabel": "Gross Amounts Offset on our Condensed Consolidated Balance Sheets"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueGrossAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and elected not to be offset.",
        "label": "Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement",
        "terseLabel": "Derivative liability, fair value"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": {
     "auth_ref": [
      "r59",
      "r61"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, deduction of liabilities not subject to a master netting arrangement and elected not to be offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against the right to receive collateral.",
        "label": "Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election",
        "negatedTotalLabel": "Net Amount (Legal Offset)"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r57",
      "r61"
     ],
     "calculation": {
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.",
        "label": "Derivative Liability, Not Offset, Policy Election Deduction",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofPotentialEffectofOffsettingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r311",
      "r313"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeRemainingMaturity1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Remaining Maturity",
        "verboseLabel": "Maturities of derivative instruments"
       }
      }
     },
     "localname": "DerivativeRemainingMaturity1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r121",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r321",
      "r325",
      "r328",
      "r330",
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenues"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r259",
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends declared"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r87",
      "r125",
      "r128",
      "r130",
      "r131",
      "r132",
      "r135",
      "r381",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss) per share attributable to Gilead common stockholders - basic (usd per share)",
        "verboseLabel": "Net income per share attributable to Gilead common stockholders - basic (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r87",
      "r125",
      "r128",
      "r130",
      "r131",
      "r132",
      "r135",
      "r381",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss) per share attributable to Gilead common stockholders - diluted (usd per share)",
        "verboseLabel": "Net income per share attributable to Gilead common stockholders - diluted (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share Attributable to Gilead Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r120",
      "r284",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Compensation and employee benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r35",
      "r153",
      "r188"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "terseLabel": "Estimated fair value to acquire equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Marketable equity securities",
        "verboseLabel": "Equity investment"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain",
        "terseLabel": "Net unrealized gain on investment of equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Loss",
        "terseLabel": "Net unrealized loss on investment of equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r10",
      "r14",
      "r185",
      "r378",
      "r395",
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Other publicly traded equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement",
        "verboseLabel": "Market value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r337",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r337",
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Summary of classification of equity securities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r338",
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r337",
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r337",
      "r338",
      "r340",
      "r341",
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r338",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r338",
      "r365"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r338",
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r343",
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r316",
      "r321",
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r192",
      "r196",
      "r197",
      "r198",
      "r199",
      "r204",
      "r206",
      "r207",
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization, finite-lived assets",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year",
        "terseLabel": "2020 (remaining three months)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r216",
      "r218",
      "r221",
      "r225",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r221",
      "r369"
     ],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount, finite-lived assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r216",
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount, finite-lived assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsScheduleofEstimatedFutureAmortizationExpenseDetails",
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign currency derivative contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign currency derivative contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r272",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Non-U.S. government securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net gain (loss) reclassified into earnings when foreign currency cash flow hedge is discontinued because it is probable that the original forecasted transactions will not occur by the end of the original period or an additional two month time period.",
        "label": "Gain (Loss) on Discontinuation of Foreign Currency Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring, Net",
        "terseLabel": "Discontinuances of cash flow hedges"
       }
      }
     },
     "localname": "GainLossOnDiscontinuationOfForeignCurrencyCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r212",
      "r213"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r314",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "Indefinite-lived assets - IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (loss) before income taxes",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r151",
      "r289"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/IncomeTaxesSummaryoftheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r284",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount",
        "terseLabel": "Non-deductible IPR&amp;D charges"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "negatedTerseLabel": "Net unrealized (gain) loss from equity securities"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r129",
      "r134"
     ],
     "calculation": {
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of stock options and equivalents (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r217",
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Amount, indefinite-lived assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r217",
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross\u00a0 Carrying Amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r214",
      "r219"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r84",
      "r150",
      "r356",
      "r359",
      "r382"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable, Current",
        "terseLabel": "Accrued interest receivable"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r211"
     ],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails": {
       "order": 3.0,
       "parentTag": "gild_InventoryNetAndInventoryNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r1",
      "r50",
      "r210"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1": {
       "order": 1.0,
       "parentTag": "gild_InventoryNetAndInventoryNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails_1": {
       "order": 2.0,
       "parentTag": "gild_InventoryNetAndInventoryNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r211"
     ],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails": {
       "order": 1.0,
       "parentTag": "gild_InventoryNetAndInventoryNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r28",
      "r211"
     ],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails": {
       "order": 2.0,
       "parentTag": "gild_InventoryNetAndInventoryNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment Owned, Balance, Shares",
        "terseLabel": "Equity securities owned (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Summary of Available-for-Sale Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r185",
      "r370",
      "r388",
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r376",
      "r401"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r16",
      "r374",
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Amounts outstanding under revolving credit facilities"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r16",
      "r247",
      "r374",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Outstanding borrowings"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Less: current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Short-term and long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net",
        "verboseLabel": "Total long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r44",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r238",
      "r241",
      "r243",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r231",
      "r234",
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r235",
      "r240",
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs involved"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r3",
      "r40"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "verboseLabel": "Long-term marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Medium-term Notes"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r49",
      "r375",
      "r400"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest, ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Change in noncontrolling interest (Note 6)"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r108",
      "r109",
      "r112"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r77",
      "r80",
      "r86",
      "r112",
      "r134",
      "r380",
      "r404"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss) attributable to Gilead",
        "totalLabel": "Net income (loss) attributable to Gilead"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r80",
      "r303",
      "r308"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestInVariableInterestEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).",
        "label": "Noncontrolling Interest in Variable Interest Entity",
        "terseLabel": "Noncontrolling interest in VIE"
       }
      }
     },
     "localname": "NoncontrollingInterestInVariableInterestEntity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesAdditionalDetailsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r41"
     ],
     "calculation": {
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationOtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Available-for-sale debt securities:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Cash flow hedges:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r67",
      "r68"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale classification and out of the held-to-maturity classification.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax",
        "terseLabel": "Unrealized gain (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r67",
      "r68",
      "r71"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax",
        "totalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r73",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Net unrealized gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r66",
      "r71"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r66",
      "r71"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "verboseLabel": "Unrealized gain (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r66",
      "r71",
      "r318",
      "r322",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gains (losses) recognized in AOCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r71",
      "r74"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassifications to net income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r71",
      "r74",
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Gains (losses) reclassified from AOCI into product sales"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofEffectofForeignCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r64",
      "r355"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Net foreign currency translation gain (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r83",
      "r252"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Net current period other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r71",
      "r74",
      "r75",
      "r184"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedLabel": "Reclassifications to net income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other\u00a0accrued\u00a0liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "terseLabel": "Deferred compensation plan"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other\u00a0long-term\u00a0obligations"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale",
        "terseLabel": "Impairment recognized"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r95",
      "r99",
      "r122"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Payments of dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecurities": {
     "auth_ref": [
      "r96",
      "r164"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.",
        "label": "Payments to Acquire Available-for-sale Securities",
        "negatedTerseLabel": "Purchases of marketable debt securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to acquire equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.",
        "label": "Payments to Acquire in Process Research and Development",
        "negatedTerseLabel": "Acquisitions, including in-process research and development, net of cash acquired",
        "terseLabel": "Payments to acquire in process research and development"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedTerseLabel": "Purchases of equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r33",
      "r34"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsSummaryofClassificationandFairValueofDerivativeInstrumentsDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofClassificationofEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.",
        "label": "Reclassification, Policy [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt financing, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuances of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Borrowing from senior unsecured term loan facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r92",
      "r93",
      "r164"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r102",
      "r105",
      "r122"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r94",
      "r164"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.",
        "label": "Proceeds from Sale of Available-for-sale Securities",
        "terseLabel": "Proceeds from sales of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product sales",
        "verboseLabel": "Total product sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r77",
      "r80",
      "r107",
      "r152",
      "r155",
      "r299",
      "r302",
      "r304",
      "r308",
      "r309"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r229",
      "r402"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r76",
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Reclassifications to net income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Repayments of debt and other obligations"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfUnsecuredDebt": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.",
        "label": "Repayments of Unsecured Debt",
        "terseLabel": "Repayments of senior unsecured notes"
       }
      }
     },
     "localname": "RepaymentsOfUnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "Acquired in-process research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r259",
      "r399"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r265",
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Product revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r85",
      "r148",
      "r149",
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/RevenuesDisaggregationofRevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Summary of Changes in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Available-for-Sale Debt Securities from Cost Basis to Fair Value"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r171",
      "r175",
      "r180",
      "r181",
      "r182",
      "r183",
      "r383",
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryoftheBalanceSheetClassificationofAvailableforSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Summary of the Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Summary of Debt Carrying Amount"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r317",
      "r325",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Summary of effect of foreign currency exchange contracts"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of classification and fair value of derivative instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r121",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r321",
      "r325",
      "r328",
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Summary of potential effect of offsetting derivatives"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of the Calculation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesRevenuesfromMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r337",
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of assets and liabilities measured at fair value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r216",
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r216",
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r224",
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r224",
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r30",
      "r31",
      "r32"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/OtherFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Revenues from Major Customers"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r47",
      "r117",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r90",
      "r209"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (usd per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r48",
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r19",
      "r20",
      "r252",
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "verboseLabel": "Issuances under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r252",
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance under equity incentive plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r19",
      "r20",
      "r252",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuances under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r259",
      "r277",
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuances under equity incentive plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized amount under stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount under stock repurchase programs"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r19",
      "r20",
      "r252",
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Shares repurchased and retired (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r252",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "terseLabel": "Value of shares repurchased and retired"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r19",
      "r20",
      "r252",
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchases of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r252",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r24",
      "r25",
      "r162"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Gilead stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gilead.com/role/StockholdersEquitySummaryofChangesinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r297",
      "r298",
      "r307"
     ],
     "calculation": {
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r282",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "negatedLabel": "Tax benefit related to settlements with taxing authorities"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
        "label": "Type of Adoption [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborations and Other Arrangements [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AcquisitionsCollaborationsandOtherArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r272",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government agencies securities",
        "verboseLabel": "U.S. government agencies securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r272",
      "r274",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesatEstimatedFairValueDetails",
      "http://www.gilead.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UsTreasuryUstInterestRateMember": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate on direct treasury obligation of U.S. government (UST).",
        "label": "US Treasury (UST) Interest Rate [Member]",
        "terseLabel": "Treasury Rate"
       }
      }
     },
     "localname": "UsTreasuryUstInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r137",
      "r138",
      "r140",
      "r141",
      "r145",
      "r146",
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Significant Accounting Policies, Estimates and Judgments"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/DebtandCreditFacilitiesAdditionalInformationDetails",
      "http://www.gilead.com/role/DebtandCreditFacilitiesSummaryofDebtCarryingAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r127",
      "r132"
     ],
     "calculation": {
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in per share calculation - diluted (in shares)",
        "totalLabel": "Shares used in per share calculation - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r126",
      "r132"
     ],
     "calculation": {
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in per share calculation - basic (in shares)",
        "verboseLabel": "Shares used in per share calculation - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gilead.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.gilead.com/role/NetIncomeLossPerShareAttributabletoGileadCommonStockholdersScheduleoftheCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3444-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(d),(e))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=SL6284422-111562"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27337-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27340-111563"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117546-209714"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118950378&loc=SL82887624-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922890-210455"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL108322424-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28511-109314"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28446-109314"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=118875152&loc=SL5864739-113975"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061190-113977"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b,c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6)(a)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62557-112803"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.Column B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12C.Column B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14.Column B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r421": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r422": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r423": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r424": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r425": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(d))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)(i)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>82
<FILENAME>0000882095-20-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000882095-20-000027-xbrl.zip
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M+;8/LTTSB;U%H)6:#[!H[U8EMXQ*P*U,LEEK@<7#I-OF@\.+0"M-LM=EIP4
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M54YY7_U+._8"V9>8X8U:9!PC38$1. 12F[J4;5]S_/;",%8:]L892'WPP(I
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MTUAI[*34/K27JJ+H0Y4A%QW!?>091;;2NW^<3&.E'<<A0)0M&S5,"41*\5H
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MB%"&1<$<6YEN?.L+7C_)/4>?@@,D,^:F4FFDIP,U2G\6/[9-&O?)-E;J>V;
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M )M=BCK[+ ,Z%@2K5U"XM@"N(16O"H ST5]KB01;3QY=%B[:I )&2Q@V*3<
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M65ZJ[BF;M)-9"%^'FK'U!$G]S G8G'.R$@)-,^1\(A,HR;1D)D).=4@JJVR
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M. J#L09[R1OTW0/ZKI_0]&776SH>O4RCG0,<I2_0BKT/!(FSAW:)AI.XAE\
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M>S!*:2_AZ!LQ[Q+V7@QQ\ Q#KT]/<C?DJ9-B[_BP7'MI"936&*WT4:F2:*7
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M[[ CMI[9CR]VUR:='?:)?K]E&90$:]J</,4V.'KE(\T+-CGRW24/Z$6A:<Z
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MU??U7-_9U>ES[9 6IT-/:BS9PY9@@OW",]YL^UH5AV,]A?EH\#(:W)T;C3H
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M+!]^N5&KNL6(3)F*9V.$WFE)N;E%>\7F$=>M>_3=74%X\@/Z%.*Z\TZ6G0D
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M(/XI))G_?DG&N'MQTR<1&BW"#<GV.,SF*"%2+5QP1V*Z5)],\B T09+#(L$
M'7IPB2&PD#1#S6QR)4I2Z\HTJ?]UU356T*.HX)T+>*?R.;6@V@L-411-TK#2
MV<U0B%9P:05J:DIO:+9.3).Z&SP%C6/B.;2[OG<<6T/[.=YX\J;NU"X^T6)G
M9)?#8I;*1G=DHTOERYQWQB;MP:+B@"QF-D)1\LR5M-9*Y"770JQG^S5HL[;F
M6JR>)U$1/$\$3_R)R KSV@"6V(Q;3 8,X0((\2F6G(O@32E 2*EH$(*?@A#Q
M;?G3GLOW9,O U\,@2Z^!.B655AZZ(P]=JN\EK8J:QP@"9>8A[C58:3086UI9
M2XU4JI)K0>[?EZ%J$LW%[Z(*H5;\S@6_4PW;C'7,<PZ"R)C]"%7.F3(#FDC!
MJ;6&.S'"[_WW-ZLL,5NJ9N_XN#TLIY[&Y:H*WO*]QZXO!:Q^VNL-8XN2?\ZS
M/-/#K->?!^WGW7;G_UL;YDC@6U1//>5F-[R8?L8*ZYE@_>>E7JJ$:B^Y!Y7-
M &BH B<SP*742B#E3"M6P/0-HI=6Y.ON,W&6E:?.Q$7-Q,D"8ZV,R(B'1$KG
M+H<IAZREI$$T(ECO".?RQIGX%.+%Z\H0QE$9PEHDK19)6T*1M%NC);3_/O_L
MLX^ \O[G9P=AEC0P+_LQE1/BQ1/-R%IOG=A^ZV_;.8VM?WQO77D9^P='MA_G
MHDSL[/WZ[?IR<5\CP+^T_?W^P= .8_BKW-ODKY\M-:0N-;=8:OQP]\794O/"
MD+?_/2+^^*^N?6U.]X^W\WC\07</?_FPM_4QC]$?I#SGVZU?VONOM[^6Y]C[
M\%>^EVWVWZ^[G]\99:1*VN:5*4A [QTX+P)8FJ@6)!E66E??80;=+3:N,VCE
M9E!D,DCB""2T 3!D?]L10D$R'BB),DIGUC;(L_R[:_R=;W[1.HG]UJ 8].?6
MC9-N]/I@,?-M-+D&FZ?#HUX_TW&H3O%2YMD?]!W1-'GO$8QQ$="6><9M!"L%
M=5+9I,IQF=DFS0,M<W72-&729$:@F0],IB2!@)(K<"*)O+RYJ*DRF@6]MG%U
ML_ J,8WG3\M>&'6!!#6E%F?_T!?%^%.O'P:Q>YMYN'\Z')0:0ME3K:OD4B;B
M&_Z.&4D=00M<*@:82MDP(Q1(H9QAG%A'TP+9J\ZHE9]13C*:C*7@@E-Y/4R9
MY&1D8!(JICFWB'1MH]O[,;=U8ZLWL>A%<)T#W9H^]%";]E]COQ?LX.C[<!N%
M.-5[F!5BDQT!]$'GA3= XB&#)),M.'0!(G5,4.XU*EY4)<TH^[E!*4,UZ:^1
M6_45M0^(VJG#B#I%22P'XTIZKBMEH(E-P)+2F@<J*==-1.VB-VYNDJ(9F:K)
MU.Z&V!T^![,T;;KL,?:Z\Q&FYR;SC&^J:HKS@_#[FWW;#]N?WGS=S6/SGX]O
M/VR3_'R?][;RW_UM+_NZN[CWU7_:W7K_>?=P]^M_O^Z(=UQQ&B@R2*$0@'4R
M!_ N@8V6"Z:C9G@W57IN@D^=/@V>/H%1$E)V\X+A)3U34S#4.?"9*B0-C@;B
MFRU)WSH_<&H>5M6Q$?/OCZ_O3!0IB<1!4G2 RBJP3(82J4OKHD*%N!RQITZF
ME9M,%E/RTFN0FLGL#)-80M@\K0B/ 5/TJI0L%^N27#VU]@ R]E+FX76"8YV(
MBYR(;^@[2]$++3U@$A%0BKRJHO5 B-+$.1<E"RO!:CN#P6EEM.5-I.R$6290
M@22EI(>2#FP2)04E8M(^(D8LV?=,7&W"<)712I;X"OAE==(M<=+Y+^\8]23%
M[(DQ)D4.*?.":ICG8+E!B7E"..EF9:^E3*2Z%C9@-B6F:&0F@ B&YK4P!C!:
M$5!1DQ"5C)G&1A0FKQX O-$I:X\H8MQ-;6+D]59^[23FM_X=.U_NL3OW)([D
MS:N3[!3LJIQ_)Z@=3-<6-!+1 ',Y)D:B&6B%$E)4E)L,$:-E!DN#3MK5D[*-
MV7ZKL)PO+">[;-KQJ W50!37@)B#.L<8 Q.%XD1JHE)L%BR?6A^TS7S;9<AM
MIW5BVP':W9:W)^VA[=3Z7,NLSW5AEI?9*CO=%V.;5"Z:B8LNM4%C1@27,$)R
M) !&3T"7O1MJ N=2:^[+AA]?5_3>13YKEDYSP;N(TEP5O/,![U0U#:](XC0
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M_$9MJ;,2"F*Q[7[ZK5BVU,N,_;_;/@X.LHVK%S*#%[(_?5:,9V_#&:^!2F,
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M>,!@V1KNB$8X-QOCQDED>,PYC!*#/*FE.<FX216V185+'/612*FI'K "LJL
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M+"*6&'!WEBBRQ'B4]]6HP3XGCF]LFTVN+L:;UQ5M*^+_GY&%'X6_0^?K]O_
M'].!+]S+P^J*@XF&;O^/&_QG>_:TC^JRE:$/P=>!#\W@\S;&EO6^?PR_?9I]
MK;W^* ZWKASWY&).MU1&MY/^L)-7X+-![-I1YVO\_5LGC(ZFR+9PX625X?DE
MUL&"&H^NON38#CYU>M7R8V?WMP>=,G5V<A;_S(.O<,]8$3"8XD1@R:D7QNA
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MU9385K*=09[GV5K,X\HCK4,MP^EG,50S-(R73"-\8]P=3>[?'\U^ U88?#O
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MD_)<JIR3H+E)^0P2HI".GB8PP;W,IVP3P@H>%3Q:"SP"DRQB3"@0(L<=T"%
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M;/Q[@#=W8/,,-*LB.BOTV5JMQ7/CU<]8FVN"_)3 SXUZJ*T<H70.&:XK%+B
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MIS'Z),Q,D.O#XQN7MQR$KXLPF\F@L=PKZJC<%\6+?M7QD:F<=0W71/@I-5Z
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M&F%76ZT+A"O&S$/RA(EC8 \E;;4>A"^)\%-JW'-#MSF3*JR0TA(.>2Y-H&M
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MEM?.()13]F()H6I$PF9I]M+;GAB2*3\\]G.4=;\(MSJS5O(NI6!_-98QFQA
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M0]5) 1A4B @JIN*4]<9Y1!\REKU]:_7 \,YB&)PKM2)U QI=\[+EZ),K&I!
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M'>IL P_9UN@.[2-PI61)DF<K4DSML'_E 7W\L!\%DL',D(27 8^*18&T*1=
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MXD)4A<E@7:V"[E@0$9C5/"1=L%C+IX:_OW1(56/5QJJ-57]6A:H4XQ.4Z-
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M;")U4J3.W 6O6X:.RP\]$FDJ@^'7!4F:4M",0KMMYL@+?*JM099%<JBR3=J
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MK=!H/&%C-)GPR;7A?GA9>(Z3,^KY(_7\D<?;4<]QLD$]'&*%PR$:M9354O;
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M#=.!%C9-YU64T#]J5*I1Z=FCTHWXTZ^19CFDH5/3F*C61A!44*40-Y0CC8E
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MYGU8%C(]T54+9Z(H- *KB2$>!$9 -3DJ.,@F*;R@M-C89L4:)3C5P%,#S_T
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MNUORP"WVYRV2!ZJCK$GR0'DUBY('1A#Z4,D#<T_GX5((YDX\E4)P8U//2?9
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MZ+]]@2,V3S^>?]G=$\W=SPSN\<>7W6/Q&;X)]\H_?]VYV/\*9/L#OOCK\/4
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M&4B:,LNG+?(:I)8#J4F:.!7<J2@\LMY+Q"EVR'+X$:(R6&'NM(JIV*8HKG:
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MG3)2&,^C*D%:5D)T/!I+H[=,I6+6X#%J(7V[D%Z,+[LD+//%$Y<8"&RJ&;$
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MV)ELU;/'Q\[@VI:=78>=+;G55'1.Q4B2$9'(2#,)-FD"NIK1TL7LI&BUL_O
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ME ^&%&R>8FQT5J5;9PK?0 PM4_A&IG"^>WA P70K(41B8/6!"*@B@>M"$I5
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MGG9>%[QZUE9D.E]\Y:!;SY-L)KXP3;"FA]WI]/%1]1K4-.K88&KU@XGY/IU
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M Y>#X<DS(C(W1%JMB96,DA0B_)Z8TMC)D9NG>D7/W<'XI)I/@V9]&]F^*)&
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M!)4\@;Q#9F>! Q(\",TGK5)4\G,<K\U[OU[>N]K\O/>OYK%?K"1C#F I"S4
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MGW>ZQ\?CDSZV7L<>,A'[VX_P[%MLT897).RC.IPD^/LE:PA>=L'B01$WLXZ
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M[6/_<110!1$V27  4K+\]#<SJ[!PT;Y1,B9BW#8) H6LS"^7RJ7R%.B01X[
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MS0*?MV/J6KM89=GJQ-@QK&3 AVE5I*:8Y!3/+8E+02A952 D@&_@(9-9D0P
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MG AG;<96R$( 799$(G3,%)85@EQ[%XBULBFO(-NVN2C;]8 @]%)H'A<&":G
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M 2 /@W%W$$7H!H"L,Q3.#0!)P9KQTH E$0^9*[C-0BMRF+0"[O'0E$[J= -
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M)8_SJ0%$ MH"R?#U8;G&&-C&& $O#4I#CO&%EB=YT_,0C!5Q]0M.^0\C&TU
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ML/7F '3HKE(->Y47_L4(=Z4RXE^4-AU3W0U3_0J5^OM+OOQJ#_X1B_;OL&(
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M] "]S!6W[E$DMGJ BLHB4C9NJYI- LKY6(T(NAR\.OFX1\5+[ ,;#NMJ9L_
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M [_57VO@^@_<4N0C-;VK2"A$V[;MP<X=+.M,-8LO3[Y/U"SP>LQDCJ,5>3-
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M!@XW% 7D!:CA(WD#S[%'\8]/"F#AR/XFKZ6\1P(=7$ WVQBU5G_'7/S]T>C
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M@PM4<W:@&&'9VBHD\?V>4 DN/.0\W&3@$Y6CI#G?AO"7( .,YGJ6J+K)4%@
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M*"!#-&KMYLLSQ.; C1Q1RZIWT<<T\X0C]AWYVNT'GO@WT%9.W2B=+(WD%C8
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M?&0U'A=3'O0E'E+[<PH%2/QH<Y+;JSSENK ;I>$3.1DI+*8D(#HSGR_)?$A
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MW5$2"' LA:"$!BCDD)%_"MEL$8RYW'8%E15S;$Q8JJU;/^E7"T ?0KW('G)
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M?A3AT:.'3J )Z@6QXT@4P\&38WZ8U,939T86A4MJT!>@'8Z8-"*6+HE+^,)
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MF,TVX>2E4DEO2?W\&L&+6+ 1*?_!W(CY<\.R$"S-MK;9RX2 54^IT8?^CA@
M5Z?4J"3$=9IBHVU\X&/N^P!N%]YTQMV !O:TNFCV"0([&@)+!8'5-IF;1WVL
M3YO,JTSF9B/@L$QL$Q#>TA7H=MR >Y_9W&B_MI&L04_'N)\"/7U<K]"@=Y 8
M=V\3W%UX_@Q'PHUS%PQ:9SLWH3)^38V!Y<- J]JV;U,?P#M>##1[9/OVDP-X
MO:<Q\(:'"'EHZOK>O<^F!D:1+W_P841 >#T>VT/N!QKFR@1S55?U]*FYXX6Y
M-:I><Z.+;S7,W7+7AK_^L-'B!07/'G%,GD%U+T' A5\U$)8)"*O=@J"IC\,<
M.PXV1 L"#'1@P5>S<?J=E#Y9IR;QZ"&H_<9=^)<#: @8&8#9&R<7#GCXR+D+
MO]S;02B&2K=\8I'/C-^1,D[-& D+.'*YT:&X1U_#89G@L.+U9YKZF,OQXN&:
M^C-*+[P#&!3G\0G7$F!<#X+P%:&FS^_OC7,G]-P$ 9VY8;8U!&H(+-+D$ */
M^CB*AL"5$&@^%P+_X4U<X_/P]RB$400:!RN @U;%<?"H3XT<*PZ:9J/5:??-
M7J,+7_7.F-D[;9D A/\V^8]^?V0)(+P>C[EO?.(AB.4ZR/O 7)L[QO7?_JMG
MF=WW']A<@=X7[X%/!W!GLT' U]/ 5R;@JWCZ<U.?_SA"X'LB_5F6]!<G/+R9
M4 %CI0]#(<MP]^2!8PU[&O:*,3F$/7WJ0\/>(NS)S)>O3S;#6X. 5%'A[O9&
MMLA3=5$U,FID+ \RMH[Z,(A&QI7(V-\',F8;B&ITU.A80G34IT8T.JY!1U6X
M:^L27>O 4D.CAL820J,^3**A<1$:.]M'4/[A39CK,N,S]X<V]U7X!,\/6Z8.
M&9<0[ZI=-:&E3Y4<+]ZMJ9K0:DZ\*+!=@7H2[[9)EUF'?"U=7K#:&%GMDW<M
M?>+DZ#%R\>1=2YV\$PT$@O5!Y@5<U(:Q!L%2@J ^9J)!<!$$98[U31Y?X1(>
MXI?IF,SUX#]\B" 8AU=.J9:_QDN-ER7"2WTF1>/E(EY:&:4Q5XA%JY$:%JL
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M9GRV#%4NKH- #P%JH3X 6W1&G U);Y:^]9-,3W:.V\I"]C7AF-X,E(O[Q&-
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M%R='#<[ J[*7DL7I)_8 $5D\L3C^<(5<'M9#;BMN<1QO"KT7VQ1K:5-?8%K
MG%/&A54U6G6]:9S-)Z$P_8NV)4:Z+ZU];1U:W1/S6I_EIH)%VYW<\T3](0O?
MC]2GCW*B.= *;IK%= Q.,)XP/Z(Q%DB<B+1U(:%AB$E>\.+#SQPYK,QQR7F#
MKQ(#T8^FN]G]34*?1Z/CZ_./63W&S" 4Y 2FS9"[,"<PX0>*7IHH)![Q^6;J
M;S J$HRYV'T-HC5F5%XUIN$3]Q^Q$OUH?CL"@"(O*J+PZ(E4< T!\_;I3",/
MBPV/@!L&F$]5"GG$)A3%&%0@T89*5!2RF,),7L]<) K1I]F+.L%XS",1:($W
M!TE,TL>221)&"?!-U@HXF7AIKJ5[]C5A48RCZBR"\Q R&@M1$ZE79!84LS:H
MFNK "[,J'<L,.> 4F;V>-",%'I"/&G+F9CP9$U54^)E(=S&F.,/@+,Z$"H>C
MWX+$PS2]D@1CCE$$,)UPR1XF'N%#F L#>-EPS 6EQ@NB3:]B)>ZF+#"X6F#0
M7(9LM=H?=__^CK>H[>JM9LNP]7K-=.Q6J^F:U*K9U*W57:OQ7\-LO$OO.FQ9
MPOWCVMB(:__Z_6W[X?-]KY\Y)9<K*!KF<@G%F@BW61C.[PEPV7 J#W$?I>G2
M-#59:O$04^=N@8I1WE5F*636:(?D=.>JD933Q9+B8NIM02FN9*E0JI7P2&"&
M"'"1&B5FP!FP$?6&2%G8D*!R=4&,BWGBPTVB/9K HA+"2%U-$N26KVB]R.5&
M,?XSREZV6EI#;^Q2];*F6::=>\W'FJ75&OF7O:PUM9:^76W+UP89%C<0[_OB
M*8CS_?5-K]TE_<YU[[;3ZX.5>]O9F(>ZA# S)_Q<P]P0@K@6U&O8QQ'5NWMB
M_DUO $CH0/!W02>\?$$D;1&FU"QJ2N68?]WP]EE(8<L!7D07I-N^O>[=D#N-
M?%*66;?][\-3CUJ+<>W&8'+0XKE+4D1>D>GTB'1/)3<^9YZ /P7]$#-!O?K]
M="$+B6FF;G<L;ZLSHCP<HY-EEKEU+:OKT0^B<A=RW^$3,.#7.G^V8K*5"VBY
M@.YU 1U0Y^DQ#, BK*I>#L5_SW'^D:ZL[=ON?>^?I*N1[G7GP_5M_]-M<=?5
M@V*\F<?:OAM"2X@O=YZX'P6^\#K-2>T+4)K(_R/\F<^EVQ8W+A#CV@7;I#4Y
MA/_R6%V55K:K\F(0N%/XWR@>>S_]'U!+ P04    " "$F6-1_\NN4F$7  #O
M"0$ $0   &=I;&0M,C R,# Y,S N>'-D[3U=<^,XCN_S*W1YN;FJ=<>RE:33
M-=U;SE=/II).*DGW[-[+%BW1-K=ET4-1[GA^_8&49,F619&V,_2>734U[4@$
M"! @"( @]<O?7\>A,\4L)C3Z>.2^:Q\Y./)I0*+AQZ.O+S>M]T=___333[_\
M5ZOUCXNG.^>*^LD81]RY9!AQ'#@_"!\YOP<X_NX,&!T[OU/VG4Q1J_5) EW2
MR8R1X8@[G7:GO?R6?0B",W=P@G#+?Q]X+>_\;-!ZW\5^RW,''CHY[;_OM/V_
M#3\,</NL^]Y%K?/33AN:N?T6&ISU6\&IWVV?N.VVZ_H2Z6O\(?9'>(P<8"R*
M/[S&'X]&G$\^'!__^/'CW8_N.\J&QQT ./['_=VS;'J4M0U)]'VA]6N?A7G[
M[K%XW4<QSIL/21@L-(<'& 7O?#H^%LRVS[OMO*W 1!2X211S%/ESW!&-HF2\
M&B#@[)C/)O@8&K6@%6;$G\,U RT"B 8!G\.4J3HY3E\>.8AS1OH)QS>4C:_P
M "4A@"31'PD*R8#@ )0FQ$(M%AJ47G/$AIA_06,<3Y"/&X?MTT^.(V1)QA/*
MN!-5  <H[DM"8\8!S#UOM=U6USUR4NG?41]QJ=)EQBI QSCDL?BK5:!X]QH'
M1\?Z!"1Q:XC0Q)R(,F!*2/;$G)B2:KOGY^?'KT)7:\FHJI]LWQ(_6V['K-LZ
M/=;O&_YJY7#;H*&8IV8TY' ;TK!Z>NJ04H;\D@(*6LX%+>[I9K2L1\>Z1*PV
M(YKBR %$MR<F'<;8?S>DTV.?)A%G,S&QSE0S,E8!YG^T"BSKT!)@TF@9*G3D
M0.)'K3% 442YQ"*>9,\F$Q(-:/H '@F5_I#K]1,>Y$:_LM*M,![RGP^(^8R&
M#9;F>,+H!#-.<%Q>)26"$<.#CT=BK6SEUOU?/@K? 25YDTH'BY-3O#X&$#\)
M);MW!3\Y!J&M'X]B$$F(TQ':9?8#/#!E'T!(1/Y?<!^BOBGW (+#_WC&)PR;
M,@X@,7A5ZZB]@'^!]PX!)S7WVE$47$><\-DM6 DVEGB/'-'TZ]-MG5,F*5%B
MR'O.^RZT]5,;/&WXSVD5D4/I)V!S4G1."=\OQ\M8EO G,0X>HD_R]_(09<!9
M$P7@DD71AEN<BBO!LH>Y"!2"N:11@", AA\Q#4D@8JH+% I?Z'F$,8_UQ*.!
M1R$D5PJI Y)YAH'$F93F.)TR4B?#ZJ1H#[(JC?$C8L#>"',"!&]+<(M(U5(4
MEF,=*3H_+_3R/_LNU?D QG3P #9>TKC)5*Q!J)9FM]WV]*19H'?HP"DZ.,BQ
M&/9+.@8.1]"&3/%M!/+"=S3>EE#KL*LE[$&$LXZ$%WISTNZ<GT6'AZE;$LHS
MI_[W$0T#S.+K/Q)P,[8D[16(U8(^:;=/UQ%TN:/_=M*N]DO"\Y'1E\5ZR_#&
M':DUX+3=/JMJ0"%W0R4XK-@*6XSBT4U(?VS-ML_QJ45\UFZ_7\N: WY'=K!'
M4GQ.QF/$9C"MR# B U#BB/=\F70CT? 1ALJ'P%I/@IJX%-+KN&W73<-4$OLA
MC1.&A2A3Q'(2%JB= K>3(S](;FFTWT*"6I+LM.&_#20)EC7[M4]&54\ O2"0
M':+P"G-$PCC[9YM"KNU#)72OW?4V$GK1JY/UY_R<_=@G-7C"4QPENK-VWEIM
M63U7YI861).#[N'8OJ!^:#K"&8QJG+OMDVYU"N0(G)]3%/NHS# @:#AD>"CI
MH8/Y<Q/CI8M,;:5.O?JID#XO(1=VJY#?'ENC_%]18'2/_DW991)S.H9P:"T1
M-J-3"_',DUG6.B'.?\IZ*-F!,^]AK^58++*EW9ZU1*C$I);>>T]F5>ND5W($
M2JCW4FPWB+!O*$SP/49BH&3 JB>GU:!J-^'<K4XK@<>1B)PRIGT7@HD+H4*@
M]"= '-7%JD8@^^A>K!S8>8S3BV/,8Q0%=P3U24A$F4#6,$!\#FMD_;;:H])*
MNJXG=R:T9%\*LU(:Y+Y^B8J\>> @7L9R,*K9$&Z^,)JC5<M?^*JZ\C\LF9HV
MX3)$<2RS$&GLD*;RG[&?,#E/MF@,=+M2:T'7DYL6IE9@L7/Q)-NT*/K?2^WH
M38%CL4[")'E&(9CB/B^&1$_L#3B4+I;KN57?=XZP!1A; J4C<)9D=9!0-A F
M;I<6)K7_==*M.L3-TMI'5TP]V(6'I&R&^'7,R5ALT*WGGKTY%6IC?>K)[4=3
M=5E(DVNT!Q=N3N&^.W.:$N<C7"[I6UZ;U5C>0@6W0I!:&\^\]OFFV@AD+A8J
MKO L= SB03.71+AYO+$!?K7>O <?92V].40AVUT.^[-+&G&&?)Z@\!YQ\7CV
MUZ^'2C+4JG3NN97]L#=8$/LSIT2BD]-XT+QU14XB) :41 E-XJ\1PR@D?^)
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MOYM ^V*#[75H?<K_<@PC'/LC/$:??OH_4$L#!!0    ( (298U&]%UY[>B@
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MF<;@7>J<B)1"D*"5)-D+B0L 8SPU.0%4H=K^4%YL(S[M6H>_BZ5J'M^?@U_
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MGUV:!-*K"YC[$_CM_"S _'V^?'DGT.+]^7)1HF(,1T;14<^"T21F+HDT7)$
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M:6FZV-1N0N.:9MHS>%_?5LA+,D6CI(Z1)YJ:(13NB^5956>\6+B?O#4-]GX
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M0YV$Y&(]8D\BLYFZ&5T=/A( !E^TWOK]O-'",?&YN^EZK.R\"NI]K4M!/[M
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M8:#1L.A=238X9SL>Z[^CD<.&VSUQ,&Y@P+Y+K;R 21Y2\/_O"*>SCZ]':7E
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MY5$SZI^AD*Q(YE026H8@9&I3G7PSIF]ZZI6U)L/3S^//.!G5-:)G)T@F6*T
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MA3=>8VAR'WUGA(?*!CV<B-J0\VBR.8<C&*5AK=R\++VWV$*JY=)JS7=A$[D
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MF0N+C@GER!7*1C"H-39+1F>-\$*E)B=7GOBV[SXB:D/.8]GVW7AT,"L45NC
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MM7TW9UYJR8+RT0#4(L6_Y!"W+F381]BMIS-MJ5M]OU@L,6\;(V6J 32.CL)
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MU, <G;$0HRH^=#EC/ _M%$TFFW#C<5_9IEIHW4=B ]XOLRKD]],_PN4DUSF
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MS?7U?!*7U_6<>3W[V^J?U)EPLP?APD/21L8L-SH_I-F[;B2"\*2,355S18-
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M8TB/=*I$GH%S2,YXM%R0>7<Q);"H+O9XF]NC9?T2PP+__=_^'U!+ P04
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MF"W*)5DPW4&9_;6L_O@Q9V1987Y6+G#R"?T;;!^#^D_0#V#H__R]Y#_\RS\
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MMRN&07IGFU6A+$E)*YB:#A7D/OY%S)=E^Q>H_P(]OW$9_:5GR4:Q:X9!L[6
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M'HT^:::CMU$)Y;S6^]1A\(;#'K5R>'ZILQR4_RY*1HHE:6S^(*)82![!E(D
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MGH0B]D*(I$]@*I :0E_](2"I]"F>/8N"YE8GZ_U):#,KM^4<;E)NW?36N7C
MC_HJ_T]5&A=]1K DWQU.WGL<4C,#^16':> EJRYOOJ-:F\/AQX_U4%7G+UK#
M*DNDN *_5@/9?$KKDDS[JEX!HI75B2!Z/K7O?QAZ/\;O4<3QS_7[Q_?H0?\
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MW#_8$(/-&)B0ZD#(#DVT3W7QA4;PRGP[@:X3_=J@;$/) Z$]%DV;H]X79SL
MULWC-@V.R.T.>N[RO4L#CJ=)3T(WN[C?^!-GE$B4>CB (DHP1!(CB*G/()9A
MA/V4,C^RVJT?Z6-JO/YA^Y"F=N3GM=2Y[;V=8X@:'K%<AM/@+-U(MWLDTN-!
MQFGU>SV".-+-N(<'I_4\</MW/.HVWW_-<_YG-I_/$H_ZV \"2(FOT\9$$I*8
M44C4G!<(29Z:!?+N-SRUF=W*93>)US"9S5P7Y0>>KF?UMIZ?^TKV.2G7;8\Z
M$_<UVI]^!Y\[[+/>9]\%_TJ6XD@%A?H:VYV2M%K*M8'3!A^HF<F1]!5>0F^X
M)(:$I E,4H&I2+THB,WS.#J),+5YK'=>/VCQ0*4.T/K4!4)L=EQNHV&P]1H<
MXX'I8@O4HV58FANW8*T%J,;"83OF-@06^[+!AV*D#9K;D/2T5[L(Q,Y-FUO+
MX^W>+M)\9QMW64L7EL]N:KC6UT#$WU<ZA6%SDR# (L;$%S#A3)E^,HAAF@IE
M^E%E]X51'*6^4=5#BSZGMIIL20K6HCI6M>Y VLQZ[!F_@5>*H] -677Z/"J#
M%)#NZ/9U:D&?Q^%D66>#5QV#(]9WS72ZU+W,5/E"_<BJ7LOK[UDYBWD:*J-6
M%U.@!"*<!!#[*8<,2\4_5&#"K=+!6/4^-0K:$KZZ+WJ0Z&U; ?"[5L$V<,)J
M<,RX:C#(!V:M7M&V#ZIP0:W7^ HK <8-M7#!YB#JPJD1UXA99=+IQCYF"_%!
M_5C.$C\)8TD9I)2$^L(K@C2A"=0'A9$N,)UBJU+TAUU,C;W6$H+?M8R@$M*2
MGXX :49"E\$S,--8(N,0<'I*^7X#2@]Z&3E@])26AP&A)Y]TF]__*OB]XHVW
MHLSN%]4>O]TW1<R3L3):*$TB?2[&E/D2AS 4TA<B(#Y.K,R74QU-;:XW<H(M
M01WSTIV$UFS>]P'8P+/?"2MK#C@'1)],<+*O4?G@G,;[K'#V>3=N^"J>Q6(E
M=&#-3;ZHPCG_+5L^W"CC(W\4Q;OO;+[BNG1H60KU?US'UU'/HS)).,1(,0;B
M,H!IG(0P4901!TD28FY43.X"&:;&*&T42%&K8GG"[C((9@0S,+0#<T\C?7U]
MH94?_*D4 *T&5V"M VB5Z#<<\0((^V0M%S%&);0+<-KGNDN:<JQ3DY7D_K[0
M@=6*66]E(\$W'??^37Q?OE&:_C'CS(L33 CDO*J=&5-(TAC!.-!IPJ,T86:'
MF%:]3HWJ=H76T;]?G4C/#'(SFNL=R(&)[22&X/=*9J"%!I74/1I95BCU6DS&
MJ.-QR\?88'%0,,;JY0O/O<I->9KR#9GKK%QW#T(L/^9U=/2;E\T#+5OJG+QO
M7@Y-QDK"F1?Y*>(<0Y]@!!$)(DC"-(51BD(L18S"T,I^&T[4J7&?UK1.T56"
M+5VO0*,MJ-0%K;Y7@+YL/;<Q8;32S52WW' .^+6P/-M[U<$>F)]''6?W@\3!
MAF"0\\?^I7V=8\O!4#]YVCE<C_UG;&KS<-19[-3?"T%*\5;4_UTG.(NB4%_1
M2"'V8D^M06D(4Q%+B!/"$AIRCX;,ZDK^Q2)-;:VIHPS93NZ>G=1+?^TOWY+A
MH)FM$.,.Q< K@4$&I4T.I$'RU_4'YUAYCPREFDR"(SL4;3(96;;LZL(MA7KI
MX7K!WZJ-R#Q_TH='3:*!C:^$_7V5%;HH\)<B9Z(L;_)R.8M)&H1Q*F&*]066
M2"H:3KP02D^*A$4^CE(K&KY EJGQ;ZM*%4?(-\H T:1PL/7QNH^2J:]W%.P'
M]_ENP;ZE1YL,!?RXY?!M=*E*1];: *U.CS%</8#:KQ?879R1O<$7XW;H%;Z\
MR0M],6^SDBG;:U5LI>I-?-\+L4ZJ(D6@*#1((>$^@=AG*0D4N\K8*E=R5V=3
MX\C-/AEL2>N<&+D39TOWQ(7HC>9@L 7.W5O0@<@@^_UC_;W.CKU#\Y-[[JYW
MW%CD'2D6BJ!*90RV>=TS-@LC''J^'\(XBM1&6*C=,&9<[8M]&82,R(0G5F&K
M1WN9&F]\WD\C#)[4+JO4\@*R7!8972VK<Y!E#G[-YH)PO1%^S!>@U-GR'_*Y
M@KT$$%"M'?AQ5?)-"Z=7?XMAH0D7(L !3"..(:)QI$SD,(!1&"<\I$$8I6CV
M+ J:CS8PV[V-,C13&Q.S%>!BG >F_E8^74ZXKO.AW<I*QOXHOQ."/KG^>$>C
MDGRGKOOLWOVP&ZW?5).@JN+Q-GO.N%CP=?MO=29C98S.$B)$)-((>H@F$)&(
M0H(##,,P# )&1(+"T(;E33J=&NG?;+'%%>"MV&IO7<M[&648#8,9@_0-[L"$
MTN!Z5^.ZEOAJFV!:L?OC&!N0^J0<HWY'92 ;)/8)R>I=9W[:=TVN*R7$BGY$
MD'K0(Y':P%*$(54+.V2QC (B0QI+14OYDLR-:>E47U9LM.YQT%ESZF#EA+EC
MS4<G83>FH3[ ')Y]3(Y&KL#U'JA?2-%+)C8+N'KFH9/=C4T_Y_0^PCIG7W$I
MUATFWI', .7;E;A^*K)YX 6HR7[A>9QCFH;0#P)=8"SE$%,909K$G >)E\;"
M-Z_=;=SOU$RB\.?$^Z_'DV&40(D/*OEU&@QD4ZG:?!RZF6A = =F)0M@G6J!
MFR-L4QI\$*1'2N[2*^*6Y<.M<>NN)F[>W(C%Q:UUW*TU;O^Z8RSQBI95/H;E
MNV?UC[Z%5 7CJSUNA-(HA(D?>! %ZI^4JPUPFJ D]41"O,#JSNF)?J9&\!LQ
M025G<R/0(??!*6#-;,D>X!J8L9V0LH\U[L:AUX#C$UV-&W7<K>]!Z/&9QUUW
MH%79Z#KY[->L_..-6+"'1U+\T03+,AF$,6<$)@F-%3FP *:"13")$_5)&OG2
MMSH#.=?AU%AB1UZ@!09KB1T#D\]B;KH'[0_)P3>BEX#HL-TT0Z;?/>>9/D?>
M>)HA<+C[-'S/90OJQ]$).^>6+?,J,5VX3L$881;R6$).I("(( HI\D.(!$NQ
M#!(4(?.:.#8]3XU__)_CJ--V;S0 6@6;;9+-:)AL10?">&!FLH+7:3MJ]:VW
MV) .A/=(6])^OM:6>U$'R+IWHS8-CK@?==!S=T?JTH!C</<Z.*8JL[:^XO-K
MD9?EQXS0;)XM7V9Q$!/!0PG57E4M BCT(4E]":47Q30B@5!K0ELM_)M%D+=1
M[T;39[?^][<15H9*2'#]J%./E>!6RE)[]!= =:"CW+B^>JFKK"S*?)YQ+=5N
MB)QM3+C92)G9KCT"/U)4^":"L)+X"FRN"5Z!>BC6<O<8%FZ%4Z]QX68]CQL8
M;H7&062XW=N./C;V(/A*E[^^9JQ8"=XVG(ER+WU")'V/:A(+1:ROL?E<[:PC
M"A'SU%8[820*[?+X&7<]-1NWE5R?1]9!78T&8$L%2Y><^3@8>ND&07=HQ]T6
ML$<@'32CA3U@O7KXS'L?U^EGC<J!']"^A0M3C][*NZU;I._^OE(TN;[ZCU*.
M"5<LYJ,XA<@+,4R5?09Q+,(T]GV)J%7>':->)T=@ZS2<:J)MB_W?0"VX<]B%
MV2 84EC?T [-7GV@ZI[RU 2E0;*@=G;\.HE13; XF2O5Z&4[CN(BFUVKMGF5
M97Y.[F>8!7$:4*&L*2R4-44QU-M"&'I8>D'(61@8.0P/6IX:UZR% UHZ,S8Y
MA*N;,2X"86!6,-3?>-Z?U'4SM\MV<I>"_7R?/_^BWJGGM?IA?SH?MC?*E#VI
M1CLM3S]PZ4[G?;;(EN*CVECQ#XNE&JM,62'5'FO?U!8)I0A3#_($25W?/H44
M(09%Y'MI[ 6Q,AG<MCS&,DQM.F^;Z+42L-(";-2H/0[.&R#SX;'="0T"^HA;
MHFZ\1]H=68,XS#;)7(Q7VB]9XW1ZXV3?E&/!FF>2S76#[_/BCLS%6T&7=]J?
M7FW6KA_S8IG]I^ Z"EY'.Y4S/XXX273U8XQCB!))8$K]!%+/(TD0Q(F'N,V=
M?UL!K,AQA$" ;[H/RSHTMIB;D=Z02 [NNJ9+L)'U"JQU@3(O8*FTN0)K#:HD
M'3T6HW'$K==Z-+8RC%N2QA&A@ZHTKNVX<=M^PJ0/BW7]Z!ORE*EYN_9.^%QX
M01"$D'AJ<%#,8HA#+X9$(NXG222BU,I%9-[UU(R]FP?UFRAU3IQ\7>&<U-:&
MSJDSW[CR+#/(60R'&>$- _+ 5-<*#7YLQ?Y)8[VI)M^(/HCCR!ZQ/DG.HO=1
MZ<T>E7UB<VCATOJ"BD(;PJQOXL0\C"6)$/0CK!A,A BFPD>0D9 ($4:"\,"M
MEN!>3U,CK&W9VN1JKG4!]T$U-+SZ@&IPE]1&K"'J^)W0?)B:??N=O5)]OA,Z
MGZ[%=^H%9_.FR1/95KK(%BO%. WUY(ORC5#6<Q.A^8U\%^6G;)$K8^M%;2F%
M^G8MKQ=\MY7:\_U)+!]TOLEGT=00G$F"8]\/&20D""#RO!22E&'(0Q3Y-!21
M3XC-KF]$V:>V8?RP$RM.*S7; /*E5M3:JAKM6\!"1OR4,LA9B"$B,8&4"JZ/
M5!.US)  >;96\B2_!2.L6O\'?PN,C?,ICNWPUOTF@<&F\%2M.MCHWHYX<TA<
MJP2V=+IJ<R%4R%R!SVIQTJG9\_E<M]1"U.O68.SQZGEO,9KX8V].QAZ7([N;
MT46X.)E6E0.GO%TMRR59Z,RN,XR9^O*$ B;4(VJ'I,.'0^G!&&/J>U3G6L6.
M2;0..IO:<K.;/"O?" I^S!9UPJS2/6/6(=9<HI01%,! $'UQ5%*8TB"$F$02
M)1Y!B2]F3U5:\[LE*9;C(K[?\7"XOQ'WV4+GC .TN=<^#-Y)0!*!TA@*BO1W
M.Y':/N>0RRB44HT&HBW>[Q;\-=!NNQT.ZW?U%WI8H,V,G[Z@&]A:V4W]5DMZ
M!;9D'23?VTE$!LKS=MC?:^5W.ZEY1UZWT^]<F(S\P^))-?I1IT+WF]@^))F/
MB2=AZL6!CF-5+()Y!(. >93$/D\BJT#ZCKZFMD!6L@'?,>'X$2S-B*(GA ;F
MB>TXHEK0*]  UF,R'@M,!DDX?J2[U\DW?EKOD^G&.UZQHXFR6,X^D?_(B[9:
M;EFEB?$D06D04A@&B$+$$PZI'_J0!I''4A0KUC!*N':\^:F102N<5::=$\AU
M\\#E> QM(AA"83S+NS7NF-CJQ:U)K7[;G] G6AYE#G=KU4[;,T^Y'@/46^RF
MDLG,(SPF-%"[ .GK7-%('P1&&#+IR5AZ(D9)[!"'O->-T5=T_(#C5DJW@\!]
M*$T]G?;(C.6-;-!X=P8-!V_A49W[]>CM=C&RU^VH?H>>L>./71C-=C,G9=F$
MI%2+" K3A,1Q @F-U?*;> 224,UN3%E(6(@)EJE3!-M^3Y-;B;5\Z]@JM\QW
M)U$UF]Z]8#7T*FT%DWN\V2D(!HDQ.^CL=>+*3NE\,I;LY L.":F^D)?*+_X^
M+]YFA6#+;P59E(1IKSN9M^L402&E0C!= S?5U69\F'+&($,(866;IP$U\FR;
M=SDUGFB%!C(O *_$!LMMN0'+2]/X% ODNRED&#P'YI(=*&N)P8[(9ZT)5S M
M4DOU#NI(.:4N!]<NGY053IV)I,Q:&B^#E)5F.ZFC[-YT->7VHXEU=JI-4;A-
M0)M$7B 093#@+%;;-19!&D8,^LJNBWT1(AS9Q1N:]CPU"C\6/6]KZ9F";FKY
M#0#EP.Q]- >!%GNK4"3X?9AX05NX^K4:33L?V8JTQ.30JK1MP"7M*8I/I7>_
M4TI6_N3 "Z/F:$-@%@F>)%"G9(?(ES[$J2]@B$,221I['C(J6>O0]]1("_T<
M=Y<M6.N@LT1&-DDY[<;$P! =#NF!.<T29*<4J'9HVR1!'0SUD4S6OK[BEHE0
MG6#K3H5JU^2(R5"==-U-A^K6A&-"U+;4W(PP*3&/8QA'@80H$J&NPR1AR@F1
M.)6^CU*7G*=M!Q,]97A[4'S2,D_I&D S0]0.CY%"MEN9>LPDNJ]FK\E"UXV/
MFP]T7Z>#E)\'#[A-RM]*<2O?E<OL4<V"<A9X"<(>QC!E(8+(HQ+BQ%>TB%/$
M/3^*?,^J8NQN\U,SP^ZR^T4F,T862YU$4J<;UE<!O^3SC%7Y!-:25S',_W/%
M[RL7@-VTW8/8;.ZZ S?P!%:"Z1.#M6A7-5POX/?FOX-L$H_#T>=$W^MAU-E^
M7+O]*7_B*=?LY#LY%/8R+/RV* 29ZZ0*^N+]E[S,*HL5B<2/0H_ ))8!1!@S
M2%CH0Q1@CP=J15<;.YMP/A<AK#ADK$0N0#3#PH'4E]Z>]>4JVR3D#@-B: <,
M#//0)H-)EI>-%D"K 5H]^DQ8[HYBO^G+'>08.9FY.U*'J<TO:,L^\^9']368
M?WG(%^+SJBX9&R,6Q4A"QDBD\U8Q2!E.82@2'% A0Y)RT^2;^XU/S1RJY .5
M@*"6T#P'YP%PW=1T*1P#4XX%$E;9.$^I?$%"SH,F1\O)>4J9[;2<)Y]QLUJJ
M%/K[B>T:YYIDH9=@/X"1GR80<5\9)[X?0QXQ0BB5- Z9S=:EHZ^I3=Q*5#MS
MHPM),ZNB)WP&GLEUT84C&3![CS\PP*-/,Z"KNU%7>P.]]Q=UDU?ZRMUV6$I@
MYD5A&'MI#&65\XBG A+N"8@BG' FXB3&5DX.DTZG1AEMS8RMO&R5CR.WIQ(C
MS,TXI6\D!R:7$TG9;$J\])"+[31$PV9A.]+O*^=?.XW$^<QK'>\Z'(UWY.%5
M6Q>1W2]N5D4A%NREND4TKP[C?B790N]C;E:/JWE5SJG]RRQ@@E-&$IB2E"G*
M$K[:AL0>#'7ZW(B$,:%&UWV&$&YJU-;H %HEP)868)-5ZPK(.DGVO$J232PR
MD0\RQ-T,^=H#-S"3UIJ!$_G*KT#GF&I]FMPY5V"CYO;?7W%<+0[]7W%\1[H5
M\&KC;'>-8*"!Z+QGT'>?XUU$& BMG9L*0_7AF$^U/BPLOPHFLF?MD/PLEK4
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M=A1AV+;:_? YZ*?=<YB>$7/E_/Y.+AY-W:PVAIP)FA6)D#!+I*F_GB6PP*2
M69%3;2(5HB!.L;5'YA@;?_TFE\M_!6V0Z%/=2\ Q^.T(DG:<="$^@7GGMW6@
ML9%O'7</-E76/(:[G4;":X3;D6F&#6H[K>=!'%O'1WL>D>CRP514U?\SH7 O
M=&:<9\W1/\JH!DT?D?*<4(ACS&"A<*0)(.$DYHQEF57W,9O)QD8"1L@JBI.;
M'^1&7,=34A>^EJ<D3ZB%/B6U@%4_;$D:PKMB 8G7DU+7?,.>E"PT/S@IV3S3
MUV)8+G>J,5>W-Y."14S%*84\PP1BDY5#"_-7%B522I(EL5,_V./3C(TRC)1[
M=<?KVRS'$+@3H-K:#Y="%=R$<$:IA^G0!8)?Z^'H3 ,;$%W:'MH0G9_NV85^
MIZU]_7TE$4<9U:\^RY@R16X2R').H-!_X@RE)BK6J?'\X1QC8X#V3M)X57=-
MY>T+[WZL< QB.TJX$+C ?. ),_<.\Z=1\=I4_L@TP_:1/ZWG0>OXCH_VK8HE
ME=3GE#KGYOL#U=^<Z^?50[DPE98GC!'$3)*,)@=-$93%D*F,P8PBDJ5*)$QQ
MMSI87=.-C2W6TM8Y=U> KD4%[Z9SL*SD=^[NV(FX'6/XPS$P>6P@_%Y#6,L*
M-L+Z+&%E XK?HE6=,PY<ILI&^\/"5%9/]227VC-WO?&$'G&)-D=ME3+&E. P
M$R8=CS,,22&9)A[%4Q%3RHK<B6GLYQX=[33-4>EJ^Y+@BZ1&Y,>N*AH7KX(E
M^X3!-C05G8,U@!^D!U)>^<EA^F')RAV7 ^;J,43?*)7%4[F@*VG,KX,ZM[2(
M:8&B".8$48@1+: >)84R9XP7>99QM\3"SMG&1E5K82^K =J-<$HBE9""0I5I
M<+&*$62"4Q@QEN4LB;*48\< 0E\8#Q1". 3*EKYN7\B%=G:O(=OKA!7"V6V#
MB=^XH*X)!PX,LM#],#+(YJ%^9+U?._K3R]?IIG60"3J?Y*DL4&S\7K$0$"=*
MP(+) B*."I1H0N&%4P_4\U..C;:_RA5XWNNGI"VCZ29GSN3NU!7.^[*-Q4+8
M48Y?> /SSD%9^"OPZ7?X]?,5V.I?963V1S_V^/CD((M9!R4B>Q3VV<CA2??J
M,Q^:;-=/VB2EL_^4=/%)_\MR$HE49B@J8)%E,<1Q6D!&--!)PC-%J=36HU6!
M^8XYQD8ZK9B@EA,804$EJ7WMF5-P=C.))Y "4T</?)PJSYQ!X(+*,Z=&'JSR
MS!G5MBO/G/OHI9G'E1_ME]?WIFM7?0>$J!01U?9%)N(<XIQ%T#32@J@0^F"C
M&,ZXDV>K8ZZQO?+;5T>5L("]@DK<?E=L73#;&1.>P!OPRLT1MPMR;D\B$B9[
M]G"Z-\J#/:GWZ8S6TX]X2H1ZOY!BNC(_33C"**9)#@4V5;@1R<V%O=2G%Q8A
MA566VK7SLIAK;/RQ(VJ5$&BDO# -:@M:6Y^'%\"">SP.DZ!J0=N,J'(VY:_@
MC^;_01+X+: *FB"U-=W;YD<=ZGTV/>K((SVSHUH_^"^O3:&5[P]2KGY=E,]/
M4Q.?O*ENDN8R4QSB+-)_F+;4+*$4XI0GBM"(1W'AE!9E.?'8:&:K8,E>Y^#+
MW2#6BV''12$@#DQ,F\NV*V/&-&*#2F[0"AZTK(@K:%Z3H&SG'C;[R1&1@[0G
MU^?[1BVV>8E;!8(G,4Y481I6)076M!5'&!:928+(9*RB1*HD$I.YO*<K*>[L
MJX,?G<SJ/2+U>W0P9;AWZOJQ?#9!=Z8_7%60_6_;M:UO]51Z:Y'".'7UG"::
M5YCN)<+\M-3[OS""[KZ*CKQV?&GL2*P_TH.706H%]%@EO%-[OY&-QR8:.+:Q
M0]?#Z,:N#_<M";S2*SO56TO]GFB&6BX__N"S9Z%YZM>R%']-9[-)C!"C.$LU
ME%EF.AUEL"!Y!GF:Q@SEVA[BV*73@-VT3G;0 *Q22?DO_XRRZ-_ >[I8O)J-
MN:8:UQK!5JC;L85_+ /3QT;@AIRO0"4S>+>6&K1BGPX>[5%&V 4GOQ6%K68>
MN+BP"QJ'=8:=GN['3=^:LB[K\MD)01%/,J*/8L1X>C05%09QQ?(TH7D6$8Q=
MSF/[$XSMW-7*]Z]N['* FQV/7()&8,9H10M27OR4WCX9X&".0=_U4QKNO]4G
M/^?V_BX7J\EOVCBYKWP$[^E2WND!/I2/)J8AB20JD!(PRK7]@#&+($L0ADDL
M\Z+@IDBX5<9$UR1C>X\W<IK<8@G^J,6TO-SIA+/[U?8%4N#7VQD?ZW?<!H".
M]UP_OO6.Z[_MO]^=XP_RCMMHV+[G5I^]O+0TJS.OMORHM! %BRE,5,(@9BR!
M!5489E01Q14IF')*I.R:;&SO_I;OM(JTO.C<T(FRZP7O9=@->,-;X3946>53
MF(2JD'PPWYL5.SZE>5?=XI//]&@R<LW_^WFZK K>OR]G^I_+YEZ3SD7=F76Q
M, 71JW3:S==>"96E^C](4Z1,]#N#C*D,2BI5)@F6++9JPGR!#&/CG"TM3(^N
M'46J"B=-(^(M75PZR/=;IVYZ&@C]P*RUI8 E[IK7+!C-VR(XM#8)OQ@#=3HY
MM2@7KXI;\Y/+\.SLA=)SZ.%:HURF^TZGE N'ZK$O_?WS[[>+4CSSU?)ZM9@^
MS6B3$51P1F2A(IC'N>EQQ0BDE%$H,TY807*EI%4!YLY91K>WU,(Y4-5)_"QV
M!!^H!.9\+2)H9;P"C93GLZ@<<'(@;1]X#43+/7%S(]US>'32ZLF'AR/.<_+O
M4./9#U\8+K65"K[\9L)]%OH<VWQ'XRS'!4DTC(3&$ MJLL>D@H*E3&(L9<2B
M7J%2'9..C1JW WFVQ;X":\%[QD9U(6]W[/>-9V!2W89R+66 U%076()$/77-
M^S813Q9(G(QVLGFVCV<@S=+O<CXM%_^85W&&4GPM5W+YX5E^D+P:/HXP:EZ(
MI$CS(BNDML-H5?"90AK'$G+,:4IR@A-L147N4X^-D-*?L_3_@%I\L)8?5 J
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M,-^\0CF0Q78II&Z6FC5"G<;9^5&&L\>L-=HQP>R?ZL' 7Y_-"#?J^GXAJPO
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MP&^"JR]A% L[M&-B4\KF:B<QKE8=-+J#C?)7P'P32F4Z#H & ; J08T!:$
M6RA<@1H'T (1PN4QU.*%\9\$E_Z-G#%#K<IIS\Y@$O0I-(1Q=*)+Q ?)VR81
MJ+D&C0E3LF#*G(H8Q(D0=9L?PE*41G&<B-RA I'+U&,[(>&?<=39 J55P71
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ML,]%#D]>UAY8<]TW^:2_9P]T*6_4^_+QL9Q_7YFC(D$9BDR*/>/*5'1.,FT
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MT!R? WNO+O55KB8HPPJQ2&A+!&L#6F019%0J2)7"),.<R#ARZ?G=/9W3ICA
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MECR)E2)QYK)O=$TV.N)O9.V5W=N)JAUO^\(J,/&N8?I+RPE:0:_JS-Z65JL
M<ZI?3J!*S=(+*::KJK"!/S*U@<LG&W;.-RB=V6B^ST=6S_2/"=YJA+57V[,N
M=/!</B__,=<T-IO^CQ3FBW!;+J=FPT7Q%_V)A^7-XK=R?B\7$U(0F<34- 97
MRD00)Y AP:' C!2FD'X1I:ZQQ/[$&QMIH1C4 NHE _=:@Y5Y%Y6IM/O266EW
MB*6TX[VW6Z# 3&E58'FC']@H6-> :56\ CNK7.OI-WC:/_Z^@ZX]2CAXL+9_
M=(\%>0>8Q5/.=IMC5MNU$Z5$0O*40B%,;=<\%9 JAJ&22214QD3.T$6IV+OS
MC8VRU_W3GBKQ+DRTW</6XIK-+V*!.?1T&NP:QML ,%Z8AMP?SC?/+K:%]?)L
MX>,@.2<![PWSMKF]QW4ZF[)[XK$>]'NG5[F\>Y +^B2?5U.^_#SGS>UQP3@G
MIOB%0%$.,641++*$0\H0XCF77!96P95GYAD;W5:2.K!#!X(6Y.H'E\"D6@D)
MMJ6\,K[3G_M$+73 Y4"B?F ;B#Q/P>>)*\]CT<F1'8\/QXWG==CA1(N/]_--
M5,7&;]0UYZ:*WW1^?UO.IORU_G.3+Q=3P@HE8I@FL8G(S$UQ,LV4<9HPPJ($
M)=RIC9/=M&-CRKIXOBE%6E?^[<ZXN 1O.\> ?Q0#\^H:P(W(VJ"JQ 5_-/\/
MDIOHAI3/H[GES(,>N=W0V#]*.S[=PT;[]Z:6:UWB]?4;7<E/6HD;OBHUXVF@
M<WU$3O(LYPFDG%"((TJAIB@!>1J3B' F);,*$;><;VQ,].UY/M_4'7\%"U,C
MV2PT:(0&1FH'*\4"<@OCSB^0@<FH%?9?02,N^#8 B@XVGU\T![+]+D;5S1:T
MQZC3)K089CC;T%ZG'1O1X3%?R8K-'K"\I:_&FSI)$Y6P#!=0X,RDBM,,4ID0
MF.5Y'+&(<R6=KJ;.SC@V7F[%,VV<C7R7IAGN VQG%WJ%+3 +GT@E7 -Y>P9(
M#WF#)\ )FRFX/^D;YP:>P.!\-N"I!WN6S=';4Y7^=:/66=?M)<PZRB]3'(D,
M81@QIFT_D3-(4BE@CB*F8H9ID3O%;MI,.C:B6<ML3E.;2@"MV+U+;5DM@!T+
M^88U,!%Y0-2]9(X#1%[+Y=C,.VRI' <D#LKDN#Q[:;W^KZ49EL[JMA>3F.09
MH9+ (E&:BV*5PX*G"J:<2)S&DN>Y5?W.<Q.-C7^VZ\S/&TD!K43M6YI_#UD[
MDO&!5V!BV8:J%;+IFA*B'O]Q',+4XM^;ZXWJ\!_7^'0-_A.?[Q_<]WG=E^*;
M%/+QR0Q_NYARN2DQ/*&QRHH$9\9YCDU,AX1,* YC_6-&TD(DQ"EPV'+>\?$&
M6VWU\;@"B[7D6Q7UW8/R;); EE&\ QN<8)AI>K;!=",TJ*2^VBJ%[C<LS@$H
MW_%N-E,/'LCF@,>Q"#67Q_L>L$K^YS>Y;D?QX7EA//A56,7W!ZJ_EA,J41%G
MD8"9* 3$!='&3893*%*$A<(R42)Q:Q-\?E*KMVGHQL&-N-6%%2\?'_7K5+?V
M>#?5/U5R6S:)=$#?]FSE!=&A3E8&M"UI02UN$T%U!6J)?1ZK;-'Q>Z@Z.^O
M1RI;% X/5-9/]O4D-^5,OVI5ZHJFVD 2/*-)"@D62--.2B%1+(>4$)'%0D2<
M.H48')EC;,90G:(Y*^?W4$_WV"NOZAB4ME[BBP *[A=>%R_>R.?3"WQ2>;]^
MW\-I!O;TGM3ST+=[^J-^$_BK_JYT^6!2CZO$3I-W;/[QVN3&[6<<7\_%'?TQ
MD1'-I>F>P--$GZ*0Y+!($@)S1'*:LRBB2+FT7/4IG!.Q#-2@55/WW/4DY77!
M[%CHK98A,'T%SKX/GW)_"?Y#Y-CWDF\42?67(&N;17_1'/W(O@[;_R)7#R8S
M_T4N5Y5+_J^Y-J0>ID_;KK <QTQQ!CEEI@4.RB#A2AM^"I-$987(W5QAUC./
MS?YKDDP>*\G!="WZ%2A;X7L[Q>R7PXZG@X <F(0;?&NAP><M?-=R!_&,.6/E
MDS#M)Q^4#9TQV:<Z]P%\=/#:A&23%$=YI 0D*8\A3E/]DQ0,9D@RR1!3:>;L
MP#\RS]@XJG(N&ZNCJ5'QB?+IK,K+NJ2'EVNDNP>PAG#";W?Q"A+'?@:'<(V\
MWBA2_8R^W:V\+HU%;T==UVKY5"X^E,]LI9YG;=B3-J7D],5$/OW'8KJ2-THM
M)Y@7&4)Q!(N""(@%$[#(J#ZI,EX4.),%2ZP:YO2<?VP,4@D&2RV9.9,N[J4
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M]7([S1J=H,6?+TXZ;+EG6PR."CQ;/^A1^O36%*$KIR;>_6XQT[]>+*O@M_$
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M//,Z__1P1UL7-=@[P;K\:9^DB"5?EV^GBY)/I1:XU 9E\]V,!>&2Y04LI*9
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M;.<=9U2.VO*XC^!1,^=T#<)O<ODRY?*P00A+\CS*!(81-KT;8Y5"35L2IK)
M$14\Y=R^-X_+S&,SP<Y6UVS$W_7M<*C_XK04W636*\ ]<]D6V]M+V/IT*G "
MV:'23E]@#U1NQQ[T0+5V?/#J++CC-.!P57=\]-PKO>,U@,=&8)*?WRWFQM^7
M<_[ZH5Q-G[0%N%!W^@\F#FD^D$4?YH^FMHR94_^)EJOW](D^R'(2LS26(E$P
MDKG0>X/(89$F%!8J5PFE-*:I?5&U*X49VW:QD=]$\I\;#8"Y;P&6\MD4NJXT
M!7*G3O5)K1 0M48.#'?M0EKL+ ,N3\^;C1$4M%2Y >VUVJ@#JH^]R:+_ A_V
MU\AH!1JU+#.S@BR2P\XTX&(-M%D-LVAN^UD@E#NWN&OG&&[7"X3&WD88:DR/
MO;&U\1Z:B+$DF!=Q DT)=8AX7$":*Z0]521)D2L6I5:G91?F&=N.UC81?7R=
M#D0M]I\P./6\M9R$R,=EZ<#*81L(@]E #._V]7)CZLM =))PQ^/#\>ME'?:H
MT^+C?H'O]W(Y?:&FJF25I; -K_^VU%Q<_>KCO"D&\V6Q^K9F_Y!\]7WQ6=.R
M7'Z1*T/FK6*($TH0C;-"018K E'$.*0HB:$42L84QSQE3KD'@>4;'PMOU*MK
MW=T 94ZQ7HR*;F'TT MI%VO_@<O3._EO5^:V7IG=^>(-J/2K_P"V&@*M(FAT
M-''\6DO0J-FN&1HN=M_3 H0,\(<6<=!3@)[P/3PJZ&N::]-L=W)]G)>K964Y
ME!_GW[3Y4$UDKCQ497+H3!OQ4V-3;&5O):1%J. $,Z@RA"&B!89,F-NT(N-)
MEN2)C)!?'FX0^<:V*7Q;/SW1Y:MQ=/E,;PM3->5U,KTYK-AM$.8#8D=3TQT"
MODF[89;;;NOX@8O8\];13OMM;2,MY4P/MZUZ]4VS1D&PT;"]WS29P3TEW?6S
M#OUD$8<1\0>E&0?%]WP><MAI/((M=WK$UV7=P=D4:J'/<KW:ZRM>R)QC6A#(
M29Q!E! $:2I2**C*N,AD(A*K>VIVTXV-WVN!'>('EP&U"+D$A:GO;)A*5G L
MK'^#^\L8.H1B@F(Y4$3F J:!8C/6R'2&:"Z/,ERDQEJCO8"-_5-!XC;EA/&(
M$"$1)#$C$$F<0()E##,D*4D+CJ-,N-2+/)S B40'J UY^[18&TO*%%ZJ!/QK
MNT?E77TF*P705K.>TQPV"7,149A_E8O95)CD2/"6SJI&*]\>I7.C@:,E\ J9
MC.DL]3#FT5N8HI>&PD=S_,A P=F6P6<_YV%H_1_]"G#Y_>1NEN5Q@57&(*?8
MU#'-4DB5+*",BSPJTCA10EJ;6!T3C<VXJD5U, RZ0+0PJP)!T_.;74L)O@<Q
MI;H0<S"B B$WD/ET%L% AI,%&ITF4]?SPQE+%EKLF4DVG_<@QMLDR[[)^72Q
M_%WO^7R]E.++8B7+]VOY3:M0C6\@;+ZTBI,TU_83E 4R95,(ABSG&<QI@G.4
M*!53>W?4;>ZQT6?R<Y;]%ZCE!UL%0*4!T"J K0[ *.' &HYK8D&]_2'=,QL[
M@NS#T8YH.]!V?Z@/Q.2AON)N_.X'6R?E.PXYW"[@I^O>QN YA)\S?<NY<28W
M%Z7;?4]X3FB:9 0JS!!$&4T@%2R">2J$S*1@E#M5U#H_U=AV@IVD8".J=R^M
M#H#MG.8PL/5,ZYZ(.3O3E\$(Z59WS#:H@WU9ZT-7V^()+]N2G&.FS^::AV8E
MO#GF$(3G&8]A@M,"(HH19+'VP:.84HTVEY0(![O2=MZQ,4GR,^G><"OYS6:+
MG2P<ZW6PLB7[0+=W.](:6#\;TAIA)_NQ#Z0'LQT#(NYJ0+KB=L%XM!YN2,/1
M5<<#H]'Y<=_&K7PI:2G?R_I_/\[U7K-<FZ)?I@W)=_JG+._H:U7C+HZ8MA,I
MA3(CIB!^44"6,@;33)N.,F:RP$X]0QSF'MM&T/3761D1P7,MHVM35GO@[2S+
MGN#LF?DW4H,W&[E_,CE%#<"5T.#N L >?5B=H0K;AM5^^H&[L#KC<MR$U7T(
M3U]7B"KEA\[NZ%0/WQ1P:?;Q/(D)3YF$))6:K+# ^E\JAXQ$"B4*H8Q;6:Q6
MLXV-GG;" B,M_#@'C;R.WFXGQ)8.;RC@^O9Y#S";;C$+:/\X@1+4]^V<<%CW
MUT;W(P_8ZB$_(KF7+W*^EK]J2<VE3N-6__=T]?AN7:XT8RUWZ< RQ8DH4 (I
M%DP;0#2#!5("(A[E^E<9DFGDPBFV$X^-7AJY';-,K&&VXY4^P.N98AJ1@7DG
MP$9H\"\M-=B(#?[H)37:%:R0U&,]]Z LY(K((2$Y/^]Y@66EQ[B7S_HK^*BM
M*7$[%_=R-=7^X/OUTL0#JV:J5<;S1)*\R/-402:%A*A(M7^&40ISDN)<Y5QI
M^\?I<HK]W&-CJ+]O;I64CU2/:VJ;;+2HKIXL:ST<;Y<XK(4=A_6$<,\T5DD-
M[@\@;00'M>2@%OVFOO81\(Z'.V)![V\X3#_LW0QW7([N77@,X49JU2'&\G7R
M^[>)1$B@*#;Y?(*:V]4(%@1A*%!,(\;S" LKKMH-.38*^OWG;^<SJL[!TDT;
M?LKVS :_?_GX_<-[\.W[[?</WZY_T8]UW+V_Y>8%+B7_^6'Q\M?FP^;]Q9L?
MS*N+6Z]N:\!!WLAC!38OVHF_7%FP_/VTY+.%*2G\<26?FD3RID1VEJ&XX'D&
M163:S@O3R%2_9S"+$)41R[AD5D707"8=VSO8NGC8*KWLV??9"G6[?3\TECV_
MXKXP^E<BM\"EEP+D7?/^F+KC%DB<+3=N\ZQG[/6%3F<FAOOK8OF-SN0W<T95
M75@QG5T_TU7STZU:&5]H;KIF[2J>3_*8Z'T^1C I"@:1PJ:O2R:@H%E&8IE0
MX1B<O4J<L;%6)250YO+*JQ'4,69[W=)8!G4' [QG:C/B@IWT-V"K&52+)2RU
M;C>@T>=5_W56D5CC\GS35O%,;O\,WNN_W !:+5\<57T"R_;M]X#QXR#X!PTP
M7R?1L!'H(.@=A:C#C.J1R*4GE-.'^;OU<FG*$>XN9FTB4V5S8I-F@A<\SF#*
MA8(HH0J2)%,PQ5F2Q5$1B<2^:+KMK&.CUT9NP!O!VY5'^$9TA^0B:_2[J;4W
M3/LV#ALX-S*W"X5LI?9)VK+&U2%EJP]\!TK8"H2S6ZJ6*UZ=B5K6@PV7IN6J
MWUZ2EO/#OA?DV6I7_^3C7'.D+%?WVM:H"J&(.ZF_8?KK]R G<2Q(P9(4YEG$
MM<_/(T@SBF&A""(TEC'A3N6I[*<>&\EO9 7+RB8K*W'!\U9>UPORUDM@9S_W
M ^P0MO).:G-IM 'YO@*Y%AW<70;9X]:]*UYA[^-;SS[P37U75([O\#N/X'/1
M(,J23Q_??KVWN >5;O.WDEQ@2:&*4TUE5/^GB%@.!5<Y3VE.6.1PX\!=@+$1
M6O1SEOP7J)2POO&7NJ3(>ZR1A4';,_(],YX7Z%X7%#S0=[FIT.\J#&0!AWT%
M'.\L^"/8?7G!8]P!;S'X:[U_G>&*<=SV&R&GDP_SU73U>BN$_O*5S?]\FLYE
M/$F5PG$L)8PC5D"4QSDD1&)M)!>9*>I=9,(J@:]SEK'M'+6@H!'Q9O,/8(0%
M7^>6IG WL-T[03"X>J9[;Z2LN<0*B8X#;_U\;;;J?QQ:J]UC#T(:5NIMF,'N
MPS[F9IQ$9XCF*U\M:IK9WO>C0K&49I!*1"'*F( TSCAD+%*D*)1VHJW:>3O/
M/#::B'].HLX+@8T&SK=;75;#QJ+L">.>N<4)7B\3TNE;[V []H3W0$9CF*^U
MH['H 5FWE>@RX(#FH8>>^W:ASP >.\*7M1GAJ[I;+AZ6]*F<%!$F*N$8QD61
M0813DX! *"P203*6R#Q)[*,+AZ./C=EK^:HVCHV$#K1R!)T%15\#2,\TO,/B
M+@ 6#C1Z#28#4:4#-FY\>$[W3LX[>F@X7CLG[QYWG?V0WRG/VW6I[5YM!)L&
MZW4M^Z;7NFQ2"PG7_T>5A&F18\U9400+2CCDK$"8JT2F$78YW+DXX]AX;",P
M:$E\ S8R>V9U7L;=[D0G*)H]D^"U0#H?WUB#$_+4YO*D@Q[66&-P>$9C_Z!G
M-OET/EW)3],7<T=_I;\GIH%I7=+Y[>MG^H_%\IWIW7/[Y[2<Y&E"I,QS2 OC
M+><9AI1J,XIH$BI4K%)%G9KB.<P]-C:J18>5[& G?%/#';!74,D/*@7 'T8%
MUX1SAX6Q(ZF>X.Z9KH(B[9Z3[HY9T-1TA^F'S5!WQ^4H4=UC"#>.*Y>KR3?Y
M8(SGWZ2QTYX?IYS.FIT=991'-)50J$A 5" )"<$8*H9Y$9FB=M3*HNJ<96R\
MU9;0T6;J1K.;@H)AU#/9N,%CS296ZG?PAGZ^Q1GZIT.^Z)Y@$&:PTG'# 78?
M]K-HOIH^-5^TL%5FWJK53J4)?Q*"J&21"?\D&40L3R#-.=&NE(PYHQE.E%,A
MCTL3CHT#*GG_\I]Q'OTR6\P?H)[SJ?YQP6;3ARK.X'CMY"+F=A9*2"1[9HI*
M5+"3%;3;]H0O&62+3$CCX^*<@UH<M@@<FAG6SUW!-N\63\]+^2CG9=6MT)0Z
M^[0HRW>T?/QUMOC7WZ1XD+]I9C._O)?[S5#K"R'TSPE-8ZXBK&":H @BA10L
MLBR!28ZI+**B(#&>S.6#R<S[[LA.(02T>OE(_?(=B=G?BW@H;FE:5L_E"DSK
M(H)O9EJGGVZJ7RV4*=KH06U!%MB! P=;KR')<D^I38W'-Y_JY3&J :,;J)2[
M 4:][5\/==S<L_O>L9I^'!L2^>!D'$2XX5D[)*8GZ3WH!%>FG%6ITU^7=\O%
MBV8@.9%4\01)S>-1$4.4%=K-Q#B!N20D981C_7>OK+.#B<9F91ZF4U7B:DC!
M1F#/S+-#?+M9-21J/9.D/V#^"6AGT B5@W8X_(])0SNCY-E,M'.?#W>T9V*V
M*:(*1Q+!B$H,49H4L,A9 =,T)RCC4:9)X]H#O1$&SD^=/GG%Q\_AZG]@-ZZX
MMP]008[F>@IEGYOJAQ_#=82H+WW<CQ$V52+?&9G-75$S[OVT_.>FC1\K4I)1
M!5EA6B"C7#,#%MIB8"B/.<TYHE;W]"WG&QM#;(NA[LD+C,!N#'$)9SNF"(A>
MSXS1 5P/$2E+7$)2R*4I!Z422_T/*<7V,=^&'B^R7)FP>OFN\7*D>/NZN9*^
MIK--N1I3K>:[J5>RJ[R<YC%"#"$81P6%".,4%BJ.H1121(*AF&=.*4;7"#,V
M4OJV?GJBR]>J3?M>C2!3ZP4<U!$RA](M+;<E@EQ[A%RQEG;<-M0*]4Q\+37
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M%UZRTV4OEF3Y2*C*?*:PQ\;SD 0EDB8<*E-:#V5%!HM8QI#'.,$H2HJ,.>4
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MT;$+2IW'R%8##7>D[*+7WO&RTX,^R=!TJ4>DL[]).EL]?ISSYF0@H0E215K
MB&@S%E&]D[)<("CS3,1)E*,4(?LLZ-.3C(V1-V*"6LX;<\'B9Y>DW3-86A!N
M (3Z/OK=!\=@XY78? 8CEXSFZ[$:*I79!S/'#.9N,+I3E\\\.V#.<K?T^\G*
M%S[KY]_?<F[JXVBK^)MI_J/G*']_%G0ES36(*&F^G2CC&8H2 FEFRF=A<[<]
M$@3R(M=^/A)<2*OR?DZSCHT>=T*#K=2@%AL8N6&4N+GM=MC;N>G!$>V93BW
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M@/R?]?2%SJJC@3?:(*E3B7[R,.2N6TX':V^P11K")*R5 9NTI#J1JZT/6"W
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MV&O3;D %3>JTFWG8I$XG-(Z2.MV>]B.GO]/EU QS3U>R.BHC>4)%QC#,DEA
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M+.(81Y"IM(!(:@NNH%Q;<$PE(DJ42+C3.<69><9&\+68X*F2$TRW@KJY7>=
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M4=4/7)V>66Y_83XV"[-K?]V4O[\!6SU!H^A1^?8S52U"MI3M917"=J -*^+
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M%J0\.<O8J+8)PV^E!'_4<CK&*$\CZG)6<05.PYQ4.$#D>5)Q!H+PYQ2'$_V
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M!EQA*A@!#<\,9U1HD5"JDM"IN8ZEW;GQ[=%!Q"L/T3Y7(*<,X<#"OHD'3K)
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M;6SLO6EWFT>2)OJ]?X5OS=<;Y=R7/MT]1XM=K7-M2R/)53/S!2=RHS"& #4
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M';MFK_*PS+BA.V1?2PH14+M(^$[UPB<X"$4FSK55Q@X1HUY?<S<8=)P-/5B
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MYMU?,Y<4)QH9ZR51Q+A](Q.B5J 9$P*%*=+<4]1U/"SNI:8'7WD0C!POZPX
MLZ5_@BXF*8,'F1VY^-([\!$U1)V--E%Y8>YY"S]4%#5.,[YF]V1[2;.#@.FG
M*8;I;.-CD=.^>6?W83$CH:^J [_^<B4:SZ,/TEK0GI';Y6RL7:X#)&L]_2-)
M[>^I\3D>);L2.&X@U?R^OHF>.K!!U_BZG<0(RB?:/AHPVMJ^,!@@EAQ$GA0F
MS;B53<+UATD:]TJU#00>QMDQ^N@ 69>W+F_P2XTE+Q-:UJIL9?1@C"V@K"Z
M6)MM&XO*H?2:M2D2N9><;A!UE+(?N.\Z0O(CXJ=6'U86EN<YG=4RS_G%C)I%
M]?F6% 6N\VK";.",-AFDPI#D0[LM8$Y0BN=2)BVXN/64YFY5XTXKC7NN#8R0
MX67;AZ&I_-P5U<3HJ%%:!4D6$E%* H)+&9C)B0F9D\U-8J\'*1HW1]C.W P@
M_PZ ]#*'J[( D= 9A04D_0V*(8-0>  1I+(B,\=UDVS.-1K&3?LU LNA,NX
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M#V4B^\1&!P[=%<L7V_XYQ39ENIX@!2E"&P:R#IY45?#>9@U%QV19BB&F)C'
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MV7E#<C$D)A4#Z5LP;LV^:+BQPCAC;]J#X7 QCHV%*^-66\@21Q<L>(Q*!^M
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M$E=T,N9H=O,X'UEDMYJLIY(('4J:7:'B?W])>38]N\SXB^B)D=J02=91W2J
M4\;4EN8^.?J!L[MYE@^OL1LFGF0"]'!9=@6)S3\N_2!M ]J<(<8Z>=:0R0NU
M<W,NTJ#6*,3M(86[ .+:"KO!X:ED.0>18P</-B]8N"P4B9%$H,FN82+B*5P&
M7X($'D(J,;$HY"XO1 [H)'N-BMV \@32G<?+^&" ?,[+L!C"7KQ=?,'9^LOE
M@RL2S'6P)Y\MCR9 X$R2Y;.\9O$9:*,2$TAGI=ZMV/O1978#Q%/)=@XGT9'?
M#ET-?_I+7IPM\=.':<39YIV,\\F2]1.@0ZE/C(VKY00<&!;I):KDLMW!C.ST
M=NA!*L9]C=WDM=DP$A\;-MMWX==9N-A2$HWVPN;:=(S,8\W8.MICI/""1EK!
M==QE.M%NL'F(BO'>&@VDW<70HAX1+YLF8<LODU_?39A0R=C:3U@%VC.,I(&E
M!(C*6A.M4?YV44\E;G6)CE6.?SY;?/[^XA,K0.SE/RH^[#5\?%UU1# ,H[K%
M47(<V5+\<+Y<?+HL,F&&,9N$!6,8!5E1$-T6#>@L>#$2K;A/_X<9A^L+C_?:
M;%@('"70+J+65W/ZM#EN.P%?,!%1!U$HVB(PUTY=M6.E#W2<BN(BHJ!@?(^\
M]STKC/>:;%CU#R?&#H+6!YRKGZ;S_(J.T-4DV"0563D0DA%3B5PM;X('SG21
MEKB2K$F?V6\1-FY_S\%]TB;ZZ !?W^@T\L,?%^.^GZU6F?X_O<<_)BE;E[@Q
MD'0*H+R.X&6HO0$<9A;1JS:MC0^@M<L^' >"9;\6CT=KKA]PKB9)YQ!$]=]8
M0E"&S@+,+H!QTG"FK*,XH2'B^@RP!X71?C+NNUO9Y=]5DC=[M@W0K^S;'SY@
MQ[(].3EQSS++@Q)9)*C!%%F39 $-<M"I<*XSD^I)MSO^V@'PA_EZNO[RMVG*
M>_8"G"0ELS**(@_+&- F2H!"2/#9)<=$]A20M!#1 +0_C0YH^V#PX1:/IU'P
MR#F&FQQMLFW&)BVTJ\=%O<Z5)H/GO%!@[+ HK8K-NXQYV2G3<'?Y<1%V<NTO
M!E/%R$#Z!3^2U&[P<!&N(V+,Q0H0SA 3#!TQ81&X=S'SK*.0N\R>V E/#U(Q
M7B;S6+4NAI;QV,FL9T3V=+4X7\8<\O(LSU\LEI\N2TF,2U&7#%;9S=XI@"IK
M",Z6:+RU9L=&.(\L,AX4!M+?HH$PQP;%"UQ27(JS_\PX6W]X-8^7;5Q"5 ZE
M@B@U'>7( @1$ 8ZI[#R**,IN-^P/+#!>>KL!&(80XMA ^#G^EE>KQ74<NQ2(
M2BZ@-NBNY-M:DIQ QQ2X#:5P^\U([8'/'B^]W4#]1XJN@]S.G4&_S[\\S_/X
MX2,N?]O>!*L8I&0:>/89E"H*T"8!##-G&9W/MDE'[&\1-FXN:"ROM8G:NH3A
M)3<76U39Q$RB;>4U$Z"<]N#K!:+67#(6,-LVTW"_1=BXP=.P,/@FQH[020<8
M>X>SJU3>+_FR.-*(E%04='B97)_@Q )!<P-)"N-,B=:V&;%Z+S6]H>D8A=_.
M\APM_0X@=,]^>T__Z3;$U&APX_'+S8UVBN M_:$5RRJ+4(<!G.B@O*1IW,O?
M#L_(@Y35(^XJ(Q>;,C))KF50M!6)'\64@U!4G461B$LO(XGI)+C[2E-O9NQ
MO7\+3P<JH0<\76R\.RQ=OAC(7 531!V4)$$5KNN3$@;6$KU6VBQCDXO>;]#5
M&:X.U?]M7 VHC ZP=<?8WS#U7V_+(PG,12EJJYU0RW\*N/J*B9-;P8-%VH]-
M[-:.](W3O[N7L[.%$CO YITM]B8OZS?P+'.2%V,Y%@1G+,5*0BL(M)W!>9:D
MT38SWF1$YV-$C6OQFJ#@6Z?JH2KINQCF64K3;0'LJWE9+#]N/G: .IA'/W?
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MO:KH8=Z$T:D$[\#6<54J6>*M_N%RHF@_A\)2D\OR?8@<%XK-D'+["7DKM74
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M!8C&2'+]8ZQ5=1J*-=$QI[,I;=ZF[D)=5_%5'V@=7JL=0+6V^%\LZ9RXEYF
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M:YTH);69C;<;F1/WMF^&LB>C$]HI[^3,V]BS,?==JJU9//J,S-W ; (&S[,
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MQ_<U#<UK/,3 %,GJF(N<W6C=+#KL:K"3WK9V-=A%B%-K_\&#?%9D#LQH")(
MKZS4$!U]BY8A*^3EHAQMUW?8U6!O[>\MQ"ZN@A^=?'>76S&&K!$E! SDG?K@
M@.QB@F*EU#YS.OV&Y (.3RO]NM.CFV;%Q2,Z"2-+OSL<??\YG(<ON'[S[T!*
MR?\(9Y<XTTZ03RWJHVL1:J-2BG:BIN!'HT",LOC0I*+N==(ZRSOM"8(7L76P
M1J:./Q^Q\]NRJN?]XL]P-L_UY<>[Y>J/L+ZX9O.*ORBYI"TH("%7H%PBBVZ9
M :UX,CDGQ_6P?,0>BW<6T!R&J:-H8&J$_<=E_K*IJ5]^#V<7WVO9_#L2[.V
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MR:NRMEQL&N_6-)1$Z8K055:)@Q*(X,5FY+GCC(> W#296O,B5=/BJAT8MB6
M#]9,!S![Q,-U6C(95#QH#HS"+5!)"G"*"2@N"EX]&/* VQGN1]1TD@H^7-O+
ML47? 7[N[;K/J[!8GUTI)O_WY7K3)_RF%ZLUDOQ>#=HZ=]U+0"0#420;D2R_
MB4T\@6'D]7 @'H2#[>?B6$KI"VJ_X\7?%RL,9S46>K_X$Z_X^AL)KMKXFYO=
MZ!4)2X,(V=1F<0X<JZW$E(O.>)UBFR&3NQ(Z;6*O*?S&5U1W0+SAI7;;^9GB
ML"^+C0NR^G\NB>OR?3/(;OWUW=GRW_\;,P5J-WTLM2=?(T0PQKI:T1 @YE1
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M[N6>O(ZL?\/EJ+^F/?\O4$L#!!0    ( (298U'@J ^FG@4  %H6   2
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M.3,P+GAS9%!+ 0(4 Q0    ( (298U&]%UY[>B@  )F\ 0 5
M  "  4M^ P!G:6QD+3(P,C P.3,P7V-A;"YX;6Q02P$"% ,4    " "$F6-1
MXGR^.K-N   _HP0 %0              @ 'XI@, 9VEL9"TR,#(P,#DS,%]D
M968N>&UL4$L! A0#%     @ A)EC47Z'>>5V'0$ (L$+ !4
M ( !WA4$ &=I;&0M,C R,# Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( (298U'*
MYYQ:1*$  !I*!P 5              "  8<S!0!G:6QD+3(P,C P.3,P7W!R
M92YX;6Q02P$"% ,4    " "$F6-1FUWQUKP'  "['P  $P
M@ '^U 4 9VEL9'$S,C R,&5X,S$Q+FAT;5!+ 0(4 Q0    ( (298U$(YNO$
MK@<   $>   3              "  >O<!0!G:6QD<3,R,#(P97@S,3(N:'1M
M4$L! A0#%     @ A)EC4>"H#Z:>!0  6A8  !(              ( !RN0%
I &=I;&1Q,S(P,C!E>#,R+FAT;5!+!08     "0 ) $P"  "8Z@4    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
